data_2kb0_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2kb0 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 99.989999999999995 109.493 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -135.6 160.22 39.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.843 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.8 mt -121.34 119.46 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.074 -0.713 . . . . 99.989999999999995 109.074 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -95.76 129.46 42.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.952 . . . . 99.989999999999995 110.059 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.411 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 46.1 t -138.32 136.75 36.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 99.989999999999995 109.143 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.08 141.11 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 99.989999999999995 109.645 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.65 131.19 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.744 -0.836 . . . . 99.989999999999995 108.744 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.85 143.98 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 99.989999999999995 109.486 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 168.17 25.65 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.278 -1.529 . . . . 99.989999999999995 109.278 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' ALA . 24.0 t70 -83.12 108.17 16.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.251 . . . . 99.989999999999995 108.983 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 53.94 -87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.069 -1.612 . . . . 99.989999999999995 109.069 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 53.47 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.178 -1.19 . . . . 99.989999999999995 109.364 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.63 -35.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 99.989999999999995 109.988 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.57 21.55 32.04 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.961 -1.256 . . . . 99.989999999999995 109.961 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -62.11 -40.6 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.283 . . . . 99.989999999999995 109.814 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.8 m -68.37 -45.65 72.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 109.925 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.566 ' SG ' ' OG ' ' A' ' 30' ' ' SER . 34.4 m -61.01 -29.65 69.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.913 . . . . 99.989999999999995 109.851 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -67.06 -42.15 85.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 109.476 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.44 -46.09 50.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 99.989999999999995 110.283 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.53 -40.32 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 99.989999999999995 110.28 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -57.92 -31.98 67.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.938 -1.101 . . . . 99.989999999999995 109.839 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -72.69 -38.02 67.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 99.989999999999995 109.58 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.557 ' HG1' ' HG1' ' A' ' 25' ' ' THR . 66.3 p -65.96 -30.96 71.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.459 -0.775 . . . . 99.989999999999995 111.292 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -166.44 -1.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.553 -1.342 . . . . 99.989999999999995 111.427 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.613 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.2 t30 92.21 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.516 -0.92 . . . . 99.989999999999995 108.516 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -179.6 58.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 99.989999999999995 109.995 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.29 -42.58 86.12 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.787 -1.196 . . . . 99.989999999999995 109.836 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.2 Cg_exo -58.11 -33.08 97.01 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.354 2.036 . . . . 99.989999999999995 112.364 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.566 ' OG ' ' SG ' ' A' ' 18' ' ' CYS . 61.4 p 35.65 37.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.65 . . . . 99.989999999999995 109.738 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 30' ' ' SER . 78.5 mm-40 -38.22 -37.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.53 -0.731 . . . . 99.989999999999995 110.531 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -128.8 124.18 34.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.034 -1.041 . . . . 99.989999999999995 109.204 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.69 147.78 34.21 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 99.989999999999995 109.643 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.54 153.21 60.33 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 99.989999999999995 112.153 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.5 -104.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 99.989999999999995 109.051 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.4 m -61.38 142.07 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 108.858 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.09 125.43 46.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 99.989999999999995 109.864 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -108.84 164.39 12.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 99.989999999999995 109.308 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -92.35 153.11 19.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.009 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -127.78 139.15 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 99.989999999999995 109.601 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.52 132.2 54.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.053 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.28 153.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 99.989999999999995 109.605 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -122.31 150.15 42.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 99.989999999999995 109.064 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.26 139.77 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 99.989999999999995 110.01 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 65.0 mtt -84.57 131.81 34.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.669 -0.863 . . . . 99.989999999999995 108.669 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 48' ' ' GLY . 74.6 mt -135.11 125.41 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 99.989999999999995 109.521 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 41.97 18.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.088 -1.205 . . . . 99.989999999999995 110.088 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 92.36 15.41 53.45 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.102 -1.234 . . . . 99.989999999999995 110.215 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.0 mm-40 -122.81 82.7 49.34 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.318 -1.107 . . . . 99.989999999999995 109.255 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.17 126.19 20.24 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.906 2.404 . . . . 99.989999999999995 113.23 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 95.9 m-85 -119.17 138.04 53.21 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.836 -0.801 . . . . 99.989999999999995 108.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 p -80.22 143.49 33.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 99.989999999999995 109.431 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -124.82 124.48 42.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 99.989999999999995 109.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.11 124.31 8.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.312 -1.515 . . . . 99.989999999999995 109.312 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.13 127.03 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.161 . . . . 99.989999999999995 109.194 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -114.44 133.96 55.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.375 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -138.79 140.52 38.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 99.989999999999995 109.359 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.1 m -70.85 137.64 49.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 99.989999999999995 109.455 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 99.989999999999995 109.489 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.222 -0.659 . . . . 99.989999999999995 109.222 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.4 m -79.5 131.86 36.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.458 -0.776 . . . . 99.989999999999995 110.156 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -102.87 -10.55 18.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 99.989999999999995 108.953 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.42 130.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 99.989999999999995 109.248 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -111.48 129.04 56.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 109.776 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.411 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 62.1 mt -113.16 145.19 41.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.516 -0.74 . . . . 99.989999999999995 109.791 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.76 147.32 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 99.989999999999995 109.052 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 22.7 t -138.74 130.52 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.651 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.56 165.76 26.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.453 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 m -105.84 145.13 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 99.989999999999995 109.113 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.76 8.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 99.989999999999995 109.679 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -88.99 -23.46 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.133 -0.979 . . . . 99.989999999999995 109.807 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.6 146.37 33.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.911 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.58 -50.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.677 2.251 . . . . 99.989999999999995 112.259 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -55.05 -35.68 64.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.484 -0.76 . . . . 99.989999999999995 109.79 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.1 p -66.71 -24.26 66.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 99.989999999999995 109.058 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -71.41 -50.91 27.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.817 . . . . 99.989999999999995 109.461 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.85 -36.28 81.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 109.638 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -51.53 -34.06 34.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 99.989999999999995 109.783 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.9 -36.4 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 110.188 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -91.61 -41.55 10.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.752 -1.217 . . . . 99.989999999999995 110.592 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.53 -37.52 87.82 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.086 -1.009 . . . . 99.989999999999995 112.037 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -113.17 -51.38 2.82 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.901 -1.124 . . . . 99.989999999999995 112.638 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.2 -39.95 82.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.97 -1.081 . . . . 99.989999999999995 113.249 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -58.27 -52.11 76.93 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.027 -1.67 . . . . 99.989999999999995 110.75 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.16 -40.6 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.677 1.585 . . . . 99.989999999999995 112.223 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.47 -31.05 67.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.405 -0.809 . . . . 99.989999999999995 110.499 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.5 tp -59.26 -24.07 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.883 -1.136 . . . . 99.989999999999995 110.006 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.5 p -58.42 -38.59 77.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 99.989999999999995 109.436 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -58.94 -29.99 67.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 99.989999999999995 109.4 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -82.94 -7.77 59.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.895 . . . . 99.989999999999995 109.811 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.11 84.9 0.19 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 109.356 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.56 89.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.65 2.233 . . . . 99.989999999999995 112.458 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -133.52 11.32 4.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 99.989999999999995 109.316 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.561 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -136.68 157.74 74.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 99.989999999999995 109.524 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -59.95 141.15 95.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.683 2.255 . . . . 99.989999999999995 112.268 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 108' ' ' THR . 97.3 m-85 -121.98 145.83 47.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.742 . . . . 99.989999999999995 109.796 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.8 131.72 54.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.607 -0.683 . . . . 99.989999999999995 109.469 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.2 tp -103.79 118.88 37.74 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.518 -0.919 . . . . 99.989999999999995 108.518 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.545 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 59.7 t -112.44 137.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 99.989999999999995 110.728 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.14 128.5 9.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.886 -2.085 . . . . 99.989999999999995 107.886 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 32.7 p -125.51 161.75 26.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.258 -1.143 . . . . 99.989999999999995 110.852 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 115' ' ' THR . 4.3 tt0 83.71 19.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.027 -0.533 . . . . 99.989999999999995 110.282 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 119' ' ' LEU . 8.2 tt -61.3 -165.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.666 -1.235 . . . . 99.989999999999995 107.666 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 60.65 -60.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 99.989999999999995 110.006 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.2 mp -60.02 -35.05 74.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.787 -1.196 . . . . 99.989999999999995 108.995 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 119' ' ' LEU . 83.3 mtm180 31.65 45.99 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.198 0.523 . . . . 99.989999999999995 110.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 7.3 t0 70.26 75.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 99.989999999999995 109.166 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -42.83 160.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 99.989999999999995 109.383 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -52.18 -55.22 4.06 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.699 2.266 . . . . 99.989999999999995 111.915 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.0 p -54.76 -28.65 50.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.819 -1.175 . . . . 99.989999999999995 109.586 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.431 ' CG2' ' OD1' ' A' ' 121' ' ' ASP . 28.5 m -78.21 -50.74 11.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.994 -1.066 . . . . 99.989999999999995 110.578 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.1 tt -55.46 -27.6 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.033 -1.042 . . . . 99.989999999999995 109.631 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.99 -45.62 80.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.221 -1.029 . . . . 99.989999999999995 108.221 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -60.69 -36.84 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.582 -0.699 . . . . 99.989999999999995 109.384 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 71.3 mt -75.15 -37.76 61.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 99.989999999999995 109.061 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.66 -39.05 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.497 -0.752 . . . . 99.989999999999995 109.504 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -60.4 -40.98 92.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.168 -0.957 . . . . 99.989999999999995 109.366 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -91.7 3.11 55.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 99.989999999999995 109.917 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.1 mttp 54.49 40.62 31.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 109.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -92.07 -52.73 4.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.15 -0.969 . . . . 99.989999999999995 109.743 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 mttt 65.46 139.45 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 99.989999999999995 109.128 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.9 154.41 74.68 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.536 2.157 . . . . 99.989999999999995 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.6 mm -93.56 140.31 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 99.989999999999995 109.343 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.86 155.43 73.03 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 109.535 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.62 -31.92 95.13 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.458 2.105 . . . . 99.989999999999995 111.793 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.47 -37.76 84.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 99.989999999999995 109.336 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.3 m -66.09 -33.59 76.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.277 -0.89 . . . . 99.989999999999995 108.987 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.59 -36.97 57.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 99.989999999999995 110.071 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -35.01 71.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 99.989999999999995 110.622 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.42 -36.25 83.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.931 -1.106 . . . . 99.989999999999995 109.79 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.25 -39.2 93.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 99.989999999999995 110.112 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.74 -45.47 74.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 99.989999999999995 109.556 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.65 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -75.79 9.61 2.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 109.514 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -71.59 -36.4 70.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.989 -1.069 . . . . 99.989999999999995 109.228 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 51.0 mt -112.43 -87.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.594 -0.691 . . . . 99.989999999999995 109.81 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -152.59 52.67 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 99.989999999999995 109.694 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.45 131.36 46.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.069 -1.019 . . . . 99.989999999999995 109.312 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.23 -51.74 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 99.989999999999995 109.927 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -160.1 155.61 25.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 99.989999999999995 110.262 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -121.02 144.42 48.54 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.722 -0.844 . . . . 99.989999999999995 108.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -142.81 154.22 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 99.989999999999995 110.285 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.514 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.8 mt-10 -120.04 142.73 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.412 -0.959 . . . . 99.989999999999995 108.412 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.545 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.07 149.84 42.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 99.989999999999995 110.697 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 161' ' ' THR . 12.8 t -112.01 107.59 16.62 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.005 -0.739 . . . . 99.989999999999995 109.005 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.36 64.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.442 -0.577 . . . . 99.989999999999995 109.442 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.5 tp -53.31 -32.07 47.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.533 -0.914 . . . . 99.989999999999995 108.533 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 163' ' ' LYS . 14.3 p -126.09 165.26 19.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.381 -0.97 . . . . 99.989999999999995 108.381 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -69.85 13.14 0.16 Allowed 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.642 -0.661 . . . . 99.989999999999995 109.396 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 161' ' ' THR . 58.5 tttm -85.48 -4.76 59.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 99.989999999999995 109.626 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.43 -50.43 2.97 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.615 -1.279 . . . . 99.989999999999995 110.255 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.668 ' CD2' ' H ' ' A' ' 165' ' ' LEU . 1.8 mm? -64.46 -39.37 93.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.242 . . . . 99.989999999999995 109.972 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -58.51 -32.07 68.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 99.989999999999995 110.361 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 53.1 t30 -73.8 -49.64 24.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 99.989999999999995 109.786 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.72 -8.34 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.803 . . . . 99.989999999999995 111.041 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -72.43 -50.33 27.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 99.989999999999995 109.817 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.89 -42.42 99.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 99.989999999999995 110.086 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -66.29 -36.31 82.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 109.731 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.03 -35.54 71.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 99.989999999999995 109.67 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.51 -40.29 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 99.989999999999995 109.618 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.2 tp -52.07 -45.88 64.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 99.989999999999995 109.689 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.64 75.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.982 . . . . 99.989999999999995 109.421 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.01 -43.58 63.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 109.667 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.1 mt -62.54 -35.73 80.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.998 . . . . 99.989999999999995 109.337 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 99.989999999999995 109.461 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.175 -0.676 . . . . 99.989999999999995 109.175 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -132.93 162.47 31.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 109.532 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.1 mm -115.49 119.9 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 99.989999999999995 109.204 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -96.93 130.59 44.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.948 . . . . 99.989999999999995 109.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.47 137.95 20.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 99.989999999999995 109.708 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.97 138.43 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 99.989999999999995 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.92 142.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.753 . . . . 99.989999999999995 109.481 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.96 143.39 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.893 . . . . 99.989999999999995 109.155 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.65 165.36 26.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.718 -1.353 . . . . 99.989999999999995 109.718 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -85.1 117.82 24.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 99.989999999999995 109.296 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.21 -105.44 1.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.431 -1.468 . . . . 99.989999999999995 109.431 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.32 -67.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 99.989999999999995 109.512 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.506 ' CG1' ' H ' ' A' ' 15' ' ' GLY . 28.4 t 54.43 -119.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 99.989999999999995 109.586 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.506 ' H ' ' CG1' ' A' ' 14' ' ' VAL . . . -95.42 25.88 22.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.641 -1.384 . . . . 99.989999999999995 109.641 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -56.92 -34.39 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 99.989999999999995 109.274 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.524 ' HG1' ' N ' ' A' ' 18' ' ' CYS . 47.4 p -66.58 -37.61 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 99.989999999999995 108.965 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.524 ' N ' ' HG1' ' A' ' 17' ' ' THR . 10.5 m -67.22 -30.82 70.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.432 -0.792 . . . . 99.989999999999995 109.869 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.6 tp -69.91 -44.78 68.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 99.989999999999995 110.287 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.3 -44.33 46.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 99.989999999999995 110.801 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.7 -32.49 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 99.989999999999995 110.066 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.6 p -66.7 -28.94 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.089 -1.007 . . . . 99.989999999999995 109.739 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 80.5 t80 -76.58 -43.43 38.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 99.989999999999995 110.393 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 p -75.35 -45.09 41.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 111.287 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.7 p -85.12 -23.09 28.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.843 -1.161 . . . . 99.989999999999995 110.243 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 23' ' ' TYR . 57.1 m-20 57.58 35.36 25.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 99.989999999999995 109.358 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -138.22 81.51 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 99.989999999999995 110.174 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.58 -41.79 90.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.111 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 24.0 Cg_exo -61.99 -10.61 18.23 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.493 2.128 . . . . 99.989999999999995 112.036 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.585 ' C ' ' H ' ' A' ' 32' ' ' TYR . 14.6 t -47.12 -32.74 4.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 99.989999999999995 109.554 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 64.65 -31.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.825 . . . . 99.989999999999995 110.283 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.585 ' H ' ' C ' ' A' ' 30' ' ' SER . 87.0 m-85 -58.36 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.832 -1.168 . . . . 99.989999999999995 108.659 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.432 ' CB ' ' O ' ' A' ' 32' ' ' TYR . 2.0 t 73.74 60.05 0.32 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.513 -0.742 . . . . 99.989999999999995 110.415 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.47 130.66 34.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.024 1.816 . . . . 99.989999999999995 111.079 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.34 56.08 2.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.06 -1.025 . . . . 99.989999999999995 110.143 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.571 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 42.1 t -119.48 134.65 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 99.989999999999995 109.679 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 36' ' ' VAL . 91.1 m-85 -160.56 -102.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 99.989999999999995 109.132 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 88.7 m-20 54.02 56.62 6.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 99.989999999999995 110.089 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 17.1 t-20 89.86 73.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 109.709 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -111.9 145.35 39.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 99.989999999999995 109.155 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.1 145.29 48.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 99.989999999999995 109.438 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.02 129.63 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 99.989999999999995 109.558 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.9 m -92.8 124.26 36.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.064 -1.022 . . . . 99.989999999999995 108.733 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.22 159.34 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 110.794 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 68.0 mtm -113.15 136.95 52.16 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.116 -0.698 . . . . 99.989999999999995 109.116 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.76 127.08 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 99.989999999999995 108.987 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 15.68 67.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.732 -1.347 . . . . 99.989999999999995 109.732 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.62 16.17 62.36 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.799 -1.321 . . . . 99.989999999999995 109.799 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -124.26 154.06 68.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.338 -1.096 . . . . 99.989999999999995 109.175 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.52 135.33 28.38 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.749 2.3 . . . . 99.989999999999995 113.258 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -145.32 154.9 42.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 99.989999999999995 109.129 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -125.54 139.23 53.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.384 -0.823 . . . . 99.989999999999995 109.869 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.37 125.25 48.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 99.989999999999995 109.094 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.07 118.28 4.83 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 99.989999999999995 109.645 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.632 ' CD2' ' N ' ' A' ' 55' ' ' LEU . 1.6 mm? -102.77 129.39 49.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.221 -1.164 . . . . 99.989999999999995 108.999 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.88 126.08 53.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 99.989999999999995 109.771 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -103.36 164.93 11.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.469 -0.769 . . . . 99.989999999999995 109.382 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 p -79.67 161.87 25.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 99.989999999999995 109.329 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 109.52 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.426 -0.583 . . . . 99.989999999999995 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -140.5 153.08 46.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 99.989999999999995 109.699 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -104.96 -5.64 20.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 109.217 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.0 133.75 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.795 . . . . 99.989999999999995 109.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -109.12 121.64 45.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.221 -0.924 . . . . 99.989999999999995 108.619 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -116.35 140.05 49.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.306 -0.871 . . . . 99.989999999999995 110.427 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.81 152.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 99.989999999999995 109.146 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 134.23 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 99.989999999999995 109.683 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -138.99 164.01 30.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 99.989999999999995 109.43 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.1 p -98.13 151.4 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 99.989999999999995 109.32 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 p -102.27 6.71 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 110.279 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -100.52 -1.08 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 99.989999999999995 110.129 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.506 ' O ' ' OG ' ' A' ' 89' ' ' SER . 69.5 m -118.86 95.82 49.55 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 99.989999999999995 109.745 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.76 -52.88 8.01 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.285 1.99 . . . . 99.989999999999995 112.6 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -40.2 65.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.099 -1.001 . . . . 99.989999999999995 109.508 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 86' ' ' SER . 54.9 p -60.34 -14.15 16.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 99.989999999999995 108.851 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -74.13 -50.66 18.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.694 -0.854 . . . . 99.989999999999995 108.694 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.72 -39.08 90.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 99.989999999999995 109.3 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -54.15 -32.14 54.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 99.989999999999995 109.625 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.26 -37.58 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 99.989999999999995 110.274 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -86.59 -27.76 23.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.742 -1.224 . . . . 99.989999999999995 110.386 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.72 -36.45 67.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.116 -0.99 . . . . 99.989999999999995 112.273 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -111.89 -50.62 2.9 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.884 -1.135 . . . . 99.989999999999995 112.509 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.487 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 33.8 m0 -68.13 -34.32 76.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.967 -1.083 . . . . 99.989999999999995 112.583 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -68.22 -51.72 24.74 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 119.964 -1.71 . . . . 99.989999999999995 111.113 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 72.9 Cg_endo -76.69 -44.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.947 1.764 . . . . 99.989999999999995 112.881 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.45 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 85.1 tt0 -59.24 -41.94 89.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 99.989999999999995 111.045 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 105' ' ' CYS . 94.2 mt -68.34 -43.35 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 99.989999999999995 110.174 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.8 m -60.28 -42.97 96.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 99.989999999999995 109.847 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -60.5 -44.85 95.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 109.937 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 100' ' ' GLU . 48.3 m80 -92.82 -10.69 35.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 110.432 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -149.65 86.96 5.27 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.941 -1.099 . . . . 99.989999999999995 109.878 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.79 -48.84 19.59 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.415 2.076 . . . . 99.989999999999995 112.072 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -147.69 110.34 4.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 99.989999999999995 109.506 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 3.5 p -154.11 150.16 22.0 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 109.326 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -47.72 118.25 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.03 1.82 . . . . 99.989999999999995 111.625 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 108' ' ' THR . 64.0 m-85 -112.9 128.9 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 99.989999999999995 110.141 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.5 tp -115.78 120.28 38.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.675 -0.861 . . . . 99.989999999999995 108.675 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 117.56 34.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 108.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.536 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 48.0 t -112.09 135.9 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.419 -0.801 . . . . 99.989999999999995 110.587 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.7 125.31 8.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.31 -1.916 . . . . 99.989999999999995 108.31 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.3 t -129.97 166.63 19.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.227 -1.161 . . . . 99.989999999999995 110.638 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 115' ' ' THR . 22.9 tp60 85.66 15.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.12 -0.491 . . . . 99.989999999999995 109.762 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 119' ' ' LEU . 25.4 pt -63.15 -158.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.869 -1.144 . . . . 99.989999999999995 108.648 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.497 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 80.4 m-20 56.97 -57.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.637 -0.664 . . . . 99.989999999999995 110.273 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.699 ' N ' ' O ' ' A' ' 117' ' ' ILE . 29.4 tp -50.74 -30.52 14.17 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.845 -1.159 . . . . 99.989999999999995 108.109 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.414 HH12 ' HD2' ' A' ' 139' ' ' PRO . 40.5 ttp180 -57.89 -15.56 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 99.989999999999995 109.59 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 47.2 p30 -101.19 1.85 39.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.001 -1.062 . . . . 99.989999999999995 109.956 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.55 150.57 76.47 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 109.632 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.9 -53.46 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.454 2.103 . . . . 99.989999999999995 111.98 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -59.17 -32.64 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 99.989999999999995 110.637 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.1 m -69.71 -51.39 34.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.886 -1.134 . . . . 99.989999999999995 109.908 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt -65.16 -35.1 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.918 . . . . 99.989999999999995 109.456 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -73.27 -44.57 59.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 99.989999999999995 109.362 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.87 -41.32 91.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 99.989999999999995 109.714 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.1 mt -74.16 -34.07 63.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 99.989999999999995 108.713 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.57 -47.73 69.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.056 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -62.6 -35.83 80.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 110.119 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -52.61 -57.09 11.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.857 -1.152 . . . . 99.989999999999995 109.562 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 134' ' ' GLN . 14.3 pttp -171.23 -50.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.058 -1.026 . . . . 99.989999999999995 110.563 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.447 ' N ' ' CG ' ' A' ' 133' ' ' LYS . 52.6 mt-30 -143.86 -119.79 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 99.989999999999995 109.852 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.88 163.22 52.51 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 110.175 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.33 174.26 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.175 2.583 . . . . 99.989999999999995 112.099 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.32 140.04 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 109.933 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.37 158.29 69.29 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 99.989999999999995 109.381 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.424 ' CB ' ' OE2' ' A' ' 156' ' ' GLU . 16.4 Cg_endo -60.99 -31.55 91.48 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.58 2.187 . . . . 99.989999999999995 111.936 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 99.989999999999995 109.186 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.4 m -69.37 -33.05 72.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.217 -0.927 . . . . 99.989999999999995 109.221 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.31 -39.6 59.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.447 -0.783 . . . . 99.989999999999995 109.921 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.51 -31.85 69.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 110.264 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -60.93 -37.53 82.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.012 . . . . 99.989999999999995 109.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 145' ' ' LEU . 7.7 mp -65.39 -31.06 71.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 110.402 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.13 69.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.908 -1.12 . . . . 99.989999999999995 110.242 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -82.09 9.49 8.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 99.989999999999995 110.399 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -113.45 -36.09 5.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.029 . . . . 99.989999999999995 109.246 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.02 17.09 9.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.538 -0.726 . . . . 99.989999999999995 110.572 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 65.48 30.23 10.87 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.216 -0.928 . . . . 99.989999999999995 109.865 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.31 143.08 56.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 108.944 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.0 -58.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.013 -1.054 . . . . 99.989999999999995 110.089 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -152.49 150.47 29.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.028 -1.045 . . . . 99.989999999999995 110.709 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -116.8 138.7 51.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.48 -0.763 . . . . 99.989999999999995 109.432 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.43 153.78 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.9 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 139' ' ' PRO . 93.2 mt-10 -110.11 132.62 54.0 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.571 -0.9 . . . . 99.989999999999995 108.571 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.536 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -136.64 146.28 45.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 99.989999999999995 110.633 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.497 ' OG ' ' OD2' ' A' ' 118' ' ' ASP . 18.0 t -115.78 108.93 16.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.954 -0.758 . . . . 99.989999999999995 108.954 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.343 0.592 . . . . 99.989999999999995 109.45 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.601 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 6.7 mp -59.61 -27.86 66.68 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.608 -0.886 . . . . 99.989999999999995 108.608 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.8 p -125.11 165.94 17.32 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.46 -0.941 . . . . 99.989999999999995 108.46 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.11 12.64 0.28 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.798 -0.563 . . . . 99.989999999999995 109.597 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 161' ' ' THR . 34.9 mtmt -89.68 3.4 52.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.989 . . . . 99.989999999999995 109.923 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.97 -49.15 1.96 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.881 -1.288 . . . . 99.989999999999995 109.881 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.514 ' H ' ' CD1' ' A' ' 165' ' ' LEU . 6.5 mp -61.86 -38.48 88.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -1.138 . . . . 99.989999999999995 110.125 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -58.53 -32.59 69.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 99.989999999999995 110.303 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -86.64 -44.61 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.046 -1.034 . . . . 99.989999999999995 109.381 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.88 -26.9 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 99.989999999999995 110.498 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.47 -46.81 71.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 99.989999999999995 110.489 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -54.52 -43.8 72.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.896 -1.127 . . . . 99.989999999999995 109.672 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.61 -38.06 73.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 99.989999999999995 109.532 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.01 -43.69 91.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.945 . . . . 99.989999999999995 110.256 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 29.9 mm -69.67 -42.81 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.932 -1.105 . . . . 99.989999999999995 109.671 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.6 tp -56.16 -45.64 79.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 99.989999999999995 109.514 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.06 84.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.114 -0.991 . . . . 99.989999999999995 109.699 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.66 -42.66 79.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 99.989999999999995 109.42 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.4 mt -64.27 -38.48 91.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 109.031 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.516 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.034 -0.728 . . . . 99.989999999999995 109.034 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.0 m -104.37 145.27 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.6 -0.687 . . . . 99.989999999999995 109.679 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.8 mt -115.07 119.94 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.732 . . . . 99.989999999999995 109.026 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.35 130.78 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 110.01 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 128.18 19.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.391 -0.818 . . . . 99.989999999999995 109.12 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.41 138.27 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 99.989999999999995 109.559 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.2 t -116.1 132.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 99.989999999999995 108.886 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.09 145.87 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.077 -1.014 . . . . 99.989999999999995 109.514 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.28 157.41 22.88 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.202 -1.559 . . . . 99.989999999999995 109.202 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 12' ' ' GLY . 60.3 t0 -86.01 105.76 16.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 99.989999999999995 109.61 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.12 69.73 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.86 -1.296 . . . . 99.989999999999995 109.86 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.98 133.58 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -1.235 . . . . 99.989999999999995 109.289 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.37 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 109.333 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 49.89 0.81 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.665 -1.374 . . . . 99.989999999999995 109.665 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HZ1' ' CB ' ' A' ' 58' ' ' THR . 73.6 tttt -61.28 -38.24 86.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.962 -1.316 . . . . 99.989999999999995 109.78 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.6 p -70.64 -37.02 73.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 99.989999999999995 109.633 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.69 -28.5 69.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 99.989999999999995 109.702 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.81 -37.3 79.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.947 . . . . 99.989999999999995 110.128 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.37 -40.6 96.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 99.989999999999995 111.15 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.484 ' O ' ' OG1' ' A' ' 25' ' ' THR . 48.3 pt -70.7 -32.14 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.74 -1.225 . . . . 99.989999999999995 110.07 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 m -57.01 -38.68 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.986 -1.071 . . . . 99.989999999999995 109.983 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -78.74 -48.48 14.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 99.989999999999995 110.122 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 p -64.59 -34.33 78.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 99.989999999999995 109.881 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 63.7 p -112.26 -109.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.072 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 25' ' ' THR . 1.3 p30 164.64 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.847 -0.798 . . . . 99.989999999999995 108.847 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -126.45 122.35 35.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.259 -0.901 . . . . 99.989999999999995 110.404 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.672 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -96.52 -39.69 0.27 Allowed Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.396 -0.964 . . . . 99.989999999999995 108.396 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 12.9 Cg_exo -66.89 -10.54 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.616 2.211 . . . . 99.989999999999995 111.13 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' TYR . 38.7 m -47.9 -36.72 12.75 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.595 -0.842 . . . . 99.989999999999995 109.209 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.6 mt-10 40.38 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 99.989999999999995 109.972 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 30' ' ' SER . 70.1 t80 -141.22 118.77 11.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.946 -1.096 . . . . 99.989999999999995 108.419 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.59 153.03 37.98 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 99.989999999999995 110.206 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.81 156.11 64.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 99.989999999999995 112.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 67.92 10.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 99.989999999999995 109.282 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.55 136.25 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.308 -0.87 . . . . 99.989999999999995 109.711 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -117.26 -1.93 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.815 . . . . 99.989999999999995 109.645 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.1 p30 -77.56 166.24 23.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.005 . . . . 99.989999999999995 110.113 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 37.5 p-10 -92.91 150.78 20.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.792 . . . . 99.989999999999995 109.619 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 74.0 t80 -134.53 147.98 50.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.459 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -102.61 138.25 39.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 99.989999999999995 109.842 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.83 138.2 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.712 . . . . 99.989999999999995 109.545 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.3 m -106.03 134.49 49.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.838 . . . . 99.989999999999995 109.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.89 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 99.989999999999995 109.958 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.8 mtp -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.796 -0.816 . . . . 99.989999999999995 108.796 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.11 135.77 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.87 . . . . 99.989999999999995 108.87 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.68 -15.11 11.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.287 -1.525 . . . . 99.989999999999995 109.287 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 49' ' ' GLU . . . -95.16 -8.73 58.69 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.322 -1.105 . . . . 99.989999999999995 110.593 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' GLY . 2.0 mm-40 155.43 131.23 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.507 -0.996 . . . . 99.989999999999995 109.367 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.87 137.01 26.2 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.003 1.802 . . . . 99.989999999999995 111.857 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 97.8 m-85 -134.57 155.49 50.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.136 -0.978 . . . . 99.989999999999995 109.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 m -119.0 141.1 48.97 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.847 -0.797 . . . . 99.989999999999995 108.847 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.91 126.34 44.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 99.989999999999995 109.891 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.65 128.51 9.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.645 -1.782 . . . . 99.989999999999995 108.645 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.2 mt -107.32 122.49 46.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -1.207 . . . . 99.989999999999995 109.2 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -111.49 135.13 52.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.41 -0.806 . . . . 99.989999999999995 109.197 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 58' ' ' THR . 57.4 t0 -94.0 151.68 19.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 109.07 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.483 ' CB ' ' HZ1' ' A' ' 16' ' ' LYS . 65.5 m -59.1 130.39 46.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.033 -1.042 . . . . 99.989999999999995 108.978 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 109.338 -179.718 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.256 0.55 . . . . 99.989999999999995 110.842 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -105.5 130.96 53.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 99.989999999999995 108.99 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.39 -37.91 89.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 99.989999999999995 110.406 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.84 144.1 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 99.989999999999995 110.449 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.39 126.68 51.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.39 -0.967 . . . . 99.989999999999995 108.39 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.6 tp -112.3 128.76 56.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 99.989999999999995 110.121 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.18 135.78 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 99.989999999999995 109.12 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 130.95 46.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.37 -0.831 . . . . 99.989999999999995 109.828 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.47 161.11 38.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 99.989999999999995 109.173 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.9 t -80.08 132.82 36.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -1.0 . . . . 99.989999999999995 109.295 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.77 -28.25 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 99.989999999999995 110.869 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.4 m -92.6 7.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.041 -1.037 . . . . 99.989999999999995 111.095 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.484 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 22.6 t -98.52 124.57 46.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.792 -1.193 . . . . 99.989999999999995 110.003 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 70.2 Cg_endo -77.56 -58.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.264 1.976 . . . . 99.989999999999995 112.61 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 89' ' ' SER . 81.4 p -55.48 -32.92 63.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.935 . . . . 99.989999999999995 109.762 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.502 ' N ' ' HG ' ' A' ' 88' ' ' SER . 41.3 m -65.08 -24.52 67.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 99.989999999999995 109.165 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -68.57 -50.84 48.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -0.774 . . . . 99.989999999999995 109.347 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 87' ' ' PRO . 52.5 mp0 -69.13 -35.72 76.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 109.723 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -54.45 -33.36 59.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 99.989999999999995 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.66 -37.98 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.933 . . . . 99.989999999999995 110.268 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -93.43 -36.25 12.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.844 -1.16 . . . . 99.989999999999995 110.839 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.71 -37.04 81.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.027 -1.045 . . . . 99.989999999999995 112.285 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -113.68 -51.65 2.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 99.989999999999995 112.611 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.198 -0.939 . . . . 99.989999999999995 113.217 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -71.25 -51.49 10.08 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.152 -1.592 . . . . 99.989999999999995 111.623 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 56.7 Cg_endo -71.87 -45.74 0.68 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.827 1.685 . . . . 99.989999999999995 113.567 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.22 -38.85 90.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.014 -1.054 . . . . 99.989999999999995 111.07 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 tp -68.58 -26.88 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 99.989999999999995 110.078 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 m -61.46 -40.02 92.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 99.989999999999995 109.858 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -54.87 -34.44 62.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.573 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 56.8 t-80 -62.34 -43.66 98.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 99.989999999999995 109.591 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.0 OUTLIER 160.64 158.52 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.47 -0.769 . . . . 99.989999999999995 109.629 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 108' ' ' THR . 13.5 Cg_endo -60.1 -160.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.759 2.306 . . . . 99.989999999999995 111.676 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 106' ' ' PRO . 20.8 mttp 42.51 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.058 . . . . 99.989999999999995 109.631 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.7 p 47.49 81.8 0.25 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.212 -0.93 . . . . 99.989999999999995 109.388 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.53 126.44 16.09 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.328 2.019 . . . . 99.989999999999995 111.573 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.28 125.21 54.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 99.989999999999995 110.017 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.5 tp -116.58 121.22 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.933 -0.765 . . . . 99.989999999999995 108.933 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.6 mt -104.58 121.83 44.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.529 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.75 134.52 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 109.897 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.5 124.89 8.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.984 -1.646 . . . . 99.989999999999995 108.984 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.8 p -110.73 159.78 17.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 99.989999999999995 110.219 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 57.67 40.8 26.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.681 -0.637 . . . . 99.989999999999995 110.663 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.5 pt -69.48 -5.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.153 . . . . 99.989999999999995 109.933 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.93 -22.66 29.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 99.989999999999995 109.096 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.4 tp -61.58 -32.73 72.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 99.989999999999995 109.497 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -58.64 -25.22 62.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 99.989999999999995 109.652 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.07 -5.2 47.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 99.989999999999995 110.116 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.12 141.32 83.72 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.003 -1.061 . . . . 99.989999999999995 109.049 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.62 -46.73 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.173 1.915 . . . . 99.989999999999995 111.894 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.8 p -61.22 -27.64 68.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.889 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.3 m -69.25 -49.02 60.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.204 -1.035 . . . . 99.989999999999995 108.204 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.02 -40.19 82.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.455 0.645 . . . . 99.989999999999995 109.3 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -74.54 -40.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.582 -0.699 . . . . 99.989999999999995 109.771 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 99.989999999999995 110.568 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 3.5 mm? -78.7 -38.78 38.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -0.996 . . . . 99.989999999999995 109.61 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.52 71.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 99.989999999999995 109.686 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -62.55 -44.41 96.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.97 -1.081 . . . . 99.989999999999995 110.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -70.44 -48.95 53.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 99.989999999999995 109.772 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -148.38 -89.32 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 99.989999999999995 109.637 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' A' ' 135' ' ' LYS . 9.0 pt20 -134.19 -119.32 0.18 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 99.989999999999995 109.594 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.475 ' H ' ' HG3' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.09 167.03 24.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.943 . . . . 99.989999999999995 109.447 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.41 165.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.998 2.465 . . . . 99.989999999999995 112.223 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.61 145.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 99.989999999999995 109.069 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.462 ' HG1' ' H ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -85.69 155.99 58.81 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.994 -1.066 . . . . 99.989999999999995 109.394 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.41 -24.03 76.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.614 2.209 . . . . 99.989999999999995 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.462 ' H ' ' HG1' ' A' ' 138' ' ' THR . 84.1 tt0 -64.13 -41.7 97.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.615 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.8 m -62.45 -36.78 83.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.962 . . . . 99.989999999999995 109.331 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.9 57.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.42 -0.8 . . . . 99.989999999999995 109.752 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.64 -34.67 77.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.091 -1.006 . . . . 99.989999999999995 110.682 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 21.0 mttm -67.3 -39.25 85.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 99.989999999999995 109.437 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -39.5 94.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 99.989999999999995 109.24 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 148' ' ' ASP . . . -75.36 -48.86 21.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.089 -1.007 . . . . 99.989999999999995 110.141 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -68.97 4.97 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 110.379 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 144' ' ' LYS . 88.2 m-20 -108.82 -20.99 12.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.958 -1.089 . . . . 99.989999999999995 109.357 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.2 mt -110.97 34.31 4.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.511 -0.743 . . . . 99.989999999999995 110.037 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.73 29.18 18.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 99.989999999999995 110.639 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.51 146.23 54.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 99.989999999999995 109.037 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.98 -61.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.034 -1.042 . . . . 99.989999999999995 110.402 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.414 ' HG2' ' N ' ' A' ' 154' ' ' TYR . 16.4 tttp -175.37 163.3 3.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 109.552 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.414 ' N ' ' HG2' ' A' ' 153' ' ' LYS . 28.7 p90 -120.04 154.75 34.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 99.989999999999995 108.922 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.0 t -132.24 140.09 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.129 -0.982 . . . . 99.989999999999995 110.057 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.9 mt-10 -100.13 126.7 46.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.276 -1.009 . . . . 99.989999999999995 108.276 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 140.73 47.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 111.071 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 161' ' ' THR . 34.6 t -104.26 102.19 11.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 99.989999999999995 108.892 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.92 72.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.209 0.528 . . . . 99.989999999999995 109.59 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.6 mt -53.56 -27.02 23.9 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.434 -0.95 . . . . 99.989999999999995 108.434 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 163' ' ' LYS . 17.5 p -123.61 161.17 25.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.031 -1.1 . . . . 99.989999999999995 108.031 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -69.97 12.35 0.22 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.696 -0.627 . . . . 99.989999999999995 109.33 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.3 mttp -90.45 0.52 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 99.989999999999995 109.866 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -91.67 -51.37 2.51 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.577 -1.297 . . . . 99.989999999999995 110.016 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.17 -40.48 96.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.133 -1.216 . . . . 99.989999999999995 109.83 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.45 -27.85 66.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 99.989999999999995 110.522 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 35.6 t-20 -76.94 -50.73 12.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 99.989999999999995 109.926 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.02 -12.13 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 99.989999999999995 110.865 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.63 -50.23 22.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.734 -1.228 . . . . 99.989999999999995 110.575 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.72 -41.95 92.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 99.989999999999995 110.057 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.01 -33.15 75.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 99.989999999999995 109.979 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.68 71.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 99.989999999999995 110.087 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.53 -39.82 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.036 -1.04 . . . . 99.989999999999995 109.787 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.3 tp -53.49 -42.14 67.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 99.989999999999995 109.907 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.92 74.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -0.947 . . . . 99.989999999999995 110.333 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.45 70.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 99.989999999999995 109.941 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.3 mt -61.96 -34.23 75.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.963 -1.085 . . . . 99.989999999999995 109.399 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.443 -0.786 . . . . 99.989999999999995 109.255 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.414 0.625 . . . . 99.989999999999995 109.316 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -136.71 160.07 39.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.399 -0.813 . . . . 99.989999999999995 109.772 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.66 121.0 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.719 . . . . 99.989999999999995 109.126 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -91.66 127.86 37.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 99.989999999999995 109.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 128.33 24.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 99.989999999999995 109.123 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.14 137.36 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 99.989999999999995 109.888 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.36 134.92 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 99.989999999999995 108.915 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -152.09 146.59 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 109.277 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 159.64 23.85 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 99.989999999999995 109.388 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' GLY . 24.6 t70 -84.31 110.28 18.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -1.213 . . . . 99.989999999999995 109.434 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.57 63.38 1.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.412 -1.475 . . . . 99.989999999999995 109.412 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.09 121.36 27.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -1.167 . . . . 99.989999999999995 109.312 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.87 -30.08 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 99.989999999999995 109.967 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.09 35.14 5.02 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.916 -1.274 . . . . 99.989999999999995 109.916 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.95 -38.59 82.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.237 . . . . 99.989999999999995 110.266 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.437 ' HG1' ' N ' ' A' ' 18' ' ' CYS . 45.7 p -63.41 -40.51 97.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.002 . . . . 99.989999999999995 110.002 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.437 ' N ' ' HG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -63.35 -26.69 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 99.989999999999995 110.058 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.14 -41.2 99.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 99.989999999999995 109.825 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.44 -40.56 89.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.123 -0.985 . . . . 99.989999999999995 110.198 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.16 -42.3 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 99.989999999999995 109.809 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -57.51 -35.82 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 110.185 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -80.05 -50.27 10.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.144 . . . . 99.989999999999995 109.801 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -59.58 -36.94 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.142 -0.974 . . . . 99.989999999999995 110.014 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 56.5 p -120.15 -113.55 0.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 109.387 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 25' ' ' THR . 11.1 m120 -167.56 12.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.806 -0.813 . . . . 99.989999999999995 108.806 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -98.09 118.82 35.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 110.344 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -86.4 -38.52 0.54 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 108.884 -0.784 . . . . 99.989999999999995 108.884 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 17.7 Cg_exo -63.26 -27.11 71.97 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.371 2.047 . . . . 99.989999999999995 111.064 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 29' ' ' PRO . 21.7 m 34.17 47.73 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.221 0.534 . . . . 99.989999999999995 110.298 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 -41.07 -32.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 99.989999999999995 110.111 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -121.7 126.0 47.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 109.488 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -99.44 109.27 54.38 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 99.989999999999995 110.032 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -52.47 160.64 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.241 1.961 . . . . 99.989999999999995 112.049 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.19 67.44 1.87 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 99.989999999999995 109.341 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 p -140.94 138.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 99.989999999999995 109.914 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.03 0.64 11.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.475 -0.766 . . . . 99.989999999999995 109.326 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -69.2 139.46 54.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 110.432 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.39 160.82 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.564 -0.71 . . . . 99.989999999999995 109.356 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.09 136.58 49.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 99.989999999999995 110.33 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 125.75 51.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.778 -0.823 . . . . 99.989999999999995 108.778 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.19 138.64 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 99.989999999999995 109.693 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 p -87.94 147.08 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.075 -1.016 . . . . 99.989999999999995 109.066 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 156.95 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 99.989999999999995 110.507 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.2 mtm -130.17 137.15 49.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.711 -0.618 . . . . 99.989999999999995 109.549 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 26.6 pt -129.82 152.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 99.989999999999995 109.096 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.99 18.2 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.369 -1.493 . . . . 99.989999999999995 109.369 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 84.83 15.06 68.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.116 -1.194 . . . . 99.989999999999995 110.116 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' ILE . 59.0 mt-10 -106.0 146.56 33.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.102 -1.234 . . . . 99.989999999999995 109.44 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.74 131.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.539 2.159 . . . . 99.989999999999995 112.829 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -143.12 160.13 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 109.532 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 m -117.23 138.79 51.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 99.989999999999995 109.093 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.8 tp -120.13 122.08 40.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 99.989999999999995 109.579 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.79 124.57 7.91 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.996 -1.642 . . . . 99.989999999999995 108.996 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -102.45 122.33 44.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 99.989999999999995 108.997 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -108.23 129.31 55.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.104 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' THR . 60.0 t0 -116.92 148.05 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.701 . . . . 99.989999999999995 109.177 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.407 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.2 p -68.65 159.16 32.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.042 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 99.989999999999995 109.187 -179.833 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.465 -0.569 . . . . 99.989999999999995 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.7 p -119.26 145.0 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 99.989999999999995 109.477 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.85 -33.87 74.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 99.989999999999995 109.934 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.65 133.71 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 99.989999999999995 110.278 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -110.7 121.42 45.27 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.109 -1.071 . . . . 99.989999999999995 108.109 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -112.81 139.18 48.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 110.351 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.3 t -122.44 135.18 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.01 -0.737 . . . . 99.989999999999995 109.01 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.55 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 38.8 t -127.77 128.27 45.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.811 . . . . 99.989999999999995 109.549 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.61 162.91 34.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 99.989999999999995 109.73 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.482 ' OG ' ' OE1' ' A' ' 116' ' ' GLN . 37.9 t -92.05 142.85 27.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 99.989999999999995 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 2.4 p -100.24 -4.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 99.989999999999995 110.109 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.6 m -89.79 -16.47 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.999 -1.063 . . . . 99.989999999999995 109.783 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -98.51 134.97 21.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.913 . . . . 99.989999999999995 109.71 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.65 -55.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.228 1.952 . . . . 99.989999999999995 112.198 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.3 m -55.13 -34.4 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 99.989999999999995 109.709 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -63.44 -25.16 68.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.097 -1.002 . . . . 99.989999999999995 109.248 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -70.36 -50.18 41.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -0.832 . . . . 99.989999999999995 109.414 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.31 -37.13 82.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 99.989999999999995 109.89 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.55 -34.36 49.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 99.989999999999995 109.815 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.98 -34.97 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 99.989999999999995 109.986 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -91.14 -37.75 13.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.863 -1.148 . . . . 99.989999999999995 110.192 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -68.0 -35.99 79.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 112.094 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -113.15 -52.55 2.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.976 -1.078 . . . . 99.989999999999995 112.528 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -68.25 -37.02 80.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 113.428 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.422 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -63.28 -51.43 68.85 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.003 -1.685 . . . . 99.989999999999995 111.395 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 59.8 Cg_endo -73.96 -43.4 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.828 1.685 . . . . 99.989999999999995 113.095 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.82 -30.24 71.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 99.989999999999995 111.23 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 tp -61.71 -25.1 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.687 -1.258 . . . . 99.989999999999995 109.874 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.44 ' CG2' ' N ' ' A' ' 103' ' ' HIS . 4.8 t -55.59 -36.61 67.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.131 -0.981 . . . . 99.989999999999995 109.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 102' ' ' THR . 52.1 m170 -51.62 -32.93 30.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 99.989999999999995 109.636 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.7 m80 -93.25 -5.99 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 99.989999999999995 109.58 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' HIS . 0.1 OUTLIER 53.23 168.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 99.989999999999995 109.541 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.19 26.11 0.55 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.837 2.358 . . . . 99.989999999999995 113.355 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -56.57 -34.52 67.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.947 -1.096 . . . . 99.989999999999995 109.829 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 159.61 38.52 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.589 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.46 147.52 93.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.864 2.376 . . . . 99.989999999999995 111.959 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.63 126.05 54.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 109.158 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.7 mt -116.98 128.16 54.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.536 -0.728 . . . . 99.989999999999995 109.854 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.1 tp -106.34 116.4 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.323 -0.992 . . . . 99.989999999999995 108.323 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.1 t -112.77 136.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 99.989999999999995 110.908 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.96 119.03 6.01 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.853 -2.099 . . . . 99.989999999999995 107.853 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.55 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 52.0 m -118.58 148.11 43.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -1.045 . . . . 99.989999999999995 110.465 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' THR . 33.2 tt0 84.48 19.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 122.067 -0.396 . . . . 99.989999999999995 110.47 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 119' ' ' LEU . 35.1 pt -62.62 -158.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.381 -1.341 . . . . 99.989999999999995 107.381 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 63.0 -61.73 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.183 . . . . 99.989999999999995 109.226 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 117' ' ' ILE . 25.1 tp -53.08 -33.9 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 99.989999999999995 108.059 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.401 HH12 ' HG3' ' A' ' 139' ' ' PRO . 33.0 ptt180 -54.36 -15.42 1.63 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.952 -1.129 . . . . 99.989999999999995 107.952 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 92.9 m-20 -108.04 57.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.226 -1.027 . . . . 99.989999999999995 108.226 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 7.9 m-20 -137.85 107.79 8.3 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.937 -0.764 . . . . 99.989999999999995 108.937 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.66 -39.83 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.879 1.719 . . . . 99.989999999999995 111.955 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m -58.73 -41.34 86.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.768 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.0 m -70.67 -48.94 52.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 99.989999999999995 108.126 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.76 -36.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.388 0.613 . . . . 99.989999999999995 109.479 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.93 -47.11 75.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 99.989999999999995 109.433 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -59.0 -38.8 80.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.709 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.16 -33.88 61.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 99.989999999999995 108.98 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.94 -41.81 64.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.553 -0.717 . . . . 99.989999999999995 109.87 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -60.16 -37.23 79.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 99.989999999999995 109.477 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.71 4.67 50.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.786 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 51.65 39.3 24.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.182 -0.949 . . . . 99.989999999999995 109.752 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -98.99 -52.17 3.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 99.989999999999995 110.027 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 mttp 68.89 146.11 0.11 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 99.989999999999995 109.144 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.3 152.24 79.54 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.593 2.195 . . . . 99.989999999999995 112.765 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.0 mm -93.5 141.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 99.989999999999995 109.046 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.53 155.21 65.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.093 -1.005 . . . . 99.989999999999995 109.591 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG3' HH12 ' A' ' 120' ' ' ARG . 18.5 Cg_endo -61.65 -28.08 82.11 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.571 2.181 . . . . 99.989999999999995 111.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.92 -38.27 90.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.325 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.4 m -65.06 -35.59 81.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 99.989999999999995 109.175 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.33 -34.07 58.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 99.989999999999995 109.817 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 99.989999999999995 110.485 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.483 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 18.5 mttp -64.45 -35.69 81.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.962 -1.086 . . . . 99.989999999999995 109.553 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.53 -40.29 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 109.679 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.54 82.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.002 . . . . 99.989999999999995 109.661 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 147' ' ' ARG . 43.8 mtt-85 -78.7 7.78 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 110.498 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 85.1 m-20 -83.31 -27.78 29.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 99.989999999999995 108.753 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.3 mt -117.38 -101.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.624 -0.672 . . . . 99.989999999999995 109.308 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -144.9 44.9 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 109.871 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.95 137.4 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 99.989999999999995 109.168 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.82 -58.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 110.354 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -156.66 146.54 20.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.72 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -122.22 153.73 38.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.394 -0.816 . . . . 99.989999999999995 109.11 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.54 157.58 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 99.989999999999995 109.904 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -104.35 128.1 52.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.449 -0.945 . . . . 99.989999999999995 108.449 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 164' ' ' GLY . 15.2 m -122.02 131.45 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.854 . . . . 99.989999999999995 110.713 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.554 ' O ' ' O ' ' A' ' 161' ' ' THR . 23.9 t -109.99 110.88 21.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 99.989999999999995 109.207 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.97 68.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.871 -0.518 . . . . 99.989999999999995 110.08 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.8 tp -51.37 -34.39 34.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.061 -1.024 . . . . 99.989999999999995 108.471 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.659 ' C ' ' H ' ' A' ' 163' ' ' LYS . 55.6 m -127.95 152.0 48.42 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.785 -1.191 . . . . 99.989999999999995 107.785 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -58.57 13.53 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.039 -1.038 . . . . 99.989999999999995 110.103 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.659 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.9 tttm -74.59 5.92 4.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 99.989999999999995 109.278 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 157' ' ' CYS . . . -98.81 -50.86 1.45 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.652 -1.261 . . . . 99.989999999999995 110.205 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 6.5 mp -68.25 -38.47 81.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -1.178 . . . . 99.989999999999995 109.939 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -61.73 -29.25 69.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.288 -0.883 . . . . 99.989999999999995 110.336 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 163' ' ' LYS . 86.8 m-20 -77.96 -49.71 13.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 99.989999999999995 110.186 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.3 m -74.39 -11.19 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 110.452 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -73.64 -46.46 46.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 99.989999999999995 110.219 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.59 -43.29 89.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 110.299 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.06 -33.39 75.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.05 -1.031 . . . . 99.989999999999995 109.663 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.06 70.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 110.152 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.18 -42.64 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.93 -1.106 . . . . 99.989999999999995 109.916 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.3 mt -54.24 -44.86 72.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 99.989999999999995 109.822 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.71 -36.6 84.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 99.989999999999995 109.715 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.44 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 99.989999999999995 109.654 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.13 -39.22 93.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 99.989999999999995 109.398 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.406 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.407 0.622 . . . . 99.989999999999995 109.604 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -124.71 159.0 31.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 99.989999999999995 109.335 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.2 mt -119.16 119.16 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.794 . . . . 99.989999999999995 109.556 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.3 132.69 38.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 99.989999999999995 109.695 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -135.87 126.6 27.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 99.989999999999995 109.465 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.84 136.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.427 -0.796 . . . . 99.989999999999995 109.709 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.4 138.12 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 99.989999999999995 109.049 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.54 144.68 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 99.989999999999995 109.295 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.63 23.1 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.629 -1.388 . . . . 99.989999999999995 109.629 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 12' ' ' GLY . 26.1 t70 -89.55 105.88 18.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -1.165 . . . . 99.989999999999995 109.43 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.73 68.78 0.5 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.733 -1.347 . . . . 99.989999999999995 109.733 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -1.151 . . . . 99.989999999999995 109.401 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.23 -45.73 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 99.989999999999995 109.309 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.29 48.94 0.88 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.506 -1.438 . . . . 99.989999999999995 109.506 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.69 -40.18 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.245 . . . . 99.989999999999995 109.726 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.8 m -64.5 -40.56 95.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 99.989999999999995 109.529 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.84 -29.77 63.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 99.989999999999995 110.036 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.34 -42.76 96.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.014 -1.054 . . . . 99.989999999999995 109.22 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -73.44 -40.1 64.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 99.989999999999995 109.545 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.89 -48.92 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 99.989999999999995 109.289 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -56.37 -32.65 64.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 99.989999999999995 109.859 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -81.1 -50.63 9.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.028 -1.045 . . . . 99.989999999999995 109.671 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 m -55.93 -44.3 78.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 99.989999999999995 109.703 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 82.1 p -118.39 -110.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.597 -0.89 . . . . 99.989999999999995 108.597 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 25' ' ' THR . 81.5 m-20 -146.06 12.56 1.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.016 . . . . 99.989999999999995 109.882 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 28' ' ' PHE . 22.7 tttm 77.91 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.568 -0.707 . . . . 99.989999999999995 109.757 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -37.16 -55.54 1.71 Allowed Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.409 -0.807 . . . . 99.989999999999995 111.482 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 28' ' ' PHE . 89.0 Cg_exo -35.43 -53.47 0.78 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.975 1.783 . . . . 99.989999999999995 112.415 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.7 t -108.72 142.82 38.69 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 108.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.22 -19.93 13.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.458 -0.941 . . . . 99.989999999999995 108.458 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -133.59 161.34 34.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.6 -0.688 . . . . 99.989999999999995 110.183 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 7.7 p -123.93 79.83 57.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.815 -0.809 . . . . 99.989999999999995 108.815 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.2 -64.05 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.699 2.266 . . . . 99.989999999999995 112.442 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.94 166.04 24.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 99.989999999999995 109.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.57 141.04 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 99.989999999999995 109.073 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.72 -84.93 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 99.989999999999995 109.491 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 52.3 p30 -148.83 -170.86 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 99.989999999999995 109.806 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 40.5 p-10 -52.56 151.35 4.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.799 . . . . 99.989999999999995 109.257 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.98 146.44 44.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 109.741 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.39 142.86 45.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 99.989999999999995 108.961 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 134.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 99.989999999999995 109.856 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.8 m -90.49 131.81 36.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 108.914 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.17 137.59 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.413 -0.805 . . . . 99.989999999999995 110.044 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 95.7 mmm -91.2 137.46 32.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.84 . . . . 99.989999999999995 108.814 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLY . 78.4 mt -131.41 132.04 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 99.989999999999995 109.193 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.8 19.33 0.5 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.765 -1.334 . . . . 99.989999999999995 109.765 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.34 15.53 62.07 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.91 -1.276 . . . . 99.989999999999995 109.91 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -114.83 125.44 29.04 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.397 -1.06 . . . . 99.989999999999995 108.869 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.14 117.07 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.038 1.825 . . . . 99.989999999999995 113.208 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -127.19 139.41 52.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.855 -0.795 . . . . 99.989999999999995 108.855 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -86.9 149.81 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 99.989999999999995 109.783 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.9 tp -131.79 133.84 45.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.425 -0.797 . . . . 99.989999999999995 109.24 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.2 131.11 8.26 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.938 -1.265 . . . . 99.989999999999995 109.938 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.84 132.99 50.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -1.105 . . . . 99.989999999999995 109.048 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.17 133.37 54.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 109.987 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 58' ' ' THR . 59.0 t0 -132.21 147.44 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.624 -0.672 . . . . 99.989999999999995 109.461 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.0 p -73.05 160.36 32.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 109.549 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.648 -179.805 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' THR . 95.2 mm-40 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.473 -0.565 . . . . 99.989999999999995 109.473 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER 85.62 50.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.383 -0.599 . . . . 99.989999999999995 109.383 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.88 -33.67 67.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 99.989999999999995 109.394 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.2 128.8 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 99.989999999999995 109.441 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -105.61 124.12 49.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 99.989999999999995 108.767 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 55.9 mt -107.82 137.46 45.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.31 -0.869 . . . . 99.989999999999995 109.961 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 97' ' ' TRP . 20.1 t -124.99 136.78 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.854 -0.795 . . . . 99.989999999999995 108.854 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.562 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 45.0 t -130.04 127.34 39.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.848 . . . . 99.989999999999995 109.843 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -136.42 165.37 25.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.942 . . . . 99.989999999999995 108.853 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.5 m -101.83 142.63 32.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 99.989999999999995 109.223 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 84' ' ' VAL . 4.1 p -102.84 -1.35 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 110.055 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.32 -21.67 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 99.989999999999995 109.882 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 m -111.96 108.67 55.37 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.772 . . . . 99.989999999999995 109.771 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -51.77 -38.27 66.73 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.022 1.815 . . . . 99.989999999999995 112.335 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.6 p -57.62 -35.22 70.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 99.989999999999995 109.154 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 86' ' ' SER . 83.7 p -67.92 -21.85 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.521 -0.918 . . . . 99.989999999999995 108.521 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -72.02 -50.45 28.43 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.569 -0.9 . . . . 99.989999999999995 108.569 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.65 -35.77 80.96 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.366 -0.834 . . . . 99.989999999999995 109.259 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -50.95 -33.83 26.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 109.297 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.3 t -62.39 -35.31 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 99.989999999999995 109.453 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -89.43 -37.56 14.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.821 -1.175 . . . . 99.989999999999995 110.247 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.07 -37.22 83.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 99.989999999999995 112.384 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -112.91 -52.05 2.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.762 -1.212 . . . . 99.989999999999995 112.699 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.536 ' CZ3' ' CG1' ' A' ' 80' ' ' VAL . 30.8 m0 -66.86 -39.43 87.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.994 -1.066 . . . . 99.989999999999995 112.593 -176.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -61.47 -52.21 71.71 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.143 -1.598 . . . . 99.989999999999995 111.05 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 38.3 Cg_endo -68.98 -43.22 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.568 1.512 . . . . 99.989999999999995 112.416 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.82 -39.81 62.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 110.5 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 105' ' ' CYS . 1.3 mp -66.63 -33.32 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.778 -1.201 . . . . 99.989999999999995 109.927 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.2 m -53.77 -39.02 65.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.998 . . . . 99.989999999999995 109.318 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -58.93 -40.7 85.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 99.989999999999995 109.739 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -99.4 1.12 43.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 109.715 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER 59.42 166.32 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.996 . . . . 99.989999999999995 109.331 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.7 39.92 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.723 2.282 . . . . 99.989999999999995 112.304 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -60.17 -35.37 75.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 99.989999999999995 110.745 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.07 157.74 49.92 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 99.989999999999995 110.471 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.73 144.64 44.5 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.034 2.489 . . . . 99.989999999999995 112.696 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -116.75 138.82 51.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.575 -0.703 . . . . 99.989999999999995 109.497 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.8 tp -116.71 123.62 47.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.696 . . . . 99.989999999999995 109.788 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -101.56 116.93 33.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.407 -0.96 . . . . 99.989999999999995 108.407 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.03 135.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 99.989999999999995 110.672 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.3 114.88 4.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.41 -1.876 . . . . 99.989999999999995 108.41 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.562 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 20.8 m -102.74 149.22 24.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -1.152 . . . . 99.989999999999995 110.503 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 60.68 41.18 15.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.931 -0.48 . . . . 99.989999999999995 110.637 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.2 pt -73.65 -6.21 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.875 -1.141 . . . . 99.989999999999995 110.191 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.487 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 84.5 m-20 -85.71 -24.03 27.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.049 -1.032 . . . . 99.989999999999995 109.217 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 121' ' ' ASP . 10.2 mp -65.01 -24.98 67.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 99.989999999999995 109.092 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -44.99 -19.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.514 -0.741 . . . . 99.989999999999995 109.231 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 119' ' ' LEU . 60.6 t0 -122.33 48.63 1.71 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.737 . . . . 99.989999999999995 109.032 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 56.4 t0 -117.72 90.55 36.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.516 -0.74 . . . . 99.989999999999995 109.21 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.6 -40.92 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.197 1.931 . . . . 99.989999999999995 112.398 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.5 t -57.87 -43.21 85.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 99.989999999999995 109.842 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.4 m -70.58 -49.56 46.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 99.989999999999995 108.232 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.0 -36.41 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.77 -0.581 . . . . 99.989999999999995 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.15 -43.83 90.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 99.989999999999995 108.896 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -61.78 -42.54 99.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 99.989999999999995 109.696 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 3.8 mm? -75.39 -33.91 61.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.885 . . . . 99.989999999999995 109.348 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.89 40.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 99.989999999999995 109.469 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.83 -35.36 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 109.495 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.38 6.81 21.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 99.989999999999995 109.719 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 61.55 44.77 8.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.645 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -140.94 139.61 34.32 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.229 -0.919 . . . . 99.989999999999995 108.882 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.88 161.83 34.22 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 99.989999999999995 109.534 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.03 145.65 97.89 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.867 2.378 . . . . 99.989999999999995 112.328 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.555 ' CG2' ' OG1' ' A' ' 141' ' ' THR . 97.1 mt -90.99 144.56 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.435 -0.791 . . . . 99.989999999999995 109.835 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.34 155.02 54.52 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.359 -0.838 . . . . 99.989999999999995 109.371 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.54 -32.79 95.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.406 2.071 . . . . 99.989999999999995 111.601 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.35 -36.61 61.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 99.989999999999995 109.971 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.555 ' OG1' ' CG2' ' A' ' 137' ' ' ILE . 65.4 p -78.57 -23.76 45.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.82 -1.175 . . . . 99.989999999999995 108.832 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.01 -43.88 51.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.448 -0.783 . . . . 99.989999999999995 109.759 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.68 -35.62 81.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 99.989999999999995 110.984 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -65.86 -38.42 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.769 -1.207 . . . . 99.989999999999995 109.431 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.7 -38.53 81.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 99.989999999999995 109.302 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.17 84.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.956 . . . . 99.989999999999995 109.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.637 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -81.26 6.54 13.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 99.989999999999995 109.62 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -111.46 -34.86 5.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 99.989999999999995 109.106 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 66.7 mt -92.68 16.9 11.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 99.989999999999995 110.63 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.2 mttt 61.2 31.23 19.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 110.264 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.93 145.18 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 109.05 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.0 t -66.56 -60.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.014 . . . . 99.989999999999995 109.952 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -152.86 157.67 41.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 99.989999999999995 109.774 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -132.15 148.61 52.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 109.224 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.477 ' CG1' ' ND2' ' A' ' 167' ' ' ASN . 46.6 t -134.11 140.95 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 110.231 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.422 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.4 mt-10 -94.86 121.84 36.88 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.33 -0.989 . . . . 99.989999999999995 108.33 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.422 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -130.69 140.63 50.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.159 -0.963 . . . . 99.989999999999995 110.761 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 161' ' ' THR . 8.7 t -115.61 115.13 25.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 99.989999999999995 109.416 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.9 -35.67 64.69 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.247 0.546 . . . . 99.989999999999995 109.86 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.45 -31.0 32.6 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.078 -1.082 . . . . 99.989999999999995 108.078 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.572 ' C ' ' H ' ' A' ' 163' ' ' LYS . 7.4 m -118.03 152.11 36.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.672 -1.232 . . . . 99.989999999999995 107.672 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.29 12.61 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.326 -0.859 . . . . 99.989999999999995 109.498 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 161' ' ' THR . 62.9 mttp -89.18 4.74 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.857 -1.152 . . . . 99.989999999999995 109.903 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -89.08 -51.0 3.1 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.489 -1.339 . . . . 99.989999999999995 109.952 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.56 -38.62 74.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 99.989999999999995 110.301 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -60.24 -29.14 68.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 99.989999999999995 110.459 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.477 ' ND2' ' CG1' ' A' ' 155' ' ' VAL . 38.6 t-20 -75.59 -49.46 18.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.58 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.0 t -79.1 -8.08 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 99.989999999999995 110.726 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -74.95 -50.38 16.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.771 -1.205 . . . . 99.989999999999995 110.331 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.69 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 99.989999999999995 110.272 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.975 . . . . 99.989999999999995 109.798 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.61 80.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 99.989999999999995 110.002 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 75.9 mt -72.89 -42.25 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.093 -1.004 . . . . 99.989999999999995 109.855 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.0 tp -57.5 -44.84 85.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 99.989999999999995 109.902 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.09 -33.4 75.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 99.989999999999995 109.894 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.7 71.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 109.696 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.9 -39.78 86.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 99.989999999999995 109.071 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 99.989999999999995 109.521 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.33 -0.619 . . . . 99.989999999999995 109.33 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.6 m -124.92 147.42 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.583 -0.698 . . . . 99.989999999999995 109.781 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.25 119.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.069 -0.715 . . . . 99.989999999999995 109.069 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -88.92 128.38 35.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 99.989999999999995 110.123 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.59 124.03 26.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.924 -0.769 . . . . 99.989999999999995 108.924 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.06 138.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 99.989999999999995 109.935 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.32 136.07 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.717 -0.846 . . . . 99.989999999999995 108.717 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.27 136.44 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 99.989999999999995 109.554 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.1 142.36 12.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 99.989999999999995 109.438 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 12' ' ' GLY . 50.7 t0 -84.99 105.06 15.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 99.989999999999995 109.551 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.0 66.16 1.09 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.271 -1.531 . . . . 99.989999999999995 109.271 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.53 130.25 34.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -1.117 . . . . 99.989999999999995 109.342 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.48 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 99.989999999999995 109.221 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.22 51.91 0.67 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.237 -1.545 . . . . 99.989999999999995 109.237 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -61.8 -39.83 93.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.239 . . . . 99.989999999999995 110.057 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.6 p -76.14 -35.55 59.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 99.989999999999995 109.967 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 68.7 m -64.1 -31.18 72.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 110.445 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.78 -42.32 81.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 99.989999999999995 109.711 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.4 mt -70.45 -40.88 73.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 109.93 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.9 -36.71 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 99.989999999999995 110.0 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.6 p -60.44 -30.5 69.69 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.351 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -82.65 -50.27 8.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 99.989999999999995 109.977 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.527 ' HG1' ' N ' ' A' ' 25' ' ' THR . 62.2 p -66.85 -40.57 87.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 99.989999999999995 110.469 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 54.8 m -105.08 -86.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.965 . . . . 99.989999999999995 109.645 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER 159.92 -10.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 99.989999999999995 110.032 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -83.92 103.92 13.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.739 -1.226 . . . . 99.989999999999995 109.783 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.638 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -65.33 -41.4 51.15 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.431 -0.793 . . . . 99.989999999999995 109.173 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 27.7 Cg_exo -59.48 -33.36 97.21 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.337 2.025 . . . . 99.989999999999995 112.068 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER 74.99 42.25 0.27 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.104 -0.997 . . . . 99.989999999999995 108.595 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 32' ' ' TYR . 96.1 mt-10 -44.84 81.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.125 0.488 . . . . 99.989999999999995 110.597 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.669 ' N ' ' O ' ' A' ' 30' ' ' SER . 11.7 t80 90.05 71.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.228 0.537 . . . . 99.989999999999995 110.403 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' TYR . 31.7 m -44.55 148.81 0.84 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 99.989999999999995 109.604 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.28 144.3 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.833 2.355 . . . . 99.989999999999995 112.415 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.03 1.02 42.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 99.989999999999995 110.171 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.54 142.29 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.119 -0.988 . . . . 99.989999999999995 109.969 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.92 16.36 22.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 99.989999999999995 109.886 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 59.2 t0 -63.82 129.1 38.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 99.989999999999995 109.679 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -70.33 151.05 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.428 -0.795 . . . . 99.989999999999995 109.588 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 98.7 m-85 -127.97 152.56 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.816 . . . . 99.989999999999995 109.866 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.59 145.48 30.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 99.989999999999995 109.261 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -128.45 147.09 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 99.989999999999995 109.842 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.3 m -120.53 142.53 49.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 99.989999999999995 109.408 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 m -124.53 158.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 99.989999999999995 109.818 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.7 mtp -112.49 140.65 47.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 99.989999999999995 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' GLY . 60.4 mt -122.1 143.78 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.883 -0.784 . . . . 99.989999999999995 108.883 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -46.4 -29.19 3.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.726 -1.75 . . . . 99.989999999999995 108.726 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.13 -92.16 0.51 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.152 -1.579 . . . . 99.989999999999995 109.152 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -126.74 156.68 73.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -1.057 . . . . 99.989999999999995 109.846 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.7 138.07 23.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.735 2.29 . . . . 99.989999999999995 112.24 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.38 152.17 50.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.084 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -117.8 157.92 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 99.989999999999995 109.673 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.17 160.3 29.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 109.28 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.19 158.28 26.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.468 -1.453 . . . . 99.989999999999995 109.468 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 mt -106.0 129.11 54.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 99.989999999999995 109.058 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -115.99 135.08 54.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.558 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -139.55 167.56 21.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 109.387 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.25 154.11 25.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.068 -1.02 . . . . 99.989999999999995 109.523 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.033 -0.729 . . . . 99.989999999999995 109.033 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.097 -0.705 . . . . 99.989999999999995 109.097 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.47 ' OG1' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -152.12 98.44 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 99.989999999999995 109.705 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.4 -34.03 74.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.917 . . . . 99.989999999999995 109.546 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.78 143.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 110.316 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 74.2 m-85 -104.71 127.3 52.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 99.989999999999995 109.402 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.7 tp -111.93 125.53 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.405 -0.81 . . . . 99.989999999999995 108.973 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.27 137.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 109.484 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 141.95 49.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 99.989999999999995 109.541 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.3 159.01 43.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 99.989999999999995 109.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -89.18 150.83 22.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.378 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 84' ' ' VAL . 6.7 p -98.48 4.43 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 99.989999999999995 110.218 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.97 -2.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 99.989999999999995 110.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -115.06 92.92 33.0 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 109.661 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.03 -50.81 12.73 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.41 2.073 . . . . 99.989999999999995 112.695 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -54.29 -38.68 66.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 99.989999999999995 109.371 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.7 p -63.65 -16.01 59.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 99.989999999999995 108.421 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.29 -50.78 13.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.991 -0.744 . . . . 99.989999999999995 108.991 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.48 -39.46 81.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 99.989999999999995 109.592 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -53.74 -31.56 48.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 109.092 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.38 -35.59 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.371 -0.831 . . . . 99.989999999999995 109.697 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -95.66 -30.06 13.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.033 -1.042 . . . . 99.989999999999995 110.605 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.56 -35.06 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.71 -1.244 . . . . 99.989999999999995 111.903 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -113.73 -49.69 2.87 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.045 -1.034 . . . . 99.989999999999995 112.36 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -76.31 3.24 11.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.719 1.007 . . . . 99.989999999999995 113.719 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -107.04 -45.98 0.12 Allowed Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.387 -1.446 . . . . 99.989999999999995 110.851 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 91.5 Cg_endo -86.12 -53.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.545 2.163 . . . . 99.989999999999995 112.767 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.57 -34.37 78.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 99.989999999999995 109.928 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.2 -27.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 99.989999999999995 109.853 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.1 p -66.46 -35.02 79.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.933 . . . . 99.989999999999995 109.764 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -56.84 -41.47 77.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.989 . . . . 99.989999999999995 109.689 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -101.28 -8.8 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 99.989999999999995 109.788 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m -147.79 77.54 10.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 109.626 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.74 -44.46 49.41 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.564 2.176 . . . . 99.989999999999995 112.062 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -150.8 104.1 3.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 99.989999999999995 109.459 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -150.38 155.79 36.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 99.989999999999995 109.437 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.95 127.78 17.54 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.42 2.08 . . . . 99.989999999999995 111.857 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 108' ' ' THR . 76.7 m-85 -116.61 137.64 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 99.989999999999995 109.769 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 tp -122.82 119.2 29.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.723 . . . . 99.989999999999995 109.449 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 112' ' ' LEU . 5.6 mp -107.56 127.08 53.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 99.989999999999995 108.818 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -112.04 133.08 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.287 -0.883 . . . . 99.989999999999995 110.03 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.67 119.82 5.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.339 -1.904 . . . . 99.989999999999995 108.339 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.9 p -118.25 169.45 9.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -1.068 . . . . 99.989999999999995 110.937 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 117' ' ' ILE . 82.3 mt-30 66.08 40.76 3.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.892 -0.595 . . . . 99.989999999999995 111.279 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 116' ' ' GLN . 15.2 tt -48.97 178.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.918 -1.114 . . . . 99.989999999999995 108.576 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 121' ' ' ASP . 87.7 m-20 54.26 26.17 6.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.819 -1.176 . . . . 99.989999999999995 109.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.9 mt 26.88 54.69 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.983 -0.448 . . . . 99.989999999999995 111.343 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 21.2 mmm180 49.61 26.85 1.91 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.834 -1.166 . . . . 99.989999999999995 110.189 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 118' ' ' ASP . 9.7 t0 79.84 -14.74 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 99.989999999999995 109.455 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.439 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.8 OUTLIER 53.97 62.34 9.04 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.314 -0.866 . . . . 99.989999999999995 109.756 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 122' ' ' ASP . 68.4 Cg_endo -92.68 -100.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 123.02 2.48 . . . . 99.989999999999995 111.504 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.3 p -81.17 -2.4 48.4 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.36 -0.978 . . . . 99.989999999999995 108.36 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.6 m -72.41 -46.36 55.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 99.989999999999995 108.956 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 pt -62.63 -34.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.29 -0.881 . . . . 99.989999999999995 109.308 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.63 -50.03 48.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 99.989999999999995 109.584 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -61.34 -36.67 80.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 99.989999999999995 110.138 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.93 -37.77 61.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 99.989999999999995 108.789 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.83 -38.49 61.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.617 -0.677 . . . . 99.989999999999995 109.475 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -60.23 -36.73 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 109.346 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -85.32 5.7 29.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 99.989999999999995 109.546 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttt 54.92 44.06 28.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 99.989999999999995 109.829 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -135.56 91.78 2.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.997 . . . . 99.989999999999995 109.416 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.85 153.22 91.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 99.989999999999995 109.819 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.31 161.77 25.96 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.853 2.369 . . . . 99.989999999999995 112.205 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.452 ' CG2' ' HG1' ' A' ' 141' ' ' THR . 27.1 mm -92.11 134.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 99.989999999999995 109.802 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.2 157.87 33.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 99.989999999999995 109.067 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -47.93 -36.28 26.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.906 2.404 . . . . 99.989999999999995 113.065 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -46.9 -40.76 14.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 99.989999999999995 110.119 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.452 ' HG1' ' CG2' ' A' ' 137' ' ' ILE . 72.1 p -89.25 -18.38 27.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.779 -1.201 . . . . 99.989999999999995 109.39 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.88 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 110.706 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.35 -34.97 78.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.135 . . . . 99.989999999999995 110.662 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 87.7 mttt -61.82 -32.92 73.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 99.989999999999995 109.292 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 tp -56.31 -38.96 72.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 99.989999999999995 109.406 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.07 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.786 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -80.65 -0.63 38.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.849 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 61.5 t0 -111.9 -43.29 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 99.989999999999995 108.814 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.6 tp -78.71 10.89 2.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.636 -0.665 . . . . 99.989999999999995 109.675 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 59.02 30.12 19.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 110.137 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.9 52.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 99.989999999999995 108.758 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.81 -58.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.075 . . . . 99.989999999999995 109.498 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -158.51 155.8 29.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 99.989999999999995 109.868 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.68 153.46 51.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 99.989999999999995 109.435 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.04 138.44 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 99.989999999999995 110.062 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 84.6 tt0 -102.6 132.22 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.157 -1.053 . . . . 99.989999999999995 108.157 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 8.4 p -167.09 176.74 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.123 . . . . 99.989999999999995 110.376 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.7 t -135.17 127.19 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.014 -1.054 . . . . 99.989999999999995 110.719 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.111 -0.699 . . . . 99.989999999999995 109.111 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.1 mt -54.66 -26.33 32.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.221 -1.029 . . . . 99.989999999999995 108.221 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 163' ' ' LYS . 27.4 m -121.3 160.87 23.05 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.276 -1.379 . . . . 99.989999999999995 107.276 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -64.62 11.17 0.05 Allowed 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.412 -0.805 . . . . 99.989999999999995 109.247 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.607 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.5 mttm -89.84 3.0 54.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.977 -1.077 . . . . 99.989999999999995 109.564 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -91.93 -50.23 2.71 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.005 -1.238 . . . . 99.989999999999995 110.005 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 6.6 mp -67.02 -44.96 78.95 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.443 -1.034 . . . . 99.989999999999995 110.646 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.41 -32.56 68.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.001 . . . . 99.989999999999995 110.922 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 25.6 t-20 -79.84 -50.88 9.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.939 -1.101 . . . . 99.989999999999995 110.063 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -75.79 -18.13 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 99.989999999999995 110.911 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.56 -47.37 27.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 99.989999999999995 110.452 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 99.989999999999995 110.233 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.45 -33.99 76.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.093 -1.005 . . . . 99.989999999999995 109.927 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.53 70.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.9 . . . . 99.989999999999995 110.323 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 29.3 mm -67.67 -40.75 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 99.989999999999995 110.112 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 3.4 mm? -56.88 -45.59 82.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 99.989999999999995 110.083 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.97 77.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 99.989999999999995 110.052 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.98 72.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 99.989999999999995 109.471 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.17 -36.72 84.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 99.989999999999995 109.511 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.529 -179.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.552 -0.536 . . . . 99.989999999999995 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -127.29 135.74 50.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 99.989999999999995 109.37 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.3 mt -113.07 114.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.834 . . . . 99.989999999999995 109.112 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -91.3 132.43 36.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 110.654 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.472 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -132.6 121.39 23.14 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.434 -0.95 . . . . 99.989999999999995 108.434 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.66 134.02 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 99.989999999999995 109.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.1 t -114.61 133.01 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.738 -0.838 . . . . 99.989999999999995 108.738 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.443 ' CG2' ' CH2' ' A' ' 97' ' ' TRP . 9.1 p -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 99.989999999999995 109.582 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.01 -173.32 37.32 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.616 -1.394 . . . . 99.989999999999995 109.616 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' GLY . 23.3 t70 -69.76 137.65 52.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 99.989999999999995 109.106 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . -37.16 -47.67 1.43 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.004 -1.239 . . . . 99.989999999999995 110.004 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . -42.53 167.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -1.209 . . . . 99.989999999999995 109.658 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 16' ' ' LYS . 2.1 t 73.42 110.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.111 -0.699 . . . . 99.989999999999995 109.111 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.27 79.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.143 -1.183 . . . . 99.989999999999995 110.143 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.5 mttp -58.05 -31.18 66.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 99.989999999999995 108.989 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 m -67.52 -44.42 78.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.399 -0.813 . . . . 99.989999999999995 109.016 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.6 m -62.14 -27.7 69.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 99.989999999999995 109.637 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -65.16 -40.27 94.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 99.989999999999995 108.506 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.37 -44.06 65.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 99.989999999999995 109.588 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mm -67.91 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.982 . . . . 99.989999999999995 109.832 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -60.03 -35.12 74.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.955 . . . . 99.989999999999995 109.812 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.96 -33.17 70.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.291 -0.88 . . . . 99.989999999999995 109.274 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.9 p -72.07 -45.77 59.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.555 -0.716 . . . . 99.989999999999995 110.879 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.593 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 46.6 p -144.01 -2.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.792 -1.193 . . . . 99.989999999999995 111.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 25' ' ' THR . 37.3 t30 90.35 118.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.57 -0.9 . . . . 99.989999999999995 108.57 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' OG ' ' A' ' 30' ' ' SER . 2.8 tttm 178.63 48.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.509 -0.477 . . . . 99.989999999999995 109.99 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.653 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -61.36 -42.75 86.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.513 -1.367 . . . . 99.989999999999995 109.525 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 22.9 Cg_exo -62.19 1.99 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.908 2.406 . . . . 99.989999999999995 112.575 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 32' ' ' TYR . 29.2 m -48.89 -42.12 35.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.986 -1.071 . . . . 99.989999999999995 109.762 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 39.38 23.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 99.989999999999995 109.62 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 30' ' ' SER . 30.3 m-85 -93.76 -102.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 99.989999999999995 109.786 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 46.5 t 54.44 63.18 7.6 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 99.989999999999995 109.984 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.576 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 32.9 Cg_endo -68.67 -26.31 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.267 1.978 . . . . 99.989999999999995 111.235 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 34' ' ' PRO . . . 154.51 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.252 -0.647 . . . . 99.989999999999995 109.252 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.69 142.02 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 99.989999999999995 109.806 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -144.16 59.76 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.842 . . . . 99.989999999999995 109.182 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -121.15 158.65 27.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 99.989999999999995 109.296 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 55' ' ' LEU . 64.6 t30 -93.97 139.25 31.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 99.989999999999995 109.216 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.75 154.14 29.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.817 . . . . 99.989999999999995 109.54 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.55 143.62 44.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 99.989999999999995 109.061 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.57 130.71 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.8 m -100.74 128.52 46.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.01 134.14 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 99.989999999999995 110.198 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.4 ttp -118.25 128.71 54.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.65 -0.87 . . . . 99.989999999999995 108.65 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 27.2 pt -131.8 152.39 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 110.162 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.44 16.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.195 -1.162 . . . . 99.989999999999995 110.195 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.55 15.68 61.46 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.778 -1.329 . . . . 99.989999999999995 109.778 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.8 mt-10 -113.32 93.73 27.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.438 -1.036 . . . . 99.989999999999995 109.523 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.91 145.6 23.87 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.12 . . . . 99.989999999999995 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 60.8 m-85 -150.72 160.79 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.18 -0.674 . . . . 99.989999999999995 109.18 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.3 m -117.7 129.31 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 99.989999999999995 109.24 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.3 tp -117.81 122.7 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.492 -0.755 . . . . 99.989999999999995 109.161 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.79 121.28 5.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 99.989999999999995 109.537 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 56.7 mt -101.62 128.05 48.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -1.121 . . . . 99.989999999999995 108.417 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 99.989999999999995 109.83 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 54.4 p30 -102.91 169.54 8.52 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.367 -0.833 . . . . 99.989999999999995 109.017 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.9 m -57.81 129.51 42.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.942 -1.099 . . . . 99.989999999999995 109.09 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 99.989999999999995 109.277 -179.819 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.038 -0.727 . . . . 99.989999999999995 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -77.0 160.11 29.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 99.989999999999995 109.141 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -121.65 -46.65 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 99.989999999999995 110.22 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.25 142.5 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 99.989999999999995 109.903 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.04 128.56 55.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.029 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.472 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 50.0 mt -108.96 141.72 40.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 109.925 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.15 136.51 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.284 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.0 t -129.1 126.16 38.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 99.989999999999995 109.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.74 168.92 18.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 99.989999999999995 109.607 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.484 ' OG ' ' OE1' ' A' ' 116' ' ' GLN . 24.1 t -97.04 137.22 36.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.219 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.8 p -85.37 -10.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 111.222 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.6 m -99.78 -0.93 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.73 -1.231 . . . . 99.989999999999995 110.215 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 12.2 t -101.52 122.4 48.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 109.44 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.17 -61.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.211 1.94 . . . . 99.989999999999995 113.096 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -52.43 -41.07 62.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.927 -1.108 . . . . 99.989999999999995 110.117 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 60.5 p -69.09 -18.68 64.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.974 . . . . 99.989999999999995 109.505 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -70.36 -50.5 38.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 99.989999999999995 109.457 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -74.4 -34.57 63.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 99.989999999999995 110.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -53.56 -39.01 64.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 99.989999999999995 109.967 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.5 -33.47 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 110.144 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.66 -25.69 62.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 111.35 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.12 -9.45 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.705 -1.247 . . . . 99.989999999999995 111.472 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -112.04 -51.44 2.85 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 99.989999999999995 111.337 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.443 ' CH2' ' CG2' ' A' ' 9' ' ' VAL . 61.6 m95 -92.4 -7.12 48.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.185 -0.947 . . . . 99.989999999999995 112.432 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -94.33 -39.98 0.3 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.318 -1.489 . . . . 99.989999999999995 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.8 Cg_endo -91.94 -49.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 99.989999999999995 113.517 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -51.6 -39.77 58.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 99.989999999999995 110.452 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.2 tp -81.68 -19.85 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 99.989999999999995 110.042 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.561 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 57.6 m -54.7 -38.33 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 99.989999999999995 110.18 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -56.4 -43.77 79.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 99.989999999999995 110.741 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -103.4 11.76 36.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.957 -1.09 . . . . 99.989999999999995 111.068 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 102' ' ' THR . 28.0 p -63.57 114.86 14.6 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.154 . . . . 99.989999999999995 109.468 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 107' ' ' LYS . 87.0 Cg_endo -83.16 -90.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.238 1.959 . . . . 99.989999999999995 112.632 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 106' ' ' PRO . 27.1 mttt -87.81 -80.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 99.989999999999995 109.308 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER 173.42 58.67 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 99.989999999999995 110.226 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 108' ' ' THR . 48.1 Cg_endo -94.06 53.01 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.955 2.437 . . . . 99.989999999999995 111.899 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.66 128.26 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 99.989999999999995 110.876 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.1 tp -124.89 116.5 22.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.274 -1.01 . . . . 99.989999999999995 108.274 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.16 125.55 44.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 99.989999999999995 108.99 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.89 134.49 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 99.989999999999995 110.201 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.5 127.02 8.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.531 -1.828 . . . . 99.989999999999995 108.531 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 3.3 t -132.05 168.01 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 99.989999999999995 110.214 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 115' ' ' THR . 21.9 tt0 84.99 20.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.765 -0.457 . . . . 99.989999999999995 109.765 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.693 ' O ' ' N ' ' A' ' 119' ' ' LEU . 39.0 pt -59.44 -155.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 99.989999999999995 108.401 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 57.99 -58.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.743 . . . . 99.989999999999995 110.255 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.693 ' N ' ' O ' ' A' ' 117' ' ' ILE . 27.9 tp -51.78 -31.79 28.38 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.04 -1.037 . . . . 99.989999999999995 108.598 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -49.44 -17.63 0.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.765 . . . . 99.989999999999995 109.482 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -118.87 62.55 0.78 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 99.989999999999995 109.006 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.65 94.29 26.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.878 -0.786 . . . . 99.989999999999995 108.878 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.28 -44.72 23.77 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.278 1.985 . . . . 99.989999999999995 112.618 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -55.59 -36.05 66.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 110.052 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 69.1 p -78.0 -42.7 31.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.864 -1.147 . . . . 99.989999999999995 108.246 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.4 -39.0 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 109.261 -0.644 . . . . 99.989999999999995 109.261 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.28 -40.06 81.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.873 . . . . 99.989999999999995 108.695 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -59.79 -43.17 94.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.744 . . . . 99.989999999999995 109.152 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.51 -29.7 56.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.858 . . . . 99.989999999999995 109.264 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.7 -41.41 43.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.549 -0.719 . . . . 99.989999999999995 109.605 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.21 -36.65 75.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.935 . . . . 99.989999999999995 109.422 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.91 6.47 24.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 99.989999999999995 109.858 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.9 mttt 58.09 43.3 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.38 -0.825 . . . . 99.989999999999995 109.908 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.89 138.81 35.97 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 109.08 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.37 154.24 53.98 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.92 -0.77 . . . . 99.989999999999995 108.92 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -46.25 147.39 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.238 1.959 . . . . 99.989999999999995 111.819 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 86.5 mt -75.58 148.98 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 99.989999999999995 109.443 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.401 ' HG1' ' H ' ' A' ' 138' ' ' THR . 0.4 OUTLIER -86.96 154.9 55.53 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 109.193 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.8 -36.2 91.87 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.432 2.088 . . . . 99.989999999999995 111.777 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.98 -36.68 80.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 99.989999999999995 109.631 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.6 m -68.66 -36.75 78.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 108.84 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.31 64.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.567 -0.708 . . . . 99.989999999999995 110.008 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.38 -32.07 73.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.092 -1.005 . . . . 99.989999999999995 110.268 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -61.12 -36.52 79.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.81 -1.182 . . . . 99.989999999999995 109.23 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.1 tp -54.74 -39.88 68.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 99.989999999999995 109.633 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.67 -46.04 70.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 99.989999999999995 109.577 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -83.71 5.02 26.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.908 . . . . 99.989999999999995 110.143 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -61.43 -36.13 79.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.965 -1.084 . . . . 99.989999999999995 109.425 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.4 mt -126.16 -73.79 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 99.989999999999995 109.46 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -169.89 55.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 99.989999999999995 109.876 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.04 143.52 50.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.991 -1.068 . . . . 99.989999999999995 109.244 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.458 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 99.3 t -67.33 -56.58 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 99.989999999999995 110.104 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 66.0 mttm -159.3 164.99 34.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.173 -0.954 . . . . 99.989999999999995 109.912 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -131.06 146.93 52.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 99.989999999999995 108.908 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 t -132.26 140.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 110.147 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.47 129.96 52.43 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.941 -1.133 . . . . 99.989999999999995 107.941 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 150.16 43.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.93 -1.106 . . . . 99.989999999999995 111.297 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.5 t -114.56 106.46 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.768 -0.827 . . . . 99.989999999999995 108.768 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.8 -34.5 64.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 99.989999999999995 109.621 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.32 -24.19 27.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.004 -1.11 . . . . 99.989999999999995 108.004 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.2 p -123.24 168.74 12.06 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.985 -1.117 . . . . 99.989999999999995 107.985 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -78.17 11.81 2.16 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.686 -0.634 . . . . 99.989999999999995 109.614 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 49.3 mttt -90.64 -5.76 55.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.035 -1.04 . . . . 99.989999999999995 109.85 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.49 -50.46 3.58 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.362 -1.399 . . . . 99.989999999999995 110.449 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 7.8 mp -65.73 -41.01 92.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.211 . . . . 99.989999999999995 110.275 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -59.12 -31.3 68.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 110.796 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 163' ' ' LYS . 21.1 m120 -78.33 -50.7 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.926 -1.108 . . . . 99.989999999999995 110.102 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 91.8 t -77.27 -12.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.387 -0.82 . . . . 99.989999999999995 110.952 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -80.46 -50.53 9.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.679 -1.263 . . . . 99.989999999999995 110.593 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.03 -45.88 92.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 99.989999999999995 110.526 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.5 -33.0 68.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 99.989999999999995 110.165 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.44 71.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 99.989999999999995 110.112 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.86 -36.28 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 99.989999999999995 110.504 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 4.0 mm? -58.22 -44.01 87.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.113 . . . . 99.989999999999995 109.597 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.6 -33.89 76.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.043 . . . . 99.989999999999995 109.156 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.6 -38.75 75.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 99.989999999999995 109.512 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 52.7 mt -59.91 -39.73 86.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -0.936 . . . . 99.989999999999995 108.792 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 99.989999999999995 109.329 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.509 -0.552 . . . . 99.989999999999995 109.509 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -123.3 160.59 26.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 99.989999999999995 109.779 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 mm -116.64 119.0 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.939 -0.763 . . . . 99.989999999999995 108.939 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -87.03 121.97 30.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.037 -1.04 . . . . 99.989999999999995 109.786 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.2 t -138.13 128.37 25.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.441 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.93 143.05 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -0.83 . . . . 99.989999999999995 109.546 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.82 133.01 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 99.989999999999995 109.059 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.591 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 26.5 t -131.45 136.07 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 99.989999999999995 109.477 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.23 147.65 17.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.433 -1.467 . . . . 99.989999999999995 109.433 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' ALA . 25.2 t70 -85.6 111.49 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.059 -1.26 . . . . 99.989999999999995 109.485 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 54.42 -85.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.355 -1.498 . . . . 99.989999999999995 109.355 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 69.23 123.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -1.127 . . . . 99.989999999999995 109.567 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.71 -43.06 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 99.989999999999995 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.59 57.69 0.42 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.554 -1.418 . . . . 99.989999999999995 109.554 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -63.36 -40.72 98.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 99.989999999999995 109.728 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.425 ' HG1' ' N ' ' A' ' 18' ' ' CYS . 69.6 p -82.82 -32.64 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 99.989999999999995 110.327 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.425 ' N ' ' HG1' ' A' ' 17' ' ' THR . 0.1 OUTLIER -65.72 -31.22 72.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.101 -1.0 . . . . 99.989999999999995 110.617 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.23 -42.41 79.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.97 -1.081 . . . . 99.989999999999995 109.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.9 -40.92 91.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.845 . . . . 99.989999999999995 109.961 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.41 -35.24 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 99.989999999999995 110.369 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.3 p -50.75 -36.61 37.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 99.989999999999995 110.459 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -76.62 -37.64 56.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.083 . . . . 99.989999999999995 109.677 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.8 p -63.64 -37.69 88.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 99.989999999999995 111.692 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -162.08 -5.85 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.371 -1.456 . . . . 99.989999999999995 111.885 -179.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.609 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.7 t30 95.17 115.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.578 -0.897 . . . . 99.989999999999995 108.578 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -179.78 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.715 -0.476 . . . . 99.989999999999995 109.715 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.85 -42.52 83.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.778 -1.202 . . . . 99.989999999999995 109.82 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.3 Cg_exo -57.75 -31.72 92.9 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.48 2.12 . . . . 99.989999999999995 112.201 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.5 p 37.68 37.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.568 -0.707 . . . . 99.989999999999995 109.768 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 30' ' ' SER . 97.1 mt-10 -36.15 -37.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 99.989999999999995 110.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 33' ' ' VAL . 68.6 t80 -125.79 122.05 35.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 99.989999999999995 108.699 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.433 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 17.1 m -63.6 148.64 93.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.125 -0.984 . . . . 99.989999999999995 109.159 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.65 141.34 91.4 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.223 1.949 . . . . 99.989999999999995 112.149 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.95 71.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 99.989999999999995 109.939 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.75 155.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 99.989999999999995 110.067 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.32 25.91 10.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 99.989999999999995 109.098 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 89.1 m-20 -60.77 143.67 54.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 99.989999999999995 110.378 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 55' ' ' LEU . 46.3 t-20 -74.12 152.42 39.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.716 . . . . 99.989999999999995 109.563 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 95.9 m-85 -127.87 146.53 50.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 99.989999999999995 109.457 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.43 134.94 49.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 99.989999999999995 109.687 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.03 152.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 99.989999999999995 109.43 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p -118.31 143.83 46.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 109.609 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.45 138.67 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 99.989999999999995 109.815 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.6 mtt -79.11 126.87 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 99.989999999999995 109.171 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' GLY . 70.5 mt -131.56 126.2 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 99.989999999999995 109.196 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.93 18.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.035 -1.226 . . . . 99.989999999999995 110.035 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 88.81 12.95 63.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.684 -1.366 . . . . 99.989999999999995 109.684 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.6 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.1 mm-40 -123.24 81.87 52.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.466 -1.02 . . . . 99.989999999999995 109.118 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 124.05 15.33 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.677 2.252 . . . . 99.989999999999995 112.91 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.6 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 96.7 m-85 -115.49 142.68 46.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.233 -0.655 . . . . 99.989999999999995 109.233 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.4 m -75.56 135.09 40.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 99.989999999999995 109.922 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -123.09 125.06 44.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.156 -0.683 . . . . 99.989999999999995 109.156 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.79 132.38 10.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.581 -1.408 . . . . 99.989999999999995 109.581 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 73.1 mt -104.57 135.2 46.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -1.105 . . . . 99.989999999999995 109.022 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.11 155.68 32.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 99.989999999999995 109.752 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.1 p30 -150.24 178.04 9.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 99.989999999999995 109.386 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 47.5 m -66.25 138.66 57.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 99.989999999999995 109.198 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 99.989999999999995 109.672 179.91 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.258 -0.645 . . . . 99.989999999999995 109.258 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -124.14 151.31 44.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.346 -0.846 . . . . 99.989999999999995 109.722 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -65.6 -35.62 81.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 99.989999999999995 109.826 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 t -138.54 133.33 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 110.104 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.99 128.59 49.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 99.989999999999995 108.981 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.4 tp -113.43 132.04 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.395 -0.815 . . . . 99.989999999999995 109.855 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.14 135.4 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 99.989999999999995 109.225 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.8 t -130.52 126.15 36.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 99.989999999999995 110.021 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.47 168.41 19.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 99.989999999999995 108.86 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 m -108.01 145.93 33.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 99.989999999999995 109.472 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -103.79 13.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 109.039 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.78 -21.54 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 109.84 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.43 150.28 68.1 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 110.061 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.95 -33.21 3.84 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 99.989999999999995 112.737 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 t -55.67 -44.63 77.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.005 . . . . 99.989999999999995 109.493 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.9 m -66.36 -24.68 66.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 99.989999999999995 109.155 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -73.5 -51.26 17.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.458 -0.776 . . . . 99.989999999999995 109.524 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.51 -39.95 70.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 110.091 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.46 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 42.0 t30 -54.32 -35.28 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 99.989999999999995 109.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 65.7 t -59.06 -34.54 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 99.989999999999995 109.735 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -86.82 -22.84 25.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 99.989999999999995 110.406 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -75.44 -30.68 60.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.905 -1.122 . . . . 99.989999999999995 111.89 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' NZ ' ' OD1' ' A' ' 11' ' ' ASP . 7.6 ttpm? -112.53 -47.38 3.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.014 -1.054 . . . . 99.989999999999995 112.223 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.591 ' CZ2' ' CG1' ' A' ' 9' ' ' VAL . 77.1 m95 -80.8 1.36 30.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.093 -1.004 . . . . 99.989999999999995 113.35 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -107.76 -41.74 0.13 Allowed Pre-proline 0 N--CA 1.503 2.192 0 O-C-N 120.402 -1.436 . . . . 99.989999999999995 110.779 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 24.3 Cg_endo -88.71 -53.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.984 2.456 . . . . 99.989999999999995 112.691 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -57.03 -37.11 71.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 110.405 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -66.12 -29.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 99.989999999999995 110.027 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.9 m -60.03 -45.31 93.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 99.989999999999995 109.931 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.16 -35.07 76.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 99.989999999999995 109.868 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -64.32 -40.91 96.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.95 . . . . 99.989999999999995 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 171.88 165.74 0.24 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 99.989999999999995 109.939 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 75.8 Cg_exo -43.25 171.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.761 2.307 . . . . 99.989999999999995 112.228 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.44 140.86 55.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 110.02 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -124.94 160.28 54.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.699 -0.852 . . . . 99.989999999999995 108.699 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.81 122.6 11.29 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.178 1.919 . . . . 99.989999999999995 111.748 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 108' ' ' THR . 76.3 m-85 -122.86 149.59 43.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 99.989999999999995 110.109 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.1 mt -112.98 120.01 39.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.715 -0.846 . . . . 99.989999999999995 108.715 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 112' ' ' LEU . 3.5 mm? -97.06 111.57 23.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 99.989999999999995 108.762 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.573 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 47.9 t -108.3 135.4 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 110.426 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.76 122.84 7.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.286 -1.926 . . . . 99.989999999999995 108.286 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.7 p -122.14 160.9 24.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -1.068 . . . . 99.989999999999995 110.477 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.504 ' CB ' ' O ' ' A' ' 115' ' ' THR . 27.8 tp60 79.99 18.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.992 -0.443 . . . . 99.989999999999995 110.233 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.654 ' O ' ' N ' ' A' ' 119' ' ' LEU . 29.0 pt -60.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.723 -1.236 . . . . 99.989999999999995 108.149 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 61.06 -62.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.607 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.654 ' N ' ' O ' ' A' ' 117' ' ' ILE . 48.7 tp -55.1 -34.75 63.94 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.089 -1.007 . . . . 99.989999999999995 108.612 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -61.8 -19.75 62.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.013 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -90.14 -19.59 24.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 99.989999999999995 109.692 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.38 141.9 80.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 99.989999999999995 109.51 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.42 -29.94 19.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.427 2.085 . . . . 99.989999999999995 112.679 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -58.26 -41.78 85.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 110.417 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 49.3 m -72.11 -47.63 49.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.982 -1.074 . . . . 99.989999999999995 108.188 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.3 mt -55.09 -36.28 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.834 -0.541 . . . . 99.989999999999995 109.641 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.84 -46.95 79.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 99.989999999999995 109.198 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -59.06 -38.12 78.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 99.989999999999995 109.725 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.419 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 83.5 mt -79.14 -35.9 41.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 99.989999999999995 109.642 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.97 66.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.342 -0.849 . . . . 99.989999999999995 109.801 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -60.9 -36.17 78.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 99.989999999999995 109.108 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.1 5.61 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 99.989999999999995 109.494 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 52.97 32.81 13.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.503 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 135' ' ' LYS . 93.5 mt-30 -96.12 -53.06 3.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.606 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 10.9 mttm 62.36 144.86 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.456 -0.778 . . . . 99.989999999999995 109.092 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.05 150.69 87.91 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.538 2.159 . . . . 99.989999999999995 112.58 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 91.9 mt -89.07 146.95 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 99.989999999999995 109.418 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.28 157.73 55.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 99.989999999999995 109.375 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.93 -28.8 81.36 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.528 2.152 . . . . 99.989999999999995 111.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.7 -38.11 86.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 99.989999999999995 109.343 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 m -66.76 -36.16 81.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.147 -0.971 . . . . 99.989999999999995 109.019 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.35 -39.98 62.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 99.989999999999995 109.796 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -60.18 -34.35 73.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 99.989999999999995 110.521 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -64.13 -37.63 88.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.013 -1.054 . . . . 99.989999999999995 109.922 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.8 tp -58.19 -40.23 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 99.989999999999995 109.861 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 148' ' ' ASP . . . -87.85 -52.01 5.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 99.989999999999995 109.844 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 147' ' ' ARG . 29.6 ttt-85 -51.34 -7.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 110.212 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' ALA . 84.4 m-20 -111.57 -15.82 13.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.971 -1.081 . . . . 99.989999999999995 109.835 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.37 29.59 6.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 111.06 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.0 mttt 58.5 30.56 19.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.9 -1.125 . . . . 99.989999999999995 110.88 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.51 144.95 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 99.989999999999995 108.83 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.45 -52.25 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.063 . . . . 99.989999999999995 109.771 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.57 ' HZ3' ' CG ' ' A' ' 171' ' ' GLU . 47.1 pttt -175.92 -179.22 1.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.352 -0.843 . . . . 99.989999999999995 109.804 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -137.78 153.99 49.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.537 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.34 148.38 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 99.989999999999995 109.61 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.22 134.6 52.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 99.989999999999995 108.861 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.01 149.75 42.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 99.989999999999995 110.875 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.416 ' H ' ' HA2' ' A' ' 164' ' ' GLY . 14.2 t -113.04 109.47 18.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.688 -0.856 . . . . 99.989999999999995 108.688 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.08 -36.45 61.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.712 -0.618 . . . . 99.989999999999995 109.564 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.0 mt -53.88 -26.95 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 108.645 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 p -124.05 170.24 10.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.484 -0.932 . . . . 99.989999999999995 108.484 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.32 12.0 1.36 Allowed 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.689 -0.632 . . . . 99.989999999999995 109.396 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 89.1 mttt -89.5 0.01 57.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 99.989999999999995 109.714 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 158' ' ' SER . . . -90.85 -51.13 2.71 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.359 -1.4 . . . . 99.989999999999995 110.298 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 7.5 mp -68.74 -41.25 79.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -1.221 . . . . 99.989999999999995 110.246 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -59.55 -35.61 74.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.127 -0.983 . . . . 99.989999999999995 110.477 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 19.4 m120 -76.89 -49.39 15.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 99.989999999999995 109.532 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.505 ' CG2' ' SG ' ' A' ' 157' ' ' CYS . 74.8 t -68.4 -9.34 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 99.989999999999995 110.536 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -74.35 -46.21 42.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 99.989999999999995 110.58 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.58 -49.31 77.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.993 -1.067 . . . . 99.989999999999995 111.367 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.57 ' CG ' ' HZ3' ' A' ' 153' ' ' LYS . 60.3 mp0 -70.72 -35.67 72.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.846 -1.159 . . . . 99.989999999999995 110.373 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.34 80.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 99.989999999999995 110.121 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.47 -38.68 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.029 -1.045 . . . . 99.989999999999995 109.915 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.37 -43.64 79.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -0.976 . . . . 99.989999999999995 109.767 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.22 83.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 99.989999999999995 109.913 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.75 59.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 99.989999999999995 109.585 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.13 -36.55 82.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 99.989999999999995 108.997 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.446 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.225 0.536 . . . . 99.989999999999995 109.559 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -143.08 154.91 44.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 99.989999999999995 109.767 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.3 mt -122.45 122.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.497 -0.752 . . . . 99.989999999999995 109.127 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -87.0 131.91 33.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 109.74 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -148.23 126.51 12.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 99.989999999999995 109.159 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.35 137.54 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 99.989999999999995 110.155 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.8 130.55 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 99.989999999999995 109.16 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -138.51 156.81 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 99.989999999999995 109.202 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.45 167.6 31.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.849 -1.301 . . . . 99.989999999999995 109.849 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -86.0 121.82 29.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.079 . . . . 99.989999999999995 109.451 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 71.05 -107.7 2.25 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 99.989999999999995 109.362 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 164.76 42.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 99.989999999999995 109.377 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.647 ' CG1' ' H ' ' A' ' 15' ' ' GLY . 1.7 p -72.17 -85.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.061 -1.025 . . . . 99.989999999999995 109.63 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.647 ' H ' ' CG1' ' A' ' 14' ' ' VAL . . . -99.2 16.12 59.57 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.399 -1.481 . . . . 99.989999999999995 109.399 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -59.76 -38.19 81.09 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 99.989999999999995 110.087 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.5 p -74.29 -35.5 63.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 99.989999999999995 109.994 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.656 ' SG ' ' NZ ' ' A' ' 27' ' ' LYS . 89.4 m -59.82 -30.76 69.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 99.989999999999995 110.824 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.0 tp -67.7 -42.44 81.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.902 -1.124 . . . . 99.989999999999995 110.268 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.09 -43.77 61.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 99.989999999999995 111.059 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 22' ' ' SER . 9.9 tp -65.85 -38.81 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 99.989999999999995 110.184 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 18' ' ' CYS . 25.7 m -54.69 -34.62 62.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.046 . . . . 99.989999999999995 110.307 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CZ ' ' A' ' 169' ' ' PHE . 82.3 t80 -70.13 -38.05 75.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 99.989999999999995 109.525 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.5 m -52.61 -37.2 57.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.932 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 179.75 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 99.989999999999995 110.584 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.658 ' ND2' ' NE2' ' A' ' 162' ' ' GLN . 25.2 t-20 96.1 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.51 -0.922 . . . . 99.989999999999995 108.51 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.656 ' NZ ' ' SG ' ' A' ' 18' ' ' CYS . 53.7 tttt -64.53 -41.0 96.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.205 0.526 . . . . 99.989999999999995 111.023 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.425 ' C ' ' H ' ' A' ' 30' ' ' SER . 1.5 m-85 -42.94 -61.41 1.75 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 99.989999999999995 110.728 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 54.4 Cg_endo -70.53 23.87 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.463 2.109 . . . . 99.989999999999995 112.632 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 68.8 m -137.76 -62.0 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.116 -0.99 . . . . 99.989999999999995 109.546 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.23 11.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.028 -1.045 . . . . 99.989999999999995 109.964 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 30' ' ' SER . 78.4 m-85 -91.59 -101.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 99.989999999999995 109.709 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 33' ' ' VAL . 3.5 p 34.15 60.04 2.03 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.655 . . . . 99.989999999999995 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HG2' ' H ' ' A' ' 35' ' ' ALA . 69.7 Cg_endo -84.23 -73.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.392 2.061 . . . . 99.989999999999995 111.863 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' ' CE2' ' A' ' 37' ' ' PHE . . . -65.35 156.46 32.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 99.989999999999995 109.648 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 p -74.02 140.59 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 99.989999999999995 109.344 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 98.2 m-85 -118.13 159.2 23.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.531 -0.731 . . . . 99.989999999999995 109.646 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.0 p30 -72.91 -167.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.842 . . . . 99.989999999999995 109.97 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.35 157.08 6.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 99.989999999999995 109.449 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -110.33 130.89 55.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.386 -0.821 . . . . 99.989999999999995 109.638 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 121.61 44.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.36 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.57 134.9 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.493 -0.754 . . . . 99.989999999999995 109.369 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 m -98.55 138.79 35.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 99.989999999999995 109.316 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.26 134.57 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.453 -0.78 . . . . 99.989999999999995 109.514 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.0 mtp -107.29 141.78 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 99.989999999999995 109.568 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 48' ' ' GLY . 73.7 mt -124.68 139.86 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.882 -0.785 . . . . 99.989999999999995 108.882 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.51 -24.02 0.59 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.605 -1.798 . . . . 99.989999999999995 108.605 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -82.89 -93.59 0.59 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.462 -1.455 . . . . 99.989999999999995 109.462 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.533 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 13.6 mm-40 -123.11 152.44 63.46 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.424 -1.045 . . . . 99.989999999999995 109.973 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.29 141.4 35.5 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.647 2.231 . . . . 99.989999999999995 112.224 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 98.9 m-85 -137.81 159.43 42.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 99.989999999999995 109.739 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -112.01 142.86 43.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 99.989999999999995 109.116 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -120.86 123.17 41.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.422 -0.799 . . . . 99.989999999999995 109.691 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.544 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -116.03 129.71 8.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.222 -1.551 . . . . 99.989999999999995 109.222 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.1 mt -107.74 136.59 47.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 99.989999999999995 109.393 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -118.86 146.26 45.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 99.989999999999995 109.765 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 52.6 p30 -156.79 164.81 37.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.422 -0.798 . . . . 99.989999999999995 109.595 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -67.49 137.08 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.261 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 99.989999999999995 109.851 -179.546 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.331 0.586 . . . . 99.989999999999995 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.7 m -141.62 126.82 18.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.826 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.74 -25.26 13.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 99.989999999999995 109.014 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.49 131.72 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.444 -0.785 . . . . 99.989999999999995 109.414 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.534 ' CE1' ' OG1' ' A' ' 108' ' ' THR . 95.5 m-85 -105.71 127.75 53.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 99.989999999999995 109.237 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 tt -118.24 129.89 55.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.428 -0.795 . . . . 99.989999999999995 110.246 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 m -129.47 148.88 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.136 -0.69 . . . . 99.989999999999995 109.136 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 140.92 34.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 99.989999999999995 109.87 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -154.98 157.33 37.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 99.989999999999995 109.315 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.5 p -83.37 157.03 22.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 99.989999999999995 109.441 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 84' ' ' VAL . 7.1 p -100.56 6.57 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 99.989999999999995 110.177 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -104.13 0.44 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 99.989999999999995 110.333 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -114.51 95.85 41.43 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 99.989999999999995 109.843 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.56 -48.87 19.22 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.298 1.999 . . . . 99.989999999999995 112.284 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 m -53.49 -40.47 65.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.046 . . . . 99.989999999999995 109.141 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 86' ' ' SER . 81.6 p -67.36 -19.75 65.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.084 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -68.66 -50.92 47.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 99.989999999999995 108.742 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.92 -34.63 75.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.474 -0.766 . . . . 99.989999999999995 109.395 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -54.25 -34.41 60.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.885 . . . . 99.989999999999995 109.746 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.55 -37.71 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 99.989999999999995 110.153 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -91.94 -44.41 8.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 99.989999999999995 110.738 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.2 -36.71 82.76 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 112.199 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -114.53 -52.31 2.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.952 -1.093 . . . . 99.989999999999995 112.901 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.6 -38.48 80.66 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.075 -1.016 . . . . 99.989999999999995 113.487 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -57.48 -52.01 77.46 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.134 -1.604 . . . . 99.989999999999995 111.084 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -70.94 -37.79 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.717 1.611 . . . . 99.989999999999995 112.787 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.97 -40.79 85.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 99.989999999999995 110.977 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.1 tp -65.01 -28.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.755 -1.215 . . . . 99.989999999999995 109.538 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -61.64 -40.84 96.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 99.989999999999995 109.939 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -54.52 -40.65 68.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 99.989999999999995 109.68 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.521 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 64.8 m170 -57.39 -40.33 77.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 99.989999999999995 109.22 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.1 m 177.83 150.75 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 99.989999999999995 109.399 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.15 -27.85 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.639 2.226 . . . . 99.989999999999995 112.319 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -127.64 137.84 52.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.76 . . . . 99.989999999999995 109.753 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 ' OG1' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -175.61 147.71 0.96 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 99.989999999999995 109.073 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.474 ' N ' ' HG1' ' A' ' 108' ' ' THR . 36.3 Cg_endo -68.84 122.01 8.91 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.217 1.945 . . . . 99.989999999999995 111.758 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -108.7 123.8 49.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 99.989999999999995 109.655 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.6 tp -117.47 125.18 50.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 109.314 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.5 tp -109.81 119.1 38.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 99.989999999999995 109.4 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 135.58 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 99.989999999999995 109.905 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.82 125.78 8.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.663 -1.775 . . . . 99.989999999999995 108.663 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.0 p -124.07 163.87 20.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -1.093 . . . . 99.989999999999995 110.575 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 68.74 33.95 3.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.802 -0.561 . . . . 99.989999999999995 110.047 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 pt -74.29 -2.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 99.989999999999995 110.723 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.5 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 80.0 m-20 -84.26 -26.55 28.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.861 -1.15 . . . . 99.989999999999995 109.603 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.86 -30.93 70.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 99.989999999999995 109.265 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -57.74 -25.38 60.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 109.644 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -99.99 26.81 6.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 109.908 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -111.64 95.73 29.1 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 99.989999999999995 109.451 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.88 -44.14 38.09 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.174 1.916 . . . . 99.989999999999995 112.142 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -57.94 -37.03 73.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.187 -0.946 . . . . 99.989999999999995 109.483 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.1 m -73.85 -47.65 36.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.753 -1.203 . . . . 99.989999999999995 107.753 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -54.34 -34.78 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.594 -0.891 . . . . 99.989999999999995 108.594 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -62.5 -46.56 87.86 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.317 -0.994 . . . . 99.989999999999995 108.317 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -59.5 -36.84 76.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.454 -0.779 . . . . 99.989999999999995 108.976 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.42 -37.53 65.87 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.665 -0.865 . . . . 99.989999999999995 108.665 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.32 75.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.676 -0.64 . . . . 99.989999999999995 109.764 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -59.18 -37.52 77.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.986 -1.071 . . . . 99.989999999999995 109.168 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -90.89 4.96 50.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 99.989999999999995 109.472 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.1 mttp 52.36 35.46 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.838 . . . . 99.989999999999995 109.496 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 135' ' ' LYS . 97.8 mt-30 -92.84 -53.84 4.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 99.989999999999995 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' GLN . 7.1 mttt 62.09 144.37 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 99.989999999999995 109.056 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 147.25 87.63 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.58 2.186 . . . . 99.989999999999995 112.487 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -78.22 149.81 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 99.989999999999995 108.79 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 154.32 60.57 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.992 -1.067 . . . . 99.989999999999995 109.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.65 -33.52 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.318 2.012 . . . . 99.989999999999995 111.819 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.05 -36.03 80.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 99.989999999999995 109.649 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.3 m -68.22 -36.99 80.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 99.989999999999995 109.245 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.5 -44.3 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -0.811 . . . . 99.989999999999995 110.099 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.587 ' OE2' ' CE2' ' A' ' 154' ' ' TYR . 99.1 mt-10 -63.67 -32.32 73.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.02 . . . . 99.989999999999995 110.35 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.528 ' NZ ' ' OD2' ' A' ' 148' ' ' ASP . 13.2 tttm -65.95 -38.17 87.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.923 -1.111 . . . . 99.989999999999995 110.157 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.99 -39.32 81.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.875 . . . . 99.989999999999995 110.172 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 148' ' ' ASP . . . -78.75 -49.74 12.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 99.989999999999995 110.018 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -60.3 -2.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 99.989999999999995 110.306 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.528 ' OD2' ' NZ ' ' A' ' 144' ' ' LYS . 86.2 m-20 -111.29 -21.58 11.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.041 . . . . 99.989999999999995 109.91 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.57 26.74 8.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 99.989999999999995 110.494 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 59.79 31.03 20.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.224 -0.922 . . . . 99.989999999999995 110.613 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.11 144.75 56.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.0 . . . . 99.989999999999995 108.866 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.94 -59.62 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 99.989999999999995 109.858 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -165.31 157.26 15.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 99.989999999999995 109.755 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CE2' ' OE2' ' A' ' 143' ' ' GLU . 21.1 p90 -117.4 144.31 45.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 99.989999999999995 109.008 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.8 t -131.09 138.51 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.8 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -102.13 129.01 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.1 -1.074 . . . . 99.989999999999995 108.1 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.403 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -138.24 146.52 42.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -0.999 . . . . 99.989999999999995 111.312 -178.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.5 ' OG ' ' OD2' ' A' ' 118' ' ' ASP . 23.6 t -115.69 110.4 19.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.461 -0.775 . . . . 99.989999999999995 109.044 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.51 61.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.761 -0.587 . . . . 99.989999999999995 109.785 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -53.75 -32.14 51.15 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.27 -1.011 . . . . 99.989999999999995 108.27 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.525 ' HG1' ' H ' ' A' ' 163' ' ' LYS . 22.2 p -125.1 166.45 16.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.542 -0.91 . . . . 99.989999999999995 108.542 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.658 ' NE2' ' ND2' ' A' ' 26' ' ' ASN . 95.2 mm-40 -70.1 12.31 0.23 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.409 -0.589 . . . . 99.989999999999995 109.409 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.525 ' H ' ' HG1' ' A' ' 161' ' ' THR . 48.6 mtmt -89.41 9.4 26.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 99.989999999999995 109.262 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.423 ' HA2' ' H ' ' A' ' 158' ' ' SER . . . -105.37 -50.64 0.91 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.001 -1.095 . . . . 99.989999999999995 110.436 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 43.8 mt -63.02 -36.7 84.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -1.234 . . . . 99.989999999999995 110.097 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -58.62 -29.75 66.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 99.989999999999995 110.999 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -94.74 -41.93 9.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.958 -1.088 . . . . 99.989999999999995 110.39 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 80.4 t -60.52 -38.52 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.844 . . . . 99.989999999999995 111.174 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 50.9 m-85 -89.94 -13.56 36.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.772 -1.205 . . . . 99.989999999999995 111.296 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.6 -50.34 72.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.715 -1.241 . . . . 99.989999999999995 109.686 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -80.79 -21.98 40.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 110.003 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.58 77.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 110.421 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.65 -43.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 99.989999999999995 109.912 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.34 -44.27 88.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 109.605 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.39 80.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -0.995 . . . . 99.989999999999995 109.698 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.17 97.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 109.828 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.58 -40.38 94.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 99.989999999999995 109.115 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.477 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.766 -0.827 . . . . 99.989999999999995 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.2 m -123.88 145.28 49.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 99.989999999999995 109.156 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.86 115.18 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 99.989999999999995 109.17 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -82.87 122.57 28.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 99.989999999999995 109.5 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -132.57 119.23 20.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 99.989999999999995 109.311 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.93 138.79 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 99.989999999999995 109.433 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.04 131.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.874 -0.788 . . . . 99.989999999999995 108.874 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.57 139.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.101 -0.999 . . . . 99.989999999999995 109.384 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.13 165.0 31.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.475 -1.45 . . . . 99.989999999999995 109.475 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 23.2 t70 -80.68 86.46 5.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.176 -1.191 . . . . 99.989999999999995 109.353 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.5 86.86 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.636 -1.386 . . . . 99.989999999999995 109.636 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.68 -5.41 45.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -1.095 . . . . 99.989999999999995 109.395 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.21 -58.06 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 99.989999999999995 110.151 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.66 16.12 26.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.488 -1.045 . . . . 99.989999999999995 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' NZ ' ' OD1' ' A' ' 57' ' ' ASP . 46.9 tttm -63.33 -41.14 98.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.828 -1.395 . . . . 99.989999999999995 110.063 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 p -68.71 -43.24 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 110.183 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.402 ' O ' ' OG ' ' A' ' 22' ' ' SER . 6.4 m -61.88 -28.56 69.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 99.989999999999995 110.766 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.39 -43.48 85.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.878 -1.139 . . . . 99.989999999999995 109.785 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.09 -40.6 82.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 99.989999999999995 109.652 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.67 -44.31 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.299 -0.875 . . . . 99.989999999999995 109.852 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 18' ' ' CYS . 24.0 m -49.97 -35.04 22.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 99.989999999999995 110.171 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -89.55 -48.51 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.839 -1.163 . . . . 99.989999999999995 110.04 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.0 m -57.35 -42.05 81.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 99.989999999999995 111.764 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 65.6 p -140.66 -12.34 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 99.989999999999995 111.683 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 25' ' ' THR . 3.4 m-20 86.4 115.48 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.371 -0.974 . . . . 99.989999999999995 108.371 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ASN . 16.4 mttt 164.48 76.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.001 -0.74 . . . . 99.989999999999995 109.001 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.613 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -62.19 -42.4 80.91 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 99.989999999999995 110.108 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.4 Cg_exo -55.58 -38.6 93.98 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.372 2.048 . . . . 99.989999999999995 112.335 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.627 ' O ' ' N ' ' A' ' 32' ' ' TYR . 1.8 p 64.55 -50.29 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 99.989999999999995 109.869 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 29' ' ' PRO . 96.4 mt-10 57.02 -72.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 99.989999999999995 109.673 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.627 ' N ' ' O ' ' A' ' 30' ' ' SER . 81.9 t80 -107.07 124.62 49.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 109.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 1.8 m -64.5 152.95 88.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 99.989999999999995 109.329 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.55 136.18 72.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.544 2.163 . . . . 99.989999999999995 112.337 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.63 71.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.753 . . . . 99.989999999999995 110.098 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.7 155.74 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 99.989999999999995 109.566 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -107.68 94.15 4.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 109.216 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -123.24 147.81 46.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 99.989999999999995 110.07 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -70.63 149.09 47.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -0.792 . . . . 99.989999999999995 109.316 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -121.28 146.37 46.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 99.989999999999995 109.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.51 146.45 41.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 99.989999999999995 109.455 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.93 141.92 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 99.989999999999995 109.45 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.5 m -97.75 134.55 40.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 99.989999999999995 109.869 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 51' ' ' TYR . 33.9 t -120.75 136.63 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 99.989999999999995 109.393 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.0 ttt -105.03 140.05 38.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 99.989999999999995 109.946 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.77 143.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 99.989999999999995 109.055 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.64 -30.96 9.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.281 -1.928 . . . . 99.989999999999995 108.281 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.46 -96.19 0.08 OUTLIER Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.556 -1.818 . . . . 99.989999999999995 108.556 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -123.03 156.59 62.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.961 . . . . 99.989999999999995 109.376 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.03 138.4 43.84 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.651 2.234 . . . . 99.989999999999995 112.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.591 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 98.8 m-85 -141.86 162.9 34.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.088 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 p -118.87 155.74 30.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 99.989999999999995 109.413 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.8 tp -118.73 118.27 31.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -0.751 . . . . 99.989999999999995 109.357 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.73 124.67 7.73 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.4 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -107.86 121.69 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -1.113 . . . . 99.989999999999995 108.481 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -121.29 149.38 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.281 -0.887 . . . . 99.989999999999995 109.691 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' NZ ' ' A' ' 16' ' ' LYS . 21.7 t70 -153.51 157.91 40.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 99.989999999999995 109.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 p -75.74 152.26 37.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 99.989999999999995 109.362 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 99.989999999999995 109.36 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.593 -0.521 . . . . 99.989999999999995 109.593 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.5 m -114.37 131.6 56.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.524 -0.735 . . . . 99.989999999999995 109.403 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.25 -39.04 88.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.351 -0.843 . . . . 99.989999999999995 109.632 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.05 131.51 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.19 -0.944 . . . . 99.989999999999995 109.957 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -102.95 125.37 49.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 99.989999999999995 108.385 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 mt -108.27 141.47 40.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.179 -0.951 . . . . 99.989999999999995 110.543 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.6 t -124.94 135.08 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.113 -0.699 . . . . 99.989999999999995 109.113 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.531 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -127.86 126.46 41.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.324 -0.86 . . . . 99.989999999999995 109.678 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -136.55 166.03 24.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.434 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 m -104.24 148.54 26.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 99.989999999999995 109.583 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 7.8 p -105.96 13.98 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 99.989999999999995 110.146 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.54 -6.81 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 99.989999999999995 110.111 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -127.81 102.96 21.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 109.85 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.68 -41.82 52.56 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.036 1.824 . . . . 99.989999999999995 111.916 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -56.55 -37.4 70.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 99.989999999999995 109.163 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -69.6 -26.21 64.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 99.989999999999995 109.244 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.47 -50.9 41.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 99.989999999999995 109.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.55 -35.0 75.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 99.989999999999995 109.603 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.586 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 41.6 t-20 -56.52 -34.39 66.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 109.95 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.22 -36.84 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.088 -1.008 . . . . 99.989999999999995 109.972 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.93 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 99.989999999999995 109.86 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -80.27 -27.46 38.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 99.989999999999995 111.34 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -112.23 -44.76 3.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.054 -1.029 . . . . 99.989999999999995 112.479 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -85.76 1.95 47.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.903 -1.123 . . . . 99.989999999999995 113.072 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -109.16 -40.63 0.12 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.471 -1.393 . . . . 99.989999999999995 110.666 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 62.3 Cg_endo -92.36 -56.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.275 2.65 . . . . 99.989999999999995 113.253 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.6 -35.28 75.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 110.892 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.69 -28.85 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.71 -1.244 . . . . 99.989999999999995 110.121 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 m -59.24 -42.18 90.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.675 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.08 -32.55 69.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 99.989999999999995 109.691 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -63.21 -41.87 99.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 99.989999999999995 109.524 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 173.08 170.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 99.989999999999995 109.248 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' CYS . 51.9 Cg_exo -49.01 -164.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.503 2.136 . . . . 99.989999999999995 112.348 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -80.98 138.28 36.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 99.989999999999995 109.623 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 168.77 16.06 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 99.989999999999995 109.343 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -40.37 98.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 99.989999999999995 111.574 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -109.38 128.89 55.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.563 -0.711 . . . . 99.989999999999995 109.957 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.3 tp -120.16 124.07 44.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 99.989999999999995 109.01 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.0 tp -103.67 120.37 40.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 109.186 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.95 134.42 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 99.989999999999995 110.064 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.92 113.0 3.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.722 -1.751 . . . . 99.989999999999995 108.722 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.531 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 13.9 m -103.11 148.79 25.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -1.13 . . . . 99.989999999999995 110.284 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 117' ' ' ILE . 92.1 mt-30 62.83 38.5 11.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 122.052 -0.405 . . . . 99.989999999999995 111.491 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 116' ' ' GLN . 21.0 pt -57.99 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.272 -1.381 . . . . 99.989999999999995 107.272 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 121' ' ' ASP . 88.6 m-20 52.3 18.51 0.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.364 -1.46 . . . . 99.989999999999995 109.146 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.3 tp 30.81 52.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.817 -0.552 . . . . 99.989999999999995 111.509 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 121' ' ' ASP . 97.8 mtt180 54.24 22.39 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 99.989999999999995 110.501 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 118' ' ' ASP . 60.9 t0 33.22 61.38 0.42 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.718 -0.614 . . . . 99.989999999999995 110.257 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 120' ' ' ARG . 81.0 m-20 -132.34 85.56 48.51 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.457 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.34 -28.33 26.6 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.5 2.133 . . . . 99.989999999999995 112.118 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -81.76 -4.34 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 99.989999999999995 109.066 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 122' ' ' ASP . 98.8 m -92.83 -47.93 6.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 99.989999999999995 109.201 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.97 -48.49 25.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.896 . . . . 99.989999999999995 110.253 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -60.8 -39.95 90.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 99.989999999999995 111.098 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -83.01 -6.61 59.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.544 -1.347 . . . . 99.989999999999995 110.39 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.45 -49.98 2.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 110.368 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.421 ' HA ' ' H ' ' A' ' 135' ' ' LYS . . . -55.08 -46.55 75.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.821 -1.174 . . . . 99.989999999999995 109.02 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -48.5 -24.72 1.38 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.423 -0.955 . . . . 99.989999999999995 108.423 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -76.27 -55.3 5.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.099 -1.075 . . . . 99.989999999999995 108.099 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 134' ' ' GLN . 36.1 ttpt -173.99 76.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 99.989999999999995 110.169 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 133' ' ' LYS . 3.7 mp0 33.27 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.65 -0.657 . . . . 99.989999999999995 110.673 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.2 tptm -90.35 -38.82 0.41 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.083 -1.011 . . . . 99.989999999999995 110.973 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 71.8 Cg_endo -89.09 127.5 1.78 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.845 2.363 . . . . 99.989999999999995 113.308 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 4.2 mp -96.9 135.55 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 99.989999999999995 109.357 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.9 155.68 72.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 109.468 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.33 -32.71 96.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.373 2.049 . . . . 99.989999999999995 111.622 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.11 -36.94 73.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 99.989999999999995 109.221 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 m -67.79 -29.78 69.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.283 -0.885 . . . . 99.989999999999995 108.692 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.03 62.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 99.989999999999995 110.213 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.97 -35.65 75.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.951 -1.093 . . . . 99.989999999999995 110.708 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 94.8 mttt -63.85 -36.84 85.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.855 -1.153 . . . . 99.989999999999995 109.318 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.5 tp -53.24 -43.2 67.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.396 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.32 -45.39 66.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.399 -0.813 . . . . 99.989999999999995 109.796 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.01 1.09 21.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 99.989999999999995 110.878 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 87.9 m-20 -66.76 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.237 . . . . 99.989999999999995 109.742 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.3 mt -121.52 -81.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.783 . . . . 99.989999999999995 109.722 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -162.76 54.16 0.2 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.333 -0.854 . . . . 99.989999999999995 109.29 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.23 137.4 54.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.855 -1.153 . . . . 99.989999999999995 109.106 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 81.4 t -66.78 -54.24 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 99.989999999999995 109.481 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -156.52 159.84 38.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 99.989999999999995 109.976 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -128.91 146.14 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.835 . . . . 99.989999999999995 108.747 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.16 152.1 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 99.989999999999995 110.436 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 129.99 54.81 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.199 -1.037 . . . . 99.989999999999995 108.199 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -134.13 143.78 48.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.968 -1.083 . . . . 99.989999999999995 110.817 -178.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 161' ' ' THR . 9.5 t -115.18 110.25 19.2 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 99.989999999999995 108.909 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.379 0.609 . . . . 99.989999999999995 109.391 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.3 mt -55.03 -27.97 48.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.259 -0.9 . . . . 99.989999999999995 108.707 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.651 ' HG1' ' H ' ' A' ' 163' ' ' LYS . 18.3 p -125.99 171.04 11.11 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.442 -0.947 . . . . 99.989999999999995 108.442 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -74.02 11.65 0.86 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.674 -0.641 . . . . 99.989999999999995 109.708 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.651 ' H ' ' HG1' ' A' ' 161' ' ' THR . 49.8 mttt -89.34 1.18 56.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 99.989999999999995 109.459 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.472 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -93.83 -51.15 2.17 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.881 -1.287 . . . . 99.989999999999995 109.881 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.38 -39.47 71.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -1.152 . . . . 99.989999999999995 110.259 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.16 -33.02 70.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.198 -0.939 . . . . 99.989999999999995 111.329 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.42 -50.32 46.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.811 -1.181 . . . . 99.989999999999995 109.354 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.22 1.63 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.496 -0.753 . . . . 99.989999999999995 110.449 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.6 -50.83 16.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.855 -1.153 . . . . 99.989999999999995 109.768 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.55 -43.88 83.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 110.014 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.31 -33.08 74.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 99.989999999999995 109.88 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.42 80.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 109.977 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 71.7 mt -73.12 -42.33 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.994 . . . . 99.989999999999995 109.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.1 tp -59.32 -46.31 88.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 99.989999999999995 110.21 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.69 78.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.972 -1.08 . . . . 99.989999999999995 109.948 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.98 66.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 99.989999999999995 109.459 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.61 -39.83 89.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 99.989999999999995 109.193 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.818 . . . . 99.989999999999995 109.514 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.011 -0.737 . . . . 99.989999999999995 109.011 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -138.71 161.68 36.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 99.989999999999995 109.888 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.2 120.23 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.755 -0.831 . . . . 99.989999999999995 108.755 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -93.12 130.74 38.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 99.989999999999995 109.974 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 t -135.0 129.65 34.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.848 . . . . 99.989999999999995 109.209 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.1 t -117.89 142.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 109.857 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.13 133.69 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.688 -0.856 . . . . 99.989999999999995 108.688 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG1' ' CH2' ' A' ' 97' ' ' TRP . 46.7 t -140.35 134.0 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.129 -0.982 . . . . 99.989999999999995 109.491 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.55 99.83 0.15 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.637 -1.385 . . . . 99.989999999999995 109.637 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.36 -40.49 90.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.061 -1.258 . . . . 99.989999999999995 109.04 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.59 120.05 5.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.345 -1.502 . . . . 99.989999999999995 109.345 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 172.08 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 99.989999999999995 109.392 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.52 -41.72 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.9 . . . . 99.989999999999995 109.371 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.11 0.79 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.368 -1.493 . . . . 99.989999999999995 109.368 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -61.13 -40.08 92.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -1.127 . . . . 99.989999999999995 109.568 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -65.13 -41.81 94.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 108.979 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -30.32 65.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.373 -0.829 . . . . 99.989999999999995 109.633 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.12 -41.75 97.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.113 -0.992 . . . . 99.989999999999995 108.608 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.13 -39.73 82.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 99.989999999999995 109.225 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.5 mm -63.66 -48.17 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 109.588 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -58.83 -36.29 74.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 99.989999999999995 110.346 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -80.15 -50.87 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 99.989999999999995 109.764 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.5 m -60.39 -41.24 93.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 99.989999999999995 109.736 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 30.2 p -112.16 -111.42 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.354 -0.841 . . . . 99.989999999999995 109.186 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.534 ' N ' ' OG1' ' A' ' 25' ' ' THR . 37.1 p-10 -173.69 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 99.989999999999995 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -102.25 106.88 17.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 99.989999999999995 110.08 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -67.73 -42.77 36.52 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 108.876 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 31.4 Cg_exo -59.77 -26.66 82.88 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.655 2.237 . . . . 99.989999999999995 112.078 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.8 m 42.56 41.86 2.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 99.989999999999995 109.683 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 96.3 mt-10 -37.56 -35.7 0.14 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.432 -0.792 . . . . 99.989999999999995 110.456 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -117.31 122.76 44.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.252 -0.905 . . . . 99.989999999999995 109.502 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 33' ' ' VAL . 34.4 m -128.29 75.61 78.85 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 99.989999999999995 109.756 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 92.7 Cg_endo -84.28 -102.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.043 2.496 . . . . 99.989999999999995 112.329 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 34' ' ' PRO . . . 158.21 41.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 99.989999999999995 108.8 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.2 -41.66 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 99.989999999999995 109.935 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.25 130.41 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 99.989999999999995 110.006 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.603 ' CG ' ' H ' ' A' ' 39' ' ' ASN . 50.9 t0 -93.52 -144.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.661 -0.866 . . . . 99.989999999999995 108.661 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.603 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 63.5 t-20 -42.71 124.94 3.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 99.989999999999995 109.718 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.454 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 58.0 t80 -132.08 150.3 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 99.989999999999995 109.517 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.454 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -103.12 141.92 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 109.513 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.78 133.81 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 99.989999999999995 109.355 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.0 m -106.19 134.53 49.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.821 . . . . 99.989999999999995 109.694 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.46 135.74 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.708 . . . . 99.989999999999995 109.353 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.8 mtm -105.67 141.26 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 99.989999999999995 109.324 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 48' ' ' GLY . 81.0 mt -122.99 141.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 99.989999999999995 109.365 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.1 -24.97 0.61 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.809 -1.716 . . . . 99.989999999999995 108.809 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -80.82 -92.37 0.48 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.53 -1.428 . . . . 99.989999999999995 109.53 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.6 mm-40 -126.45 154.32 75.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.405 -1.056 . . . . 99.989999999999995 109.717 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.71 138.26 37.56 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.729 2.286 . . . . 99.989999999999995 112.599 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 97.3 m-85 -131.76 154.19 49.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.479 -0.763 . . . . 99.989999999999995 109.161 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.9 p -118.0 148.19 42.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.828 . . . . 99.989999999999995 109.463 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.82 122.44 37.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 99.989999999999995 109.58 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.34 126.53 8.85 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.102 -1.599 . . . . 99.989999999999995 109.102 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.503 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 66.5 mt -105.1 137.22 43.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -1.175 . . . . 99.989999999999995 109.367 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.487 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.7 m-85 -122.25 149.82 43.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 109.022 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 56' ' ' PHE . 84.0 m-20 -136.82 161.53 35.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 99.989999999999995 109.367 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 162.73 21.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 109.171 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 109.372 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.677 -0.49 . . . . 99.989999999999995 109.677 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.3 m -117.57 128.41 54.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 99.989999999999995 109.654 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -66.17 -33.92 76.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 99.989999999999995 109.957 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.09 132.67 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.354 -0.841 . . . . 99.989999999999995 109.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -111.63 126.26 54.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 99.989999999999995 109.024 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.2 140.35 44.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.922 . . . . 99.989999999999995 109.949 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.4 136.03 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 99.989999999999995 109.165 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.2 t -129.83 121.72 27.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 99.989999999999995 109.853 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -145.97 163.23 35.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.303 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -89.58 137.57 32.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.152 -0.967 . . . . 99.989999999999995 109.395 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -93.66 -12.64 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.945 . . . . 99.989999999999995 110.31 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.4 t -90.43 -13.82 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.035 -1.04 . . . . 99.989999999999995 110.015 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 m -100.6 128.59 29.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 99.989999999999995 109.684 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.624 ' CG ' ' NE2' ' A' ' 134' ' ' GLN . 45.7 Cg_endo -73.55 -46.36 0.35 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.988 1.792 . . . . 99.989999999999995 112.298 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -55.31 -41.78 72.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.848 -1.158 . . . . 99.989999999999995 108.933 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.2 p -68.29 -23.09 64.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.018 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -72.08 -50.82 25.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 99.989999999999995 109.319 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -67.91 -37.0 81.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 99.989999999999995 109.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.47 -34.38 57.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 109.684 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.41 -38.25 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 99.989999999999995 110.457 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -93.79 -32.79 13.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 99.989999999999995 110.91 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -68.49 -36.58 79.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.883 -1.135 . . . . 99.989999999999995 112.416 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -113.62 -52.0 2.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.886 -1.134 . . . . 99.989999999999995 112.619 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.438 ' CH2' ' CG1' ' A' ' 9' ' ' VAL . 72.7 m95 -67.54 -30.71 70.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.963 . . . . 99.989999999999995 113.026 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 1.9 t -72.57 -51.06 7.43 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.141 -1.599 . . . . 99.989999999999995 111.439 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.68 -47.75 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.953 1.769 . . . . 99.989999999999995 113.23 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -58.08 -40.07 80.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 99.989999999999995 111.016 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 tp -64.18 -24.55 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 99.989999999999995 110.223 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -57.76 -39.61 77.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 99.989999999999995 110.479 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -53.56 -32.5 51.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 99.989999999999995 110.685 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -84.45 7.1 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.054 . . . . 99.989999999999995 110.483 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.7 m 55.35 69.78 1.84 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 99.989999999999995 109.284 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.49 128.0 26.26 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.604 2.202 . . . . 99.989999999999995 112.472 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -151.73 -39.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.69 -0.856 . . . . 99.989999999999995 108.69 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -62.72 156.14 66.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.502 -0.749 . . . . 99.989999999999995 109.166 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.25 135.68 71.78 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.691 2.261 . . . . 99.989999999999995 112.459 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 108' ' ' THR . 98.1 m-85 -116.58 137.76 51.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 99.989999999999995 109.356 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.3 tp -117.53 124.76 49.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 99.989999999999995 109.451 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.51 120.43 40.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 108.853 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.92 137.54 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.848 . . . . 99.989999999999995 110.357 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.0 129.25 9.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.214 -1.954 . . . . 99.989999999999995 108.214 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.9 t -118.14 156.92 27.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.136 -1.214 . . . . 99.989999999999995 111.18 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 61.36 38.42 16.24 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.895 -0.593 . . . . 99.989999999999995 110.73 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 pt -72.3 -3.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.096 . . . . 99.989999999999995 109.764 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 86.1 m-20 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 99.989999999999995 109.378 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.98 -32.81 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 99.989999999999995 109.26 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -59.88 -25.16 64.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 99.989999999999995 109.241 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 59.6 t0 -83.91 8.21 15.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.785 . . . . 99.989999999999995 109.61 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -117.95 85.32 22.96 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.45 -0.781 . . . . 99.989999999999995 109.222 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.74 -23.81 16.54 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.696 2.264 . . . . 99.989999999999995 112.35 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.2 p -58.52 -30.01 66.74 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.852 -1.155 . . . . 99.989999999999995 109.852 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.2 m -80.44 -52.81 7.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 99.989999999999995 110.009 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.6 pt -56.51 -20.67 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 109.31 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.34 -50.38 70.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 108.701 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -56.49 -31.29 63.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 99.989999999999995 109.734 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.04 -36.04 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 109.074 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.01 -38.82 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 99.989999999999995 109.864 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -59.68 -36.29 76.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.051 . . . . 99.989999999999995 109.276 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.13 8.14 16.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.394 -0.816 . . . . 99.989999999999995 109.614 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.95 34.96 24.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 99.989999999999995 109.35 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.624 ' NE2' ' CG ' ' A' ' 87' ' ' PRO . 56.9 tt0 -127.4 121.12 30.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.386 -0.821 . . . . 99.989999999999995 108.811 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -92.79 156.49 40.76 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.41 -0.806 . . . . 99.989999999999995 110.058 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.17 160.35 42.44 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.118 2.545 . . . . 99.989999999999995 112.057 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.8 mm -97.46 126.04 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 99.989999999999995 109.389 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.36 155.69 79.03 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.843 . . . . 99.989999999999995 109.422 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.39 -34.48 98.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.433 2.089 . . . . 99.989999999999995 111.619 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.44 -37.22 77.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 99.989999999999995 108.871 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -67.4 -32.82 73.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -0.814 . . . . 99.989999999999995 109.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.96 -39.71 61.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.72 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.41 -32.31 70.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 110.107 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 69.4 tttt -61.86 -38.82 89.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.956 -1.09 . . . . 99.989999999999995 109.651 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.41 -34.64 78.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 99.989999999999995 110.136 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.01 88.72 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.993 -1.067 . . . . 99.989999999999995 108.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -86.06 8.44 20.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.35 -0.844 . . . . 99.989999999999995 110.121 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 90.3 m-20 -84.22 -24.6 29.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.794 -1.191 . . . . 99.989999999999995 108.847 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.8 mt -121.07 -104.0 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.628 -0.67 . . . . 99.989999999999995 109.275 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -145.71 43.72 1.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 109.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.06 141.76 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 99.989999999999995 109.342 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.23 -65.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 110.113 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -145.67 160.37 41.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.132 -0.98 . . . . 99.989999999999995 110.418 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -131.28 150.5 52.12 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.842 -0.799 . . . . 99.989999999999995 108.842 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.55 154.09 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.037 -1.039 . . . . 99.989999999999995 110.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -109.66 133.94 52.54 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.488 -0.93 . . . . 99.989999999999995 108.488 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.53 140.21 48.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 99.989999999999995 111.025 -178.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . 39.9 t -106.89 105.58 15.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.44 -0.787 . . . . 99.989999999999995 109.036 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.82 70.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.601 . . . . 99.989999999999995 109.558 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.7 tp -50.91 -31.01 16.26 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.561 -0.903 . . . . 99.989999999999995 108.561 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.549 ' C ' ' H ' ' A' ' 163' ' ' LYS . 18.7 p -123.84 162.45 23.23 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.196 -1.038 . . . . 99.989999999999995 108.196 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.09 12.32 0.12 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.553 -0.717 . . . . 99.989999999999995 109.344 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 161' ' ' THR . 67.7 mttm -88.11 2.28 52.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 99.989999999999995 109.684 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.72 -51.52 2.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.897 -1.281 . . . . 99.989999999999995 109.897 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.48 -40.64 73.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -1.226 . . . . 99.989999999999995 109.936 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.23 -29.94 70.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 110.407 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -71.72 -50.95 25.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 99.989999999999995 109.523 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.1 m -80.35 -4.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -0.763 . . . . 99.989999999999995 110.566 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.81 -50.17 21.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.181 . . . . 99.989999999999995 110.052 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.92 -42.39 99.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 99.989999999999995 110.246 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.36 -34.68 78.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 99.989999999999995 110.023 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.9 74.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 99.989999999999995 110.568 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.6 -41.48 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.899 -1.126 . . . . 99.989999999999995 110.392 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.77 -41.72 82.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.987 . . . . 99.989999999999995 110.223 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.15 77.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.961 -1.087 . . . . 99.989999999999995 110.128 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.22 89.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 99.989999999999995 110.094 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.5 mt -65.23 -37.63 87.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.997 -1.064 . . . . 99.989999999999995 109.387 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.461 -179.85 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.277 0.561 . . . . 99.989999999999995 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 157.48 46.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 99.989999999999995 109.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.8 mt -118.8 120.8 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.985 -0.746 . . . . 99.989999999999995 108.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -81.62 128.35 33.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 99.989999999999995 109.307 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 t -132.89 115.57 15.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 99.989999999999995 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -109.72 132.22 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 99.989999999999995 109.316 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.05 142.97 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.404 -0.81 . . . . 99.989999999999995 109.674 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.99 145.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.29 -0.881 . . . . 99.989999999999995 108.983 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 171.94 22.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.907 -1.277 . . . . 99.989999999999995 109.907 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 12' ' ' GLY . 59.1 t0 -74.04 134.03 42.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -1.116 . . . . 99.989999999999995 109.128 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . -27.77 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.499 2.855 0 N-CA-C 111.01 -0.836 . . . . 99.989999999999995 111.01 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . -41.4 -37.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.023 -1.281 . . . . 99.989999999999995 110.567 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' ASP . 58.1 t -69.3 123.97 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.671 -1.268 . . . . 99.989999999999995 109.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 73.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.593 -1.403 . . . . 99.989999999999995 109.593 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.1 pttp -61.26 -33.62 73.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 99.989999999999995 109.528 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.4 p -70.38 -42.0 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 99.989999999999995 109.633 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.1 m -60.39 -25.99 66.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 110.009 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.72 -39.77 88.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 99.989999999999995 109.387 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD1' ' OD2' ' A' ' 57' ' ' ASP . 70.1 mt -64.94 -42.23 94.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.269 -0.894 . . . . 99.989999999999995 109.538 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mm -70.14 -49.02 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 99.989999999999995 109.713 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.2 m -57.26 -36.66 71.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 99.989999999999995 109.5 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.74 -44.49 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 110.206 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.1 m -65.79 -47.6 74.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 99.989999999999995 110.108 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.8 p -84.48 -19.5 33.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 99.989999999999995 109.711 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.82 36.76 22.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 99.989999999999995 109.366 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -141.23 82.54 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 99.989999999999995 109.467 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.664 ' CE2' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -55.28 -44.25 99.53 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.202 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -56.48 -15.83 16.65 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.28 1.987 . . . . 99.989999999999995 111.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' TYR . 95.6 p -59.86 -34.18 72.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 108.995 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.3 mt-10 37.68 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.648 -0.657 . . . . 99.989999999999995 110.321 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.2 m-85 -83.76 -95.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.019 -1.051 . . . . 99.989999999999995 109.279 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 32' ' ' TYR . 6.4 p 36.52 57.76 3.41 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.445 -0.784 . . . . 99.989999999999995 110.964 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.77 -18.46 32.23 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.815 2.344 . . . . 99.989999999999995 112.08 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.47 -172.68 2.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.329 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.28 140.66 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.199 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.16 -90.06 0.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 99.989999999999995 109.623 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.7 p30 -138.15 -173.39 3.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 109.904 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -67.33 149.23 50.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 99.989999999999995 109.831 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -118.13 146.71 43.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.732 . . . . 99.989999999999995 109.204 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 137.25 45.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 99.989999999999995 109.148 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.4 138.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.861 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -93.3 133.94 36.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 99.989999999999995 109.284 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.1 t -120.36 135.06 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 99.989999999999995 109.731 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -93.57 130.59 39.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 99.989999999999995 109.316 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 68.5 mt -132.8 126.82 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 99.989999999999995 109.151 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.54 17.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.73 -1.348 . . . . 99.989999999999995 109.73 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.15 13.87 58.26 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.057 -1.217 . . . . 99.989999999999995 110.057 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 11.3 mt-10 -119.61 85.86 33.55 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.414 -1.051 . . . . 99.989999999999995 109.282 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -53.7 125.66 19.34 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.681 2.254 . . . . 99.989999999999995 113.195 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 91.3 m-85 -121.61 143.22 49.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.688 . . . . 99.989999999999995 109.232 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.5 m -76.03 131.25 39.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 99.989999999999995 109.32 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -128.1 129.6 46.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 99.989999999999995 109.57 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.79 143.45 14.64 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.562 -1.415 . . . . 99.989999999999995 109.562 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.17 132.24 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 99.989999999999995 109.407 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -118.09 131.28 56.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.809 . . . . 99.989999999999995 109.774 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.8 p30 -136.19 172.38 13.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 99.989999999999995 109.773 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.2 m -71.5 138.25 48.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 99.989999999999995 109.59 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 99.989999999999995 109.596 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.613 -0.514 . . . . 99.989999999999995 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 5.1 p -126.03 153.95 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.506 -0.746 . . . . 99.989999999999995 109.372 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 75' ' ' THR . 90.5 m-20 -138.21 -41.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 109.718 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.02 132.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 110.0 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -108.43 126.95 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 99.989999999999995 109.142 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 tp -118.53 126.37 51.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 99.989999999999995 109.546 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.86 138.68 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 109.263 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 133.84 48.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 99.989999999999995 109.542 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -138.45 158.47 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 99.989999999999995 109.379 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -77.24 138.74 39.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 99.989999999999995 109.377 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.49 -18.07 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.143 -0.973 . . . . 99.989999999999995 110.364 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 61.1 t -85.8 -8.19 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.09 -1.006 . . . . 99.989999999999995 110.374 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -103.09 107.07 54.02 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 99.989999999999995 109.976 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.18 -49.08 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.032 1.822 . . . . 99.989999999999995 112.005 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 m -58.71 -39.56 81.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 108.95 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.9 t -62.86 -21.74 66.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.472 -0.768 . . . . 99.989999999999995 109.029 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -74.43 -50.05 19.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 109.163 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -66.07 -39.2 89.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 109.481 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -57.01 -32.91 66.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 99.989999999999995 109.214 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.8 t -60.91 -37.39 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 99.989999999999995 109.787 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -94.31 -11.06 30.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.012 -1.055 . . . . 99.989999999999995 110.229 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -73.74 -33.61 64.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.646 -1.283 . . . . 99.989999999999995 111.493 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.47 -41.9 3.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.136 -0.977 . . . . 99.989999999999995 112.25 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -82.12 0.84 38.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.094 -1.004 . . . . 99.989999999999995 112.836 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.555 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -108.22 -42.75 0.12 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.49 -1.381 . . . . 99.989999999999995 110.414 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 42.9 Cg_endo -93.71 -59.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.211 2.608 . . . . 99.989999999999995 112.468 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 99.989999999999995 109.583 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.619 ' CG1' ' CE1' ' A' ' 110' ' ' PHE . 8.0 tp -54.08 -26.59 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.594 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 46.5 m -58.85 -37.93 77.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 99.989999999999995 109.759 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -53.29 -40.57 64.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 99.989999999999995 109.867 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.436 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 65.7 m170 -55.17 -36.17 65.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 99.989999999999995 109.262 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 0.7 OUTLIER 168.73 154.0 0.14 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 109.214 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.63 -33.0 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.523 2.148 . . . . 99.989999999999995 111.92 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -139.83 137.51 35.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 99.989999999999995 109.424 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -177.37 139.64 0.43 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 99.989999999999995 109.303 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.71 125.37 12.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.191 1.928 . . . . 99.989999999999995 112.202 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.619 ' CE1' ' CG1' ' A' ' 101' ' ' ILE . 86.8 m-85 -116.53 138.92 51.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 99.989999999999995 109.024 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 mp -114.89 121.2 42.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.454 -0.778 . . . . 99.989999999999995 110.035 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -110.92 125.18 53.39 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.024 -1.102 . . . . 99.989999999999995 108.024 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.0 t -117.1 138.59 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.14 -0.975 . . . . 99.989999999999995 110.977 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.4 122.1 6.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.257 -1.937 . . . . 99.989999999999995 108.257 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 t -114.33 167.35 10.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -1.115 . . . . 99.989999999999995 110.618 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 58.74 39.37 24.33 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 120.972 0.415 . . . . 99.989999999999995 110.18 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.51 -7.18 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.969 -1.082 . . . . 99.989999999999995 109.873 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.476 ' O ' ' OD2' ' A' ' 121' ' ' ASP . 53.8 p30 -83.69 -3.08 57.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 99.989999999999995 109.345 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 30.2 tp -78.29 -27.27 47.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.389 -1.337 . . . . 99.989999999999995 107.389 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -84.94 93.3 8.52 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.208 -1.405 . . . . 99.989999999999995 107.208 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 2.4 p30 169.04 -49.45 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.131 -1.063 . . . . 99.989999999999995 108.131 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.1 141.44 94.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.546 -0.721 . . . . 99.989999999999995 109.234 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.52 -31.1 27.86 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.248 1.966 . . . . 99.989999999999995 112.223 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.7 m -54.3 -33.1 58.02 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 99.989999999999995 110.29 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 56.7 p -79.49 -51.11 9.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 99.989999999999995 111.012 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.15 -29.77 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 99.989999999999995 110.333 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.32 -50.09 35.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 99.989999999999995 109.663 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.17 -35.19 76.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 99.989999999999995 109.921 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.6 mt -74.42 -39.25 62.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.01 . . . . 99.989999999999995 108.891 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.11 -35.92 37.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 99.989999999999995 109.486 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -59.69 -34.97 73.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 109.143 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -86.54 7.35 26.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 99.989999999999995 109.621 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttt 56.88 37.02 28.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -136.83 136.12 38.52 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.11 -0.994 . . . . 99.989999999999995 109.118 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -116.89 157.76 45.57 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 109.137 -0.69 . . . . 99.989999999999995 109.137 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -53.01 155.84 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.836 2.357 . . . . 99.989999999999995 111.909 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.3 mt -98.57 142.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 109.637 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.433 ' HG1' ' H ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -81.2 158.49 69.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.366 -0.833 . . . . 99.989999999999995 109.65 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.83 -23.05 75.8 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 111.522 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.433 ' H ' ' HG1' ' A' ' 138' ' ' THR . 84.2 tt0 -61.98 -38.59 89.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.42 -0.8 . . . . 99.989999999999995 109.524 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 m -63.67 -36.01 82.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.418 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.33 -39.4 59.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 99.989999999999995 110.007 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.32 -34.68 72.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.043 -1.035 . . . . 99.989999999999995 111.081 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.94 -36.24 80.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.706 -1.247 . . . . 99.989999999999995 109.425 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.06 -36.09 76.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 110.085 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.12 -51.81 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.922 -1.111 . . . . 99.989999999999995 110.561 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -65.01 -1.86 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 110.286 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -110.21 -24.0 10.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 99.989999999999995 110.007 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.97 16.01 22.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 99.989999999999995 111.733 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 59.3 mttp 56.89 36.16 27.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.322 -1.486 . . . . 99.989999999999995 111.318 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 165.93 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.774 -1.204 . . . . 99.989999999999995 109.62 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 151' ' ' ALA . 71.8 t 59.35 132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.262 1.029 . . . . 99.989999999999995 109.561 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -129.46 149.33 51.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.258 -1.016 . . . . 99.989999999999995 108.258 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.17 143.65 49.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.03 -1.044 . . . . 99.989999999999995 109.85 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 t -138.36 147.01 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.837 . . . . 99.989999999999995 109.431 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -97.33 120.89 38.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.303 -0.999 . . . . 99.989999999999995 108.303 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -131.04 141.1 50.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.962 . . . . 99.989999999999995 110.932 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 161' ' ' THR . 29.5 t -111.62 102.8 11.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.666 -0.864 . . . . 99.989999999999995 108.666 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -70.18 -28.69 65.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.785 -0.572 . . . . 99.989999999999995 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.56 -25.92 67.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.521 -0.918 . . . . 99.989999999999995 108.521 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 163' ' ' LYS . 21.2 m -123.86 160.52 27.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.28 -1.007 . . . . 99.989999999999995 108.28 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.664 ' NE2' ' CE2' ' A' ' 28' ' ' PHE . 89.5 mm-40 -65.41 11.47 0.06 Allowed 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.496 -0.753 . . . . 99.989999999999995 109.628 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.568 ' H ' ' C ' ' A' ' 161' ' ' THR . 97.7 mttt -94.01 5.13 52.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.051 . . . . 99.989999999999995 110.053 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.447 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -101.58 -51.14 1.14 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.641 -1.266 . . . . 99.989999999999995 110.274 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 8.1 mp -63.35 -42.02 98.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.219 -1.165 . . . . 99.989999999999995 110.267 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -58.81 -30.37 67.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 110.216 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -85.67 -50.07 7.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.373 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.24 -34.8 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.768 . . . . 99.989999999999995 110.303 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -68.71 -49.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 99.989999999999995 110.285 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.54 -43.82 93.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 99.989999999999995 110.612 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.03 -45.13 71.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 99.989999999999995 110.262 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.62 -35.96 61.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 99.989999999999995 110.408 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 95.0 mt -68.9 -36.7 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.831 -1.168 . . . . 99.989999999999995 110.482 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.8 tp -53.55 -51.33 63.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.972 -1.08 . . . . 99.989999999999995 110.259 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.5 71.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 99.989999999999995 110.079 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.39 66.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 99.989999999999995 109.758 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 3.6 mm? -63.02 -35.54 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.984 -1.073 . . . . 99.989999999999995 109.75 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.561 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.401 -0.592 . . . . 99.989999999999995 109.401 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -63.02 -33.11 74.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 99.989999999999995 109.493 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -135.6 160.22 39.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.843 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.8 mt -121.34 119.46 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.074 -0.713 . . . . 99.989999999999995 109.074 179.458 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -95.76 129.46 42.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.952 . . . . 99.989999999999995 110.059 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.411 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 46.1 t -138.32 136.75 36.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 99.989999999999995 109.143 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.08 141.11 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 99.989999999999995 109.645 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.65 131.19 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.744 -0.836 . . . . 99.989999999999995 108.744 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.85 143.98 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 99.989999999999995 109.486 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 168.17 25.65 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.278 -1.529 . . . . 99.989999999999995 109.278 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' ALA . 24.0 t70 -83.12 108.17 16.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.251 . . . . 99.989999999999995 108.983 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 53.94 -87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.069 -1.612 . . . . 99.989999999999995 109.069 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 53.47 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.178 -1.19 . . . . 99.989999999999995 109.364 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.6 m -66.63 -35.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 99.989999999999995 109.988 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.57 21.55 32.04 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.961 -1.256 . . . . 99.989999999999995 109.961 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 58.9 tttt -62.11 -40.6 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.283 . . . . 99.989999999999995 109.814 179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.8 m -68.37 -45.65 72.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 109.925 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.566 ' SG ' ' OG ' ' A' ' 30' ' ' SER . 34.4 m -61.01 -29.65 69.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.913 . . . . 99.989999999999995 109.851 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -67.06 -42.15 85.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 109.476 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.44 -46.09 50.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 99.989999999999995 110.283 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.53 -40.32 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 99.989999999999995 110.28 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -57.92 -31.98 67.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.938 -1.101 . . . . 99.989999999999995 109.839 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -72.69 -38.02 67.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 99.989999999999995 109.58 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.557 ' HG1' ' HG1' ' A' ' 25' ' ' THR . 66.3 p -65.96 -30.96 71.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.459 -0.775 . . . . 99.989999999999995 111.292 -178.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -166.44 -1.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.553 -1.342 . . . . 99.989999999999995 111.427 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.613 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.2 t30 92.21 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.516 -0.92 . . . . 99.989999999999995 108.516 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.4 tttm -179.6 58.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 99.989999999999995 109.995 179.127 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.29 -42.58 86.12 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.787 -1.196 . . . . 99.989999999999995 109.836 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.2 Cg_exo -58.11 -33.08 97.01 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.354 2.036 . . . . 99.989999999999995 112.364 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.566 ' OG ' ' SG ' ' A' ' 18' ' ' CYS . 61.4 p 35.65 37.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.65 . . . . 99.989999999999995 109.738 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 30' ' ' SER . 78.5 mm-40 -38.22 -37.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.53 -0.731 . . . . 99.989999999999995 110.531 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -128.8 124.18 34.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.034 -1.041 . . . . 99.989999999999995 109.204 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.69 147.78 34.21 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 99.989999999999995 109.643 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.54 153.21 60.33 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 99.989999999999995 112.153 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.5 -104.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 99.989999999999995 109.051 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.4 m -61.38 142.07 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 108.858 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.09 125.43 46.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 99.989999999999995 109.864 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -108.84 164.39 12.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 99.989999999999995 109.308 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -92.35 153.11 19.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.009 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -127.78 139.15 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 99.989999999999995 109.601 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.52 132.2 54.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.053 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.28 153.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 99.989999999999995 109.605 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -122.31 150.15 42.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 99.989999999999995 109.064 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.26 139.77 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 99.989999999999995 110.01 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 65.0 mtt -84.57 131.81 34.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.669 -0.863 . . . . 99.989999999999995 108.669 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 48' ' ' GLY . 74.6 mt -135.11 125.41 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 99.989999999999995 109.521 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 41.97 18.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.088 -1.205 . . . . 99.989999999999995 110.088 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 92.36 15.41 53.45 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.102 -1.234 . . . . 99.989999999999995 110.215 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.0 mm-40 -122.81 82.7 49.34 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.318 -1.107 . . . . 99.989999999999995 109.255 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.17 126.19 20.24 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.906 2.404 . . . . 99.989999999999995 113.23 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 95.9 m-85 -119.17 138.04 53.21 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.836 -0.801 . . . . 99.989999999999995 108.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 p -80.22 143.49 33.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 99.989999999999995 109.431 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -124.82 124.48 42.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 99.989999999999995 109.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.11 124.31 8.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.312 -1.515 . . . . 99.989999999999995 109.312 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.13 127.03 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.161 . . . . 99.989999999999995 109.194 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -114.44 133.96 55.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.375 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -138.79 140.52 38.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 99.989999999999995 109.359 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.1 m -70.85 137.64 49.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 99.989999999999995 109.455 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.58 57.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 99.989999999999995 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 61' ' ' GLN . . . 77.24 -111.61 3.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.828 -1.309 . . . . 99.989999999999995 109.828 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 63' ' ' ASP . 90.7 mt-30 44.29 -104.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 99.989999999999995 109.688 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.444 ' C ' ' H ' ' A' ' 64' ' ' TYR . 82.6 tt0 61.49 -67.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.59 -0.694 . . . . 99.989999999999995 109.611 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' GLN . 92.7 m-20 -50.48 -14.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.596 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.444 ' H ' ' C ' ' A' ' 62' ' ' GLU . 49.3 m-85 -84.4 10.4 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 99.989999999999995 109.522 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.0 t0 49.67 48.44 21.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 99.989999999999995 109.663 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 61' ' ' GLN . 41.6 ttm180 -54.58 -34.37 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 99.989999999999995 109.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.7 tp 56.79 75.34 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 99.989999999999995 109.445 -179.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.531 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 4.3 ttt180 -54.43 -47.13 98.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 99.989999999999995 110.442 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 51.8 Cg_exo -52.05 -29.72 37.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.563 2.175 . . . . 99.989999999999995 112.92 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' C ' ' H ' ' A' ' 72' ' ' TYR . 97.6 mt 40.6 31.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 99.989999999999995 109.709 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 6.0 t 52.11 4.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 99.989999999999995 109.851 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.579 ' H ' ' C ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -176.71 82.18 0.26 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 99.989999999999995 109.371 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.55 135.35 69.85 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.754 2.303 . . . . 99.989999999999995 112.22 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -96.51 3.75 52.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 99.989999999999995 109.222 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.4 m -79.5 131.86 36.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.458 -0.776 . . . . 99.989999999999995 110.156 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -102.87 -10.55 18.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 99.989999999999995 108.953 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.4 t -135.42 130.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 99.989999999999995 109.248 179.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -111.48 129.04 56.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 109.776 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.411 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 62.1 mt -113.16 145.19 41.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.516 -0.74 . . . . 99.989999999999995 109.791 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 28.3 m -129.76 147.32 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 99.989999999999995 109.052 179.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 22.7 t -138.74 130.52 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.651 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.56 165.76 26.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.453 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 m -105.84 145.13 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 99.989999999999995 109.113 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.76 8.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 99.989999999999995 109.679 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -88.99 -23.46 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.133 -0.979 . . . . 99.989999999999995 109.807 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.6 146.37 33.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.911 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.58 -50.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.677 2.251 . . . . 99.989999999999995 112.259 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -55.05 -35.68 64.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.484 -0.76 . . . . 99.989999999999995 109.79 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.1 p -66.71 -24.26 66.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 99.989999999999995 109.058 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -71.41 -50.91 27.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.817 . . . . 99.989999999999995 109.461 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.85 -36.28 81.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 109.638 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -51.53 -34.06 34.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 99.989999999999995 109.783 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.9 -36.4 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 110.188 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -91.61 -41.55 10.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.752 -1.217 . . . . 99.989999999999995 110.592 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.53 -37.52 87.82 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.086 -1.009 . . . . 99.989999999999995 112.037 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -113.17 -51.38 2.82 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.901 -1.124 . . . . 99.989999999999995 112.638 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.2 -39.95 82.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.97 -1.081 . . . . 99.989999999999995 113.249 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.417 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -58.27 -52.11 76.93 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.027 -1.67 . . . . 99.989999999999995 110.75 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.417 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.16 -40.6 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.677 1.585 . . . . 99.989999999999995 112.223 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.47 -31.05 67.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.405 -0.809 . . . . 99.989999999999995 110.499 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 5.5 tp -59.26 -24.07 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.883 -1.136 . . . . 99.989999999999995 110.006 -179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 62.5 p -58.42 -38.59 77.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 99.989999999999995 109.436 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -58.94 -29.99 67.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 99.989999999999995 109.4 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -82.94 -7.77 59.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.895 . . . . 99.989999999999995 109.811 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.11 84.9 0.19 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 109.356 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.56 89.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.65 2.233 . . . . 99.989999999999995 112.458 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -133.52 11.32 4.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 99.989999999999995 109.316 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.561 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -136.68 157.74 74.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 99.989999999999995 109.524 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -59.95 141.15 95.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.683 2.255 . . . . 99.989999999999995 112.268 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 108' ' ' THR . 97.3 m-85 -121.98 145.83 47.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.742 . . . . 99.989999999999995 109.796 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 5.2 mp -121.8 131.72 54.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.607 -0.683 . . . . 99.989999999999995 109.469 179.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 26.2 tp -103.79 118.88 37.74 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.518 -0.919 . . . . 99.989999999999995 108.518 179.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.545 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 59.7 t -112.44 137.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 99.989999999999995 110.728 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.14 128.5 9.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.886 -2.085 . . . . 99.989999999999995 107.886 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 32.7 p -125.51 161.75 26.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.258 -1.143 . . . . 99.989999999999995 110.852 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 115' ' ' THR . 4.3 tt0 83.71 19.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.027 -0.533 . . . . 99.989999999999995 110.282 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 119' ' ' LEU . 8.2 tt -61.3 -165.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.666 -1.235 . . . . 99.989999999999995 107.666 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 60.65 -60.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 99.989999999999995 110.006 -179.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.2 mp -60.02 -35.05 74.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.787 -1.196 . . . . 99.989999999999995 108.995 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 119' ' ' LEU . 83.3 mtm180 31.65 45.99 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.198 0.523 . . . . 99.989999999999995 110.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.437 ' CB ' ' O ' ' A' ' 120' ' ' ARG . 7.3 t0 70.26 75.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 99.989999999999995 109.166 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -42.83 160.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 99.989999999999995 109.383 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 6.7 Cg_endo -52.18 -55.22 4.06 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.699 2.266 . . . . 99.989999999999995 111.915 -179.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.0 p -54.76 -28.65 50.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.819 -1.175 . . . . 99.989999999999995 109.586 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.431 ' CG2' ' OD1' ' A' ' 121' ' ' ASP . 28.5 m -78.21 -50.74 11.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.994 -1.066 . . . . 99.989999999999995 110.578 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 13.1 tt -55.46 -27.6 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.033 -1.042 . . . . 99.989999999999995 109.631 -178.544 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.99 -45.62 80.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.221 -1.029 . . . . 99.989999999999995 108.221 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -60.69 -36.84 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.582 -0.699 . . . . 99.989999999999995 109.384 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 71.3 mt -75.15 -37.76 61.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 99.989999999999995 109.061 179.24 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.66 -39.05 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.497 -0.752 . . . . 99.989999999999995 109.504 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -60.4 -40.98 92.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.168 -0.957 . . . . 99.989999999999995 109.366 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -91.7 3.11 55.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 99.989999999999995 109.917 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.1 mttp 54.49 40.62 31.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 109.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -92.07 -52.73 4.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.15 -0.969 . . . . 99.989999999999995 109.743 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 mttt 65.46 139.45 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 99.989999999999995 109.128 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.9 154.41 74.68 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.536 2.157 . . . . 99.989999999999995 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.6 mm -93.56 140.31 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 99.989999999999995 109.343 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.86 155.43 73.03 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 109.535 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.62 -31.92 95.13 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.458 2.105 . . . . 99.989999999999995 111.793 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.47 -37.76 84.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 99.989999999999995 109.336 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.3 m -66.09 -33.59 76.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.277 -0.89 . . . . 99.989999999999995 108.987 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.59 -36.97 57.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 99.989999999999995 110.071 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -35.01 71.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 99.989999999999995 110.622 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.42 -36.25 83.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.931 -1.106 . . . . 99.989999999999995 109.79 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 46.2 tp -63.25 -39.2 93.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 99.989999999999995 110.112 -179.628 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.74 -45.47 74.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 99.989999999999995 109.556 -179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.65 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -75.79 9.61 2.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 109.514 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -71.59 -36.4 70.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.989 -1.069 . . . . 99.989999999999995 109.228 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 51.0 mt -112.43 -87.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.594 -0.691 . . . . 99.989999999999995 109.81 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -152.59 52.67 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 99.989999999999995 109.694 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -64.45 131.36 46.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.069 -1.019 . . . . 99.989999999999995 109.312 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.23 -51.74 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 99.989999999999995 109.927 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -160.1 155.61 25.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 99.989999999999995 110.262 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -121.02 144.42 48.54 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.722 -0.844 . . . . 99.989999999999995 108.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -142.81 154.22 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 99.989999999999995 110.285 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.514 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.8 mt-10 -120.04 142.73 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.412 -0.959 . . . . 99.989999999999995 108.412 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.545 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.07 149.84 42.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 99.989999999999995 110.697 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 161' ' ' THR . 12.8 t -112.01 107.59 16.62 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.005 -0.739 . . . . 99.989999999999995 109.005 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.36 64.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.442 -0.577 . . . . 99.989999999999995 109.442 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.5 tp -53.31 -32.07 47.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.533 -0.914 . . . . 99.989999999999995 108.533 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 163' ' ' LYS . 14.3 p -126.09 165.26 19.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.381 -0.97 . . . . 99.989999999999995 108.381 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -69.85 13.14 0.16 Allowed 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.642 -0.661 . . . . 99.989999999999995 109.396 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 161' ' ' THR . 58.5 tttm -85.48 -4.76 59.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 99.989999999999995 109.626 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.43 -50.43 2.97 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.615 -1.279 . . . . 99.989999999999995 110.255 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.668 ' CD2' ' H ' ' A' ' 165' ' ' LEU . 1.8 mm? -64.46 -39.37 93.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.242 . . . . 99.989999999999995 109.972 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -58.51 -32.07 68.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 99.989999999999995 110.361 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.514 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 53.1 t30 -73.8 -49.64 24.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 99.989999999999995 109.786 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.72 -8.34 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.803 . . . . 99.989999999999995 111.041 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -72.43 -50.33 27.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 99.989999999999995 109.817 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.89 -42.42 99.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 99.989999999999995 110.086 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -66.29 -36.31 82.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 109.731 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.03 -35.54 71.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 99.989999999999995 109.67 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.51 -40.29 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 99.989999999999995 109.618 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.2 tp -52.07 -45.88 64.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 99.989999999999995 109.689 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.66 -33.64 75.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.982 . . . . 99.989999999999995 109.421 -179.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.01 -43.58 63.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 109.667 -179.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.1 mt -62.54 -35.73 80.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.998 . . . . 99.989999999999995 109.337 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 99.989999999999995 109.461 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.474 -0.565 . . . . 99.989999999999995 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -96.58 138.94 33.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 109.175 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -132.93 162.47 31.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 109.532 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 31.1 mm -115.49 119.9 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 99.989999999999995 109.204 179.656 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -96.93 130.59 44.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.948 . . . . 99.989999999999995 109.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -149.47 137.95 20.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 99.989999999999995 109.708 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.97 138.43 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 99.989999999999995 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.92 142.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.753 . . . . 99.989999999999995 109.481 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 12.7 p -139.96 143.39 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.893 . . . . 99.989999999999995 109.155 179.675 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.65 165.36 26.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.718 -1.353 . . . . 99.989999999999995 109.718 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -85.1 117.82 24.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 99.989999999999995 109.296 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.21 -105.44 1.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.431 -1.468 . . . . 99.989999999999995 109.431 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.32 -67.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 99.989999999999995 109.512 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.506 ' CG1' ' H ' ' A' ' 15' ' ' GLY . 28.4 t 54.43 -119.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 99.989999999999995 109.586 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.506 ' H ' ' CG1' ' A' ' 14' ' ' VAL . . . -95.42 25.88 22.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.641 -1.384 . . . . 99.989999999999995 109.641 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -56.92 -34.39 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 99.989999999999995 109.274 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.524 ' HG1' ' N ' ' A' ' 18' ' ' CYS . 47.4 p -66.58 -37.61 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 99.989999999999995 108.965 179.51 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.524 ' N ' ' HG1' ' A' ' 17' ' ' THR . 10.5 m -67.22 -30.82 70.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.432 -0.792 . . . . 99.989999999999995 109.869 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.6 tp -69.91 -44.78 68.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 99.989999999999995 110.287 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.3 -44.33 46.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 99.989999999999995 110.801 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 9.9 tp -64.7 -32.49 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 99.989999999999995 110.066 -179.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.6 p -66.7 -28.94 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.089 -1.007 . . . . 99.989999999999995 109.739 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 80.5 t80 -76.58 -43.43 38.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 99.989999999999995 110.393 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 p -75.35 -45.09 41.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 111.287 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.7 p -85.12 -23.09 28.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.843 -1.161 . . . . 99.989999999999995 110.243 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 23' ' ' TYR . 57.1 m-20 57.58 35.36 25.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 99.989999999999995 109.358 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -138.22 81.51 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 99.989999999999995 110.174 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.58 -41.79 90.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.111 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 24.0 Cg_exo -61.99 -10.61 18.23 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.493 2.128 . . . . 99.989999999999995 112.036 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.585 ' C ' ' H ' ' A' ' 32' ' ' TYR . 14.6 t -47.12 -32.74 4.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 99.989999999999995 109.554 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 64.65 -31.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.825 . . . . 99.989999999999995 110.283 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.585 ' H ' ' C ' ' A' ' 30' ' ' SER . 87.0 m-85 -58.36 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.832 -1.168 . . . . 99.989999999999995 108.659 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' CB ' ' O ' ' A' ' 32' ' ' TYR . 2.0 t 73.74 60.05 0.32 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.513 -0.742 . . . . 99.989999999999995 110.415 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.47 130.66 34.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.024 1.816 . . . . 99.989999999999995 111.079 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.34 56.08 2.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.06 -1.025 . . . . 99.989999999999995 110.143 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.571 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 42.1 t -119.48 134.65 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 99.989999999999995 109.679 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 36' ' ' VAL . 91.1 m-85 -160.56 -102.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 99.989999999999995 109.132 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 88.7 m-20 54.02 56.62 6.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 99.989999999999995 110.089 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 17.1 t-20 89.86 73.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.318 0.58 . . . . 99.989999999999995 109.709 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 57.2 t80 -111.9 145.35 39.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 99.989999999999995 109.155 179.828 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.1 145.29 48.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 99.989999999999995 109.438 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 44.0 t -126.02 129.63 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 99.989999999999995 109.558 179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.9 m -92.8 124.26 36.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.064 -1.022 . . . . 99.989999999999995 108.733 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.22 159.34 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 110.794 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 68.0 mtm -113.15 136.95 52.16 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.116 -0.698 . . . . 99.989999999999995 109.116 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.76 127.08 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 99.989999999999995 108.987 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 15.68 67.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.732 -1.347 . . . . 99.989999999999995 109.732 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.62 16.17 62.36 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.799 -1.321 . . . . 99.989999999999995 109.799 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -124.26 154.06 68.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.338 -1.096 . . . . 99.989999999999995 109.175 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.52 135.33 28.38 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.749 2.3 . . . . 99.989999999999995 113.258 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -145.32 154.9 42.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 99.989999999999995 109.129 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -125.54 139.23 53.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.384 -0.823 . . . . 99.989999999999995 109.869 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.37 125.25 48.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 99.989999999999995 109.094 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -111.07 118.28 4.83 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 99.989999999999995 109.645 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.632 ' CD2' ' N ' ' A' ' 55' ' ' LEU . 1.6 mm? -102.77 129.39 49.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.221 -1.164 . . . . 99.989999999999995 108.999 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.88 126.08 53.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 99.989999999999995 109.771 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -103.36 164.93 11.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.469 -0.769 . . . . 99.989999999999995 109.382 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 40.3 p -79.67 161.87 25.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 99.989999999999995 109.329 179.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' O ' ' OE1' ' A' ' 62' ' ' GLU . . . -166.99 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 109.52 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.493 ' O ' ' OD1' ' A' ' 65' ' ' ASP . . . -85.03 -1.31 88.78 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.727 -1.349 . . . . 99.989999999999995 109.727 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.419 ' HG2' HH22 ' A' ' 68' ' ' ARG . 89.0 mt-30 -59.8 -27.65 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.201 . . . . 99.989999999999995 110.146 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.59 ' C ' ' H ' ' A' ' 64' ' ' TYR . 51.8 mp0 -76.18 -161.88 0.2 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 109.589 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 52.6 p30 -62.98 11.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 99.989999999999995 110.545 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.59 ' H ' ' C ' ' A' ' 62' ' ' GLU . 80.6 m-85 -102.83 18.47 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 99.989999999999995 109.124 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 60' ' ' GLY . 93.7 m-20 -43.86 -14.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 99.989999999999995 109.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.648 ' CG ' HH11 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -44.84 -30.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.977 -1.077 . . . . 99.989999999999995 109.338 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 tp -59.71 -34.54 73.04 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.146 -0.971 . . . . 99.989999999999995 109.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 10.7 mpt_? -46.61 -66.13 0.57 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.128 -0.983 . . . . 99.989999999999995 110.817 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 11.0 Cg_endo -57.12 -32.39 93.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.142 1.894 . . . . 99.989999999999995 112.154 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 71' ' ' SER . 41.4 tp -61.26 -36.42 79.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 99.989999999999995 109.458 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LEU . 5.5 p 35.55 75.56 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.644 -0.66 . . . . 99.989999999999995 110.24 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.621 ' H ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -110.71 -43.34 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 99.989999999999995 110.229 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.621 ' CD ' ' H ' ' A' ' 72' ' ' TYR . 34.7 Cg_exo -59.26 137.76 80.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.848 2.366 . . . . 99.989999999999995 112.679 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -131.27 135.6 47.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 99.989999999999995 109.426 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -140.5 153.08 46.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 99.989999999999995 109.699 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -104.96 -5.64 20.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 109.217 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.0 133.75 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.795 . . . . 99.989999999999995 109.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -109.12 121.64 45.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.221 -0.924 . . . . 99.989999999999995 108.619 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -116.35 140.05 49.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.306 -0.871 . . . . 99.989999999999995 110.427 -179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.81 152.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 99.989999999999995 109.146 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 134.23 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 99.989999999999995 109.683 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -138.99 164.01 30.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 99.989999999999995 109.43 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.1 p -98.13 151.4 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 99.989999999999995 109.32 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.9 p -102.27 6.71 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 110.279 -179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -100.52 -1.08 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 99.989999999999995 110.129 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.506 ' O ' ' OG ' ' A' ' 89' ' ' SER . 69.5 m -118.86 95.82 49.55 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 99.989999999999995 109.745 -179.486 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.76 -52.88 8.01 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.285 1.99 . . . . 99.989999999999995 112.6 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -40.2 65.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.099 -1.001 . . . . 99.989999999999995 109.508 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.506 ' OG ' ' O ' ' A' ' 86' ' ' SER . 54.9 p -60.34 -14.15 16.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 99.989999999999995 108.851 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -74.13 -50.66 18.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.694 -0.854 . . . . 99.989999999999995 108.694 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.72 -39.08 90.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 99.989999999999995 109.3 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -54.15 -32.14 54.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 99.989999999999995 109.625 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 73.8 t -59.26 -37.58 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 99.989999999999995 110.274 -179.383 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -86.59 -27.76 23.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.742 -1.224 . . . . 99.989999999999995 110.386 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.72 -36.45 67.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.116 -0.99 . . . . 99.989999999999995 112.273 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -111.89 -50.62 2.9 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.884 -1.135 . . . . 99.989999999999995 112.509 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.487 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 33.8 m0 -68.13 -34.32 76.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.967 -1.083 . . . . 99.989999999999995 112.583 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.411 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -68.22 -51.72 24.74 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 119.964 -1.71 . . . . 99.989999999999995 111.113 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.411 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 72.9 Cg_endo -76.69 -44.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.947 1.764 . . . . 99.989999999999995 112.881 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.45 ' O ' ' ND1' ' A' ' 104' ' ' HIS . 85.1 tt0 -59.24 -41.94 89.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 99.989999999999995 111.045 -178.493 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 105' ' ' CYS . 94.2 mt -68.34 -43.35 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 99.989999999999995 110.174 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.8 m -60.28 -42.97 96.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 99.989999999999995 109.847 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -60.5 -44.85 95.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 109.937 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.45 ' ND1' ' O ' ' A' ' 100' ' ' GLU . 48.3 m80 -92.82 -10.69 35.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 110.432 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -149.65 86.96 5.27 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.941 -1.099 . . . . 99.989999999999995 109.878 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.79 -48.84 19.59 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.415 2.076 . . . . 99.989999999999995 112.072 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 29.0 mttt -147.69 110.34 4.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 99.989999999999995 109.506 179.644 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 3.5 p -154.11 150.16 22.0 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 109.326 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -47.72 118.25 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.03 1.82 . . . . 99.989999999999995 111.625 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 108' ' ' THR . 64.0 m-85 -112.9 128.9 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 99.989999999999995 110.141 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 32.5 tp -115.78 120.28 38.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.675 -0.861 . . . . 99.989999999999995 108.675 179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 117.56 34.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 108.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.536 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 48.0 t -112.09 135.9 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.419 -0.801 . . . . 99.989999999999995 110.587 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.7 125.31 8.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.31 -1.916 . . . . 99.989999999999995 108.31 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.3 t -129.97 166.63 19.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.227 -1.161 . . . . 99.989999999999995 110.638 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 115' ' ' THR . 22.9 tp60 85.66 15.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.12 -0.491 . . . . 99.989999999999995 109.762 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 119' ' ' LEU . 25.4 pt -63.15 -158.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.869 -1.144 . . . . 99.989999999999995 108.648 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.497 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 80.4 m-20 56.97 -57.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.637 -0.664 . . . . 99.989999999999995 110.273 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.699 ' N ' ' O ' ' A' ' 117' ' ' ILE . 29.4 tp -50.74 -30.52 14.17 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.845 -1.159 . . . . 99.989999999999995 108.109 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.414 HH12 ' HD2' ' A' ' 139' ' ' PRO . 40.5 ttp180 -57.89 -15.56 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 99.989999999999995 109.59 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 47.2 p30 -101.19 1.85 39.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.001 -1.062 . . . . 99.989999999999995 109.956 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.55 150.57 76.47 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 109.632 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.9 -53.46 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.454 2.103 . . . . 99.989999999999995 111.98 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -59.17 -32.64 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 99.989999999999995 110.637 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.1 m -69.71 -51.39 34.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.886 -1.134 . . . . 99.989999999999995 109.908 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt -65.16 -35.1 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.918 . . . . 99.989999999999995 109.456 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -73.27 -44.57 59.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 99.989999999999995 109.362 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.87 -41.32 91.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 99.989999999999995 109.714 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 88.1 mt -74.16 -34.07 63.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 99.989999999999995 108.713 178.885 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.57 -47.73 69.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.056 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -62.6 -35.83 80.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 110.119 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -52.61 -57.09 11.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.857 -1.152 . . . . 99.989999999999995 109.562 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.447 ' CG ' ' N ' ' A' ' 134' ' ' GLN . 14.3 pttp -171.23 -50.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.058 -1.026 . . . . 99.989999999999995 110.563 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.447 ' N ' ' CG ' ' A' ' 133' ' ' LYS . 52.6 mt-30 -143.86 -119.79 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 99.989999999999995 109.852 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.88 163.22 52.51 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 110.175 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.33 174.26 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.175 2.583 . . . . 99.989999999999995 112.099 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.32 140.04 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 109.933 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.37 158.29 69.29 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 99.989999999999995 109.381 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.424 ' CB ' ' OE2' ' A' ' 156' ' ' GLU . 16.4 Cg_endo -60.99 -31.55 91.48 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.58 2.187 . . . . 99.989999999999995 111.936 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 99.989999999999995 109.186 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.4 m -69.37 -33.05 72.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.217 -0.927 . . . . 99.989999999999995 109.221 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.31 -39.6 59.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.447 -0.783 . . . . 99.989999999999995 109.921 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.51 -31.85 69.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 110.264 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -60.93 -37.53 82.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.012 . . . . 99.989999999999995 109.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.5 ' N ' ' CD1' ' A' ' 145' ' ' LEU . 7.7 mp -65.39 -31.06 71.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 110.402 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.13 69.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.908 -1.12 . . . . 99.989999999999995 110.242 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -82.09 9.49 8.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 99.989999999999995 110.399 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -113.45 -36.09 5.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.029 . . . . 99.989999999999995 109.246 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.02 17.09 9.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.538 -0.726 . . . . 99.989999999999995 110.572 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 65.48 30.23 10.87 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.216 -0.928 . . . . 99.989999999999995 109.865 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.31 143.08 56.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 108.944 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 73.0 t -66.0 -58.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.013 -1.054 . . . . 99.989999999999995 110.089 -179.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -152.49 150.47 29.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.028 -1.045 . . . . 99.989999999999995 110.709 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -116.8 138.7 51.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.48 -0.763 . . . . 99.989999999999995 109.432 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 6.2 m -141.43 153.78 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.9 179.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 139' ' ' PRO . 93.2 mt-10 -110.11 132.62 54.0 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.571 -0.9 . . . . 99.989999999999995 108.571 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.536 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -136.64 146.28 45.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 99.989999999999995 110.633 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.497 ' OG ' ' OD2' ' A' ' 118' ' ' ASP . 18.0 t -115.78 108.93 16.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.954 -0.758 . . . . 99.989999999999995 108.954 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.343 0.592 . . . . 99.989999999999995 109.45 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.601 ' O ' ' CD2' ' A' ' 28' ' ' PHE . 6.7 mp -59.61 -27.86 66.68 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.608 -0.886 . . . . 99.989999999999995 108.608 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.8 p -125.11 165.94 17.32 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.46 -0.941 . . . . 99.989999999999995 108.46 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.11 12.64 0.28 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.798 -0.563 . . . . 99.989999999999995 109.597 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.491 ' H ' ' C ' ' A' ' 161' ' ' THR . 34.9 mtmt -89.68 3.4 52.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.989 . . . . 99.989999999999995 109.923 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.97 -49.15 1.96 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.881 -1.288 . . . . 99.989999999999995 109.881 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.514 ' H ' ' CD1' ' A' ' 165' ' ' LEU . 6.5 mp -61.86 -38.48 88.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -1.138 . . . . 99.989999999999995 110.125 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -58.53 -32.59 69.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 99.989999999999995 110.303 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -86.64 -44.61 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.046 -1.034 . . . . 99.989999999999995 109.381 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.88 -26.9 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 99.989999999999995 110.498 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -67.47 -46.81 71.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 99.989999999999995 110.489 -179.737 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -54.52 -43.8 72.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.896 -1.127 . . . . 99.989999999999995 109.672 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -70.61 -38.06 73.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 99.989999999999995 109.532 179.685 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.01 -43.69 91.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.945 . . . . 99.989999999999995 110.256 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 29.9 mm -69.67 -42.81 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.932 -1.105 . . . . 99.989999999999995 109.671 179.861 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.6 tp -56.16 -45.64 79.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 99.989999999999995 109.514 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.06 84.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.114 -0.991 . . . . 99.989999999999995 109.699 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.66 -42.66 79.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 99.989999999999995 109.42 -179.561 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.4 mt -64.27 -38.48 91.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 109.031 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.516 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.348 -0.612 . . . . 99.989999999999995 109.348 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.17 -30.87 71.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 109.034 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.0 m -104.37 145.27 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.6 -0.687 . . . . 99.989999999999995 109.679 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.8 mt -115.07 119.94 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.732 . . . . 99.989999999999995 109.026 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.35 130.78 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 110.01 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 128.18 19.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.391 -0.818 . . . . 99.989999999999995 109.12 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.41 138.27 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 99.989999999999995 109.559 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 32.2 t -116.1 132.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 99.989999999999995 108.886 179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.6 p -152.09 145.87 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.077 -1.014 . . . . 99.989999999999995 109.514 179.715 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.28 157.41 22.88 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.202 -1.559 . . . . 99.989999999999995 109.202 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 12' ' ' GLY . 60.3 t0 -86.01 105.76 16.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 99.989999999999995 109.61 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.12 69.73 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.86 -1.296 . . . . 99.989999999999995 109.86 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -87.98 133.58 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -1.235 . . . . 99.989999999999995 109.289 -179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.37 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 109.333 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 49.89 0.81 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.665 -1.374 . . . . 99.989999999999995 109.665 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' HZ1' ' CB ' ' A' ' 58' ' ' THR . 73.6 tttt -61.28 -38.24 86.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.962 -1.316 . . . . 99.989999999999995 109.78 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.6 p -70.64 -37.02 73.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 99.989999999999995 109.633 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.69 -28.5 69.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 99.989999999999995 109.702 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.81 -37.3 79.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.947 . . . . 99.989999999999995 110.128 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.37 -40.6 96.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 99.989999999999995 111.15 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.484 ' O ' ' OG1' ' A' ' 25' ' ' THR . 48.3 pt -70.7 -32.14 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.74 -1.225 . . . . 99.989999999999995 110.07 -179.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 m -57.01 -38.68 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.986 -1.071 . . . . 99.989999999999995 109.983 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -78.74 -48.48 14.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 99.989999999999995 110.122 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 p -64.59 -34.33 78.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 99.989999999999995 109.881 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.484 ' OG1' ' O ' ' A' ' 21' ' ' ILE . 63.7 p -112.26 -109.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.072 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 25' ' ' THR . 1.3 p30 164.64 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.847 -0.798 . . . . 99.989999999999995 108.847 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -126.45 122.35 35.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.259 -0.901 . . . . 99.989999999999995 110.404 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.672 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -96.52 -39.69 0.27 Allowed Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.396 -0.964 . . . . 99.989999999999995 108.396 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 12.9 Cg_exo -66.89 -10.54 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.616 2.211 . . . . 99.989999999999995 111.13 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' TYR . 38.7 m -47.9 -36.72 12.75 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.595 -0.842 . . . . 99.989999999999995 109.209 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.6 mt-10 40.38 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 99.989999999999995 109.972 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 30' ' ' SER . 70.1 t80 -141.22 118.77 11.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.946 -1.096 . . . . 99.989999999999995 108.419 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.59 153.03 37.98 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 99.989999999999995 110.206 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.81 156.11 64.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 99.989999999999995 112.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 67.92 10.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 99.989999999999995 109.282 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.55 136.25 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.308 -0.87 . . . . 99.989999999999995 109.711 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -117.26 -1.93 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.815 . . . . 99.989999999999995 109.645 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.1 p30 -77.56 166.24 23.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.005 . . . . 99.989999999999995 110.113 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 37.5 p-10 -92.91 150.78 20.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.792 . . . . 99.989999999999995 109.619 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 74.0 t80 -134.53 147.98 50.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.459 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -102.61 138.25 39.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 99.989999999999995 109.842 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.83 138.2 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.712 . . . . 99.989999999999995 109.545 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.3 m -106.03 134.49 49.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.838 . . . . 99.989999999999995 109.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.89 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 99.989999999999995 109.958 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.8 mtp -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.796 -0.816 . . . . 99.989999999999995 108.796 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 68.9 mt -129.11 135.77 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.87 . . . . 99.989999999999995 108.87 179.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.68 -15.11 11.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.287 -1.525 . . . . 99.989999999999995 109.287 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.531 ' O ' ' CB ' ' A' ' 49' ' ' GLU . . . -95.16 -8.73 58.69 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.322 -1.105 . . . . 99.989999999999995 110.593 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' GLY . 2.0 mm-40 155.43 131.23 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.507 -0.996 . . . . 99.989999999999995 109.367 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.87 137.01 26.2 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.003 1.802 . . . . 99.989999999999995 111.857 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 97.8 m-85 -134.57 155.49 50.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.136 -0.978 . . . . 99.989999999999995 109.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 m -119.0 141.1 48.97 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.847 -0.797 . . . . 99.989999999999995 108.847 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.91 126.34 44.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 99.989999999999995 109.891 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.65 128.51 9.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.645 -1.782 . . . . 99.989999999999995 108.645 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.2 mt -107.32 122.49 46.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -1.207 . . . . 99.989999999999995 109.2 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -111.49 135.13 52.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.41 -0.806 . . . . 99.989999999999995 109.197 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 58' ' ' THR . 57.4 t0 -94.0 151.68 19.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 109.07 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.483 ' CB ' ' HZ1' ' A' ' 16' ' ' LYS . 65.5 m -59.1 130.39 46.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.033 -1.042 . . . . 99.989999999999995 108.978 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.08 150.33 29.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 109.338 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.96 -6.7 66.98 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 99.989999999999995 109.436 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -58.39 -22.67 54.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 99.989999999999995 109.362 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.625 ' C ' ' H ' ' A' ' 64' ' ' TYR . 96.3 mt-10 -76.89 -171.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.476 -0.765 . . . . 99.989999999999995 109.496 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 53.4 p30 -63.31 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 99.989999999999995 110.714 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.625 ' H ' ' C ' ' A' ' 62' ' ' GLU . 83.5 m-85 -118.82 17.99 13.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 99.989999999999995 109.214 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 65' ' ' ASP . 51.2 p30 -70.54 6.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 99.989999999999995 110.204 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.56 -33.49 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.998 . . . . 99.989999999999995 109.194 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 68' ' ' ARG . 64.3 mt -61.57 -35.75 78.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 99.989999999999995 109.958 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 70' ' ' LEU . 1.6 mtt180 55.84 165.73 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.021 -1.049 . . . . 99.989999999999995 109.144 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -48.28 -1.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.371 2.047 . . . . 99.989999999999995 112.558 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' A' ' 68' ' ' ARG . 82.4 mt -56.39 -30.6 62.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 99.989999999999995 110.293 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.7 m -61.68 -38.28 87.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.918 -1.114 . . . . 99.989999999999995 109.942 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -130.61 84.1 60.01 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 99.989999999999995 109.686 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 74' ' ' GLN . 47.5 Cg_endo -76.95 176.12 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.53 2.153 . . . . 99.989999999999995 112.557 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.526 ' O ' ' O ' ' A' ' 73' ' ' PRO . 63.5 tp60 35.73 101.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.79 -0.569 . . . . 99.989999999999995 110.842 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -105.5 130.96 53.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 99.989999999999995 108.99 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.39 -37.91 89.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 99.989999999999995 110.406 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.84 144.1 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 99.989999999999995 110.449 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.39 126.68 51.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.39 -0.967 . . . . 99.989999999999995 108.39 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 42.6 tp -112.3 128.76 56.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 99.989999999999995 110.121 -179.434 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.5 t -123.18 135.78 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 99.989999999999995 109.12 179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 130.95 46.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.37 -0.831 . . . . 99.989999999999995 109.828 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.47 161.11 38.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 99.989999999999995 109.173 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.9 t -80.08 132.82 36.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -1.0 . . . . 99.989999999999995 109.295 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.77 -28.25 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 99.989999999999995 110.869 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 33.4 m -92.6 7.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.041 -1.037 . . . . 99.989999999999995 111.095 -178.539 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.484 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 22.6 t -98.52 124.57 46.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.792 -1.193 . . . . 99.989999999999995 110.003 -179.578 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 70.2 Cg_endo -77.56 -58.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.264 1.976 . . . . 99.989999999999995 112.61 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.502 ' HG ' ' N ' ' A' ' 89' ' ' SER . 81.4 p -55.48 -32.92 63.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.935 . . . . 99.989999999999995 109.762 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.502 ' N ' ' HG ' ' A' ' 88' ' ' SER . 41.3 m -65.08 -24.52 67.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 99.989999999999995 109.165 179.309 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 56.3 t80 -68.57 -50.84 48.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -0.774 . . . . 99.989999999999995 109.347 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 87' ' ' PRO . 52.5 mp0 -69.13 -35.72 76.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 109.723 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -54.45 -33.36 59.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 99.989999999999995 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.66 -37.98 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.933 . . . . 99.989999999999995 110.268 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 30.0 tttt -93.43 -36.25 12.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.844 -1.16 . . . . 99.989999999999995 110.839 -179.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.71 -37.04 81.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.027 -1.045 . . . . 99.989999999999995 112.285 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -113.68 -51.65 2.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 99.989999999999995 112.611 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.198 -0.939 . . . . 99.989999999999995 113.217 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.437 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -71.25 -51.49 10.08 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.152 -1.592 . . . . 99.989999999999995 111.623 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.437 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 56.7 Cg_endo -71.87 -45.74 0.68 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.827 1.685 . . . . 99.989999999999995 113.567 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.22 -38.85 90.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.014 -1.054 . . . . 99.989999999999995 111.07 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.4 tp -68.58 -26.88 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 99.989999999999995 110.078 -179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 m -61.46 -40.02 92.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 99.989999999999995 109.858 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -54.87 -34.44 62.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.573 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 56.8 t-80 -62.34 -43.66 98.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 99.989999999999995 109.591 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.0 OUTLIER 160.64 158.52 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.47 -0.769 . . . . 99.989999999999995 109.629 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 108' ' ' THR . 13.5 Cg_endo -60.1 -160.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.759 2.306 . . . . 99.989999999999995 111.676 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 106' ' ' PRO . 20.8 mttp 42.51 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.058 . . . . 99.989999999999995 109.631 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.7 p 47.49 81.8 0.25 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.212 -0.93 . . . . 99.989999999999995 109.388 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.53 126.44 16.09 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.328 2.019 . . . . 99.989999999999995 111.573 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -113.28 125.21 54.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 99.989999999999995 110.017 -179.426 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 40.5 tp -116.58 121.22 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.933 -0.765 . . . . 99.989999999999995 108.933 179.222 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.6 mt -104.58 121.83 44.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.529 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.75 134.52 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 109.897 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.5 124.89 8.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.984 -1.646 . . . . 99.989999999999995 108.984 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.8 p -110.73 159.78 17.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 99.989999999999995 110.219 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 57.67 40.8 26.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.681 -0.637 . . . . 99.989999999999995 110.663 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.5 pt -69.48 -5.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.153 . . . . 99.989999999999995 109.933 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.93 -22.66 29.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 99.989999999999995 109.096 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 31.4 tp -61.58 -32.73 72.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 99.989999999999995 109.497 -179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 67.7 ttt180 -58.64 -25.22 62.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 99.989999999999995 109.652 179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.07 -5.2 47.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 99.989999999999995 110.116 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.12 141.32 83.72 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.003 -1.061 . . . . 99.989999999999995 109.049 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.62 -46.73 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.173 1.915 . . . . 99.989999999999995 111.894 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.8 p -61.22 -27.64 68.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.889 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.3 m -69.25 -49.02 60.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.204 -1.035 . . . . 99.989999999999995 108.204 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.02 -40.19 82.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.455 0.645 . . . . 99.989999999999995 109.3 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -74.54 -40.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.582 -0.699 . . . . 99.989999999999995 109.771 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 99.989999999999995 110.568 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 3.5 mm? -78.7 -38.78 38.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -0.996 . . . . 99.989999999999995 109.61 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.52 71.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 99.989999999999995 109.686 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -62.55 -44.41 96.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.97 -1.081 . . . . 99.989999999999995 110.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -70.44 -48.95 53.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 99.989999999999995 109.772 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -148.38 -89.32 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 99.989999999999995 109.637 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.475 ' HG3' ' H ' ' A' ' 135' ' ' LYS . 9.0 pt20 -134.19 -119.32 0.18 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 99.989999999999995 109.594 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.475 ' H ' ' HG3' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.09 167.03 24.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.943 . . . . 99.989999999999995 109.447 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.41 165.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.998 2.465 . . . . 99.989999999999995 112.223 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.61 145.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 99.989999999999995 109.069 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.462 ' HG1' ' H ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -85.69 155.99 58.81 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.994 -1.066 . . . . 99.989999999999995 109.394 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.41 -24.03 76.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.614 2.209 . . . . 99.989999999999995 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.462 ' H ' ' HG1' ' A' ' 138' ' ' THR . 84.1 tt0 -64.13 -41.7 97.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.615 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.8 m -62.45 -36.78 83.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.962 . . . . 99.989999999999995 109.331 179.882 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.9 57.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.42 -0.8 . . . . 99.989999999999995 109.752 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.64 -34.67 77.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.091 -1.006 . . . . 99.989999999999995 110.682 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 21.0 mttm -67.3 -39.25 85.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 99.989999999999995 109.437 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -62.7 -39.5 94.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 99.989999999999995 109.24 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.408 ' C ' ' H ' ' A' ' 148' ' ' ASP . . . -75.36 -48.86 21.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.089 -1.007 . . . . 99.989999999999995 110.141 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -68.97 4.97 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 110.379 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 144' ' ' LYS . 88.2 m-20 -108.82 -20.99 12.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.958 -1.089 . . . . 99.989999999999995 109.357 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 38.2 mt -110.97 34.31 4.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.511 -0.743 . . . . 99.989999999999995 110.037 -179.631 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.73 29.18 18.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 99.989999999999995 110.639 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.51 146.23 54.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 99.989999999999995 109.037 179.51 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.98 -61.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.034 -1.042 . . . . 99.989999999999995 110.402 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.414 ' HG2' ' N ' ' A' ' 154' ' ' TYR . 16.4 tttp -175.37 163.3 3.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 109.552 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.414 ' N ' ' HG2' ' A' ' 153' ' ' LYS . 28.7 p90 -120.04 154.75 34.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 99.989999999999995 108.922 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 28.0 t -132.24 140.09 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.129 -0.982 . . . . 99.989999999999995 110.057 -179.926 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.9 mt-10 -100.13 126.7 46.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.276 -1.009 . . . . 99.989999999999995 108.276 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 140.73 47.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 111.071 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 161' ' ' THR . 34.6 t -104.26 102.19 11.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 99.989999999999995 108.892 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.92 72.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.209 0.528 . . . . 99.989999999999995 109.59 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.6 mt -53.56 -27.02 23.9 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.434 -0.95 . . . . 99.989999999999995 108.434 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 163' ' ' LYS . 17.5 p -123.61 161.17 25.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.031 -1.1 . . . . 99.989999999999995 108.031 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -69.97 12.35 0.22 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.696 -0.627 . . . . 99.989999999999995 109.33 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.523 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.3 mttp -90.45 0.52 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 99.989999999999995 109.866 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -91.67 -51.37 2.51 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.577 -1.297 . . . . 99.989999999999995 110.016 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.17 -40.48 96.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.133 -1.216 . . . . 99.989999999999995 109.83 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.45 -27.85 66.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 99.989999999999995 110.522 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 35.6 t-20 -76.94 -50.73 12.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 99.989999999999995 109.926 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.02 -12.13 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 99.989999999999995 110.865 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.63 -50.23 22.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.734 -1.228 . . . . 99.989999999999995 110.575 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.72 -41.95 92.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 99.989999999999995 110.057 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -65.01 -33.15 75.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 99.989999999999995 109.979 -179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.68 71.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 99.989999999999995 110.087 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.53 -39.82 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.036 -1.04 . . . . 99.989999999999995 109.787 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.3 tp -53.49 -42.14 67.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 99.989999999999995 109.907 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.92 74.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -0.947 . . . . 99.989999999999995 110.333 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.45 70.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 99.989999999999995 109.941 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.3 mt -61.96 -34.23 75.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.963 -1.085 . . . . 99.989999999999995 109.399 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.443 -0.786 . . . . 99.989999999999995 109.255 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.528 -0.545 . . . . 99.989999999999995 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.86 -36.0 78.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 99.989999999999995 109.316 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -136.71 160.07 39.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.399 -0.813 . . . . 99.989999999999995 109.772 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.66 121.0 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.719 . . . . 99.989999999999995 109.126 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -91.66 127.86 37.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 99.989999999999995 109.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -138.74 128.33 24.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 99.989999999999995 109.123 179.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 47.2 t -113.14 137.36 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 99.989999999999995 109.888 -179.54 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.36 134.92 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 99.989999999999995 108.915 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -152.09 146.59 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 109.277 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 159.64 23.85 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 99.989999999999995 109.388 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' GLY . 24.6 t70 -84.31 110.28 18.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -1.213 . . . . 99.989999999999995 109.434 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.57 63.38 1.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.412 -1.475 . . . . 99.989999999999995 109.412 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -85.09 121.36 27.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -1.167 . . . . 99.989999999999995 109.312 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.87 -30.08 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 99.989999999999995 109.967 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.09 35.14 5.02 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.916 -1.274 . . . . 99.989999999999995 109.916 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 87.8 tttt -59.95 -38.59 82.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.237 . . . . 99.989999999999995 110.266 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.437 ' HG1' ' N ' ' A' ' 18' ' ' CYS . 45.7 p -63.41 -40.51 97.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.002 . . . . 99.989999999999995 110.002 -179.402 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.437 ' N ' ' HG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -63.35 -26.69 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 99.989999999999995 110.058 -179.674 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.14 -41.2 99.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 99.989999999999995 109.825 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.1 mt -66.44 -40.56 89.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.123 -0.985 . . . . 99.989999999999995 110.198 -179.649 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.16 -42.3 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 99.989999999999995 109.809 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -57.51 -35.82 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 110.185 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -80.05 -50.27 10.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.144 . . . . 99.989999999999995 109.801 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 71.6 p -59.58 -36.94 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.142 -0.974 . . . . 99.989999999999995 110.014 -179.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 56.5 p -120.15 -113.55 0.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 109.387 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 25' ' ' THR . 11.1 m120 -167.56 12.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.806 -0.813 . . . . 99.989999999999995 108.806 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -98.09 118.82 35.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 110.344 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -86.4 -38.52 0.54 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 108.884 -0.784 . . . . 99.989999999999995 108.884 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 17.7 Cg_exo -63.26 -27.11 71.97 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.371 2.047 . . . . 99.989999999999995 111.064 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 29' ' ' PRO . 21.7 m 34.17 47.73 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.221 0.534 . . . . 99.989999999999995 110.298 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 -41.07 -32.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 99.989999999999995 110.111 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -121.7 126.0 47.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 109.488 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -99.44 109.27 54.38 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 99.989999999999995 110.032 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -52.47 160.64 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.241 1.961 . . . . 99.989999999999995 112.049 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.19 67.44 1.87 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 99.989999999999995 109.341 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.3 p -140.94 138.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 99.989999999999995 109.914 179.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.03 0.64 11.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.475 -0.766 . . . . 99.989999999999995 109.326 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -69.2 139.46 54.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 110.432 -179.165 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.39 160.82 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.564 -0.71 . . . . 99.989999999999995 109.356 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.09 136.58 49.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 99.989999999999995 110.33 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 125.75 51.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.778 -0.823 . . . . 99.989999999999995 108.778 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.19 138.64 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 99.989999999999995 109.693 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 p -87.94 147.08 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.075 -1.016 . . . . 99.989999999999995 109.066 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 156.95 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 99.989999999999995 110.507 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.2 mtm -130.17 137.15 49.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.711 -0.618 . . . . 99.989999999999995 109.549 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 26.6 pt -129.82 152.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 99.989999999999995 109.096 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.99 18.2 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.369 -1.493 . . . . 99.989999999999995 109.369 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 84.83 15.06 68.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.116 -1.194 . . . . 99.989999999999995 110.116 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.457 ' N ' ' O ' ' A' ' 46' ' ' ILE . 59.0 mt-10 -106.0 146.56 33.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.102 -1.234 . . . . 99.989999999999995 109.44 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.74 131.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.539 2.159 . . . . 99.989999999999995 112.829 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -143.12 160.13 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 109.532 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 m -117.23 138.79 51.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 99.989999999999995 109.093 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.8 tp -120.13 122.08 40.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 99.989999999999995 109.579 179.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.79 124.57 7.91 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.996 -1.642 . . . . 99.989999999999995 108.996 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -102.45 122.33 44.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 99.989999999999995 108.997 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -108.23 129.31 55.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.104 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' THR . 60.0 t0 -116.92 148.05 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.701 . . . . 99.989999999999995 109.177 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.407 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.2 p -68.65 159.16 32.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.042 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -143.07 161.53 37.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 99.989999999999995 109.187 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' GLN . . . -41.26 -66.28 0.96 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.787 -1.325 . . . . 99.989999999999995 109.787 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLY . 46.2 tt0 59.75 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 99.989999999999995 109.266 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -174.56 -87.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 99.989999999999995 109.819 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 53.2 p30 -81.05 13.4 2.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 99.989999999999995 110.77 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -74.09 4.15 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.835 -1.166 . . . . 99.989999999999995 109.071 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 66' ' ' ARG . 83.0 m-20 58.33 47.45 13.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.728 -0.607 . . . . 99.989999999999995 110.34 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.557 ' CG ' HH11 ' A' ' 66' ' ' ARG . 0.2 OUTLIER 35.1 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.327 0.584 . . . . 99.989999999999995 110.093 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 31.1 tp -72.02 123.47 22.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 99.989999999999995 109.159 -179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.406 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 2.2 mtm180 -74.92 -56.83 1.98 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 99.989999999999995 110.666 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.406 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 76.9 Cg_exo -40.14 -27.94 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.183 1.922 . . . . 99.989999999999995 112.352 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 61.4 mt -116.4 62.03 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 109.313 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.8 m -136.89 144.06 43.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 99.989999999999995 109.405 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.63 76.27 36.01 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 99.989999999999995 109.513 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.85 -34.05 90.29 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.547 2.165 . . . . 99.989999999999995 112.165 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -113.84 131.47 56.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 99.989999999999995 109.465 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 30.7 p -119.26 145.0 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 99.989999999999995 109.477 179.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.85 -33.87 74.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 99.989999999999995 109.934 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.65 133.71 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 99.989999999999995 110.278 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -110.7 121.42 45.27 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.109 -1.071 . . . . 99.989999999999995 108.109 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -112.81 139.18 48.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 110.351 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.3 t -122.44 135.18 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.01 -0.737 . . . . 99.989999999999995 109.01 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.55 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 38.8 t -127.77 128.27 45.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.811 . . . . 99.989999999999995 109.549 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.61 162.91 34.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 99.989999999999995 109.73 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.482 ' OG ' ' OE1' ' A' ' 116' ' ' GLN . 37.9 t -92.05 142.85 27.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 99.989999999999995 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.449 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 2.4 p -100.24 -4.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 99.989999999999995 110.109 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 30.6 m -89.79 -16.47 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.999 -1.063 . . . . 99.989999999999995 109.783 179.934 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -98.51 134.97 21.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.913 . . . . 99.989999999999995 109.71 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.65 -55.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.228 1.952 . . . . 99.989999999999995 112.198 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.3 m -55.13 -34.4 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 99.989999999999995 109.709 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -63.44 -25.16 68.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.097 -1.002 . . . . 99.989999999999995 109.248 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -70.36 -50.18 41.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -0.832 . . . . 99.989999999999995 109.414 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.31 -37.13 82.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 99.989999999999995 109.89 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.55 -34.36 49.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 99.989999999999995 109.815 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.98 -34.97 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 99.989999999999995 109.986 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -91.14 -37.75 13.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.863 -1.148 . . . . 99.989999999999995 110.192 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -68.0 -35.99 79.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 112.094 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -113.15 -52.55 2.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.976 -1.078 . . . . 99.989999999999995 112.528 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -68.25 -37.02 80.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 113.428 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.422 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -63.28 -51.43 68.85 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.003 -1.685 . . . . 99.989999999999995 111.395 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.422 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 59.8 Cg_endo -73.96 -43.4 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.828 1.685 . . . . 99.989999999999995 113.095 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.82 -30.24 71.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 99.989999999999995 111.23 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.7 tp -61.71 -25.1 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.687 -1.258 . . . . 99.989999999999995 109.874 -179.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.44 ' CG2' ' N ' ' A' ' 103' ' ' HIS . 4.8 t -55.59 -36.61 67.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.131 -0.981 . . . . 99.989999999999995 109.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 102' ' ' THR . 52.1 m170 -51.62 -32.93 30.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 99.989999999999995 109.636 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.7 m80 -93.25 -5.99 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 99.989999999999995 109.58 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' HIS . 0.1 OUTLIER 53.23 168.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 99.989999999999995 109.541 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.19 26.11 0.55 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.837 2.358 . . . . 99.989999999999995 113.355 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -56.57 -34.52 67.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.947 -1.096 . . . . 99.989999999999995 109.829 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 159.61 38.52 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.589 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.46 147.52 93.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.864 2.376 . . . . 99.989999999999995 111.959 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.63 126.05 54.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 109.158 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.7 mt -116.98 128.16 54.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.536 -0.728 . . . . 99.989999999999995 109.854 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.1 tp -106.34 116.4 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.323 -0.992 . . . . 99.989999999999995 108.323 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.1 t -112.77 136.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 99.989999999999995 110.908 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.96 119.03 6.01 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.853 -2.099 . . . . 99.989999999999995 107.853 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.55 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 52.0 m -118.58 148.11 43.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -1.045 . . . . 99.989999999999995 110.465 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' THR . 33.2 tt0 84.48 19.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 122.067 -0.396 . . . . 99.989999999999995 110.47 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 119' ' ' LEU . 35.1 pt -62.62 -158.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.381 -1.341 . . . . 99.989999999999995 107.381 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 63.0 -61.73 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.183 . . . . 99.989999999999995 109.226 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 117' ' ' ILE . 25.1 tp -53.08 -33.9 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 99.989999999999995 108.059 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.401 HH12 ' HG3' ' A' ' 139' ' ' PRO . 33.0 ptt180 -54.36 -15.42 1.63 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.952 -1.129 . . . . 99.989999999999995 107.952 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 92.9 m-20 -108.04 57.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.226 -1.027 . . . . 99.989999999999995 108.226 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.477 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 7.9 m-20 -137.85 107.79 8.3 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.937 -0.764 . . . . 99.989999999999995 108.937 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.66 -39.83 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.879 1.719 . . . . 99.989999999999995 111.955 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m -58.73 -41.34 86.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.768 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.0 m -70.67 -48.94 52.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 99.989999999999995 108.126 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.76 -36.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.388 0.613 . . . . 99.989999999999995 109.479 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.93 -47.11 75.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 99.989999999999995 109.433 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -59.0 -38.8 80.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.709 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.16 -33.88 61.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 99.989999999999995 108.98 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.94 -41.81 64.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.553 -0.717 . . . . 99.989999999999995 109.87 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -60.16 -37.23 79.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 99.989999999999995 109.477 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.71 4.67 50.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.786 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 51.65 39.3 24.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.182 -0.949 . . . . 99.989999999999995 109.752 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -98.99 -52.17 3.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 99.989999999999995 110.027 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 mttp 68.89 146.11 0.11 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 99.989999999999995 109.144 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.3 152.24 79.54 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.593 2.195 . . . . 99.989999999999995 112.765 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.0 mm -93.5 141.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 99.989999999999995 109.046 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.53 155.21 65.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.093 -1.005 . . . . 99.989999999999995 109.591 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.401 ' HG3' HH12 ' A' ' 120' ' ' ARG . 18.5 Cg_endo -61.65 -28.08 82.11 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.571 2.181 . . . . 99.989999999999995 111.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.92 -38.27 90.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.325 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 45.4 m -65.06 -35.59 81.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 99.989999999999995 109.175 179.622 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.33 -34.07 58.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 99.989999999999995 109.817 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 99.989999999999995 110.485 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.483 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 18.5 mttp -64.45 -35.69 81.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.962 -1.086 . . . . 99.989999999999995 109.553 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.53 -40.29 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 109.679 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.15 -43.54 82.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.002 . . . . 99.989999999999995 109.661 -179.897 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.489 ' HG2' HH11 ' A' ' 147' ' ' ARG . 43.8 mtt-85 -78.7 7.78 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 110.498 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 85.1 m-20 -83.31 -27.78 29.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 99.989999999999995 108.753 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.3 mt -117.38 -101.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.624 -0.672 . . . . 99.989999999999995 109.308 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -144.9 44.9 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 109.871 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -61.95 137.4 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 99.989999999999995 109.168 179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.82 -58.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 110.354 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -156.66 146.54 20.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.72 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -122.22 153.73 38.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.394 -0.816 . . . . 99.989999999999995 109.11 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.54 157.58 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 99.989999999999995 109.904 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -104.35 128.1 52.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.449 -0.945 . . . . 99.989999999999995 108.449 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.425 ' SG ' ' O ' ' A' ' 164' ' ' GLY . 15.2 m -122.02 131.45 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.854 . . . . 99.989999999999995 110.713 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.554 ' O ' ' O ' ' A' ' 161' ' ' THR . 23.9 t -109.99 110.88 21.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 99.989999999999995 109.207 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.97 68.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.871 -0.518 . . . . 99.989999999999995 110.08 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 49.8 tp -51.37 -34.39 34.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.061 -1.024 . . . . 99.989999999999995 108.471 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.659 ' C ' ' H ' ' A' ' 163' ' ' LYS . 55.6 m -127.95 152.0 48.42 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.785 -1.191 . . . . 99.989999999999995 107.785 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -58.57 13.53 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.039 -1.038 . . . . 99.989999999999995 110.103 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.659 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.9 tttm -74.59 5.92 4.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 99.989999999999995 109.278 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.425 ' O ' ' SG ' ' A' ' 157' ' ' CYS . . . -98.81 -50.86 1.45 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.652 -1.261 . . . . 99.989999999999995 110.205 -179.761 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.529 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 6.5 mp -68.25 -38.47 81.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -1.178 . . . . 99.989999999999995 109.939 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -61.73 -29.25 69.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.288 -0.883 . . . . 99.989999999999995 110.336 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 163' ' ' LYS . 86.8 m-20 -77.96 -49.71 13.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 99.989999999999995 110.186 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.3 m -74.39 -11.19 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 110.452 -179.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -73.64 -46.46 46.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 99.989999999999995 110.219 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.59 -43.29 89.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 110.299 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.06 -33.39 75.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.05 -1.031 . . . . 99.989999999999995 109.663 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.06 70.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 110.152 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.18 -42.64 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.93 -1.106 . . . . 99.989999999999995 109.916 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.3 mt -54.24 -44.86 72.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 99.989999999999995 109.822 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.71 -36.6 84.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 99.989999999999995 109.715 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.44 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 99.989999999999995 109.654 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.13 -39.22 93.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 99.989999999999995 109.398 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.406 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.409 -0.589 . . . . 99.989999999999995 109.409 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 60.08 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.68 -0.637 . . . . 99.989999999999995 109.604 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -124.71 159.0 31.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 99.989999999999995 109.335 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.2 mt -119.16 119.16 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.794 . . . . 99.989999999999995 109.556 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.3 132.69 38.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 99.989999999999995 109.695 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -135.87 126.6 27.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 99.989999999999995 109.465 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.84 136.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.427 -0.796 . . . . 99.989999999999995 109.709 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.4 138.12 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 99.989999999999995 109.049 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.54 144.68 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 99.989999999999995 109.295 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.63 23.1 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.629 -1.388 . . . . 99.989999999999995 109.629 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 12' ' ' GLY . 26.1 t70 -89.55 105.88 18.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -1.165 . . . . 99.989999999999995 109.43 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.73 68.78 0.5 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.733 -1.347 . . . . 99.989999999999995 109.733 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -1.151 . . . . 99.989999999999995 109.401 -179.995 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.23 -45.73 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 99.989999999999995 109.309 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.29 48.94 0.88 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.506 -1.438 . . . . 99.989999999999995 109.506 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 68.1 tttt -59.69 -40.18 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.245 . . . . 99.989999999999995 109.726 -179.787 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.8 m -64.5 -40.56 95.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 99.989999999999995 109.529 179.967 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.84 -29.77 63.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 99.989999999999995 110.036 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.34 -42.76 96.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.014 -1.054 . . . . 99.989999999999995 109.22 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -73.44 -40.1 64.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 99.989999999999995 109.545 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.89 -48.92 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 99.989999999999995 109.289 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -56.37 -32.65 64.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 99.989999999999995 109.859 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -81.1 -50.63 9.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.028 -1.045 . . . . 99.989999999999995 109.671 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 m -55.93 -44.3 78.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 99.989999999999995 109.703 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 82.1 p -118.39 -110.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.597 -0.89 . . . . 99.989999999999995 108.597 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 25' ' ' THR . 81.5 m-20 -146.06 12.56 1.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.016 . . . . 99.989999999999995 109.882 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 28' ' ' PHE . 22.7 tttm 77.91 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.568 -0.707 . . . . 99.989999999999995 109.757 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -37.16 -55.54 1.71 Allowed Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.409 -0.807 . . . . 99.989999999999995 111.482 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.413 ' C ' ' O ' ' A' ' 28' ' ' PHE . 89.0 Cg_exo -35.43 -53.47 0.78 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.975 1.783 . . . . 99.989999999999995 112.415 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.7 t -108.72 142.82 38.69 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 108.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.22 -19.93 13.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.458 -0.941 . . . . 99.989999999999995 108.458 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -133.59 161.34 34.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.6 -0.688 . . . . 99.989999999999995 110.183 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.455 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 7.7 p -123.93 79.83 57.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.815 -0.809 . . . . 99.989999999999995 108.815 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.2 -64.05 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.699 2.266 . . . . 99.989999999999995 112.442 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.94 166.04 24.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 99.989999999999995 109.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.57 141.04 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 99.989999999999995 109.073 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.72 -84.93 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 99.989999999999995 109.491 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 52.3 p30 -148.83 -170.86 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 99.989999999999995 109.806 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 40.5 p-10 -52.56 151.35 4.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.799 . . . . 99.989999999999995 109.257 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.98 146.44 44.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 109.741 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.39 142.86 45.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 99.989999999999995 108.961 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 134.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 99.989999999999995 109.856 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.8 m -90.49 131.81 36.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 108.914 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.17 137.59 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.413 -0.805 . . . . 99.989999999999995 110.044 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 95.7 mmm -91.2 137.46 32.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.84 . . . . 99.989999999999995 108.814 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLY . 78.4 mt -131.41 132.04 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 99.989999999999995 109.193 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.8 19.33 0.5 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.765 -1.334 . . . . 99.989999999999995 109.765 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.34 15.53 62.07 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.91 -1.276 . . . . 99.989999999999995 109.91 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 -114.83 125.44 29.04 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.397 -1.06 . . . . 99.989999999999995 108.869 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.14 117.07 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.038 1.825 . . . . 99.989999999999995 113.208 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 48.5 m-85 -127.19 139.41 52.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.855 -0.795 . . . . 99.989999999999995 108.855 178.77 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -86.9 149.81 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 99.989999999999995 109.783 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.9 tp -131.79 133.84 45.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.425 -0.797 . . . . 99.989999999999995 109.24 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.2 131.11 8.26 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.938 -1.265 . . . . 99.989999999999995 109.938 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.84 132.99 50.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -1.105 . . . . 99.989999999999995 109.048 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.17 133.37 54.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 109.987 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 58' ' ' THR . 59.0 t0 -132.21 147.44 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.624 -0.672 . . . . 99.989999999999995 109.461 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.0 p -73.05 160.36 32.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 109.549 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.73 155.69 46.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.648 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.54 9.12 72.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.724 -1.35 . . . . 99.989999999999995 109.724 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -84.46 48.85 1.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.171 -1.193 . . . . 99.989999999999995 109.367 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.19 -33.29 74.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 99.989999999999995 110.07 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -53.41 -30.47 40.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 99.989999999999995 110.615 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.44 0.38 57.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.854 -1.154 . . . . 99.989999999999995 109.532 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 45.34 45.17 9.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.8 . . . . 99.989999999999995 109.612 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -56.53 -32.54 65.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 99.989999999999995 109.75 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.25 124.02 39.07 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 109.585 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.639 ' C ' ' H ' ' A' ' 70' ' ' LEU . 5.4 mtt180 -150.86 160.89 31.52 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.02 -1.104 . . . . 99.989999999999995 108.02 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.25 10.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.518 2.145 . . . . 99.989999999999995 112.534 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.639 ' H ' ' C ' ' A' ' 68' ' ' ARG . 83.1 mt -59.34 -38.22 79.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.095 . . . . 99.989999999999995 109.915 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 t -130.13 151.22 50.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 99.989999999999995 109.963 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -121.67 84.93 43.56 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 99.989999999999995 109.074 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.91 148.15 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.708 2.272 . . . . 99.989999999999995 112.623 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' THR . 95.2 mm-40 -79.93 -63.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.473 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER 85.62 50.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.383 -0.599 . . . . 99.989999999999995 109.383 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.88 -33.67 67.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 99.989999999999995 109.394 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.2 128.8 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 99.989999999999995 109.441 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -105.61 124.12 49.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 99.989999999999995 108.767 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 55.9 mt -107.82 137.46 45.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.31 -0.869 . . . . 99.989999999999995 109.961 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 97' ' ' TRP . 20.1 t -124.99 136.78 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.854 -0.795 . . . . 99.989999999999995 108.854 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.562 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 45.0 t -130.04 127.34 39.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.848 . . . . 99.989999999999995 109.843 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -136.42 165.37 25.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.942 . . . . 99.989999999999995 108.853 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.5 m -101.83 142.63 32.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 99.989999999999995 109.223 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 84' ' ' VAL . 4.1 p -102.84 -1.35 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 110.055 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 78.2 t -85.32 -21.67 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 99.989999999999995 109.882 179.763 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.407 ' O ' ' OG ' ' A' ' 89' ' ' SER . 1.6 m -111.96 108.67 55.37 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.772 . . . . 99.989999999999995 109.771 -179.512 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -51.77 -38.27 66.73 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.022 1.815 . . . . 99.989999999999995 112.335 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.6 p -57.62 -35.22 70.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 99.989999999999995 109.154 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.407 ' OG ' ' O ' ' A' ' 86' ' ' SER . 83.7 p -67.92 -21.85 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.521 -0.918 . . . . 99.989999999999995 108.521 179.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -72.02 -50.45 28.43 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.569 -0.9 . . . . 99.989999999999995 108.569 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.65 -35.77 80.96 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.366 -0.834 . . . . 99.989999999999995 109.259 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -50.95 -33.83 26.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 109.297 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 81.3 t -62.39 -35.31 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 99.989999999999995 109.453 179.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -89.43 -37.56 14.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.821 -1.175 . . . . 99.989999999999995 110.247 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.07 -37.22 83.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 99.989999999999995 112.384 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -112.91 -52.05 2.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.762 -1.212 . . . . 99.989999999999995 112.699 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.536 ' CZ3' ' CG1' ' A' ' 80' ' ' VAL . 30.8 m0 -66.86 -39.43 87.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.994 -1.066 . . . . 99.989999999999995 112.593 -176.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.455 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -61.47 -52.21 71.71 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.143 -1.598 . . . . 99.989999999999995 111.05 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.455 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 38.3 Cg_endo -68.98 -43.22 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.568 1.512 . . . . 99.989999999999995 112.416 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.82 -39.81 62.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 99.989999999999995 110.5 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.44 ' O ' ' N ' ' A' ' 105' ' ' CYS . 1.3 mp -66.63 -33.32 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.778 -1.201 . . . . 99.989999999999995 109.927 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.2 m -53.77 -39.02 65.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.998 . . . . 99.989999999999995 109.318 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -58.93 -40.7 85.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 99.989999999999995 109.739 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -99.4 1.12 43.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 109.715 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER 59.42 166.32 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.996 . . . . 99.989999999999995 109.331 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.7 39.92 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.723 2.282 . . . . 99.989999999999995 112.304 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -60.17 -35.37 75.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 99.989999999999995 110.745 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.07 157.74 49.92 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 99.989999999999995 110.471 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.73 144.64 44.5 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.034 2.489 . . . . 99.989999999999995 112.696 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -116.75 138.82 51.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.575 -0.703 . . . . 99.989999999999995 109.497 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 45.8 tp -116.71 123.62 47.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.696 . . . . 99.989999999999995 109.788 -179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -101.56 116.93 33.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.407 -0.96 . . . . 99.989999999999995 108.407 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.03 135.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 99.989999999999995 110.672 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.3 114.88 4.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.41 -1.876 . . . . 99.989999999999995 108.41 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.562 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 20.8 m -102.74 149.22 24.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -1.152 . . . . 99.989999999999995 110.503 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.5 mt-30 60.68 41.18 15.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.931 -0.48 . . . . 99.989999999999995 110.637 179.166 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.2 pt -73.65 -6.21 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.875 -1.141 . . . . 99.989999999999995 110.191 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.487 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 84.5 m-20 -85.71 -24.03 27.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.049 -1.032 . . . . 99.989999999999995 109.217 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.516 ' O ' ' N ' ' A' ' 121' ' ' ASP . 10.2 mp -65.01 -24.98 67.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 99.989999999999995 109.092 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -44.99 -19.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.514 -0.741 . . . . 99.989999999999995 109.231 179.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 119' ' ' LEU . 60.6 t0 -122.33 48.63 1.71 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.737 . . . . 99.989999999999995 109.032 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 56.4 t0 -117.72 90.55 36.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.516 -0.74 . . . . 99.989999999999995 109.21 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.6 -40.92 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.197 1.931 . . . . 99.989999999999995 112.398 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.5 t -57.87 -43.21 85.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 99.989999999999995 109.842 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 45.4 m -70.58 -49.56 46.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 99.989999999999995 108.232 178.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.0 -36.41 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.77 -0.581 . . . . 99.989999999999995 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.15 -43.83 90.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 99.989999999999995 108.896 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -61.78 -42.54 99.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 99.989999999999995 109.696 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.516 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 3.8 mm? -75.39 -33.91 61.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.885 . . . . 99.989999999999995 109.348 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.89 40.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 99.989999999999995 109.469 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.83 -35.36 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 109.495 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.38 6.81 21.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 99.989999999999995 109.719 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 61.55 44.77 8.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.645 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -140.94 139.61 34.32 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.229 -0.919 . . . . 99.989999999999995 108.882 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.88 161.83 34.22 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 99.989999999999995 109.534 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.03 145.65 97.89 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.867 2.378 . . . . 99.989999999999995 112.328 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.555 ' CG2' ' OG1' ' A' ' 141' ' ' THR . 97.1 mt -90.99 144.56 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.435 -0.791 . . . . 99.989999999999995 109.835 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.34 155.02 54.52 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.359 -0.838 . . . . 99.989999999999995 109.371 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.54 -32.79 95.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.406 2.071 . . . . 99.989999999999995 111.601 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.35 -36.61 61.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 99.989999999999995 109.971 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.555 ' OG1' ' CG2' ' A' ' 137' ' ' ILE . 65.4 p -78.57 -23.76 45.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.82 -1.175 . . . . 99.989999999999995 108.832 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.01 -43.88 51.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.448 -0.783 . . . . 99.989999999999995 109.759 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.68 -35.62 81.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 99.989999999999995 110.984 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -65.86 -38.42 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.769 -1.207 . . . . 99.989999999999995 109.431 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 34.2 tp -59.7 -38.53 81.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 99.989999999999995 109.302 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.17 84.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.956 . . . . 99.989999999999995 109.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.637 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -81.26 6.54 13.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 99.989999999999995 109.62 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -111.46 -34.86 5.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 99.989999999999995 109.106 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 66.7 mt -92.68 16.9 11.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 99.989999999999995 110.63 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.2 mttt 61.2 31.23 19.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 110.264 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.93 145.18 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 109.05 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 87.0 t -66.56 -60.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.014 . . . . 99.989999999999995 109.952 -179.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.9 mttm -152.86 157.67 41.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 99.989999999999995 109.774 179.992 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -132.15 148.61 52.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 109.224 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.477 ' CG1' ' ND2' ' A' ' 167' ' ' ASN . 46.6 t -134.11 140.95 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 110.231 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.422 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.4 mt-10 -94.86 121.84 36.88 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.33 -0.989 . . . . 99.989999999999995 108.33 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.422 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -130.69 140.63 50.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.159 -0.963 . . . . 99.989999999999995 110.761 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 161' ' ' THR . 8.7 t -115.61 115.13 25.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 99.989999999999995 109.416 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.9 -35.67 64.69 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.247 0.546 . . . . 99.989999999999995 109.86 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.45 -31.0 32.6 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.078 -1.082 . . . . 99.989999999999995 108.078 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.572 ' C ' ' H ' ' A' ' 163' ' ' LYS . 7.4 m -118.03 152.11 36.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.672 -1.232 . . . . 99.989999999999995 107.672 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.29 12.61 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.326 -0.859 . . . . 99.989999999999995 109.498 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.572 ' H ' ' C ' ' A' ' 161' ' ' THR . 62.9 mttp -89.18 4.74 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.857 -1.152 . . . . 99.989999999999995 109.903 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -89.08 -51.0 3.1 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.489 -1.339 . . . . 99.989999999999995 109.952 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.56 -38.62 74.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 99.989999999999995 110.301 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -60.24 -29.14 68.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 99.989999999999995 110.459 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.477 ' ND2' ' CG1' ' A' ' 155' ' ' VAL . 38.6 t-20 -75.59 -49.46 18.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.58 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 73.0 t -79.1 -8.08 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 99.989999999999995 110.726 -179.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 76.1 t80 -74.95 -50.38 16.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.771 -1.205 . . . . 99.989999999999995 110.331 -179.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.69 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 99.989999999999995 110.272 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 85.0 tt0 -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.975 . . . . 99.989999999999995 109.798 -179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.61 80.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 99.989999999999995 110.002 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 75.9 mt -72.89 -42.25 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.093 -1.004 . . . . 99.989999999999995 109.855 179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.0 tp -57.5 -44.84 85.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 99.989999999999995 109.902 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.09 -33.4 75.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 99.989999999999995 109.894 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.7 71.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 109.696 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.9 -39.78 86.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 99.989999999999995 109.071 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 99.989999999999995 109.521 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.514 -0.551 . . . . 99.989999999999995 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -63.05 -34.44 77.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 99.989999999999995 109.33 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.6 m -124.92 147.42 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.583 -0.698 . . . . 99.989999999999995 109.781 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.25 119.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.069 -0.715 . . . . 99.989999999999995 109.069 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -88.92 128.38 35.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 99.989999999999995 110.123 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.59 124.03 26.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.924 -0.769 . . . . 99.989999999999995 108.924 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.06 138.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 99.989999999999995 109.935 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.2 t -111.32 136.07 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.717 -0.846 . . . . 99.989999999999995 108.717 179.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 54.2 t -133.27 136.44 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 99.989999999999995 109.554 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.1 142.36 12.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 99.989999999999995 109.438 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 12' ' ' GLY . 50.7 t0 -84.99 105.06 15.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 99.989999999999995 109.551 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.0 66.16 1.09 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.271 -1.531 . . . . 99.989999999999995 109.271 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -81.53 130.25 34.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -1.117 . . . . 99.989999999999995 109.342 -179.875 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.48 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 99.989999999999995 109.221 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.22 51.91 0.67 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.237 -1.545 . . . . 99.989999999999995 109.237 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 86.3 tttt -61.8 -39.83 93.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.239 . . . . 99.989999999999995 110.057 -179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.6 p -76.14 -35.55 59.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 99.989999999999995 109.967 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 68.7 m -64.1 -31.18 72.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 110.445 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.78 -42.32 81.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 99.989999999999995 109.711 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.4 mt -70.45 -40.88 73.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 109.93 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.9 -36.71 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 99.989999999999995 110.0 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.6 p -60.44 -30.5 69.69 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.351 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -82.65 -50.27 8.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 99.989999999999995 109.977 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.527 ' HG1' ' N ' ' A' ' 25' ' ' THR . 62.2 p -66.85 -40.57 87.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 99.989999999999995 110.469 -179.27 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 54.8 m -105.08 -86.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.965 . . . . 99.989999999999995 109.645 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER 159.92 -10.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 99.989999999999995 110.032 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -83.92 103.92 13.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.739 -1.226 . . . . 99.989999999999995 109.783 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.638 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -65.33 -41.4 51.15 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.431 -0.793 . . . . 99.989999999999995 109.173 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 27.7 Cg_exo -59.48 -33.36 97.21 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.337 2.025 . . . . 99.989999999999995 112.068 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER 74.99 42.25 0.27 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.104 -0.997 . . . . 99.989999999999995 108.595 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 32' ' ' TYR . 96.1 mt-10 -44.84 81.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.125 0.488 . . . . 99.989999999999995 110.597 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.669 ' N ' ' O ' ' A' ' 30' ' ' SER . 11.7 t80 90.05 71.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.228 0.537 . . . . 99.989999999999995 110.403 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.414 ' C ' ' O ' ' A' ' 32' ' ' TYR . 31.7 m -44.55 148.81 0.84 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 99.989999999999995 109.604 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.28 144.3 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.833 2.355 . . . . 99.989999999999995 112.415 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.03 1.02 42.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 99.989999999999995 110.171 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.54 142.29 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.119 -0.988 . . . . 99.989999999999995 109.969 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.92 16.36 22.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 99.989999999999995 109.886 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 59.2 t0 -63.82 129.1 38.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 99.989999999999995 109.679 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -70.33 151.05 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.428 -0.795 . . . . 99.989999999999995 109.588 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 98.7 m-85 -127.97 152.56 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.816 . . . . 99.989999999999995 109.866 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.59 145.48 30.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 99.989999999999995 109.261 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -128.45 147.09 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 99.989999999999995 109.842 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 58.3 m -120.53 142.53 49.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 99.989999999999995 109.408 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 m -124.53 158.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 99.989999999999995 109.818 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.7 mtp -112.49 140.65 47.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 99.989999999999995 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.403 ' O ' ' C ' ' A' ' 47' ' ' GLY . 60.4 mt -122.1 143.78 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.883 -0.784 . . . . 99.989999999999995 108.883 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -46.4 -29.19 3.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.726 -1.75 . . . . 99.989999999999995 108.726 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -81.13 -92.16 0.51 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.152 -1.579 . . . . 99.989999999999995 109.152 179.487 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -126.74 156.68 73.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -1.057 . . . . 99.989999999999995 109.846 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.7 138.07 23.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.735 2.29 . . . . 99.989999999999995 112.24 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -131.38 152.17 50.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.084 179.416 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 17.8 p -117.8 157.92 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 99.989999999999995 109.673 -179.745 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.17 160.3 29.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 109.28 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.19 158.28 26.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.468 -1.453 . . . . 99.989999999999995 109.468 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 mt -106.0 129.11 54.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 99.989999999999995 109.058 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -115.99 135.08 54.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.558 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -139.55 167.56 21.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 99.989999999999995 109.387 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.25 154.11 25.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.068 -1.02 . . . . 99.989999999999995 109.523 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.74 ' H ' HH12 ' A' ' 66' ' ' ARG . . . -114.49 24.64 11.7 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.033 -0.729 . . . . 99.989999999999995 109.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.35 125.72 3.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.85 -1.7 . . . . 99.989999999999995 108.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 49.4 tp60 -109.28 112.38 24.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -1.093 . . . . 99.989999999999995 109.45 -179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.16 -115.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 99.989999999999995 109.443 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -87.34 12.17 12.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 110.119 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.98 -7.22 56.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 99.989999999999995 109.314 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 85.8 m-20 45.39 46.64 10.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.853 . . . . 99.989999999999995 109.751 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.74 HH12 ' H ' ' A' ' 59' ' ' ALA . 58.0 mtp180 -57.31 -23.38 48.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 109.853 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.66 7.67 16.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.328 -0.857 . . . . 99.989999999999995 109.87 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.638 ' CG ' HH11 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -46.51 -51.59 35.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 99.989999999999995 110.797 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 56.6 Cg_endo -74.14 -101.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.822 1.681 . . . . 99.989999999999995 112.348 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.73 -110.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 99.989999999999995 109.611 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.1 p -160.65 162.61 32.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 99.989999999999995 109.604 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -130.32 72.94 81.71 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 99.989999999999995 109.184 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.22 65.1 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.038 2.492 . . . . 99.989999999999995 112.737 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -128.85 124.92 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 99.989999999999995 109.097 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.47 ' OG1' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -152.12 98.44 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 99.989999999999995 109.705 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.4 -34.03 74.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.917 . . . . 99.989999999999995 109.546 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.78 143.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 110.316 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 74.2 m-85 -104.71 127.3 52.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 99.989999999999995 109.402 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 30.7 tp -111.93 125.53 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.405 -0.81 . . . . 99.989999999999995 108.973 179.592 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.27 137.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 109.484 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 141.95 49.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 99.989999999999995 109.541 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.3 159.01 43.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 99.989999999999995 109.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -89.18 150.83 22.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.378 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.464 ' CG2' ' O ' ' A' ' 84' ' ' VAL . 6.7 p -98.48 4.43 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 99.989999999999995 110.218 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.97 -2.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 99.989999999999995 110.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -115.06 92.92 33.0 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 109.661 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.03 -50.81 12.73 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.41 2.073 . . . . 99.989999999999995 112.695 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -54.29 -38.68 66.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 99.989999999999995 109.371 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.7 p -63.65 -16.01 59.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 99.989999999999995 108.421 179.401 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.29 -50.78 13.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.991 -0.744 . . . . 99.989999999999995 108.991 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.48 -39.46 81.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 99.989999999999995 109.592 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -53.74 -31.56 48.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 109.092 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 75.8 t -60.38 -35.59 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.371 -0.831 . . . . 99.989999999999995 109.697 179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -95.66 -30.06 13.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.033 -1.042 . . . . 99.989999999999995 110.605 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.56 -35.06 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.71 -1.244 . . . . 99.989999999999995 111.903 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -113.73 -49.69 2.87 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.045 -1.034 . . . . 99.989999999999995 112.36 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 79.3 m95 -76.31 3.24 11.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.719 1.007 . . . . 99.989999999999995 113.719 -176.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.481 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 0.9 OUTLIER -107.04 -45.98 0.12 Allowed Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.387 -1.446 . . . . 99.989999999999995 110.851 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.481 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 91.5 Cg_endo -86.12 -53.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.545 2.163 . . . . 99.989999999999995 112.767 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.57 -34.37 78.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 99.989999999999995 109.928 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.2 -27.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 99.989999999999995 109.853 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.1 p -66.46 -35.02 79.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.933 . . . . 99.989999999999995 109.764 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -56.84 -41.47 77.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.989 . . . . 99.989999999999995 109.689 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -101.28 -8.8 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 99.989999999999995 109.788 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m -147.79 77.54 10.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 109.626 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.74 -44.46 49.41 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.564 2.176 . . . . 99.989999999999995 112.062 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -150.8 104.1 3.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 99.989999999999995 109.459 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -150.38 155.79 36.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 99.989999999999995 109.437 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.95 127.78 17.54 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.42 2.08 . . . . 99.989999999999995 111.857 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 108' ' ' THR . 76.7 m-85 -116.61 137.64 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 99.989999999999995 109.769 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 8.2 tp -122.82 119.2 29.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.723 . . . . 99.989999999999995 109.449 179.826 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.563 ' CD1' ' N ' ' A' ' 112' ' ' LEU . 5.6 mp -107.56 127.08 53.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 99.989999999999995 108.818 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -112.04 133.08 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.287 -0.883 . . . . 99.989999999999995 110.03 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.67 119.82 5.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.339 -1.904 . . . . 99.989999999999995 108.339 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.9 p -118.25 169.45 9.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -1.068 . . . . 99.989999999999995 110.937 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 117' ' ' ILE . 82.3 mt-30 66.08 40.76 3.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.892 -0.595 . . . . 99.989999999999995 111.279 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 116' ' ' GLN . 15.2 tt -48.97 178.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.918 -1.114 . . . . 99.989999999999995 108.576 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 121' ' ' ASP . 87.7 m-20 54.26 26.17 6.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.819 -1.176 . . . . 99.989999999999995 109.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.9 mt 26.88 54.69 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.983 -0.448 . . . . 99.989999999999995 111.343 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 21.2 mmm180 49.61 26.85 1.91 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.834 -1.166 . . . . 99.989999999999995 110.189 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 118' ' ' ASP . 9.7 t0 79.84 -14.74 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 99.989999999999995 109.455 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.439 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.8 OUTLIER 53.97 62.34 9.04 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.314 -0.866 . . . . 99.989999999999995 109.756 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.439 ' HD3' ' N ' ' A' ' 122' ' ' ASP . 68.4 Cg_endo -92.68 -100.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 123.02 2.48 . . . . 99.989999999999995 111.504 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.3 p -81.17 -2.4 48.4 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.36 -0.978 . . . . 99.989999999999995 108.36 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.6 m -72.41 -46.36 55.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 99.989999999999995 108.956 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 6.9 pt -62.63 -34.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.29 -0.881 . . . . 99.989999999999995 109.308 -179.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.63 -50.03 48.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 99.989999999999995 109.584 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -61.34 -36.67 80.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 99.989999999999995 110.138 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.93 -37.77 61.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 99.989999999999995 108.789 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.83 -38.49 61.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.617 -0.677 . . . . 99.989999999999995 109.475 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -60.23 -36.73 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 109.346 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -85.32 5.7 29.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 99.989999999999995 109.546 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttt 54.92 44.06 28.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 99.989999999999995 109.829 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -135.56 91.78 2.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.997 . . . . 99.989999999999995 109.416 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.85 153.22 91.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 99.989999999999995 109.819 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.31 161.77 25.96 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.853 2.369 . . . . 99.989999999999995 112.205 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.452 ' CG2' ' HG1' ' A' ' 141' ' ' THR . 27.1 mm -92.11 134.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 99.989999999999995 109.802 -179.488 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -98.2 157.87 33.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 99.989999999999995 109.067 -179.639 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -47.93 -36.28 26.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.906 2.404 . . . . 99.989999999999995 113.065 -179.356 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -46.9 -40.76 14.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 99.989999999999995 110.119 -178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.452 ' HG1' ' CG2' ' A' ' 137' ' ' ILE . 72.1 p -89.25 -18.38 27.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.779 -1.201 . . . . 99.989999999999995 109.39 179.453 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.3 -49.88 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 110.706 -179.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.35 -34.97 78.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.135 . . . . 99.989999999999995 110.662 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 87.7 mttt -61.82 -32.92 73.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 99.989999999999995 109.292 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 tp -56.31 -38.96 72.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 99.989999999999995 109.406 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.07 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.786 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -80.65 -0.63 38.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.849 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 61.5 t0 -111.9 -43.29 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 99.989999999999995 108.814 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 9.6 tp -78.71 10.89 2.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.636 -0.665 . . . . 99.989999999999995 109.675 -179.557 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 59.02 30.12 19.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 110.137 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.9 52.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 99.989999999999995 108.758 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.81 -58.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.075 . . . . 99.989999999999995 109.498 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 50.1 tttp -158.51 155.8 29.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 99.989999999999995 109.868 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.68 153.46 51.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 99.989999999999995 109.435 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 39.3 t -133.04 138.44 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 99.989999999999995 110.062 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 84.6 tt0 -102.6 132.22 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.157 -1.053 . . . . 99.989999999999995 108.157 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 8.4 p -167.09 176.74 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.123 . . . . 99.989999999999995 110.376 -178.786 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 28.7 t -135.17 127.19 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.014 -1.054 . . . . 99.989999999999995 110.719 -179.189 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.111 -0.699 . . . . 99.989999999999995 109.111 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.1 mt -54.66 -26.33 32.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.221 -1.029 . . . . 99.989999999999995 108.221 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 163' ' ' LYS . 27.4 m -121.3 160.87 23.05 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.276 -1.379 . . . . 99.989999999999995 107.276 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -64.62 11.17 0.05 Allowed 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.412 -0.805 . . . . 99.989999999999995 109.247 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.607 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.5 mttm -89.84 3.0 54.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.977 -1.077 . . . . 99.989999999999995 109.564 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -91.93 -50.23 2.71 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.005 -1.238 . . . . 99.989999999999995 110.005 -179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.524 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 6.6 mp -67.02 -44.96 78.95 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.443 -1.034 . . . . 99.989999999999995 110.646 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.41 -32.56 68.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.001 . . . . 99.989999999999995 110.922 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 25.6 t-20 -79.84 -50.88 9.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.939 -1.101 . . . . 99.989999999999995 110.063 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.6 m -75.79 -18.13 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 99.989999999999995 110.911 -178.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.56 -47.37 27.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 99.989999999999995 110.452 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 99.989999999999995 110.233 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -67.45 -33.99 76.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.093 -1.005 . . . . 99.989999999999995 109.927 -179.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.53 70.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.9 . . . . 99.989999999999995 110.323 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 29.3 mm -67.67 -40.75 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 99.989999999999995 110.112 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.527 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 3.4 mm? -56.88 -45.59 82.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 99.989999999999995 110.083 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.97 77.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 99.989999999999995 110.052 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.98 72.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 99.989999999999995 109.471 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.17 -36.72 84.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 99.989999999999995 109.511 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.529 -179.736 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.338 -0.615 . . . . 99.989999999999995 109.338 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -130.4 116.78 18.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 99.989999999999995 109.552 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -127.29 135.74 50.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 99.989999999999995 109.37 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 68.3 mt -113.07 114.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.834 . . . . 99.989999999999995 109.112 179.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -91.3 132.43 36.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 110.654 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.472 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -132.6 121.39 23.14 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.434 -0.95 . . . . 99.989999999999995 108.434 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.66 134.02 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 99.989999999999995 109.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 26.1 t -114.61 133.01 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.738 -0.838 . . . . 99.989999999999995 108.738 179.536 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.443 ' CG2' ' CH2' ' A' ' 97' ' ' TRP . 9.1 p -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 99.989999999999995 109.582 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.01 -173.32 37.32 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.616 -1.394 . . . . 99.989999999999995 109.616 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' GLY . 23.3 t70 -69.76 137.65 52.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 99.989999999999995 109.106 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . -37.16 -47.67 1.43 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.004 -1.239 . . . . 99.989999999999995 110.004 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.502 ' O ' ' O ' ' A' ' 12' ' ' GLY . . . -42.53 167.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -1.209 . . . . 99.989999999999995 109.658 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.585 ' O ' ' N ' ' A' ' 16' ' ' LYS . 2.1 t 73.42 110.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.111 -0.699 . . . . 99.989999999999995 109.111 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.27 79.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.143 -1.183 . . . . 99.989999999999995 110.143 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.5 mttp -58.05 -31.18 66.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 99.989999999999995 108.989 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 m -67.52 -44.42 78.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.399 -0.813 . . . . 99.989999999999995 109.016 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.6 m -62.14 -27.7 69.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 99.989999999999995 109.637 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -65.16 -40.27 94.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 99.989999999999995 108.506 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 59.8 mt -71.37 -44.06 65.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 99.989999999999995 109.588 179.861 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mm -67.91 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.982 . . . . 99.989999999999995 109.832 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 29.6 t -60.03 -35.12 74.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.955 . . . . 99.989999999999995 109.812 -179.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.96 -33.17 70.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.291 -0.88 . . . . 99.989999999999995 109.274 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 60.9 p -72.07 -45.77 59.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.555 -0.716 . . . . 99.989999999999995 110.879 -179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.593 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 46.6 p -144.01 -2.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.792 -1.193 . . . . 99.989999999999995 111.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 25' ' ' THR . 37.3 t30 90.35 118.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.57 -0.9 . . . . 99.989999999999995 108.57 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.503 ' O ' ' OG ' ' A' ' 30' ' ' SER . 2.8 tttm 178.63 48.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.509 -0.477 . . . . 99.989999999999995 109.99 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.653 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -61.36 -42.75 86.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.513 -1.367 . . . . 99.989999999999995 109.525 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 22.9 Cg_exo -62.19 1.99 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.908 2.406 . . . . 99.989999999999995 112.575 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 32' ' ' TYR . 29.2 m -48.89 -42.12 35.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.986 -1.071 . . . . 99.989999999999995 109.762 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 39.38 23.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 99.989999999999995 109.62 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 30' ' ' SER . 30.3 m-85 -93.76 -102.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 99.989999999999995 109.786 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.539 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 46.5 t 54.44 63.18 7.6 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 99.989999999999995 109.984 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.576 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 32.9 Cg_endo -68.67 -26.31 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.267 1.978 . . . . 99.989999999999995 111.235 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.576 ' CB ' ' O ' ' A' ' 34' ' ' PRO . . . 154.51 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.252 -0.647 . . . . 99.989999999999995 109.252 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.69 142.02 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 99.989999999999995 109.806 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -144.16 59.76 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.842 . . . . 99.989999999999995 109.182 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -121.15 158.65 27.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 99.989999999999995 109.296 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 55' ' ' LEU . 64.6 t30 -93.97 139.25 31.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 99.989999999999995 109.216 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.75 154.14 29.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.817 . . . . 99.989999999999995 109.54 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.55 143.62 44.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 99.989999999999995 109.061 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.57 130.71 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.8 m -100.74 128.52 46.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.01 134.14 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 99.989999999999995 110.198 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.4 ttp -118.25 128.71 54.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.65 -0.87 . . . . 99.989999999999995 108.65 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 27.2 pt -131.8 152.39 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 110.162 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.44 16.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.195 -1.162 . . . . 99.989999999999995 110.195 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.55 15.68 61.46 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.778 -1.329 . . . . 99.989999999999995 109.778 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.8 mt-10 -113.32 93.73 27.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.438 -1.036 . . . . 99.989999999999995 109.523 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.91 145.6 23.87 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.12 . . . . 99.989999999999995 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 60.8 m-85 -150.72 160.79 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.18 -0.674 . . . . 99.989999999999995 109.18 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.3 m -117.7 129.31 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 99.989999999999995 109.24 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 34.3 tp -117.81 122.7 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.492 -0.755 . . . . 99.989999999999995 109.161 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.79 121.28 5.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 99.989999999999995 109.537 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 56.7 mt -101.62 128.05 48.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -1.121 . . . . 99.989999999999995 108.417 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 99.989999999999995 109.83 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 54.4 p30 -102.91 169.54 8.52 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.367 -0.833 . . . . 99.989999999999995 109.017 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.9 m -57.81 129.51 42.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.942 -1.099 . . . . 99.989999999999995 109.09 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.32 -66.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 99.989999999999995 109.277 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.69 53.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.665 -1.374 . . . . 99.989999999999995 109.665 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -90.09 51.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -1.202 . . . . 99.989999999999995 109.139 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 97.0 mt-10 -59.39 -33.47 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 99.989999999999995 109.922 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -45.74 -34.88 3.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.021 -1.049 . . . . 99.989999999999995 110.517 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.22 -6.27 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.846 -1.159 . . . . 99.989999999999995 109.556 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 62' ' ' GLU . 92.3 m-20 49.07 40.78 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 99.989999999999995 109.898 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -62.93 -33.77 76.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.938 -1.101 . . . . 99.989999999999995 110.064 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.4 mt -90.03 7.77 35.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 99.989999999999995 111.047 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -48.55 -47.99 68.99 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.639 -1.288 . . . . 99.989999999999995 110.003 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 73.4 Cg_endo -89.28 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.584 2.19 . . . . 99.989999999999995 112.598 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER 168.7 96.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 99.989999999999995 109.01 -179.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -62.96 -34.13 76.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 99.989999999999995 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -109.91 163.22 17.63 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 99.989999999999995 109.336 -179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.16 -71.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.597 2.198 . . . . 99.989999999999995 112.464 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -145.14 163.99 32.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 109.038 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -77.0 160.11 29.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 99.989999999999995 109.141 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -121.65 -46.65 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 99.989999999999995 110.22 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.25 142.5 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 99.989999999999995 109.903 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.04 128.56 55.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.029 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 50.0 mt -108.96 141.72 40.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 109.925 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.15 136.51 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.284 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.0 t -129.1 126.16 38.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 99.989999999999995 109.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.74 168.92 18.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 99.989999999999995 109.607 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.484 ' OG ' ' OE1' ' A' ' 116' ' ' GLN . 24.1 t -97.04 137.22 36.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.219 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 10.8 p -85.37 -10.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 111.222 -179.085 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 26.6 m -99.78 -0.93 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.73 -1.231 . . . . 99.989999999999995 110.215 -179.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 12.2 t -101.52 122.4 48.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 109.44 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.17 -61.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.211 1.94 . . . . 99.989999999999995 113.096 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -52.43 -41.07 62.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.927 -1.108 . . . . 99.989999999999995 110.117 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 60.5 p -69.09 -18.68 64.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.974 . . . . 99.989999999999995 109.505 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 61.7 t80 -70.36 -50.5 38.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 99.989999999999995 109.457 179.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -74.4 -34.57 63.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 99.989999999999995 110.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -53.56 -39.01 64.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 99.989999999999995 109.967 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.5 -33.47 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 110.144 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.66 -25.69 62.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 111.35 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.12 -9.45 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.705 -1.247 . . . . 99.989999999999995 111.472 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -112.04 -51.44 2.85 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 99.989999999999995 111.337 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.443 ' CH2' ' CG2' ' A' ' 9' ' ' VAL . 61.6 m95 -92.4 -7.12 48.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.185 -0.947 . . . . 99.989999999999995 112.432 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -94.33 -39.98 0.3 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.318 -1.489 . . . . 99.989999999999995 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.8 Cg_endo -91.94 -49.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 99.989999999999995 113.517 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -51.6 -39.77 58.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 99.989999999999995 110.452 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.2 tp -81.68 -19.85 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 99.989999999999995 110.042 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.561 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 57.6 m -54.7 -38.33 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 99.989999999999995 110.18 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -56.4 -43.77 79.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 99.989999999999995 110.741 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -103.4 11.76 36.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.957 -1.09 . . . . 99.989999999999995 111.068 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.561 ' SG ' ' O ' ' A' ' 102' ' ' THR . 28.0 p -63.57 114.86 14.6 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.154 . . . . 99.989999999999995 109.468 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 107' ' ' LYS . 87.0 Cg_endo -83.16 -90.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.238 1.959 . . . . 99.989999999999995 112.632 179.862 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.413 ' H ' ' HG2' ' A' ' 106' ' ' PRO . 27.1 mttt -87.81 -80.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 99.989999999999995 109.308 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER 173.42 58.67 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 99.989999999999995 110.226 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.45 ' HD3' ' N ' ' A' ' 108' ' ' THR . 48.1 Cg_endo -94.06 53.01 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.955 2.437 . . . . 99.989999999999995 111.899 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.66 128.26 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 99.989999999999995 110.876 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 11.1 tp -124.89 116.5 22.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.274 -1.01 . . . . 99.989999999999995 108.274 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.16 125.55 44.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 99.989999999999995 108.99 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.89 134.49 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 99.989999999999995 110.201 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.5 127.02 8.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.531 -1.828 . . . . 99.989999999999995 108.531 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 3.3 t -132.05 168.01 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 99.989999999999995 110.214 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.544 ' CB ' ' O ' ' A' ' 115' ' ' THR . 21.9 tt0 84.99 20.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.765 -0.457 . . . . 99.989999999999995 109.765 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.693 ' O ' ' N ' ' A' ' 119' ' ' LEU . 39.0 pt -59.44 -155.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 99.989999999999995 108.401 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 57.99 -58.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.743 . . . . 99.989999999999995 110.255 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.693 ' N ' ' O ' ' A' ' 117' ' ' ILE . 27.9 tp -51.78 -31.79 28.38 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.04 -1.037 . . . . 99.989999999999995 108.598 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -49.44 -17.63 0.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.765 . . . . 99.989999999999995 109.482 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -118.87 62.55 0.78 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 99.989999999999995 109.006 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.65 94.29 26.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.878 -0.786 . . . . 99.989999999999995 108.878 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.28 -44.72 23.77 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.278 1.985 . . . . 99.989999999999995 112.618 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -55.59 -36.05 66.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 110.052 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 69.1 p -78.0 -42.7 31.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.864 -1.147 . . . . 99.989999999999995 108.246 178.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.4 -39.0 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 109.261 -0.644 . . . . 99.989999999999995 109.261 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.28 -40.06 81.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.873 . . . . 99.989999999999995 108.695 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -59.79 -43.17 94.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.744 . . . . 99.989999999999995 109.152 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.51 -29.7 56.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.858 . . . . 99.989999999999995 109.264 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.7 -41.41 43.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.549 -0.719 . . . . 99.989999999999995 109.605 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.21 -36.65 75.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.935 . . . . 99.989999999999995 109.422 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.91 6.47 24.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 99.989999999999995 109.858 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.9 mttt 58.09 43.3 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.38 -0.825 . . . . 99.989999999999995 109.908 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.89 138.81 35.97 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 109.08 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.37 154.24 53.98 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.92 -0.77 . . . . 99.989999999999995 108.92 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -46.25 147.39 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.238 1.959 . . . . 99.989999999999995 111.819 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 86.5 mt -75.58 148.98 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 99.989999999999995 109.443 -179.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.401 ' HG1' ' H ' ' A' ' 138' ' ' THR . 0.4 OUTLIER -86.96 154.9 55.53 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 109.193 179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.8 -36.2 91.87 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.432 2.088 . . . . 99.989999999999995 111.777 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.98 -36.68 80.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 99.989999999999995 109.631 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 61.6 m -68.66 -36.75 78.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 108.84 179.229 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.31 64.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.567 -0.708 . . . . 99.989999999999995 110.008 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.38 -32.07 73.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.092 -1.005 . . . . 99.989999999999995 110.268 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -61.12 -36.52 79.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.81 -1.182 . . . . 99.989999999999995 109.23 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.1 tp -54.74 -39.88 68.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 99.989999999999995 109.633 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -68.67 -46.04 70.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 99.989999999999995 109.577 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -83.71 5.02 26.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.908 . . . . 99.989999999999995 110.143 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -61.43 -36.13 79.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.965 -1.084 . . . . 99.989999999999995 109.425 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.4 mt -126.16 -73.79 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 99.989999999999995 109.46 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -169.89 55.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 99.989999999999995 109.876 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.04 143.52 50.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.991 -1.068 . . . . 99.989999999999995 109.244 179.425 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.458 ' O ' ' CG ' ' A' ' 153' ' ' LYS . 99.3 t -67.33 -56.58 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 99.989999999999995 110.104 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.458 ' CG ' ' O ' ' A' ' 152' ' ' VAL . 66.0 mttm -159.3 164.99 34.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.173 -0.954 . . . . 99.989999999999995 109.912 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -131.06 146.93 52.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 99.989999999999995 108.908 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 t -132.26 140.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.234 -0.916 . . . . 99.989999999999995 110.147 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.47 129.96 52.43 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.941 -1.133 . . . . 99.989999999999995 107.941 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 150.16 43.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.93 -1.106 . . . . 99.989999999999995 111.297 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 21.5 t -114.56 106.46 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.768 -0.827 . . . . 99.989999999999995 108.768 179.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.8 -34.5 64.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 99.989999999999995 109.621 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.32 -24.19 27.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.004 -1.11 . . . . 99.989999999999995 108.004 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.2 p -123.24 168.74 12.06 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.985 -1.117 . . . . 99.989999999999995 107.985 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -78.17 11.81 2.16 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.686 -0.634 . . . . 99.989999999999995 109.614 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 49.3 mttt -90.64 -5.76 55.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.035 -1.04 . . . . 99.989999999999995 109.85 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.49 -50.46 3.58 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.362 -1.399 . . . . 99.989999999999995 110.449 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.474 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 7.8 mp -65.73 -41.01 92.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.211 . . . . 99.989999999999995 110.275 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -59.12 -31.3 68.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 110.796 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 163' ' ' LYS . 21.1 m120 -78.33 -50.7 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.926 -1.108 . . . . 99.989999999999995 110.102 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 91.8 t -77.27 -12.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.387 -0.82 . . . . 99.989999999999995 110.952 -179.277 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.5 t80 -80.46 -50.53 9.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.679 -1.263 . . . . 99.989999999999995 110.593 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.03 -45.88 92.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 99.989999999999995 110.526 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.5 -33.0 68.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 99.989999999999995 110.165 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.59 -33.44 71.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 99.989999999999995 110.112 -179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 88.5 mt -65.86 -36.28 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 99.989999999999995 110.504 -179.729 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.526 ' CD2' ' N ' ' A' ' 174' ' ' LEU . 4.0 mm? -58.22 -44.01 87.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.113 . . . . 99.989999999999995 109.597 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.6 -33.89 76.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.043 . . . . 99.989999999999995 109.156 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -57.6 -38.75 75.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 99.989999999999995 109.512 -179.725 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 52.7 mt -59.91 -39.73 86.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -0.936 . . . . 99.989999999999995 108.792 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 99.989999999999995 109.329 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.48 -0.563 . . . . 99.989999999999995 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.87 -31.75 71.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 99.989999999999995 109.509 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -123.3 160.59 26.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 99.989999999999995 109.779 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.2 mm -116.64 119.0 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.939 -0.763 . . . . 99.989999999999995 108.939 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -87.03 121.97 30.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.037 -1.04 . . . . 99.989999999999995 109.786 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.2 t -138.13 128.37 25.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.441 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.93 143.05 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -0.83 . . . . 99.989999999999995 109.546 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.82 133.01 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 99.989999999999995 109.059 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.591 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 26.5 t -131.45 136.07 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 99.989999999999995 109.477 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.23 147.65 17.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.433 -1.467 . . . . 99.989999999999995 109.433 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' ALA . 25.2 t70 -85.6 111.49 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.059 -1.26 . . . . 99.989999999999995 109.485 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.406 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 54.42 -85.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.355 -1.498 . . . . 99.989999999999995 109.355 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.561 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 69.23 123.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -1.127 . . . . 99.989999999999995 109.567 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.71 -43.06 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 99.989999999999995 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.59 57.69 0.42 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.554 -1.418 . . . . 99.989999999999995 109.554 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -63.36 -40.72 98.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 99.989999999999995 109.728 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.425 ' HG1' ' N ' ' A' ' 18' ' ' CYS . 69.6 p -82.82 -32.64 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 99.989999999999995 110.327 -179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.425 ' N ' ' HG1' ' A' ' 17' ' ' THR . 0.1 OUTLIER -65.72 -31.22 72.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.101 -1.0 . . . . 99.989999999999995 110.617 -179.174 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.23 -42.41 79.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.97 -1.081 . . . . 99.989999999999995 109.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.9 -40.92 91.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.845 . . . . 99.989999999999995 109.961 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.41 -35.24 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 99.989999999999995 110.369 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.3 p -50.75 -36.61 37.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 99.989999999999995 110.459 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -76.62 -37.64 56.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.083 . . . . 99.989999999999995 109.677 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.8 p -63.64 -37.69 88.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 99.989999999999995 111.692 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -162.08 -5.85 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.371 -1.456 . . . . 99.989999999999995 111.885 -179.051 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.7 t30 95.17 115.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.578 -0.897 . . . . 99.989999999999995 108.578 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -179.78 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.715 -0.476 . . . . 99.989999999999995 109.715 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.85 -42.52 83.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.778 -1.202 . . . . 99.989999999999995 109.82 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.3 Cg_exo -57.75 -31.72 92.9 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.48 2.12 . . . . 99.989999999999995 112.201 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.5 p 37.68 37.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.568 -0.707 . . . . 99.989999999999995 109.768 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 30' ' ' SER . 97.1 mt-10 -36.15 -37.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 99.989999999999995 110.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 33' ' ' VAL . 68.6 t80 -125.79 122.05 35.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 99.989999999999995 108.699 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 17.1 m -63.6 148.64 93.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.125 -0.984 . . . . 99.989999999999995 109.159 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.65 141.34 91.4 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.223 1.949 . . . . 99.989999999999995 112.149 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.95 71.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 99.989999999999995 109.939 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.75 155.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 99.989999999999995 110.067 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.32 25.91 10.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 99.989999999999995 109.098 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 89.1 m-20 -60.77 143.67 54.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 99.989999999999995 110.378 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 55' ' ' LEU . 46.3 t-20 -74.12 152.42 39.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.716 . . . . 99.989999999999995 109.563 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 95.9 m-85 -127.87 146.53 50.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 99.989999999999995 109.457 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.43 134.94 49.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 99.989999999999995 109.687 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.03 152.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 99.989999999999995 109.43 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p -118.31 143.83 46.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 109.609 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.45 138.67 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 99.989999999999995 109.815 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.6 mtt -79.11 126.87 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 99.989999999999995 109.171 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' GLY . 70.5 mt -131.56 126.2 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 99.989999999999995 109.196 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.93 18.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.035 -1.226 . . . . 99.989999999999995 110.035 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 88.81 12.95 63.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.684 -1.366 . . . . 99.989999999999995 109.684 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.6 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.1 mm-40 -123.24 81.87 52.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.466 -1.02 . . . . 99.989999999999995 109.118 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 124.05 15.33 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.677 2.252 . . . . 99.989999999999995 112.91 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.6 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 96.7 m-85 -115.49 142.68 46.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.233 -0.655 . . . . 99.989999999999995 109.233 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.4 m -75.56 135.09 40.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 99.989999999999995 109.922 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -123.09 125.06 44.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.156 -0.683 . . . . 99.989999999999995 109.156 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.79 132.38 10.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.581 -1.408 . . . . 99.989999999999995 109.581 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 73.1 mt -104.57 135.2 46.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -1.105 . . . . 99.989999999999995 109.022 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.11 155.68 32.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 99.989999999999995 109.752 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.1 p30 -150.24 178.04 9.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 99.989999999999995 109.386 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 47.5 m -66.25 138.66 57.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 99.989999999999995 109.198 179.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . 176.49 145.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 99.989999999999995 109.672 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -87.77 -179.6 47.59 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.589 -1.405 . . . . 99.989999999999995 109.589 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 63' ' ' ASP . 5.9 tt0 44.6 16.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -1.138 . . . . 99.989999999999995 109.263 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 64' ' ' TYR . 84.7 tt0 -44.78 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 99.989999999999995 109.382 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 65' ' ' ASP . 96.7 m-20 -25.1 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.819 0.342 . . . . 99.989999999999995 110.169 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.6 m-85 -8.91 72.86 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.283 0.563 . . . . 99.989999999999995 111.872 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' A' ' 63' ' ' ASP . 94.6 m-20 -94.79 -6.1 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 99.989999999999995 109.443 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.75 74.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.481 -0.762 . . . . 99.989999999999995 109.655 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.28 -38.18 85.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.927 . . . . 99.989999999999995 109.444 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.644 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 2.4 ttp180 -112.46 -43.21 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.347 -0.845 . . . . 99.989999999999995 109.946 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.644 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.0 Cg_exo -61.26 -2.4 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.967 2.444 . . . . 99.989999999999995 112.379 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.9 tp -51.43 -38.53 54.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.5 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.2 t -109.25 137.28 47.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 109.057 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 52.19 58.75 15.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 99.989999999999995 108.912 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.11 141.3 97.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.662 2.241 . . . . 99.989999999999995 112.799 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -131.04 137.96 49.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 99.989999999999995 109.258 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -124.14 151.31 44.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.346 -0.846 . . . . 99.989999999999995 109.722 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -65.6 -35.62 81.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 99.989999999999995 109.826 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 35.9 t -138.54 133.33 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 99.989999999999995 110.104 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.99 128.59 49.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 99.989999999999995 108.981 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.4 tp -113.43 132.04 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.395 -0.815 . . . . 99.989999999999995 109.855 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.14 135.4 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 99.989999999999995 109.225 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.8 t -130.52 126.15 36.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 99.989999999999995 110.021 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.47 168.41 19.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 99.989999999999995 108.86 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 m -108.01 145.93 33.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 99.989999999999995 109.472 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 14.9 p -103.79 13.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 109.039 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.78 -21.54 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 109.84 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.43 150.28 68.1 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 110.061 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.95 -33.21 3.84 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 99.989999999999995 112.737 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 t -55.67 -44.63 77.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.005 . . . . 99.989999999999995 109.493 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 40.9 m -66.36 -24.68 66.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 99.989999999999995 109.155 179.191 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -73.5 -51.26 17.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.458 -0.776 . . . . 99.989999999999995 109.524 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.51 -39.95 70.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 110.091 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.46 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 42.0 t30 -54.32 -35.28 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 99.989999999999995 109.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 65.7 t -59.06 -34.54 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 99.989999999999995 109.735 -179.592 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -86.82 -22.84 25.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 99.989999999999995 110.406 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -75.44 -30.68 60.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.905 -1.122 . . . . 99.989999999999995 111.89 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' NZ ' ' OD1' ' A' ' 11' ' ' ASP . 7.6 ttpm? -112.53 -47.38 3.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.014 -1.054 . . . . 99.989999999999995 112.223 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.591 ' CZ2' ' CG1' ' A' ' 9' ' ' VAL . 77.1 m95 -80.8 1.36 30.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.093 -1.004 . . . . 99.989999999999995 113.35 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.589 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -107.76 -41.74 0.13 Allowed Pre-proline 0 N--CA 1.503 2.192 0 O-C-N 120.402 -1.436 . . . . 99.989999999999995 110.779 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 24.3 Cg_endo -88.71 -53.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.984 2.456 . . . . 99.989999999999995 112.691 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -57.03 -37.11 71.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 110.405 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -66.12 -29.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 99.989999999999995 110.027 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.9 m -60.03 -45.31 93.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 99.989999999999995 109.931 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.16 -35.07 76.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 99.989999999999995 109.868 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -64.32 -40.91 96.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.95 . . . . 99.989999999999995 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 171.88 165.74 0.24 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 99.989999999999995 109.939 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 75.8 Cg_exo -43.25 171.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.761 2.307 . . . . 99.989999999999995 112.228 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.44 140.86 55.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 110.02 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -124.94 160.28 54.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.699 -0.852 . . . . 99.989999999999995 108.699 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.81 122.6 11.29 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.178 1.919 . . . . 99.989999999999995 111.748 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 108' ' ' THR . 76.3 m-85 -122.86 149.59 43.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 99.989999999999995 110.109 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 85.1 mt -112.98 120.01 39.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.715 -0.846 . . . . 99.989999999999995 108.715 178.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 112' ' ' LEU . 3.5 mm? -97.06 111.57 23.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 99.989999999999995 108.762 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.573 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 47.9 t -108.3 135.4 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 110.426 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.76 122.84 7.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.286 -1.926 . . . . 99.989999999999995 108.286 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.7 p -122.14 160.9 24.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -1.068 . . . . 99.989999999999995 110.477 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.504 ' CB ' ' O ' ' A' ' 115' ' ' THR . 27.8 tp60 79.99 18.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.992 -0.443 . . . . 99.989999999999995 110.233 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.654 ' O ' ' N ' ' A' ' 119' ' ' LEU . 29.0 pt -60.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.723 -1.236 . . . . 99.989999999999995 108.149 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 61.06 -62.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.607 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.654 ' N ' ' O ' ' A' ' 117' ' ' ILE . 48.7 tp -55.1 -34.75 63.94 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.089 -1.007 . . . . 99.989999999999995 108.612 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -61.8 -19.75 62.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.013 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -90.14 -19.59 24.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 99.989999999999995 109.692 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.38 141.9 80.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 99.989999999999995 109.51 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.42 -29.94 19.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.427 2.085 . . . . 99.989999999999995 112.679 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -58.26 -41.78 85.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 99.989999999999995 110.417 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 49.3 m -72.11 -47.63 49.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.982 -1.074 . . . . 99.989999999999995 108.188 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.3 mt -55.09 -36.28 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.834 -0.541 . . . . 99.989999999999995 109.641 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.84 -46.95 79.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 99.989999999999995 109.198 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -59.06 -38.12 78.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 99.989999999999995 109.725 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.419 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 83.5 mt -79.14 -35.9 41.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 99.989999999999995 109.642 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.97 66.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.342 -0.849 . . . . 99.989999999999995 109.801 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -60.9 -36.17 78.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 99.989999999999995 109.108 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.1 5.61 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 99.989999999999995 109.494 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 52.97 32.81 13.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.503 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 135' ' ' LYS . 93.5 mt-30 -96.12 -53.06 3.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 109.606 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.419 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 10.9 mttm 62.36 144.86 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.456 -0.778 . . . . 99.989999999999995 109.092 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.05 150.69 87.91 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.538 2.159 . . . . 99.989999999999995 112.58 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 91.9 mt -89.07 146.95 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 99.989999999999995 109.418 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.28 157.73 55.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 99.989999999999995 109.375 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.93 -28.8 81.36 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.528 2.152 . . . . 99.989999999999995 111.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.7 -38.11 86.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 99.989999999999995 109.343 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 m -66.76 -36.16 81.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.147 -0.971 . . . . 99.989999999999995 109.019 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.35 -39.98 62.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 99.989999999999995 109.796 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -60.18 -34.35 73.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 99.989999999999995 110.521 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -64.13 -37.63 88.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.013 -1.054 . . . . 99.989999999999995 109.922 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.8 tp -58.19 -40.23 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 99.989999999999995 109.861 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 148' ' ' ASP . . . -87.85 -52.01 5.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 99.989999999999995 109.844 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.455 ' HG2' HH11 ' A' ' 147' ' ' ARG . 29.6 ttt-85 -51.34 -7.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 110.212 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.523 ' H ' ' C ' ' A' ' 146' ' ' ALA . 84.4 m-20 -111.57 -15.82 13.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.971 -1.081 . . . . 99.989999999999995 109.835 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.37 29.59 6.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 99.989999999999995 111.06 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.0 mttt 58.5 30.56 19.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.9 -1.125 . . . . 99.989999999999995 110.88 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -71.51 144.95 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 99.989999999999995 108.83 179.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.45 -52.25 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.063 . . . . 99.989999999999995 109.771 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.57 ' HZ3' ' CG ' ' A' ' 171' ' ' GLU . 47.1 pttt -175.92 -179.22 1.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.352 -0.843 . . . . 99.989999999999995 109.804 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -137.78 153.99 49.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.537 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 33.6 m -137.34 148.38 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 99.989999999999995 109.61 179.608 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.22 134.6 52.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 99.989999999999995 108.861 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.01 149.75 42.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 99.989999999999995 110.875 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.416 ' H ' ' HA2' ' A' ' 164' ' ' GLY . 14.2 t -113.04 109.47 18.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.688 -0.856 . . . . 99.989999999999995 108.688 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.08 -36.45 61.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.712 -0.618 . . . . 99.989999999999995 109.564 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.0 mt -53.88 -26.95 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 108.645 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 p -124.05 170.24 10.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.484 -0.932 . . . . 99.989999999999995 108.484 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.32 12.0 1.36 Allowed 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.689 -0.632 . . . . 99.989999999999995 109.396 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 89.1 mttt -89.5 0.01 57.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 99.989999999999995 109.714 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.416 ' HA2' ' H ' ' A' ' 158' ' ' SER . . . -90.85 -51.13 2.71 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.359 -1.4 . . . . 99.989999999999995 110.298 -179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.472 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 7.5 mp -68.74 -41.25 79.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -1.221 . . . . 99.989999999999995 110.246 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -59.55 -35.61 74.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.127 -0.983 . . . . 99.989999999999995 110.477 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 19.4 m120 -76.89 -49.39 15.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 99.989999999999995 109.532 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.505 ' CG2' ' SG ' ' A' ' 157' ' ' CYS . 74.8 t -68.4 -9.34 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 99.989999999999995 110.536 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 72.1 t80 -74.35 -46.21 42.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 99.989999999999995 110.58 -179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.58 -49.31 77.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.993 -1.067 . . . . 99.989999999999995 111.367 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.57 ' CG ' ' HZ3' ' A' ' 153' ' ' LYS . 60.3 mp0 -70.72 -35.67 72.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.846 -1.159 . . . . 99.989999999999995 110.373 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.34 80.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 99.989999999999995 110.121 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 97.8 mt -63.47 -38.68 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.029 -1.045 . . . . 99.989999999999995 109.915 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.37 -43.64 79.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -0.976 . . . . 99.989999999999995 109.767 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.51 -36.22 83.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 99.989999999999995 109.913 -179.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -52.76 -37.75 59.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 99.989999999999995 109.585 -179.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.13 -36.55 82.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 99.989999999999995 108.997 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.446 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.418 ' H3 ' ' H ' ' A' ' 2' ' ' GLN . 51.7 ttm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.499 -0.556 . . . . 99.989999999999995 109.499 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.418 ' H ' ' H3 ' ' A' ' 1' ' ' MET . 91.3 mt-30 -122.24 117.47 26.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 99.989999999999995 109.559 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -143.08 154.91 44.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 99.989999999999995 109.767 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 61.3 mt -122.45 122.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.497 -0.752 . . . . 99.989999999999995 109.127 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -87.0 131.91 33.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 109.74 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.544 ' SG ' ' O ' ' A' ' 54' ' ' GLY . 0.0 OUTLIER -148.23 126.51 12.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 99.989999999999995 109.159 179.696 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.35 137.54 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 99.989999999999995 110.155 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 59.9 t -116.8 130.55 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 99.989999999999995 109.16 179.582 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -138.51 156.81 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 99.989999999999995 109.202 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.45 167.6 31.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.849 -1.301 . . . . 99.989999999999995 109.849 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -86.0 121.82 29.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.079 . . . . 99.989999999999995 109.451 179.757 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.515 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 71.05 -107.7 2.25 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 99.989999999999995 109.362 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 164.76 42.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 99.989999999999995 109.377 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.647 ' CG1' ' H ' ' A' ' 15' ' ' GLY . 1.7 p -72.17 -85.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.061 -1.025 . . . . 99.989999999999995 109.63 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.647 ' H ' ' CG1' ' A' ' 14' ' ' VAL . . . -99.2 16.12 59.57 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.399 -1.481 . . . . 99.989999999999995 109.399 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -59.76 -38.19 81.09 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 99.989999999999995 110.087 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.5 p -74.29 -35.5 63.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 99.989999999999995 109.994 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.656 ' SG ' ' NZ ' ' A' ' 27' ' ' LYS . 89.4 m -59.82 -30.76 69.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 99.989999999999995 110.824 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.0 tp -67.7 -42.44 81.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.902 -1.124 . . . . 99.989999999999995 110.268 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.09 -43.77 61.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 99.989999999999995 111.059 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 22' ' ' SER . 9.9 tp -65.85 -38.81 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 99.989999999999995 110.184 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.464 ' OG ' ' O ' ' A' ' 18' ' ' CYS . 25.7 m -54.69 -34.62 62.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.046 . . . . 99.989999999999995 110.307 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CZ ' ' A' ' 169' ' ' PHE . 82.3 t80 -70.13 -38.05 75.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 99.989999999999995 109.525 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 28.5 m -52.61 -37.2 57.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.932 -179.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 179.75 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 99.989999999999995 110.584 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.658 ' ND2' ' NE2' ' A' ' 162' ' ' GLN . 25.2 t-20 96.1 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.51 -0.922 . . . . 99.989999999999995 108.51 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.656 ' NZ ' ' SG ' ' A' ' 18' ' ' CYS . 53.7 tttt -64.53 -41.0 96.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.205 0.526 . . . . 99.989999999999995 111.023 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.425 ' C ' ' H ' ' A' ' 30' ' ' SER . 1.5 m-85 -42.94 -61.41 1.75 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 99.989999999999995 110.728 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 54.4 Cg_endo -70.53 23.87 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.463 2.109 . . . . 99.989999999999995 112.632 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 68.8 m -137.76 -62.0 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.116 -0.99 . . . . 99.989999999999995 109.546 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.23 11.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.028 -1.045 . . . . 99.989999999999995 109.964 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 30' ' ' SER . 78.4 m-85 -91.59 -101.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 99.989999999999995 109.709 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.526 ' CG2' ' O ' ' A' ' 33' ' ' VAL . 3.5 p 34.15 60.04 2.03 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.655 . . . . 99.989999999999995 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.429 ' HG2' ' H ' ' A' ' 35' ' ' ALA . 69.7 Cg_endo -84.23 -73.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.392 2.061 . . . . 99.989999999999995 111.863 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' ' CE2' ' A' ' 37' ' ' PHE . . . -65.35 156.46 32.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 99.989999999999995 109.648 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 p -74.02 140.59 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 99.989999999999995 109.344 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 98.2 m-85 -118.13 159.2 23.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.531 -0.731 . . . . 99.989999999999995 109.646 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.0 p30 -72.91 -167.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.842 . . . . 99.989999999999995 109.97 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.35 157.08 6.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 99.989999999999995 109.449 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -110.33 130.89 55.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.386 -0.821 . . . . 99.989999999999995 109.638 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 121.61 44.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.36 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.4 t -127.57 134.9 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.493 -0.754 . . . . 99.989999999999995 109.369 179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 m -98.55 138.79 35.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 99.989999999999995 109.316 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.26 134.57 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.453 -0.78 . . . . 99.989999999999995 109.514 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.0 mtp -107.29 141.78 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 99.989999999999995 109.568 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.463 ' O ' ' N ' ' A' ' 48' ' ' GLY . 73.7 mt -124.68 139.86 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.882 -0.785 . . . . 99.989999999999995 108.882 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.51 -24.02 0.59 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.605 -1.798 . . . . 99.989999999999995 108.605 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.463 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -82.89 -93.59 0.59 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.462 -1.455 . . . . 99.989999999999995 109.462 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.533 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 13.6 mm-40 -123.11 152.44 63.46 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.424 -1.045 . . . . 99.989999999999995 109.973 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.29 141.4 35.5 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.647 2.231 . . . . 99.989999999999995 112.224 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 98.9 m-85 -137.81 159.43 42.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 99.989999999999995 109.739 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -112.01 142.86 43.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 99.989999999999995 109.116 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -120.86 123.17 41.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.422 -0.799 . . . . 99.989999999999995 109.691 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.544 ' O ' ' SG ' ' A' ' 6' ' ' CYS . . . -116.03 129.71 8.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.222 -1.551 . . . . 99.989999999999995 109.222 179.617 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.1 mt -107.74 136.59 47.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 99.989999999999995 109.393 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -118.86 146.26 45.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 99.989999999999995 109.765 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 52.6 p30 -156.79 164.81 37.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.422 -0.798 . . . . 99.989999999999995 109.595 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -67.49 137.08 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.261 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.93 134.35 42.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 99.989999999999995 109.851 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.09 -29.99 69.45 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.636 -1.386 . . . . 99.989999999999995 109.636 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -76.2 48.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -1.166 . . . . 99.989999999999995 109.529 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.84 -29.79 63.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 99.989999999999995 109.597 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.37 -23.44 66.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 99.989999999999995 111.04 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -110.4 9.12 23.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.916 -1.115 . . . . 99.989999999999995 110.966 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 66' ' ' ARG . 85.3 m-20 -51.87 -42.4 62.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 99.989999999999995 109.471 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' C ' ' O ' ' A' ' 65' ' ' ASP . 25.7 ttt-85 25.98 58.63 0.06 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.17 0.51 . . . . 99.989999999999995 110.748 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -93.44 134.41 35.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 99.989999999999995 109.838 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.651 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 4.5 ttt180 -126.76 -45.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.56 -0.713 . . . . 99.989999999999995 109.738 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.651 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.4 Cg_exo -69.02 -16.0 40.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.478 2.119 . . . . 99.989999999999995 111.811 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt -106.46 70.28 0.82 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.703 -0.851 . . . . 99.989999999999995 108.703 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 86.0 p -71.71 -28.15 63.5 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.495 -0.753 . . . . 99.989999999999995 109.153 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 7.6 t80 -147.41 86.75 6.26 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 99.989999999999995 109.776 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.56 146.63 25.63 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.526 2.151 . . . . 99.989999999999995 112.001 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -108.08 151.72 25.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 99.989999999999995 109.762 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 58.7 m -141.62 126.82 18.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.826 179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.74 -25.26 13.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 99.989999999999995 109.014 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.49 131.72 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.444 -0.785 . . . . 99.989999999999995 109.414 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.534 ' CE1' ' OG1' ' A' ' 108' ' ' THR . 95.5 m-85 -105.71 127.75 53.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 99.989999999999995 109.237 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 7.2 tt -118.24 129.89 55.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.428 -0.795 . . . . 99.989999999999995 110.246 -179.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 25.3 m -129.47 148.88 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.136 -0.69 . . . . 99.989999999999995 109.136 179.205 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 140.92 34.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 99.989999999999995 109.87 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 15.8 p90 -154.98 157.33 37.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 99.989999999999995 109.315 179.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.5 p -83.37 157.03 22.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 99.989999999999995 109.441 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.478 ' CG2' ' O ' ' A' ' 84' ' ' VAL . 7.1 p -100.56 6.57 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 99.989999999999995 110.177 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.9 m -104.13 0.44 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 99.989999999999995 110.333 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.477 ' O ' ' OG ' ' A' ' 89' ' ' SER . 0.7 OUTLIER -114.51 95.85 41.43 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 99.989999999999995 109.843 -179.407 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.56 -48.87 19.22 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.298 1.999 . . . . 99.989999999999995 112.284 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 m -53.49 -40.47 65.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.046 . . . . 99.989999999999995 109.141 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.477 ' OG ' ' O ' ' A' ' 86' ' ' SER . 81.6 p -67.36 -19.75 65.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.084 179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -68.66 -50.92 47.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 99.989999999999995 108.742 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.92 -34.63 75.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.474 -0.766 . . . . 99.989999999999995 109.395 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 48.3 t30 -54.25 -34.41 60.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.885 . . . . 99.989999999999995 109.746 -179.704 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.55 -37.71 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 99.989999999999995 110.153 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -91.94 -44.41 8.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 99.989999999999995 110.738 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.2 -36.71 82.76 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 112.199 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -114.53 -52.31 2.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.952 -1.093 . . . . 99.989999999999995 112.901 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.6 -38.48 80.66 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.075 -1.016 . . . . 99.989999999999995 113.487 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.435 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -57.48 -52.01 77.46 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.134 -1.604 . . . . 99.989999999999995 111.084 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.435 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -70.94 -37.79 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.717 1.611 . . . . 99.989999999999995 112.787 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.97 -40.79 85.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 99.989999999999995 110.977 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 9.1 tp -65.01 -28.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.755 -1.215 . . . . 99.989999999999995 109.538 -179.468 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -61.64 -40.84 96.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 99.989999999999995 109.939 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -54.52 -40.65 68.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 99.989999999999995 109.68 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.521 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 64.8 m170 -57.39 -40.33 77.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 99.989999999999995 109.22 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.1 m 177.83 150.75 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 99.989999999999995 109.399 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.15 -27.85 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.639 2.226 . . . . 99.989999999999995 112.319 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -127.64 137.84 52.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.76 . . . . 99.989999999999995 109.753 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 ' OG1' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -175.61 147.71 0.96 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 99.989999999999995 109.073 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.474 ' N ' ' HG1' ' A' ' 108' ' ' THR . 36.3 Cg_endo -68.84 122.01 8.91 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.217 1.945 . . . . 99.989999999999995 111.758 179.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -108.7 123.8 49.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 99.989999999999995 109.655 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 29.6 tp -117.47 125.18 50.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 109.314 179.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 49.5 tp -109.81 119.1 38.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 99.989999999999995 109.4 179.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 135.58 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 99.989999999999995 109.905 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.82 125.78 8.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.663 -1.775 . . . . 99.989999999999995 108.663 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.0 p -124.07 163.87 20.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -1.093 . . . . 99.989999999999995 110.575 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 68.74 33.95 3.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.802 -0.561 . . . . 99.989999999999995 110.047 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 pt -74.29 -2.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 99.989999999999995 110.723 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.5 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 80.0 m-20 -84.26 -26.55 28.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.861 -1.15 . . . . 99.989999999999995 109.603 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 28.2 tp -60.86 -30.93 70.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 99.989999999999995 109.265 179.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -57.74 -25.38 60.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 99.989999999999995 109.644 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -99.99 26.81 6.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 109.908 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -111.64 95.73 29.1 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 99.989999999999995 109.451 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.88 -44.14 38.09 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.174 1.916 . . . . 99.989999999999995 112.142 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -57.94 -37.03 73.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.187 -0.946 . . . . 99.989999999999995 109.483 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 30.1 m -73.85 -47.65 36.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.753 -1.203 . . . . 99.989999999999995 107.753 178.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -54.34 -34.78 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.594 -0.891 . . . . 99.989999999999995 108.594 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -62.5 -46.56 87.86 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.317 -0.994 . . . . 99.989999999999995 108.317 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -59.5 -36.84 76.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.454 -0.779 . . . . 99.989999999999995 108.976 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 77.8 mt -73.42 -37.53 65.87 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.665 -0.865 . . . . 99.989999999999995 108.665 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.32 75.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.676 -0.64 . . . . 99.989999999999995 109.764 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -59.18 -37.52 77.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.986 -1.071 . . . . 99.989999999999995 109.168 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -90.89 4.96 50.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 99.989999999999995 109.472 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.1 mttp 52.36 35.46 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.838 . . . . 99.989999999999995 109.496 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 135' ' ' LYS . 97.8 mt-30 -92.84 -53.84 4.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 99.989999999999995 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.436 ' O ' ' O ' ' A' ' 134' ' ' GLN . 7.1 mttt 62.09 144.37 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 99.989999999999995 109.056 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 147.25 87.63 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.58 2.186 . . . . 99.989999999999995 112.487 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -78.22 149.81 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 99.989999999999995 108.79 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 154.32 60.57 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.992 -1.067 . . . . 99.989999999999995 109.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.65 -33.52 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.318 2.012 . . . . 99.989999999999995 111.819 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.05 -36.03 80.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 99.989999999999995 109.649 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.3 m -68.22 -36.99 80.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 99.989999999999995 109.245 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.5 -44.3 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -0.811 . . . . 99.989999999999995 110.099 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.587 ' OE2' ' CE2' ' A' ' 154' ' ' TYR . 99.1 mt-10 -63.67 -32.32 73.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.02 . . . . 99.989999999999995 110.35 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.528 ' NZ ' ' OD2' ' A' ' 148' ' ' ASP . 13.2 tttm -65.95 -38.17 87.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.923 -1.111 . . . . 99.989999999999995 110.157 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.99 -39.32 81.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.875 . . . . 99.989999999999995 110.172 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.452 ' C ' ' H ' ' A' ' 148' ' ' ASP . . . -78.75 -49.74 12.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 99.989999999999995 110.018 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -60.3 -2.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 99.989999999999995 110.306 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.528 ' OD2' ' NZ ' ' A' ' 144' ' ' LYS . 86.2 m-20 -111.29 -21.58 11.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.041 . . . . 99.989999999999995 109.91 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.57 26.74 8.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 99.989999999999995 110.494 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 59.79 31.03 20.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.224 -0.922 . . . . 99.989999999999995 110.613 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -66.11 144.75 56.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.0 . . . . 99.989999999999995 108.866 179.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.94 -59.62 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 99.989999999999995 109.858 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -165.31 157.26 15.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 99.989999999999995 109.755 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CE2' ' OE2' ' A' ' 143' ' ' GLU . 21.1 p90 -117.4 144.31 45.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 99.989999999999995 109.008 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.8 t -131.09 138.51 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.8 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -102.13 129.01 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.1 -1.074 . . . . 99.989999999999995 108.1 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.403 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -138.24 146.52 42.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -0.999 . . . . 99.989999999999995 111.312 -178.07 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.5 ' OG ' ' OD2' ' A' ' 118' ' ' ASP . 23.6 t -115.69 110.4 19.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.461 -0.775 . . . . 99.989999999999995 109.044 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.51 61.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.761 -0.587 . . . . 99.989999999999995 109.785 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -53.75 -32.14 51.15 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.27 -1.011 . . . . 99.989999999999995 108.27 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.525 ' HG1' ' H ' ' A' ' 163' ' ' LYS . 22.2 p -125.1 166.45 16.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.542 -0.91 . . . . 99.989999999999995 108.542 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.658 ' NE2' ' ND2' ' A' ' 26' ' ' ASN . 95.2 mm-40 -70.1 12.31 0.23 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.409 -0.589 . . . . 99.989999999999995 109.409 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.525 ' H ' ' HG1' ' A' ' 161' ' ' THR . 48.6 mtmt -89.41 9.4 26.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 99.989999999999995 109.262 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.423 ' HA2' ' H ' ' A' ' 158' ' ' SER . . . -105.37 -50.64 0.91 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.001 -1.095 . . . . 99.989999999999995 110.436 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 43.8 mt -63.02 -36.7 84.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -1.234 . . . . 99.989999999999995 110.097 -179.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -58.62 -29.75 66.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 99.989999999999995 110.999 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -94.74 -41.93 9.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.958 -1.088 . . . . 99.989999999999995 110.39 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 80.4 t -60.52 -38.52 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.844 . . . . 99.989999999999995 111.174 -178.554 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 50.9 m-85 -89.94 -13.56 36.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.772 -1.205 . . . . 99.989999999999995 111.296 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.6 -50.34 72.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.715 -1.241 . . . . 99.989999999999995 109.686 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -80.79 -21.98 40.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 110.003 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.58 77.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 110.421 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.65 -43.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 99.989999999999995 109.912 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.34 -44.27 88.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 99.989999999999995 109.605 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.39 80.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -0.995 . . . . 99.989999999999995 109.698 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -60.56 -43.17 97.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 109.828 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.58 -40.38 94.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 99.989999999999995 109.115 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.477 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.401 -0.592 . . . . 99.989999999999995 109.401 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 50.25 25.37 1.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 99.989999999999995 108.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.2 m -123.88 145.28 49.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 99.989999999999995 109.156 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 30.7 mm -109.86 115.18 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 99.989999999999995 109.17 179.71 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -82.87 122.57 28.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 99.989999999999995 109.5 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.3 t -132.57 119.23 20.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 99.989999999999995 109.311 179.833 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.93 138.79 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 99.989999999999995 109.433 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.04 131.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.874 -0.788 . . . . 99.989999999999995 108.874 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.57 139.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.101 -0.999 . . . . 99.989999999999995 109.384 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.13 165.0 31.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.475 -1.45 . . . . 99.989999999999995 109.475 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 23.2 t70 -80.68 86.46 5.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.176 -1.191 . . . . 99.989999999999995 109.353 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.5 86.86 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.636 -1.386 . . . . 99.989999999999995 109.636 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.68 -5.41 45.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -1.095 . . . . 99.989999999999995 109.395 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.21 -58.06 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 99.989999999999995 110.151 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.66 16.12 26.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.488 -1.045 . . . . 99.989999999999995 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' NZ ' ' OD1' ' A' ' 57' ' ' ASP . 46.9 tttm -63.33 -41.14 98.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.828 -1.395 . . . . 99.989999999999995 110.063 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 p -68.71 -43.24 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 110.183 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.402 ' O ' ' OG ' ' A' ' 22' ' ' SER . 6.4 m -61.88 -28.56 69.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 99.989999999999995 110.766 -179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 46.7 tp -66.39 -43.48 85.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.878 -1.139 . . . . 99.989999999999995 109.785 -179.891 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.09 -40.6 82.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 99.989999999999995 109.652 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.67 -44.31 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.299 -0.875 . . . . 99.989999999999995 109.852 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 18' ' ' CYS . 24.0 m -49.97 -35.04 22.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 99.989999999999995 110.171 -178.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -89.55 -48.51 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.839 -1.163 . . . . 99.989999999999995 110.04 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 37.0 m -57.35 -42.05 81.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 99.989999999999995 111.764 -178.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 65.6 p -140.66 -12.34 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 99.989999999999995 111.683 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 25' ' ' THR . 3.4 m-20 86.4 115.48 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.371 -0.974 . . . . 99.989999999999995 108.371 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ASN . 16.4 mttt 164.48 76.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.001 -0.74 . . . . 99.989999999999995 109.001 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.613 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -62.19 -42.4 80.91 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 99.989999999999995 110.108 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.4 Cg_exo -55.58 -38.6 93.98 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.372 2.048 . . . . 99.989999999999995 112.335 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.627 ' O ' ' N ' ' A' ' 32' ' ' TYR . 1.8 p 64.55 -50.29 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 99.989999999999995 109.869 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.551 ' N ' ' O ' ' A' ' 29' ' ' PRO . 96.4 mt-10 57.02 -72.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 99.989999999999995 109.673 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.627 ' N ' ' O ' ' A' ' 30' ' ' SER . 81.9 t80 -107.07 124.62 49.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 109.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 1.8 m -64.5 152.95 88.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 99.989999999999995 109.329 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.55 136.18 72.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.544 2.163 . . . . 99.989999999999995 112.337 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.63 71.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.753 . . . . 99.989999999999995 110.098 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.7 155.74 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 99.989999999999995 109.566 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -107.68 94.15 4.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 109.216 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -123.24 147.81 46.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 99.989999999999995 110.07 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -70.63 149.09 47.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -0.792 . . . . 99.989999999999995 109.316 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -121.28 146.37 46.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 99.989999999999995 109.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.51 146.45 41.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 99.989999999999995 109.455 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.93 141.92 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 99.989999999999995 109.45 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.5 m -97.75 134.55 40.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 99.989999999999995 109.869 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 51' ' ' TYR . 33.9 t -120.75 136.63 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 99.989999999999995 109.393 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.0 ttt -105.03 140.05 38.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 99.989999999999995 109.946 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 67.0 mt -119.77 143.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 99.989999999999995 109.055 179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.64 -30.96 9.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.281 -1.928 . . . . 99.989999999999995 108.281 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . -72.46 -96.19 0.08 OUTLIER Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.556 -1.818 . . . . 99.989999999999995 108.556 178.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -123.03 156.59 62.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.961 . . . . 99.989999999999995 109.376 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.03 138.4 43.84 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.651 2.234 . . . . 99.989999999999995 112.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.591 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 98.8 m-85 -141.86 162.9 34.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 99.989999999999995 109.088 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 p -118.87 155.74 30.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 99.989999999999995 109.413 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.8 tp -118.73 118.27 31.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -0.751 . . . . 99.989999999999995 109.357 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.73 124.67 7.73 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.366 -1.494 . . . . 99.989999999999995 109.366 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.4 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 0.3 OUTLIER -107.86 121.69 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -1.113 . . . . 99.989999999999995 108.481 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 99.1 m-85 -121.29 149.38 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.281 -0.887 . . . . 99.989999999999995 109.691 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' NZ ' ' A' ' 16' ' ' LYS . 21.7 t70 -153.51 157.91 40.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 99.989999999999995 109.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 p -75.74 152.26 37.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 99.989999999999995 109.362 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -160.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 99.989999999999995 109.36 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' OE2' ' A' ' 62' ' ' GLU . . . -54.06 -52.53 42.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.492 -1.443 . . . . 99.989999999999995 109.492 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -61.99 133.94 55.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -1.202 . . . . 99.989999999999995 109.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 63' ' ' ASP . 53.2 mp0 -116.74 -43.23 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.118 -0.697 . . . . 99.989999999999995 109.118 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.641 ' C ' ' H ' ' A' ' 65' ' ' ASP . 90.3 m-20 -28.17 -67.77 0.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.086 -0.384 . . . . 99.989999999999995 111.685 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 12.1 p90 -56.49 15.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.809 -1.182 . . . . 99.989999999999995 111.649 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.641 ' H ' ' C ' ' A' ' 63' ' ' ASP . 54.2 p30 -89.36 2.25 54.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.654 -1.279 . . . . 99.989999999999995 109.558 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -60.3 -36.94 79.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.0 mt 46.43 72.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 99.989999999999995 109.496 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -61.07 169.48 2.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 99.989999999999995 108.803 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -46.1 -10.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.345 2.03 . . . . 99.989999999999995 112.134 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ARG . 30.2 tp -57.67 -45.91 84.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 99.989999999999995 108.793 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -125.08 142.38 51.53 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.975 -0.75 . . . . 99.989999999999995 108.975 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -138.0 79.87 31.42 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 99.989999999999995 109.82 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -52.74 138.85 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.306 2.004 . . . . 99.989999999999995 111.535 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -100.36 122.17 42.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 99.989999999999995 109.593 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.5 m -114.37 131.6 56.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.524 -0.735 . . . . 99.989999999999995 109.403 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.25 -39.04 88.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.351 -0.843 . . . . 99.989999999999995 109.632 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.05 131.51 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.19 -0.944 . . . . 99.989999999999995 109.957 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -102.95 125.37 49.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 99.989999999999995 108.385 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 mt -108.27 141.47 40.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.179 -0.951 . . . . 99.989999999999995 110.543 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 51.6 t -124.94 135.08 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.113 -0.699 . . . . 99.989999999999995 109.113 179.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.531 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -127.86 126.46 41.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.324 -0.86 . . . . 99.989999999999995 109.678 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -136.55 166.03 24.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.434 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 m -104.24 148.54 26.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 99.989999999999995 109.583 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.508 ' CG2' ' O ' ' A' ' 137' ' ' ILE . 7.8 p -105.96 13.98 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 99.989999999999995 110.146 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 29.9 m -105.54 -6.81 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 99.989999999999995 110.111 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -127.81 102.96 21.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 109.85 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.1 Cg_exo -50.68 -41.82 52.56 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.036 1.824 . . . . 99.989999999999995 111.916 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -56.55 -37.4 70.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 99.989999999999995 109.163 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 20.1 m -69.6 -26.21 64.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 99.989999999999995 109.244 179.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.47 -50.9 41.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 99.989999999999995 109.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.55 -35.0 75.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 99.989999999999995 109.603 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.586 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 41.6 t-20 -56.52 -34.39 66.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 109.95 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 67.1 t -62.22 -36.84 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.088 -1.008 . . . . 99.989999999999995 109.972 -179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.93 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 99.989999999999995 109.86 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -80.27 -27.46 38.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 99.989999999999995 111.34 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -112.23 -44.76 3.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.054 -1.029 . . . . 99.989999999999995 112.479 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -85.76 1.95 47.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.903 -1.123 . . . . 99.989999999999995 113.072 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.611 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -109.16 -40.63 0.12 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.471 -1.393 . . . . 99.989999999999995 110.666 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.611 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 62.3 Cg_endo -92.36 -56.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.275 2.65 . . . . 99.989999999999995 113.253 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.6 -35.28 75.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 110.892 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.69 -28.85 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.71 -1.244 . . . . 99.989999999999995 110.121 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 m -59.24 -42.18 90.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.675 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.08 -32.55 69.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 99.989999999999995 109.691 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -63.21 -41.87 99.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 99.989999999999995 109.524 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 173.08 170.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 99.989999999999995 109.248 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' CYS . 51.9 Cg_exo -49.01 -164.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.503 2.136 . . . . 99.989999999999995 112.348 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 64.0 mttm -80.98 138.28 36.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 99.989999999999995 109.623 -179.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 168.77 16.06 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 99.989999999999995 109.343 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -40.37 98.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 99.989999999999995 111.574 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 63.8 t80 -109.38 128.89 55.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.563 -0.711 . . . . 99.989999999999995 109.957 -179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 15.3 tp -120.16 124.07 44.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 99.989999999999995 109.01 179.442 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 39.0 tp -103.67 120.37 40.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 109.186 179.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -108.95 134.42 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 99.989999999999995 110.064 -179.335 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.92 113.0 3.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.722 -1.751 . . . . 99.989999999999995 108.722 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.531 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 13.9 m -103.11 148.79 25.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -1.13 . . . . 99.989999999999995 110.284 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.494 ' O ' ' O ' ' A' ' 117' ' ' ILE . 92.1 mt-30 62.83 38.5 11.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 122.052 -0.405 . . . . 99.989999999999995 111.491 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 116' ' ' GLN . 21.0 pt -57.99 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.272 -1.381 . . . . 99.989999999999995 107.272 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 121' ' ' ASP . 88.6 m-20 52.3 18.51 0.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.364 -1.46 . . . . 99.989999999999995 109.146 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.3 tp 30.81 52.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.817 -0.552 . . . . 99.989999999999995 111.509 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 121' ' ' ASP . 97.8 mtt180 54.24 22.39 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 99.989999999999995 110.501 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 118' ' ' ASP . 60.9 t0 33.22 61.38 0.42 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.718 -0.614 . . . . 99.989999999999995 110.257 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 120' ' ' ARG . 81.0 m-20 -132.34 85.56 48.51 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.457 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.34 -28.33 26.6 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.5 2.133 . . . . 99.989999999999995 112.118 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -81.76 -4.34 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 99.989999999999995 109.066 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.406 ' HG1' ' CB ' ' A' ' 122' ' ' ASP . 98.8 m -92.83 -47.93 6.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 99.989999999999995 109.201 179.15 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 0.3 OUTLIER -76.97 -48.49 25.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.896 . . . . 99.989999999999995 110.253 -179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -60.8 -39.95 90.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 99.989999999999995 111.098 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -83.01 -6.61 59.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.544 -1.347 . . . . 99.989999999999995 110.39 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 91.2 mt -115.45 -49.98 2.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 110.368 -179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.421 ' HA ' ' H ' ' A' ' 135' ' ' LYS . . . -55.08 -46.55 75.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.821 -1.174 . . . . 99.989999999999995 109.02 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -48.5 -24.72 1.38 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.423 -0.955 . . . . 99.989999999999995 108.423 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -76.27 -55.3 5.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.099 -1.075 . . . . 99.989999999999995 108.099 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 134' ' ' GLN . 36.1 ttpt -173.99 76.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 99.989999999999995 110.169 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 133' ' ' LYS . 3.7 mp0 33.27 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.65 -0.657 . . . . 99.989999999999995 110.673 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.2 tptm -90.35 -38.82 0.41 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.083 -1.011 . . . . 99.989999999999995 110.973 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 71.8 Cg_endo -89.09 127.5 1.78 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.845 2.363 . . . . 99.989999999999995 113.308 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 4.2 mp -96.9 135.55 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 99.989999999999995 109.357 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.9 155.68 72.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 109.468 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.33 -32.71 96.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.373 2.049 . . . . 99.989999999999995 111.622 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.11 -36.94 73.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 99.989999999999995 109.221 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 m -67.79 -29.78 69.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.283 -0.885 . . . . 99.989999999999995 108.692 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.03 62.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 99.989999999999995 110.213 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.97 -35.65 75.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.951 -1.093 . . . . 99.989999999999995 110.708 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 94.8 mttt -63.85 -36.84 85.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.855 -1.153 . . . . 99.989999999999995 109.318 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.5 tp -53.24 -43.2 67.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.396 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -70.32 -45.39 66.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.399 -0.813 . . . . 99.989999999999995 109.796 -179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.01 1.09 21.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 99.989999999999995 110.878 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 87.9 m-20 -66.76 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.237 . . . . 99.989999999999995 109.742 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 77.3 mt -121.52 -81.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.783 . . . . 99.989999999999995 109.722 -179.792 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -162.76 54.16 0.2 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.333 -0.854 . . . . 99.989999999999995 109.29 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.23 137.4 54.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.855 -1.153 . . . . 99.989999999999995 109.106 -179.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 81.4 t -66.78 -54.24 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 99.989999999999995 109.481 -179.902 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 58.4 mttm -156.52 159.84 38.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 99.989999999999995 109.976 179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -128.91 146.14 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.835 . . . . 99.989999999999995 108.747 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.8 m -140.16 152.1 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 99.989999999999995 110.436 -179.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 129.99 54.81 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.199 -1.037 . . . . 99.989999999999995 108.199 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -134.13 143.78 48.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.968 -1.083 . . . . 99.989999999999995 110.817 -178.603 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 161' ' ' THR . 9.5 t -115.18 110.25 19.2 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 99.989999999999995 108.909 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.379 0.609 . . . . 99.989999999999995 109.391 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.3 mt -55.03 -27.97 48.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.259 -0.9 . . . . 99.989999999999995 108.707 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.651 ' HG1' ' H ' ' A' ' 163' ' ' LYS . 18.3 p -125.99 171.04 11.11 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.442 -0.947 . . . . 99.989999999999995 108.442 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -74.02 11.65 0.86 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.674 -0.641 . . . . 99.989999999999995 109.708 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.651 ' H ' ' HG1' ' A' ' 161' ' ' THR . 49.8 mttt -89.34 1.18 56.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 99.989999999999995 109.459 -179.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.472 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -93.83 -51.15 2.17 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.881 -1.287 . . . . 99.989999999999995 109.881 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.38 -39.47 71.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -1.152 . . . . 99.989999999999995 110.259 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.16 -33.02 70.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.198 -0.939 . . . . 99.989999999999995 111.329 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.42 -50.32 46.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.811 -1.181 . . . . 99.989999999999995 109.354 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.22 1.63 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.496 -0.753 . . . . 99.989999999999995 110.449 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.6 -50.83 16.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.855 -1.153 . . . . 99.989999999999995 109.768 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.55 -43.88 83.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 110.014 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -66.31 -33.08 74.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 99.989999999999995 109.88 -179.693 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.42 80.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 99.989999999999995 109.977 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 71.7 mt -73.12 -42.33 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.994 . . . . 99.989999999999995 109.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.1 tp -59.32 -46.31 88.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 99.989999999999995 110.21 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.69 78.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.972 -1.08 . . . . 99.989999999999995 109.948 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.98 66.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 99.989999999999995 109.459 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.61 -39.83 89.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 99.989999999999995 109.193 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.818 . . . . 99.989999999999995 109.514 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.409 -0.589 . . . . 99.989999999999995 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 59.1 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.011 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -138.71 161.68 36.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 99.989999999999995 109.888 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.2 120.23 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.755 -0.831 . . . . 99.989999999999995 108.755 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -93.12 130.74 38.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 99.989999999999995 109.974 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 t -135.0 129.65 34.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.848 . . . . 99.989999999999995 109.209 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.1 t -117.89 142.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 109.857 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.13 133.69 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.688 -0.856 . . . . 99.989999999999995 108.688 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.438 ' CG1' ' CH2' ' A' ' 97' ' ' TRP . 46.7 t -140.35 134.0 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.129 -0.982 . . . . 99.989999999999995 109.491 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.55 99.83 0.15 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.637 -1.385 . . . . 99.989999999999995 109.637 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.36 -40.49 90.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.061 -1.258 . . . . 99.989999999999995 109.04 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . -84.59 120.05 5.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.345 -1.502 . . . . 99.989999999999995 109.345 179.791 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 172.08 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 99.989999999999995 109.392 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.52 -41.72 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.9 . . . . 99.989999999999995 109.371 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.11 0.79 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.368 -1.493 . . . . 99.989999999999995 109.368 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -61.13 -40.08 92.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -1.127 . . . . 99.989999999999995 109.568 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -65.13 -41.81 94.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -0.978 . . . . 99.989999999999995 108.979 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -30.32 65.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.373 -0.829 . . . . 99.989999999999995 109.633 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.12 -41.75 97.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.113 -0.992 . . . . 99.989999999999995 108.608 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.13 -39.73 82.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 99.989999999999995 109.225 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.5 mm -63.66 -48.17 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 109.588 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -58.83 -36.29 74.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 99.989999999999995 110.346 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -80.15 -50.87 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 99.989999999999995 109.764 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.5 m -60.39 -41.24 93.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 99.989999999999995 109.736 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.534 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 30.2 p -112.16 -111.42 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.354 -0.841 . . . . 99.989999999999995 109.186 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.534 ' N ' ' OG1' ' A' ' 25' ' ' THR . 37.1 p-10 -173.69 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 99.989999999999995 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -102.25 106.88 17.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 99.989999999999995 110.08 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -67.73 -42.77 36.52 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.264 -0.898 . . . . 99.989999999999995 108.876 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 31.4 Cg_exo -59.77 -26.66 82.88 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.655 2.237 . . . . 99.989999999999995 112.078 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.8 m 42.56 41.86 2.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 99.989999999999995 109.683 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 96.3 mt-10 -37.56 -35.7 0.14 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.432 -0.792 . . . . 99.989999999999995 110.456 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -117.31 122.76 44.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.252 -0.905 . . . . 99.989999999999995 109.502 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.431 ' CG2' ' O ' ' A' ' 33' ' ' VAL . 34.4 m -128.29 75.61 78.85 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 99.989999999999995 109.756 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.566 ' O ' ' CB ' ' A' ' 35' ' ' ALA . 92.7 Cg_endo -84.28 -102.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.043 2.496 . . . . 99.989999999999995 112.329 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . 0.566 ' CB ' ' O ' ' A' ' 34' ' ' PRO . . . 158.21 41.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 99.989999999999995 108.8 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.2 -41.66 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 99.989999999999995 109.935 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.25 130.41 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 99.989999999999995 110.006 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.603 ' CG ' ' H ' ' A' ' 39' ' ' ASN . 50.9 t0 -93.52 -144.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.661 -0.866 . . . . 99.989999999999995 108.661 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.603 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 63.5 t-20 -42.71 124.94 3.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 99.989999999999995 109.718 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.454 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 58.0 t80 -132.08 150.3 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 99.989999999999995 109.517 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.454 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -103.12 141.92 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 99.989999999999995 109.513 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.78 133.81 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 99.989999999999995 109.355 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.0 m -106.19 134.53 49.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.821 . . . . 99.989999999999995 109.694 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.46 135.74 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.708 . . . . 99.989999999999995 109.353 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.8 mtm -105.67 141.26 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 99.989999999999995 109.324 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.454 ' O ' ' N ' ' A' ' 48' ' ' GLY . 81.0 mt -122.99 141.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 99.989999999999995 109.365 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.1 -24.97 0.61 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.809 -1.716 . . . . 99.989999999999995 108.809 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.454 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . -80.82 -92.37 0.48 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.53 -1.428 . . . . 99.989999999999995 109.53 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.6 mm-40 -126.45 154.32 75.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.405 -1.056 . . . . 99.989999999999995 109.717 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.71 138.26 37.56 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.729 2.286 . . . . 99.989999999999995 112.599 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.451 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 97.3 m-85 -131.76 154.19 49.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.479 -0.763 . . . . 99.989999999999995 109.161 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.9 p -118.0 148.19 42.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.828 . . . . 99.989999999999995 109.463 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.82 122.44 37.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 99.989999999999995 109.58 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.34 126.53 8.85 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.102 -1.599 . . . . 99.989999999999995 109.102 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.503 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 66.5 mt -105.1 137.22 43.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -1.175 . . . . 99.989999999999995 109.367 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.487 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.7 m-85 -122.25 149.82 43.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 109.022 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 56' ' ' PHE . 84.0 m-20 -136.82 161.53 35.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 99.989999999999995 109.367 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 162.73 21.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 109.171 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.72 151.3 33.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 109.372 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.51 45.34 1.32 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 99.989999999999995 109.437 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.558 ' O ' ' N ' ' A' ' 63' ' ' ASP . 63.3 tt0 -99.27 120.81 40.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -1.115 . . . . 99.989999999999995 109.816 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.613 ' C ' ' H ' ' A' ' 64' ' ' TYR . 84.3 tt0 61.1 -65.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.677 -0.639 . . . . 99.989999999999995 110.222 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.558 ' N ' ' O ' ' A' ' 61' ' ' GLN . 52.9 p30 -63.12 13.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 110.457 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.613 ' H ' ' C ' ' A' ' 62' ' ' GLU . 75.9 t80 -97.27 9.2 42.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.009 . . . . 99.989999999999995 109.129 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.19 -43.44 95.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 99.989999999999995 109.948 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -175.42 3.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 99.989999999999995 109.49 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 55.5 mt -88.4 136.48 32.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 99.989999999999995 110.059 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.693 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 6.4 ttt180 -135.74 -42.96 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 99.989999999999995 110.436 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.693 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 14.0 Cg_exo -67.69 24.12 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.636 2.224 . . . . 99.989999999999995 112.182 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.508 ' H ' ' C ' ' A' ' 68' ' ' ARG . 70.7 mt -57.03 -31.97 65.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 99.989999999999995 109.571 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER 38.74 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 99.989999999999995 110.265 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.523 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 39.7 p90 -118.36 149.64 46.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 99.989999999999995 109.013 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.95 -37.23 44.97 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.32 2.013 . . . . 99.989999999999995 112.276 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -174.82 115.72 0.17 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 99.989999999999995 109.677 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.523 ' OG1' ' CD1' ' A' ' 72' ' ' TYR . 43.3 m -117.57 128.41 54.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 99.989999999999995 109.654 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -66.17 -33.92 76.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 99.989999999999995 109.957 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.09 132.67 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.354 -0.841 . . . . 99.989999999999995 109.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -111.63 126.26 54.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 99.989999999999995 109.024 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.2 140.35 44.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.922 . . . . 99.989999999999995 109.949 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.4 136.03 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 99.989999999999995 109.165 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.2 t -129.83 121.72 27.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 99.989999999999995 109.853 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 44.1 p90 -145.97 163.23 35.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 109.303 179.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -89.58 137.57 32.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.152 -0.967 . . . . 99.989999999999995 109.395 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -93.66 -12.64 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.945 . . . . 99.989999999999995 110.31 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 72.4 t -90.43 -13.82 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.035 -1.04 . . . . 99.989999999999995 110.015 -179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 m -100.6 128.59 29.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 99.989999999999995 109.684 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.624 ' CG ' ' NE2' ' A' ' 134' ' ' GLN . 45.7 Cg_endo -73.55 -46.36 0.35 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.988 1.792 . . . . 99.989999999999995 112.298 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -55.31 -41.78 72.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.848 -1.158 . . . . 99.989999999999995 108.933 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 84.2 p -68.29 -23.09 64.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 99.989999999999995 109.018 179.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -72.08 -50.82 25.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 99.989999999999995 109.319 179.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -67.91 -37.0 81.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 99.989999999999995 109.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.47 -34.38 57.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 109.684 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.41 -38.25 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 99.989999999999995 110.457 -179.625 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -93.79 -32.79 13.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 99.989999999999995 110.91 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -68.49 -36.58 79.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.883 -1.135 . . . . 99.989999999999995 112.416 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -113.62 -52.0 2.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.886 -1.134 . . . . 99.989999999999995 112.619 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.438 ' CH2' ' CG1' ' A' ' 9' ' ' VAL . 72.7 m95 -67.54 -30.71 70.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.963 . . . . 99.989999999999995 113.026 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.426 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 1.9 t -72.57 -51.06 7.43 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.141 -1.599 . . . . 99.989999999999995 111.439 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.68 -47.75 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.953 1.769 . . . . 99.989999999999995 113.23 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -58.08 -40.07 80.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 99.989999999999995 111.016 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 1.9 tp -64.18 -24.55 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 99.989999999999995 110.223 -179.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -57.76 -39.61 77.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 99.989999999999995 110.479 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -53.56 -32.5 51.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 99.989999999999995 110.685 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.45 ' CE1' ' CB ' ' A' ' 71' ' ' SER . 97.1 m-70 -84.45 7.1 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.054 . . . . 99.989999999999995 110.483 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.7 m 55.35 69.78 1.84 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 99.989999999999995 109.284 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.49 128.0 26.26 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.604 2.202 . . . . 99.989999999999995 112.472 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -151.73 -39.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.69 -0.856 . . . . 99.989999999999995 108.69 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -62.72 156.14 66.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.502 -0.749 . . . . 99.989999999999995 109.166 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.25 135.68 71.78 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.691 2.261 . . . . 99.989999999999995 112.459 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 108' ' ' THR . 98.1 m-85 -116.58 137.76 51.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 99.989999999999995 109.356 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 38.3 tp -117.53 124.76 49.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 99.989999999999995 109.451 179.679 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.51 120.43 40.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 108.853 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.92 137.54 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.848 . . . . 99.989999999999995 110.357 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.0 129.25 9.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.214 -1.954 . . . . 99.989999999999995 108.214 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 9.9 t -118.14 156.92 27.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.136 -1.214 . . . . 99.989999999999995 111.18 -178.074 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 61.36 38.42 16.24 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.895 -0.593 . . . . 99.989999999999995 110.73 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 pt -72.3 -3.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.096 . . . . 99.989999999999995 109.764 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 86.1 m-20 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 99.989999999999995 109.378 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 43.7 tp -57.98 -32.81 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 99.989999999999995 109.26 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -59.88 -25.16 64.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 99.989999999999995 109.241 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 59.6 t0 -83.91 8.21 15.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.785 . . . . 99.989999999999995 109.61 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -117.95 85.32 22.96 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.45 -0.781 . . . . 99.989999999999995 109.222 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.74 -23.81 16.54 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.696 2.264 . . . . 99.989999999999995 112.35 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.2 p -58.52 -30.01 66.74 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.852 -1.155 . . . . 99.989999999999995 109.852 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 73.2 m -80.44 -52.81 7.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 99.989999999999995 110.009 179.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 2.6 pt -56.51 -20.67 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.167 -0.958 . . . . 99.989999999999995 109.31 -178.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.34 -50.38 70.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 108.701 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -56.49 -31.29 63.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 99.989999999999995 109.734 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.04 -36.04 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 99.989999999999995 109.074 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.01 -38.82 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 99.989999999999995 109.864 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -59.68 -36.29 76.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.051 . . . . 99.989999999999995 109.276 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.13 8.14 16.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.394 -0.816 . . . . 99.989999999999995 109.614 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.95 34.96 24.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 99.989999999999995 109.35 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.624 ' NE2' ' CG ' ' A' ' 87' ' ' PRO . 56.9 tt0 -127.4 121.12 30.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.386 -0.821 . . . . 99.989999999999995 108.811 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -92.79 156.49 40.76 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.41 -0.806 . . . . 99.989999999999995 110.058 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.17 160.35 42.44 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.118 2.545 . . . . 99.989999999999995 112.057 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.8 mm -97.46 126.04 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 99.989999999999995 109.389 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.36 155.69 79.03 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.843 . . . . 99.989999999999995 109.422 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.39 -34.48 98.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.433 2.089 . . . . 99.989999999999995 111.619 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.44 -37.22 77.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 99.989999999999995 108.871 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -67.4 -32.82 73.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -0.814 . . . . 99.989999999999995 109.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.96 -39.71 61.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.72 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.41 -32.31 70.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 99.989999999999995 110.107 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 69.4 tttt -61.86 -38.82 89.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.956 -1.09 . . . . 99.989999999999995 109.651 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 60.1 mt -63.41 -34.64 78.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 99.989999999999995 110.136 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.01 88.72 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.993 -1.067 . . . . 99.989999999999995 108.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -86.06 8.44 20.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.35 -0.844 . . . . 99.989999999999995 110.121 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 90.3 m-20 -84.22 -24.6 29.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.794 -1.191 . . . . 99.989999999999995 108.847 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.8 mt -121.07 -104.0 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.628 -0.67 . . . . 99.989999999999995 109.275 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -145.71 43.72 1.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 99.989999999999995 109.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.06 141.76 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 99.989999999999995 109.342 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 59.8 t -75.23 -65.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 99.989999999999995 110.113 -179.686 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 67.6 mttt -145.67 160.37 41.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.132 -0.98 . . . . 99.989999999999995 110.418 -179.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -131.28 150.5 52.12 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.842 -0.799 . . . . 99.989999999999995 108.842 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.55 154.09 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.037 -1.039 . . . . 99.989999999999995 110.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -109.66 133.94 52.54 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.488 -0.93 . . . . 99.989999999999995 108.488 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.53 140.21 48.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 99.989999999999995 111.025 -178.458 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . 39.9 t -106.89 105.58 15.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.44 -0.787 . . . . 99.989999999999995 109.036 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.82 70.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.601 . . . . 99.989999999999995 109.558 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.7 tp -50.91 -31.01 16.26 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.561 -0.903 . . . . 99.989999999999995 108.561 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.549 ' C ' ' H ' ' A' ' 163' ' ' LYS . 18.7 p -123.84 162.45 23.23 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.196 -1.038 . . . . 99.989999999999995 108.196 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.09 12.32 0.12 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.553 -0.717 . . . . 99.989999999999995 109.344 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.549 ' H ' ' C ' ' A' ' 161' ' ' THR . 67.7 mttm -88.11 2.28 52.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 99.989999999999995 109.684 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.72 -51.52 2.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.897 -1.281 . . . . 99.989999999999995 109.897 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.48 -40.64 73.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -1.226 . . . . 99.989999999999995 109.936 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.23 -29.94 70.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 99.989999999999995 110.407 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -71.72 -50.95 25.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 99.989999999999995 109.523 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.1 m -80.35 -4.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -0.763 . . . . 99.989999999999995 110.566 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.81 -50.17 21.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.181 . . . . 99.989999999999995 110.052 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.92 -42.39 99.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 99.989999999999995 110.246 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.36 -34.68 78.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 99.989999999999995 110.023 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.9 74.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 99.989999999999995 110.568 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.6 -41.48 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.899 -1.126 . . . . 99.989999999999995 110.392 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.77 -41.72 82.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.987 . . . . 99.989999999999995 110.223 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.15 77.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.961 -1.087 . . . . 99.989999999999995 110.128 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.22 89.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 99.989999999999995 110.094 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.5 mt -65.23 -37.63 87.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.997 -1.064 . . . . 99.989999999999995 109.387 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.461 -179.85 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mmm . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.354 -0.61 . . . . 99.989999999999995 109.354 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -120.57 152.09 38.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.506 -0.746 . . . . 99.989999999999995 109.487 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 157.48 46.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 99.989999999999995 109.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.8 mt -118.8 120.8 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.985 -0.746 . . . . 99.989999999999995 108.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -81.62 128.35 33.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 99.989999999999995 109.307 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 t -132.89 115.57 15.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 99.989999999999995 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -109.72 132.22 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 99.989999999999995 109.316 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.9 p -128.05 142.97 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.404 -0.81 . . . . 99.989999999999995 109.674 -179.453 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.99 145.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.29 -0.881 . . . . 99.989999999999995 108.983 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 171.94 22.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.907 -1.277 . . . . 99.989999999999995 109.907 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 12' ' ' GLY . 59.1 t0 -74.04 134.03 42.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -1.116 . . . . 99.989999999999995 109.128 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . -27.77 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.499 2.855 0 N-CA-C 111.01 -0.836 . . . . 99.989999999999995 111.01 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . -41.4 -37.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.023 -1.281 . . . . 99.989999999999995 110.567 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.504 ' N ' ' O ' ' A' ' 11' ' ' ASP . 58.1 t -69.3 123.97 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.671 -1.268 . . . . 99.989999999999995 109.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 73.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.593 -1.403 . . . . 99.989999999999995 109.593 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.1 pttp -61.26 -33.62 73.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 99.989999999999995 109.528 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.4 p -70.38 -42.0 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 99.989999999999995 109.633 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.1 m -60.39 -25.99 66.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 110.009 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 44.4 tp -66.72 -39.77 88.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 99.989999999999995 109.387 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.423 ' CD1' ' OD2' ' A' ' 57' ' ' ASP . 70.1 mt -64.94 -42.23 94.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.269 -0.894 . . . . 99.989999999999995 109.538 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mm -70.14 -49.02 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 99.989999999999995 109.713 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.2 m -57.26 -36.66 71.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 99.989999999999995 109.5 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.74 -44.49 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 110.206 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.1 m -65.79 -47.6 74.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 99.989999999999995 110.108 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.8 p -84.48 -19.5 33.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 99.989999999999995 109.711 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.82 36.76 22.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 99.989999999999995 109.366 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -141.23 82.54 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 99.989999999999995 109.467 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.664 ' CE2' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -55.28 -44.25 99.53 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.202 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -56.48 -15.83 16.65 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.28 1.987 . . . . 99.989999999999995 111.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' TYR . 95.6 p -59.86 -34.18 72.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 108.995 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.3 mt-10 37.68 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.648 -0.657 . . . . 99.989999999999995 110.321 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.2 m-85 -83.76 -95.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.019 -1.051 . . . . 99.989999999999995 109.279 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' C ' ' O ' ' A' ' 32' ' ' TYR . 6.4 p 36.52 57.76 3.41 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.445 -0.784 . . . . 99.989999999999995 110.964 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.77 -18.46 32.23 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.815 2.344 . . . . 99.989999999999995 112.08 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.47 -172.68 2.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 99.989999999999995 109.329 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.28 140.66 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.199 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.16 -90.06 0.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 99.989999999999995 109.623 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.7 p30 -138.15 -173.39 3.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 99.989999999999995 109.904 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -67.33 149.23 50.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 99.989999999999995 109.831 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -118.13 146.71 43.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.732 . . . . 99.989999999999995 109.204 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 137.25 45.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 99.989999999999995 109.148 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.4 138.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 99.989999999999995 109.861 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -93.3 133.94 36.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 99.989999999999995 109.284 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.1 t -120.36 135.06 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 99.989999999999995 109.731 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -93.57 130.59 39.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 99.989999999999995 109.316 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 68.5 mt -132.8 126.82 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 99.989999999999995 109.151 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.54 17.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.73 -1.348 . . . . 99.989999999999995 109.73 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.15 13.87 58.26 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.057 -1.217 . . . . 99.989999999999995 110.057 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 11.3 mt-10 -119.61 85.86 33.55 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.414 -1.051 . . . . 99.989999999999995 109.282 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -53.7 125.66 19.34 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.681 2.254 . . . . 99.989999999999995 113.195 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 91.3 m-85 -121.61 143.22 49.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.688 . . . . 99.989999999999995 109.232 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.5 m -76.03 131.25 39.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 99.989999999999995 109.32 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -128.1 129.6 46.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 99.989999999999995 109.57 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.79 143.45 14.64 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.562 -1.415 . . . . 99.989999999999995 109.562 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.17 132.24 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 99.989999999999995 109.407 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -118.09 131.28 56.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.809 . . . . 99.989999999999995 109.774 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.8 p30 -136.19 172.38 13.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 99.989999999999995 109.773 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.2 m -71.5 138.25 48.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 99.989999999999995 109.59 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.79 52.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 99.989999999999995 109.596 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.39 -127.63 34.93 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.641 -1.384 . . . . 99.989999999999995 109.641 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 57.05 39.68 29.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -1.053 . . . . 99.989999999999995 109.786 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -79.8 -41.74 25.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.153 -0.967 . . . . 99.989999999999995 109.405 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 51.9 p30 -85.43 14.09 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 99.989999999999995 110.435 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.419 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -84.29 5.53 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.918 -1.114 . . . . 99.989999999999995 109.176 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.2 t0 73.59 12.32 4.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 99.989999999999995 109.426 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -58.14 -32.47 68.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.411 -0.805 . . . . 99.989999999999995 109.293 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 68' ' ' ARG . 49.4 mt -58.8 172.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 99.989999999999995 109.859 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.579 ' C ' ' H ' ' A' ' 70' ' ' LEU . 1.6 mmt180 61.06 146.94 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.661 -0.866 . . . . 99.989999999999995 108.661 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 15.9 Cg_endo -60.34 26.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 99.989999999999995 112.326 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.579 ' H ' ' C ' ' A' ' 68' ' ' ARG . 15.2 tp -51.71 -61.5 2.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 99.989999999999995 109.119 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 p -85.63 -3.61 58.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 109.635 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' PRO . 7.8 m-85 58.33 58.57 6.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 99.989999999999995 109.769 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.9 147.26 95.58 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 99.989999999999995 111.841 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -141.5 160.65 39.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 99.989999999999995 109.613 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 5.1 p -126.03 153.95 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.506 -0.746 . . . . 99.989999999999995 109.372 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 75' ' ' THR . 90.5 m-20 -138.21 -41.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 99.989999999999995 109.718 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.02 132.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 99.989999999999995 110.0 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -108.43 126.95 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 99.989999999999995 109.142 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 tp -118.53 126.37 51.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 99.989999999999995 109.546 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.86 138.68 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 99.989999999999995 109.263 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 133.84 48.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 99.989999999999995 109.542 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 31.6 p90 -138.45 158.47 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 99.989999999999995 109.379 179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -77.24 138.74 39.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 99.989999999999995 109.377 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.49 -18.07 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.143 -0.973 . . . . 99.989999999999995 110.364 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.419 ' O ' ' CG1' ' A' ' 85' ' ' VAL . 61.1 t -85.8 -8.19 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.09 -1.006 . . . . 99.989999999999995 110.374 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -103.09 107.07 54.02 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 99.989999999999995 109.976 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.18 -49.08 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.032 1.822 . . . . 99.989999999999995 112.005 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 m -58.71 -39.56 81.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 99.989999999999995 108.95 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 25.9 t -62.86 -21.74 66.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.472 -0.768 . . . . 99.989999999999995 109.029 179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -74.43 -50.05 19.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 109.163 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -66.07 -39.2 89.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 99.989999999999995 109.481 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -57.01 -32.91 66.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 99.989999999999995 109.214 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.8 t -60.91 -37.39 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 99.989999999999995 109.787 -179.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -94.31 -11.06 30.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.012 -1.055 . . . . 99.989999999999995 110.229 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -73.74 -33.61 64.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.646 -1.283 . . . . 99.989999999999995 111.493 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.47 -41.9 3.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.136 -0.977 . . . . 99.989999999999995 112.25 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -82.12 0.84 38.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.094 -1.004 . . . . 99.989999999999995 112.836 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.555 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -108.22 -42.75 0.12 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.49 -1.381 . . . . 99.989999999999995 110.414 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.555 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 42.9 Cg_endo -93.71 -59.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.211 2.608 . . . . 99.989999999999995 112.468 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 99.989999999999995 109.583 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.619 ' CG1' ' CE1' ' A' ' 110' ' ' PHE . 8.0 tp -54.08 -26.59 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.594 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 46.5 m -58.85 -37.93 77.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 99.989999999999995 109.759 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -53.29 -40.57 64.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 99.989999999999995 109.867 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.436 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 65.7 m170 -55.17 -36.17 65.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 99.989999999999995 109.262 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 0.7 OUTLIER 168.73 154.0 0.14 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 99.989999999999995 109.214 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.63 -33.0 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.523 2.148 . . . . 99.989999999999995 111.92 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -139.83 137.51 35.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 99.989999999999995 109.424 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -177.37 139.64 0.43 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 99.989999999999995 109.303 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.71 125.37 12.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.191 1.928 . . . . 99.989999999999995 112.202 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.619 ' CE1' ' CG1' ' A' ' 101' ' ' ILE . 86.8 m-85 -116.53 138.92 51.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 99.989999999999995 109.024 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.6 mp -114.89 121.2 42.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.454 -0.778 . . . . 99.989999999999995 110.035 -179.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -110.92 125.18 53.39 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.024 -1.102 . . . . 99.989999999999995 108.024 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 36.0 t -117.1 138.59 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.14 -0.975 . . . . 99.989999999999995 110.977 -178.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.4 122.1 6.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.257 -1.937 . . . . 99.989999999999995 108.257 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 t -114.33 167.35 10.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -1.115 . . . . 99.989999999999995 110.618 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 58.74 39.37 24.33 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 120.972 0.415 . . . . 99.989999999999995 110.18 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.51 -7.18 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.969 -1.082 . . . . 99.989999999999995 109.873 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.476 ' O ' ' OD2' ' A' ' 121' ' ' ASP . 53.8 p30 -83.69 -3.08 57.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 99.989999999999995 109.345 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . . . . . . . . . 30.2 tp -78.29 -27.27 47.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.389 -1.337 . . . . 99.989999999999995 107.389 178.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -84.94 93.3 8.52 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.208 -1.405 . . . . 99.989999999999995 107.208 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 2.4 p30 169.04 -49.45 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.131 -1.063 . . . . 99.989999999999995 108.131 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.1 141.44 94.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.546 -0.721 . . . . 99.989999999999995 109.234 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.52 -31.1 27.86 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.248 1.966 . . . . 99.989999999999995 112.223 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.7 m -54.3 -33.1 58.02 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 99.989999999999995 110.29 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 56.7 p -79.49 -51.11 9.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 99.989999999999995 111.012 -179.105 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.15 -29.77 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 99.989999999999995 110.333 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.32 -50.09 35.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 99.989999999999995 109.663 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.17 -35.19 76.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 99.989999999999995 109.921 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.6 mt -74.42 -39.25 62.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.01 . . . . 99.989999999999995 108.891 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.11 -35.92 37.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 99.989999999999995 109.486 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -59.69 -34.97 73.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.081 -1.012 . . . . 99.989999999999995 109.143 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -86.54 7.35 26.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 99.989999999999995 109.621 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttt 56.88 37.02 28.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 99.989999999999995 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -136.83 136.12 38.52 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.11 -0.994 . . . . 99.989999999999995 109.118 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -116.89 157.76 45.57 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 109.137 -0.69 . . . . 99.989999999999995 109.137 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -53.01 155.84 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.836 2.357 . . . . 99.989999999999995 111.909 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.3 mt -98.57 142.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 99.989999999999995 109.637 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.433 ' HG1' ' H ' ' A' ' 140' ' ' GLU . 0.6 OUTLIER -81.2 158.49 69.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.366 -0.833 . . . . 99.989999999999995 109.65 -179.554 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.83 -23.05 75.8 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.684 2.256 . . . . 99.989999999999995 111.522 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.433 ' H ' ' HG1' ' A' ' 138' ' ' THR . 84.2 tt0 -61.98 -38.59 89.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.42 -0.8 . . . . 99.989999999999995 109.524 179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 m -63.67 -36.01 82.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 99.989999999999995 109.418 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.33 -39.4 59.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 99.989999999999995 110.007 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.32 -34.68 72.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.043 -1.035 . . . . 99.989999999999995 111.081 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.94 -36.24 80.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.706 -1.247 . . . . 99.989999999999995 109.425 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.06 -36.09 76.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 99.989999999999995 110.085 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -81.12 -51.81 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.922 -1.111 . . . . 99.989999999999995 110.561 -179.131 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -65.01 -1.86 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 99.989999999999995 110.286 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -110.21 -24.0 10.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 99.989999999999995 110.007 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.97 16.01 22.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 99.989999999999995 111.733 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.526 ' O ' ' CB ' ' A' ' 151' ' ' ALA . 59.3 mttp 56.89 36.16 27.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.322 -1.486 . . . . 99.989999999999995 111.318 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.526 ' CB ' ' O ' ' A' ' 150' ' ' LYS . . . 165.93 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.774 -1.204 . . . . 99.989999999999995 109.62 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.487 ' O ' ' O ' ' A' ' 151' ' ' ALA . 71.8 t 59.35 132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.262 1.029 . . . . 99.989999999999995 109.561 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -129.46 149.33 51.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.258 -1.016 . . . . 99.989999999999995 108.258 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.17 143.65 49.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.03 -1.044 . . . . 99.989999999999995 109.85 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 t -138.36 147.01 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.837 . . . . 99.989999999999995 109.431 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -97.33 120.89 38.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.303 -0.999 . . . . 99.989999999999995 108.303 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -131.04 141.1 50.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.962 . . . . 99.989999999999995 110.932 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 161' ' ' THR . 29.5 t -111.62 102.8 11.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.666 -0.864 . . . . 99.989999999999995 108.666 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -70.18 -28.69 65.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.785 -0.572 . . . . 99.989999999999995 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.3 mp -61.56 -25.92 67.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.521 -0.918 . . . . 99.989999999999995 108.521 179.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.568 ' C ' ' H ' ' A' ' 163' ' ' LYS . 21.2 m -123.86 160.52 27.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.28 -1.007 . . . . 99.989999999999995 108.28 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.664 ' NE2' ' CE2' ' A' ' 28' ' ' PHE . 89.5 mm-40 -65.41 11.47 0.06 Allowed 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.496 -0.753 . . . . 99.989999999999995 109.628 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.568 ' H ' ' C ' ' A' ' 161' ' ' THR . 97.7 mttt -94.01 5.13 52.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.051 . . . . 99.989999999999995 110.053 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.447 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -101.58 -51.14 1.14 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.641 -1.266 . . . . 99.989999999999995 110.274 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.484 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 8.1 mp -63.35 -42.02 98.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.219 -1.165 . . . . 99.989999999999995 110.267 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -58.81 -30.37 67.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 99.989999999999995 110.216 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -85.67 -50.07 7.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 99.989999999999995 109.373 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 71.5 t -62.24 -34.8 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.768 . . . . 99.989999999999995 110.303 -179.59 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 68.3 t80 -68.71 -49.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 99.989999999999995 110.285 -179.593 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.54 -43.82 93.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 99.989999999999995 110.612 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.03 -45.13 71.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 99.989999999999995 110.262 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.62 -35.96 61.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 99.989999999999995 110.408 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 95.0 mt -68.9 -36.7 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.831 -1.168 . . . . 99.989999999999995 110.482 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.8 tp -53.55 -51.33 63.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.972 -1.08 . . . . 99.989999999999995 110.259 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.5 71.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 99.989999999999995 110.079 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.39 66.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 99.989999999999995 109.758 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.558 ' N ' ' CD2' ' A' ' 177' ' ' LEU . 3.6 mm? -63.02 -35.54 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.984 -1.073 . . . . 99.989999999999995 109.75 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.561 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -135.6 160.22 39.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -0.801 . . . . 0.0 109.843 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 176' ' ' ALA . 72.8 mt -121.34 119.46 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -95.76 129.46 42.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.952 . . . . 0.0 110.059 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 79' ' ' LEU . 46.1 t -138.32 136.75 36.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 0.0 109.143 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.08 141.11 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.65 131.19 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.85 143.98 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.486 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 168.17 25.65 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' ALA . 24.0 t70 -83.12 108.17 16.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.251 . . . . 0.0 108.983 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 53.94 -87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 53.47 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.178 -1.19 . . . . 0.0 109.364 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 14' ' ' VAL . 3.6 m -66.63 -35.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 0.0 109.988 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.57 21.55 32.04 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 58.9 tttt -62.11 -40.6 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.283 . . . . 0.0 109.814 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.8 m -68.37 -45.65 72.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.562 ' SG ' ' OG ' ' A' ' 30' ' ' SER . 34.4 m -61.01 -29.65 69.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.913 . . . . 0.0 109.851 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -67.06 -42.15 85.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.44 -46.09 50.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.53 -40.32 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -57.92 -31.98 67.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 109.839 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -72.69 -38.02 67.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -65.96 -30.96 71.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.459 -0.775 . . . . 0.0 111.292 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -166.44 -1.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.553 -1.342 . . . . 0.0 111.427 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.613 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.2 t30 92.21 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HZ2' ' HA ' ' A' ' 30' ' ' SER . 10.4 tttm -179.6 58.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.995 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.29 -42.58 86.12 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.787 -1.196 . . . . 0.0 109.836 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.2 Cg_exo -58.11 -33.08 97.01 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.354 2.036 . . . . 0.0 112.364 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' SG ' ' A' ' 18' ' ' CYS . 61.4 p 35.65 37.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.65 . . . . 0.0 109.738 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 30' ' ' SER . 78.5 mm-40 -38.22 -37.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.53 -0.731 . . . . 0.0 110.531 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -128.8 124.18 34.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.034 -1.041 . . . . 0.0 109.204 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.69 147.78 34.21 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.643 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.54 153.21 60.33 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 0.0 112.153 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.5 -104.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 109.051 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.4 m -61.38 142.07 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.858 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.09 125.43 46.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.864 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -108.84 164.39 12.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.308 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -92.35 153.11 19.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.009 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -127.78 139.15 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.601 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.52 132.2 54.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.053 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.28 153.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -122.31 150.15 42.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.064 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.26 139.77 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 110.01 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 65.0 mtt -84.57 131.81 34.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 48' ' ' GLY . 74.6 mt -135.11 125.41 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 109.521 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 41.97 18.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 92.36 15.41 53.45 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.102 -1.234 . . . . 0.0 110.215 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.0 mm-40 -122.81 82.7 49.34 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.318 -1.107 . . . . 0.0 109.255 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.17 126.19 20.24 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.906 2.404 . . . . 0.0 113.23 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 95.9 m-85 -119.17 138.04 53.21 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 p -80.22 143.49 33.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -124.82 124.48 42.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.0 109.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.11 124.31 8.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.13 127.03 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.161 . . . . 0.0 109.194 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -114.44 133.96 55.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -138.79 140.52 38.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.1 m -70.85 137.64 49.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.455 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.4 m -79.5 131.86 36.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.458 -0.776 . . . . 0.0 110.156 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -102.87 -10.55 18.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 108.953 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' A' ' 175' ' ' ALA . 47.4 t -135.42 130.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.248 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -111.48 129.04 56.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.236 -0.915 . . . . 0.0 109.776 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 6' ' ' CYS . 62.1 mt -113.16 145.19 41.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.516 -0.74 . . . . 0.0 109.791 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 111' ' ' LEU . 28.3 m -129.76 147.32 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.052 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 22.7 t -138.74 130.52 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.651 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.56 165.76 26.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 m -105.84 145.13 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.113 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.76 8.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.679 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -88.99 -23.46 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.133 -0.979 . . . . 0.0 109.807 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.6 146.37 33.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.58 -50.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.677 2.251 . . . . 0.0 112.259 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -55.05 -35.68 64.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.1 p -66.71 -24.26 66.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.058 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -71.41 -50.91 27.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.817 . . . . 0.0 109.461 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.85 -36.28 81.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -51.53 -34.06 34.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.783 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.9 -36.4 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -91.61 -41.55 10.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.752 -1.217 . . . . 0.0 110.592 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.53 -37.52 87.82 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.086 -1.009 . . . . 0.0 112.037 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -113.17 -51.38 2.82 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.901 -1.124 . . . . 0.0 112.638 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.2 -39.95 82.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.97 -1.081 . . . . 0.0 113.249 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.785 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.1 t -58.27 -52.11 76.93 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.027 -1.67 . . . . 0.0 110.75 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.16 -40.6 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.677 1.585 . . . . 0.0 112.223 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.47 -31.05 67.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.405 -0.809 . . . . 0.0 110.499 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 98' ' ' VAL . 5.5 tp -59.26 -24.07 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.883 -1.136 . . . . 0.0 110.006 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 99' ' ' PRO . 62.5 p -58.42 -38.59 77.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 109.436 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -58.94 -29.99 67.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.4 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -82.94 -7.77 59.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.895 . . . . 0.0 109.811 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.11 84.9 0.19 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.0 109.356 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.56 89.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.65 2.233 . . . . 0.0 112.458 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -133.52 11.32 4.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.316 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.561 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -136.68 157.74 74.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -59.95 141.15 95.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.683 2.255 . . . . 0.0 112.268 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 108' ' ' THR . 97.3 m-85 -121.98 145.83 47.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.742 . . . . 0.0 109.796 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.74 ' O ' HG22 ' A' ' 80' ' ' VAL . 5.2 mp -121.8 131.72 54.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.607 -0.683 . . . . 0.0 109.469 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.804 HD22 ' HB2' ' A' ' 146' ' ' ALA . 26.2 tp -103.79 118.88 37.74 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.545 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 59.7 t -112.44 137.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.728 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.14 128.5 9.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 32.7 p -125.51 161.75 26.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.258 -1.143 . . . . 0.0 110.852 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 115' ' ' THR . 27.4 tt0 83.71 19.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 119' ' ' LEU . 8.2 tt -61.3 -165.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.622 ' N ' HG23 ' A' ' 117' ' ' ILE . 86.1 m-20 60.65 -60.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 110.006 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.2 mp -60.02 -35.05 74.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.787 -1.196 . . . . 0.0 108.995 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 119' ' ' LEU . 83.3 mtm180 31.65 45.99 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.465 ' OD2' HD12 ' A' ' 129' ' ' LEU . 7.3 t0 70.26 75.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.166 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -42.83 160.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.383 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 126' ' ' ILE . 6.7 Cg_endo -52.18 -55.22 4.06 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.699 2.266 . . . . 0.0 111.915 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.0 p -54.76 -28.65 50.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.819 -1.175 . . . . 0.0 109.586 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.431 ' CG2' ' OD1' ' A' ' 121' ' ' ASP . 28.5 m -78.21 -50.74 11.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.994 -1.066 . . . . 0.0 110.578 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 123' ' ' PRO . 13.1 tt -55.46 -27.6 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.033 -1.042 . . . . 0.0 109.631 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.99 -45.62 80.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -60.69 -36.84 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.582 -0.699 . . . . 0.0 109.384 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.465 HD12 ' OD2' ' A' ' 121' ' ' ASP . 71.3 mt -75.15 -37.76 61.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.061 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.66 -39.05 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -60.4 -40.98 92.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.168 -0.957 . . . . 0.0 109.366 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -91.7 3.11 55.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 109.917 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.1 mttp 54.49 40.62 31.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -92.07 -52.73 4.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.15 -0.969 . . . . 0.0 109.743 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 mttt 65.46 139.45 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.9 154.41 74.68 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.536 2.157 . . . . 0.0 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.6 mm -93.56 140.31 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.86 155.43 73.03 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.62 -31.92 95.13 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.47 -37.76 84.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.3 m -66.09 -33.59 76.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.277 -0.89 . . . . 0.0 108.987 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.59 -36.97 57.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -35.01 71.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.622 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.42 -36.25 83.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.931 -1.106 . . . . 0.0 109.79 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 145' ' ' LEU . 46.2 tp -63.25 -39.2 93.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.804 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -67.74 -45.47 74.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 109.556 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.664 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -75.79 9.61 2.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -71.59 -36.4 70.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 51.0 mt -112.43 -87.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.594 -0.691 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -152.59 52.67 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.451 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -64.45 131.36 46.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.312 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.23 -51.74 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.927 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -160.1 155.61 25.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.262 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -121.02 144.42 48.54 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -142.81 154.22 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 110.285 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.8 mt-10 -120.04 142.73 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.545 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.07 149.84 42.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.697 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 161' ' ' THR . 12.8 t -112.01 107.59 16.62 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.36 64.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.5 tp -53.31 -32.07 47.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 158' ' ' SER . 14.3 p -126.09 165.26 19.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -69.85 13.14 0.16 Allowed 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.642 -0.661 . . . . 0.0 109.396 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 161' ' ' THR . 58.5 tttm -85.48 -4.76 59.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.43 -50.43 2.97 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.255 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.966 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.8 mm? -64.46 -39.37 93.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.242 . . . . 0.0 109.972 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -58.51 -32.07 68.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.361 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 53.1 t30 -73.8 -49.64 24.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.786 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.72 -8.34 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.803 . . . . 0.0 111.041 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -72.43 -50.33 27.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.817 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.89 -42.42 99.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 110.086 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -66.29 -36.31 82.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.03 -35.54 71.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.51 -40.29 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.2 tp -52.07 -45.88 64.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.689 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -62.66 -33.64 75.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.982 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 4' ' ' ILE . . . -52.01 -43.58 63.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.667 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.1 mt -62.54 -35.73 80.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.998 . . . . 0.0 109.337 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 99.989999999999995 109.461 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -132.93 162.47 31.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.532 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 176' ' ' ALA . 31.1 mm -115.49 119.9 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.204 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -96.93 130.59 44.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.948 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.659 ' SG ' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -149.47 137.95 20.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.708 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.97 138.43 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.92 142.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.753 . . . . 0.0 109.481 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.523 HG23 HG21 ' A' ' 58' ' ' THR . 12.7 p -139.96 143.39 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.893 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.65 165.36 26.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -85.1 117.82 24.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.296 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.21 -105.44 1.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.32 -67.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.512 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 15' ' ' GLY . 28.4 t 54.43 -119.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.586 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.616 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -95.42 25.88 22.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -56.92 -34.39 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 0.0 109.274 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -66.58 -37.61 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 108.965 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.65 ' SG ' HG11 ' A' ' 33' ' ' VAL . 10.5 m -67.22 -30.82 70.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.432 -0.792 . . . . 0.0 109.869 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.6 tp -69.91 -44.78 68.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.287 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.3 -44.33 46.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.801 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 21' ' ' ILE . 9.9 tp -64.7 -32.49 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 110.066 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.6 p -66.7 -28.94 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 80.5 t80 -76.58 -43.43 38.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 p -75.35 -45.09 41.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 111.287 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.7 p -85.12 -23.09 28.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.843 -1.161 . . . . 0.0 110.243 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 23' ' ' TYR . 57.1 m-20 57.58 35.36 25.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.358 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -138.22 81.51 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.174 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.58 -41.79 90.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.111 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 24.0 Cg_exo -61.99 -10.61 18.23 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.493 2.128 . . . . 0.0 112.036 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 32' ' ' TYR . 14.6 t -47.12 -32.74 4.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 64.65 -31.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.825 . . . . 0.0 110.283 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.644 ' C ' HG23 ' A' ' 33' ' ' VAL . 87.0 m-85 -58.36 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.832 -1.168 . . . . 0.0 108.659 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.65 HG11 ' SG ' ' A' ' 18' ' ' CYS . 2.0 t 73.74 60.05 0.32 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.513 -0.742 . . . . 0.0 110.415 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.47 130.66 34.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.024 1.816 . . . . 0.0 111.079 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.34 56.08 2.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.06 -1.025 . . . . 0.0 110.143 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.571 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 42.1 t -119.48 134.65 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.679 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 36' ' ' VAL . 91.1 m-85 -160.56 -102.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 88.7 m-20 54.02 56.62 6.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.089 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 17.1 t-20 89.86 73.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.318 0.58 . . . . 0.0 109.709 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HE2' HG22 ' A' ' 42' ' ' VAL . 57.2 t80 -111.9 145.35 39.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.1 145.29 48.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.435 HG22 ' HE2' ' A' ' 40' ' ' TYR . 44.0 t -126.02 129.63 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.9 m -92.8 124.26 36.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.064 -1.022 . . . . 0.0 108.733 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.22 159.34 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 110.794 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 68.0 mtm -113.15 136.95 52.16 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.76 127.08 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 108.987 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 15.68 67.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.62 16.17 62.36 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -124.26 154.06 68.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.338 -1.096 . . . . 0.0 109.175 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.52 135.33 28.38 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.749 2.3 . . . . 0.0 113.258 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -145.32 154.9 42.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.129 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -125.54 139.23 53.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.384 -0.823 . . . . 0.0 109.869 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.37 125.25 48.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.094 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' C ' HD22 ' A' ' 55' ' ' LEU . . . -111.07 118.28 4.83 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.924 HD22 ' N ' ' A' ' 55' ' ' LEU . 1.6 mm? -102.77 129.39 49.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.221 -1.164 . . . . 0.0 108.999 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.88 126.08 53.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.771 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -103.36 164.93 11.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.469 -0.769 . . . . 0.0 109.382 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 9' ' ' VAL . 40.3 p -79.67 161.87 25.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.52 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -140.5 153.08 46.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.699 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -104.96 -5.64 20.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.0 133.75 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.795 . . . . 0.0 109.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -109.12 121.64 45.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 108.619 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.659 HD12 ' SG ' ' A' ' 6' ' ' CYS . 53.6 mt -116.35 140.05 49.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.81 152.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 134.23 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -138.99 164.01 30.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.43 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.1 p -98.13 151.4 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 109.32 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 84' ' ' VAL . 12.9 p -102.27 6.71 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -100.52 -1.08 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 0.0 110.129 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -118.86 95.82 49.55 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 109.745 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.76 -52.88 8.01 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -40.2 65.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.099 -1.001 . . . . 0.0 109.508 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 93' ' ' VAL . 54.9 p -60.34 -14.15 16.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 108.851 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -74.13 -50.66 18.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.72 -39.08 90.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.3 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -54.15 -32.14 54.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 89' ' ' SER . 73.8 t -59.26 -37.58 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 110.274 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -86.59 -27.76 23.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.742 -1.224 . . . . 0.0 110.386 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.72 -36.45 67.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.116 -0.99 . . . . 0.0 112.273 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -111.89 -50.62 2.9 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.884 -1.135 . . . . 0.0 112.509 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.487 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 33.8 m0 -68.13 -34.32 76.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.967 -1.083 . . . . 0.0 112.583 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.43 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -68.22 -51.72 24.74 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 119.964 -1.71 . . . . 0.0 111.113 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 72.9 Cg_endo -76.69 -44.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.947 1.764 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.24 -41.94 89.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 111.045 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 105' ' ' CYS . 94.2 mt -68.34 -43.35 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 110.174 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.8 m -60.28 -42.97 96.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.847 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -60.5 -44.85 95.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.937 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -92.82 -10.69 35.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.432 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -149.65 86.96 5.27 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.941 -1.099 . . . . 0.0 109.878 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.79 -48.84 19.59 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.415 2.076 . . . . 0.0 112.072 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 108' ' ' THR . 29.0 mttt -147.69 110.34 4.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.506 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 3.5 p -154.11 150.16 22.0 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.326 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -47.72 118.25 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.03 1.82 . . . . 0.0 111.625 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 108' ' ' THR . 64.0 m-85 -112.9 128.9 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.741 HD21 ' OE1' ' A' ' 171' ' ' GLU . 32.5 tp -115.78 120.28 38.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 117.56 34.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 108.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.536 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 48.0 t -112.09 135.9 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.419 -0.801 . . . . 0.0 110.587 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.7 125.31 8.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.3 t -129.97 166.63 19.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.227 -1.161 . . . . 0.0 110.638 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 115' ' ' THR . 22.9 tp60 85.66 15.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.762 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 119' ' ' LEU . 25.4 pt -63.15 -158.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.869 -1.144 . . . . 0.0 108.648 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.497 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 80.4 m-20 56.97 -57.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.637 -0.664 . . . . 0.0 110.273 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.699 ' N ' ' O ' ' A' ' 117' ' ' ILE . 29.4 tp -50.74 -30.52 14.17 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.845 -1.159 . . . . 0.0 108.109 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.466 HH12 ' HD2' ' A' ' 139' ' ' PRO . 40.5 ttp180 -57.89 -15.56 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 47.2 p30 -101.19 1.85 39.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.55 150.57 76.47 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.9 -53.46 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.454 2.103 . . . . 0.0 111.98 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -59.17 -32.64 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 110.637 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.1 m -69.71 -51.39 34.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.886 -1.134 . . . . 0.0 109.908 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt -65.16 -35.1 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.918 . . . . 0.0 109.456 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -73.27 -44.57 59.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.362 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.87 -41.32 91.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 129' ' ' LEU . 88.1 mt -74.16 -34.07 63.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 108.713 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.57 -47.73 69.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.056 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -62.6 -35.83 80.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.204 -0.935 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -52.61 -57.09 11.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.857 -1.152 . . . . 0.0 109.562 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 134' ' ' GLN . 14.3 pttp -171.23 -50.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 133' ' ' LYS . 50.8 mt-30 -143.86 -119.79 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.852 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.88 163.22 52.51 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 110.175 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.33 174.26 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.175 2.583 . . . . 0.0 112.099 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.32 140.04 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.37 158.29 69.29 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 109.381 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.466 ' HD2' HH12 ' A' ' 120' ' ' ARG . 16.4 Cg_endo -60.99 -31.55 91.48 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.58 2.187 . . . . 0.0 111.936 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.4 m -69.37 -33.05 72.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.217 -0.927 . . . . 0.0 109.221 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.31 -39.6 59.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.447 -0.783 . . . . 0.0 109.921 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.51 -31.85 69.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -60.93 -37.53 82.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.012 . . . . 0.0 109.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.703 ' N ' HD12 ' A' ' 145' ' ' LEU . 7.7 mp -65.39 -31.06 71.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.402 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.13 69.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.908 -1.12 . . . . 0.0 110.242 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -82.09 9.49 8.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.399 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -113.45 -36.09 5.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.029 . . . . 0.0 109.246 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.02 17.09 9.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.538 -0.726 . . . . 0.0 110.572 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 65.48 30.23 10.87 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.216 -0.928 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.31 143.08 56.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 108.944 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 110' ' ' PHE . 73.0 t -66.0 -58.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.013 -1.054 . . . . 0.0 110.089 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -152.49 150.47 29.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.028 -1.045 . . . . 0.0 110.709 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -116.8 138.7 51.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.48 -0.763 . . . . 0.0 109.432 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.421 HG11 ' OE2' ' A' ' 171' ' ' GLU . 6.2 m -141.43 153.78 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 139' ' ' PRO . 93.2 mt-10 -110.11 132.62 54.0 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.536 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -136.64 146.28 45.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 0.0 110.633 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 161' ' ' THR . 18.0 t -115.78 108.93 16.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.343 0.592 . . . . 0.0 109.45 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 160' ' ' LEU . 6.7 mp -59.61 -27.86 66.68 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.8 p -125.11 165.94 17.32 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.11 12.64 0.28 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.798 -0.563 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 161' ' ' THR . 34.9 mtmt -89.68 3.4 52.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.989 . . . . 0.0 109.923 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.97 -49.15 1.96 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.745 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.5 mp -61.86 -38.48 88.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -1.138 . . . . 0.0 110.125 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -58.53 -32.59 69.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 110.303 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -86.64 -44.61 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.046 -1.034 . . . . 0.0 109.381 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.88 -26.9 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 110.498 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CE2' HG13 ' A' ' 173' ' ' ILE . 71.9 t80 -67.47 -46.81 71.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -54.52 -43.8 72.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.896 -1.127 . . . . 0.0 109.672 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.741 ' OE1' HD21 ' A' ' 111' ' ' LEU . 96.7 mt-10 -70.61 -38.06 73.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.01 -43.69 91.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.256 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.403 HG13 ' CE2' ' A' ' 169' ' ' PHE . 29.9 mm -69.67 -42.81 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.932 -1.105 . . . . 0.0 109.671 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.6 tp -56.16 -45.64 79.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.06 84.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.446 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -56.66 -42.66 79.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.4 mt -64.27 -38.48 91.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.516 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.0 m -104.37 145.27 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.6 -0.687 . . . . 0.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.8 mt -115.07 119.94 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.732 . . . . 0.0 109.026 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.35 130.78 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 0.0 110.01 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 128.18 19.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.391 -0.818 . . . . 0.0 109.12 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.41 138.27 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG13 HD23 ' A' ' 79' ' ' LEU . 32.2 t -116.1 132.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 0.0 108.886 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.627 HG23 ' OG1' ' A' ' 58' ' ' THR . 14.6 p -152.09 145.87 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.077 -1.014 . . . . 0.0 109.514 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.28 157.41 22.88 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 12' ' ' GLY . 60.3 t0 -86.01 105.76 16.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.61 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.12 69.73 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -87.98 133.58 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -1.235 . . . . 0.0 109.289 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.37 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.333 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 49.89 0.81 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 73.6 tttt -61.28 -38.24 86.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.962 -1.316 . . . . 0.0 109.78 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.6 p -70.64 -37.02 73.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.69 -28.5 69.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.81 -37.3 79.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.947 . . . . 0.0 110.128 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.37 -40.6 96.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 111.15 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 pt -70.7 -32.14 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.74 -1.225 . . . . 0.0 110.07 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 m -57.01 -38.68 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.986 -1.071 . . . . 0.0 109.983 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -78.74 -48.48 14.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.122 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 p -64.59 -34.33 78.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.881 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 63.7 p -112.26 -109.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 25' ' ' THR . 1.3 p30 164.64 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -126.45 122.35 35.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.259 -0.901 . . . . 0.0 110.404 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.672 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -96.52 -39.69 0.27 Allowed Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 12.9 Cg_exo -66.89 -10.54 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.616 2.211 . . . . 0.0 111.13 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' TYR . 38.7 m -47.9 -36.72 12.75 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.209 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.6 mt-10 40.38 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.972 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 30' ' ' SER . 70.1 t80 -141.22 118.77 11.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.946 -1.096 . . . . 0.0 108.419 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.59 153.03 37.98 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.81 156.11 64.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 112.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 67.92 10.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.55 136.25 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -117.26 -1.93 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.815 . . . . 0.0 109.645 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.1 p30 -77.56 166.24 23.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.005 . . . . 0.0 110.113 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 37.5 p-10 -92.91 150.78 20.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.792 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 74.0 t80 -134.53 147.98 50.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -102.61 138.25 39.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 0.0 109.842 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.83 138.2 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.712 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.3 m -106.03 134.49 49.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.838 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.89 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 109.958 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.8 mtp -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.745 HG22 ' H ' ' A' ' 48' ' ' GLY . 68.9 mt -129.11 135.77 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.87 . . . . 0.0 108.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.68 -15.11 11.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.745 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -95.16 -8.73 58.69 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.322 -1.105 . . . . 0.0 110.593 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' GLY . 2.0 mm-40 155.43 131.23 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.507 -0.996 . . . . 0.0 109.367 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.87 137.01 26.2 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.003 1.802 . . . . 0.0 111.857 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 97.8 m-85 -134.57 155.49 50.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.136 -0.978 . . . . 0.0 109.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 m -119.0 141.1 48.97 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.91 126.34 44.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.65 128.51 9.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.2 mt -107.32 122.49 46.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -1.207 . . . . 0.0 109.2 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -111.49 135.13 52.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.41 -0.806 . . . . 0.0 109.197 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 58' ' ' THR . 57.4 t0 -94.0 151.68 19.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.188 -0.945 . . . . 0.0 109.07 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.627 ' OG1' HG23 ' A' ' 9' ' ' VAL . 65.5 m -59.1 130.39 46.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.033 -1.042 . . . . 0.0 108.978 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.718 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.256 0.55 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -105.5 130.96 53.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.0 108.99 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.39 -37.91 89.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.84 144.1 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.449 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.39 126.68 51.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 8' ' ' VAL . 42.6 tp -112.3 128.76 56.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.665 HG21 ' CE2' ' A' ' 110' ' ' PHE . 40.5 t -123.18 135.78 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 130.95 46.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.37 -0.831 . . . . 0.0 109.828 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.47 161.11 38.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.9 t -80.08 132.82 36.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -1.0 . . . . 0.0 109.295 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.77 -28.25 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 110.869 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.573 HG21 HD23 ' A' ' 119' ' ' LEU . 33.4 m -92.6 7.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.041 -1.037 . . . . 0.0 111.095 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t -98.52 124.57 46.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.792 -1.193 . . . . 0.0 110.003 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 70.2 Cg_endo -77.56 -58.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.264 1.976 . . . . 0.0 112.61 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.4 p -55.48 -32.92 63.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.935 . . . . 0.0 109.762 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 m -65.08 -24.52 67.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.165 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CZ ' HG22 ' A' ' 141' ' ' THR . 56.3 t80 -68.57 -50.84 48.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -0.774 . . . . 0.0 109.347 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 87' ' ' PRO . 52.5 mp0 -69.13 -35.72 76.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -54.45 -33.36 59.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.66 -37.98 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.933 . . . . 0.0 110.268 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.684 ' HD2' HD21 ' A' ' 145' ' ' LEU . 30.0 tttt -93.43 -36.25 12.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.844 -1.16 . . . . 0.0 110.839 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.71 -37.04 81.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.027 -1.045 . . . . 0.0 112.285 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -113.68 -51.65 2.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 0.0 112.611 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.198 -0.939 . . . . 0.0 113.217 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -71.25 -51.49 10.08 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.152 -1.592 . . . . 0.0 111.623 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 56.7 Cg_endo -71.87 -45.74 0.68 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.827 1.685 . . . . 0.0 113.567 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.22 -38.85 90.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.014 -1.054 . . . . 0.0 111.07 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 98' ' ' VAL . 3.4 tp -68.58 -26.88 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 110.078 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 m -61.46 -40.02 92.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 109.858 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -54.87 -34.44 62.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.573 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 56.8 t-80 -62.34 -43.66 98.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 0.0 109.591 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.0 OUTLIER 160.64 158.52 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 108' ' ' THR . 13.5 Cg_endo -60.1 -160.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.759 2.306 . . . . 0.0 111.676 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 106' ' ' PRO . 20.8 mttp 42.51 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.058 . . . . 0.0 109.631 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.7 p 47.49 81.8 0.25 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.53 126.44 16.09 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.328 2.019 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -113.28 125.21 54.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.017 -179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 153' ' ' LYS . 40.5 tp -116.58 121.22 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.6 mt -104.58 121.83 44.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.75 134.52 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.5 124.89 8.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.8 p -110.73 159.78 17.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.219 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 57.67 40.8 26.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.681 -0.637 . . . . 0.0 110.663 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.5 pt -69.48 -5.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.153 . . . . 0.0 109.933 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.93 -22.66 29.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 0.0 109.096 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 85' ' ' VAL . 31.4 tp -61.58 -32.73 72.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.407 HH22 ' HB ' ' A' ' 138' ' ' THR . 67.7 ttt180 -58.64 -25.22 62.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.652 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.07 -5.2 47.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 110.116 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.12 141.32 83.72 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.003 -1.061 . . . . 0.0 109.049 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.62 -46.73 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.173 1.915 . . . . 0.0 111.894 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.8 p -61.22 -27.64 68.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.889 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.3 m -69.25 -49.02 60.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.02 -40.19 82.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.455 0.645 . . . . 0.0 109.3 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -74.54 -40.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.582 -0.699 . . . . 0.0 109.771 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.568 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 3.5 mm? -78.7 -38.78 38.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -0.996 . . . . 0.0 109.61 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.52 71.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 109.686 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -62.55 -44.41 96.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.97 -1.081 . . . . 0.0 110.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -70.44 -48.95 53.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.772 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -148.38 -89.32 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.47 ' HG3' ' H ' ' A' ' 135' ' ' LYS . 9.0 pt20 -134.19 -119.32 0.18 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.594 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.47 ' H ' ' HG3' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.09 167.03 24.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.41 165.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.998 2.465 . . . . 0.0 112.223 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.61 145.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.407 ' HB ' HH22 ' A' ' 120' ' ' ARG . 0.2 OUTLIER -85.69 155.99 58.81 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.994 -1.066 . . . . 0.0 109.394 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.41 -24.03 76.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.614 2.209 . . . . 0.0 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.13 -41.7 97.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.41 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 46.8 m -62.45 -36.78 83.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.962 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.9 57.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.64 -34.67 77.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.091 -1.006 . . . . 0.0 110.682 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 21.0 mttm -67.3 -39.25 85.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.437 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.684 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -62.7 -39.5 94.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 0.0 109.24 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.574 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -75.36 -48.86 21.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.089 -1.007 . . . . 0.0 110.141 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -68.97 4.97 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 144' ' ' LYS . 88.2 m-20 -108.82 -20.99 12.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.958 -1.089 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.402 ' CD1' HG21 ' A' ' 98' ' ' VAL . 38.2 mt -110.97 34.31 4.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.73 29.18 18.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.639 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.574 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -67.51 146.23 54.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.98 -61.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.034 -1.042 . . . . 0.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 154' ' ' TYR . 16.4 tttp -175.37 163.3 3.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.427 ' N ' ' HG2' ' A' ' 153' ' ' LYS . 28.7 p90 -120.04 154.75 34.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.623 HG21 ' OE1' ' A' ' 171' ' ' GLU . 28.0 t -132.24 140.09 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.9 mt-10 -100.13 126.7 46.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 140.73 47.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 111.071 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 161' ' ' THR . 34.6 t -104.26 102.19 11.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 108.892 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.92 72.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.209 0.528 . . . . 0.0 109.59 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.6 mt -53.56 -27.02 23.9 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 158' ' ' SER . 17.5 p -123.61 161.17 25.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -69.97 12.35 0.22 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.696 -0.627 . . . . 0.0 109.33 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.3 mttp -90.45 0.52 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.866 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -91.67 -51.37 2.51 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.016 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.17 -40.48 96.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.133 -1.216 . . . . 0.0 109.83 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.45 -27.85 66.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.522 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 35.6 t-20 -76.94 -50.73 12.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 109.926 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.02 -12.13 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.865 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.63 -50.23 22.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.734 -1.228 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.72 -41.95 92.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 0.0 110.057 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.623 ' OE1' HG21 ' A' ' 155' ' ' VAL . 83.9 tt0 -65.01 -33.15 75.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.979 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.68 71.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.53 -39.82 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.036 -1.04 . . . . 0.0 109.787 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.3 tp -53.49 -42.14 67.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.92 74.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -0.947 . . . . 0.0 110.333 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.45 70.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.941 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.3 mt -61.96 -34.23 75.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.963 -1.085 . . . . 0.0 109.399 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.443 -0.786 . . . . 99.989999999999995 109.255 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.414 0.625 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -136.71 160.07 39.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.772 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.66 121.0 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -91.66 127.86 37.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.74 128.33 24.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 109.123 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.446 HG21 HG21 ' A' ' 75' ' ' THR . 47.2 t -113.14 137.36 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.36 134.92 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -152.09 146.59 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.105 -0.997 . . . . 0.0 109.277 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 159.64 23.85 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' GLY . 24.6 t70 -84.31 110.28 18.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -1.213 . . . . 0.0 109.434 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.57 63.38 1.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -85.09 121.36 27.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -1.167 . . . . 0.0 109.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.87 -30.08 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.967 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.09 35.14 5.02 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 87.8 tttt -59.95 -38.59 82.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.237 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.7 p -63.41 -40.51 97.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.002 . . . . 0.0 110.002 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -26.69 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.058 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.14 -41.2 99.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.825 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 24' ' ' THR . 83.1 mt -66.44 -40.56 89.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.123 -0.985 . . . . 0.0 110.198 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.16 -42.3 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.809 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -57.51 -35.82 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.185 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -80.05 -50.27 10.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.144 . . . . 0.0 109.801 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 20' ' ' LEU . 71.6 p -59.58 -36.94 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.142 -0.974 . . . . 0.0 110.014 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 56.5 p -120.15 -113.55 0.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 25' ' ' THR . 69.2 m-20 -167.56 12.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -98.09 118.82 35.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -86.4 -38.52 0.54 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 17.7 Cg_exo -63.26 -27.11 71.97 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.371 2.047 . . . . 0.0 111.064 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 29' ' ' PRO . 21.7 m 34.17 47.73 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.221 0.534 . . . . 0.0 110.298 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 -41.07 -32.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -121.7 126.0 47.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.257 -0.902 . . . . 0.0 109.488 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -99.44 109.27 54.38 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -52.47 160.64 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.241 1.961 . . . . 0.0 112.049 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.19 67.44 1.87 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 38' ' ' ASP . 12.3 p -140.94 138.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.03 0.64 11.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.475 -0.766 . . . . 0.0 109.326 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' H ' HG22 ' A' ' 36' ' ' VAL . 88.3 m-20 -69.2 139.46 54.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -0.882 . . . . 0.0 110.432 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.39 160.82 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.09 136.58 49.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 110.33 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 125.75 51.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.19 138.64 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 p -87.94 147.08 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.075 -1.016 . . . . 0.0 109.066 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 156.95 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 110.507 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.2 mtm -130.17 137.15 49.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.711 -0.618 . . . . 0.0 109.549 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 26.6 pt -129.82 152.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 109.096 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.99 18.2 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 84.83 15.06 68.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . 59.0 mt-10 -106.0 146.56 33.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.102 -1.234 . . . . 0.0 109.44 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.74 131.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.539 2.159 . . . . 0.0 112.829 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -143.12 160.13 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.532 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 m -117.23 138.79 51.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 0.0 109.093 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 41.8 tp -120.13 122.08 40.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 109.579 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.79 124.57 7.91 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -102.45 122.33 44.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.997 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -108.23 129.31 55.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.46 -0.775 . . . . 0.0 109.104 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' THR . 60.0 t0 -116.92 148.05 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.701 . . . . 0.0 109.177 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.407 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.2 p -68.65 159.16 32.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.042 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 -179.833 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 HG21 ' A' ' 7' ' ' VAL . 30.7 p -119.26 145.0 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 109.477 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.85 -33.87 74.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.934 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.65 133.71 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -110.7 121.42 45.27 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -112.81 139.18 48.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.351 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.3 t -122.44 135.18 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.497 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 38.8 t -127.77 128.27 45.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.811 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.61 162.91 34.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 109.73 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.556 ' OG ' HG22 ' A' ' 85' ' ' VAL . 37.9 t -92.05 142.85 27.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.4 p -100.24 -4.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.109 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.571 HG11 HD23 ' A' ' 119' ' ' LEU . 30.6 m -89.79 -16.47 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.999 -1.063 . . . . 0.0 109.783 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -98.51 134.97 21.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.65 -55.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.228 1.952 . . . . 0.0 112.198 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.3 m -55.13 -34.4 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 109.709 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -63.44 -25.16 68.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.097 -1.002 . . . . 0.0 109.248 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 137' ' ' ILE . 64.9 t80 -70.36 -50.18 41.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -0.832 . . . . 0.0 109.414 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.31 -37.13 82.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.55 -34.36 49.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 109.815 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.98 -34.97 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 109.986 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -91.14 -37.75 13.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.863 -1.148 . . . . 0.0 110.192 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -68.0 -35.99 79.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 112.094 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -113.15 -52.55 2.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.976 -1.078 . . . . 0.0 112.528 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -68.25 -37.02 80.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.156 -0.965 . . . . 0.0 113.428 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.0 t -63.28 -51.43 68.85 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.003 -1.685 . . . . 0.0 111.395 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' O ' HG22 ' A' ' 102' ' ' THR . 59.8 Cg_endo -73.96 -43.4 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.828 1.685 . . . . 0.0 113.095 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.82 -30.24 71.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 0.0 111.23 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 98' ' ' VAL . 3.7 tp -61.71 -25.1 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.687 -1.258 . . . . 0.0 109.874 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' PRO . 4.8 t -55.59 -36.61 67.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.131 -0.981 . . . . 0.0 109.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 102' ' ' THR . 52.1 m170 -51.62 -32.93 30.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.7 m80 -93.25 -5.99 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.58 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' HIS . 0.1 OUTLIER 53.23 168.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.541 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.19 26.11 0.55 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.837 2.358 . . . . 0.0 113.355 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -56.57 -34.52 67.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.947 -1.096 . . . . 0.0 109.829 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 159.61 38.52 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.418 -0.801 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.46 147.52 93.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.864 2.376 . . . . 0.0 111.959 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.63 126.05 54.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.158 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.7 mt -116.98 128.16 54.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.536 -0.728 . . . . 0.0 109.854 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.1 tp -106.34 116.4 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.1 t -112.77 136.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.908 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.96 119.03 6.01 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 52.0 m -118.58 148.11 43.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -1.045 . . . . 0.0 110.465 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' THR . 33.2 tt0 84.48 19.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 122.067 -0.396 . . . . 0.0 110.47 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 119' ' ' LEU . 35.1 pt -62.62 -158.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 63.0 -61.73 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.183 . . . . 0.0 109.226 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 117' ' ' ILE . 25.1 tp -53.08 -33.9 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 139' ' ' PRO . 33.0 ptt180 -54.36 -15.42 1.63 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 92.9 m-20 -108.04 57.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.609 ' OD2' HD12 ' A' ' 119' ' ' LEU . 7.9 m-20 -137.85 107.79 8.3 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.66 -39.83 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.879 1.719 . . . . 0.0 111.955 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m -58.73 -41.34 86.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.0 m -70.67 -48.94 52.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 108.126 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.76 -36.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.388 0.613 . . . . 0.0 109.479 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.93 -47.11 75.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.433 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -59.0 -38.8 80.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.709 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.16 -33.88 61.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 108.98 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.94 -41.81 64.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -60.16 -37.23 79.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 109.477 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.71 4.67 50.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.786 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 51.65 39.3 24.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.182 -0.949 . . . . 0.0 109.752 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -98.99 -52.17 3.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.027 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 mttp 68.89 146.11 0.11 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.3 152.24 79.54 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.593 2.195 . . . . 0.0 112.765 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.423 HG21 ' CE1' ' A' ' 90' ' ' PHE . 27.0 mm -93.5 141.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 109.046 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.53 155.21 65.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.093 -1.005 . . . . 0.0 109.591 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HG3' HH12 ' A' ' 120' ' ' ARG . 18.5 Cg_endo -61.65 -28.08 82.11 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.571 2.181 . . . . 0.0 111.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.92 -38.27 90.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 45.4 m -65.06 -35.59 81.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.33 -34.07 58.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.817 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 110.485 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.483 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 18.5 mttp -64.45 -35.69 81.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.962 -1.086 . . . . 0.0 109.553 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.53 -40.29 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.769 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -67.15 -43.54 82.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.002 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 147' ' ' ARG . 43.8 mtt-85 -78.7 7.78 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 85.1 m-20 -83.31 -27.78 29.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 0.0 108.753 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.3 mt -117.38 -101.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.624 -0.672 . . . . 0.0 109.308 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -144.9 44.9 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.871 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.769 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -61.95 137.4 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 109.168 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.82 -58.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.354 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -156.66 146.54 20.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.72 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -122.22 153.73 38.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.394 -0.816 . . . . 0.0 109.11 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.54 157.58 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.904 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -104.35 128.1 52.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' HG13 ' A' ' 168' ' ' VAL . 15.2 m -122.02 131.45 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.854 . . . . 0.0 110.713 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.583 ' HB2' HD11 ' A' ' 117' ' ' ILE . 23.9 t -109.99 110.88 21.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.97 68.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.871 -0.518 . . . . 0.0 110.08 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 28' ' ' PHE . 49.8 tp -51.37 -34.39 34.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.061 -1.024 . . . . 0.0 108.471 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.654 ' C ' ' H ' ' A' ' 163' ' ' LYS . 55.6 m -127.95 152.0 48.42 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -58.57 13.53 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.039 -1.038 . . . . 0.0 110.103 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.654 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.9 tttm -74.59 5.92 4.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 0.0 109.278 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -98.81 -50.86 1.45 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.205 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.753 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.5 mp -68.25 -38.47 81.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -1.178 . . . . 0.0 109.939 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -61.73 -29.25 69.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.288 -0.883 . . . . 0.0 110.336 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 163' ' ' LYS . 86.8 m-20 -77.96 -49.71 13.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 110.186 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 157' ' ' CYS . 11.3 m -74.39 -11.19 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 110.452 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -73.64 -46.46 46.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.59 -43.29 89.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.299 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.06 -33.39 75.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.05 -1.031 . . . . 0.0 109.663 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.06 70.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 110.152 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.18 -42.64 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.93 -1.106 . . . . 0.0 109.916 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.3 mt -54.24 -44.86 72.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.822 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.71 -36.6 84.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.715 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.44 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.654 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.13 -39.22 93.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.398 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.406 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.407 0.622 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -124.71 159.0 31.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.2 mt -119.16 119.16 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.794 . . . . 0.0 109.556 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.3 132.69 38.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -135.87 126.6 27.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 109.465 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.84 136.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.427 -0.796 . . . . 0.0 109.709 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.4 138.12 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.049 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.54 144.68 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.295 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.63 23.1 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 12' ' ' GLY . 26.1 t70 -89.55 105.88 18.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -1.165 . . . . 0.0 109.43 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.73 68.78 0.5 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -1.151 . . . . 0.0 109.401 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.23 -45.73 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.309 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.29 48.94 0.88 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 68.1 tttt -59.69 -40.18 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.245 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.641 HG21 HG21 ' A' ' 33' ' ' VAL . 41.8 m -64.5 -40.56 95.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.529 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.84 -29.77 63.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.036 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.34 -42.76 96.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.014 -1.054 . . . . 0.0 109.22 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -73.44 -40.1 64.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.89 -48.92 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -56.37 -32.65 64.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -81.1 -50.63 9.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 m -55.93 -44.3 78.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 82.1 p -118.39 -110.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 25' ' ' THR . 81.5 m-20 -146.06 12.56 1.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.016 . . . . 0.0 109.882 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 28' ' ' PHE . 22.7 tttm 77.91 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.568 -0.707 . . . . 0.0 109.757 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -37.16 -55.54 1.71 Allowed Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.409 -0.807 . . . . 0.0 111.482 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 89.0 Cg_exo -35.43 -53.47 0.78 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.975 1.783 . . . . 0.0 112.415 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.7 t -108.72 142.82 38.69 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.311 -0.868 . . . . 0.0 108.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.22 -19.93 13.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -133.59 161.34 34.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.6 -0.688 . . . . 0.0 110.183 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 33' ' ' VAL . 7.7 p -123.93 79.83 57.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.2 -64.05 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.699 2.266 . . . . 0.0 112.442 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.94 166.04 24.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.57 141.04 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.72 -84.93 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 52.3 p30 -148.83 -170.86 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.806 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 40.5 p-10 -52.56 151.35 4.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.799 . . . . 0.0 109.257 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.98 146.44 44.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.741 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.39 142.86 45.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 108.961 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 134.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.8 m -90.49 131.81 36.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 108.914 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.17 137.59 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.413 -0.805 . . . . 0.0 110.044 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 95.7 mmm -91.2 137.46 32.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.84 . . . . 0.0 108.814 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLY . 78.4 mt -131.41 132.04 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.8 19.33 0.5 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.34 15.53 62.07 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 4.1 mt-10 -114.83 125.44 29.04 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.397 -1.06 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.14 117.07 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.038 1.825 . . . . 0.0 113.208 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 49' ' ' GLU . 48.5 m-85 -127.19 139.41 52.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -86.9 149.81 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.783 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.9 tp -131.79 133.84 45.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.425 -0.797 . . . . 0.0 109.24 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.2 131.11 8.26 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.84 132.99 50.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -1.105 . . . . 0.0 109.048 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.17 133.37 54.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 58' ' ' THR . 59.0 t0 -132.21 147.44 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.0 p -73.05 160.36 32.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.648 -179.805 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' THR . 95.2 mm-40 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER 85.62 50.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.88 -33.67 67.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.2 128.8 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.441 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -105.61 124.12 49.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 108.767 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 55.9 mt -107.82 137.46 45.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 97' ' ' TRP . 20.1 t -124.99 136.78 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.596 ' HG ' ' HG1' ' A' ' 115' ' ' THR . 45.0 t -130.04 127.34 39.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.848 . . . . 0.0 109.843 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -136.42 165.37 25.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.942 . . . . 0.0 108.853 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.5 m -101.83 142.63 32.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.223 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 84' ' ' VAL . 4.1 p -102.84 -1.35 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.055 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.6 HG11 HG21 ' A' ' 125' ' ' THR . 78.2 t -85.32 -21.67 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.882 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.6 m -111.96 108.67 55.37 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.772 . . . . 0.0 109.771 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -51.77 -38.27 66.73 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.022 1.815 . . . . 0.0 112.335 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.6 p -57.62 -35.22 70.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 109.154 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -67.92 -21.85 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -72.02 -50.45 28.43 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.65 -35.77 80.96 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -50.95 -33.83 26.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.525 HG22 ' CZ3' ' A' ' 97' ' ' TRP . 81.3 t -62.39 -35.31 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -89.43 -37.56 14.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.821 -1.175 . . . . 0.0 110.247 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.07 -37.22 83.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 112.384 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -112.91 -52.05 2.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.762 -1.212 . . . . 0.0 112.699 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.616 ' O ' HD13 ' A' ' 101' ' ' ILE . 30.8 m0 -66.86 -39.43 87.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.994 -1.066 . . . . 0.0 112.593 -176.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -61.47 -52.21 71.71 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.143 -1.598 . . . . 0.0 111.05 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 38.3 Cg_endo -68.98 -43.22 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.568 1.512 . . . . 0.0 112.416 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.82 -39.81 62.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.5 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.616 HD13 ' O ' ' A' ' 97' ' ' TRP . 1.3 mp -66.63 -33.32 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.778 -1.201 . . . . 0.0 109.927 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.2 m -53.77 -39.02 65.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -58.93 -40.7 85.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.739 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -99.4 1.12 43.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER 59.42 166.32 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.996 . . . . 0.0 109.331 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.7 39.92 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.723 2.282 . . . . 0.0 112.304 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -60.17 -35.37 75.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.745 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.07 157.74 49.92 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 110.471 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.73 144.64 44.5 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.034 2.489 . . . . 0.0 112.696 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -116.75 138.82 51.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 153' ' ' LYS . 45.8 tp -116.71 123.62 47.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -101.56 116.93 33.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.03 135.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.672 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.3 114.88 4.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.642 HG22 ' HG3' ' A' ' 116' ' ' GLN . 20.8 m -102.74 149.22 24.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -1.152 . . . . 0.0 110.503 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.642 ' HG3' HG22 ' A' ' 115' ' ' THR . 91.5 mt-30 60.68 41.18 15.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.931 -0.48 . . . . 0.0 110.637 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.2 pt -73.65 -6.21 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.875 -1.141 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.487 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 84.5 m-20 -85.71 -24.03 27.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.049 -1.032 . . . . 0.0 109.217 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 116' ' ' GLN . 10.2 mp -65.01 -24.98 67.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HE ' HG11 ' A' ' 84' ' ' VAL . 97.0 mtt180 -44.99 -19.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.514 -0.741 . . . . 0.0 109.231 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 119' ' ' LEU . 60.6 t0 -122.33 48.63 1.71 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.737 . . . . 0.0 109.032 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 56.4 t0 -117.72 90.55 36.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.516 -0.74 . . . . 0.0 109.21 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.6 -40.92 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.197 1.931 . . . . 0.0 112.398 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.5 t -57.87 -43.21 85.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.842 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.6 HG21 HG11 ' A' ' 85' ' ' VAL . 45.4 m -70.58 -49.56 46.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 108.232 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.0 -36.41 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.15 -43.83 90.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 108.896 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -61.78 -42.54 99.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.696 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 129' ' ' LEU . 3.8 mm? -75.39 -33.91 61.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.885 . . . . 0.0 109.348 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.89 40.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.83 -35.36 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.495 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.38 6.81 21.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.719 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 61.55 44.77 8.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -140.94 139.61 34.32 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.229 -0.919 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.88 161.83 34.22 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.534 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.03 145.65 97.89 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.867 2.378 . . . . 0.0 112.328 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.555 ' CG2' ' OG1' ' A' ' 141' ' ' THR . 97.1 mt -90.99 144.56 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.435 -0.791 . . . . 0.0 109.835 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.34 155.02 54.52 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.54 -32.79 95.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.35 -36.61 61.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.555 ' OG1' ' CG2' ' A' ' 137' ' ' ILE . 65.4 p -78.57 -23.76 45.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.82 -1.175 . . . . 0.0 108.832 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.01 -43.88 51.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.448 -0.783 . . . . 0.0 109.759 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.68 -35.62 81.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 110.984 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -65.86 -38.42 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 149' ' ' LEU . 34.2 tp -59.7 -38.53 81.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 109.302 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.17 84.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.956 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.648 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -81.26 6.54 13.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -111.46 -34.86 5.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.106 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 145' ' ' LEU . 66.7 mt -92.68 16.9 11.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.63 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.2 mttt 61.2 31.23 19.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.93 145.18 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.641 HG12 ' HG3' ' A' ' 153' ' ' LYS . 87.0 t -66.56 -60.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.952 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.641 ' HG3' HG12 ' A' ' 152' ' ' VAL . 68.9 mttm -152.86 157.67 41.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -132.15 148.61 52.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.623 HG21 ' OE1' ' A' ' 171' ' ' GLU . 46.6 t -134.11 140.95 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -0.957 . . . . 0.0 110.231 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.86 121.84 36.88 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.422 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -130.69 140.63 50.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.159 -0.963 . . . . 0.0 110.761 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 161' ' ' THR . 8.7 t -115.61 115.13 25.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.416 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.9 -35.67 64.69 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.247 0.546 . . . . 0.0 109.86 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.45 -31.0 32.6 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.538 ' O ' ' O ' ' A' ' 158' ' ' SER . 7.4 m -118.03 152.11 36.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.29 12.61 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 161' ' ' THR . 62.9 mttp -89.18 4.74 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.857 -1.152 . . . . 0.0 109.903 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -89.08 -51.0 3.1 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.952 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.56 -38.62 74.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 110.301 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -60.24 -29.14 68.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.477 ' ND2' ' CG1' ' A' ' 155' ' ' VAL . 38.6 t-20 -75.59 -49.46 18.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.58 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 168' ' ' VAL . 73.0 t -79.1 -8.08 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 110.726 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 173' ' ' ILE . 76.1 t80 -74.95 -50.38 16.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.771 -1.205 . . . . 0.0 110.331 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.69 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 110.272 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.623 ' OE1' HG21 ' A' ' 155' ' ' VAL . 85.0 tt0 -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.975 . . . . 0.0 109.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.61 80.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 110.002 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.573 HD11 ' CE2' ' A' ' 169' ' ' PHE . 75.9 mt -72.89 -42.25 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.093 -1.004 . . . . 0.0 109.855 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.0 tp -57.5 -44.84 85.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.902 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.09 -33.4 75.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.7 71.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.9 -39.78 86.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 0.0 109.071 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 99.989999999999995 109.521 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.6 m -124.92 147.42 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.583 -0.698 . . . . 0.0 109.781 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.25 119.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -88.92 128.38 35.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.59 124.03 26.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.06 138.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 0.0 109.935 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.571 HG22 HD23 ' A' ' 79' ' ' LEU . 46.2 t -111.32 136.07 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.615 HG11 ' CH2' ' A' ' 97' ' ' TRP . 54.2 t -133.27 136.44 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.1 142.36 12.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 12' ' ' GLY . 50.7 t0 -84.99 105.06 15.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 109.551 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.0 66.16 1.09 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -81.53 130.25 34.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -1.117 . . . . 0.0 109.342 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.48 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.22 51.91 0.67 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 86.3 tttt -61.8 -39.83 93.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.239 . . . . 0.0 110.057 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.6 p -76.14 -35.55 59.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 109.967 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 68.7 m -64.1 -31.18 72.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.445 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.78 -42.32 81.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.711 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.4 mt -70.45 -40.88 73.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.93 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.9 -36.71 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.6 p -60.44 -30.5 69.69 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.351 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -82.65 -50.27 8.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.977 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -66.85 -40.57 87.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 0.0 110.469 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 54.8 m -105.08 -86.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.965 . . . . 0.0 109.645 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER 159.92 -10.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.032 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -83.92 103.92 13.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.739 -1.226 . . . . 0.0 109.783 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.638 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -65.33 -41.4 51.15 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.431 -0.793 . . . . 0.0 109.173 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 27.7 Cg_exo -59.48 -33.36 97.21 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.337 2.025 . . . . 0.0 112.068 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER 74.99 42.25 0.27 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.104 -0.997 . . . . 0.0 108.595 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 32' ' ' TYR . 96.1 mt-10 -44.84 81.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.125 0.488 . . . . 0.0 110.597 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.669 ' N ' ' O ' ' A' ' 30' ' ' SER . 11.7 t80 90.05 71.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.228 0.537 . . . . 0.0 110.403 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG12 ' OG ' ' A' ' 30' ' ' SER . 31.7 m -44.55 148.81 0.84 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 109.604 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.28 144.3 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.833 2.355 . . . . 0.0 112.415 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.03 1.02 42.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.171 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.54 142.29 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.92 16.36 22.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.886 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 59.2 t0 -63.82 129.1 38.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -70.33 151.05 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.428 -0.795 . . . . 0.0 109.588 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 98.7 m-85 -127.97 152.56 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.816 . . . . 0.0 109.866 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.59 145.48 30.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.261 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -128.45 147.09 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 109.842 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.578 HG23 HG22 ' A' ' 52' ' ' THR . 58.3 m -120.53 142.53 49.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.408 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 m -124.53 158.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 109.818 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.7 mtp -112.49 140.65 47.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 51' ' ' TYR . 60.4 mt -122.1 143.78 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -46.4 -29.19 3.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.509 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -81.13 -92.16 0.51 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -126.74 156.68 73.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -1.057 . . . . 0.0 109.846 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.7 138.07 23.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.735 2.29 . . . . 0.0 112.24 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.543 ' CD1' HD12 ' A' ' 46' ' ' ILE . 89.9 m-85 -131.38 152.17 50.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 0.0 109.084 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.578 HG22 HG23 ' A' ' 43' ' ' THR . 17.8 p -117.8 157.92 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.17 160.3 29.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.19 158.28 26.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 mt -106.0 129.11 54.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.058 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -115.99 135.08 54.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 0.0 109.558 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -139.55 167.56 21.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.387 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.25 154.11 25.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.068 -1.02 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.44 ' OG1' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -152.12 98.44 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.4 -34.03 74.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.917 . . . . 0.0 109.546 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.78 143.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 74.2 m-85 -104.71 127.3 52.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.402 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 8' ' ' VAL . 30.7 tp -111.93 125.53 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.405 -0.81 . . . . 0.0 108.973 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.27 137.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 141.95 49.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 109.541 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.3 159.01 43.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 109.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -89.18 150.83 22.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 109.378 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.678 ' O ' HG22 ' A' ' 84' ' ' VAL . 6.7 p -98.48 4.43 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.97 -2.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -115.06 92.92 33.0 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.204 -0.935 . . . . 0.0 109.661 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.03 -50.81 12.73 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.41 2.073 . . . . 0.0 112.695 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -54.29 -38.68 66.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 109.371 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 93' ' ' VAL . 60.7 p -63.65 -16.01 59.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.29 -50.78 13.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.48 -39.46 81.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.592 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -53.74 -31.56 48.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.092 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 89' ' ' SER . 75.8 t -60.38 -35.59 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.697 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -95.66 -30.06 13.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.033 -1.042 . . . . 0.0 110.605 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.56 -35.06 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.71 -1.244 . . . . 0.0 111.903 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -113.73 -49.69 2.87 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.045 -1.034 . . . . 0.0 112.36 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.615 ' CH2' HG11 ' A' ' 9' ' ' VAL . 79.3 m95 -76.31 3.24 11.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -107.04 -45.98 0.12 Allowed Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.387 -1.446 . . . . 0.0 110.851 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 91.5 Cg_endo -86.12 -53.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.545 2.163 . . . . 0.0 112.767 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.57 -34.37 78.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.928 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.2 -27.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.853 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.1 p -66.46 -35.02 79.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.933 . . . . 0.0 109.764 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -56.84 -41.47 77.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -101.28 -8.8 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m -147.79 77.54 10.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.74 -44.46 49.41 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.564 2.176 . . . . 0.0 112.062 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -150.8 104.1 3.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -150.38 155.79 36.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.437 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.95 127.78 17.54 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.42 2.08 . . . . 0.0 111.857 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 108' ' ' THR . 76.7 m-85 -116.61 137.64 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.769 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 153' ' ' LYS . 8.2 tp -122.82 119.2 29.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.723 . . . . 0.0 109.449 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 112' ' ' LEU . 5.6 mp -107.56 127.08 53.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 108.818 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -112.04 133.08 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.67 119.82 5.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.9 p -118.25 169.45 9.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -1.068 . . . . 0.0 110.937 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 117' ' ' ILE . 82.3 mt-30 66.08 40.76 3.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 116' ' ' GLN . 15.2 tt -48.97 178.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.918 -1.114 . . . . 0.0 108.576 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 121' ' ' ASP . 87.7 m-20 54.26 26.17 6.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.819 -1.176 . . . . 0.0 109.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.9 mt 26.88 54.69 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.983 -0.448 . . . . 0.0 111.343 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 21.2 mmm180 49.61 26.85 1.91 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.834 -1.166 . . . . 0.0 110.189 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 118' ' ' ASP . 9.7 t0 79.84 -14.74 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.0 109.455 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.449 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.8 OUTLIER 53.97 62.34 9.04 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.756 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 122' ' ' ASP . 68.4 Cg_endo -92.68 -100.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 123.02 2.48 . . . . 0.0 111.504 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.3 p -81.17 -2.4 48.4 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.6 m -72.41 -46.36 55.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 108.956 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 126' ' ' ILE . 6.9 pt -62.63 -34.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.29 -0.881 . . . . 0.0 109.308 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.63 -50.03 48.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -61.34 -36.67 80.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 0.0 110.138 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.93 -37.77 61.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 108.789 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.83 -38.49 61.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 109.475 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -60.23 -36.73 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 109.346 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -85.32 5.7 29.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.546 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttt 54.92 44.06 28.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.829 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -135.56 91.78 2.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.997 . . . . 0.0 109.416 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.85 153.22 91.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.31 161.77 25.96 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.853 2.369 . . . . 0.0 112.205 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.11 134.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -98.2 157.87 33.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 109.067 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 142' ' ' ALA . 2.1 Cg_endo -47.93 -36.28 26.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.906 2.404 . . . . 0.0 113.065 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.535 ' H ' HG23 ' A' ' 138' ' ' THR . 84.6 tt0 -46.9 -40.76 14.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 110.119 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.1 p -89.25 -18.38 27.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.779 -1.201 . . . . 0.0 109.39 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 139' ' ' PRO . . . -76.3 -49.88 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.706 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.35 -34.97 78.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.135 . . . . 0.0 110.662 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 87.7 mttt -61.82 -32.92 73.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 0.0 109.292 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 tp -56.31 -38.96 72.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.406 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.07 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.786 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -80.65 -0.63 38.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 61.5 t0 -111.9 -43.29 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 108.814 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.553 HD11 HG21 ' A' ' 98' ' ' VAL . 9.6 tp -78.71 10.89 2.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.636 -0.665 . . . . 0.0 109.675 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 59.02 30.12 19.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -0.952 . . . . 0.0 110.137 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.9 52.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 108.758 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.81 -58.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.075 . . . . 0.0 109.498 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.626 ' O ' HD12 ' A' ' 111' ' ' LEU . 50.1 tttp -158.51 155.8 29.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.868 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.68 153.46 51.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.531 HG21 ' OE1' ' A' ' 171' ' ' GLU . 39.3 t -133.04 138.44 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 84.6 tt0 -102.6 132.22 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.428 ' HB3' HD22 ' A' ' 167' ' ' ASN . 8.4 p -167.09 176.74 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.123 . . . . 0.0 110.376 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 117' ' ' ILE . 28.7 t -135.17 127.19 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.014 -1.054 . . . . 0.0 110.719 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.1 mt -54.66 -26.33 32.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.562 ' C ' ' H ' ' A' ' 163' ' ' LYS . 27.4 m -121.3 160.87 23.05 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -64.62 11.17 0.05 Allowed 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.412 -0.805 . . . . 0.0 109.247 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.5 mttm -89.84 3.0 54.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.977 -1.077 . . . . 0.0 109.564 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.528 ' O ' HG22 ' A' ' 168' ' ' VAL . . . -91.93 -50.23 2.71 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.6 mp -67.02 -44.96 78.95 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.443 -1.034 . . . . 0.0 110.646 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.41 -32.56 68.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 25.6 t-20 -79.84 -50.88 9.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.939 -1.101 . . . . 0.0 110.063 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 164' ' ' GLY . 15.6 m -75.79 -18.13 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 110.911 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.56 -47.37 27.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 0.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 110.233 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.531 ' OE1' HG21 ' A' ' 155' ' ' VAL . 80.9 tt0 -67.45 -33.99 76.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.093 -1.005 . . . . 0.0 109.927 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.53 70.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.9 . . . . 0.0 110.323 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 29.3 mm -67.67 -40.75 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.112 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 174' ' ' LEU . 3.4 mm? -56.88 -45.59 82.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 0.0 110.083 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.97 77.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.052 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.98 72.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.17 -36.72 84.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.0 109.511 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.529 -179.736 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -127.29 135.74 50.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.37 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 176' ' ' ALA . 68.3 mt -113.07 114.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.834 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -91.3 132.43 36.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.472 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -132.6 121.39 23.14 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.66 134.02 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 79' ' ' LEU . 26.1 t -114.61 133.01 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG21 ' CH2' ' A' ' 97' ' ' TRP . 9.1 p -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 0.0 109.582 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.01 -173.32 37.32 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' GLY . 23.3 t70 -69.76 137.65 52.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . -37.16 -47.67 1.43 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.626 ' C ' HG23 ' A' ' 14' ' ' VAL . . . -42.53 167.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -1.209 . . . . 0.0 109.658 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.626 HG23 ' C ' ' A' ' 13' ' ' ALA . 2.1 t 73.42 110.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.27 79.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.5 mttp -58.05 -31.18 66.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 108.989 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 m -67.52 -44.42 78.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.399 -0.813 . . . . 0.0 109.016 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.6 m -62.14 -27.7 69.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 109.637 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -65.16 -40.27 94.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 108.506 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.911 ' O ' HG23 ' A' ' 24' ' ' THR . 59.8 mt -71.37 -44.06 65.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 0.0 109.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mm -67.91 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.982 . . . . 0.0 109.832 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.401 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 29.6 t -60.03 -35.12 74.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.955 . . . . 0.0 109.812 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.96 -33.17 70.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.911 HG23 ' O ' ' A' ' 20' ' ' LEU . 60.9 p -72.07 -45.77 59.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 110.879 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.593 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 46.6 p -144.01 -2.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.792 -1.193 . . . . 0.0 111.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 25' ' ' THR . 37.3 t30 90.35 118.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' OG ' ' A' ' 30' ' ' SER . 2.8 tttm 178.63 48.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.99 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.653 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -61.36 -42.75 86.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.513 -1.367 . . . . 0.0 109.525 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 22.9 Cg_exo -62.19 1.99 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.908 2.406 . . . . 0.0 112.575 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 32' ' ' TYR . 29.2 m -48.89 -42.12 35.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.986 -1.071 . . . . 0.0 109.762 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 39.38 23.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.62 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 30' ' ' SER . 30.3 m-85 -93.76 -102.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.786 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.793 ' O ' HG12 ' A' ' 33' ' ' VAL . 46.5 t 54.44 63.18 7.6 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.717 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 32.9 Cg_endo -68.67 -26.31 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.267 1.978 . . . . 0.0 111.235 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 34' ' ' PRO . . . 154.51 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.69 142.02 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -144.16 59.76 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.842 . . . . 0.0 109.182 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -121.15 158.65 27.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.296 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 55' ' ' LEU . 64.6 t30 -93.97 139.25 31.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.75 154.14 29.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.817 . . . . 0.0 109.54 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.55 143.62 44.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 0.0 109.061 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.57 130.71 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.8 m -100.74 128.52 46.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.01 134.14 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 0.0 110.198 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.4 ttp -118.25 128.71 54.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 27.2 pt -131.8 152.39 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.44 16.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.55 15.68 61.46 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.8 mt-10 -113.32 93.73 27.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.438 -1.036 . . . . 0.0 109.523 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.91 145.6 23.87 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.12 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 60.8 m-85 -150.72 160.79 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.3 m -117.7 129.31 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 0.0 109.24 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 53' ' ' LEU . 34.3 tp -117.81 122.7 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.492 -0.755 . . . . 0.0 109.161 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.79 121.28 5.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 56.7 mt -101.62 128.05 48.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 108.417 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.83 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 54.4 p30 -102.91 169.54 8.52 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.367 -0.833 . . . . 0.0 109.017 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.9 m -57.81 129.51 42.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.942 -1.099 . . . . 0.0 109.09 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 109.277 -179.819 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -77.0 160.11 29.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.141 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -121.65 -46.65 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.25 142.5 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 109.903 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.04 128.56 55.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.029 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.472 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 50.0 mt -108.96 141.72 40.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.15 136.51 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.284 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.0 t -129.1 126.16 38.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 0.0 109.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.74 168.92 18.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.484 ' OG ' ' OE1' ' A' ' 116' ' ' GLN . 24.1 t -97.04 137.22 36.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 84' ' ' VAL . 10.8 p -85.37 -10.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.262 -0.899 . . . . 0.0 111.222 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.638 HG22 ' OE1' ' A' ' 116' ' ' GLN . 26.6 m -99.78 -0.93 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.73 -1.231 . . . . 0.0 110.215 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 12.2 t -101.52 122.4 48.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.17 -61.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.211 1.94 . . . . 0.0 113.096 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -52.43 -41.07 62.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.927 -1.108 . . . . 0.0 110.117 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 60.5 p -69.09 -18.68 64.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.974 . . . . 0.0 109.505 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CD1' HD13 ' A' ' 137' ' ' ILE . 61.7 t80 -70.36 -50.5 38.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -74.4 -34.57 63.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -53.56 -39.01 64.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.967 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.5 -33.47 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.66 -25.69 62.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 111.35 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.12 -9.45 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.705 -1.247 . . . . 0.0 111.472 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -112.04 -51.44 2.85 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 111.337 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.54 ' CH2' HG21 ' A' ' 9' ' ' VAL . 61.6 m95 -92.4 -7.12 48.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.185 -0.947 . . . . 0.0 112.432 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -94.33 -39.98 0.3 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.318 -1.489 . . . . 0.0 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.8 Cg_endo -91.94 -49.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 0.0 113.517 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -51.6 -39.77 58.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.452 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 101' ' ' ILE . 9.2 tp -81.68 -19.85 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.042 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 57.6 m -54.7 -38.33 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -56.4 -43.77 79.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 110.741 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -103.4 11.76 36.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.957 -1.09 . . . . 0.0 111.068 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 28.0 p -63.57 114.86 14.6 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.154 . . . . 0.0 109.468 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.16 -90.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.238 1.959 . . . . 0.0 112.632 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.48 ' C ' HG22 ' A' ' 108' ' ' THR . 27.1 mttt -87.81 -80.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.308 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER 173.42 58.67 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.226 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 108' ' ' THR . 48.1 Cg_endo -94.06 53.01 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.955 2.437 . . . . 0.0 111.899 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.66 128.26 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.876 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 153' ' ' LYS . 11.1 tp -124.89 116.5 22.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.16 125.55 44.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 108.99 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.89 134.49 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 110.201 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.5 127.02 8.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 3.3 t -132.05 168.01 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.638 ' OE1' HG22 ' A' ' 85' ' ' VAL . 21.9 tt0 84.99 20.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.693 ' O ' ' N ' ' A' ' 119' ' ' LEU . 39.0 pt -59.44 -155.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 108.401 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 57.99 -58.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.743 . . . . 0.0 110.255 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.693 ' N ' ' O ' ' A' ' 117' ' ' ILE . 27.9 tp -51.78 -31.79 28.38 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.04 -1.037 . . . . 0.0 108.598 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -49.44 -17.63 0.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.765 . . . . 0.0 109.482 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -118.87 62.55 0.78 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 109.006 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.65 94.29 26.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.28 -44.72 23.77 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.278 1.985 . . . . 0.0 112.618 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -55.59 -36.05 66.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.052 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.57 HG21 HD11 ' A' ' 119' ' ' LEU . 69.1 p -78.0 -42.7 31.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.864 -1.147 . . . . 0.0 108.246 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.4 -39.0 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.28 -40.06 81.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.873 . . . . 0.0 108.695 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -59.79 -43.17 94.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.744 . . . . 0.0 109.152 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.51 -29.7 56.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.858 . . . . 0.0 109.264 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.7 -41.41 43.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.549 -0.719 . . . . 0.0 109.605 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.21 -36.65 75.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.91 6.47 24.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.858 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.9 mttt 58.09 43.3 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.89 138.81 35.97 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.177 -0.952 . . . . 0.0 109.08 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.37 154.24 53.98 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -46.25 147.39 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.238 1.959 . . . . 0.0 111.819 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.462 HD13 ' CD1' ' A' ' 90' ' ' PHE . 86.5 mt -75.58 148.98 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.96 154.9 55.53 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.264 -0.898 . . . . 0.0 109.193 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.8 -36.2 91.87 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.432 2.088 . . . . 0.0 111.777 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.98 -36.68 80.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.631 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 61.6 m -68.66 -36.75 78.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.153 -0.967 . . . . 0.0 108.84 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.31 64.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.567 -0.708 . . . . 0.0 110.008 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.38 -32.07 73.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -61.12 -36.52 79.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.81 -1.182 . . . . 0.0 109.23 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.1 tp -54.74 -39.88 68.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -68.67 -46.04 70.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.577 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -83.71 5.02 26.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.908 . . . . 0.0 110.143 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -61.43 -36.13 79.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.965 -1.084 . . . . 0.0 109.425 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.4 mt -126.16 -73.79 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 109.46 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -169.89 55.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 0.0 109.876 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -71.04 143.52 50.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.991 -1.068 . . . . 0.0 109.244 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.645 HG12 ' HG3' ' A' ' 153' ' ' LYS . 99.3 t -67.33 -56.58 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.104 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.645 ' HG3' HG12 ' A' ' 152' ' ' VAL . 66.0 mttm -159.3 164.99 34.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.173 -0.954 . . . . 0.0 109.912 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -131.06 146.93 52.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 108.908 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 t -132.26 140.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.47 129.96 52.43 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 150.16 43.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.93 -1.106 . . . . 0.0 111.297 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 117' ' ' ILE . 21.5 t -114.56 106.46 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -73.8 -34.5 64.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 109.621 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.32 -24.19 27.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.2 p -123.24 168.74 12.06 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -78.17 11.81 2.16 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.686 -0.634 . . . . 0.0 109.614 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 49.3 mttt -90.64 -5.76 55.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.035 -1.04 . . . . 0.0 109.85 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.49 -50.46 3.58 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.449 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.686 ' N ' HD12 ' A' ' 165' ' ' LEU . 7.8 mp -65.73 -41.01 92.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.211 . . . . 0.0 110.275 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -59.12 -31.3 68.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 163' ' ' LYS . 21.1 m120 -78.33 -50.7 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.926 -1.108 . . . . 0.0 110.102 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 172' ' ' ALA . 91.8 t -77.27 -12.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 173' ' ' ILE . 72.5 t80 -80.46 -50.53 9.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.679 -1.263 . . . . 0.0 110.593 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.03 -45.88 92.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.526 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.5 -33.0 68.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.165 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 168' ' ' VAL . . . -59.59 -33.44 71.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.112 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 169' ' ' PHE . 88.5 mt -65.86 -36.28 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 0.0 110.504 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 174' ' ' LEU . 4.0 mm? -58.22 -44.01 87.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.113 . . . . 0.0 109.597 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.6 -33.89 76.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.043 . . . . 0.0 109.156 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.438 ' HA ' HD13 ' A' ' 4' ' ' ILE . . . -57.6 -38.75 75.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 52.7 mt -59.91 -39.73 86.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -0.936 . . . . 0.0 108.792 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 99.989999999999995 109.329 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -123.3 160.59 26.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.779 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 176' ' ' ALA . 33.2 mm -116.64 119.0 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -87.03 121.97 30.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.037 -1.04 . . . . 0.0 109.786 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.2 t -138.13 128.37 25.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.93 143.05 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -0.83 . . . . 0.0 109.546 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.82 133.01 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.059 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.591 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 26.5 t -131.45 136.07 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.23 147.65 17.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' ALA . 25.2 t70 -85.6 111.49 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.059 -1.26 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 54.42 -85.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.23 123.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -1.127 . . . . 0.0 109.567 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.71 -43.06 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.59 57.69 0.42 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -63.36 -40.72 98.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 0.0 109.728 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -82.82 -32.64 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -31.22 72.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.23 -42.41 79.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.97 -1.081 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.9 -40.92 91.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.41 -35.24 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.3 p -50.75 -36.61 37.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 110.459 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -76.62 -37.64 56.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.083 . . . . 0.0 109.677 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.8 p -63.64 -37.69 88.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 111.692 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -162.08 -5.85 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.371 -1.456 . . . . 0.0 111.885 -179.051 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.609 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.7 t30 95.17 115.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -179.78 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.85 -42.52 83.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.778 -1.202 . . . . 0.0 109.82 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.3 Cg_exo -57.75 -31.72 92.9 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.48 2.12 . . . . 0.0 112.201 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.5 p 37.68 37.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.568 -0.707 . . . . 0.0 109.768 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 30' ' ' SER . 97.1 mt-10 -36.15 -37.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 110.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 33' ' ' VAL . 68.6 t80 -125.79 122.05 35.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 108.699 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.433 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 17.1 m -63.6 148.64 93.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.125 -0.984 . . . . 0.0 109.159 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.65 141.34 91.4 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.223 1.949 . . . . 0.0 112.149 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.95 71.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.939 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.75 155.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 110.067 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.32 25.91 10.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.098 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 89.1 m-20 -60.77 143.67 54.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 110.378 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 55' ' ' LEU . 46.3 t-20 -74.12 152.42 39.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.716 . . . . 0.0 109.563 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 95.9 m-85 -127.87 146.53 50.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.43 134.94 49.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.03 152.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 109.43 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p -118.31 143.83 46.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.45 138.67 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 109.815 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.6 mtt -79.11 126.87 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 0.0 109.171 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' GLY . 70.5 mt -131.56 126.2 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.196 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.93 18.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 88.81 12.95 63.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.6 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.1 mm-40 -123.24 81.87 52.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.466 -1.02 . . . . 0.0 109.118 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 124.05 15.33 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.677 2.252 . . . . 0.0 112.91 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.6 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 96.7 m-85 -115.49 142.68 46.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.4 m -75.56 135.09 40.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.922 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -123.09 125.06 44.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.79 132.38 10.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 73.1 mt -104.57 135.2 46.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -1.105 . . . . 0.0 109.022 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.11 155.68 32.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 109.752 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.1 p30 -150.24 178.04 9.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 47.5 m -66.25 138.66 57.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 0.0 109.198 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -124.14 151.31 44.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.346 -0.846 . . . . 0.0 109.722 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -65.6 -35.62 81.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG21 ' HB1' ' A' ' 175' ' ' ALA . 35.9 t -138.54 133.33 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.99 128.59 49.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 108.981 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.4 tp -113.43 132.04 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.395 -0.815 . . . . 0.0 109.855 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.14 135.4 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 0.0 109.225 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.8 t -130.52 126.15 36.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 110.021 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.47 168.41 19.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 108.86 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 m -108.01 145.93 33.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.472 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 84' ' ' VAL . 14.9 p -103.79 13.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.039 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.78 -21.54 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.43 150.28 68.1 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.257 -0.902 . . . . 0.0 110.061 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.95 -33.21 3.84 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.737 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 t -55.67 -44.63 77.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.005 . . . . 0.0 109.493 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.735 ' O ' HG23 ' A' ' 93' ' ' VAL . 40.9 m -66.36 -24.68 66.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.155 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -73.5 -51.26 17.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.458 -0.776 . . . . 0.0 109.524 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.51 -39.95 70.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.091 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.46 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 42.0 t30 -54.32 -35.28 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 89' ' ' SER . 65.7 t -59.06 -34.54 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 0.0 109.735 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -86.82 -22.84 25.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 0.0 110.406 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -75.44 -30.68 60.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' NZ ' ' OD1' ' A' ' 11' ' ' ASP . 7.6 ttpm? -112.53 -47.38 3.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.014 -1.054 . . . . 0.0 112.223 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.591 ' CZ2' ' CG1' ' A' ' 9' ' ' VAL . 77.1 m95 -80.8 1.36 30.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.093 -1.004 . . . . 0.0 113.35 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.607 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -107.76 -41.74 0.13 Allowed Pre-proline 0 N--CA 1.503 2.192 0 O-C-N 120.402 -1.436 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 24.3 Cg_endo -88.71 -53.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.984 2.456 . . . . 0.0 112.691 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -57.03 -37.11 71.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -66.12 -29.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.027 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.9 m -60.03 -45.31 93.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.931 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.16 -35.07 76.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -64.32 -40.91 96.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.95 . . . . 0.0 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 171.88 165.74 0.24 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 109.939 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 75.8 Cg_exo -43.25 171.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.761 2.307 . . . . 0.0 112.228 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.44 140.86 55.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 110.02 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -124.94 160.28 54.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.81 122.6 11.29 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.178 1.919 . . . . 0.0 111.748 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 108' ' ' THR . 76.3 m-85 -122.86 149.59 43.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.109 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.437 ' C ' HD22 ' A' ' 112' ' ' LEU . 85.1 mt -112.98 120.01 39.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 112' ' ' LEU . 3.5 mm? -97.06 111.57 23.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 0.0 108.762 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.609 HG13 HG23 ' A' ' 155' ' ' VAL . 47.9 t -108.3 135.4 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.76 122.84 7.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.7 p -122.14 160.9 24.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -1.068 . . . . 0.0 110.477 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.504 ' CB ' ' O ' ' A' ' 115' ' ' THR . 4.4 tp-100 79.99 18.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.992 -0.443 . . . . 0.0 110.233 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.654 ' O ' ' N ' ' A' ' 119' ' ' LEU . 29.0 pt -60.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.723 -1.236 . . . . 0.0 108.149 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 61.06 -62.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.654 ' N ' ' O ' ' A' ' 117' ' ' ILE . 48.7 tp -55.1 -34.75 63.94 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.089 -1.007 . . . . 0.0 108.612 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -61.8 -19.75 62.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.013 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -90.14 -19.59 24.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.692 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.38 141.9 80.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.42 -29.94 19.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.427 2.085 . . . . 0.0 112.679 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -58.26 -41.78 85.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 49.3 m -72.11 -47.63 49.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.982 -1.074 . . . . 0.0 108.188 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.3 mt -55.09 -36.28 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.834 -0.541 . . . . 0.0 109.641 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.84 -46.95 79.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -59.06 -38.12 78.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 83.5 mt -79.14 -35.9 41.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 109.642 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.97 66.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -60.9 -36.17 78.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.1 5.61 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 52.97 32.81 13.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 135' ' ' LYS . 93.5 mt-30 -96.12 -53.06 3.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 109.606 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.489 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 10.9 mttm 62.36 144.86 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.456 -0.778 . . . . 0.0 109.092 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.05 150.69 87.91 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.538 2.159 . . . . 0.0 112.58 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 91.9 mt -89.07 146.95 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.418 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.28 157.73 55.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.375 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.93 -28.8 81.36 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.528 2.152 . . . . 0.0 111.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.7 -38.11 86.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.343 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 m -66.76 -36.16 81.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.147 -0.971 . . . . 0.0 109.019 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.35 -39.98 62.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 0.0 109.796 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -60.18 -34.35 73.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.521 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -64.13 -37.63 88.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.013 -1.054 . . . . 0.0 109.922 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.8 tp -58.19 -40.23 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.861 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.83 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -87.85 -52.01 5.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 147' ' ' ARG . 29.6 ttt-85 -51.34 -7.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 146' ' ' ALA . 84.4 m-20 -111.57 -15.82 13.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.971 -1.081 . . . . 0.0 109.835 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.37 29.59 6.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 0.0 111.06 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.0 mttt 58.5 30.56 19.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.9 -1.125 . . . . 0.0 110.88 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.83 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -71.51 144.95 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 108.83 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.45 -52.25 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.063 . . . . 0.0 109.771 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HZ2' ' CG ' ' A' ' 171' ' ' GLU . 47.1 pttt -175.92 -179.22 1.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.352 -0.843 . . . . 0.0 109.804 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -137.78 153.99 49.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.609 HG23 HG13 ' A' ' 113' ' ' VAL . 33.6 m -137.34 148.38 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.61 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.22 134.6 52.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.861 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.01 149.75 42.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 110.875 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.2 t -113.04 109.47 18.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.08 -36.45 61.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.712 -0.618 . . . . 0.0 109.564 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.0 mt -53.88 -26.95 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.645 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 p -124.05 170.24 10.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.32 12.0 1.36 Allowed 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.396 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 89.1 mttt -89.5 0.01 57.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 0.0 109.714 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.85 -51.13 2.71 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.298 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.697 ' N ' HD12 ' A' ' 165' ' ' LEU . 7.5 mp -68.74 -41.25 79.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -1.221 . . . . 0.0 110.246 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -59.55 -35.61 74.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.477 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 19.4 m120 -76.89 -49.39 15.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.532 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 168' ' ' VAL . 74.8 t -68.4 -9.34 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.536 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 173' ' ' ILE . 72.1 t80 -74.35 -46.21 42.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.58 -49.31 77.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.993 -1.067 . . . . 0.0 111.367 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 167' ' ' ASN . 60.3 mp0 -70.72 -35.67 72.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.846 -1.159 . . . . 0.0 110.373 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.34 80.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.813 HD11 ' CE2' ' A' ' 169' ' ' PHE . 97.8 mt -63.47 -38.68 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.029 -1.045 . . . . 0.0 109.915 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.37 -43.64 79.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -0.976 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.45 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.51 -36.22 83.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 109.913 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.498 ' HA ' HG21 ' A' ' 4' ' ' ILE . . . -52.76 -37.75 59.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.585 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.13 -36.55 82.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 108.997 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.446 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.225 0.536 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -143.08 154.91 44.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.767 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.54 HD13 ' HB1' ' A' ' 176' ' ' ALA . 61.3 mt -122.45 122.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.497 -0.752 . . . . 0.0 109.127 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -87.0 131.91 33.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.74 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 126.51 12.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.35 137.54 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 HD22 ' A' ' 79' ' ' LEU . 59.9 t -116.8 130.55 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.16 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -138.51 156.81 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.45 167.6 31.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.577 ' CG ' HD22 ' A' ' 92' ' ' ASN . 61.1 t0 -86.0 121.82 29.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.079 . . . . 0.0 109.451 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.695 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 71.05 -107.7 2.25 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 164.76 42.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.377 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.953 HG13 ' H ' ' A' ' 15' ' ' GLY . 1.7 p -72.17 -85.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.061 -1.025 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.953 ' H ' HG13 ' A' ' 14' ' ' VAL . . . -99.2 16.12 59.57 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -59.76 -38.19 81.09 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.5 p -74.29 -35.5 63.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.994 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.647 ' SG ' ' NZ ' ' A' ' 27' ' ' LYS . 89.4 m -59.82 -30.76 69.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.0 tp -67.7 -42.44 81.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.902 -1.124 . . . . 0.0 110.268 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.09 -43.77 61.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 111.059 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 22' ' ' SER . 9.9 tp -65.85 -38.81 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 0.0 110.184 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 25.7 m -54.69 -34.62 62.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.046 . . . . 0.0 110.307 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CZ ' ' A' ' 169' ' ' PHE . 82.3 t80 -70.13 -38.05 75.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.525 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.566 ' C ' HG22 ' A' ' 25' ' ' THR . 28.5 m -52.61 -37.2 57.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.932 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 179.75 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 110.584 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.606 ' CB ' ' O ' ' A' ' 25' ' ' THR . 25.2 t-20 96.1 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.647 ' NZ ' ' SG ' ' A' ' 18' ' ' CYS . 53.7 tttt -64.53 -41.0 96.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.205 0.526 . . . . 0.0 111.023 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 27' ' ' LYS . 1.5 m-85 -42.94 -61.41 1.75 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.728 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 54.4 Cg_endo -70.53 23.87 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.463 2.109 . . . . 0.0 112.632 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 68.8 m -137.76 -62.0 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.116 -0.99 . . . . 0.0 109.546 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.23 11.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 30' ' ' SER . 78.4 m-85 -91.59 -101.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 109.709 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 33' ' ' VAL . 3.5 p 34.15 60.04 2.03 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.655 . . . . 0.0 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 33' ' ' VAL . 69.7 Cg_endo -84.23 -73.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.392 2.061 . . . . 0.0 111.863 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' ' CE2' ' A' ' 37' ' ' PHE . . . -65.35 156.46 32.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 p -74.02 140.59 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 98.2 m-85 -118.13 159.2 23.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.531 -0.731 . . . . 0.0 109.646 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.0 p30 -72.91 -167.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.842 . . . . 0.0 109.97 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.35 157.08 6.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -110.33 130.89 55.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.386 -0.821 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 121.61 44.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.36 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' A' ' 23' ' ' TYR . 48.4 t -127.57 134.9 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.493 -0.754 . . . . 0.0 109.369 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 m -98.55 138.79 35.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.26 134.57 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.453 -0.78 . . . . 0.0 109.514 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.0 mtp -107.29 141.78 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 0.0 109.568 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 48' ' ' GLY . 73.7 mt -124.68 139.86 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.51 -24.02 0.59 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -82.89 -93.59 0.59 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.533 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 13.6 mm-40 -123.11 152.44 63.46 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.424 -1.045 . . . . 0.0 109.973 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.29 141.4 35.5 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.647 2.231 . . . . 0.0 112.224 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 98.9 m-85 -137.81 159.43 42.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 109.739 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -112.01 142.86 43.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 109.116 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -120.86 123.17 41.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.422 -0.799 . . . . 0.0 109.691 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.03 129.71 8.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.1 mt -107.74 136.59 47.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -118.86 146.26 45.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.765 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 52.6 p30 -156.79 164.81 37.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.422 -0.798 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -67.49 137.08 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.851 -179.546 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.331 0.586 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 78' ' ' PHE . 58.7 m -141.62 126.82 18.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.826 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.74 -25.26 13.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.014 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.49 131.72 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.444 -0.785 . . . . 0.0 109.414 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.644 ' CD2' HD11 ' A' ' 101' ' ' ILE . 95.5 m-85 -105.71 127.75 53.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.237 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.425 HD22 HG22 ' A' ' 8' ' ' VAL . 7.2 tt -118.24 129.89 55.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.428 -0.795 . . . . 0.0 110.246 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 111' ' ' LEU . 25.3 m -129.47 148.88 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 140.92 34.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.87 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 112' ' ' LEU . 15.8 p90 -154.98 157.33 37.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.5 p -83.37 157.03 22.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 109.441 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 84' ' ' VAL . 7.1 p -100.56 6.57 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 0.0 110.177 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.774 HG11 HD23 ' A' ' 119' ' ' LEU . 14.9 m -104.13 0.44 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 110.333 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.51 95.85 41.43 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 109.843 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.56 -48.87 19.22 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.298 1.999 . . . . 0.0 112.284 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 m -53.49 -40.47 65.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.046 . . . . 0.0 109.141 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -67.36 -19.75 65.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.084 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -68.66 -50.92 47.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 108.742 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.92 -34.63 75.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.395 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.577 HD22 ' CG ' ' A' ' 11' ' ' ASP . 48.3 t30 -54.25 -34.41 60.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.885 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.55 -37.71 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -91.94 -44.41 8.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 110.738 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.2 -36.71 82.76 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 112.199 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -114.53 -52.31 2.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.952 -1.093 . . . . 0.0 112.901 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.6 -38.48 80.66 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.075 -1.016 . . . . 0.0 113.487 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.1 t -57.48 -52.01 77.46 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.134 -1.604 . . . . 0.0 111.084 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -70.94 -37.79 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.717 1.611 . . . . 0.0 112.787 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.97 -40.79 85.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.644 HD11 ' CD2' ' A' ' 78' ' ' PHE . 9.1 tp -65.01 -28.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.755 -1.215 . . . . 0.0 109.538 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -61.64 -40.84 96.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.939 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -54.52 -40.65 68.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.521 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 64.8 m170 -57.39 -40.33 77.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 109.22 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.1 m 177.83 150.75 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.399 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.15 -27.85 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.639 2.226 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -127.64 137.84 52.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.76 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.464 ' OG1' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -175.61 147.71 0.96 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.073 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.84 122.01 8.91 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.217 1.945 . . . . 0.0 111.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -108.7 123.8 49.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.495 ' O ' HG22 ' A' ' 80' ' ' VAL . 29.6 tp -117.47 125.18 50.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 109.314 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 82' ' ' PHE . 49.5 tp -109.81 119.1 38.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.4 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 135.58 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.905 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.82 125.78 8.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.0 p -124.07 163.87 20.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -1.093 . . . . 0.0 110.575 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 68.74 33.95 3.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.802 -0.561 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 pt -74.29 -2.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 0.0 110.723 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.5 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 80.0 m-20 -84.26 -26.55 28.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.861 -1.15 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.774 HD23 HG11 ' A' ' 85' ' ' VAL . 28.2 tp -60.86 -30.93 70.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 109.265 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -57.74 -25.38 60.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.644 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -99.99 26.81 6.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -111.64 95.73 29.1 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.88 -44.14 38.09 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.174 1.916 . . . . 0.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -57.94 -37.03 73.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.187 -0.946 . . . . 0.0 109.483 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.665 HG21 HD21 ' A' ' 119' ' ' LEU . 30.1 m -73.85 -47.65 36.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -54.34 -34.78 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -62.5 -46.56 87.86 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -59.5 -36.84 76.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.454 -0.779 . . . . 0.0 108.976 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.443 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 77.8 mt -73.42 -37.53 65.87 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.32 75.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.676 -0.64 . . . . 0.0 109.764 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -59.18 -37.52 77.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.986 -1.071 . . . . 0.0 109.168 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -90.89 4.96 50.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.472 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.1 mttp 52.36 35.46 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.838 . . . . 0.0 109.496 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 135' ' ' LYS . 97.8 mt-30 -92.84 -53.84 4.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 7.1 mttt 62.09 144.37 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.056 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 147.25 87.63 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.58 2.186 . . . . 0.0 112.487 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -78.22 149.81 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.79 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 154.32 60.57 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.992 -1.067 . . . . 0.0 109.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.65 -33.52 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.318 2.012 . . . . 0.0 111.819 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.05 -36.03 80.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.649 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.3 m -68.22 -36.99 80.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 109.245 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.5 -44.3 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -0.811 . . . . 0.0 110.099 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.587 ' OE2' ' CE2' ' A' ' 154' ' ' TYR . 99.1 mt-10 -63.67 -32.32 73.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.02 . . . . 0.0 110.35 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.528 ' NZ ' ' OD2' ' A' ' 148' ' ' ASP . 13.2 tttm -65.95 -38.17 87.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.923 -1.111 . . . . 0.0 110.157 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.99 -39.32 81.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.689 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -78.75 -49.74 12.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 110.018 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -60.3 -2.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.306 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.528 ' OD2' ' NZ ' ' A' ' 144' ' ' LYS . 86.2 m-20 -111.29 -21.58 11.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.041 . . . . 0.0 109.91 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.57 26.74 8.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.494 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 59.79 31.03 20.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.224 -0.922 . . . . 0.0 110.613 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.689 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -66.11 144.75 56.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.0 . . . . 0.0 108.866 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.94 -59.62 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -165.31 157.26 15.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.755 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CE2' ' OE2' ' A' ' 143' ' ' GLU . 21.1 p90 -117.4 144.31 45.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.8 t -131.09 138.51 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -102.13 129.01 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.455 ' HB2' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -138.24 146.52 42.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -0.999 . . . . 0.0 111.312 -178.07 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.5 ' OG ' ' OD2' ' A' ' 118' ' ' ASP . 23.6 t -115.69 110.4 19.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.461 -0.775 . . . . 0.0 109.044 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.51 61.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.761 -0.587 . . . . 0.0 109.785 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -53.75 -32.14 51.15 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 22.2 p -125.1 166.45 16.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.518 ' OE1' ' ND2' ' A' ' 26' ' ' ASN . 29.3 mm100 -70.1 12.31 0.23 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 161' ' ' THR . 48.6 mtmt -89.41 9.4 26.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.262 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 158' ' ' SER . . . -105.37 -50.64 0.91 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.436 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 23' ' ' TYR . 43.8 mt -63.02 -36.7 84.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -1.234 . . . . 0.0 110.097 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -58.62 -29.75 66.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.999 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -94.74 -41.93 9.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.958 -1.088 . . . . 0.0 110.39 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 157' ' ' CYS . 80.4 t -60.52 -38.52 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 111.174 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 50.9 m-85 -89.94 -13.56 36.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.772 -1.205 . . . . 0.0 111.296 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.6 -50.34 72.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.715 -1.241 . . . . 0.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -80.79 -21.98 40.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 110.003 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.58 77.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.421 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.65 -43.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.912 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.34 -44.27 88.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.39 80.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.698 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.54 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -60.56 -43.17 97.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.58 -40.38 94.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.115 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.477 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.2 m -123.88 145.28 49.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.156 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HB ' HD12 ' A' ' 53' ' ' LEU . 30.7 mm -109.86 115.18 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.17 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -82.87 122.57 28.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.5 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 53' ' ' LEU . 47.3 t -132.57 119.23 20.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.311 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.93 138.79 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.04 131.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.57 139.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.101 -0.999 . . . . 0.0 109.384 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.13 165.0 31.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 23.2 t70 -80.68 86.46 5.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.176 -1.191 . . . . 0.0 109.353 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.5 86.86 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.68 -5.41 45.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -1.095 . . . . 0.0 109.395 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.21 -58.06 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.66 16.12 26.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' NZ ' ' OD1' ' A' ' 57' ' ' ASP . 46.9 tttm -63.33 -41.14 98.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.828 -1.395 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 p -68.71 -43.24 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 110.183 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -61.88 -28.56 69.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 110.766 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.441 HD22 ' SG ' ' A' ' 81' ' ' CYS . 46.7 tp -66.39 -43.48 85.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.878 -1.139 . . . . 0.0 109.785 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.09 -40.6 82.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.652 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.67 -44.31 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.299 -0.875 . . . . 0.0 109.852 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 m -49.97 -35.04 22.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.171 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -89.55 -48.51 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.839 -1.163 . . . . 0.0 110.04 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.431 HG22 HG23 ' A' ' 25' ' ' THR . 37.0 m -57.35 -42.05 81.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 111.764 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 65.6 p -140.66 -12.34 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 111.683 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 25' ' ' THR . 3.4 m-20 86.4 115.48 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ASN . 16.4 mttt 164.48 76.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.613 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -62.19 -42.4 80.91 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 110.108 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.4 Cg_exo -55.58 -38.6 93.98 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.372 2.048 . . . . 0.0 112.335 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.627 ' O ' ' N ' ' A' ' 32' ' ' TYR . 1.8 p 64.55 -50.29 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 109.869 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 29' ' ' PRO . 96.4 mt-10 57.02 -72.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.673 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.627 ' N ' ' O ' ' A' ' 30' ' ' SER . 81.9 t80 -107.07 124.62 49.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 1.8 m -64.5 152.95 88.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.55 136.18 72.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.544 2.163 . . . . 0.0 112.337 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.63 71.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.753 . . . . 0.0 110.098 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.7 155.74 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.566 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -107.68 94.15 4.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -123.24 147.81 46.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -70.63 149.09 47.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.316 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -121.28 146.37 46.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.51 146.45 41.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 109.455 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.93 141.92 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.5 m -97.75 134.55 40.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 51' ' ' TYR . 33.9 t -120.75 136.63 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.0 ttt -105.03 140.05 38.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 0.0 109.946 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 48' ' ' GLY . 67.0 mt -119.77 143.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 0.0 109.055 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.64 -30.96 9.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.281 -1.928 . . . . 0.0 108.281 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -72.46 -96.19 0.08 OUTLIER Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -123.03 156.59 62.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.961 . . . . 0.0 109.376 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.03 138.4 43.84 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.651 2.234 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CD2' HD12 ' A' ' 46' ' ' ILE . 98.8 m-85 -141.86 162.9 34.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 p -118.87 155.74 30.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 6' ' ' CYS . 35.8 tp -118.73 118.27 31.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -0.751 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.73 124.67 7.73 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.637 HD13 ' N ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -107.86 121.69 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -1.113 . . . . 0.0 108.481 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.637 ' N ' HD13 ' A' ' 55' ' ' LEU . 99.1 m-85 -121.29 149.38 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.281 -0.887 . . . . 0.0 109.691 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' NZ ' ' A' ' 16' ' ' LYS . 21.7 t70 -153.51 157.91 40.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 p -75.74 152.26 37.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 0.0 109.362 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 0.0 109.36 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.5 m -114.37 131.6 56.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.524 -0.735 . . . . 0.0 109.403 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.25 -39.04 88.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.05 131.51 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.19 -0.944 . . . . 0.0 109.957 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -102.95 125.37 49.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 108.385 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 mt -108.27 141.47 40.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.179 -0.951 . . . . 0.0 110.543 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.908 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 51.6 t -124.94 135.08 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.524 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -127.86 126.46 41.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -136.55 166.03 24.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 0.0 109.434 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 m -104.24 148.54 26.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.583 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.719 ' O ' HG22 ' A' ' 84' ' ' VAL . 7.8 p -105.96 13.98 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.146 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.468 HG12 HD12 ' A' ' 119' ' ' LEU . 29.9 m -105.54 -6.81 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -127.81 102.96 21.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 109.85 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' A' ' 137' ' ' ILE . 50.1 Cg_exo -50.68 -41.82 52.56 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.036 1.824 . . . . 0.0 111.916 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -56.55 -37.4 70.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.163 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 m -69.6 -26.21 64.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.244 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.47 -50.9 41.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.55 -35.0 75.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.586 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 41.6 t-20 -56.52 -34.39 66.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 89' ' ' SER . 67.1 t -62.22 -36.84 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.088 -1.008 . . . . 0.0 109.972 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.93 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -80.27 -27.46 38.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 111.34 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -112.23 -44.76 3.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.054 -1.029 . . . . 0.0 112.479 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -85.76 1.95 47.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.903 -1.123 . . . . 0.0 113.072 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.648 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -109.16 -40.63 0.12 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.471 -1.393 . . . . 0.0 110.666 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.648 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 62.3 Cg_endo -92.36 -56.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.275 2.65 . . . . 0.0 113.253 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.6 -35.28 75.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.892 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.69 -28.85 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.71 -1.244 . . . . 0.0 110.121 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 m -59.24 -42.18 90.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 0.0 109.675 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.08 -32.55 69.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 0.0 109.691 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -63.21 -41.87 99.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 173.08 170.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 109.248 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' CYS . 51.9 Cg_exo -49.01 -164.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.503 2.136 . . . . 0.0 112.348 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' NZ ' HD13 ' A' ' 149' ' ' LEU . 64.0 mttm -80.98 138.28 36.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 168.77 16.06 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -40.37 98.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.574 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.908 ' CZ ' HG21 ' A' ' 80' ' ' VAL . 63.8 t80 -109.38 128.89 55.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.563 -0.711 . . . . 0.0 109.957 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 153' ' ' LYS . 15.3 tp -120.16 124.07 44.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 112' ' ' LEU . 39.0 tp -103.67 120.37 40.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.186 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.429 HG13 HG23 ' A' ' 155' ' ' VAL . 38.8 t -108.95 134.42 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.92 113.0 3.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 116' ' ' GLN . 13.9 m -103.11 148.79 25.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -1.13 . . . . 0.0 110.284 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' A' ' 115' ' ' THR . 92.1 mt-30 62.83 38.5 11.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 122.052 -0.405 . . . . 0.0 111.491 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 116' ' ' GLN . 21.0 pt -57.99 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 121' ' ' ASP . 88.6 m-20 52.3 18.51 0.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.364 -1.46 . . . . 0.0 109.146 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.3 tp 30.81 52.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.817 -0.552 . . . . 0.0 111.509 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 121' ' ' ASP . 97.8 mtt180 54.24 22.39 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.501 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 118' ' ' ASP . 60.9 t0 33.22 61.38 0.42 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.718 -0.614 . . . . 0.0 110.257 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 120' ' ' ARG . 81.0 m-20 -132.34 85.56 48.51 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.34 -28.33 26.6 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.5 2.133 . . . . 0.0 112.118 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -81.76 -4.34 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.066 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 98.8 m -92.83 -47.93 6.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.201 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -76.97 -48.49 25.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 110.253 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -60.8 -39.95 90.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 111.098 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -83.01 -6.61 59.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.544 -1.347 . . . . 0.0 110.39 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 129' ' ' LEU . 91.2 mt -115.45 -49.98 2.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 135' ' ' LYS . . . -55.08 -46.55 75.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 109.02 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -48.5 -24.72 1.38 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -76.27 -55.3 5.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 134' ' ' GLN . 36.1 ttpt -173.99 76.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 0.0 110.169 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 133' ' ' LYS . 3.7 mp0 33.27 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.65 -0.657 . . . . 0.0 110.673 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.2 tptm -90.35 -38.82 0.41 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 110.973 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 71.8 Cg_endo -89.09 127.5 1.78 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.845 2.363 . . . . 0.0 113.308 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 4.2 mp -96.9 135.55 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 109.357 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.9 155.68 72.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.468 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.33 -32.71 96.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.373 2.049 . . . . 0.0 111.622 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.11 -36.94 73.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.221 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 m -67.79 -29.78 69.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.283 -0.885 . . . . 0.0 108.692 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.03 62.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 0.0 110.213 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.97 -35.65 75.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.951 -1.093 . . . . 0.0 110.708 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 94.8 mttt -63.85 -36.84 85.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.855 -1.153 . . . . 0.0 109.318 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.5 tp -53.24 -43.2 67.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.753 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -70.32 -45.39 66.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.01 1.09 21.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.878 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 87.9 m-20 -66.76 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.237 . . . . 0.0 109.742 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.404 HD13 ' NZ ' ' A' ' 107' ' ' LYS . 77.3 mt -121.52 -81.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.783 . . . . 0.0 109.722 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -162.76 54.16 0.2 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.753 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -68.23 137.4 54.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.855 -1.153 . . . . 0.0 109.106 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.595 HG12 ' HG3' ' A' ' 153' ' ' LYS . 81.4 t -66.78 -54.24 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.481 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.595 ' HG3' HG12 ' A' ' 152' ' ' VAL . 58.4 mttm -156.52 159.84 38.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -128.91 146.14 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.57 HG11 ' OE1' ' A' ' 171' ' ' GLU . 34.8 m -140.16 152.1 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 110.436 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 129.99 54.81 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -134.13 143.78 48.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.968 -1.083 . . . . 0.0 110.817 -178.603 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 161' ' ' THR . 9.5 t -115.18 110.25 19.2 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.379 0.609 . . . . 0.0 109.391 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.3 mt -55.03 -27.97 48.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.259 -0.9 . . . . 0.0 108.707 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.3 p -125.99 171.04 11.11 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -74.02 11.65 0.86 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.674 -0.641 . . . . 0.0 109.708 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -89.34 1.18 56.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.472 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -93.83 -51.15 2.17 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.38 -39.47 71.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -1.152 . . . . 0.0 110.259 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.16 -33.02 70.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.198 -0.939 . . . . 0.0 111.329 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.42 -50.32 46.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.811 -1.181 . . . . 0.0 109.354 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.22 1.63 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.496 -0.753 . . . . 0.0 110.449 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.6 -50.83 16.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.855 -1.153 . . . . 0.0 109.768 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.55 -43.88 83.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 110.014 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.57 ' OE1' HG11 ' A' ' 155' ' ' VAL . 97.1 mt-10 -66.31 -33.08 74.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 109.88 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.42 80.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.977 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 71.7 mt -73.12 -42.33 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.994 . . . . 0.0 109.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.1 tp -59.32 -46.31 88.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.69 78.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.98 66.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.459 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.61 -39.83 89.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.193 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.818 . . . . 99.989999999999995 109.514 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -138.71 161.68 36.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.888 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.2 120.23 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -93.12 130.74 38.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 t -135.0 129.65 34.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.1 t -117.89 142.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.857 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.13 133.69 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 ' CH2' ' A' ' 97' ' ' TRP . 46.7 t -140.35 134.0 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.129 -0.982 . . . . 0.0 109.491 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.55 99.83 0.15 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.36 -40.49 90.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.061 -1.258 . . . . 0.0 109.04 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -84.59 120.05 5.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 172.08 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.52 -41.72 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.11 0.79 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -61.13 -40.08 92.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -1.127 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -65.13 -41.81 94.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -30.32 65.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.12 -41.75 97.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.113 -0.992 . . . . 0.0 108.608 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.13 -39.73 82.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.225 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.5 mm -63.66 -48.17 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -58.83 -36.29 74.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 110.346 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -80.15 -50.87 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.5 m -60.39 -41.24 93.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.736 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 30.2 p -112.16 -111.42 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 109.186 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.555 ' N ' ' OG1' ' A' ' 25' ' ' THR . 37.1 p-10 -173.69 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -102.25 106.88 17.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -67.73 -42.77 36.52 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.264 -0.898 . . . . 0.0 108.876 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 31.4 Cg_exo -59.77 -26.66 82.88 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.655 2.237 . . . . 0.0 112.078 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.8 m 42.56 41.86 2.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 0.0 109.683 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 96.3 mt-10 -37.56 -35.7 0.14 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.432 -0.792 . . . . 0.0 110.456 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -117.31 122.76 44.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 33' ' ' VAL . 34.4 m -128.29 75.61 78.85 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PRO . . . . . 0.727 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 92.7 Cg_endo -84.28 -102.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.043 2.496 . . . . 0.0 112.329 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 34' ' ' PRO . . . 158.21 41.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.2 -41.66 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.935 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.25 130.41 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 39' ' ' ASN . 50.9 t0 -93.52 -144.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.572 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 63.5 t-20 -42.71 124.94 3.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.454 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 58.0 t80 -132.08 150.3 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.454 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -103.12 141.92 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.78 133.81 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.0 m -106.19 134.53 49.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.46 135.74 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.708 . . . . 0.0 109.353 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.8 mtm -105.67 141.26 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 109.324 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 48' ' ' GLY . 81.0 mt -122.99 141.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.365 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.1 -24.97 0.61 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -80.82 -92.37 0.48 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.6 mm-40 -126.45 154.32 75.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.405 -1.056 . . . . 0.0 109.717 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.71 138.26 37.56 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.729 2.286 . . . . 0.0 112.599 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.606 ' CD2' HD12 ' A' ' 46' ' ' ILE . 97.3 m-85 -131.76 154.19 49.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.9 p -118.0 148.19 42.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.828 . . . . 0.0 109.463 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.82 122.44 37.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 0.0 109.58 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.34 126.53 8.85 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.503 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 66.5 mt -105.1 137.22 43.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -1.175 . . . . 0.0 109.367 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.487 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.7 m-85 -122.25 149.82 43.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 109.022 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 56' ' ' PHE . 84.0 m-20 -136.82 161.53 35.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 162.73 21.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.171 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.372 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.3 m -117.57 128.41 54.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 0.0 109.654 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -66.17 -33.92 76.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.957 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.09 132.67 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.354 -0.841 . . . . 0.0 109.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -111.63 126.26 54.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.024 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.2 140.35 44.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.922 . . . . 0.0 109.949 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.4 136.03 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 0.0 109.165 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.2 t -129.83 121.72 27.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 115' ' ' THR . 44.1 p90 -145.97 163.23 35.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 109.303 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -89.58 137.57 32.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -93.66 -12.64 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 119' ' ' LEU . 72.4 t -90.43 -13.82 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.035 -1.04 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 m -100.6 128.59 29.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.684 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.475 ' CG ' ' OE1' ' A' ' 134' ' ' GLN . 45.7 Cg_endo -73.55 -46.36 0.35 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.988 1.792 . . . . 0.0 112.298 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -55.31 -41.78 72.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.848 -1.158 . . . . 0.0 108.933 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 93' ' ' VAL . 84.2 p -68.29 -23.09 64.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.018 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.639 ' CE1' HG21 ' A' ' 137' ' ' ILE . 57.0 t80 -72.08 -50.82 25.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 0.0 109.319 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -67.91 -37.0 81.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.47 -34.38 57.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.684 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 89' ' ' SER . 74.4 t -61.41 -38.25 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 110.457 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -93.79 -32.79 13.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.91 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -68.49 -36.58 79.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.883 -1.135 . . . . 0.0 112.416 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -113.62 -52.0 2.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.886 -1.134 . . . . 0.0 112.619 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.444 ' CH2' HG11 ' A' ' 9' ' ' VAL . 72.7 m95 -67.54 -30.71 70.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.963 . . . . 0.0 113.026 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 101' ' ' ILE . 1.9 t -72.57 -51.06 7.43 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.141 -1.599 . . . . 0.0 111.439 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.68 -47.75 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.953 1.769 . . . . 0.0 113.23 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -58.08 -40.07 80.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 111.016 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 98' ' ' VAL . 1.9 tp -64.18 -24.55 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.223 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -57.76 -39.61 77.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 110.479 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -53.56 -32.5 51.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.685 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -84.45 7.1 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.054 . . . . 0.0 110.483 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.7 m 55.35 69.78 1.84 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.284 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.49 128.0 26.26 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.604 2.202 . . . . 0.0 112.472 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -151.73 -39.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -62.72 156.14 66.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.502 -0.749 . . . . 0.0 109.166 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.25 135.68 71.78 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.691 2.261 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 108' ' ' THR . 98.1 m-85 -116.58 137.76 51.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.0 109.356 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 111' ' ' LEU . 38.3 tp -117.53 124.76 49.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.451 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.51 120.43 40.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 108.853 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.92 137.54 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.848 . . . . 0.0 110.357 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.0 129.25 9.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 82' ' ' PHE . 9.9 t -118.14 156.92 27.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.136 -1.214 . . . . 0.0 111.18 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 61.36 38.42 16.24 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 pt -72.3 -3.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.096 . . . . 0.0 109.764 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 86.1 m-20 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 109.378 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.597 ' HB3' HG21 ' A' ' 85' ' ' VAL . 43.7 tp -57.98 -32.81 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.26 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -59.88 -25.16 64.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.241 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 59.6 t0 -83.91 8.21 15.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.785 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -117.95 85.32 22.96 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.45 -0.781 . . . . 0.0 109.222 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.74 -23.81 16.54 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.2 p -58.52 -30.01 66.74 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.852 -1.155 . . . . 0.0 109.852 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.479 HG21 HD21 ' A' ' 119' ' ' LEU . 73.2 m -80.44 -52.81 7.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 110.009 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.46 HG23 ' H ' ' A' ' 126' ' ' ILE . 2.6 pt -56.51 -20.67 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.167 -0.958 . . . . 0.0 109.31 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.34 -50.38 70.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -56.49 -31.29 63.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.734 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.04 -36.04 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 109.074 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.01 -38.82 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.864 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -59.68 -36.29 76.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.051 . . . . 0.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.13 8.14 16.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.394 -0.816 . . . . 0.0 109.614 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.95 34.96 24.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 109.35 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.475 ' OE1' ' CG ' ' A' ' 87' ' ' PRO . 7.5 tt0 -127.4 121.12 30.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.386 -0.821 . . . . 0.0 108.811 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -92.79 156.49 40.76 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.41 -0.806 . . . . 0.0 110.058 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.17 160.35 42.44 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.118 2.545 . . . . 0.0 112.057 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' A' ' 90' ' ' PHE . 26.8 mm -97.46 126.04 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.36 155.69 79.03 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.39 -34.48 98.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.433 2.089 . . . . 0.0 111.619 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.44 -37.22 77.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 108.871 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -67.4 -32.82 73.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -0.814 . . . . 0.0 109.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.96 -39.71 61.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.72 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.41 -32.31 70.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.107 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 69.4 tttt -61.86 -38.82 89.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.956 -1.09 . . . . 0.0 109.651 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 90' ' ' PHE . 60.1 mt -63.41 -34.64 78.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 110.136 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.01 88.72 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.993 -1.067 . . . . 0.0 108.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -86.06 8.44 20.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 90.3 m-20 -84.22 -24.6 29.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 108.847 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.8 mt -121.07 -104.0 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.628 -0.67 . . . . 0.0 109.275 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -145.71 43.72 1.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.06 141.76 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.715 HG12 ' HG3' ' A' ' 153' ' ' LYS . 59.8 t -75.23 -65.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.715 ' HG3' HG12 ' A' ' 152' ' ' VAL . 67.6 mttt -145.67 160.37 41.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -131.28 150.5 52.12 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.55 154.09 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.037 -1.039 . . . . 0.0 110.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -109.66 133.94 52.54 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.53 140.21 48.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 111.025 -178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . 39.9 t -106.89 105.58 15.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.44 -0.787 . . . . 0.0 109.036 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.82 70.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.601 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.7 tp -50.91 -31.01 16.26 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 163' ' ' LYS . 18.7 p -123.84 162.45 23.23 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.09 12.32 0.12 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.553 -0.717 . . . . 0.0 109.344 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 161' ' ' THR . 67.7 mttm -88.11 2.28 52.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.684 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.72 -51.52 2.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.48 -40.64 73.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -1.226 . . . . 0.0 109.936 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.23 -29.94 70.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.407 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -71.72 -50.95 25.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.1 m -80.35 -4.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -0.763 . . . . 0.0 110.566 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.81 -50.17 21.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.181 . . . . 0.0 110.052 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.92 -42.39 99.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.246 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.36 -34.68 78.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.023 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.9 74.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 110.568 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.6 -41.48 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.899 -1.126 . . . . 0.0 110.392 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.77 -41.72 82.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.987 . . . . 0.0 110.223 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.15 77.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.961 -1.087 . . . . 0.0 110.128 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.22 89.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 110.094 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.5 mt -65.23 -37.63 87.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.997 -1.064 . . . . 0.0 109.387 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.461 -179.85 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.277 0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 157.48 46.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.8 mt -118.8 120.8 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -81.62 128.35 33.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.307 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 t -132.89 115.57 15.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -109.72 132.22 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.58 HG11 HD21 ' A' ' 20' ' ' LEU . 7.9 p -128.05 142.97 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.404 -0.81 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.99 145.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 108.983 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 171.94 22.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 12' ' ' GLY . 59.1 t0 -74.04 134.03 42.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -1.116 . . . . 0.0 109.128 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . -27.77 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.499 2.855 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . -41.4 -37.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.023 -1.281 . . . . 0.0 110.567 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 11' ' ' ASP . 58.1 t -69.3 123.97 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.671 -1.268 . . . . 0.0 109.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 73.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.1 pttp -61.26 -33.62 73.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.528 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.4 p -70.38 -42.0 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.1 m -60.39 -25.99 66.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 0.0 110.009 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 19' ' ' LEU . 44.4 tp -66.72 -39.77 88.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.387 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.58 HD21 HG11 ' A' ' 8' ' ' VAL . 70.1 mt -64.94 -42.23 94.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.269 -0.894 . . . . 0.0 109.538 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mm -70.14 -49.02 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.713 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.2 m -57.26 -36.66 71.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 109.5 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.74 -44.49 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.1 m -65.79 -47.6 74.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 110.108 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.8 p -84.48 -19.5 33.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.711 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.82 36.76 22.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -141.23 82.54 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -55.28 -44.25 99.53 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -56.48 -15.83 16.65 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.28 1.987 . . . . 0.0 111.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' TYR . 95.6 p -59.86 -34.18 72.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 108.995 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.3 mt-10 37.68 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.648 -0.657 . . . . 0.0 110.321 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.2 m-85 -83.76 -95.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.019 -1.051 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 33' ' ' VAL . 6.4 p 36.52 57.76 3.41 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.445 -0.784 . . . . 0.0 110.964 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.77 -18.46 32.23 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.815 2.344 . . . . 0.0 112.08 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.47 -172.68 2.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.28 140.66 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.846 . . . . 0.0 109.199 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.16 -90.06 0.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.7 p30 -138.15 -173.39 3.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.904 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -67.33 149.23 50.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.831 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -118.13 146.71 43.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.732 . . . . 0.0 109.204 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 137.25 45.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.148 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.4 138.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.861 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -93.3 133.94 36.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.284 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.1 t -120.36 135.06 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.731 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -93.57 130.59 39.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.316 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 68.5 mt -132.8 126.82 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.151 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.54 17.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.15 13.87 58.26 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 11.3 mt-10 -119.61 85.86 33.55 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.414 -1.051 . . . . 0.0 109.282 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -53.7 125.66 19.34 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.681 2.254 . . . . 0.0 113.195 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 91.3 m-85 -121.61 143.22 49.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.688 . . . . 0.0 109.232 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.5 m -76.03 131.25 39.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.32 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -128.1 129.6 46.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.79 143.45 14.64 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.17 132.24 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.407 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -118.09 131.28 56.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.809 . . . . 0.0 109.774 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.8 p30 -136.19 172.38 13.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.773 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.2 m -71.5 138.25 48.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.59 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.596 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 5.1 p -126.03 153.95 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 75' ' ' THR . 90.5 m-20 -138.21 -41.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.718 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.02 132.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 110.0 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -108.43 126.95 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 109.142 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 tp -118.53 126.37 51.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 109.546 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.86 138.68 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 133.84 48.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.515 ' CG ' HG21 ' A' ' 93' ' ' VAL . 31.6 p90 -138.45 158.47 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 109.379 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -77.24 138.74 39.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 109.377 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.49 -18.07 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.143 -0.973 . . . . 0.0 110.364 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 85' ' ' VAL . 61.1 t -85.8 -8.19 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.09 -1.006 . . . . 0.0 110.374 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -103.09 107.07 54.02 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.976 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.18 -49.08 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.032 1.822 . . . . 0.0 112.005 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 m -58.71 -39.56 81.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 108.95 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.756 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.9 t -62.86 -21.74 66.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.472 -0.768 . . . . 0.0 109.029 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -74.43 -50.05 19.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -66.07 -39.2 89.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -57.01 -32.91 66.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.214 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 89' ' ' SER . 71.8 t -60.91 -37.39 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -94.31 -11.06 30.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.012 -1.055 . . . . 0.0 110.229 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -73.74 -33.61 64.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.646 -1.283 . . . . 0.0 111.493 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.47 -41.9 3.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.136 -0.977 . . . . 0.0 112.25 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -82.12 0.84 38.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.094 -1.004 . . . . 0.0 112.836 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.592 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -108.22 -42.75 0.12 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.49 -1.381 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.592 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 42.9 Cg_endo -93.71 -59.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.211 2.608 . . . . 0.0 112.468 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.619 ' CG1' ' CE1' ' A' ' 110' ' ' PHE . 8.0 tp -54.08 -26.59 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.594 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 46.5 m -58.85 -37.93 77.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.759 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -53.29 -40.57 64.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.867 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.436 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 65.7 m170 -55.17 -36.17 65.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 109.262 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 0.7 OUTLIER 168.73 154.0 0.14 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.63 -33.0 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.523 2.148 . . . . 0.0 111.92 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -139.83 137.51 35.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.424 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -177.37 139.64 0.43 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 0.0 109.303 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.71 125.37 12.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.191 1.928 . . . . 0.0 112.202 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.619 ' CE1' ' CG1' ' A' ' 101' ' ' ILE . 86.8 m-85 -116.53 138.92 51.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 111' ' ' LEU . 6.6 mp -114.89 121.2 42.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.454 -0.778 . . . . 0.0 110.035 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -110.92 125.18 53.39 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.765 HG11 HG22 ' A' ' 168' ' ' VAL . 36.0 t -117.1 138.59 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.14 -0.975 . . . . 0.0 110.977 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.4 122.1 6.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 t -114.33 167.35 10.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -1.115 . . . . 0.0 110.618 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 58.74 39.37 24.33 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.51 -7.18 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.969 -1.082 . . . . 0.0 109.873 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.476 ' O ' ' OD2' ' A' ' 121' ' ' ASP . 53.8 p30 -83.69 -3.08 57.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.345 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.455 ' HG ' HG21 ' A' ' 125' ' ' THR . 30.2 tp -78.29 -27.27 47.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -84.94 93.3 8.52 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 2.4 p30 169.04 -49.45 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.1 141.44 94.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.546 -0.721 . . . . 0.0 109.234 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.52 -31.1 27.86 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.248 1.966 . . . . 0.0 112.223 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.7 m -54.3 -33.1 58.02 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.29 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.455 HG21 ' HG ' ' A' ' 119' ' ' LEU . 56.7 p -79.49 -51.11 9.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 111.012 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.15 -29.77 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 0.0 110.333 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.32 -50.09 35.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 109.663 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.17 -35.19 76.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.6 mt -74.42 -39.25 62.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 108.891 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.11 -35.92 37.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 109.486 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -59.69 -34.97 73.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 109.143 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -86.54 7.35 26.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.621 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttt 56.88 37.02 28.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -136.83 136.12 38.52 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.11 -0.994 . . . . 0.0 109.118 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -116.89 157.76 45.57 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -53.01 155.84 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.836 2.357 . . . . 0.0 111.909 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.3 mt -98.57 142.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.2 158.49 69.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.366 -0.833 . . . . 0.0 109.65 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.83 -23.05 75.8 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.684 2.256 . . . . 0.0 111.522 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.98 -38.59 89.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 m -63.67 -36.01 82.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.33 -39.4 59.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.32 -34.68 72.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.043 -1.035 . . . . 0.0 111.081 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.94 -36.24 80.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.706 -1.247 . . . . 0.0 109.425 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.06 -36.09 76.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 110.085 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 152' ' ' VAL . . . -81.12 -51.81 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.922 -1.111 . . . . 0.0 110.561 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -65.01 -1.86 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.286 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -110.21 -24.0 10.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 110.007 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.97 16.01 22.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 111.733 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 59.3 mttp 56.89 36.16 27.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.322 -1.486 . . . . 0.0 111.318 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 165.93 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.774 -1.204 . . . . 0.0 109.62 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.713 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 71.8 t 59.35 132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.262 1.029 . . . . 0.0 109.561 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -129.46 149.33 51.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.17 143.65 49.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.03 -1.044 . . . . 0.0 109.85 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 t -138.36 147.01 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -97.33 120.89 38.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -131.04 141.1 50.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.962 . . . . 0.0 110.932 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 161' ' ' THR . 29.5 t -111.62 102.8 11.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -70.18 -28.69 65.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.785 -0.572 . . . . 0.0 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 160' ' ' LEU . 6.3 mp -61.56 -25.92 67.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 163' ' ' LYS . 21.2 m -123.86 160.52 27.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.514 ' OE1' ' CE2' ' A' ' 28' ' ' PHE . 23.5 mm100 -65.41 11.47 0.06 Allowed 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 161' ' ' THR . 97.7 mttt -94.01 5.13 52.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.051 . . . . 0.0 110.053 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.447 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -101.58 -51.14 1.14 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.274 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 165' ' ' LEU . 8.1 mp -63.35 -42.02 98.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.219 -1.165 . . . . 0.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -58.81 -30.37 67.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -85.67 -50.07 7.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.765 HG22 HG11 ' A' ' 113' ' ' VAL . 71.5 t -62.24 -34.8 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.768 . . . . 0.0 110.303 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.858 ' CE2' HD11 ' A' ' 173' ' ' ILE . 68.3 t80 -68.71 -49.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 0.0 110.285 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.54 -43.82 93.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 0.0 110.612 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.03 -45.13 71.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 110.262 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.62 -35.96 61.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.408 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.858 HD11 ' CE2' ' A' ' 169' ' ' PHE . 95.0 mt -68.9 -36.7 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.831 -1.168 . . . . 0.0 110.482 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.8 tp -53.55 -51.33 63.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.972 -1.08 . . . . 0.0 110.259 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.5 71.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.079 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.39 66.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 109.758 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 177' ' ' LEU . 3.6 mm? -63.02 -35.54 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.984 -1.073 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.561 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -63.02 -33.11 74.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -135.6 160.22 39.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -0.801 . . . . 0.0 109.843 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 176' ' ' ALA . 72.8 mt -121.34 119.46 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -95.76 129.46 42.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.952 . . . . 0.0 110.059 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 79' ' ' LEU . 46.1 t -138.32 136.75 36.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 0.0 109.143 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.08 141.11 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.65 131.19 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.85 143.98 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.486 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 168.17 25.65 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' ALA . 24.0 t70 -83.12 108.17 16.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.251 . . . . 0.0 108.983 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 53.94 -87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 53.47 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.178 -1.19 . . . . 0.0 109.364 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 14' ' ' VAL . 3.6 m -66.63 -35.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 0.0 109.988 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.57 21.55 32.04 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 58.9 tttt -62.11 -40.6 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.283 . . . . 0.0 109.814 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.8 m -68.37 -45.65 72.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.562 ' SG ' ' OG ' ' A' ' 30' ' ' SER . 34.4 m -61.01 -29.65 69.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.913 . . . . 0.0 109.851 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -67.06 -42.15 85.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.44 -46.09 50.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.53 -40.32 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -57.92 -31.98 67.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 109.839 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -72.69 -38.02 67.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -65.96 -30.96 71.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.459 -0.775 . . . . 0.0 111.292 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -166.44 -1.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.553 -1.342 . . . . 0.0 111.427 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.613 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.2 t30 92.21 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HZ2' ' HA ' ' A' ' 30' ' ' SER . 10.4 tttm -179.6 58.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.995 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.29 -42.58 86.12 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.787 -1.196 . . . . 0.0 109.836 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.2 Cg_exo -58.11 -33.08 97.01 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.354 2.036 . . . . 0.0 112.364 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' SG ' ' A' ' 18' ' ' CYS . 61.4 p 35.65 37.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.65 . . . . 0.0 109.738 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 30' ' ' SER . 78.5 mm-40 -38.22 -37.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.53 -0.731 . . . . 0.0 110.531 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -128.8 124.18 34.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.034 -1.041 . . . . 0.0 109.204 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.69 147.78 34.21 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.643 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.54 153.21 60.33 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 0.0 112.153 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.5 -104.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 109.051 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.4 m -61.38 142.07 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.858 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.09 125.43 46.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.864 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -108.84 164.39 12.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.308 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -92.35 153.11 19.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.009 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -127.78 139.15 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.601 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.52 132.2 54.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.053 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.28 153.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -122.31 150.15 42.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.064 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.26 139.77 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 110.01 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 65.0 mtt -84.57 131.81 34.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 48' ' ' GLY . 74.6 mt -135.11 125.41 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 109.521 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 41.97 18.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 92.36 15.41 53.45 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.102 -1.234 . . . . 0.0 110.215 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.0 mm-40 -122.81 82.7 49.34 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.318 -1.107 . . . . 0.0 109.255 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.17 126.19 20.24 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.906 2.404 . . . . 0.0 113.23 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 95.9 m-85 -119.17 138.04 53.21 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 p -80.22 143.49 33.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -124.82 124.48 42.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.0 109.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.11 124.31 8.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.13 127.03 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.161 . . . . 0.0 109.194 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -114.44 133.96 55.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -138.79 140.52 38.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.407 ' HA ' HH12 ' A' ' 66' ' ' ARG . 51.1 m -70.85 137.64 49.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.455 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.58 57.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 61' ' ' GLN . . . 77.24 -111.61 3.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 63' ' ' ASP . 90.7 mt-30 44.29 -104.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 0.0 109.688 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 64' ' ' TYR . 82.6 tt0 61.49 -67.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.59 -0.694 . . . . 0.0 109.611 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' GLN . 92.7 m-20 -50.48 -14.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.596 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.43 ' N ' ' C ' ' A' ' 62' ' ' GLU . 49.3 m-85 -84.4 10.4 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 109.522 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.0 t0 49.67 48.44 21.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.663 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 61' ' ' GLN . 41.6 ttm180 -54.58 -34.37 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 109.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 67' ' ' LEU . 31.7 tp 56.79 75.34 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 109.445 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.531 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 4.3 ttt180 -54.43 -47.13 98.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 110.442 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 51.8 Cg_exo -52.05 -29.72 37.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.563 2.175 . . . . 0.0 112.92 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 72' ' ' TYR . 97.6 mt 40.6 31.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 0.0 109.709 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 6.0 t 52.11 4.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.851 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' H ' ' C ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -176.71 82.18 0.26 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 109.371 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.55 135.35 69.85 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.754 2.303 . . . . 0.0 112.22 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -96.51 3.75 52.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.222 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.4 m -79.5 131.86 36.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.458 -0.776 . . . . 0.0 110.156 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -102.87 -10.55 18.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 108.953 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' A' ' 175' ' ' ALA . 47.4 t -135.42 130.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.248 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -111.48 129.04 56.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.236 -0.915 . . . . 0.0 109.776 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 6' ' ' CYS . 62.1 mt -113.16 145.19 41.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.516 -0.74 . . . . 0.0 109.791 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 111' ' ' LEU . 28.3 m -129.76 147.32 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.052 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 22.7 t -138.74 130.52 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.651 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.56 165.76 26.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 m -105.84 145.13 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.113 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.76 8.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.679 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -88.99 -23.46 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.133 -0.979 . . . . 0.0 109.807 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.6 146.37 33.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.58 -50.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.677 2.251 . . . . 0.0 112.259 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -55.05 -35.68 64.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.1 p -66.71 -24.26 66.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.058 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -71.41 -50.91 27.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.817 . . . . 0.0 109.461 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.85 -36.28 81.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -51.53 -34.06 34.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.783 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.9 -36.4 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -91.61 -41.55 10.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.752 -1.217 . . . . 0.0 110.592 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.53 -37.52 87.82 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.086 -1.009 . . . . 0.0 112.037 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -113.17 -51.38 2.82 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.901 -1.124 . . . . 0.0 112.638 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.2 -39.95 82.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.97 -1.081 . . . . 0.0 113.249 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.785 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.1 t -58.27 -52.11 76.93 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.027 -1.67 . . . . 0.0 110.75 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.16 -40.6 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.677 1.585 . . . . 0.0 112.223 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.47 -31.05 67.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.405 -0.809 . . . . 0.0 110.499 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 98' ' ' VAL . 5.5 tp -59.26 -24.07 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.883 -1.136 . . . . 0.0 110.006 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 99' ' ' PRO . 62.5 p -58.42 -38.59 77.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 109.436 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -58.94 -29.99 67.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.4 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -82.94 -7.77 59.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.895 . . . . 0.0 109.811 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.11 84.9 0.19 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.0 109.356 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.56 89.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.65 2.233 . . . . 0.0 112.458 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -133.52 11.32 4.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.316 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.561 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -136.68 157.74 74.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -59.95 141.15 95.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.683 2.255 . . . . 0.0 112.268 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 108' ' ' THR . 97.3 m-85 -121.98 145.83 47.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.742 . . . . 0.0 109.796 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.74 ' O ' HG22 ' A' ' 80' ' ' VAL . 5.2 mp -121.8 131.72 54.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.607 -0.683 . . . . 0.0 109.469 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.804 HD22 ' HB2' ' A' ' 146' ' ' ALA . 26.2 tp -103.79 118.88 37.74 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.545 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 59.7 t -112.44 137.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.728 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.14 128.5 9.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 32.7 p -125.51 161.75 26.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.258 -1.143 . . . . 0.0 110.852 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 115' ' ' THR . 27.4 tt0 83.71 19.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 119' ' ' LEU . 8.2 tt -61.3 -165.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.622 ' N ' HG23 ' A' ' 117' ' ' ILE . 86.1 m-20 60.65 -60.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 110.006 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.2 mp -60.02 -35.05 74.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.787 -1.196 . . . . 0.0 108.995 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 119' ' ' LEU . 83.3 mtm180 31.65 45.99 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.465 ' OD2' HD12 ' A' ' 129' ' ' LEU . 7.3 t0 70.26 75.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.166 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -42.83 160.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.383 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 126' ' ' ILE . 6.7 Cg_endo -52.18 -55.22 4.06 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.699 2.266 . . . . 0.0 111.915 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.0 p -54.76 -28.65 50.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.819 -1.175 . . . . 0.0 109.586 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.431 ' CG2' ' OD1' ' A' ' 121' ' ' ASP . 28.5 m -78.21 -50.74 11.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.994 -1.066 . . . . 0.0 110.578 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 123' ' ' PRO . 13.1 tt -55.46 -27.6 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.033 -1.042 . . . . 0.0 109.631 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.99 -45.62 80.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -60.69 -36.84 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.582 -0.699 . . . . 0.0 109.384 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.465 HD12 ' OD2' ' A' ' 121' ' ' ASP . 71.3 mt -75.15 -37.76 61.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.061 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.66 -39.05 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -60.4 -40.98 92.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.168 -0.957 . . . . 0.0 109.366 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 81.7 m-20 -91.7 3.11 55.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 109.917 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.1 mttp 54.49 40.62 31.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -92.07 -52.73 4.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.15 -0.969 . . . . 0.0 109.743 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 mttt 65.46 139.45 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.9 154.41 74.68 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.536 2.157 . . . . 0.0 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.6 mm -93.56 140.31 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.86 155.43 73.03 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.62 -31.92 95.13 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.47 -37.76 84.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.3 m -66.09 -33.59 76.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.277 -0.89 . . . . 0.0 108.987 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.59 -36.97 57.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -35.01 71.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.622 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.42 -36.25 83.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.931 -1.106 . . . . 0.0 109.79 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 145' ' ' LEU . 46.2 tp -63.25 -39.2 93.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.804 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -67.74 -45.47 74.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 109.556 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.664 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -75.79 9.61 2.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -71.59 -36.4 70.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 51.0 mt -112.43 -87.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.594 -0.691 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -152.59 52.67 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.451 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -64.45 131.36 46.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.312 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.23 -51.74 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.927 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -160.1 155.61 25.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.262 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -121.02 144.42 48.54 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -142.81 154.22 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 110.285 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.8 mt-10 -120.04 142.73 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.545 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.07 149.84 42.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.697 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 161' ' ' THR . 12.8 t -112.01 107.59 16.62 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.36 64.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.5 tp -53.31 -32.07 47.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 158' ' ' SER . 14.3 p -126.09 165.26 19.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -69.85 13.14 0.16 Allowed 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.642 -0.661 . . . . 0.0 109.396 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 161' ' ' THR . 58.5 tttm -85.48 -4.76 59.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.43 -50.43 2.97 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.255 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.966 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.8 mm? -64.46 -39.37 93.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.242 . . . . 0.0 109.972 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -58.51 -32.07 68.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.361 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 53.1 t30 -73.8 -49.64 24.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.786 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.72 -8.34 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.803 . . . . 0.0 111.041 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -72.43 -50.33 27.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.817 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.89 -42.42 99.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 110.086 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -66.29 -36.31 82.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.03 -35.54 71.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.51 -40.29 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.2 tp -52.07 -45.88 64.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.689 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -62.66 -33.64 75.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.982 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 4' ' ' ILE . . . -52.01 -43.58 63.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.667 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.1 mt -62.54 -35.73 80.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.998 . . . . 0.0 109.337 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 99.989999999999995 109.461 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -96.58 138.94 33.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.175 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -132.93 162.47 31.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.532 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 176' ' ' ALA . 31.1 mm -115.49 119.9 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.204 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -96.93 130.59 44.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.948 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.659 ' SG ' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -149.47 137.95 20.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.708 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.97 138.43 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.92 142.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.753 . . . . 0.0 109.481 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG23 HG21 ' A' ' 58' ' ' THR . 12.7 p -139.96 143.39 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.893 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.65 165.36 26.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -85.1 117.82 24.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.296 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.21 -105.44 1.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.32 -67.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.512 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 15' ' ' GLY . 28.4 t 54.43 -119.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.586 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.616 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -95.42 25.88 22.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -56.92 -34.39 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 0.0 109.274 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -66.58 -37.61 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 108.965 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.65 ' SG ' HG11 ' A' ' 33' ' ' VAL . 10.5 m -67.22 -30.82 70.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.432 -0.792 . . . . 0.0 109.869 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.6 tp -69.91 -44.78 68.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.287 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.3 -44.33 46.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.801 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 21' ' ' ILE . 9.9 tp -64.7 -32.49 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 110.066 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.6 p -66.7 -28.94 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 80.5 t80 -76.58 -43.43 38.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 p -75.35 -45.09 41.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 111.287 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.7 p -85.12 -23.09 28.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.843 -1.161 . . . . 0.0 110.243 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 23' ' ' TYR . 57.1 m-20 57.58 35.36 25.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.358 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -138.22 81.51 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.174 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.58 -41.79 90.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.111 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 24.0 Cg_exo -61.99 -10.61 18.23 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.493 2.128 . . . . 0.0 112.036 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 32' ' ' TYR . 14.6 t -47.12 -32.74 4.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 64.65 -31.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.825 . . . . 0.0 110.283 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.644 ' C ' HG23 ' A' ' 33' ' ' VAL . 87.0 m-85 -58.36 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.832 -1.168 . . . . 0.0 108.659 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.65 HG11 ' SG ' ' A' ' 18' ' ' CYS . 2.0 t 73.74 60.05 0.32 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.513 -0.742 . . . . 0.0 110.415 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.47 130.66 34.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.024 1.816 . . . . 0.0 111.079 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.34 56.08 2.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.06 -1.025 . . . . 0.0 110.143 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.571 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 42.1 t -119.48 134.65 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.679 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 36' ' ' VAL . 91.1 m-85 -160.56 -102.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 88.7 m-20 54.02 56.62 6.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.089 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 17.1 t-20 89.86 73.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.318 0.58 . . . . 0.0 109.709 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HE2' HG22 ' A' ' 42' ' ' VAL . 57.2 t80 -111.9 145.35 39.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.1 145.29 48.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG22 ' HE2' ' A' ' 40' ' ' TYR . 44.0 t -126.02 129.63 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.9 m -92.8 124.26 36.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.064 -1.022 . . . . 0.0 108.733 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.22 159.34 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 110.794 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 68.0 mtm -113.15 136.95 52.16 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.76 127.08 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 108.987 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 15.68 67.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.62 16.17 62.36 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -124.26 154.06 68.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.338 -1.096 . . . . 0.0 109.175 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.52 135.33 28.38 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.749 2.3 . . . . 0.0 113.258 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -145.32 154.9 42.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.129 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -125.54 139.23 53.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.384 -0.823 . . . . 0.0 109.869 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.37 125.25 48.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.094 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' C ' HD22 ' A' ' 55' ' ' LEU . . . -111.07 118.28 4.83 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.924 HD22 ' N ' ' A' ' 55' ' ' LEU . 1.6 mm? -102.77 129.39 49.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.221 -1.164 . . . . 0.0 108.999 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.88 126.08 53.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.771 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -103.36 164.93 11.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.469 -0.769 . . . . 0.0 109.382 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 9' ' ' VAL . 40.3 p -79.67 161.87 25.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' O ' ' OE1' ' A' ' 62' ' ' GLU . . . -166.99 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.52 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.493 ' O ' ' OD1' ' A' ' 65' ' ' ASP . . . -85.03 -1.31 88.78 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.456 ' HG2' HH22 ' A' ' 68' ' ' ARG . 89.0 mt-30 -59.8 -27.65 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.201 . . . . 0.0 110.146 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 64' ' ' TYR . 51.8 mp0 -76.18 -161.88 0.2 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.589 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 52.6 p30 -62.98 11.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.545 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.583 ' O ' ' N ' ' A' ' 66' ' ' ARG . 80.6 m-85 -102.83 18.47 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 0.0 109.124 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 60' ' ' GLY . 93.7 m-20 -43.86 -14.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 0.0 109.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -44.84 -30.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.977 -1.077 . . . . 0.0 109.338 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 tp -59.71 -34.54 73.04 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 109.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 10.7 mpt_? -46.61 -66.13 0.57 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.128 -0.983 . . . . 0.0 110.817 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 11.0 Cg_endo -57.12 -32.39 93.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.142 1.894 . . . . 0.0 112.154 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 71' ' ' SER . 41.4 tp -61.26 -36.42 79.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.458 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LEU . 5.5 p 35.55 75.56 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.644 -0.66 . . . . 0.0 110.24 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.691 ' H ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -110.71 -43.34 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 110.229 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 72' ' ' TYR . 34.7 Cg_exo -59.26 137.76 80.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.848 2.366 . . . . 0.0 112.679 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -131.27 135.6 47.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 109.426 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -140.5 153.08 46.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.699 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -104.96 -5.64 20.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.0 133.75 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.795 . . . . 0.0 109.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -109.12 121.64 45.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 108.619 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.659 HD12 ' SG ' ' A' ' 6' ' ' CYS . 53.6 mt -116.35 140.05 49.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.81 152.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 134.23 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -138.99 164.01 30.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.43 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.1 p -98.13 151.4 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 109.32 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 84' ' ' VAL . 12.9 p -102.27 6.71 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -100.52 -1.08 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 0.0 110.129 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -118.86 95.82 49.55 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 109.745 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.76 -52.88 8.01 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -40.2 65.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.099 -1.001 . . . . 0.0 109.508 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 93' ' ' VAL . 54.9 p -60.34 -14.15 16.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 108.851 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -74.13 -50.66 18.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.72 -39.08 90.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.3 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -54.15 -32.14 54.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 89' ' ' SER . 73.8 t -59.26 -37.58 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 110.274 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -86.59 -27.76 23.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.742 -1.224 . . . . 0.0 110.386 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.72 -36.45 67.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.116 -0.99 . . . . 0.0 112.273 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -111.89 -50.62 2.9 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.884 -1.135 . . . . 0.0 112.509 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.487 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 33.8 m0 -68.13 -34.32 76.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.967 -1.083 . . . . 0.0 112.583 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.43 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -68.22 -51.72 24.74 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 119.964 -1.71 . . . . 0.0 111.113 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 72.9 Cg_endo -76.69 -44.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.947 1.764 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.24 -41.94 89.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 111.045 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 105' ' ' CYS . 94.2 mt -68.34 -43.35 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 110.174 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.8 m -60.28 -42.97 96.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.847 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -60.5 -44.85 95.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.937 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -92.82 -10.69 35.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.432 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -149.65 86.96 5.27 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.941 -1.099 . . . . 0.0 109.878 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.79 -48.84 19.59 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.415 2.076 . . . . 0.0 112.072 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 108' ' ' THR . 29.0 mttt -147.69 110.34 4.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.506 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 3.5 p -154.11 150.16 22.0 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.326 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -47.72 118.25 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.03 1.82 . . . . 0.0 111.625 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 108' ' ' THR . 64.0 m-85 -112.9 128.9 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.741 HD21 ' OE1' ' A' ' 171' ' ' GLU . 32.5 tp -115.78 120.28 38.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 117.56 34.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 108.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.536 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 48.0 t -112.09 135.9 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.419 -0.801 . . . . 0.0 110.587 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.7 125.31 8.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.3 t -129.97 166.63 19.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.227 -1.161 . . . . 0.0 110.638 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 115' ' ' THR . 22.9 tp60 85.66 15.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.762 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 119' ' ' LEU . 25.4 pt -63.15 -158.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.869 -1.144 . . . . 0.0 108.648 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.497 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 80.4 m-20 56.97 -57.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.637 -0.664 . . . . 0.0 110.273 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.699 ' N ' ' O ' ' A' ' 117' ' ' ILE . 29.4 tp -50.74 -30.52 14.17 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.845 -1.159 . . . . 0.0 108.109 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.466 HH12 ' HD2' ' A' ' 139' ' ' PRO . 40.5 ttp180 -57.89 -15.56 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 47.2 p30 -101.19 1.85 39.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.55 150.57 76.47 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.9 -53.46 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.454 2.103 . . . . 0.0 111.98 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -59.17 -32.64 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 110.637 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.1 m -69.71 -51.39 34.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.886 -1.134 . . . . 0.0 109.908 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt -65.16 -35.1 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.918 . . . . 0.0 109.456 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -73.27 -44.57 59.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.362 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.87 -41.32 91.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 129' ' ' LEU . 88.1 mt -74.16 -34.07 63.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 108.713 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.57 -47.73 69.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.056 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -62.6 -35.83 80.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.204 -0.935 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -52.61 -57.09 11.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.857 -1.152 . . . . 0.0 109.562 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 134' ' ' GLN . 14.3 pttp -171.23 -50.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 133' ' ' LYS . 50.8 mt-30 -143.86 -119.79 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.852 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.88 163.22 52.51 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 110.175 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.33 174.26 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.175 2.583 . . . . 0.0 112.099 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.32 140.04 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.37 158.29 69.29 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 109.381 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.466 ' HD2' HH12 ' A' ' 120' ' ' ARG . 16.4 Cg_endo -60.99 -31.55 91.48 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.58 2.187 . . . . 0.0 111.936 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.4 m -69.37 -33.05 72.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.217 -0.927 . . . . 0.0 109.221 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.31 -39.6 59.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.447 -0.783 . . . . 0.0 109.921 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.51 -31.85 69.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -60.93 -37.53 82.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.012 . . . . 0.0 109.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.703 ' N ' HD12 ' A' ' 145' ' ' LEU . 7.7 mp -65.39 -31.06 71.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.402 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.13 69.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.908 -1.12 . . . . 0.0 110.242 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -82.09 9.49 8.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.399 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -113.45 -36.09 5.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.029 . . . . 0.0 109.246 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.02 17.09 9.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.538 -0.726 . . . . 0.0 110.572 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 65.48 30.23 10.87 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.216 -0.928 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.31 143.08 56.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 108.944 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 110' ' ' PHE . 73.0 t -66.0 -58.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.013 -1.054 . . . . 0.0 110.089 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -152.49 150.47 29.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.028 -1.045 . . . . 0.0 110.709 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -116.8 138.7 51.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.48 -0.763 . . . . 0.0 109.432 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.421 HG11 ' OE2' ' A' ' 171' ' ' GLU . 6.2 m -141.43 153.78 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 139' ' ' PRO . 93.2 mt-10 -110.11 132.62 54.0 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.536 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -136.64 146.28 45.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 0.0 110.633 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 161' ' ' THR . 18.0 t -115.78 108.93 16.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.343 0.592 . . . . 0.0 109.45 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 160' ' ' LEU . 6.7 mp -59.61 -27.86 66.68 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.8 p -125.11 165.94 17.32 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.11 12.64 0.28 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.798 -0.563 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 161' ' ' THR . 34.9 mtmt -89.68 3.4 52.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.989 . . . . 0.0 109.923 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.97 -49.15 1.96 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.745 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.5 mp -61.86 -38.48 88.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -1.138 . . . . 0.0 110.125 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -58.53 -32.59 69.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 110.303 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -86.64 -44.61 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.046 -1.034 . . . . 0.0 109.381 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.88 -26.9 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 110.498 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CE2' HG13 ' A' ' 173' ' ' ILE . 71.9 t80 -67.47 -46.81 71.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -54.52 -43.8 72.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.896 -1.127 . . . . 0.0 109.672 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.741 ' OE1' HD21 ' A' ' 111' ' ' LEU . 96.7 mt-10 -70.61 -38.06 73.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.01 -43.69 91.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.256 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.403 HG13 ' CE2' ' A' ' 169' ' ' PHE . 29.9 mm -69.67 -42.81 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.932 -1.105 . . . . 0.0 109.671 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.6 tp -56.16 -45.64 79.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.06 84.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.446 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -56.66 -42.66 79.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.4 mt -64.27 -38.48 91.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.516 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.17 -30.87 71.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.034 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.0 m -104.37 145.27 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.6 -0.687 . . . . 0.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.8 mt -115.07 119.94 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.732 . . . . 0.0 109.026 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.35 130.78 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 0.0 110.01 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 128.18 19.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.391 -0.818 . . . . 0.0 109.12 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.41 138.27 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG13 HD23 ' A' ' 79' ' ' LEU . 32.2 t -116.1 132.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 0.0 108.886 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.627 HG23 ' OG1' ' A' ' 58' ' ' THR . 14.6 p -152.09 145.87 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.077 -1.014 . . . . 0.0 109.514 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.28 157.41 22.88 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 12' ' ' GLY . 60.3 t0 -86.01 105.76 16.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.61 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.12 69.73 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -87.98 133.58 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -1.235 . . . . 0.0 109.289 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.37 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.333 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 49.89 0.81 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 73.6 tttt -61.28 -38.24 86.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.962 -1.316 . . . . 0.0 109.78 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.6 p -70.64 -37.02 73.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.69 -28.5 69.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.81 -37.3 79.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.947 . . . . 0.0 110.128 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.37 -40.6 96.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 111.15 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 pt -70.7 -32.14 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.74 -1.225 . . . . 0.0 110.07 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 m -57.01 -38.68 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.986 -1.071 . . . . 0.0 109.983 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -78.74 -48.48 14.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.122 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 p -64.59 -34.33 78.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.881 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 63.7 p -112.26 -109.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 25' ' ' THR . 1.3 p30 164.64 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -126.45 122.35 35.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.259 -0.901 . . . . 0.0 110.404 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.672 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -96.52 -39.69 0.27 Allowed Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 12.9 Cg_exo -66.89 -10.54 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.616 2.211 . . . . 0.0 111.13 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' TYR . 38.7 m -47.9 -36.72 12.75 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.209 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.6 mt-10 40.38 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.972 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 30' ' ' SER . 70.1 t80 -141.22 118.77 11.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.946 -1.096 . . . . 0.0 108.419 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.59 153.03 37.98 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.81 156.11 64.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 112.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 67.92 10.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.55 136.25 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -117.26 -1.93 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.815 . . . . 0.0 109.645 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.1 p30 -77.56 166.24 23.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.005 . . . . 0.0 110.113 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 37.5 p-10 -92.91 150.78 20.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.792 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 74.0 t80 -134.53 147.98 50.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -102.61 138.25 39.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 0.0 109.842 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.83 138.2 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.712 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.3 m -106.03 134.49 49.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.838 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.89 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 109.958 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.8 mtp -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.745 HG22 ' H ' ' A' ' 48' ' ' GLY . 68.9 mt -129.11 135.77 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.87 . . . . 0.0 108.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.68 -15.11 11.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.745 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -95.16 -8.73 58.69 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.322 -1.105 . . . . 0.0 110.593 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' GLY . 2.0 mm-40 155.43 131.23 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.507 -0.996 . . . . 0.0 109.367 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.87 137.01 26.2 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.003 1.802 . . . . 0.0 111.857 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 97.8 m-85 -134.57 155.49 50.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.136 -0.978 . . . . 0.0 109.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 m -119.0 141.1 48.97 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.91 126.34 44.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.65 128.51 9.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.2 mt -107.32 122.49 46.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -1.207 . . . . 0.0 109.2 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -111.49 135.13 52.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.41 -0.806 . . . . 0.0 109.197 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 58' ' ' THR . 57.4 t0 -94.0 151.68 19.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.188 -0.945 . . . . 0.0 109.07 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.627 ' OG1' HG23 ' A' ' 9' ' ' VAL . 65.5 m -59.1 130.39 46.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.033 -1.042 . . . . 0.0 108.978 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.08 150.33 29.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.96 -6.7 66.98 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 51.0 tp60 -58.39 -22.67 54.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 0.0 109.362 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' A' ' 64' ' ' TYR . 96.3 mt-10 -76.89 -171.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.476 -0.765 . . . . 0.0 109.496 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 53.4 p30 -63.31 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 110.714 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.585 ' H ' ' C ' ' A' ' 62' ' ' GLU . 83.5 m-85 -118.82 17.99 13.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.214 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 65' ' ' ASP . 51.2 p30 -70.54 6.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 110.204 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.56 -33.49 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.998 . . . . 0.0 109.194 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 68' ' ' ARG . 64.3 mt -61.57 -35.75 78.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 0.0 109.958 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 70' ' ' LEU . 1.6 mtt180 55.84 165.73 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.021 -1.049 . . . . 0.0 109.144 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -48.28 -1.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.371 2.047 . . . . 0.0 112.558 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 68' ' ' ARG . 82.4 mt -56.39 -30.6 62.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.293 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.7 m -61.68 -38.28 87.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.918 -1.114 . . . . 0.0 109.942 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -130.61 84.1 60.01 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.686 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 74' ' ' GLN . 47.5 Cg_endo -76.95 176.12 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.53 2.153 . . . . 0.0 112.557 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.526 ' O ' ' O ' ' A' ' 73' ' ' PRO . 63.5 tp60 35.73 101.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.79 -0.569 . . . . 0.0 110.842 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -105.5 130.96 53.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.0 108.99 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.39 -37.91 89.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.84 144.1 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.449 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.39 126.68 51.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 8' ' ' VAL . 42.6 tp -112.3 128.76 56.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.665 HG21 ' CE2' ' A' ' 110' ' ' PHE . 40.5 t -123.18 135.78 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 130.95 46.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.37 -0.831 . . . . 0.0 109.828 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.47 161.11 38.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.9 t -80.08 132.82 36.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -1.0 . . . . 0.0 109.295 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.77 -28.25 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 110.869 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.573 HG21 HD23 ' A' ' 119' ' ' LEU . 33.4 m -92.6 7.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.041 -1.037 . . . . 0.0 111.095 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t -98.52 124.57 46.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.792 -1.193 . . . . 0.0 110.003 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 70.2 Cg_endo -77.56 -58.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.264 1.976 . . . . 0.0 112.61 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.4 p -55.48 -32.92 63.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.935 . . . . 0.0 109.762 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 m -65.08 -24.52 67.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.165 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CZ ' HG22 ' A' ' 141' ' ' THR . 56.3 t80 -68.57 -50.84 48.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -0.774 . . . . 0.0 109.347 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 87' ' ' PRO . 52.5 mp0 -69.13 -35.72 76.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -54.45 -33.36 59.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.66 -37.98 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.933 . . . . 0.0 110.268 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.684 ' HD2' HD21 ' A' ' 145' ' ' LEU . 30.0 tttt -93.43 -36.25 12.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.844 -1.16 . . . . 0.0 110.839 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.71 -37.04 81.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.027 -1.045 . . . . 0.0 112.285 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -113.68 -51.65 2.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 0.0 112.611 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.198 -0.939 . . . . 0.0 113.217 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -71.25 -51.49 10.08 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.152 -1.592 . . . . 0.0 111.623 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 56.7 Cg_endo -71.87 -45.74 0.68 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.827 1.685 . . . . 0.0 113.567 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.22 -38.85 90.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.014 -1.054 . . . . 0.0 111.07 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 98' ' ' VAL . 3.4 tp -68.58 -26.88 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 110.078 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 m -61.46 -40.02 92.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 109.858 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -54.87 -34.44 62.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.573 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 56.8 t-80 -62.34 -43.66 98.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 0.0 109.591 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.0 OUTLIER 160.64 158.52 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 108' ' ' THR . 13.5 Cg_endo -60.1 -160.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.759 2.306 . . . . 0.0 111.676 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 106' ' ' PRO . 20.8 mttp 42.51 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.058 . . . . 0.0 109.631 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.7 p 47.49 81.8 0.25 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.53 126.44 16.09 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.328 2.019 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -113.28 125.21 54.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.017 -179.426 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 153' ' ' LYS . 40.5 tp -116.58 121.22 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.6 mt -104.58 121.83 44.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.75 134.52 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.5 124.89 8.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.8 p -110.73 159.78 17.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.219 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 57.67 40.8 26.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.681 -0.637 . . . . 0.0 110.663 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.5 pt -69.48 -5.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.153 . . . . 0.0 109.933 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.93 -22.66 29.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 0.0 109.096 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 85' ' ' VAL . 31.4 tp -61.58 -32.73 72.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.407 HH22 ' HB ' ' A' ' 138' ' ' THR . 67.7 ttt180 -58.64 -25.22 62.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.652 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.07 -5.2 47.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 110.116 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.12 141.32 83.72 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.003 -1.061 . . . . 0.0 109.049 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.62 -46.73 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.173 1.915 . . . . 0.0 111.894 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.8 p -61.22 -27.64 68.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.889 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.3 m -69.25 -49.02 60.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.02 -40.19 82.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.455 0.645 . . . . 0.0 109.3 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -74.54 -40.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.582 -0.699 . . . . 0.0 109.771 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.568 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 3.5 mm? -78.7 -38.78 38.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -0.996 . . . . 0.0 109.61 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.52 71.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 109.686 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -62.55 -44.41 96.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.97 -1.081 . . . . 0.0 110.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -70.44 -48.95 53.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.772 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -148.38 -89.32 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.47 ' HG3' ' H ' ' A' ' 135' ' ' LYS . 9.0 pt20 -134.19 -119.32 0.18 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.594 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.47 ' H ' ' HG3' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.09 167.03 24.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.41 165.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.998 2.465 . . . . 0.0 112.223 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.61 145.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.407 ' HB ' HH22 ' A' ' 120' ' ' ARG . 0.2 OUTLIER -85.69 155.99 58.81 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.994 -1.066 . . . . 0.0 109.394 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.41 -24.03 76.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.614 2.209 . . . . 0.0 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.13 -41.7 97.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.41 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 46.8 m -62.45 -36.78 83.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.962 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.9 57.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.64 -34.67 77.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.091 -1.006 . . . . 0.0 110.682 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 21.0 mttm -67.3 -39.25 85.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.437 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.684 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -62.7 -39.5 94.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 0.0 109.24 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.574 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -75.36 -48.86 21.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.089 -1.007 . . . . 0.0 110.141 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -68.97 4.97 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 144' ' ' LYS . 88.2 m-20 -108.82 -20.99 12.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.958 -1.089 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.402 ' CD1' HG21 ' A' ' 98' ' ' VAL . 38.2 mt -110.97 34.31 4.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.73 29.18 18.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.639 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.574 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -67.51 146.23 54.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.98 -61.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.034 -1.042 . . . . 0.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 154' ' ' TYR . 16.4 tttp -175.37 163.3 3.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.427 ' N ' ' HG2' ' A' ' 153' ' ' LYS . 28.7 p90 -120.04 154.75 34.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.623 HG21 ' OE1' ' A' ' 171' ' ' GLU . 28.0 t -132.24 140.09 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.9 mt-10 -100.13 126.7 46.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 140.73 47.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 111.071 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 161' ' ' THR . 34.6 t -104.26 102.19 11.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 108.892 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.92 72.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.209 0.528 . . . . 0.0 109.59 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.6 mt -53.56 -27.02 23.9 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 158' ' ' SER . 17.5 p -123.61 161.17 25.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -69.97 12.35 0.22 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.696 -0.627 . . . . 0.0 109.33 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.3 mttp -90.45 0.52 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.866 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -91.67 -51.37 2.51 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.016 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.17 -40.48 96.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.133 -1.216 . . . . 0.0 109.83 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.45 -27.85 66.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.522 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 35.6 t-20 -76.94 -50.73 12.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 109.926 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.02 -12.13 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.865 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.63 -50.23 22.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.734 -1.228 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.72 -41.95 92.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 0.0 110.057 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.623 ' OE1' HG21 ' A' ' 155' ' ' VAL . 83.9 tt0 -65.01 -33.15 75.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.979 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.68 71.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.53 -39.82 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.036 -1.04 . . . . 0.0 109.787 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.3 tp -53.49 -42.14 67.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.92 74.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -0.947 . . . . 0.0 110.333 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.45 70.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.941 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.3 mt -61.96 -34.23 75.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.963 -1.085 . . . . 0.0 109.399 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.443 -0.786 . . . . 99.989999999999995 109.255 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.86 -36.0 78.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 0.0 109.316 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -136.71 160.07 39.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.772 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.66 121.0 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -91.66 127.86 37.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.74 128.33 24.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 109.123 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.446 HG21 HG21 ' A' ' 75' ' ' THR . 47.2 t -113.14 137.36 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.36 134.92 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -152.09 146.59 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.105 -0.997 . . . . 0.0 109.277 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 159.64 23.85 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' GLY . 24.6 t70 -84.31 110.28 18.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -1.213 . . . . 0.0 109.434 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.57 63.38 1.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -85.09 121.36 27.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -1.167 . . . . 0.0 109.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.87 -30.08 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.967 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.09 35.14 5.02 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 87.8 tttt -59.95 -38.59 82.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.237 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.7 p -63.41 -40.51 97.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.002 . . . . 0.0 110.002 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -26.69 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.058 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.14 -41.2 99.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.825 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 24' ' ' THR . 83.1 mt -66.44 -40.56 89.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.123 -0.985 . . . . 0.0 110.198 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.16 -42.3 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.809 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -57.51 -35.82 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.185 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -80.05 -50.27 10.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.144 . . . . 0.0 109.801 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 20' ' ' LEU . 71.6 p -59.58 -36.94 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.142 -0.974 . . . . 0.0 110.014 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 56.5 p -120.15 -113.55 0.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 25' ' ' THR . 69.2 m-20 -167.56 12.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -98.09 118.82 35.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -86.4 -38.52 0.54 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 17.7 Cg_exo -63.26 -27.11 71.97 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.371 2.047 . . . . 0.0 111.064 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 29' ' ' PRO . 21.7 m 34.17 47.73 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.221 0.534 . . . . 0.0 110.298 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 -41.07 -32.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -121.7 126.0 47.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.257 -0.902 . . . . 0.0 109.488 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -99.44 109.27 54.38 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -52.47 160.64 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.241 1.961 . . . . 0.0 112.049 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.19 67.44 1.87 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 38' ' ' ASP . 12.3 p -140.94 138.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.03 0.64 11.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.475 -0.766 . . . . 0.0 109.326 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' H ' HG22 ' A' ' 36' ' ' VAL . 88.3 m-20 -69.2 139.46 54.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -0.882 . . . . 0.0 110.432 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.39 160.82 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.09 136.58 49.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 110.33 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 125.75 51.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.19 138.64 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 p -87.94 147.08 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.075 -1.016 . . . . 0.0 109.066 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 156.95 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 110.507 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.2 mtm -130.17 137.15 49.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.711 -0.618 . . . . 0.0 109.549 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 26.6 pt -129.82 152.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 109.096 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.99 18.2 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 84.83 15.06 68.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . 59.0 mt-10 -106.0 146.56 33.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.102 -1.234 . . . . 0.0 109.44 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.74 131.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.539 2.159 . . . . 0.0 112.829 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -143.12 160.13 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.532 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 m -117.23 138.79 51.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 0.0 109.093 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 41.8 tp -120.13 122.08 40.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 109.579 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.79 124.57 7.91 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -102.45 122.33 44.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.997 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -108.23 129.31 55.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.46 -0.775 . . . . 0.0 109.104 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' THR . 60.0 t0 -116.92 148.05 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.701 . . . . 0.0 109.177 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.407 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.2 p -68.65 159.16 32.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.042 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -143.07 161.53 37.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' GLN . . . -41.26 -66.28 0.96 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLY . 46.2 tt0 59.75 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 0.0 109.266 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -174.56 -87.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 0.0 109.819 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 53.2 p30 -81.05 13.4 2.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 110.77 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -74.09 4.15 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.835 -1.166 . . . . 0.0 109.071 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 66' ' ' ARG . 83.0 m-20 58.33 47.45 13.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.728 -0.607 . . . . 0.0 110.34 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 66' ' ' ARG . 0.2 OUTLIER 35.1 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.327 0.584 . . . . 0.0 110.093 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.568 HD23 HD12 ' A' ' 70' ' ' LEU . 31.1 tp -72.02 123.47 22.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.159 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 2.2 mtm180 -74.92 -56.83 1.98 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 110.666 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 76.9 Cg_exo -40.14 -27.94 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.183 1.922 . . . . 0.0 112.352 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.568 HD12 HD23 ' A' ' 67' ' ' LEU . 61.4 mt -116.4 62.03 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.313 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.8 m -136.89 144.06 43.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.405 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.63 76.27 36.01 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 109.513 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.85 -34.05 90.29 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.547 2.165 . . . . 0.0 112.165 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -113.84 131.47 56.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 HG21 ' A' ' 7' ' ' VAL . 30.7 p -119.26 145.0 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 109.477 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.85 -33.87 74.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.934 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.65 133.71 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -110.7 121.42 45.27 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -112.81 139.18 48.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.351 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.3 t -122.44 135.18 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.497 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 38.8 t -127.77 128.27 45.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.811 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.61 162.91 34.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 109.73 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.556 ' OG ' HG22 ' A' ' 85' ' ' VAL . 37.9 t -92.05 142.85 27.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.4 p -100.24 -4.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.109 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.571 HG11 HD23 ' A' ' 119' ' ' LEU . 30.6 m -89.79 -16.47 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.999 -1.063 . . . . 0.0 109.783 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -98.51 134.97 21.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.65 -55.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.228 1.952 . . . . 0.0 112.198 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.3 m -55.13 -34.4 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 109.709 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -63.44 -25.16 68.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.097 -1.002 . . . . 0.0 109.248 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 137' ' ' ILE . 64.9 t80 -70.36 -50.18 41.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -0.832 . . . . 0.0 109.414 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.31 -37.13 82.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.55 -34.36 49.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 109.815 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.98 -34.97 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 109.986 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -91.14 -37.75 13.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.863 -1.148 . . . . 0.0 110.192 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -68.0 -35.99 79.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 112.094 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -113.15 -52.55 2.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.976 -1.078 . . . . 0.0 112.528 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -68.25 -37.02 80.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.156 -0.965 . . . . 0.0 113.428 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.0 t -63.28 -51.43 68.85 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.003 -1.685 . . . . 0.0 111.395 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' O ' HG22 ' A' ' 102' ' ' THR . 59.8 Cg_endo -73.96 -43.4 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.828 1.685 . . . . 0.0 113.095 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.82 -30.24 71.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 0.0 111.23 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 98' ' ' VAL . 3.7 tp -61.71 -25.1 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.687 -1.258 . . . . 0.0 109.874 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' PRO . 4.8 t -55.59 -36.61 67.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.131 -0.981 . . . . 0.0 109.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 102' ' ' THR . 52.1 m170 -51.62 -32.93 30.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.7 m80 -93.25 -5.99 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.58 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' HIS . 0.1 OUTLIER 53.23 168.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.541 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.19 26.11 0.55 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.837 2.358 . . . . 0.0 113.355 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -56.57 -34.52 67.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.947 -1.096 . . . . 0.0 109.829 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 159.61 38.52 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.418 -0.801 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.46 147.52 93.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.864 2.376 . . . . 0.0 111.959 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.63 126.05 54.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.158 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.7 mt -116.98 128.16 54.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.536 -0.728 . . . . 0.0 109.854 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.1 tp -106.34 116.4 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.1 t -112.77 136.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.908 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.96 119.03 6.01 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 52.0 m -118.58 148.11 43.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -1.045 . . . . 0.0 110.465 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' THR . 33.2 tt0 84.48 19.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 122.067 -0.396 . . . . 0.0 110.47 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 119' ' ' LEU . 35.1 pt -62.62 -158.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 63.0 -61.73 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.183 . . . . 0.0 109.226 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 117' ' ' ILE . 25.1 tp -53.08 -33.9 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 139' ' ' PRO . 33.0 ptt180 -54.36 -15.42 1.63 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 92.9 m-20 -108.04 57.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.609 ' OD2' HD12 ' A' ' 119' ' ' LEU . 7.9 m-20 -137.85 107.79 8.3 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.66 -39.83 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.879 1.719 . . . . 0.0 111.955 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m -58.73 -41.34 86.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.0 m -70.67 -48.94 52.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 108.126 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.76 -36.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.388 0.613 . . . . 0.0 109.479 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.93 -47.11 75.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.433 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -59.0 -38.8 80.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.709 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.16 -33.88 61.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 108.98 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.94 -41.81 64.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -60.16 -37.23 79.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 109.477 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.71 4.67 50.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.786 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 51.65 39.3 24.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.182 -0.949 . . . . 0.0 109.752 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -98.99 -52.17 3.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.027 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 mttp 68.89 146.11 0.11 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.3 152.24 79.54 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.593 2.195 . . . . 0.0 112.765 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.423 HG21 ' CE1' ' A' ' 90' ' ' PHE . 27.0 mm -93.5 141.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 109.046 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.53 155.21 65.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.093 -1.005 . . . . 0.0 109.591 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HG3' HH12 ' A' ' 120' ' ' ARG . 18.5 Cg_endo -61.65 -28.08 82.11 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.571 2.181 . . . . 0.0 111.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.92 -38.27 90.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 45.4 m -65.06 -35.59 81.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.33 -34.07 58.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.817 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 110.485 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.483 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 18.5 mttp -64.45 -35.69 81.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.962 -1.086 . . . . 0.0 109.553 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.53 -40.29 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.769 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -67.15 -43.54 82.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.002 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 147' ' ' ARG . 43.8 mtt-85 -78.7 7.78 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 85.1 m-20 -83.31 -27.78 29.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 0.0 108.753 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.3 mt -117.38 -101.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.624 -0.672 . . . . 0.0 109.308 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -144.9 44.9 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.871 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.769 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -61.95 137.4 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 109.168 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.82 -58.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.354 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -156.66 146.54 20.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.72 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -122.22 153.73 38.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.394 -0.816 . . . . 0.0 109.11 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.54 157.58 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.904 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -104.35 128.1 52.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' HG13 ' A' ' 168' ' ' VAL . 15.2 m -122.02 131.45 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.854 . . . . 0.0 110.713 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.583 ' HB2' HD11 ' A' ' 117' ' ' ILE . 23.9 t -109.99 110.88 21.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.97 68.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.871 -0.518 . . . . 0.0 110.08 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 28' ' ' PHE . 49.8 tp -51.37 -34.39 34.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.061 -1.024 . . . . 0.0 108.471 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.654 ' C ' ' H ' ' A' ' 163' ' ' LYS . 55.6 m -127.95 152.0 48.42 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -58.57 13.53 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.039 -1.038 . . . . 0.0 110.103 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.654 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.9 tttm -74.59 5.92 4.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 0.0 109.278 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -98.81 -50.86 1.45 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.205 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.753 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.5 mp -68.25 -38.47 81.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -1.178 . . . . 0.0 109.939 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -61.73 -29.25 69.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.288 -0.883 . . . . 0.0 110.336 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 163' ' ' LYS . 86.8 m-20 -77.96 -49.71 13.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 110.186 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 157' ' ' CYS . 11.3 m -74.39 -11.19 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 110.452 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -73.64 -46.46 46.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.59 -43.29 89.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.299 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.06 -33.39 75.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.05 -1.031 . . . . 0.0 109.663 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.06 70.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 110.152 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.18 -42.64 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.93 -1.106 . . . . 0.0 109.916 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.3 mt -54.24 -44.86 72.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.822 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.71 -36.6 84.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.715 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.44 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.654 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.13 -39.22 93.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.398 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.406 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 60.08 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.68 -0.637 . . . . 0.0 109.604 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -124.71 159.0 31.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.2 mt -119.16 119.16 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.794 . . . . 0.0 109.556 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.3 132.69 38.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -135.87 126.6 27.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 109.465 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.84 136.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.427 -0.796 . . . . 0.0 109.709 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.4 138.12 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.049 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.54 144.68 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.295 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.63 23.1 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 12' ' ' GLY . 26.1 t70 -89.55 105.88 18.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -1.165 . . . . 0.0 109.43 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.73 68.78 0.5 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -1.151 . . . . 0.0 109.401 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.23 -45.73 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.309 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.29 48.94 0.88 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 68.1 tttt -59.69 -40.18 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.245 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.641 HG21 HG21 ' A' ' 33' ' ' VAL . 41.8 m -64.5 -40.56 95.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.529 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.84 -29.77 63.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.036 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.34 -42.76 96.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.014 -1.054 . . . . 0.0 109.22 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -73.44 -40.1 64.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.89 -48.92 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -56.37 -32.65 64.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -81.1 -50.63 9.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 m -55.93 -44.3 78.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 82.1 p -118.39 -110.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 25' ' ' THR . 81.5 m-20 -146.06 12.56 1.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.016 . . . . 0.0 109.882 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 28' ' ' PHE . 22.7 tttm 77.91 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.568 -0.707 . . . . 0.0 109.757 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -37.16 -55.54 1.71 Allowed Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.409 -0.807 . . . . 0.0 111.482 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 89.0 Cg_exo -35.43 -53.47 0.78 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.975 1.783 . . . . 0.0 112.415 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.7 t -108.72 142.82 38.69 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.311 -0.868 . . . . 0.0 108.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.22 -19.93 13.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -133.59 161.34 34.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.6 -0.688 . . . . 0.0 110.183 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 33' ' ' VAL . 7.7 p -123.93 79.83 57.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.2 -64.05 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.699 2.266 . . . . 0.0 112.442 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.94 166.04 24.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.57 141.04 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.72 -84.93 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 52.3 p30 -148.83 -170.86 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.806 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 40.5 p-10 -52.56 151.35 4.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.799 . . . . 0.0 109.257 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.98 146.44 44.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.741 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.39 142.86 45.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 108.961 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 134.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.8 m -90.49 131.81 36.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 108.914 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.17 137.59 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.413 -0.805 . . . . 0.0 110.044 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 95.7 mmm -91.2 137.46 32.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.84 . . . . 0.0 108.814 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLY . 78.4 mt -131.41 132.04 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.8 19.33 0.5 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.34 15.53 62.07 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 4.1 mt-10 -114.83 125.44 29.04 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.397 -1.06 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.14 117.07 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.038 1.825 . . . . 0.0 113.208 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 49' ' ' GLU . 48.5 m-85 -127.19 139.41 52.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -86.9 149.81 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.783 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.9 tp -131.79 133.84 45.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.425 -0.797 . . . . 0.0 109.24 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.2 131.11 8.26 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.84 132.99 50.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -1.105 . . . . 0.0 109.048 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.17 133.37 54.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 58' ' ' THR . 59.0 t0 -132.21 147.44 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.0 p -73.05 160.36 32.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.73 155.69 46.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.648 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.54 9.12 72.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -84.46 48.85 1.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.171 -1.193 . . . . 0.0 109.367 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.19 -33.29 74.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.07 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -53.41 -30.47 40.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 0.0 110.615 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.44 0.38 57.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.854 -1.154 . . . . 0.0 109.532 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 45.34 45.17 9.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.8 . . . . 0.0 109.612 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -56.53 -32.54 65.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 109.75 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.25 124.02 39.07 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.585 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 70' ' ' LEU . 5.4 mtt180 -150.86 160.89 31.52 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.25 10.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.518 2.145 . . . . 0.0 112.534 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 68' ' ' ARG . 83.1 mt -59.34 -38.22 79.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.095 . . . . 0.0 109.915 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 t -130.13 151.22 50.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 0.0 109.963 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -121.67 84.93 43.56 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.91 148.15 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.708 2.272 . . . . 0.0 112.623 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' THR . 95.2 mm-40 -79.93 -63.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER 85.62 50.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.88 -33.67 67.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.2 128.8 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.441 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -105.61 124.12 49.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 108.767 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 55.9 mt -107.82 137.46 45.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 97' ' ' TRP . 20.1 t -124.99 136.78 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.596 ' HG ' ' HG1' ' A' ' 115' ' ' THR . 45.0 t -130.04 127.34 39.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.848 . . . . 0.0 109.843 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -136.42 165.37 25.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.942 . . . . 0.0 108.853 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.5 m -101.83 142.63 32.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.223 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 84' ' ' VAL . 4.1 p -102.84 -1.35 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.055 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.6 HG11 HG21 ' A' ' 125' ' ' THR . 78.2 t -85.32 -21.67 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.882 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.6 m -111.96 108.67 55.37 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.772 . . . . 0.0 109.771 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -51.77 -38.27 66.73 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.022 1.815 . . . . 0.0 112.335 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.6 p -57.62 -35.22 70.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 109.154 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -67.92 -21.85 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -72.02 -50.45 28.43 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.65 -35.77 80.96 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -50.95 -33.83 26.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.525 HG22 ' CZ3' ' A' ' 97' ' ' TRP . 81.3 t -62.39 -35.31 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -89.43 -37.56 14.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.821 -1.175 . . . . 0.0 110.247 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.07 -37.22 83.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 112.384 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -112.91 -52.05 2.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.762 -1.212 . . . . 0.0 112.699 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.616 ' O ' HD13 ' A' ' 101' ' ' ILE . 30.8 m0 -66.86 -39.43 87.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.994 -1.066 . . . . 0.0 112.593 -176.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -61.47 -52.21 71.71 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.143 -1.598 . . . . 0.0 111.05 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 38.3 Cg_endo -68.98 -43.22 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.568 1.512 . . . . 0.0 112.416 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.82 -39.81 62.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.5 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.616 HD13 ' O ' ' A' ' 97' ' ' TRP . 1.3 mp -66.63 -33.32 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.778 -1.201 . . . . 0.0 109.927 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.2 m -53.77 -39.02 65.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 42.8 t-80 -58.93 -40.7 85.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.739 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -99.4 1.12 43.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER 59.42 166.32 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.996 . . . . 0.0 109.331 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.7 39.92 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.723 2.282 . . . . 0.0 112.304 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -60.17 -35.37 75.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.745 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.07 157.74 49.92 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 110.471 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.73 144.64 44.5 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.034 2.489 . . . . 0.0 112.696 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -116.75 138.82 51.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 153' ' ' LYS . 45.8 tp -116.71 123.62 47.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -101.56 116.93 33.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.03 135.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.672 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.3 114.88 4.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.642 HG22 ' HG3' ' A' ' 116' ' ' GLN . 20.8 m -102.74 149.22 24.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -1.152 . . . . 0.0 110.503 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.642 ' HG3' HG22 ' A' ' 115' ' ' THR . 91.5 mt-30 60.68 41.18 15.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.931 -0.48 . . . . 0.0 110.637 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.2 pt -73.65 -6.21 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.875 -1.141 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.487 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 84.5 m-20 -85.71 -24.03 27.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.049 -1.032 . . . . 0.0 109.217 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 116' ' ' GLN . 10.2 mp -65.01 -24.98 67.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HE ' HG11 ' A' ' 84' ' ' VAL . 97.0 mtt180 -44.99 -19.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.514 -0.741 . . . . 0.0 109.231 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 119' ' ' LEU . 60.6 t0 -122.33 48.63 1.71 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.737 . . . . 0.0 109.032 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 56.4 t0 -117.72 90.55 36.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.516 -0.74 . . . . 0.0 109.21 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.6 -40.92 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.197 1.931 . . . . 0.0 112.398 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.5 t -57.87 -43.21 85.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.842 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.6 HG21 HG11 ' A' ' 85' ' ' VAL . 45.4 m -70.58 -49.56 46.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 108.232 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.0 -36.41 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.15 -43.83 90.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 108.896 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -61.78 -42.54 99.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.696 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 129' ' ' LEU . 3.8 mm? -75.39 -33.91 61.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.885 . . . . 0.0 109.348 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.89 40.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.83 -35.36 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.495 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.38 6.81 21.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.719 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 61.55 44.77 8.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -140.94 139.61 34.32 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.229 -0.919 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.88 161.83 34.22 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.534 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.03 145.65 97.89 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.867 2.378 . . . . 0.0 112.328 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.555 ' CG2' ' OG1' ' A' ' 141' ' ' THR . 97.1 mt -90.99 144.56 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.435 -0.791 . . . . 0.0 109.835 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.34 155.02 54.52 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.54 -32.79 95.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.35 -36.61 61.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.555 ' OG1' ' CG2' ' A' ' 137' ' ' ILE . 65.4 p -78.57 -23.76 45.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.82 -1.175 . . . . 0.0 108.832 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.01 -43.88 51.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.448 -0.783 . . . . 0.0 109.759 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.68 -35.62 81.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 110.984 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -65.86 -38.42 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 149' ' ' LEU . 34.2 tp -59.7 -38.53 81.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 109.302 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.17 84.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.956 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.648 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -81.26 6.54 13.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -111.46 -34.86 5.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.106 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 145' ' ' LEU . 66.7 mt -92.68 16.9 11.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.63 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.2 mttt 61.2 31.23 19.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.93 145.18 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.641 HG12 ' HG3' ' A' ' 153' ' ' LYS . 87.0 t -66.56 -60.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.952 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.641 ' HG3' HG12 ' A' ' 152' ' ' VAL . 68.9 mttm -152.86 157.67 41.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -132.15 148.61 52.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.623 HG21 ' OE1' ' A' ' 171' ' ' GLU . 46.6 t -134.11 140.95 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -0.957 . . . . 0.0 110.231 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.86 121.84 36.88 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.422 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -130.69 140.63 50.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.159 -0.963 . . . . 0.0 110.761 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 161' ' ' THR . 8.7 t -115.61 115.13 25.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.416 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.9 -35.67 64.69 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.247 0.546 . . . . 0.0 109.86 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.45 -31.0 32.6 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.538 ' O ' ' O ' ' A' ' 158' ' ' SER . 7.4 m -118.03 152.11 36.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.29 12.61 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 161' ' ' THR . 62.9 mttp -89.18 4.74 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.857 -1.152 . . . . 0.0 109.903 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -89.08 -51.0 3.1 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.952 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.56 -38.62 74.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 110.301 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -60.24 -29.14 68.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.477 ' ND2' ' CG1' ' A' ' 155' ' ' VAL . 38.6 t-20 -75.59 -49.46 18.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.58 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 168' ' ' VAL . 73.0 t -79.1 -8.08 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 110.726 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 173' ' ' ILE . 76.1 t80 -74.95 -50.38 16.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.771 -1.205 . . . . 0.0 110.331 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.69 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 110.272 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.623 ' OE1' HG21 ' A' ' 155' ' ' VAL . 85.0 tt0 -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.975 . . . . 0.0 109.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.61 80.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 110.002 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.573 HD11 ' CE2' ' A' ' 169' ' ' PHE . 75.9 mt -72.89 -42.25 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.093 -1.004 . . . . 0.0 109.855 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.0 tp -57.5 -44.84 85.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.902 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.09 -33.4 75.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.7 71.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.9 -39.78 86.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 0.0 109.071 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 99.989999999999995 109.521 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -63.05 -34.44 77.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.33 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.6 m -124.92 147.42 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.583 -0.698 . . . . 0.0 109.781 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.25 119.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -88.92 128.38 35.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.59 124.03 26.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.06 138.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 0.0 109.935 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.571 HG22 HD23 ' A' ' 79' ' ' LEU . 46.2 t -111.32 136.07 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.615 HG11 ' CH2' ' A' ' 97' ' ' TRP . 54.2 t -133.27 136.44 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.1 142.36 12.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 12' ' ' GLY . 50.7 t0 -84.99 105.06 15.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 109.551 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.0 66.16 1.09 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -81.53 130.25 34.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -1.117 . . . . 0.0 109.342 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.48 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.22 51.91 0.67 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 86.3 tttt -61.8 -39.83 93.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.239 . . . . 0.0 110.057 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.6 p -76.14 -35.55 59.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 109.967 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 68.7 m -64.1 -31.18 72.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.445 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.78 -42.32 81.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.711 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.4 mt -70.45 -40.88 73.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.93 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.9 -36.71 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.6 p -60.44 -30.5 69.69 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.351 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -82.65 -50.27 8.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.977 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -66.85 -40.57 87.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 0.0 110.469 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 54.8 m -105.08 -86.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.965 . . . . 0.0 109.645 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER 159.92 -10.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.032 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -83.92 103.92 13.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.739 -1.226 . . . . 0.0 109.783 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.638 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -65.33 -41.4 51.15 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.431 -0.793 . . . . 0.0 109.173 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 27.7 Cg_exo -59.48 -33.36 97.21 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.337 2.025 . . . . 0.0 112.068 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER 74.99 42.25 0.27 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.104 -0.997 . . . . 0.0 108.595 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 32' ' ' TYR . 96.1 mt-10 -44.84 81.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.125 0.488 . . . . 0.0 110.597 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.669 ' N ' ' O ' ' A' ' 30' ' ' SER . 11.7 t80 90.05 71.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.228 0.537 . . . . 0.0 110.403 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG12 ' OG ' ' A' ' 30' ' ' SER . 31.7 m -44.55 148.81 0.84 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 109.604 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.28 144.3 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.833 2.355 . . . . 0.0 112.415 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.03 1.02 42.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.171 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.54 142.29 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.92 16.36 22.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.886 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 59.2 t0 -63.82 129.1 38.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -70.33 151.05 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.428 -0.795 . . . . 0.0 109.588 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 98.7 m-85 -127.97 152.56 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.816 . . . . 0.0 109.866 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.59 145.48 30.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.261 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -128.45 147.09 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 109.842 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.578 HG23 HG22 ' A' ' 52' ' ' THR . 58.3 m -120.53 142.53 49.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.408 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 m -124.53 158.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 109.818 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.7 mtp -112.49 140.65 47.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 51' ' ' TYR . 60.4 mt -122.1 143.78 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -46.4 -29.19 3.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.509 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -81.13 -92.16 0.51 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -126.74 156.68 73.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -1.057 . . . . 0.0 109.846 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.7 138.07 23.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.735 2.29 . . . . 0.0 112.24 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.543 ' CD1' HD12 ' A' ' 46' ' ' ILE . 89.9 m-85 -131.38 152.17 50.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 0.0 109.084 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.578 HG22 HG23 ' A' ' 43' ' ' THR . 17.8 p -117.8 157.92 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.17 160.3 29.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.19 158.28 26.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 mt -106.0 129.11 54.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.058 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -115.99 135.08 54.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 0.0 109.558 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -139.55 167.56 21.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.387 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.25 154.11 25.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.068 -1.02 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.768 ' H ' HH12 ' A' ' 66' ' ' ARG . . . -114.49 24.64 11.7 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.35 125.72 3.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.765 HE22 ' HB2' ' A' ' 66' ' ' ARG . 7.8 tp-100 -109.28 112.38 24.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -1.093 . . . . 0.0 109.45 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.16 -115.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 109.443 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -87.34 12.17 12.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.119 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.98 -7.22 56.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 0.0 109.314 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 85.8 m-20 45.39 46.64 10.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.853 . . . . 0.0 109.751 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.768 HH12 ' H ' ' A' ' 59' ' ' ALA . 58.0 mtp180 -57.31 -23.38 48.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 109.853 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.66 7.67 16.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.328 -0.857 . . . . 0.0 109.87 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.651 ' CG ' HH11 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -46.51 -51.59 35.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 110.797 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 56.6 Cg_endo -74.14 -101.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.822 1.681 . . . . 0.0 112.348 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.73 -110.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 0.0 109.611 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.1 p -160.65 162.61 32.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 0.0 109.604 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -130.32 72.94 81.71 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 0.0 109.184 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.22 65.1 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.038 2.492 . . . . 0.0 112.737 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -128.85 124.92 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.097 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.44 ' OG1' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -152.12 98.44 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.4 -34.03 74.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.917 . . . . 0.0 109.546 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.78 143.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 74.2 m-85 -104.71 127.3 52.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.402 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 8' ' ' VAL . 30.7 tp -111.93 125.53 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.405 -0.81 . . . . 0.0 108.973 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.27 137.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 141.95 49.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 109.541 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.3 159.01 43.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 109.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -89.18 150.83 22.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 109.378 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.678 ' O ' HG22 ' A' ' 84' ' ' VAL . 6.7 p -98.48 4.43 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.97 -2.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -115.06 92.92 33.0 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.204 -0.935 . . . . 0.0 109.661 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.03 -50.81 12.73 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.41 2.073 . . . . 0.0 112.695 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -54.29 -38.68 66.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 109.371 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 93' ' ' VAL . 60.7 p -63.65 -16.01 59.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.29 -50.78 13.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.48 -39.46 81.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.592 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -53.74 -31.56 48.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.092 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 89' ' ' SER . 75.8 t -60.38 -35.59 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.697 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -95.66 -30.06 13.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.033 -1.042 . . . . 0.0 110.605 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.56 -35.06 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.71 -1.244 . . . . 0.0 111.903 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -113.73 -49.69 2.87 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.045 -1.034 . . . . 0.0 112.36 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.615 ' CH2' HG11 ' A' ' 9' ' ' VAL . 79.3 m95 -76.31 3.24 11.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -107.04 -45.98 0.12 Allowed Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.387 -1.446 . . . . 0.0 110.851 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 91.5 Cg_endo -86.12 -53.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.545 2.163 . . . . 0.0 112.767 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.57 -34.37 78.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.928 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.2 -27.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.853 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.1 p -66.46 -35.02 79.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.933 . . . . 0.0 109.764 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -56.84 -41.47 77.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -101.28 -8.8 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m -147.79 77.54 10.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.74 -44.46 49.41 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.564 2.176 . . . . 0.0 112.062 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -150.8 104.1 3.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -150.38 155.79 36.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.437 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.95 127.78 17.54 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.42 2.08 . . . . 0.0 111.857 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 108' ' ' THR . 76.7 m-85 -116.61 137.64 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.769 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 153' ' ' LYS . 8.2 tp -122.82 119.2 29.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.723 . . . . 0.0 109.449 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 112' ' ' LEU . 5.6 mp -107.56 127.08 53.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 108.818 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -112.04 133.08 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.67 119.82 5.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.9 p -118.25 169.45 9.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -1.068 . . . . 0.0 110.937 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 117' ' ' ILE . 82.3 mt-30 66.08 40.76 3.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 116' ' ' GLN . 15.2 tt -48.97 178.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.918 -1.114 . . . . 0.0 108.576 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 121' ' ' ASP . 87.7 m-20 54.26 26.17 6.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.819 -1.176 . . . . 0.0 109.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.9 mt 26.88 54.69 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.983 -0.448 . . . . 0.0 111.343 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 21.2 mmm180 49.61 26.85 1.91 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.834 -1.166 . . . . 0.0 110.189 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 118' ' ' ASP . 9.7 t0 79.84 -14.74 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.0 109.455 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.449 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.8 OUTLIER 53.97 62.34 9.04 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.756 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 122' ' ' ASP . 68.4 Cg_endo -92.68 -100.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 123.02 2.48 . . . . 0.0 111.504 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.3 p -81.17 -2.4 48.4 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.6 m -72.41 -46.36 55.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 108.956 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 126' ' ' ILE . 6.9 pt -62.63 -34.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.29 -0.881 . . . . 0.0 109.308 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.63 -50.03 48.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -61.34 -36.67 80.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 0.0 110.138 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.93 -37.77 61.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 108.789 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.83 -38.49 61.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 109.475 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -60.23 -36.73 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 109.346 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -85.32 5.7 29.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.546 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttt 54.92 44.06 28.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.829 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -135.56 91.78 2.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.997 . . . . 0.0 109.416 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.85 153.22 91.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.31 161.77 25.96 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.853 2.369 . . . . 0.0 112.205 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.11 134.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -98.2 157.87 33.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 109.067 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 142' ' ' ALA . 2.1 Cg_endo -47.93 -36.28 26.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.906 2.404 . . . . 0.0 113.065 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.535 ' H ' HG23 ' A' ' 138' ' ' THR . 84.6 tt0 -46.9 -40.76 14.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 110.119 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.1 p -89.25 -18.38 27.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.779 -1.201 . . . . 0.0 109.39 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 139' ' ' PRO . . . -76.3 -49.88 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.706 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.35 -34.97 78.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.135 . . . . 0.0 110.662 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 87.7 mttt -61.82 -32.92 73.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 0.0 109.292 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 tp -56.31 -38.96 72.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.406 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.07 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.786 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -80.65 -0.63 38.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 61.5 t0 -111.9 -43.29 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 108.814 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.553 HD11 HG21 ' A' ' 98' ' ' VAL . 9.6 tp -78.71 10.89 2.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.636 -0.665 . . . . 0.0 109.675 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 59.02 30.12 19.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -0.952 . . . . 0.0 110.137 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.9 52.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 108.758 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.81 -58.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.075 . . . . 0.0 109.498 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.626 ' O ' HD12 ' A' ' 111' ' ' LEU . 50.1 tttp -158.51 155.8 29.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.868 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.68 153.46 51.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.531 HG21 ' OE1' ' A' ' 171' ' ' GLU . 39.3 t -133.04 138.44 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 84.6 tt0 -102.6 132.22 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.428 ' HB3' HD22 ' A' ' 167' ' ' ASN . 8.4 p -167.09 176.74 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.123 . . . . 0.0 110.376 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 117' ' ' ILE . 28.7 t -135.17 127.19 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.014 -1.054 . . . . 0.0 110.719 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.1 mt -54.66 -26.33 32.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.562 ' C ' ' H ' ' A' ' 163' ' ' LYS . 27.4 m -121.3 160.87 23.05 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -64.62 11.17 0.05 Allowed 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.412 -0.805 . . . . 0.0 109.247 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.5 mttm -89.84 3.0 54.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.977 -1.077 . . . . 0.0 109.564 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.528 ' O ' HG22 ' A' ' 168' ' ' VAL . . . -91.93 -50.23 2.71 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.6 mp -67.02 -44.96 78.95 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.443 -1.034 . . . . 0.0 110.646 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.41 -32.56 68.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 25.6 t-20 -79.84 -50.88 9.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.939 -1.101 . . . . 0.0 110.063 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 164' ' ' GLY . 15.6 m -75.79 -18.13 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 110.911 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.56 -47.37 27.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 0.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 110.233 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.531 ' OE1' HG21 ' A' ' 155' ' ' VAL . 80.9 tt0 -67.45 -33.99 76.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.093 -1.005 . . . . 0.0 109.927 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.53 70.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.9 . . . . 0.0 110.323 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 29.3 mm -67.67 -40.75 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.112 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 174' ' ' LEU . 3.4 mm? -56.88 -45.59 82.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 0.0 110.083 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.97 77.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.052 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.98 72.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.17 -36.72 84.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.0 109.511 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.529 -179.736 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -130.4 116.78 18.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 109.552 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -127.29 135.74 50.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.37 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 176' ' ' ALA . 68.3 mt -113.07 114.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.834 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -91.3 132.43 36.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.472 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -132.6 121.39 23.14 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.66 134.02 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 79' ' ' LEU . 26.1 t -114.61 133.01 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG21 ' CH2' ' A' ' 97' ' ' TRP . 9.1 p -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 0.0 109.582 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.01 -173.32 37.32 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' GLY . 23.3 t70 -69.76 137.65 52.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . -37.16 -47.67 1.43 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.626 ' C ' HG23 ' A' ' 14' ' ' VAL . . . -42.53 167.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -1.209 . . . . 0.0 109.658 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.626 HG23 ' C ' ' A' ' 13' ' ' ALA . 2.1 t 73.42 110.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.27 79.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.5 mttp -58.05 -31.18 66.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 108.989 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 m -67.52 -44.42 78.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.399 -0.813 . . . . 0.0 109.016 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.6 m -62.14 -27.7 69.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 109.637 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -65.16 -40.27 94.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 108.506 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.911 ' O ' HG23 ' A' ' 24' ' ' THR . 59.8 mt -71.37 -44.06 65.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 0.0 109.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mm -67.91 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.982 . . . . 0.0 109.832 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.401 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 29.6 t -60.03 -35.12 74.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.955 . . . . 0.0 109.812 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.96 -33.17 70.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.911 HG23 ' O ' ' A' ' 20' ' ' LEU . 60.9 p -72.07 -45.77 59.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 110.879 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.593 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 46.6 p -144.01 -2.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.792 -1.193 . . . . 0.0 111.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 25' ' ' THR . 37.3 t30 90.35 118.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' OG ' ' A' ' 30' ' ' SER . 2.8 tttm 178.63 48.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.99 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.653 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -61.36 -42.75 86.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.513 -1.367 . . . . 0.0 109.525 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 22.9 Cg_exo -62.19 1.99 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.908 2.406 . . . . 0.0 112.575 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 32' ' ' TYR . 29.2 m -48.89 -42.12 35.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.986 -1.071 . . . . 0.0 109.762 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 39.38 23.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.62 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 30' ' ' SER . 30.3 m-85 -93.76 -102.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.786 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.793 ' O ' HG12 ' A' ' 33' ' ' VAL . 46.5 t 54.44 63.18 7.6 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.717 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 32.9 Cg_endo -68.67 -26.31 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.267 1.978 . . . . 0.0 111.235 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 34' ' ' PRO . . . 154.51 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.69 142.02 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -144.16 59.76 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.842 . . . . 0.0 109.182 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -121.15 158.65 27.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.296 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 55' ' ' LEU . 64.6 t30 -93.97 139.25 31.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.75 154.14 29.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.817 . . . . 0.0 109.54 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.55 143.62 44.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 0.0 109.061 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.57 130.71 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.8 m -100.74 128.52 46.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.01 134.14 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 0.0 110.198 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.4 ttp -118.25 128.71 54.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 27.2 pt -131.8 152.39 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.44 16.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.55 15.68 61.46 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.8 mt-10 -113.32 93.73 27.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.438 -1.036 . . . . 0.0 109.523 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.91 145.6 23.87 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.12 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 60.8 m-85 -150.72 160.79 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.3 m -117.7 129.31 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 0.0 109.24 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 53' ' ' LEU . 34.3 tp -117.81 122.7 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.492 -0.755 . . . . 0.0 109.161 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.79 121.28 5.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 56.7 mt -101.62 128.05 48.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 108.417 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.83 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 54.4 p30 -102.91 169.54 8.52 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.367 -0.833 . . . . 0.0 109.017 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.9 m -57.81 129.51 42.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.942 -1.099 . . . . 0.0 109.09 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.32 -66.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 109.277 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.69 53.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -90.09 51.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -1.202 . . . . 0.0 109.139 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 97.0 mt-10 -59.39 -33.47 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.922 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -45.74 -34.88 3.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.021 -1.049 . . . . 0.0 110.517 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.22 -6.27 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.846 -1.159 . . . . 0.0 109.556 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 62' ' ' GLU . 92.3 m-20 49.07 40.78 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 0.0 109.898 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -62.93 -33.77 76.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.938 -1.101 . . . . 0.0 110.064 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.4 mt -90.03 7.77 35.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 0.0 111.047 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -48.55 -47.99 68.99 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.639 -1.288 . . . . 0.0 110.003 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 73.4 Cg_endo -89.28 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.584 2.19 . . . . 0.0 112.598 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 72' ' ' TYR . 0.7 OUTLIER 168.7 96.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 0.0 109.01 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -62.96 -34.13 76.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 0.0 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -109.91 163.22 17.63 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 0.0 109.336 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.16 -71.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.597 2.198 . . . . 0.0 112.464 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -145.14 163.99 32.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 0.0 109.038 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -77.0 160.11 29.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.141 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -121.65 -46.65 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.25 142.5 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 109.903 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.04 128.56 55.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.029 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 50.0 mt -108.96 141.72 40.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.15 136.51 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.284 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.0 t -129.1 126.16 38.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 0.0 109.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.74 168.92 18.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.484 ' OG ' ' OE1' ' A' ' 116' ' ' GLN . 24.1 t -97.04 137.22 36.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 84' ' ' VAL . 10.8 p -85.37 -10.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.262 -0.899 . . . . 0.0 111.222 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.638 HG22 ' OE1' ' A' ' 116' ' ' GLN . 26.6 m -99.78 -0.93 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.73 -1.231 . . . . 0.0 110.215 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 12.2 t -101.52 122.4 48.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.17 -61.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.211 1.94 . . . . 0.0 113.096 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -52.43 -41.07 62.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.927 -1.108 . . . . 0.0 110.117 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 60.5 p -69.09 -18.68 64.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.974 . . . . 0.0 109.505 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CD1' HD13 ' A' ' 137' ' ' ILE . 61.7 t80 -70.36 -50.5 38.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -74.4 -34.57 63.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -53.56 -39.01 64.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.967 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.5 -33.47 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.66 -25.69 62.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 111.35 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.12 -9.45 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.705 -1.247 . . . . 0.0 111.472 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -112.04 -51.44 2.85 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 111.337 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.54 ' CH2' HG21 ' A' ' 9' ' ' VAL . 61.6 m95 -92.4 -7.12 48.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.185 -0.947 . . . . 0.0 112.432 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -94.33 -39.98 0.3 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.318 -1.489 . . . . 0.0 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.8 Cg_endo -91.94 -49.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 0.0 113.517 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -51.6 -39.77 58.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.452 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 101' ' ' ILE . 9.2 tp -81.68 -19.85 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.042 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 57.6 m -54.7 -38.33 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -56.4 -43.77 79.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 110.741 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -103.4 11.76 36.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.957 -1.09 . . . . 0.0 111.068 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 28.0 p -63.57 114.86 14.6 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.154 . . . . 0.0 109.468 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.16 -90.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.238 1.959 . . . . 0.0 112.632 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.48 ' C ' HG22 ' A' ' 108' ' ' THR . 27.1 mttt -87.81 -80.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.308 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER 173.42 58.67 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.226 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 108' ' ' THR . 48.1 Cg_endo -94.06 53.01 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.955 2.437 . . . . 0.0 111.899 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.66 128.26 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.876 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 153' ' ' LYS . 11.1 tp -124.89 116.5 22.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.16 125.55 44.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 108.99 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.89 134.49 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 110.201 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.5 127.02 8.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 3.3 t -132.05 168.01 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.638 ' OE1' HG22 ' A' ' 85' ' ' VAL . 21.9 tt0 84.99 20.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.693 ' O ' ' N ' ' A' ' 119' ' ' LEU . 39.0 pt -59.44 -155.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 108.401 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 57.99 -58.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.743 . . . . 0.0 110.255 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.693 ' N ' ' O ' ' A' ' 117' ' ' ILE . 27.9 tp -51.78 -31.79 28.38 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.04 -1.037 . . . . 0.0 108.598 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -49.44 -17.63 0.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.765 . . . . 0.0 109.482 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -118.87 62.55 0.78 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 109.006 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.65 94.29 26.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.28 -44.72 23.77 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.278 1.985 . . . . 0.0 112.618 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -55.59 -36.05 66.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.052 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.57 HG21 HD11 ' A' ' 119' ' ' LEU . 69.1 p -78.0 -42.7 31.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.864 -1.147 . . . . 0.0 108.246 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.4 -39.0 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.28 -40.06 81.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.873 . . . . 0.0 108.695 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -59.79 -43.17 94.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.744 . . . . 0.0 109.152 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.51 -29.7 56.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.858 . . . . 0.0 109.264 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.7 -41.41 43.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.549 -0.719 . . . . 0.0 109.605 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.21 -36.65 75.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.91 6.47 24.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.858 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.9 mttt 58.09 43.3 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.89 138.81 35.97 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.177 -0.952 . . . . 0.0 109.08 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.37 154.24 53.98 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -46.25 147.39 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.238 1.959 . . . . 0.0 111.819 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.462 HD13 ' CD1' ' A' ' 90' ' ' PHE . 86.5 mt -75.58 148.98 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.96 154.9 55.53 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.264 -0.898 . . . . 0.0 109.193 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.8 -36.2 91.87 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.432 2.088 . . . . 0.0 111.777 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.98 -36.68 80.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.631 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 61.6 m -68.66 -36.75 78.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.153 -0.967 . . . . 0.0 108.84 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.31 64.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.567 -0.708 . . . . 0.0 110.008 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.38 -32.07 73.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -61.12 -36.52 79.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.81 -1.182 . . . . 0.0 109.23 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.1 tp -54.74 -39.88 68.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -68.67 -46.04 70.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.577 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -83.71 5.02 26.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.908 . . . . 0.0 110.143 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -61.43 -36.13 79.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.965 -1.084 . . . . 0.0 109.425 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.4 mt -126.16 -73.79 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 109.46 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -169.89 55.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 0.0 109.876 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -71.04 143.52 50.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.991 -1.068 . . . . 0.0 109.244 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.645 HG12 ' HG3' ' A' ' 153' ' ' LYS . 99.3 t -67.33 -56.58 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.104 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.645 ' HG3' HG12 ' A' ' 152' ' ' VAL . 66.0 mttm -159.3 164.99 34.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.173 -0.954 . . . . 0.0 109.912 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -131.06 146.93 52.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 108.908 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 t -132.26 140.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.47 129.96 52.43 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 150.16 43.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.93 -1.106 . . . . 0.0 111.297 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 117' ' ' ILE . 21.5 t -114.56 106.46 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -73.8 -34.5 64.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 109.621 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.32 -24.19 27.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.2 p -123.24 168.74 12.06 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -78.17 11.81 2.16 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.686 -0.634 . . . . 0.0 109.614 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 49.3 mttt -90.64 -5.76 55.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.035 -1.04 . . . . 0.0 109.85 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.49 -50.46 3.58 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.449 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.686 ' N ' HD12 ' A' ' 165' ' ' LEU . 7.8 mp -65.73 -41.01 92.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.211 . . . . 0.0 110.275 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -59.12 -31.3 68.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 163' ' ' LYS . 21.1 m120 -78.33 -50.7 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.926 -1.108 . . . . 0.0 110.102 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 172' ' ' ALA . 91.8 t -77.27 -12.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 173' ' ' ILE . 72.5 t80 -80.46 -50.53 9.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.679 -1.263 . . . . 0.0 110.593 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.03 -45.88 92.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.526 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.5 -33.0 68.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.165 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 168' ' ' VAL . . . -59.59 -33.44 71.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.112 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 169' ' ' PHE . 88.5 mt -65.86 -36.28 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 0.0 110.504 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 174' ' ' LEU . 4.0 mm? -58.22 -44.01 87.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.113 . . . . 0.0 109.597 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.6 -33.89 76.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.043 . . . . 0.0 109.156 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.438 ' HA ' HD13 ' A' ' 4' ' ' ILE . . . -57.6 -38.75 75.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 52.7 mt -59.91 -39.73 86.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -0.936 . . . . 0.0 108.792 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 99.989999999999995 109.329 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.87 -31.75 71.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.509 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -123.3 160.59 26.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.779 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 176' ' ' ALA . 33.2 mm -116.64 119.0 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -87.03 121.97 30.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.037 -1.04 . . . . 0.0 109.786 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.2 t -138.13 128.37 25.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.93 143.05 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -0.83 . . . . 0.0 109.546 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.82 133.01 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.059 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.591 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 26.5 t -131.45 136.07 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.23 147.65 17.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' ALA . 25.2 t70 -85.6 111.49 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.059 -1.26 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 54.42 -85.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.23 123.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -1.127 . . . . 0.0 109.567 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.71 -43.06 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.59 57.69 0.42 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -63.36 -40.72 98.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 0.0 109.728 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -82.82 -32.64 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -31.22 72.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.23 -42.41 79.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.97 -1.081 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.9 -40.92 91.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.41 -35.24 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.3 p -50.75 -36.61 37.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 110.459 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -76.62 -37.64 56.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.083 . . . . 0.0 109.677 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.8 p -63.64 -37.69 88.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 111.692 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -162.08 -5.85 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.371 -1.456 . . . . 0.0 111.885 -179.051 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.7 t30 95.17 115.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -179.78 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.85 -42.52 83.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.778 -1.202 . . . . 0.0 109.82 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.3 Cg_exo -57.75 -31.72 92.9 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.48 2.12 . . . . 0.0 112.201 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.5 p 37.68 37.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.568 -0.707 . . . . 0.0 109.768 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 30' ' ' SER . 97.1 mt-10 -36.15 -37.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 110.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 33' ' ' VAL . 68.6 t80 -125.79 122.05 35.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 108.699 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.433 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 17.1 m -63.6 148.64 93.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.125 -0.984 . . . . 0.0 109.159 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.65 141.34 91.4 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.223 1.949 . . . . 0.0 112.149 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.95 71.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.939 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.75 155.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 110.067 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.32 25.91 10.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.098 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 89.1 m-20 -60.77 143.67 54.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 110.378 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 55' ' ' LEU . 46.3 t-20 -74.12 152.42 39.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.716 . . . . 0.0 109.563 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 95.9 m-85 -127.87 146.53 50.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.43 134.94 49.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.03 152.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 109.43 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p -118.31 143.83 46.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.45 138.67 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 109.815 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.6 mtt -79.11 126.87 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 0.0 109.171 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' GLY . 70.5 mt -131.56 126.2 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.196 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.93 18.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 88.81 12.95 63.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.6 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.1 mm-40 -123.24 81.87 52.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.466 -1.02 . . . . 0.0 109.118 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 124.05 15.33 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.677 2.252 . . . . 0.0 112.91 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.6 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 96.7 m-85 -115.49 142.68 46.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.4 m -75.56 135.09 40.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.922 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -123.09 125.06 44.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.79 132.38 10.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 73.1 mt -104.57 135.2 46.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -1.105 . . . . 0.0 109.022 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.11 155.68 32.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 109.752 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.1 p30 -150.24 178.04 9.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 47.5 m -66.25 138.66 57.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 0.0 109.198 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 176.49 145.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -87.77 -179.6 47.59 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 63' ' ' ASP . 42.1 tt0 44.6 16.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -1.138 . . . . 0.0 109.263 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 64' ' ' TYR . 84.7 tt0 -44.78 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 65' ' ' ASP . 96.7 m-20 -25.1 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.819 0.342 . . . . 0.0 110.169 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.6 m-85 -8.91 72.86 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.283 0.563 . . . . 0.0 111.872 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' A' ' 63' ' ' ASP . 94.6 m-20 -94.79 -6.1 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.443 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.75 74.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.481 -0.762 . . . . 0.0 109.655 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.28 -38.18 85.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.927 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.723 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 2.4 ttp180 -112.46 -43.21 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.347 -0.845 . . . . 0.0 109.946 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.723 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.0 Cg_exo -61.26 -2.4 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.967 2.444 . . . . 0.0 112.379 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.9 tp -51.43 -38.53 54.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.2 t -109.25 137.28 47.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.057 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 52.19 58.75 15.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 108.912 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.11 141.3 97.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.662 2.241 . . . . 0.0 112.799 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -131.04 137.96 49.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -124.14 151.31 44.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.346 -0.846 . . . . 0.0 109.722 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -65.6 -35.62 81.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG21 ' HB1' ' A' ' 175' ' ' ALA . 35.9 t -138.54 133.33 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.99 128.59 49.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 108.981 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.4 tp -113.43 132.04 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.395 -0.815 . . . . 0.0 109.855 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.14 135.4 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 0.0 109.225 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.8 t -130.52 126.15 36.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 110.021 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.47 168.41 19.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 108.86 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 m -108.01 145.93 33.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.472 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 84' ' ' VAL . 14.9 p -103.79 13.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.039 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.78 -21.54 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.43 150.28 68.1 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.257 -0.902 . . . . 0.0 110.061 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.95 -33.21 3.84 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.737 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 t -55.67 -44.63 77.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.005 . . . . 0.0 109.493 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.735 ' O ' HG23 ' A' ' 93' ' ' VAL . 40.9 m -66.36 -24.68 66.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.155 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -73.5 -51.26 17.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.458 -0.776 . . . . 0.0 109.524 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.51 -39.95 70.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.091 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.46 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 42.0 t30 -54.32 -35.28 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 89' ' ' SER . 65.7 t -59.06 -34.54 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 0.0 109.735 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -86.82 -22.84 25.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 0.0 110.406 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -75.44 -30.68 60.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' NZ ' ' OD1' ' A' ' 11' ' ' ASP . 7.6 ttpm? -112.53 -47.38 3.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.014 -1.054 . . . . 0.0 112.223 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.591 ' CZ2' ' CG1' ' A' ' 9' ' ' VAL . 77.1 m95 -80.8 1.36 30.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.093 -1.004 . . . . 0.0 113.35 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.607 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -107.76 -41.74 0.13 Allowed Pre-proline 0 N--CA 1.503 2.192 0 O-C-N 120.402 -1.436 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 24.3 Cg_endo -88.71 -53.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.984 2.456 . . . . 0.0 112.691 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -57.03 -37.11 71.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -66.12 -29.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.027 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.9 m -60.03 -45.31 93.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.931 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.16 -35.07 76.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.737 ' HD1' ' HB2' ' A' ' 105' ' ' CYS . 30.7 t-80 -64.32 -40.91 96.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.95 . . . . 0.0 109.79 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.737 ' HB2' ' HD1' ' A' ' 104' ' ' HIS . 0.1 OUTLIER 171.88 165.74 0.24 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 109.939 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 75.8 Cg_exo -43.25 171.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.761 2.307 . . . . 0.0 112.228 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.44 140.86 55.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 110.02 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -124.94 160.28 54.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.81 122.6 11.29 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.178 1.919 . . . . 0.0 111.748 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 108' ' ' THR . 76.3 m-85 -122.86 149.59 43.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.109 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.437 ' C ' HD22 ' A' ' 112' ' ' LEU . 85.1 mt -112.98 120.01 39.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 112' ' ' LEU . 3.5 mm? -97.06 111.57 23.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 0.0 108.762 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.609 HG13 HG23 ' A' ' 155' ' ' VAL . 47.9 t -108.3 135.4 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.76 122.84 7.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.7 p -122.14 160.9 24.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -1.068 . . . . 0.0 110.477 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.504 ' CB ' ' O ' ' A' ' 115' ' ' THR . 4.4 tp-100 79.99 18.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.992 -0.443 . . . . 0.0 110.233 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.654 ' O ' ' N ' ' A' ' 119' ' ' LEU . 29.0 pt -60.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.723 -1.236 . . . . 0.0 108.149 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 61.06 -62.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.654 ' N ' ' O ' ' A' ' 117' ' ' ILE . 48.7 tp -55.1 -34.75 63.94 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.089 -1.007 . . . . 0.0 108.612 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -61.8 -19.75 62.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.013 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -90.14 -19.59 24.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.692 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.38 141.9 80.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.42 -29.94 19.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.427 2.085 . . . . 0.0 112.679 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -58.26 -41.78 85.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 49.3 m -72.11 -47.63 49.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.982 -1.074 . . . . 0.0 108.188 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.3 mt -55.09 -36.28 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.834 -0.541 . . . . 0.0 109.641 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.84 -46.95 79.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -59.06 -38.12 78.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 83.5 mt -79.14 -35.9 41.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 109.642 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.97 66.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -60.9 -36.17 78.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.1 5.61 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 52.97 32.81 13.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 135' ' ' LYS . 93.5 mt-30 -96.12 -53.06 3.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 109.606 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.489 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 10.9 mttm 62.36 144.86 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.456 -0.778 . . . . 0.0 109.092 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.05 150.69 87.91 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.538 2.159 . . . . 0.0 112.58 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 91.9 mt -89.07 146.95 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.418 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.28 157.73 55.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.375 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.93 -28.8 81.36 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.528 2.152 . . . . 0.0 111.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.7 -38.11 86.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.343 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 m -66.76 -36.16 81.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.147 -0.971 . . . . 0.0 109.019 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.35 -39.98 62.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 0.0 109.796 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -60.18 -34.35 73.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.521 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -64.13 -37.63 88.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.013 -1.054 . . . . 0.0 109.922 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.8 tp -58.19 -40.23 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.861 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.83 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -87.85 -52.01 5.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 147' ' ' ARG . 29.6 ttt-85 -51.34 -7.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 146' ' ' ALA . 84.4 m-20 -111.57 -15.82 13.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.971 -1.081 . . . . 0.0 109.835 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.37 29.59 6.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 0.0 111.06 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.0 mttt 58.5 30.56 19.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.9 -1.125 . . . . 0.0 110.88 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.83 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -71.51 144.95 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 108.83 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.45 -52.25 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.063 . . . . 0.0 109.771 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HZ2' ' CG ' ' A' ' 171' ' ' GLU . 47.1 pttt -175.92 -179.22 1.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.352 -0.843 . . . . 0.0 109.804 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -137.78 153.99 49.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.609 HG23 HG13 ' A' ' 113' ' ' VAL . 33.6 m -137.34 148.38 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.61 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.22 134.6 52.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.861 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.01 149.75 42.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 110.875 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.2 t -113.04 109.47 18.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.08 -36.45 61.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.712 -0.618 . . . . 0.0 109.564 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 61.0 mt -53.88 -26.95 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.645 179.886 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 p -124.05 170.24 10.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.32 12.0 1.36 Allowed 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.396 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 89.1 mttt -89.5 0.01 57.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 0.0 109.714 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.85 -51.13 2.71 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.298 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.697 ' N ' HD12 ' A' ' 165' ' ' LEU . 7.5 mp -68.74 -41.25 79.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -1.221 . . . . 0.0 110.246 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -59.55 -35.61 74.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.477 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 19.4 m120 -76.89 -49.39 15.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.532 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 168' ' ' VAL . 74.8 t -68.4 -9.34 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.536 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 173' ' ' ILE . 72.1 t80 -74.35 -46.21 42.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.58 -49.31 77.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.993 -1.067 . . . . 0.0 111.367 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 167' ' ' ASN . 60.3 mp0 -70.72 -35.67 72.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.846 -1.159 . . . . 0.0 110.373 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.34 80.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.813 HD11 ' CE2' ' A' ' 169' ' ' PHE . 97.8 mt -63.47 -38.68 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.029 -1.045 . . . . 0.0 109.915 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.37 -43.64 79.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -0.976 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.45 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.51 -36.22 83.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 109.913 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.498 ' HA ' HG21 ' A' ' 4' ' ' ILE . . . -52.76 -37.75 59.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.585 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.13 -36.55 82.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 108.997 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.446 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -122.24 117.47 26.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 0.0 109.559 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -143.08 154.91 44.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.767 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.54 HD13 ' HB1' ' A' ' 176' ' ' ALA . 61.3 mt -122.45 122.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.497 -0.752 . . . . 0.0 109.127 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -87.0 131.91 33.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.74 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 126.51 12.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.35 137.54 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 HD22 ' A' ' 79' ' ' LEU . 59.9 t -116.8 130.55 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.16 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -138.51 156.81 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.45 167.6 31.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.577 ' CG ' HD22 ' A' ' 92' ' ' ASN . 61.1 t0 -86.0 121.82 29.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.079 . . . . 0.0 109.451 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.695 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 71.05 -107.7 2.25 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 164.76 42.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.377 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.953 HG13 ' H ' ' A' ' 15' ' ' GLY . 1.7 p -72.17 -85.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.061 -1.025 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.953 ' H ' HG13 ' A' ' 14' ' ' VAL . . . -99.2 16.12 59.57 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -59.76 -38.19 81.09 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.5 p -74.29 -35.5 63.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.994 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.647 ' SG ' ' NZ ' ' A' ' 27' ' ' LYS . 89.4 m -59.82 -30.76 69.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.0 tp -67.7 -42.44 81.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.902 -1.124 . . . . 0.0 110.268 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.09 -43.77 61.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 111.059 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 22' ' ' SER . 9.9 tp -65.85 -38.81 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 0.0 110.184 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 25.7 m -54.69 -34.62 62.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.046 . . . . 0.0 110.307 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CZ ' ' A' ' 169' ' ' PHE . 82.3 t80 -70.13 -38.05 75.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.525 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.566 ' C ' HG22 ' A' ' 25' ' ' THR . 28.5 m -52.61 -37.2 57.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.932 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 179.75 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 110.584 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.606 ' CB ' ' O ' ' A' ' 25' ' ' THR . 25.2 t-20 96.1 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.647 ' NZ ' ' SG ' ' A' ' 18' ' ' CYS . 53.7 tttt -64.53 -41.0 96.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.205 0.526 . . . . 0.0 111.023 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 27' ' ' LYS . 1.5 m-85 -42.94 -61.41 1.75 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.728 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 54.4 Cg_endo -70.53 23.87 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.463 2.109 . . . . 0.0 112.632 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 68.8 m -137.76 -62.0 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.116 -0.99 . . . . 0.0 109.546 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.23 11.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 30' ' ' SER . 78.4 m-85 -91.59 -101.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 109.709 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 33' ' ' VAL . 3.5 p 34.15 60.04 2.03 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.655 . . . . 0.0 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 33' ' ' VAL . 69.7 Cg_endo -84.23 -73.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.392 2.061 . . . . 0.0 111.863 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' ' CE2' ' A' ' 37' ' ' PHE . . . -65.35 156.46 32.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 p -74.02 140.59 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 98.2 m-85 -118.13 159.2 23.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.531 -0.731 . . . . 0.0 109.646 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.0 p30 -72.91 -167.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.842 . . . . 0.0 109.97 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.35 157.08 6.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -110.33 130.89 55.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.386 -0.821 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 121.61 44.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.36 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' A' ' 23' ' ' TYR . 48.4 t -127.57 134.9 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.493 -0.754 . . . . 0.0 109.369 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 m -98.55 138.79 35.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.26 134.57 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.453 -0.78 . . . . 0.0 109.514 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.0 mtp -107.29 141.78 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 0.0 109.568 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 48' ' ' GLY . 73.7 mt -124.68 139.86 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.51 -24.02 0.59 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -82.89 -93.59 0.59 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.533 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 13.6 mm-40 -123.11 152.44 63.46 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.424 -1.045 . . . . 0.0 109.973 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.29 141.4 35.5 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.647 2.231 . . . . 0.0 112.224 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 98.9 m-85 -137.81 159.43 42.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 109.739 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -112.01 142.86 43.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 109.116 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -120.86 123.17 41.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.422 -0.799 . . . . 0.0 109.691 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.03 129.71 8.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.1 mt -107.74 136.59 47.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -118.86 146.26 45.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.765 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 52.6 p30 -156.79 164.81 37.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.422 -0.798 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -67.49 137.08 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.93 134.35 42.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.851 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.09 -29.99 69.45 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -76.2 48.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -1.166 . . . . 0.0 109.529 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.84 -29.79 63.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.597 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.37 -23.44 66.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 111.04 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -110.4 9.12 23.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 66' ' ' ARG . 85.3 m-20 -51.87 -42.4 62.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.0 109.471 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' C ' ' O ' ' A' ' 65' ' ' ASP . 25.7 ttt-85 25.98 58.63 0.06 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.17 0.51 . . . . 0.0 110.748 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -93.44 134.41 35.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 109.838 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.736 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 4.5 ttt180 -126.76 -45.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.56 -0.713 . . . . 0.0 109.738 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.736 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.4 Cg_exo -69.02 -16.0 40.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.478 2.119 . . . . 0.0 111.811 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt -106.46 70.28 0.82 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 86.0 p -71.71 -28.15 63.5 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 109.153 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 7.6 t80 -147.41 86.75 6.26 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.776 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.56 146.63 25.63 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.526 2.151 . . . . 0.0 112.001 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -108.08 151.72 25.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 109.762 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 78' ' ' PHE . 58.7 m -141.62 126.82 18.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.826 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.74 -25.26 13.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.014 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.49 131.72 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.444 -0.785 . . . . 0.0 109.414 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.644 ' CD2' HD11 ' A' ' 101' ' ' ILE . 95.5 m-85 -105.71 127.75 53.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.237 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.425 HD22 HG22 ' A' ' 8' ' ' VAL . 7.2 tt -118.24 129.89 55.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.428 -0.795 . . . . 0.0 110.246 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 111' ' ' LEU . 25.3 m -129.47 148.88 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 140.92 34.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.87 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 112' ' ' LEU . 15.8 p90 -154.98 157.33 37.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.5 p -83.37 157.03 22.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 109.441 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 84' ' ' VAL . 7.1 p -100.56 6.57 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 0.0 110.177 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.774 HG11 HD23 ' A' ' 119' ' ' LEU . 14.9 m -104.13 0.44 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 110.333 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.51 95.85 41.43 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 109.843 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.56 -48.87 19.22 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.298 1.999 . . . . 0.0 112.284 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 m -53.49 -40.47 65.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.046 . . . . 0.0 109.141 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -67.36 -19.75 65.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.084 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -68.66 -50.92 47.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 108.742 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.92 -34.63 75.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.395 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.577 HD22 ' CG ' ' A' ' 11' ' ' ASP . 48.3 t30 -54.25 -34.41 60.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.885 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.55 -37.71 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -91.94 -44.41 8.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 110.738 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.2 -36.71 82.76 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 112.199 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -114.53 -52.31 2.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.952 -1.093 . . . . 0.0 112.901 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.6 -38.48 80.66 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.075 -1.016 . . . . 0.0 113.487 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.1 t -57.48 -52.01 77.46 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.134 -1.604 . . . . 0.0 111.084 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -70.94 -37.79 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.717 1.611 . . . . 0.0 112.787 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.97 -40.79 85.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.644 HD11 ' CD2' ' A' ' 78' ' ' PHE . 9.1 tp -65.01 -28.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.755 -1.215 . . . . 0.0 109.538 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -61.64 -40.84 96.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.939 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -54.52 -40.65 68.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.521 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 64.8 m170 -57.39 -40.33 77.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 109.22 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.1 m 177.83 150.75 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.399 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.15 -27.85 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.639 2.226 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -127.64 137.84 52.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.76 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.464 ' OG1' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -175.61 147.71 0.96 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.073 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.84 122.01 8.91 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.217 1.945 . . . . 0.0 111.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -108.7 123.8 49.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.495 ' O ' HG22 ' A' ' 80' ' ' VAL . 29.6 tp -117.47 125.18 50.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 109.314 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 82' ' ' PHE . 49.5 tp -109.81 119.1 38.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.4 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 135.58 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.905 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.82 125.78 8.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.0 p -124.07 163.87 20.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -1.093 . . . . 0.0 110.575 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 68.74 33.95 3.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.802 -0.561 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 pt -74.29 -2.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 0.0 110.723 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.5 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 80.0 m-20 -84.26 -26.55 28.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.861 -1.15 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.774 HD23 HG11 ' A' ' 85' ' ' VAL . 28.2 tp -60.86 -30.93 70.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 109.265 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -57.74 -25.38 60.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.644 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -99.99 26.81 6.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -111.64 95.73 29.1 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.88 -44.14 38.09 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.174 1.916 . . . . 0.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -57.94 -37.03 73.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.187 -0.946 . . . . 0.0 109.483 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.665 HG21 HD21 ' A' ' 119' ' ' LEU . 30.1 m -73.85 -47.65 36.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -54.34 -34.78 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -62.5 -46.56 87.86 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -59.5 -36.84 76.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.454 -0.779 . . . . 0.0 108.976 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.443 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 77.8 mt -73.42 -37.53 65.87 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.32 75.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.676 -0.64 . . . . 0.0 109.764 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -59.18 -37.52 77.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.986 -1.071 . . . . 0.0 109.168 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -90.89 4.96 50.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.472 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.1 mttp 52.36 35.46 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.838 . . . . 0.0 109.496 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 135' ' ' LYS . 97.8 mt-30 -92.84 -53.84 4.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 7.1 mttt 62.09 144.37 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.056 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 147.25 87.63 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.58 2.186 . . . . 0.0 112.487 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -78.22 149.81 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.79 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 154.32 60.57 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.992 -1.067 . . . . 0.0 109.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.65 -33.52 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.318 2.012 . . . . 0.0 111.819 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.05 -36.03 80.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.649 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.3 m -68.22 -36.99 80.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 109.245 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.5 -44.3 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -0.811 . . . . 0.0 110.099 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.587 ' OE2' ' CE2' ' A' ' 154' ' ' TYR . 99.1 mt-10 -63.67 -32.32 73.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.02 . . . . 0.0 110.35 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.528 ' NZ ' ' OD2' ' A' ' 148' ' ' ASP . 13.2 tttm -65.95 -38.17 87.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.923 -1.111 . . . . 0.0 110.157 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.99 -39.32 81.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.689 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -78.75 -49.74 12.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 110.018 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -60.3 -2.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.306 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.528 ' OD2' ' NZ ' ' A' ' 144' ' ' LYS . 86.2 m-20 -111.29 -21.58 11.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.041 . . . . 0.0 109.91 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.57 26.74 8.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.494 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 59.79 31.03 20.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.224 -0.922 . . . . 0.0 110.613 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.689 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -66.11 144.75 56.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.0 . . . . 0.0 108.866 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.94 -59.62 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -165.31 157.26 15.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.755 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CE2' ' OE2' ' A' ' 143' ' ' GLU . 21.1 p90 -117.4 144.31 45.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.8 t -131.09 138.51 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -102.13 129.01 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.455 ' HB2' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -138.24 146.52 42.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -0.999 . . . . 0.0 111.312 -178.07 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.5 ' OG ' ' OD2' ' A' ' 118' ' ' ASP . 23.6 t -115.69 110.4 19.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.461 -0.775 . . . . 0.0 109.044 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.51 61.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.761 -0.587 . . . . 0.0 109.785 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -53.75 -32.14 51.15 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 22.2 p -125.1 166.45 16.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.518 ' OE1' ' ND2' ' A' ' 26' ' ' ASN . 29.3 mm100 -70.1 12.31 0.23 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 161' ' ' THR . 48.6 mtmt -89.41 9.4 26.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.262 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 158' ' ' SER . . . -105.37 -50.64 0.91 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.436 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 23' ' ' TYR . 43.8 mt -63.02 -36.7 84.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -1.234 . . . . 0.0 110.097 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -58.62 -29.75 66.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.999 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -94.74 -41.93 9.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.958 -1.088 . . . . 0.0 110.39 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 157' ' ' CYS . 80.4 t -60.52 -38.52 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 111.174 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 50.9 m-85 -89.94 -13.56 36.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.772 -1.205 . . . . 0.0 111.296 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.6 -50.34 72.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.715 -1.241 . . . . 0.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -80.79 -21.98 40.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 110.003 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.58 77.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.421 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.65 -43.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.912 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.34 -44.27 88.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.39 80.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.698 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.54 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -60.56 -43.17 97.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.58 -40.38 94.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.115 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.477 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 50.25 25.37 1.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 108.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.2 m -123.88 145.28 49.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.156 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HB ' HD12 ' A' ' 53' ' ' LEU . 30.7 mm -109.86 115.18 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.17 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -82.87 122.57 28.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.5 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 53' ' ' LEU . 47.3 t -132.57 119.23 20.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.311 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.93 138.79 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.04 131.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.57 139.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.101 -0.999 . . . . 0.0 109.384 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.13 165.0 31.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 23.2 t70 -80.68 86.46 5.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.176 -1.191 . . . . 0.0 109.353 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.5 86.86 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.68 -5.41 45.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -1.095 . . . . 0.0 109.395 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.21 -58.06 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.66 16.12 26.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' NZ ' ' OD1' ' A' ' 57' ' ' ASP . 46.9 tttm -63.33 -41.14 98.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.828 -1.395 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 p -68.71 -43.24 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 110.183 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -61.88 -28.56 69.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 110.766 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.441 HD22 ' SG ' ' A' ' 81' ' ' CYS . 46.7 tp -66.39 -43.48 85.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.878 -1.139 . . . . 0.0 109.785 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.09 -40.6 82.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.652 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.67 -44.31 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.299 -0.875 . . . . 0.0 109.852 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 m -49.97 -35.04 22.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.171 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -89.55 -48.51 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.839 -1.163 . . . . 0.0 110.04 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.431 HG22 HG23 ' A' ' 25' ' ' THR . 37.0 m -57.35 -42.05 81.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 111.764 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 65.6 p -140.66 -12.34 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 111.683 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 25' ' ' THR . 3.4 m-20 86.4 115.48 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ASN . 16.4 mttt 164.48 76.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.613 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -62.19 -42.4 80.91 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 110.108 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.4 Cg_exo -55.58 -38.6 93.98 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.372 2.048 . . . . 0.0 112.335 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.627 ' O ' ' N ' ' A' ' 32' ' ' TYR . 1.8 p 64.55 -50.29 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 109.869 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 29' ' ' PRO . 96.4 mt-10 57.02 -72.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.673 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.627 ' N ' ' O ' ' A' ' 30' ' ' SER . 81.9 t80 -107.07 124.62 49.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 1.8 m -64.5 152.95 88.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.55 136.18 72.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.544 2.163 . . . . 0.0 112.337 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.63 71.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.753 . . . . 0.0 110.098 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.7 155.74 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.566 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -107.68 94.15 4.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -123.24 147.81 46.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -70.63 149.09 47.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.316 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -121.28 146.37 46.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.51 146.45 41.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 109.455 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.93 141.92 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.5 m -97.75 134.55 40.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 51' ' ' TYR . 33.9 t -120.75 136.63 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.0 ttt -105.03 140.05 38.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 0.0 109.946 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 48' ' ' GLY . 67.0 mt -119.77 143.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 0.0 109.055 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.64 -30.96 9.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.281 -1.928 . . . . 0.0 108.281 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -72.46 -96.19 0.08 OUTLIER Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -123.03 156.59 62.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.961 . . . . 0.0 109.376 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.03 138.4 43.84 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.651 2.234 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CD2' HD12 ' A' ' 46' ' ' ILE . 98.8 m-85 -141.86 162.9 34.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 p -118.87 155.74 30.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 6' ' ' CYS . 35.8 tp -118.73 118.27 31.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -0.751 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.73 124.67 7.73 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.637 HD13 ' N ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -107.86 121.69 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -1.113 . . . . 0.0 108.481 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.637 ' N ' HD13 ' A' ' 55' ' ' LEU . 99.1 m-85 -121.29 149.38 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.281 -0.887 . . . . 0.0 109.691 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' NZ ' ' A' ' 16' ' ' LYS . 21.7 t70 -153.51 157.91 40.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 p -75.74 152.26 37.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 0.0 109.362 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -160.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 0.0 109.36 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' OE2' ' A' ' 62' ' ' GLU . . . -54.06 -52.53 42.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -61.99 133.94 55.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -1.202 . . . . 0.0 109.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 63' ' ' ASP . 53.2 mp0 -116.74 -43.23 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 65' ' ' ASP . 90.3 m-20 -28.17 -67.77 0.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.086 -0.384 . . . . 0.0 111.685 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 12.1 p90 -56.49 15.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.809 -1.182 . . . . 0.0 111.649 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.599 ' H ' ' C ' ' A' ' 63' ' ' ASP . 54.2 p30 -89.36 2.25 54.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.654 -1.279 . . . . 0.0 109.558 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -60.3 -36.94 79.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.0 mt 46.43 72.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.496 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -61.07 169.48 2.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 108.803 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -46.1 -10.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.345 2.03 . . . . 0.0 112.134 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ARG . 30.2 tp -57.67 -45.91 84.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 0.0 108.793 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -125.08 142.38 51.53 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -138.0 79.87 31.42 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.82 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -52.74 138.85 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.306 2.004 . . . . 0.0 111.535 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -100.36 122.17 42.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.593 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.5 m -114.37 131.6 56.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.524 -0.735 . . . . 0.0 109.403 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.25 -39.04 88.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.05 131.51 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.19 -0.944 . . . . 0.0 109.957 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -102.95 125.37 49.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 108.385 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 mt -108.27 141.47 40.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.179 -0.951 . . . . 0.0 110.543 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.908 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 51.6 t -124.94 135.08 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.524 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -127.86 126.46 41.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -136.55 166.03 24.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 0.0 109.434 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 m -104.24 148.54 26.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.583 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.719 ' O ' HG22 ' A' ' 84' ' ' VAL . 7.8 p -105.96 13.98 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.146 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.468 HG12 HD12 ' A' ' 119' ' ' LEU . 29.9 m -105.54 -6.81 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -127.81 102.96 21.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 109.85 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' A' ' 137' ' ' ILE . 50.1 Cg_exo -50.68 -41.82 52.56 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.036 1.824 . . . . 0.0 111.916 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -56.55 -37.4 70.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.163 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 m -69.6 -26.21 64.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.244 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.47 -50.9 41.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.55 -35.0 75.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.586 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 41.6 t-20 -56.52 -34.39 66.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 89' ' ' SER . 67.1 t -62.22 -36.84 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.088 -1.008 . . . . 0.0 109.972 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.93 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -80.27 -27.46 38.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 111.34 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -112.23 -44.76 3.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.054 -1.029 . . . . 0.0 112.479 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -85.76 1.95 47.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.903 -1.123 . . . . 0.0 113.072 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.648 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -109.16 -40.63 0.12 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.471 -1.393 . . . . 0.0 110.666 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.648 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 62.3 Cg_endo -92.36 -56.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.275 2.65 . . . . 0.0 113.253 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.6 -35.28 75.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.892 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.69 -28.85 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.71 -1.244 . . . . 0.0 110.121 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 m -59.24 -42.18 90.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 0.0 109.675 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.08 -32.55 69.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 0.0 109.691 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -63.21 -41.87 99.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 173.08 170.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 109.248 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' CYS . 51.9 Cg_exo -49.01 -164.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.503 2.136 . . . . 0.0 112.348 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' NZ ' HD13 ' A' ' 149' ' ' LEU . 64.0 mttm -80.98 138.28 36.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 168.77 16.06 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -40.37 98.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.574 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.908 ' CZ ' HG21 ' A' ' 80' ' ' VAL . 63.8 t80 -109.38 128.89 55.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.563 -0.711 . . . . 0.0 109.957 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 153' ' ' LYS . 15.3 tp -120.16 124.07 44.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 112' ' ' LEU . 39.0 tp -103.67 120.37 40.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.186 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.429 HG13 HG23 ' A' ' 155' ' ' VAL . 38.8 t -108.95 134.42 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.92 113.0 3.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 116' ' ' GLN . 13.9 m -103.11 148.79 25.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -1.13 . . . . 0.0 110.284 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' A' ' 115' ' ' THR . 92.1 mt-30 62.83 38.5 11.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 122.052 -0.405 . . . . 0.0 111.491 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 116' ' ' GLN . 21.0 pt -57.99 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 121' ' ' ASP . 88.6 m-20 52.3 18.51 0.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.364 -1.46 . . . . 0.0 109.146 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.3 tp 30.81 52.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.817 -0.552 . . . . 0.0 111.509 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 121' ' ' ASP . 97.8 mtt180 54.24 22.39 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.501 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 118' ' ' ASP . 60.9 t0 33.22 61.38 0.42 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.718 -0.614 . . . . 0.0 110.257 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 120' ' ' ARG . 81.0 m-20 -132.34 85.56 48.51 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.34 -28.33 26.6 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.5 2.133 . . . . 0.0 112.118 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -81.76 -4.34 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.066 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 98.8 m -92.83 -47.93 6.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.201 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -76.97 -48.49 25.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 110.253 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -60.8 -39.95 90.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 111.098 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -83.01 -6.61 59.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.544 -1.347 . . . . 0.0 110.39 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 129' ' ' LEU . 91.2 mt -115.45 -49.98 2.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 135' ' ' LYS . . . -55.08 -46.55 75.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 109.02 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -48.5 -24.72 1.38 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -76.27 -55.3 5.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 134' ' ' GLN . 36.1 ttpt -173.99 76.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 0.0 110.169 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 133' ' ' LYS . 3.7 mp0 33.27 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.65 -0.657 . . . . 0.0 110.673 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.2 tptm -90.35 -38.82 0.41 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 110.973 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 71.8 Cg_endo -89.09 127.5 1.78 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.845 2.363 . . . . 0.0 113.308 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 4.2 mp -96.9 135.55 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 109.357 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.9 155.68 72.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.468 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.33 -32.71 96.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.373 2.049 . . . . 0.0 111.622 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.11 -36.94 73.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.221 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 m -67.79 -29.78 69.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.283 -0.885 . . . . 0.0 108.692 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.03 62.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 0.0 110.213 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.97 -35.65 75.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.951 -1.093 . . . . 0.0 110.708 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 94.8 mttt -63.85 -36.84 85.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.855 -1.153 . . . . 0.0 109.318 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.5 tp -53.24 -43.2 67.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.753 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -70.32 -45.39 66.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.01 1.09 21.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.878 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 87.9 m-20 -66.76 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.237 . . . . 0.0 109.742 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.404 HD13 ' NZ ' ' A' ' 107' ' ' LYS . 77.3 mt -121.52 -81.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.783 . . . . 0.0 109.722 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -162.76 54.16 0.2 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.753 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -68.23 137.4 54.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.855 -1.153 . . . . 0.0 109.106 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.595 HG12 ' HG3' ' A' ' 153' ' ' LYS . 81.4 t -66.78 -54.24 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.481 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.595 ' HG3' HG12 ' A' ' 152' ' ' VAL . 58.4 mttm -156.52 159.84 38.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -128.91 146.14 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.57 HG11 ' OE1' ' A' ' 171' ' ' GLU . 34.8 m -140.16 152.1 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 110.436 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 129.99 54.81 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -134.13 143.78 48.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.968 -1.083 . . . . 0.0 110.817 -178.603 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 161' ' ' THR . 9.5 t -115.18 110.25 19.2 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.379 0.609 . . . . 0.0 109.391 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.3 mt -55.03 -27.97 48.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.259 -0.9 . . . . 0.0 108.707 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.3 p -125.99 171.04 11.11 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -74.02 11.65 0.86 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.674 -0.641 . . . . 0.0 109.708 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -89.34 1.18 56.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.472 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -93.83 -51.15 2.17 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.38 -39.47 71.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -1.152 . . . . 0.0 110.259 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.16 -33.02 70.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.198 -0.939 . . . . 0.0 111.329 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.42 -50.32 46.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.811 -1.181 . . . . 0.0 109.354 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.22 1.63 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.496 -0.753 . . . . 0.0 110.449 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.6 -50.83 16.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.855 -1.153 . . . . 0.0 109.768 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.55 -43.88 83.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 110.014 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.57 ' OE1' HG11 ' A' ' 155' ' ' VAL . 97.1 mt-10 -66.31 -33.08 74.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 109.88 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.42 80.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.977 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 71.7 mt -73.12 -42.33 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.994 . . . . 0.0 109.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.1 tp -59.32 -46.31 88.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.69 78.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.98 66.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.459 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.61 -39.83 89.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.193 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.818 . . . . 99.989999999999995 109.514 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 59.1 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.382 -0.824 . . . . 0.0 109.011 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -138.71 161.68 36.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.888 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.2 120.23 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -93.12 130.74 38.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 t -135.0 129.65 34.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.1 t -117.89 142.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.857 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.13 133.69 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 ' CH2' ' A' ' 97' ' ' TRP . 46.7 t -140.35 134.0 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.129 -0.982 . . . . 0.0 109.491 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.55 99.83 0.15 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.36 -40.49 90.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.061 -1.258 . . . . 0.0 109.04 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -84.59 120.05 5.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 172.08 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.52 -41.72 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.11 0.79 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -61.13 -40.08 92.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -1.127 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -65.13 -41.81 94.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -30.32 65.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.12 -41.75 97.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.113 -0.992 . . . . 0.0 108.608 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.13 -39.73 82.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.225 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.5 mm -63.66 -48.17 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -58.83 -36.29 74.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 110.346 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -80.15 -50.87 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.5 m -60.39 -41.24 93.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.736 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 30.2 p -112.16 -111.42 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 109.186 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.555 ' N ' ' OG1' ' A' ' 25' ' ' THR . 37.1 p-10 -173.69 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -102.25 106.88 17.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -67.73 -42.77 36.52 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.264 -0.898 . . . . 0.0 108.876 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 31.4 Cg_exo -59.77 -26.66 82.88 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.655 2.237 . . . . 0.0 112.078 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.8 m 42.56 41.86 2.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 0.0 109.683 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 96.3 mt-10 -37.56 -35.7 0.14 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.432 -0.792 . . . . 0.0 110.456 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -117.31 122.76 44.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 33' ' ' VAL . 34.4 m -128.29 75.61 78.85 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.727 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 92.7 Cg_endo -84.28 -102.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.043 2.496 . . . . 0.0 112.329 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 34' ' ' PRO . . . 158.21 41.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.2 -41.66 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.935 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.25 130.41 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 39' ' ' ASN . 50.9 t0 -93.52 -144.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.572 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 63.5 t-20 -42.71 124.94 3.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.454 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 58.0 t80 -132.08 150.3 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.454 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -103.12 141.92 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.78 133.81 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.0 m -106.19 134.53 49.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.46 135.74 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.708 . . . . 0.0 109.353 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.8 mtm -105.67 141.26 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 109.324 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 48' ' ' GLY . 81.0 mt -122.99 141.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.365 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.1 -24.97 0.61 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -80.82 -92.37 0.48 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.6 mm-40 -126.45 154.32 75.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.405 -1.056 . . . . 0.0 109.717 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.71 138.26 37.56 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.729 2.286 . . . . 0.0 112.599 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.606 ' CD2' HD12 ' A' ' 46' ' ' ILE . 97.3 m-85 -131.76 154.19 49.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.9 p -118.0 148.19 42.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.828 . . . . 0.0 109.463 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.82 122.44 37.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 0.0 109.58 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.34 126.53 8.85 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.503 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 66.5 mt -105.1 137.22 43.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -1.175 . . . . 0.0 109.367 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.487 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.7 m-85 -122.25 149.82 43.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 109.022 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 56' ' ' PHE . 84.0 m-20 -136.82 161.53 35.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 162.73 21.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.171 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.72 151.3 33.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.372 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.51 45.34 1.32 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 63' ' ' ASP . 63.3 tt0 -99.27 120.81 40.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -1.115 . . . . 0.0 109.816 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' A' ' 64' ' ' TYR . 84.3 tt0 61.1 -65.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.677 -0.639 . . . . 0.0 110.222 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 61' ' ' GLN . 52.9 p30 -63.12 13.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.457 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 75.9 t80 -97.27 9.2 42.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.009 . . . . 0.0 109.129 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.19 -43.44 95.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.948 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -175.42 3.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 109.49 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HB3' HD21 ' A' ' 70' ' ' LEU . 55.5 mt -88.4 136.48 32.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 0.0 110.059 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.787 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 6.4 ttt180 -135.74 -42.96 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 0.0 110.436 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.787 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 14.0 Cg_exo -67.69 24.12 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.636 2.224 . . . . 0.0 112.182 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 71' ' ' SER . 70.7 mt -57.03 -31.97 65.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 0.0 109.571 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER 38.74 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 110.265 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 39.7 p90 -118.36 149.64 46.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 0.0 109.013 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.95 -37.23 44.97 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.32 2.013 . . . . 0.0 112.276 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -174.82 115.72 0.17 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 109.677 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.515 ' OG1' ' CD1' ' A' ' 72' ' ' TYR . 43.3 m -117.57 128.41 54.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 0.0 109.654 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -66.17 -33.92 76.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.957 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.09 132.67 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.354 -0.841 . . . . 0.0 109.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -111.63 126.26 54.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.024 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.2 140.35 44.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.922 . . . . 0.0 109.949 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.4 136.03 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 0.0 109.165 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.2 t -129.83 121.72 27.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 115' ' ' THR . 44.1 p90 -145.97 163.23 35.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 109.303 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -89.58 137.57 32.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -93.66 -12.64 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 119' ' ' LEU . 72.4 t -90.43 -13.82 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.035 -1.04 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 m -100.6 128.59 29.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.684 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.475 ' CG ' ' OE1' ' A' ' 134' ' ' GLN . 45.7 Cg_endo -73.55 -46.36 0.35 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.988 1.792 . . . . 0.0 112.298 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -55.31 -41.78 72.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.848 -1.158 . . . . 0.0 108.933 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 93' ' ' VAL . 84.2 p -68.29 -23.09 64.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.018 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.639 ' CE1' HG21 ' A' ' 137' ' ' ILE . 57.0 t80 -72.08 -50.82 25.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 0.0 109.319 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -67.91 -37.0 81.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.47 -34.38 57.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.684 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 89' ' ' SER . 74.4 t -61.41 -38.25 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 110.457 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -93.79 -32.79 13.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.91 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -68.49 -36.58 79.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.883 -1.135 . . . . 0.0 112.416 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -113.62 -52.0 2.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.886 -1.134 . . . . 0.0 112.619 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.444 ' CH2' HG11 ' A' ' 9' ' ' VAL . 72.7 m95 -67.54 -30.71 70.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.963 . . . . 0.0 113.026 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 101' ' ' ILE . 1.9 t -72.57 -51.06 7.43 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.141 -1.599 . . . . 0.0 111.439 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.68 -47.75 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.953 1.769 . . . . 0.0 113.23 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -58.08 -40.07 80.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 111.016 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 98' ' ' VAL . 1.9 tp -64.18 -24.55 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.223 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -57.76 -39.61 77.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 110.479 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -53.56 -32.5 51.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.685 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.45 ' CE1' ' CB ' ' A' ' 71' ' ' SER . 97.1 m-70 -84.45 7.1 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.054 . . . . 0.0 110.483 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.7 m 55.35 69.78 1.84 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.284 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.49 128.0 26.26 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.604 2.202 . . . . 0.0 112.472 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -151.73 -39.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -62.72 156.14 66.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.502 -0.749 . . . . 0.0 109.166 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.25 135.68 71.78 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.691 2.261 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 108' ' ' THR . 98.1 m-85 -116.58 137.76 51.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.0 109.356 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 111' ' ' LEU . 38.3 tp -117.53 124.76 49.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.451 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.51 120.43 40.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 108.853 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.92 137.54 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.848 . . . . 0.0 110.357 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.0 129.25 9.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 82' ' ' PHE . 9.9 t -118.14 156.92 27.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.136 -1.214 . . . . 0.0 111.18 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 61.36 38.42 16.24 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 pt -72.3 -3.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.096 . . . . 0.0 109.764 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 86.1 m-20 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 109.378 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.597 ' HB3' HG21 ' A' ' 85' ' ' VAL . 43.7 tp -57.98 -32.81 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.26 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -59.88 -25.16 64.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.241 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 59.6 t0 -83.91 8.21 15.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.785 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -117.95 85.32 22.96 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.45 -0.781 . . . . 0.0 109.222 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.74 -23.81 16.54 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.2 p -58.52 -30.01 66.74 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.852 -1.155 . . . . 0.0 109.852 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.479 HG21 HD21 ' A' ' 119' ' ' LEU . 73.2 m -80.44 -52.81 7.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 110.009 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.46 HG23 ' H ' ' A' ' 126' ' ' ILE . 2.6 pt -56.51 -20.67 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.167 -0.958 . . . . 0.0 109.31 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.34 -50.38 70.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -56.49 -31.29 63.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.734 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.04 -36.04 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 109.074 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.01 -38.82 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.864 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -59.68 -36.29 76.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.051 . . . . 0.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.13 8.14 16.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.394 -0.816 . . . . 0.0 109.614 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.95 34.96 24.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 109.35 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.475 ' OE1' ' CG ' ' A' ' 87' ' ' PRO . 7.5 tt0 -127.4 121.12 30.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.386 -0.821 . . . . 0.0 108.811 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -92.79 156.49 40.76 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.41 -0.806 . . . . 0.0 110.058 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.17 160.35 42.44 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.118 2.545 . . . . 0.0 112.057 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' A' ' 90' ' ' PHE . 26.8 mm -97.46 126.04 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.36 155.69 79.03 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.39 -34.48 98.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.433 2.089 . . . . 0.0 111.619 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.44 -37.22 77.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 108.871 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -67.4 -32.82 73.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -0.814 . . . . 0.0 109.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.96 -39.71 61.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.72 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.41 -32.31 70.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.107 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 69.4 tttt -61.86 -38.82 89.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.956 -1.09 . . . . 0.0 109.651 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 90' ' ' PHE . 60.1 mt -63.41 -34.64 78.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 110.136 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.01 88.72 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.993 -1.067 . . . . 0.0 108.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -86.06 8.44 20.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 90.3 m-20 -84.22 -24.6 29.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 108.847 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.8 mt -121.07 -104.0 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.628 -0.67 . . . . 0.0 109.275 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -145.71 43.72 1.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.06 141.76 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.715 HG12 ' HG3' ' A' ' 153' ' ' LYS . 59.8 t -75.23 -65.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.715 ' HG3' HG12 ' A' ' 152' ' ' VAL . 67.6 mttt -145.67 160.37 41.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -131.28 150.5 52.12 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.55 154.09 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.037 -1.039 . . . . 0.0 110.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -109.66 133.94 52.54 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.53 140.21 48.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 111.025 -178.458 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . 39.9 t -106.89 105.58 15.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.44 -0.787 . . . . 0.0 109.036 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.82 70.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.601 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.7 tp -50.91 -31.01 16.26 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 163' ' ' LYS . 18.7 p -123.84 162.45 23.23 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.09 12.32 0.12 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.553 -0.717 . . . . 0.0 109.344 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 161' ' ' THR . 67.7 mttm -88.11 2.28 52.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.684 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.72 -51.52 2.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.48 -40.64 73.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -1.226 . . . . 0.0 109.936 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.23 -29.94 70.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.407 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -71.72 -50.95 25.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.1 m -80.35 -4.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -0.763 . . . . 0.0 110.566 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.81 -50.17 21.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.181 . . . . 0.0 110.052 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.92 -42.39 99.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.246 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.36 -34.68 78.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.023 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.9 74.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 110.568 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.6 -41.48 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.899 -1.126 . . . . 0.0 110.392 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.77 -41.72 82.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.987 . . . . 0.0 110.223 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.15 77.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.961 -1.087 . . . . 0.0 110.128 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.22 89.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 110.094 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.5 mt -65.23 -37.63 87.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.997 -1.064 . . . . 0.0 109.387 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.461 -179.85 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mmm . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -120.57 152.09 38.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.506 -0.746 . . . . 0.0 109.487 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 157.48 46.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.8 mt -118.8 120.8 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -81.62 128.35 33.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.307 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 t -132.89 115.57 15.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -109.72 132.22 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.58 HG11 HD21 ' A' ' 20' ' ' LEU . 7.9 p -128.05 142.97 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.404 -0.81 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.99 145.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 108.983 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 171.94 22.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 12' ' ' GLY . 59.1 t0 -74.04 134.03 42.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -1.116 . . . . 0.0 109.128 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . -27.77 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.499 2.855 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . -41.4 -37.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.023 -1.281 . . . . 0.0 110.567 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 11' ' ' ASP . 58.1 t -69.3 123.97 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.671 -1.268 . . . . 0.0 109.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 73.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.1 pttp -61.26 -33.62 73.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.528 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.4 p -70.38 -42.0 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.1 m -60.39 -25.99 66.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 0.0 110.009 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 19' ' ' LEU . 44.4 tp -66.72 -39.77 88.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.387 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.58 HD21 HG11 ' A' ' 8' ' ' VAL . 70.1 mt -64.94 -42.23 94.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.269 -0.894 . . . . 0.0 109.538 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mm -70.14 -49.02 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.713 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.2 m -57.26 -36.66 71.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 109.5 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.74 -44.49 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.1 m -65.79 -47.6 74.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 110.108 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.8 p -84.48 -19.5 33.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.711 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.82 36.76 22.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -141.23 82.54 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.652 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -55.28 -44.25 99.53 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -56.48 -15.83 16.65 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.28 1.987 . . . . 0.0 111.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' TYR . 95.6 p -59.86 -34.18 72.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 108.995 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.3 mt-10 37.68 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.648 -0.657 . . . . 0.0 110.321 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.2 m-85 -83.76 -95.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.019 -1.051 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 33' ' ' VAL . 6.4 p 36.52 57.76 3.41 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.445 -0.784 . . . . 0.0 110.964 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.77 -18.46 32.23 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.815 2.344 . . . . 0.0 112.08 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.47 -172.68 2.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.28 140.66 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.846 . . . . 0.0 109.199 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.16 -90.06 0.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.7 p30 -138.15 -173.39 3.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.904 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -67.33 149.23 50.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.831 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -118.13 146.71 43.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.732 . . . . 0.0 109.204 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 137.25 45.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.148 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.4 138.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.861 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -93.3 133.94 36.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.284 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.1 t -120.36 135.06 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.731 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -93.57 130.59 39.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.316 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 68.5 mt -132.8 126.82 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.151 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.54 17.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.15 13.87 58.26 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 11.3 mt-10 -119.61 85.86 33.55 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.414 -1.051 . . . . 0.0 109.282 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -53.7 125.66 19.34 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.681 2.254 . . . . 0.0 113.195 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 91.3 m-85 -121.61 143.22 49.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.688 . . . . 0.0 109.232 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.5 m -76.03 131.25 39.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.32 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -128.1 129.6 46.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.79 143.45 14.64 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.17 132.24 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.407 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -118.09 131.28 56.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.809 . . . . 0.0 109.774 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.8 p30 -136.19 172.38 13.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.773 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.2 m -71.5 138.25 48.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.59 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.79 52.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.596 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.39 -127.63 34.93 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 57.05 39.68 29.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -1.053 . . . . 0.0 109.786 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -79.8 -41.74 25.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.153 -0.967 . . . . 0.0 109.405 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 51.9 p30 -85.43 14.09 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 110.435 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.419 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -84.29 5.53 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.918 -1.114 . . . . 0.0 109.176 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.2 t0 73.59 12.32 4.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 0.0 109.426 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -58.14 -32.47 68.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.411 -0.805 . . . . 0.0 109.293 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 68' ' ' ARG . 49.4 mt -58.8 172.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 0.0 109.859 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 70' ' ' LEU . 1.6 mmt180 61.06 146.94 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 15.9 Cg_endo -60.34 26.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 0.0 112.326 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 68' ' ' ARG . 15.2 tp -51.71 -61.5 2.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 0.0 109.119 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 p -85.63 -3.61 58.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 109.635 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' PRO . 7.8 m-85 58.33 58.57 6.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.769 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.9 147.26 95.58 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 0.0 111.841 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -141.5 160.65 39.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 5.1 p -126.03 153.95 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 75' ' ' THR . 90.5 m-20 -138.21 -41.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.718 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.02 132.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 110.0 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -108.43 126.95 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 109.142 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 tp -118.53 126.37 51.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 109.546 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.86 138.68 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 133.84 48.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.515 ' CG ' HG21 ' A' ' 93' ' ' VAL . 31.6 p90 -138.45 158.47 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 109.379 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -77.24 138.74 39.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 109.377 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.49 -18.07 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.143 -0.973 . . . . 0.0 110.364 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 85' ' ' VAL . 61.1 t -85.8 -8.19 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.09 -1.006 . . . . 0.0 110.374 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -103.09 107.07 54.02 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.976 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.18 -49.08 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.032 1.822 . . . . 0.0 112.005 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 m -58.71 -39.56 81.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 108.95 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.756 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.9 t -62.86 -21.74 66.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.472 -0.768 . . . . 0.0 109.029 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -74.43 -50.05 19.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -66.07 -39.2 89.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -57.01 -32.91 66.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.214 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 89' ' ' SER . 71.8 t -60.91 -37.39 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -94.31 -11.06 30.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.012 -1.055 . . . . 0.0 110.229 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -73.74 -33.61 64.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.646 -1.283 . . . . 0.0 111.493 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.47 -41.9 3.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.136 -0.977 . . . . 0.0 112.25 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -82.12 0.84 38.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.094 -1.004 . . . . 0.0 112.836 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.592 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -108.22 -42.75 0.12 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.49 -1.381 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.592 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 42.9 Cg_endo -93.71 -59.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.211 2.608 . . . . 0.0 112.468 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.619 ' CG1' ' CE1' ' A' ' 110' ' ' PHE . 8.0 tp -54.08 -26.59 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.594 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 46.5 m -58.85 -37.93 77.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.759 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -53.29 -40.57 64.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.867 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.436 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 65.7 m170 -55.17 -36.17 65.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 109.262 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 0.7 OUTLIER 168.73 154.0 0.14 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.63 -33.0 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.523 2.148 . . . . 0.0 111.92 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -139.83 137.51 35.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.424 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -177.37 139.64 0.43 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 0.0 109.303 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.71 125.37 12.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.191 1.928 . . . . 0.0 112.202 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.619 ' CE1' ' CG1' ' A' ' 101' ' ' ILE . 86.8 m-85 -116.53 138.92 51.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 111' ' ' LEU . 6.6 mp -114.89 121.2 42.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.454 -0.778 . . . . 0.0 110.035 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -110.92 125.18 53.39 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.765 HG11 HG22 ' A' ' 168' ' ' VAL . 36.0 t -117.1 138.59 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.14 -0.975 . . . . 0.0 110.977 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.4 122.1 6.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 t -114.33 167.35 10.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -1.115 . . . . 0.0 110.618 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 58.74 39.37 24.33 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.51 -7.18 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.969 -1.082 . . . . 0.0 109.873 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.476 ' O ' ' OD2' ' A' ' 121' ' ' ASP . 53.8 p30 -83.69 -3.08 57.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.345 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.455 ' HG ' HG21 ' A' ' 125' ' ' THR . 30.2 tp -78.29 -27.27 47.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -84.94 93.3 8.52 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 2.4 p30 169.04 -49.45 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.1 141.44 94.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.546 -0.721 . . . . 0.0 109.234 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.52 -31.1 27.86 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.248 1.966 . . . . 0.0 112.223 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.7 m -54.3 -33.1 58.02 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.29 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.455 HG21 ' HG ' ' A' ' 119' ' ' LEU . 56.7 p -79.49 -51.11 9.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 111.012 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.15 -29.77 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 0.0 110.333 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.32 -50.09 35.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 109.663 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.17 -35.19 76.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.6 mt -74.42 -39.25 62.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 108.891 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.11 -35.92 37.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 109.486 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -59.69 -34.97 73.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 109.143 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -86.54 7.35 26.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.621 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttt 56.88 37.02 28.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -136.83 136.12 38.52 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.11 -0.994 . . . . 0.0 109.118 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -116.89 157.76 45.57 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -53.01 155.84 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.836 2.357 . . . . 0.0 111.909 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.3 mt -98.57 142.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.2 158.49 69.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.366 -0.833 . . . . 0.0 109.65 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.83 -23.05 75.8 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.684 2.256 . . . . 0.0 111.522 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.98 -38.59 89.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 m -63.67 -36.01 82.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.33 -39.4 59.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.32 -34.68 72.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.043 -1.035 . . . . 0.0 111.081 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.94 -36.24 80.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.706 -1.247 . . . . 0.0 109.425 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.06 -36.09 76.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 110.085 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 152' ' ' VAL . . . -81.12 -51.81 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.922 -1.111 . . . . 0.0 110.561 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -65.01 -1.86 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.286 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -110.21 -24.0 10.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 110.007 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.97 16.01 22.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 111.733 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 59.3 mttp 56.89 36.16 27.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.322 -1.486 . . . . 0.0 111.318 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 165.93 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.774 -1.204 . . . . 0.0 109.62 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.713 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 71.8 t 59.35 132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.262 1.029 . . . . 0.0 109.561 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -129.46 149.33 51.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.17 143.65 49.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.03 -1.044 . . . . 0.0 109.85 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 t -138.36 147.01 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -97.33 120.89 38.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -131.04 141.1 50.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.962 . . . . 0.0 110.932 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 161' ' ' THR . 29.5 t -111.62 102.8 11.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -70.18 -28.69 65.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.785 -0.572 . . . . 0.0 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 160' ' ' LEU . 6.3 mp -61.56 -25.92 67.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 163' ' ' LYS . 21.2 m -123.86 160.52 27.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.514 ' OE1' ' CE2' ' A' ' 28' ' ' PHE . 23.5 mm100 -65.41 11.47 0.06 Allowed 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 161' ' ' THR . 97.7 mttt -94.01 5.13 52.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.051 . . . . 0.0 110.053 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.447 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -101.58 -51.14 1.14 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.274 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 165' ' ' LEU . 8.1 mp -63.35 -42.02 98.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.219 -1.165 . . . . 0.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -58.81 -30.37 67.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -85.67 -50.07 7.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.765 HG22 HG11 ' A' ' 113' ' ' VAL . 71.5 t -62.24 -34.8 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.768 . . . . 0.0 110.303 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.858 ' CE2' HD11 ' A' ' 173' ' ' ILE . 68.3 t80 -68.71 -49.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 0.0 110.285 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.54 -43.82 93.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 0.0 110.612 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.03 -45.13 71.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 110.262 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.62 -35.96 61.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.408 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.858 HD11 ' CE2' ' A' ' 169' ' ' PHE . 95.0 mt -68.9 -36.7 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.831 -1.168 . . . . 0.0 110.482 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.8 tp -53.55 -51.33 63.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.972 -1.08 . . . . 0.0 110.259 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.5 71.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.079 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.39 66.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 109.758 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 177' ' ' LEU . 3.6 mm? -63.02 -35.54 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.984 -1.073 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.561 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 . . . . . 0 N--CA 1.49 1.552 0 CA-C-O 121.289 0.566 . . . . 0.0 109.493 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -135.6 160.22 39.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -0.801 . . . . 0.0 109.843 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 176' ' ' ALA . 72.8 mt -121.34 119.46 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -95.76 129.46 42.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.952 . . . . 0.0 110.059 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 79' ' ' LEU . 46.1 t -138.32 136.75 36.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 0.0 109.143 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.08 141.11 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.65 131.19 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.85 143.98 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.486 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 168.17 25.65 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' ALA . 24.0 t70 -83.12 108.17 16.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.251 . . . . 0.0 108.983 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 53.94 -87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 53.47 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.178 -1.19 . . . . 0.0 109.364 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 14' ' ' VAL . 3.6 m -66.63 -35.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 0.0 109.988 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.57 21.55 32.04 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 58.9 tttt -62.11 -40.6 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.283 . . . . 0.0 109.814 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.8 m -68.37 -45.65 72.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.562 ' SG ' ' OG ' ' A' ' 30' ' ' SER . 34.4 m -61.01 -29.65 69.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.913 . . . . 0.0 109.851 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -67.06 -42.15 85.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.44 -46.09 50.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.53 -40.32 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -57.92 -31.98 67.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 109.839 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -72.69 -38.02 67.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -65.96 -30.96 71.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.459 -0.775 . . . . 0.0 111.292 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -166.44 -1.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.553 -1.342 . . . . 0.0 111.427 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.613 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.2 t30 92.21 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HZ2' ' HA ' ' A' ' 30' ' ' SER . 10.4 tttm -179.6 58.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.995 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.29 -42.58 86.12 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.787 -1.196 . . . . 0.0 109.836 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.2 Cg_exo -58.11 -33.08 97.01 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.354 2.036 . . . . 0.0 112.364 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' SG ' ' A' ' 18' ' ' CYS . 61.4 p 35.65 37.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.65 . . . . 0.0 109.738 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 30' ' ' SER . 78.5 mm-40 -38.22 -37.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.53 -0.731 . . . . 0.0 110.531 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -128.8 124.18 34.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.034 -1.041 . . . . 0.0 109.204 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.69 147.78 34.21 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.643 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.54 153.21 60.33 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 0.0 112.153 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.5 -104.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 109.051 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.4 m -61.38 142.07 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.858 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.09 125.43 46.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.864 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -108.84 164.39 12.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.308 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -92.35 153.11 19.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.009 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -127.78 139.15 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.601 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.52 132.2 54.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.053 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.28 153.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -122.31 150.15 42.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.064 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.26 139.77 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 110.01 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 65.0 mtt -84.57 131.81 34.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 48' ' ' GLY . 74.6 mt -135.11 125.41 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 109.521 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 41.97 18.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 92.36 15.41 53.45 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.102 -1.234 . . . . 0.0 110.215 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.0 mm-40 -122.81 82.7 49.34 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.318 -1.107 . . . . 0.0 109.255 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.17 126.19 20.24 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.906 2.404 . . . . 0.0 113.23 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 95.9 m-85 -119.17 138.04 53.21 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 p -80.22 143.49 33.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -124.82 124.48 42.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.0 109.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.11 124.31 8.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.13 127.03 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.161 . . . . 0.0 109.194 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -114.44 133.96 55.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -138.79 140.52 38.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 51.1 m -70.85 137.64 49.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.455 179.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 179.989 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 . . . . . 0 N--CA 1.491 1.593 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.4 m -79.5 131.86 36.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.458 -0.776 . . . . 0.0 110.156 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -102.87 -10.55 18.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 108.953 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' A' ' 175' ' ' ALA . 47.4 t -135.42 130.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.248 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -111.48 129.04 56.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.236 -0.915 . . . . 0.0 109.776 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 6' ' ' CYS . 62.1 mt -113.16 145.19 41.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.516 -0.74 . . . . 0.0 109.791 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 111' ' ' LEU . 28.3 m -129.76 147.32 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.052 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 22.7 t -138.74 130.52 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.651 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.56 165.76 26.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 m -105.84 145.13 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.113 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.76 8.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.679 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -88.99 -23.46 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.133 -0.979 . . . . 0.0 109.807 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.6 146.37 33.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.58 -50.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.677 2.251 . . . . 0.0 112.259 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -55.05 -35.68 64.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.1 p -66.71 -24.26 66.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.058 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -71.41 -50.91 27.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.817 . . . . 0.0 109.461 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.85 -36.28 81.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -51.53 -34.06 34.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.783 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.9 -36.4 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -91.61 -41.55 10.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.752 -1.217 . . . . 0.0 110.592 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.53 -37.52 87.82 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.086 -1.009 . . . . 0.0 112.037 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -113.17 -51.38 2.82 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.901 -1.124 . . . . 0.0 112.638 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.2 -39.95 82.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.97 -1.081 . . . . 0.0 113.249 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.785 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.1 t -58.27 -52.11 76.93 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.027 -1.67 . . . . 0.0 110.75 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.16 -40.6 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.677 1.585 . . . . 0.0 112.223 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.47 -31.05 67.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.405 -0.809 . . . . 0.0 110.499 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 98' ' ' VAL . 5.5 tp -59.26 -24.07 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.883 -1.136 . . . . 0.0 110.006 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 99' ' ' PRO . 62.5 p -58.42 -38.59 77.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 109.436 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -58.94 -29.99 67.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.4 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -82.94 -7.77 59.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.895 . . . . 0.0 109.811 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.11 84.9 0.19 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.0 109.356 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.56 89.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.65 2.233 . . . . 0.0 112.458 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -133.52 11.32 4.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.316 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.561 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -136.68 157.74 74.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -59.95 141.15 95.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.683 2.255 . . . . 0.0 112.268 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 108' ' ' THR . 97.3 m-85 -121.98 145.83 47.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.742 . . . . 0.0 109.796 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.74 ' O ' HG22 ' A' ' 80' ' ' VAL . 5.2 mp -121.8 131.72 54.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.607 -0.683 . . . . 0.0 109.469 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.804 HD22 ' HB2' ' A' ' 146' ' ' ALA . 26.2 tp -103.79 118.88 37.74 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.545 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 59.7 t -112.44 137.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.728 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.14 128.5 9.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 32.7 p -125.51 161.75 26.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.258 -1.143 . . . . 0.0 110.852 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 115' ' ' THR . 4.3 tt0 83.71 19.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 119' ' ' LEU . 8.2 tt -61.3 -165.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.622 ' N ' HG23 ' A' ' 117' ' ' ILE . 86.1 m-20 60.65 -60.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 110.006 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.2 mp -60.02 -35.05 74.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.787 -1.196 . . . . 0.0 108.995 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 119' ' ' LEU . 83.3 mtm180 31.65 45.99 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.465 ' OD2' HD12 ' A' ' 129' ' ' LEU . 7.3 t0 70.26 75.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.166 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -42.83 160.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.383 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 126' ' ' ILE . 6.7 Cg_endo -52.18 -55.22 4.06 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.699 2.266 . . . . 0.0 111.915 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.0 p -54.76 -28.65 50.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.819 -1.175 . . . . 0.0 109.586 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.431 ' CG2' ' OD1' ' A' ' 121' ' ' ASP . 28.5 m -78.21 -50.74 11.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.994 -1.066 . . . . 0.0 110.578 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 123' ' ' PRO . 13.1 tt -55.46 -27.6 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.033 -1.042 . . . . 0.0 109.631 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.99 -45.62 80.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -60.69 -36.84 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.582 -0.699 . . . . 0.0 109.384 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.465 HD12 ' OD2' ' A' ' 121' ' ' ASP . 71.3 mt -75.15 -37.76 61.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.061 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.66 -39.05 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -60.4 -40.98 92.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.168 -0.957 . . . . 0.0 109.366 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -91.7 3.11 55.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 109.917 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.1 mttp 54.49 40.62 31.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -92.07 -52.73 4.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.15 -0.969 . . . . 0.0 109.743 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 mttt 65.46 139.45 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.9 154.41 74.68 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.536 2.157 . . . . 0.0 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.6 mm -93.56 140.31 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.86 155.43 73.03 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.62 -31.92 95.13 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.47 -37.76 84.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.3 m -66.09 -33.59 76.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.277 -0.89 . . . . 0.0 108.987 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.59 -36.97 57.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -35.01 71.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.622 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.42 -36.25 83.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.931 -1.106 . . . . 0.0 109.79 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 145' ' ' LEU . 46.2 tp -63.25 -39.2 93.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.804 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -67.74 -45.47 74.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 109.556 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.664 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -75.79 9.61 2.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -71.59 -36.4 70.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 51.0 mt -112.43 -87.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.594 -0.691 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -152.59 52.67 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.451 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -64.45 131.36 46.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.312 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.23 -51.74 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.927 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -160.1 155.61 25.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.262 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -121.02 144.42 48.54 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -142.81 154.22 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 110.285 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.8 mt-10 -120.04 142.73 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.545 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.07 149.84 42.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.697 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 161' ' ' THR . 12.8 t -112.01 107.59 16.62 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.36 64.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.5 tp -53.31 -32.07 47.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 158' ' ' SER . 14.3 p -126.09 165.26 19.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -69.85 13.14 0.16 Allowed 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.642 -0.661 . . . . 0.0 109.396 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 161' ' ' THR . 58.5 tttm -85.48 -4.76 59.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.43 -50.43 2.97 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.255 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.966 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.8 mm? -64.46 -39.37 93.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.242 . . . . 0.0 109.972 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -58.51 -32.07 68.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.361 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 53.1 t30 -73.8 -49.64 24.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.786 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.72 -8.34 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.803 . . . . 0.0 111.041 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -72.43 -50.33 27.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.817 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.89 -42.42 99.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 110.086 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -66.29 -36.31 82.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.03 -35.54 71.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.51 -40.29 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.2 tp -52.07 -45.88 64.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.689 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -62.66 -33.64 75.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.982 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 4' ' ' ILE . . . -52.01 -43.58 63.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.667 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.1 mt -62.54 -35.73 80.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.998 . . . . 0.0 109.337 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 99.989999999999995 109.461 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 . . . . . 0 N--CA 1.492 1.631 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -132.93 162.47 31.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.532 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 176' ' ' ALA . 31.1 mm -115.49 119.9 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.204 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -96.93 130.59 44.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.948 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.659 ' SG ' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -149.47 137.95 20.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.708 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.97 138.43 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.92 142.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.753 . . . . 0.0 109.481 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.523 HG23 HG21 ' A' ' 58' ' ' THR . 12.7 p -139.96 143.39 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.893 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.65 165.36 26.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -85.1 117.82 24.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.296 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.21 -105.44 1.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.32 -67.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.512 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 15' ' ' GLY . 28.4 t 54.43 -119.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.586 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.616 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -95.42 25.88 22.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -56.92 -34.39 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 0.0 109.274 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -66.58 -37.61 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 108.965 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.65 ' SG ' HG11 ' A' ' 33' ' ' VAL . 10.5 m -67.22 -30.82 70.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.432 -0.792 . . . . 0.0 109.869 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.6 tp -69.91 -44.78 68.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.287 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.3 -44.33 46.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.801 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 21' ' ' ILE . 9.9 tp -64.7 -32.49 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 110.066 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.6 p -66.7 -28.94 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.462 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 80.5 t80 -76.58 -43.43 38.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 p -75.35 -45.09 41.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 111.287 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.7 p -85.12 -23.09 28.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.843 -1.161 . . . . 0.0 110.243 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 23' ' ' TYR . 57.1 m-20 57.58 35.36 25.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.358 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -138.22 81.51 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.174 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.58 -41.79 90.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.111 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 24.0 Cg_exo -61.99 -10.61 18.23 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.493 2.128 . . . . 0.0 112.036 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 32' ' ' TYR . 14.6 t -47.12 -32.74 4.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 64.65 -31.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.825 . . . . 0.0 110.283 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.644 ' C ' HG23 ' A' ' 33' ' ' VAL . 87.0 m-85 -58.36 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.832 -1.168 . . . . 0.0 108.659 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.65 HG11 ' SG ' ' A' ' 18' ' ' CYS . 2.0 t 73.74 60.05 0.32 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.513 -0.742 . . . . 0.0 110.415 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.47 130.66 34.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.024 1.816 . . . . 0.0 111.079 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.34 56.08 2.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.06 -1.025 . . . . 0.0 110.143 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.571 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 42.1 t -119.48 134.65 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.679 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 36' ' ' VAL . 91.1 m-85 -160.56 -102.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 88.7 m-20 54.02 56.62 6.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.089 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 17.1 t-20 89.86 73.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.318 0.58 . . . . 0.0 109.709 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HE2' HG22 ' A' ' 42' ' ' VAL . 57.2 t80 -111.9 145.35 39.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.1 145.29 48.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.435 HG22 ' HE2' ' A' ' 40' ' ' TYR . 44.0 t -126.02 129.63 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.9 m -92.8 124.26 36.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.064 -1.022 . . . . 0.0 108.733 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.22 159.34 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 110.794 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 68.0 mtm -113.15 136.95 52.16 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.76 127.08 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 108.987 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 15.68 67.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.62 16.17 62.36 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -124.26 154.06 68.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.338 -1.096 . . . . 0.0 109.175 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.52 135.33 28.38 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.749 2.3 . . . . 0.0 113.258 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -145.32 154.9 42.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.129 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -125.54 139.23 53.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.384 -0.823 . . . . 0.0 109.869 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.37 125.25 48.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.094 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.49 ' C ' HD22 ' A' ' 55' ' ' LEU . . . -111.07 118.28 4.83 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.924 HD22 ' N ' ' A' ' 55' ' ' LEU . 1.6 mm? -102.77 129.39 49.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.221 -1.164 . . . . 0.0 108.999 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.88 126.08 53.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.771 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -103.36 164.93 11.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.469 -0.769 . . . . 0.0 109.382 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 9' ' ' VAL . 40.3 p -79.67 161.87 25.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.52 -179.845 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.426 -0.583 . . . . 0.0 109.426 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -140.5 153.08 46.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.699 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -104.96 -5.64 20.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.0 133.75 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.795 . . . . 0.0 109.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -109.12 121.64 45.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 108.619 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.659 HD12 ' SG ' ' A' ' 6' ' ' CYS . 53.6 mt -116.35 140.05 49.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.81 152.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 134.23 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -138.99 164.01 30.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.43 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.1 p -98.13 151.4 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 109.32 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 84' ' ' VAL . 12.9 p -102.27 6.71 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -100.52 -1.08 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 0.0 110.129 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -118.86 95.82 49.55 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 109.745 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.76 -52.88 8.01 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -40.2 65.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.099 -1.001 . . . . 0.0 109.508 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 93' ' ' VAL . 54.9 p -60.34 -14.15 16.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 108.851 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -74.13 -50.66 18.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.72 -39.08 90.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.3 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -54.15 -32.14 54.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 89' ' ' SER . 73.8 t -59.26 -37.58 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 110.274 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -86.59 -27.76 23.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.742 -1.224 . . . . 0.0 110.386 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.72 -36.45 67.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.116 -0.99 . . . . 0.0 112.273 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -111.89 -50.62 2.9 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.884 -1.135 . . . . 0.0 112.509 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.487 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 33.8 m0 -68.13 -34.32 76.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.967 -1.083 . . . . 0.0 112.583 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.43 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -68.22 -51.72 24.74 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 119.964 -1.71 . . . . 0.0 111.113 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 72.9 Cg_endo -76.69 -44.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.947 1.764 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.24 -41.94 89.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 111.045 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 105' ' ' CYS . 94.2 mt -68.34 -43.35 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 110.174 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.8 m -60.28 -42.97 96.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.847 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -60.5 -44.85 95.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.937 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -92.82 -10.69 35.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.432 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -149.65 86.96 5.27 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.941 -1.099 . . . . 0.0 109.878 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.79 -48.84 19.59 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.415 2.076 . . . . 0.0 112.072 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 108' ' ' THR . 29.0 mttt -147.69 110.34 4.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.506 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 3.5 p -154.11 150.16 22.0 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.326 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -47.72 118.25 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.03 1.82 . . . . 0.0 111.625 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 108' ' ' THR . 64.0 m-85 -112.9 128.9 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.741 HD21 ' OE1' ' A' ' 171' ' ' GLU . 32.5 tp -115.78 120.28 38.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 117.56 34.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 108.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.536 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 48.0 t -112.09 135.9 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.419 -0.801 . . . . 0.0 110.587 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.7 125.31 8.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.3 t -129.97 166.63 19.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.227 -1.161 . . . . 0.0 110.638 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 115' ' ' THR . 22.9 tp60 85.66 15.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.762 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 119' ' ' LEU . 25.4 pt -63.15 -158.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.869 -1.144 . . . . 0.0 108.648 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.497 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 80.4 m-20 56.97 -57.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.637 -0.664 . . . . 0.0 110.273 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.699 ' N ' ' O ' ' A' ' 117' ' ' ILE . 29.4 tp -50.74 -30.52 14.17 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.845 -1.159 . . . . 0.0 108.109 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.466 HH12 ' HD2' ' A' ' 139' ' ' PRO . 40.5 ttp180 -57.89 -15.56 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 47.2 p30 -101.19 1.85 39.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.55 150.57 76.47 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.9 -53.46 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.454 2.103 . . . . 0.0 111.98 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -59.17 -32.64 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 110.637 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.1 m -69.71 -51.39 34.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.886 -1.134 . . . . 0.0 109.908 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt -65.16 -35.1 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.918 . . . . 0.0 109.456 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -73.27 -44.57 59.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.362 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.87 -41.32 91.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 129' ' ' LEU . 88.1 mt -74.16 -34.07 63.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 108.713 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.57 -47.73 69.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.056 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -62.6 -35.83 80.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.204 -0.935 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -52.61 -57.09 11.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.857 -1.152 . . . . 0.0 109.562 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 134' ' ' GLN . 14.3 pttp -171.23 -50.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 133' ' ' LYS . 52.6 mt-30 -143.86 -119.79 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.852 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.88 163.22 52.51 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 110.175 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.33 174.26 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.175 2.583 . . . . 0.0 112.099 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.32 140.04 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.37 158.29 69.29 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 109.381 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.466 ' HD2' HH12 ' A' ' 120' ' ' ARG . 16.4 Cg_endo -60.99 -31.55 91.48 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.58 2.187 . . . . 0.0 111.936 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.4 m -69.37 -33.05 72.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.217 -0.927 . . . . 0.0 109.221 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.31 -39.6 59.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.447 -0.783 . . . . 0.0 109.921 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.51 -31.85 69.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -60.93 -37.53 82.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.012 . . . . 0.0 109.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.703 ' N ' HD12 ' A' ' 145' ' ' LEU . 7.7 mp -65.39 -31.06 71.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.402 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.13 69.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.908 -1.12 . . . . 0.0 110.242 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -82.09 9.49 8.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.399 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -113.45 -36.09 5.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.029 . . . . 0.0 109.246 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.02 17.09 9.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.538 -0.726 . . . . 0.0 110.572 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 65.48 30.23 10.87 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.216 -0.928 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.31 143.08 56.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 108.944 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 110' ' ' PHE . 73.0 t -66.0 -58.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.013 -1.054 . . . . 0.0 110.089 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -152.49 150.47 29.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.028 -1.045 . . . . 0.0 110.709 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -116.8 138.7 51.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.48 -0.763 . . . . 0.0 109.432 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.421 HG11 ' OE2' ' A' ' 171' ' ' GLU . 6.2 m -141.43 153.78 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 139' ' ' PRO . 93.2 mt-10 -110.11 132.62 54.0 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.536 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -136.64 146.28 45.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 0.0 110.633 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 161' ' ' THR . 18.0 t -115.78 108.93 16.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.343 0.592 . . . . 0.0 109.45 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 160' ' ' LEU . 6.7 mp -59.61 -27.86 66.68 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.8 p -125.11 165.94 17.32 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.11 12.64 0.28 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.798 -0.563 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 161' ' ' THR . 34.9 mtmt -89.68 3.4 52.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.989 . . . . 0.0 109.923 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.97 -49.15 1.96 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.745 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.5 mp -61.86 -38.48 88.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -1.138 . . . . 0.0 110.125 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -58.53 -32.59 69.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 110.303 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -86.64 -44.61 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.046 -1.034 . . . . 0.0 109.381 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.88 -26.9 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 110.498 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CE2' HG13 ' A' ' 173' ' ' ILE . 71.9 t80 -67.47 -46.81 71.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -54.52 -43.8 72.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.896 -1.127 . . . . 0.0 109.672 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.741 ' OE1' HD21 ' A' ' 111' ' ' LEU . 96.7 mt-10 -70.61 -38.06 73.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.01 -43.69 91.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.256 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.403 HG13 ' CE2' ' A' ' 169' ' ' PHE . 29.9 mm -69.67 -42.81 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.932 -1.105 . . . . 0.0 109.671 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.6 tp -56.16 -45.64 79.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.06 84.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.446 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -56.66 -42.66 79.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.4 mt -64.27 -38.48 91.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.516 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 . . . . . 0 N--CA 1.49 1.555 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.0 m -104.37 145.27 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.6 -0.687 . . . . 0.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.8 mt -115.07 119.94 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.732 . . . . 0.0 109.026 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.35 130.78 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 0.0 110.01 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 128.18 19.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.391 -0.818 . . . . 0.0 109.12 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.41 138.27 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.447 HG13 HD23 ' A' ' 79' ' ' LEU . 32.2 t -116.1 132.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 0.0 108.886 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.627 HG23 ' OG1' ' A' ' 58' ' ' THR . 14.6 p -152.09 145.87 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.077 -1.014 . . . . 0.0 109.514 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.28 157.41 22.88 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 12' ' ' GLY . 60.3 t0 -86.01 105.76 16.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.61 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.12 69.73 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -87.98 133.58 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -1.235 . . . . 0.0 109.289 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.37 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.333 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 49.89 0.81 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 73.6 tttt -61.28 -38.24 86.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.962 -1.316 . . . . 0.0 109.78 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.6 p -70.64 -37.02 73.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.69 -28.5 69.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.81 -37.3 79.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.947 . . . . 0.0 110.128 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.37 -40.6 96.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 111.15 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 pt -70.7 -32.14 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.74 -1.225 . . . . 0.0 110.07 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 m -57.01 -38.68 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.986 -1.071 . . . . 0.0 109.983 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -78.74 -48.48 14.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.122 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 p -64.59 -34.33 78.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.881 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 63.7 p -112.26 -109.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 25' ' ' THR . 1.3 p30 164.64 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -126.45 122.35 35.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.259 -0.901 . . . . 0.0 110.404 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.672 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -96.52 -39.69 0.27 Allowed Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 12.9 Cg_exo -66.89 -10.54 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.616 2.211 . . . . 0.0 111.13 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' TYR . 38.7 m -47.9 -36.72 12.75 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.209 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.6 mt-10 40.38 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.972 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 30' ' ' SER . 70.1 t80 -141.22 118.77 11.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.946 -1.096 . . . . 0.0 108.419 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.59 153.03 37.98 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.81 156.11 64.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 112.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 67.92 10.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.55 136.25 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -117.26 -1.93 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.815 . . . . 0.0 109.645 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.1 p30 -77.56 166.24 23.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.005 . . . . 0.0 110.113 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 37.5 p-10 -92.91 150.78 20.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.792 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 74.0 t80 -134.53 147.98 50.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -102.61 138.25 39.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 0.0 109.842 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.83 138.2 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.712 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.3 m -106.03 134.49 49.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.838 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.89 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 109.958 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.8 mtp -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.745 HG22 ' H ' ' A' ' 48' ' ' GLY . 68.9 mt -129.11 135.77 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.87 . . . . 0.0 108.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.68 -15.11 11.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.745 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -95.16 -8.73 58.69 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.322 -1.105 . . . . 0.0 110.593 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' GLY . 2.0 mm-40 155.43 131.23 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.507 -0.996 . . . . 0.0 109.367 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.87 137.01 26.2 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.003 1.802 . . . . 0.0 111.857 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 97.8 m-85 -134.57 155.49 50.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.136 -0.978 . . . . 0.0 109.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 m -119.0 141.1 48.97 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.91 126.34 44.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.65 128.51 9.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.2 mt -107.32 122.49 46.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -1.207 . . . . 0.0 109.2 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -111.49 135.13 52.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.41 -0.806 . . . . 0.0 109.197 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 58' ' ' THR . 57.4 t0 -94.0 151.68 19.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.188 -0.945 . . . . 0.0 109.07 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.627 ' OG1' HG23 ' A' ' 9' ' ' VAL . 65.5 m -59.1 130.39 46.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.033 -1.042 . . . . 0.0 108.978 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.718 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.5 tp60 . . . . . 0 N--CA 1.497 1.877 0 CA-C-O 121.256 0.55 . . . . 0.0 110.842 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -105.5 130.96 53.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.0 108.99 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.39 -37.91 89.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.84 144.1 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.449 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.39 126.68 51.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 8' ' ' VAL . 42.6 tp -112.3 128.76 56.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.665 HG21 ' CE2' ' A' ' 110' ' ' PHE . 40.5 t -123.18 135.78 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 130.95 46.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.37 -0.831 . . . . 0.0 109.828 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.47 161.11 38.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.9 t -80.08 132.82 36.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -1.0 . . . . 0.0 109.295 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.77 -28.25 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 110.869 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.573 HG21 HD23 ' A' ' 119' ' ' LEU . 33.4 m -92.6 7.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.041 -1.037 . . . . 0.0 111.095 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t -98.52 124.57 46.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.792 -1.193 . . . . 0.0 110.003 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.439 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 70.2 Cg_endo -77.56 -58.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.264 1.976 . . . . 0.0 112.61 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.4 p -55.48 -32.92 63.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.935 . . . . 0.0 109.762 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 m -65.08 -24.52 67.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.165 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CZ ' HG22 ' A' ' 141' ' ' THR . 56.3 t80 -68.57 -50.84 48.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -0.774 . . . . 0.0 109.347 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 87' ' ' PRO . 52.5 mp0 -69.13 -35.72 76.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -54.45 -33.36 59.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.66 -37.98 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.933 . . . . 0.0 110.268 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.684 ' HD2' HD21 ' A' ' 145' ' ' LEU . 30.0 tttt -93.43 -36.25 12.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.844 -1.16 . . . . 0.0 110.839 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.71 -37.04 81.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.027 -1.045 . . . . 0.0 112.285 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -113.68 -51.65 2.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 0.0 112.611 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.198 -0.939 . . . . 0.0 113.217 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -71.25 -51.49 10.08 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.152 -1.592 . . . . 0.0 111.623 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 56.7 Cg_endo -71.87 -45.74 0.68 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.827 1.685 . . . . 0.0 113.567 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.22 -38.85 90.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.014 -1.054 . . . . 0.0 111.07 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 98' ' ' VAL . 3.4 tp -68.58 -26.88 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 110.078 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 m -61.46 -40.02 92.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 109.858 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -54.87 -34.44 62.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.573 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 56.8 t-80 -62.34 -43.66 98.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 0.0 109.591 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.0 OUTLIER 160.64 158.52 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 108' ' ' THR . 13.5 Cg_endo -60.1 -160.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.759 2.306 . . . . 0.0 111.676 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 106' ' ' PRO . 20.8 mttp 42.51 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.058 . . . . 0.0 109.631 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.7 p 47.49 81.8 0.25 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.53 126.44 16.09 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.328 2.019 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -113.28 125.21 54.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.017 -179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 153' ' ' LYS . 40.5 tp -116.58 121.22 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.6 mt -104.58 121.83 44.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.75 134.52 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.5 124.89 8.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.8 p -110.73 159.78 17.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.219 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 57.67 40.8 26.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.681 -0.637 . . . . 0.0 110.663 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.5 pt -69.48 -5.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.153 . . . . 0.0 109.933 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.93 -22.66 29.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 0.0 109.096 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 85' ' ' VAL . 31.4 tp -61.58 -32.73 72.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.407 HH22 ' HB ' ' A' ' 138' ' ' THR . 67.7 ttt180 -58.64 -25.22 62.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.652 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.07 -5.2 47.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 110.116 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.12 141.32 83.72 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.003 -1.061 . . . . 0.0 109.049 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.62 -46.73 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.173 1.915 . . . . 0.0 111.894 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.8 p -61.22 -27.64 68.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.889 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.3 m -69.25 -49.02 60.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.02 -40.19 82.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.455 0.645 . . . . 0.0 109.3 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -74.54 -40.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.582 -0.699 . . . . 0.0 109.771 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.568 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 3.5 mm? -78.7 -38.78 38.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -0.996 . . . . 0.0 109.61 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.52 71.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 109.686 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -62.55 -44.41 96.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.97 -1.081 . . . . 0.0 110.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -70.44 -48.95 53.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.772 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -148.38 -89.32 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.47 ' HG3' ' H ' ' A' ' 135' ' ' LYS . 9.0 pt20 -134.19 -119.32 0.18 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.594 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.47 ' H ' ' HG3' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.09 167.03 24.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.41 165.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.998 2.465 . . . . 0.0 112.223 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.61 145.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.407 ' HB ' HH22 ' A' ' 120' ' ' ARG . 0.2 OUTLIER -85.69 155.99 58.81 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.994 -1.066 . . . . 0.0 109.394 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.41 -24.03 76.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.614 2.209 . . . . 0.0 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.13 -41.7 97.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.41 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 46.8 m -62.45 -36.78 83.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.962 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.9 57.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.64 -34.67 77.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.091 -1.006 . . . . 0.0 110.682 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 21.0 mttm -67.3 -39.25 85.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.437 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.684 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -62.7 -39.5 94.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 0.0 109.24 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.574 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -75.36 -48.86 21.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.089 -1.007 . . . . 0.0 110.141 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -68.97 4.97 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 144' ' ' LYS . 88.2 m-20 -108.82 -20.99 12.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.958 -1.089 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.402 ' CD1' HG21 ' A' ' 98' ' ' VAL . 38.2 mt -110.97 34.31 4.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.73 29.18 18.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.639 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.574 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -67.51 146.23 54.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.98 -61.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.034 -1.042 . . . . 0.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 154' ' ' TYR . 16.4 tttp -175.37 163.3 3.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.427 ' N ' ' HG2' ' A' ' 153' ' ' LYS . 28.7 p90 -120.04 154.75 34.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.623 HG21 ' OE1' ' A' ' 171' ' ' GLU . 28.0 t -132.24 140.09 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.9 mt-10 -100.13 126.7 46.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 140.73 47.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 111.071 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 161' ' ' THR . 34.6 t -104.26 102.19 11.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 108.892 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.92 72.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.209 0.528 . . . . 0.0 109.59 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.6 mt -53.56 -27.02 23.9 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 158' ' ' SER . 17.5 p -123.61 161.17 25.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -69.97 12.35 0.22 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.696 -0.627 . . . . 0.0 109.33 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.3 mttp -90.45 0.52 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.866 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -91.67 -51.37 2.51 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.016 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.17 -40.48 96.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.133 -1.216 . . . . 0.0 109.83 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.45 -27.85 66.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.522 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 35.6 t-20 -76.94 -50.73 12.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 109.926 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.02 -12.13 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.865 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.63 -50.23 22.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.734 -1.228 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.72 -41.95 92.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 0.0 110.057 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.623 ' OE1' HG21 ' A' ' 155' ' ' VAL . 83.9 tt0 -65.01 -33.15 75.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.979 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.68 71.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.53 -39.82 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.036 -1.04 . . . . 0.0 109.787 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.3 tp -53.49 -42.14 67.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.92 74.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -0.947 . . . . 0.0 110.333 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.45 70.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.941 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.3 mt -61.96 -34.23 75.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.963 -1.085 . . . . 0.0 109.399 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.443 -0.786 . . . . 99.989999999999995 109.255 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 . . . . . 0 N--CA 1.49 1.539 0 CA-C-O 121.414 0.625 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -136.71 160.07 39.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.772 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.66 121.0 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -91.66 127.86 37.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.74 128.33 24.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 109.123 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.446 HG21 HG21 ' A' ' 75' ' ' THR . 47.2 t -113.14 137.36 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.36 134.92 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -152.09 146.59 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.105 -0.997 . . . . 0.0 109.277 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 159.64 23.85 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' GLY . 24.6 t70 -84.31 110.28 18.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -1.213 . . . . 0.0 109.434 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.57 63.38 1.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -85.09 121.36 27.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -1.167 . . . . 0.0 109.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.87 -30.08 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.967 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.09 35.14 5.02 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 87.8 tttt -59.95 -38.59 82.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.237 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.7 p -63.41 -40.51 97.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.002 . . . . 0.0 110.002 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -26.69 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.058 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.14 -41.2 99.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.825 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 24' ' ' THR . 83.1 mt -66.44 -40.56 89.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.123 -0.985 . . . . 0.0 110.198 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.16 -42.3 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.809 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -57.51 -35.82 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.185 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -80.05 -50.27 10.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.144 . . . . 0.0 109.801 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 20' ' ' LEU . 71.6 p -59.58 -36.94 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.142 -0.974 . . . . 0.0 110.014 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 56.5 p -120.15 -113.55 0.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 25' ' ' THR . 11.1 m120 -167.56 12.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -98.09 118.82 35.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.687 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -86.4 -38.52 0.54 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 17.7 Cg_exo -63.26 -27.11 71.97 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.371 2.047 . . . . 0.0 111.064 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 29' ' ' PRO . 21.7 m 34.17 47.73 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.221 0.534 . . . . 0.0 110.298 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 -41.07 -32.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -121.7 126.0 47.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.257 -0.902 . . . . 0.0 109.488 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -99.44 109.27 54.38 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -52.47 160.64 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.241 1.961 . . . . 0.0 112.049 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.19 67.44 1.87 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 38' ' ' ASP . 12.3 p -140.94 138.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.03 0.64 11.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.475 -0.766 . . . . 0.0 109.326 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.414 ' H ' HG22 ' A' ' 36' ' ' VAL . 88.3 m-20 -69.2 139.46 54.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -0.882 . . . . 0.0 110.432 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.39 160.82 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.09 136.58 49.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 110.33 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 125.75 51.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.19 138.64 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 p -87.94 147.08 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.075 -1.016 . . . . 0.0 109.066 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 156.95 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 110.507 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.2 mtm -130.17 137.15 49.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.711 -0.618 . . . . 0.0 109.549 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 26.6 pt -129.82 152.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 109.096 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.99 18.2 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 84.83 15.06 68.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . 59.0 mt-10 -106.0 146.56 33.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.102 -1.234 . . . . 0.0 109.44 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.74 131.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.539 2.159 . . . . 0.0 112.829 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -143.12 160.13 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.532 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 m -117.23 138.79 51.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 0.0 109.093 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 41.8 tp -120.13 122.08 40.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 109.579 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.79 124.57 7.91 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -102.45 122.33 44.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.997 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -108.23 129.31 55.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.46 -0.775 . . . . 0.0 109.104 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' THR . 60.0 t0 -116.92 148.05 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.701 . . . . 0.0 109.177 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.407 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.2 p -68.65 159.16 32.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.042 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 -179.833 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 . . . . . 0 N--CA 1.493 1.72 0 N-CA-C 109.465 -0.569 . . . . 0.0 109.465 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 HG21 ' A' ' 7' ' ' VAL . 30.7 p -119.26 145.0 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 109.477 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.85 -33.87 74.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.934 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.65 133.71 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -110.7 121.42 45.27 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -112.81 139.18 48.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.351 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.3 t -122.44 135.18 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.497 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 38.8 t -127.77 128.27 45.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.811 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.61 162.91 34.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 109.73 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.556 ' OG ' HG22 ' A' ' 85' ' ' VAL . 37.9 t -92.05 142.85 27.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.4 p -100.24 -4.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.109 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.571 HG11 HD23 ' A' ' 119' ' ' LEU . 30.6 m -89.79 -16.47 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.999 -1.063 . . . . 0.0 109.783 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -98.51 134.97 21.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.65 -55.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.228 1.952 . . . . 0.0 112.198 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.3 m -55.13 -34.4 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 109.709 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -63.44 -25.16 68.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.097 -1.002 . . . . 0.0 109.248 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 137' ' ' ILE . 64.9 t80 -70.36 -50.18 41.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -0.832 . . . . 0.0 109.414 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.31 -37.13 82.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.55 -34.36 49.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 109.815 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.98 -34.97 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 109.986 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -91.14 -37.75 13.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.863 -1.148 . . . . 0.0 110.192 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -68.0 -35.99 79.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 112.094 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -113.15 -52.55 2.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.976 -1.078 . . . . 0.0 112.528 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -68.25 -37.02 80.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.156 -0.965 . . . . 0.0 113.428 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.0 t -63.28 -51.43 68.85 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.003 -1.685 . . . . 0.0 111.395 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.496 ' O ' HG22 ' A' ' 102' ' ' THR . 59.8 Cg_endo -73.96 -43.4 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.828 1.685 . . . . 0.0 113.095 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.82 -30.24 71.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 0.0 111.23 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 98' ' ' VAL . 3.7 tp -61.71 -25.1 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.687 -1.258 . . . . 0.0 109.874 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' PRO . 4.8 t -55.59 -36.61 67.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.131 -0.981 . . . . 0.0 109.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 102' ' ' THR . 52.1 m170 -51.62 -32.93 30.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.7 m80 -93.25 -5.99 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.58 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' HIS . 0.1 OUTLIER 53.23 168.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.541 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.19 26.11 0.55 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.837 2.358 . . . . 0.0 113.355 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -56.57 -34.52 67.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.947 -1.096 . . . . 0.0 109.829 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 159.61 38.52 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.418 -0.801 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.46 147.52 93.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.864 2.376 . . . . 0.0 111.959 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.63 126.05 54.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.158 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.7 mt -116.98 128.16 54.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.536 -0.728 . . . . 0.0 109.854 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.1 tp -106.34 116.4 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.1 t -112.77 136.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.908 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.96 119.03 6.01 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 52.0 m -118.58 148.11 43.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -1.045 . . . . 0.0 110.465 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' THR . 33.2 tt0 84.48 19.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 122.067 -0.396 . . . . 0.0 110.47 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 119' ' ' LEU . 35.1 pt -62.62 -158.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 63.0 -61.73 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.183 . . . . 0.0 109.226 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 117' ' ' ILE . 25.1 tp -53.08 -33.9 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 139' ' ' PRO . 33.0 ptt180 -54.36 -15.42 1.63 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 92.9 m-20 -108.04 57.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.609 ' OD2' HD12 ' A' ' 119' ' ' LEU . 7.9 m-20 -137.85 107.79 8.3 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.66 -39.83 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.879 1.719 . . . . 0.0 111.955 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m -58.73 -41.34 86.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.0 m -70.67 -48.94 52.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 108.126 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.76 -36.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.388 0.613 . . . . 0.0 109.479 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.93 -47.11 75.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.433 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -59.0 -38.8 80.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.709 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.16 -33.88 61.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 108.98 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.94 -41.81 64.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -60.16 -37.23 79.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 109.477 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.71 4.67 50.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.786 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 51.65 39.3 24.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.182 -0.949 . . . . 0.0 109.752 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -98.99 -52.17 3.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.027 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 mttp 68.89 146.11 0.11 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.3 152.24 79.54 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.593 2.195 . . . . 0.0 112.765 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.423 HG21 ' CE1' ' A' ' 90' ' ' PHE . 27.0 mm -93.5 141.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 109.046 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.53 155.21 65.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.093 -1.005 . . . . 0.0 109.591 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HG3' HH12 ' A' ' 120' ' ' ARG . 18.5 Cg_endo -61.65 -28.08 82.11 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.571 2.181 . . . . 0.0 111.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.92 -38.27 90.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 45.4 m -65.06 -35.59 81.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.33 -34.07 58.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.817 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 110.485 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.483 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 18.5 mttp -64.45 -35.69 81.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.962 -1.086 . . . . 0.0 109.553 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.53 -40.29 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.769 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -67.15 -43.54 82.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.002 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 147' ' ' ARG . 43.8 mtt-85 -78.7 7.78 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 85.1 m-20 -83.31 -27.78 29.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 0.0 108.753 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.3 mt -117.38 -101.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.624 -0.672 . . . . 0.0 109.308 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -144.9 44.9 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.871 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.769 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -61.95 137.4 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 109.168 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.82 -58.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.354 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -156.66 146.54 20.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.72 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -122.22 153.73 38.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.394 -0.816 . . . . 0.0 109.11 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.54 157.58 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.904 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -104.35 128.1 52.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' HG13 ' A' ' 168' ' ' VAL . 15.2 m -122.02 131.45 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.854 . . . . 0.0 110.713 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.583 ' HB2' HD11 ' A' ' 117' ' ' ILE . 23.9 t -109.99 110.88 21.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.97 68.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.871 -0.518 . . . . 0.0 110.08 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 28' ' ' PHE . 49.8 tp -51.37 -34.39 34.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.061 -1.024 . . . . 0.0 108.471 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.654 ' C ' ' H ' ' A' ' 163' ' ' LYS . 55.6 m -127.95 152.0 48.42 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -58.57 13.53 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.039 -1.038 . . . . 0.0 110.103 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.654 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.9 tttm -74.59 5.92 4.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 0.0 109.278 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -98.81 -50.86 1.45 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.205 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.753 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.5 mp -68.25 -38.47 81.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -1.178 . . . . 0.0 109.939 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -61.73 -29.25 69.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.288 -0.883 . . . . 0.0 110.336 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 163' ' ' LYS . 86.8 m-20 -77.96 -49.71 13.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 110.186 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 157' ' ' CYS . 11.3 m -74.39 -11.19 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 110.452 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -73.64 -46.46 46.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.59 -43.29 89.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.299 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.06 -33.39 75.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.05 -1.031 . . . . 0.0 109.663 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.06 70.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 110.152 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.18 -42.64 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.93 -1.106 . . . . 0.0 109.916 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.3 mt -54.24 -44.86 72.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.822 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.71 -36.6 84.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.715 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.44 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.654 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.13 -39.22 93.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.398 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.406 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 . . . . . 0 N--CA 1.493 1.708 0 CA-C-O 121.407 0.622 . . . . 0.0 109.604 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -124.71 159.0 31.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.2 mt -119.16 119.16 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.794 . . . . 0.0 109.556 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.3 132.69 38.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -135.87 126.6 27.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 109.465 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.84 136.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.427 -0.796 . . . . 0.0 109.709 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.4 138.12 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.049 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.54 144.68 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.295 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.63 23.1 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 12' ' ' GLY . 26.1 t70 -89.55 105.88 18.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -1.165 . . . . 0.0 109.43 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.73 68.78 0.5 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -1.151 . . . . 0.0 109.401 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.23 -45.73 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.309 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.29 48.94 0.88 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 68.1 tttt -59.69 -40.18 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.245 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.641 HG21 HG21 ' A' ' 33' ' ' VAL . 41.8 m -64.5 -40.56 95.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.529 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.84 -29.77 63.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.036 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.34 -42.76 96.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.014 -1.054 . . . . 0.0 109.22 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -73.44 -40.1 64.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.89 -48.92 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -56.37 -32.65 64.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -81.1 -50.63 9.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 m -55.93 -44.3 78.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 82.1 p -118.39 -110.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 25' ' ' THR . 81.5 m-20 -146.06 12.56 1.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.016 . . . . 0.0 109.882 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 28' ' ' PHE . 22.7 tttm 77.91 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.568 -0.707 . . . . 0.0 109.757 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -37.16 -55.54 1.71 Allowed Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.409 -0.807 . . . . 0.0 111.482 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 89.0 Cg_exo -35.43 -53.47 0.78 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.975 1.783 . . . . 0.0 112.415 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.7 t -108.72 142.82 38.69 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.311 -0.868 . . . . 0.0 108.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.22 -19.93 13.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -133.59 161.34 34.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.6 -0.688 . . . . 0.0 110.183 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 33' ' ' VAL . 7.7 p -123.93 79.83 57.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.2 -64.05 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.699 2.266 . . . . 0.0 112.442 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.94 166.04 24.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.57 141.04 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.72 -84.93 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 52.3 p30 -148.83 -170.86 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.806 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 40.5 p-10 -52.56 151.35 4.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.799 . . . . 0.0 109.257 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.98 146.44 44.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.741 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.39 142.86 45.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 108.961 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 134.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.8 m -90.49 131.81 36.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 108.914 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.17 137.59 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.413 -0.805 . . . . 0.0 110.044 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 95.7 mmm -91.2 137.46 32.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.84 . . . . 0.0 108.814 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLY . 78.4 mt -131.41 132.04 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.8 19.33 0.5 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.34 15.53 62.07 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 4.1 mt-10 -114.83 125.44 29.04 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.397 -1.06 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.14 117.07 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.038 1.825 . . . . 0.0 113.208 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 49' ' ' GLU . 48.5 m-85 -127.19 139.41 52.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -86.9 149.81 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.783 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.9 tp -131.79 133.84 45.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.425 -0.797 . . . . 0.0 109.24 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.2 131.11 8.26 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.84 132.99 50.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -1.105 . . . . 0.0 109.048 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.17 133.37 54.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 58' ' ' THR . 59.0 t0 -132.21 147.44 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.0 p -73.05 160.36 32.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.648 -179.805 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' THR . 95.2 mm-40 . . . . . 0 N--CA 1.492 1.645 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER 85.62 50.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.88 -33.67 67.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.2 128.8 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.441 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -105.61 124.12 49.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 108.767 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 55.9 mt -107.82 137.46 45.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 97' ' ' TRP . 20.1 t -124.99 136.78 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.596 ' HG ' ' HG1' ' A' ' 115' ' ' THR . 45.0 t -130.04 127.34 39.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.848 . . . . 0.0 109.843 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -136.42 165.37 25.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.942 . . . . 0.0 108.853 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.5 m -101.83 142.63 32.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.223 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 84' ' ' VAL . 4.1 p -102.84 -1.35 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.055 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.6 HG11 HG21 ' A' ' 125' ' ' THR . 78.2 t -85.32 -21.67 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.882 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.6 m -111.96 108.67 55.37 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.772 . . . . 0.0 109.771 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -51.77 -38.27 66.73 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.022 1.815 . . . . 0.0 112.335 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.6 p -57.62 -35.22 70.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 109.154 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -67.92 -21.85 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -72.02 -50.45 28.43 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.65 -35.77 80.96 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -50.95 -33.83 26.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.525 HG22 ' CZ3' ' A' ' 97' ' ' TRP . 81.3 t -62.39 -35.31 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -89.43 -37.56 14.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.821 -1.175 . . . . 0.0 110.247 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.07 -37.22 83.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 112.384 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -112.91 -52.05 2.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.762 -1.212 . . . . 0.0 112.699 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.616 ' O ' HD13 ' A' ' 101' ' ' ILE . 30.8 m0 -66.86 -39.43 87.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.994 -1.066 . . . . 0.0 112.593 -176.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -61.47 -52.21 71.71 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.143 -1.598 . . . . 0.0 111.05 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 38.3 Cg_endo -68.98 -43.22 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.568 1.512 . . . . 0.0 112.416 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.82 -39.81 62.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.5 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.616 HD13 ' O ' ' A' ' 97' ' ' TRP . 1.3 mp -66.63 -33.32 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.778 -1.201 . . . . 0.0 109.927 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.2 m -53.77 -39.02 65.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -58.93 -40.7 85.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.739 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -99.4 1.12 43.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER 59.42 166.32 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.996 . . . . 0.0 109.331 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.7 39.92 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.723 2.282 . . . . 0.0 112.304 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -60.17 -35.37 75.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.745 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.07 157.74 49.92 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 110.471 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.73 144.64 44.5 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.034 2.489 . . . . 0.0 112.696 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -116.75 138.82 51.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 153' ' ' LYS . 45.8 tp -116.71 123.62 47.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -101.56 116.93 33.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.03 135.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.672 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.3 114.88 4.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.642 HG22 ' HG3' ' A' ' 116' ' ' GLN . 20.8 m -102.74 149.22 24.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -1.152 . . . . 0.0 110.503 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.642 ' HG3' HG22 ' A' ' 115' ' ' THR . 91.5 mt-30 60.68 41.18 15.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.931 -0.48 . . . . 0.0 110.637 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.2 pt -73.65 -6.21 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.875 -1.141 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.487 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 84.5 m-20 -85.71 -24.03 27.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.049 -1.032 . . . . 0.0 109.217 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 116' ' ' GLN . 10.2 mp -65.01 -24.98 67.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HE ' HG11 ' A' ' 84' ' ' VAL . 97.0 mtt180 -44.99 -19.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.514 -0.741 . . . . 0.0 109.231 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 119' ' ' LEU . 60.6 t0 -122.33 48.63 1.71 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.737 . . . . 0.0 109.032 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 56.4 t0 -117.72 90.55 36.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.516 -0.74 . . . . 0.0 109.21 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.6 -40.92 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.197 1.931 . . . . 0.0 112.398 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.5 t -57.87 -43.21 85.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.842 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.6 HG21 HG11 ' A' ' 85' ' ' VAL . 45.4 m -70.58 -49.56 46.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 108.232 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.0 -36.41 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.15 -43.83 90.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 108.896 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -61.78 -42.54 99.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.696 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 129' ' ' LEU . 3.8 mm? -75.39 -33.91 61.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.885 . . . . 0.0 109.348 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.89 40.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.83 -35.36 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.495 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.38 6.81 21.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.719 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 61.55 44.77 8.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -140.94 139.61 34.32 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.229 -0.919 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.88 161.83 34.22 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.534 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.03 145.65 97.89 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.867 2.378 . . . . 0.0 112.328 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.555 ' CG2' ' OG1' ' A' ' 141' ' ' THR . 97.1 mt -90.99 144.56 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.435 -0.791 . . . . 0.0 109.835 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.34 155.02 54.52 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.54 -32.79 95.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.35 -36.61 61.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.555 ' OG1' ' CG2' ' A' ' 137' ' ' ILE . 65.4 p -78.57 -23.76 45.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.82 -1.175 . . . . 0.0 108.832 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.01 -43.88 51.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.448 -0.783 . . . . 0.0 109.759 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.68 -35.62 81.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 110.984 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -65.86 -38.42 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 149' ' ' LEU . 34.2 tp -59.7 -38.53 81.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 109.302 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.17 84.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.956 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.648 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -81.26 6.54 13.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -111.46 -34.86 5.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.106 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 145' ' ' LEU . 66.7 mt -92.68 16.9 11.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.63 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.2 mttt 61.2 31.23 19.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.93 145.18 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.641 HG12 ' HG3' ' A' ' 153' ' ' LYS . 87.0 t -66.56 -60.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.952 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.641 ' HG3' HG12 ' A' ' 152' ' ' VAL . 68.9 mttm -152.86 157.67 41.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -132.15 148.61 52.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.623 HG21 ' OE1' ' A' ' 171' ' ' GLU . 46.6 t -134.11 140.95 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -0.957 . . . . 0.0 110.231 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.86 121.84 36.88 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.422 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -130.69 140.63 50.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.159 -0.963 . . . . 0.0 110.761 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 161' ' ' THR . 8.7 t -115.61 115.13 25.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.416 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.9 -35.67 64.69 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.247 0.546 . . . . 0.0 109.86 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.45 -31.0 32.6 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.538 ' O ' ' O ' ' A' ' 158' ' ' SER . 7.4 m -118.03 152.11 36.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.29 12.61 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 161' ' ' THR . 62.9 mttp -89.18 4.74 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.857 -1.152 . . . . 0.0 109.903 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -89.08 -51.0 3.1 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.952 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.56 -38.62 74.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 110.301 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -60.24 -29.14 68.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.477 ' ND2' ' CG1' ' A' ' 155' ' ' VAL . 38.6 t-20 -75.59 -49.46 18.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.58 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 168' ' ' VAL . 73.0 t -79.1 -8.08 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 110.726 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 173' ' ' ILE . 76.1 t80 -74.95 -50.38 16.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.771 -1.205 . . . . 0.0 110.331 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.69 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 110.272 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.623 ' OE1' HG21 ' A' ' 155' ' ' VAL . 85.0 tt0 -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.975 . . . . 0.0 109.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.61 80.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 110.002 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.573 HD11 ' CE2' ' A' ' 169' ' ' PHE . 75.9 mt -72.89 -42.25 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.093 -1.004 . . . . 0.0 109.855 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.0 tp -57.5 -44.84 85.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.902 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.09 -33.4 75.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.7 71.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.9 -39.78 86.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 0.0 109.071 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 99.989999999999995 109.521 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 . . . . . 0 N--CA 1.49 1.571 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.6 m -124.92 147.42 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.583 -0.698 . . . . 0.0 109.781 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.25 119.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -88.92 128.38 35.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.59 124.03 26.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.06 138.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 0.0 109.935 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.571 HG22 HD23 ' A' ' 79' ' ' LEU . 46.2 t -111.32 136.07 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.615 HG11 ' CH2' ' A' ' 97' ' ' TRP . 54.2 t -133.27 136.44 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.1 142.36 12.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 12' ' ' GLY . 50.7 t0 -84.99 105.06 15.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 109.551 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.0 66.16 1.09 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -81.53 130.25 34.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -1.117 . . . . 0.0 109.342 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.48 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.22 51.91 0.67 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 86.3 tttt -61.8 -39.83 93.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.239 . . . . 0.0 110.057 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.6 p -76.14 -35.55 59.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 109.967 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 68.7 m -64.1 -31.18 72.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.445 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.78 -42.32 81.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.711 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.4 mt -70.45 -40.88 73.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.93 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.9 -36.71 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.6 p -60.44 -30.5 69.69 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.351 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -82.65 -50.27 8.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.977 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -66.85 -40.57 87.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 0.0 110.469 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 54.8 m -105.08 -86.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.965 . . . . 0.0 109.645 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER 159.92 -10.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.032 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -83.92 103.92 13.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.739 -1.226 . . . . 0.0 109.783 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.638 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -65.33 -41.4 51.15 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.431 -0.793 . . . . 0.0 109.173 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 27.7 Cg_exo -59.48 -33.36 97.21 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.337 2.025 . . . . 0.0 112.068 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER 74.99 42.25 0.27 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.104 -0.997 . . . . 0.0 108.595 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 32' ' ' TYR . 96.1 mt-10 -44.84 81.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.125 0.488 . . . . 0.0 110.597 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.669 ' N ' ' O ' ' A' ' 30' ' ' SER . 11.7 t80 90.05 71.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.228 0.537 . . . . 0.0 110.403 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.494 HG12 ' OG ' ' A' ' 30' ' ' SER . 31.7 m -44.55 148.81 0.84 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 109.604 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.28 144.3 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.833 2.355 . . . . 0.0 112.415 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.03 1.02 42.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.171 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.54 142.29 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.92 16.36 22.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.886 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 59.2 t0 -63.82 129.1 38.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -70.33 151.05 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.428 -0.795 . . . . 0.0 109.588 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 98.7 m-85 -127.97 152.56 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.816 . . . . 0.0 109.866 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.59 145.48 30.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.261 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -128.45 147.09 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 109.842 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.578 HG23 HG22 ' A' ' 52' ' ' THR . 58.3 m -120.53 142.53 49.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.408 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 m -124.53 158.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 109.818 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.7 mtp -112.49 140.65 47.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 51' ' ' TYR . 60.4 mt -122.1 143.78 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -46.4 -29.19 3.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.509 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -81.13 -92.16 0.51 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -126.74 156.68 73.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -1.057 . . . . 0.0 109.846 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.7 138.07 23.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.735 2.29 . . . . 0.0 112.24 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.543 ' CD1' HD12 ' A' ' 46' ' ' ILE . 89.9 m-85 -131.38 152.17 50.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 0.0 109.084 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.578 HG22 HG23 ' A' ' 43' ' ' THR . 17.8 p -117.8 157.92 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.17 160.3 29.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.19 158.28 26.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 mt -106.0 129.11 54.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.058 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -115.99 135.08 54.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 0.0 109.558 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -139.55 167.56 21.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.387 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.25 154.11 25.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.068 -1.02 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.613 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.868 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.492 1.64 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.44 ' OG1' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -152.12 98.44 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.4 -34.03 74.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.917 . . . . 0.0 109.546 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.78 143.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 74.2 m-85 -104.71 127.3 52.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.402 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 8' ' ' VAL . 30.7 tp -111.93 125.53 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.405 -0.81 . . . . 0.0 108.973 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.27 137.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 141.95 49.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 109.541 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.3 159.01 43.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 109.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -89.18 150.83 22.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 109.378 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.678 ' O ' HG22 ' A' ' 84' ' ' VAL . 6.7 p -98.48 4.43 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.97 -2.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -115.06 92.92 33.0 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.204 -0.935 . . . . 0.0 109.661 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.03 -50.81 12.73 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.41 2.073 . . . . 0.0 112.695 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -54.29 -38.68 66.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 109.371 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 93' ' ' VAL . 60.7 p -63.65 -16.01 59.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.29 -50.78 13.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.48 -39.46 81.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.592 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -53.74 -31.56 48.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.092 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 89' ' ' SER . 75.8 t -60.38 -35.59 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.697 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -95.66 -30.06 13.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.033 -1.042 . . . . 0.0 110.605 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.56 -35.06 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.71 -1.244 . . . . 0.0 111.903 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -113.73 -49.69 2.87 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.045 -1.034 . . . . 0.0 112.36 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.615 ' CH2' HG11 ' A' ' 9' ' ' VAL . 79.3 m95 -76.31 3.24 11.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -107.04 -45.98 0.12 Allowed Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.387 -1.446 . . . . 0.0 110.851 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 91.5 Cg_endo -86.12 -53.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.545 2.163 . . . . 0.0 112.767 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.57 -34.37 78.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.928 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.2 -27.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.853 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.1 p -66.46 -35.02 79.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.933 . . . . 0.0 109.764 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -56.84 -41.47 77.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -101.28 -8.8 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m -147.79 77.54 10.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.74 -44.46 49.41 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.564 2.176 . . . . 0.0 112.062 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -150.8 104.1 3.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -150.38 155.79 36.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.437 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.95 127.78 17.54 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.42 2.08 . . . . 0.0 111.857 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 108' ' ' THR . 76.7 m-85 -116.61 137.64 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.769 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 153' ' ' LYS . 8.2 tp -122.82 119.2 29.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.723 . . . . 0.0 109.449 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 112' ' ' LEU . 5.6 mp -107.56 127.08 53.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 108.818 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -112.04 133.08 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.67 119.82 5.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.9 p -118.25 169.45 9.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -1.068 . . . . 0.0 110.937 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 117' ' ' ILE . 82.3 mt-30 66.08 40.76 3.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 116' ' ' GLN . 15.2 tt -48.97 178.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.918 -1.114 . . . . 0.0 108.576 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 121' ' ' ASP . 87.7 m-20 54.26 26.17 6.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.819 -1.176 . . . . 0.0 109.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.9 mt 26.88 54.69 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.983 -0.448 . . . . 0.0 111.343 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 21.2 mmm180 49.61 26.85 1.91 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.834 -1.166 . . . . 0.0 110.189 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 118' ' ' ASP . 9.7 t0 79.84 -14.74 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.0 109.455 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.449 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.8 OUTLIER 53.97 62.34 9.04 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.756 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 122' ' ' ASP . 68.4 Cg_endo -92.68 -100.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 123.02 2.48 . . . . 0.0 111.504 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.3 p -81.17 -2.4 48.4 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.6 m -72.41 -46.36 55.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 108.956 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 126' ' ' ILE . 6.9 pt -62.63 -34.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.29 -0.881 . . . . 0.0 109.308 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.63 -50.03 48.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -61.34 -36.67 80.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 0.0 110.138 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.93 -37.77 61.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 108.789 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.83 -38.49 61.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 109.475 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -60.23 -36.73 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 109.346 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -85.32 5.7 29.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.546 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttt 54.92 44.06 28.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.829 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -135.56 91.78 2.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.997 . . . . 0.0 109.416 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.85 153.22 91.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.31 161.77 25.96 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.853 2.369 . . . . 0.0 112.205 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.11 134.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -98.2 157.87 33.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 109.067 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 142' ' ' ALA . 2.1 Cg_endo -47.93 -36.28 26.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.906 2.404 . . . . 0.0 113.065 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.535 ' H ' HG23 ' A' ' 138' ' ' THR . 84.6 tt0 -46.9 -40.76 14.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 110.119 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.1 p -89.25 -18.38 27.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.779 -1.201 . . . . 0.0 109.39 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 139' ' ' PRO . . . -76.3 -49.88 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.706 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.35 -34.97 78.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.135 . . . . 0.0 110.662 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 87.7 mttt -61.82 -32.92 73.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 0.0 109.292 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 tp -56.31 -38.96 72.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.406 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.07 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.786 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -80.65 -0.63 38.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 61.5 t0 -111.9 -43.29 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 108.814 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.553 HD11 HG21 ' A' ' 98' ' ' VAL . 9.6 tp -78.71 10.89 2.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.636 -0.665 . . . . 0.0 109.675 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 59.02 30.12 19.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -0.952 . . . . 0.0 110.137 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.9 52.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 108.758 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.81 -58.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.075 . . . . 0.0 109.498 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.626 ' O ' HD12 ' A' ' 111' ' ' LEU . 50.1 tttp -158.51 155.8 29.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.868 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.68 153.46 51.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.531 HG21 ' OE1' ' A' ' 171' ' ' GLU . 39.3 t -133.04 138.44 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 84.6 tt0 -102.6 132.22 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.428 ' HB3' HD22 ' A' ' 167' ' ' ASN . 8.4 p -167.09 176.74 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.123 . . . . 0.0 110.376 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 117' ' ' ILE . 28.7 t -135.17 127.19 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.014 -1.054 . . . . 0.0 110.719 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.1 mt -54.66 -26.33 32.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.562 ' C ' ' H ' ' A' ' 163' ' ' LYS . 27.4 m -121.3 160.87 23.05 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -64.62 11.17 0.05 Allowed 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.412 -0.805 . . . . 0.0 109.247 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.5 mttm -89.84 3.0 54.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.977 -1.077 . . . . 0.0 109.564 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.528 ' O ' HG22 ' A' ' 168' ' ' VAL . . . -91.93 -50.23 2.71 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.6 mp -67.02 -44.96 78.95 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.443 -1.034 . . . . 0.0 110.646 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.41 -32.56 68.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 25.6 t-20 -79.84 -50.88 9.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.939 -1.101 . . . . 0.0 110.063 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 164' ' ' GLY . 15.6 m -75.79 -18.13 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 110.911 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.56 -47.37 27.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 0.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 110.233 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.531 ' OE1' HG21 ' A' ' 155' ' ' VAL . 80.9 tt0 -67.45 -33.99 76.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.093 -1.005 . . . . 0.0 109.927 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.53 70.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.9 . . . . 0.0 110.323 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 29.3 mm -67.67 -40.75 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.112 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 174' ' ' LEU . 3.4 mm? -56.88 -45.59 82.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 0.0 110.083 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.97 77.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.052 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.98 72.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.17 -36.72 84.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.0 109.511 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.529 -179.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 . . . . . 0 N--CA 1.491 1.621 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -127.29 135.74 50.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.37 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 176' ' ' ALA . 68.3 mt -113.07 114.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.834 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -91.3 132.43 36.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.472 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -132.6 121.39 23.14 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.66 134.02 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 79' ' ' LEU . 26.1 t -114.61 133.01 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG21 ' CH2' ' A' ' 97' ' ' TRP . 9.1 p -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 0.0 109.582 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.01 -173.32 37.32 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' GLY . 23.3 t70 -69.76 137.65 52.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . -37.16 -47.67 1.43 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.626 ' C ' HG23 ' A' ' 14' ' ' VAL . . . -42.53 167.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -1.209 . . . . 0.0 109.658 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.626 HG23 ' C ' ' A' ' 13' ' ' ALA . 2.1 t 73.42 110.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.27 79.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.5 mttp -58.05 -31.18 66.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 108.989 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 m -67.52 -44.42 78.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.399 -0.813 . . . . 0.0 109.016 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.6 m -62.14 -27.7 69.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 109.637 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -65.16 -40.27 94.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 108.506 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.911 ' O ' HG23 ' A' ' 24' ' ' THR . 59.8 mt -71.37 -44.06 65.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 0.0 109.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mm -67.91 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.982 . . . . 0.0 109.832 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.401 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 29.6 t -60.03 -35.12 74.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.955 . . . . 0.0 109.812 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.96 -33.17 70.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.911 HG23 ' O ' ' A' ' 20' ' ' LEU . 60.9 p -72.07 -45.77 59.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 110.879 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.593 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 46.6 p -144.01 -2.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.792 -1.193 . . . . 0.0 111.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 25' ' ' THR . 37.3 t30 90.35 118.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' OG ' ' A' ' 30' ' ' SER . 2.8 tttm 178.63 48.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.99 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.653 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -61.36 -42.75 86.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.513 -1.367 . . . . 0.0 109.525 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 22.9 Cg_exo -62.19 1.99 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.908 2.406 . . . . 0.0 112.575 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 32' ' ' TYR . 29.2 m -48.89 -42.12 35.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.986 -1.071 . . . . 0.0 109.762 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 39.38 23.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.62 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 30' ' ' SER . 30.3 m-85 -93.76 -102.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.786 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.793 ' O ' HG12 ' A' ' 33' ' ' VAL . 46.5 t 54.44 63.18 7.6 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.717 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 32.9 Cg_endo -68.67 -26.31 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.267 1.978 . . . . 0.0 111.235 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 34' ' ' PRO . . . 154.51 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.69 142.02 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -144.16 59.76 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.842 . . . . 0.0 109.182 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -121.15 158.65 27.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.296 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 55' ' ' LEU . 64.6 t30 -93.97 139.25 31.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.75 154.14 29.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.817 . . . . 0.0 109.54 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.55 143.62 44.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 0.0 109.061 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.57 130.71 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.8 m -100.74 128.52 46.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.01 134.14 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 0.0 110.198 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.4 ttp -118.25 128.71 54.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 27.2 pt -131.8 152.39 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.44 16.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.55 15.68 61.46 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.8 mt-10 -113.32 93.73 27.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.438 -1.036 . . . . 0.0 109.523 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.91 145.6 23.87 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.12 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 60.8 m-85 -150.72 160.79 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.3 m -117.7 129.31 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 0.0 109.24 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 53' ' ' LEU . 34.3 tp -117.81 122.7 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.492 -0.755 . . . . 0.0 109.161 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.79 121.28 5.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 56.7 mt -101.62 128.05 48.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 108.417 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.83 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 54.4 p30 -102.91 169.54 8.52 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.367 -0.833 . . . . 0.0 109.017 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.9 m -57.81 129.51 42.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.942 -1.099 . . . . 0.0 109.09 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 109.277 -179.819 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 109.038 -0.727 . . . . 0.0 109.038 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -77.0 160.11 29.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.141 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -121.65 -46.65 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.25 142.5 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 109.903 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.04 128.56 55.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.029 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.472 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 50.0 mt -108.96 141.72 40.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.15 136.51 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.284 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.0 t -129.1 126.16 38.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 0.0 109.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.74 168.92 18.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.484 ' OG ' ' OE1' ' A' ' 116' ' ' GLN . 24.1 t -97.04 137.22 36.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 84' ' ' VAL . 10.8 p -85.37 -10.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.262 -0.899 . . . . 0.0 111.222 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.638 HG22 ' OE1' ' A' ' 116' ' ' GLN . 26.6 m -99.78 -0.93 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.73 -1.231 . . . . 0.0 110.215 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 12.2 t -101.52 122.4 48.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.17 -61.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.211 1.94 . . . . 0.0 113.096 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -52.43 -41.07 62.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.927 -1.108 . . . . 0.0 110.117 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 60.5 p -69.09 -18.68 64.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.974 . . . . 0.0 109.505 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CD1' HD13 ' A' ' 137' ' ' ILE . 61.7 t80 -70.36 -50.5 38.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -74.4 -34.57 63.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -53.56 -39.01 64.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.967 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.5 -33.47 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.66 -25.69 62.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 111.35 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.12 -9.45 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.705 -1.247 . . . . 0.0 111.472 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -112.04 -51.44 2.85 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 111.337 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.54 ' CH2' HG21 ' A' ' 9' ' ' VAL . 61.6 m95 -92.4 -7.12 48.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.185 -0.947 . . . . 0.0 112.432 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -94.33 -39.98 0.3 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.318 -1.489 . . . . 0.0 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.8 Cg_endo -91.94 -49.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 0.0 113.517 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -51.6 -39.77 58.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.452 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 101' ' ' ILE . 9.2 tp -81.68 -19.85 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.042 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 57.6 m -54.7 -38.33 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -56.4 -43.77 79.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 110.741 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -103.4 11.76 36.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.957 -1.09 . . . . 0.0 111.068 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 28.0 p -63.57 114.86 14.6 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.154 . . . . 0.0 109.468 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.16 -90.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.238 1.959 . . . . 0.0 112.632 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.48 ' C ' HG22 ' A' ' 108' ' ' THR . 27.1 mttt -87.81 -80.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.308 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER 173.42 58.67 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.226 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 108' ' ' THR . 48.1 Cg_endo -94.06 53.01 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.955 2.437 . . . . 0.0 111.899 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.66 128.26 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.876 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 153' ' ' LYS . 11.1 tp -124.89 116.5 22.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.16 125.55 44.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 108.99 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.89 134.49 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 110.201 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.5 127.02 8.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 3.3 t -132.05 168.01 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.638 ' OE1' HG22 ' A' ' 85' ' ' VAL . 21.9 tt0 84.99 20.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.693 ' O ' ' N ' ' A' ' 119' ' ' LEU . 39.0 pt -59.44 -155.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 108.401 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 57.99 -58.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.743 . . . . 0.0 110.255 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.693 ' N ' ' O ' ' A' ' 117' ' ' ILE . 27.9 tp -51.78 -31.79 28.38 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.04 -1.037 . . . . 0.0 108.598 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -49.44 -17.63 0.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.765 . . . . 0.0 109.482 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -118.87 62.55 0.78 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 109.006 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.65 94.29 26.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.28 -44.72 23.77 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.278 1.985 . . . . 0.0 112.618 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -55.59 -36.05 66.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.052 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.57 HG21 HD11 ' A' ' 119' ' ' LEU . 69.1 p -78.0 -42.7 31.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.864 -1.147 . . . . 0.0 108.246 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.4 -39.0 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.28 -40.06 81.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.873 . . . . 0.0 108.695 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -59.79 -43.17 94.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.744 . . . . 0.0 109.152 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.51 -29.7 56.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.858 . . . . 0.0 109.264 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.7 -41.41 43.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.549 -0.719 . . . . 0.0 109.605 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.21 -36.65 75.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.91 6.47 24.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.858 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.9 mttt 58.09 43.3 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.89 138.81 35.97 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.177 -0.952 . . . . 0.0 109.08 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.37 154.24 53.98 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -46.25 147.39 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.238 1.959 . . . . 0.0 111.819 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.462 HD13 ' CD1' ' A' ' 90' ' ' PHE . 86.5 mt -75.58 148.98 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.96 154.9 55.53 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.264 -0.898 . . . . 0.0 109.193 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.8 -36.2 91.87 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.432 2.088 . . . . 0.0 111.777 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.98 -36.68 80.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.631 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 61.6 m -68.66 -36.75 78.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.153 -0.967 . . . . 0.0 108.84 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.31 64.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.567 -0.708 . . . . 0.0 110.008 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.38 -32.07 73.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -61.12 -36.52 79.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.81 -1.182 . . . . 0.0 109.23 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.1 tp -54.74 -39.88 68.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -68.67 -46.04 70.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.577 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -83.71 5.02 26.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.908 . . . . 0.0 110.143 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -61.43 -36.13 79.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.965 -1.084 . . . . 0.0 109.425 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.4 mt -126.16 -73.79 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 109.46 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -169.89 55.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 0.0 109.876 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -71.04 143.52 50.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.991 -1.068 . . . . 0.0 109.244 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.645 HG12 ' HG3' ' A' ' 153' ' ' LYS . 99.3 t -67.33 -56.58 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.104 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.645 ' HG3' HG12 ' A' ' 152' ' ' VAL . 66.0 mttm -159.3 164.99 34.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.173 -0.954 . . . . 0.0 109.912 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -131.06 146.93 52.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 108.908 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 t -132.26 140.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.47 129.96 52.43 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 150.16 43.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.93 -1.106 . . . . 0.0 111.297 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 117' ' ' ILE . 21.5 t -114.56 106.46 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -73.8 -34.5 64.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 109.621 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.32 -24.19 27.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.2 p -123.24 168.74 12.06 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -78.17 11.81 2.16 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.686 -0.634 . . . . 0.0 109.614 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 49.3 mttt -90.64 -5.76 55.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.035 -1.04 . . . . 0.0 109.85 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.49 -50.46 3.58 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.449 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.686 ' N ' HD12 ' A' ' 165' ' ' LEU . 7.8 mp -65.73 -41.01 92.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.211 . . . . 0.0 110.275 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -59.12 -31.3 68.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 163' ' ' LYS . 21.1 m120 -78.33 -50.7 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.926 -1.108 . . . . 0.0 110.102 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 172' ' ' ALA . 91.8 t -77.27 -12.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 173' ' ' ILE . 72.5 t80 -80.46 -50.53 9.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.679 -1.263 . . . . 0.0 110.593 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.03 -45.88 92.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.526 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.5 -33.0 68.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.165 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 168' ' ' VAL . . . -59.59 -33.44 71.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.112 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 169' ' ' PHE . 88.5 mt -65.86 -36.28 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 0.0 110.504 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 174' ' ' LEU . 4.0 mm? -58.22 -44.01 87.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.113 . . . . 0.0 109.597 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.6 -33.89 76.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.043 . . . . 0.0 109.156 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.438 ' HA ' HD13 ' A' ' 4' ' ' ILE . . . -57.6 -38.75 75.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 52.7 mt -59.91 -39.73 86.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -0.936 . . . . 0.0 108.792 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 99.989999999999995 109.329 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 . . . . . 0 N--CA 1.489 1.52 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -123.3 160.59 26.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.779 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 176' ' ' ALA . 33.2 mm -116.64 119.0 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -87.03 121.97 30.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.037 -1.04 . . . . 0.0 109.786 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.2 t -138.13 128.37 25.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.93 143.05 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -0.83 . . . . 0.0 109.546 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.82 133.01 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.059 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.591 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 26.5 t -131.45 136.07 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.23 147.65 17.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' ALA . 25.2 t70 -85.6 111.49 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.059 -1.26 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 54.42 -85.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.23 123.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -1.127 . . . . 0.0 109.567 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.71 -43.06 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.59 57.69 0.42 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -63.36 -40.72 98.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 0.0 109.728 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -82.82 -32.64 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -31.22 72.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.23 -42.41 79.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.97 -1.081 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.9 -40.92 91.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.41 -35.24 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.3 p -50.75 -36.61 37.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 110.459 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -76.62 -37.64 56.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.083 . . . . 0.0 109.677 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.8 p -63.64 -37.69 88.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 111.692 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -162.08 -5.85 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.371 -1.456 . . . . 0.0 111.885 -179.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.609 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.7 t30 95.17 115.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -179.78 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.85 -42.52 83.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.778 -1.202 . . . . 0.0 109.82 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.3 Cg_exo -57.75 -31.72 92.9 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.48 2.12 . . . . 0.0 112.201 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.5 p 37.68 37.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.568 -0.707 . . . . 0.0 109.768 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 30' ' ' SER . 97.1 mt-10 -36.15 -37.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 110.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 33' ' ' VAL . 68.6 t80 -125.79 122.05 35.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 108.699 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.433 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 17.1 m -63.6 148.64 93.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.125 -0.984 . . . . 0.0 109.159 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.65 141.34 91.4 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.223 1.949 . . . . 0.0 112.149 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.95 71.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.939 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.75 155.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 110.067 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.32 25.91 10.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.098 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.419 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 89.1 m-20 -60.77 143.67 54.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 110.378 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 55' ' ' LEU . 46.3 t-20 -74.12 152.42 39.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.716 . . . . 0.0 109.563 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 95.9 m-85 -127.87 146.53 50.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.43 134.94 49.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.03 152.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 109.43 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p -118.31 143.83 46.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.45 138.67 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 109.815 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.6 mtt -79.11 126.87 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 0.0 109.171 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' GLY . 70.5 mt -131.56 126.2 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.196 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.93 18.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 88.81 12.95 63.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.6 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.1 mm-40 -123.24 81.87 52.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.466 -1.02 . . . . 0.0 109.118 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 124.05 15.33 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.677 2.252 . . . . 0.0 112.91 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.6 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 96.7 m-85 -115.49 142.68 46.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.4 m -75.56 135.09 40.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.922 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -123.09 125.06 44.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.79 132.38 10.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 73.1 mt -104.57 135.2 46.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -1.105 . . . . 0.0 109.022 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.11 155.68 32.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 109.752 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.1 p30 -150.24 178.04 9.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 47.5 m -66.25 138.66 57.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 0.0 109.198 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . . . . . . 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.91 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 . . . . . 0 N--CA 1.491 1.62 0 N-CA-C 109.258 -0.645 . . . . 0.0 109.258 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -124.14 151.31 44.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.346 -0.846 . . . . 0.0 109.722 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -65.6 -35.62 81.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.45 HG21 ' HB1' ' A' ' 175' ' ' ALA . 35.9 t -138.54 133.33 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.99 128.59 49.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 108.981 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.4 tp -113.43 132.04 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.395 -0.815 . . . . 0.0 109.855 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.14 135.4 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 0.0 109.225 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.8 t -130.52 126.15 36.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 110.021 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.47 168.41 19.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 108.86 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 m -108.01 145.93 33.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.472 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 84' ' ' VAL . 14.9 p -103.79 13.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.039 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.78 -21.54 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.43 150.28 68.1 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.257 -0.902 . . . . 0.0 110.061 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.95 -33.21 3.84 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.737 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 t -55.67 -44.63 77.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.005 . . . . 0.0 109.493 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.735 ' O ' HG23 ' A' ' 93' ' ' VAL . 40.9 m -66.36 -24.68 66.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.155 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -73.5 -51.26 17.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.458 -0.776 . . . . 0.0 109.524 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.51 -39.95 70.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.091 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.46 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 42.0 t30 -54.32 -35.28 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 89' ' ' SER . 65.7 t -59.06 -34.54 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 0.0 109.735 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -86.82 -22.84 25.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 0.0 110.406 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -75.44 -30.68 60.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.487 ' NZ ' ' OD1' ' A' ' 11' ' ' ASP . 7.6 ttpm? -112.53 -47.38 3.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.014 -1.054 . . . . 0.0 112.223 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.591 ' CZ2' ' CG1' ' A' ' 9' ' ' VAL . 77.1 m95 -80.8 1.36 30.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.093 -1.004 . . . . 0.0 113.35 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.607 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -107.76 -41.74 0.13 Allowed Pre-proline 0 N--CA 1.503 2.192 0 O-C-N 120.402 -1.436 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 24.3 Cg_endo -88.71 -53.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.984 2.456 . . . . 0.0 112.691 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -57.03 -37.11 71.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -66.12 -29.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.027 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.9 m -60.03 -45.31 93.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.931 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.16 -35.07 76.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 30.7 t-80 -64.32 -40.91 96.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.95 . . . . 0.0 109.79 179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.4 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.1 OUTLIER 171.88 165.74 0.24 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 109.939 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 75.8 Cg_exo -43.25 171.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.761 2.307 . . . . 0.0 112.228 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.44 140.86 55.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 110.02 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -124.94 160.28 54.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.81 122.6 11.29 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.178 1.919 . . . . 0.0 111.748 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 108' ' ' THR . 76.3 m-85 -122.86 149.59 43.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.109 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.437 ' C ' HD22 ' A' ' 112' ' ' LEU . 85.1 mt -112.98 120.01 39.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 112' ' ' LEU . 3.5 mm? -97.06 111.57 23.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 0.0 108.762 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.609 HG13 HG23 ' A' ' 155' ' ' VAL . 47.9 t -108.3 135.4 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.76 122.84 7.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.7 p -122.14 160.9 24.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -1.068 . . . . 0.0 110.477 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.6 HE21 HD11 ' A' ' 160' ' ' LEU . 27.8 tp60 79.99 18.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.992 -0.443 . . . . 0.0 110.233 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.654 ' O ' ' N ' ' A' ' 119' ' ' LEU . 29.0 pt -60.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.723 -1.236 . . . . 0.0 108.149 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 61.06 -62.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.654 ' N ' ' O ' ' A' ' 117' ' ' ILE . 48.7 tp -55.1 -34.75 63.94 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.089 -1.007 . . . . 0.0 108.612 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -61.8 -19.75 62.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.013 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -90.14 -19.59 24.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.692 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.38 141.9 80.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.42 -29.94 19.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.427 2.085 . . . . 0.0 112.679 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -58.26 -41.78 85.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 49.3 m -72.11 -47.63 49.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.982 -1.074 . . . . 0.0 108.188 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.3 mt -55.09 -36.28 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.834 -0.541 . . . . 0.0 109.641 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.84 -46.95 79.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -59.06 -38.12 78.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 83.5 mt -79.14 -35.9 41.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 109.642 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.97 66.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -60.9 -36.17 78.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.1 5.61 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 52.97 32.81 13.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 135' ' ' LYS . 93.5 mt-30 -96.12 -53.06 3.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 109.606 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.489 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 10.9 mttm 62.36 144.86 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.456 -0.778 . . . . 0.0 109.092 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.05 150.69 87.91 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.538 2.159 . . . . 0.0 112.58 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 91.9 mt -89.07 146.95 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.418 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.28 157.73 55.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.375 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.93 -28.8 81.36 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.528 2.152 . . . . 0.0 111.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.7 -38.11 86.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.343 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 m -66.76 -36.16 81.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.147 -0.971 . . . . 0.0 109.019 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.35 -39.98 62.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 0.0 109.796 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -60.18 -34.35 73.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.521 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -64.13 -37.63 88.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.013 -1.054 . . . . 0.0 109.922 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.8 tp -58.19 -40.23 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.861 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.83 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -87.85 -52.01 5.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 147' ' ' ARG . 29.6 ttt-85 -51.34 -7.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 146' ' ' ALA . 84.4 m-20 -111.57 -15.82 13.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.971 -1.081 . . . . 0.0 109.835 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.37 29.59 6.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 0.0 111.06 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.0 mttt 58.5 30.56 19.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.9 -1.125 . . . . 0.0 110.88 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.83 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -71.51 144.95 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 108.83 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.45 -52.25 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.063 . . . . 0.0 109.771 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HZ2' ' CG ' ' A' ' 171' ' ' GLU . 47.1 pttt -175.92 -179.22 1.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.352 -0.843 . . . . 0.0 109.804 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -137.78 153.99 49.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.609 HG23 HG13 ' A' ' 113' ' ' VAL . 33.6 m -137.34 148.38 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.61 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.22 134.6 52.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.861 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.01 149.75 42.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 110.875 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.2 t -113.04 109.47 18.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.08 -36.45 61.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.712 -0.618 . . . . 0.0 109.564 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.6 HD11 HE21 ' A' ' 116' ' ' GLN . 61.0 mt -53.88 -26.95 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.645 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 p -124.05 170.24 10.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.32 12.0 1.36 Allowed 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.396 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 89.1 mttt -89.5 0.01 57.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 0.0 109.714 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.85 -51.13 2.71 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.298 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.697 ' N ' HD12 ' A' ' 165' ' ' LEU . 7.5 mp -68.74 -41.25 79.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -1.221 . . . . 0.0 110.246 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -59.55 -35.61 74.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.477 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 19.4 m120 -76.89 -49.39 15.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.532 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 168' ' ' VAL . 74.8 t -68.4 -9.34 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.536 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 173' ' ' ILE . 72.1 t80 -74.35 -46.21 42.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.58 -49.31 77.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.993 -1.067 . . . . 0.0 111.367 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 167' ' ' ASN . 60.3 mp0 -70.72 -35.67 72.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.846 -1.159 . . . . 0.0 110.373 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.34 80.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.813 HD11 ' CE2' ' A' ' 169' ' ' PHE . 97.8 mt -63.47 -38.68 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.029 -1.045 . . . . 0.0 109.915 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.37 -43.64 79.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -0.976 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.45 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.51 -36.22 83.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 109.913 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.498 ' HA ' HG21 ' A' ' 4' ' ' ILE . . . -52.76 -37.75 59.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.585 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.13 -36.55 82.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 108.997 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.446 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 . . . . . 0 N--CA 1.492 1.642 0 CA-C-O 121.225 0.536 . . . . 0.0 109.559 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -143.08 154.91 44.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.767 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.54 HD13 ' HB1' ' A' ' 176' ' ' ALA . 61.3 mt -122.45 122.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.497 -0.752 . . . . 0.0 109.127 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -87.0 131.91 33.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.74 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 126.51 12.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.35 137.54 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 HD22 ' A' ' 79' ' ' LEU . 59.9 t -116.8 130.55 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.16 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -138.51 156.81 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.45 167.6 31.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.577 ' CG ' HD22 ' A' ' 92' ' ' ASN . 61.1 t0 -86.0 121.82 29.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.079 . . . . 0.0 109.451 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.695 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 71.05 -107.7 2.25 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 164.76 42.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.377 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.953 HG13 ' H ' ' A' ' 15' ' ' GLY . 1.7 p -72.17 -85.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.061 -1.025 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.953 ' H ' HG13 ' A' ' 14' ' ' VAL . . . -99.2 16.12 59.57 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -59.76 -38.19 81.09 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.5 p -74.29 -35.5 63.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.994 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.647 ' SG ' ' NZ ' ' A' ' 27' ' ' LYS . 89.4 m -59.82 -30.76 69.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.0 tp -67.7 -42.44 81.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.902 -1.124 . . . . 0.0 110.268 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.09 -43.77 61.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 111.059 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 22' ' ' SER . 9.9 tp -65.85 -38.81 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 0.0 110.184 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 25.7 m -54.69 -34.62 62.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.046 . . . . 0.0 110.307 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CZ ' ' A' ' 169' ' ' PHE . 82.3 t80 -70.13 -38.05 75.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.525 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.566 ' C ' HG22 ' A' ' 25' ' ' THR . 28.5 m -52.61 -37.2 57.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.932 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 179.75 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 110.584 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.658 ' ND2' ' NE2' ' A' ' 162' ' ' GLN . 25.2 t-20 96.1 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.647 ' NZ ' ' SG ' ' A' ' 18' ' ' CYS . 53.7 tttt -64.53 -41.0 96.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.205 0.526 . . . . 0.0 111.023 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 27' ' ' LYS . 1.5 m-85 -42.94 -61.41 1.75 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.728 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 54.4 Cg_endo -70.53 23.87 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.463 2.109 . . . . 0.0 112.632 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 68.8 m -137.76 -62.0 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.116 -0.99 . . . . 0.0 109.546 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.23 11.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 30' ' ' SER . 78.4 m-85 -91.59 -101.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 109.709 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 33' ' ' VAL . 3.5 p 34.15 60.04 2.03 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.655 . . . . 0.0 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 33' ' ' VAL . 69.7 Cg_endo -84.23 -73.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.392 2.061 . . . . 0.0 111.863 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' ' CE2' ' A' ' 37' ' ' PHE . . . -65.35 156.46 32.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 p -74.02 140.59 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 98.2 m-85 -118.13 159.2 23.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.531 -0.731 . . . . 0.0 109.646 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.0 p30 -72.91 -167.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.842 . . . . 0.0 109.97 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.35 157.08 6.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -110.33 130.89 55.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.386 -0.821 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 121.61 44.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.36 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' A' ' 23' ' ' TYR . 48.4 t -127.57 134.9 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.493 -0.754 . . . . 0.0 109.369 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 m -98.55 138.79 35.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.26 134.57 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.453 -0.78 . . . . 0.0 109.514 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.0 mtp -107.29 141.78 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 0.0 109.568 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 48' ' ' GLY . 73.7 mt -124.68 139.86 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.51 -24.02 0.59 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -82.89 -93.59 0.59 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.533 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 13.6 mm-40 -123.11 152.44 63.46 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.424 -1.045 . . . . 0.0 109.973 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.29 141.4 35.5 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.647 2.231 . . . . 0.0 112.224 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 98.9 m-85 -137.81 159.43 42.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 109.739 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -112.01 142.86 43.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 109.116 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -120.86 123.17 41.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.422 -0.799 . . . . 0.0 109.691 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.03 129.71 8.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.1 mt -107.74 136.59 47.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -118.86 146.26 45.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.765 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.455 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 52.6 p30 -156.79 164.81 37.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.422 -0.798 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -67.49 137.08 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.851 -179.546 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 . . . . . 0 N--CA 1.492 1.665 0 CA-C-O 121.331 0.586 . . . . 0.0 109.762 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 78' ' ' PHE . 58.7 m -141.62 126.82 18.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.826 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.74 -25.26 13.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.014 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.49 131.72 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.444 -0.785 . . . . 0.0 109.414 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.644 ' CD2' HD11 ' A' ' 101' ' ' ILE . 95.5 m-85 -105.71 127.75 53.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.237 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.425 HD22 HG22 ' A' ' 8' ' ' VAL . 7.2 tt -118.24 129.89 55.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.428 -0.795 . . . . 0.0 110.246 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 111' ' ' LEU . 25.3 m -129.47 148.88 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 140.92 34.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.87 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 112' ' ' LEU . 15.8 p90 -154.98 157.33 37.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.5 p -83.37 157.03 22.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 109.441 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 84' ' ' VAL . 7.1 p -100.56 6.57 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 0.0 110.177 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.774 HG11 HD23 ' A' ' 119' ' ' LEU . 14.9 m -104.13 0.44 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 110.333 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.51 95.85 41.43 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 109.843 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.56 -48.87 19.22 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.298 1.999 . . . . 0.0 112.284 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 m -53.49 -40.47 65.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.046 . . . . 0.0 109.141 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -67.36 -19.75 65.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.084 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -68.66 -50.92 47.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 108.742 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.92 -34.63 75.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.395 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.577 HD22 ' CG ' ' A' ' 11' ' ' ASP . 48.3 t30 -54.25 -34.41 60.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.885 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.55 -37.71 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -91.94 -44.41 8.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 110.738 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.2 -36.71 82.76 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 112.199 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -114.53 -52.31 2.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.952 -1.093 . . . . 0.0 112.901 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.6 -38.48 80.66 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.075 -1.016 . . . . 0.0 113.487 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.1 t -57.48 -52.01 77.46 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.134 -1.604 . . . . 0.0 111.084 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -70.94 -37.79 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.717 1.611 . . . . 0.0 112.787 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.97 -40.79 85.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.644 HD11 ' CD2' ' A' ' 78' ' ' PHE . 9.1 tp -65.01 -28.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.755 -1.215 . . . . 0.0 109.538 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -61.64 -40.84 96.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.939 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -54.52 -40.65 68.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.521 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 64.8 m170 -57.39 -40.33 77.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 109.22 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.1 m 177.83 150.75 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.399 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.15 -27.85 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.639 2.226 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -127.64 137.84 52.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.76 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.464 ' OG1' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -175.61 147.71 0.96 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.073 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.84 122.01 8.91 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.217 1.945 . . . . 0.0 111.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -108.7 123.8 49.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.495 ' O ' HG22 ' A' ' 80' ' ' VAL . 29.6 tp -117.47 125.18 50.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 109.314 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 82' ' ' PHE . 49.5 tp -109.81 119.1 38.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.4 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 135.58 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.905 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.82 125.78 8.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.0 p -124.07 163.87 20.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -1.093 . . . . 0.0 110.575 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 68.74 33.95 3.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.802 -0.561 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 pt -74.29 -2.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 0.0 110.723 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.5 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 80.0 m-20 -84.26 -26.55 28.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.861 -1.15 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.774 HD23 HG11 ' A' ' 85' ' ' VAL . 28.2 tp -60.86 -30.93 70.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 109.265 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -57.74 -25.38 60.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.644 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -99.99 26.81 6.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -111.64 95.73 29.1 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.88 -44.14 38.09 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.174 1.916 . . . . 0.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -57.94 -37.03 73.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.187 -0.946 . . . . 0.0 109.483 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.665 HG21 HD21 ' A' ' 119' ' ' LEU . 30.1 m -73.85 -47.65 36.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -54.34 -34.78 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -62.5 -46.56 87.86 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -59.5 -36.84 76.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.454 -0.779 . . . . 0.0 108.976 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.443 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 77.8 mt -73.42 -37.53 65.87 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.32 75.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.676 -0.64 . . . . 0.0 109.764 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -59.18 -37.52 77.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.986 -1.071 . . . . 0.0 109.168 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -90.89 4.96 50.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.472 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.1 mttp 52.36 35.46 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.838 . . . . 0.0 109.496 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 135' ' ' LYS . 97.8 mt-30 -92.84 -53.84 4.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 7.1 mttt 62.09 144.37 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.056 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 147.25 87.63 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.58 2.186 . . . . 0.0 112.487 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -78.22 149.81 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.79 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 154.32 60.57 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.992 -1.067 . . . . 0.0 109.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.65 -33.52 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.318 2.012 . . . . 0.0 111.819 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.05 -36.03 80.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.649 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.3 m -68.22 -36.99 80.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 109.245 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.5 -44.3 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -0.811 . . . . 0.0 110.099 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.587 ' OE2' ' CE2' ' A' ' 154' ' ' TYR . 99.1 mt-10 -63.67 -32.32 73.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.02 . . . . 0.0 110.35 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.528 ' NZ ' ' OD2' ' A' ' 148' ' ' ASP . 13.2 tttm -65.95 -38.17 87.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.923 -1.111 . . . . 0.0 110.157 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.99 -39.32 81.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.689 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -78.75 -49.74 12.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 110.018 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -60.3 -2.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.306 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.528 ' OD2' ' NZ ' ' A' ' 144' ' ' LYS . 86.2 m-20 -111.29 -21.58 11.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.041 . . . . 0.0 109.91 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.57 26.74 8.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.494 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 59.79 31.03 20.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.224 -0.922 . . . . 0.0 110.613 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.689 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -66.11 144.75 56.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.0 . . . . 0.0 108.866 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.94 -59.62 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -165.31 157.26 15.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.755 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CE2' ' OE2' ' A' ' 143' ' ' GLU . 21.1 p90 -117.4 144.31 45.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.8 t -131.09 138.51 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -102.13 129.01 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.455 ' HB2' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -138.24 146.52 42.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -0.999 . . . . 0.0 111.312 -178.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.5 ' OG ' ' OD2' ' A' ' 118' ' ' ASP . 23.6 t -115.69 110.4 19.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.461 -0.775 . . . . 0.0 109.044 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.51 61.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.761 -0.587 . . . . 0.0 109.785 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -53.75 -32.14 51.15 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 22.2 p -125.1 166.45 16.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.658 ' NE2' ' ND2' ' A' ' 26' ' ' ASN . 95.2 mm-40 -70.1 12.31 0.23 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 161' ' ' THR . 48.6 mtmt -89.41 9.4 26.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.262 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 158' ' ' SER . . . -105.37 -50.64 0.91 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.436 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 23' ' ' TYR . 43.8 mt -63.02 -36.7 84.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -1.234 . . . . 0.0 110.097 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -58.62 -29.75 66.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.999 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -94.74 -41.93 9.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.958 -1.088 . . . . 0.0 110.39 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 157' ' ' CYS . 80.4 t -60.52 -38.52 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 111.174 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 50.9 m-85 -89.94 -13.56 36.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.772 -1.205 . . . . 0.0 111.296 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.6 -50.34 72.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.715 -1.241 . . . . 0.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -80.79 -21.98 40.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 110.003 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.58 77.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.421 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.65 -43.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.912 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.34 -44.27 88.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.39 80.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.698 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.54 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -60.56 -43.17 97.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.58 -40.38 94.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.115 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.477 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 . . . . . 0 N--CA 1.489 1.512 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.2 m -123.88 145.28 49.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.156 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HB ' HD12 ' A' ' 53' ' ' LEU . 30.7 mm -109.86 115.18 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.17 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -82.87 122.57 28.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.5 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 53' ' ' LEU . 47.3 t -132.57 119.23 20.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.311 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.93 138.79 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.04 131.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.57 139.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.101 -0.999 . . . . 0.0 109.384 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.13 165.0 31.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.586 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 23.2 t70 -80.68 86.46 5.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.176 -1.191 . . . . 0.0 109.353 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.5 86.86 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.68 -5.41 45.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -1.095 . . . . 0.0 109.395 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.21 -58.06 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.66 16.12 26.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.54 ' NZ ' ' OD1' ' A' ' 57' ' ' ASP . 46.9 tttm -63.33 -41.14 98.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.828 -1.395 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 p -68.71 -43.24 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 110.183 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -61.88 -28.56 69.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 110.766 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.441 HD22 ' SG ' ' A' ' 81' ' ' CYS . 46.7 tp -66.39 -43.48 85.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.878 -1.139 . . . . 0.0 109.785 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.09 -40.6 82.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.652 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.67 -44.31 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.299 -0.875 . . . . 0.0 109.852 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 m -49.97 -35.04 22.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.171 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -89.55 -48.51 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.839 -1.163 . . . . 0.0 110.04 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.431 HG22 HG23 ' A' ' 25' ' ' THR . 37.0 m -57.35 -42.05 81.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 111.764 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 65.6 p -140.66 -12.34 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 111.683 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 25' ' ' THR . 3.4 m-20 86.4 115.48 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ASN . 16.4 mttt 164.48 76.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.613 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -62.19 -42.4 80.91 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 110.108 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.4 Cg_exo -55.58 -38.6 93.98 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.372 2.048 . . . . 0.0 112.335 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.627 ' O ' ' N ' ' A' ' 32' ' ' TYR . 1.8 p 64.55 -50.29 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 109.869 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 29' ' ' PRO . 96.4 mt-10 57.02 -72.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.673 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.627 ' N ' ' O ' ' A' ' 30' ' ' SER . 81.9 t80 -107.07 124.62 49.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 1.8 m -64.5 152.95 88.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.55 136.18 72.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.544 2.163 . . . . 0.0 112.337 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.63 71.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.753 . . . . 0.0 110.098 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.7 155.74 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.566 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -107.68 94.15 4.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -123.24 147.81 46.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -70.63 149.09 47.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.316 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -121.28 146.37 46.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.51 146.45 41.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 109.455 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.93 141.92 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.5 m -97.75 134.55 40.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 51' ' ' TYR . 33.9 t -120.75 136.63 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.0 ttt -105.03 140.05 38.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 0.0 109.946 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 48' ' ' GLY . 67.0 mt -119.77 143.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 0.0 109.055 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.64 -30.96 9.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.281 -1.928 . . . . 0.0 108.281 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -72.46 -96.19 0.08 OUTLIER Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -123.03 156.59 62.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.961 . . . . 0.0 109.376 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.03 138.4 43.84 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.651 2.234 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CD2' HD12 ' A' ' 46' ' ' ILE . 98.8 m-85 -141.86 162.9 34.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 p -118.87 155.74 30.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 6' ' ' CYS . 35.8 tp -118.73 118.27 31.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -0.751 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.73 124.67 7.73 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.637 HD13 ' N ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -107.86 121.69 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -1.113 . . . . 0.0 108.481 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.637 ' N ' HD13 ' A' ' 55' ' ' LEU . 99.1 m-85 -121.29 149.38 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.281 -0.887 . . . . 0.0 109.691 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' NZ ' ' A' ' 16' ' ' LYS . 21.7 t70 -153.51 157.91 40.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 p -75.74 152.26 37.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 0.0 109.362 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 0.0 109.36 179.938 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 . . . . . 0 N--CA 1.49 1.527 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.5 m -114.37 131.6 56.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.524 -0.735 . . . . 0.0 109.403 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.25 -39.04 88.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.05 131.51 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.19 -0.944 . . . . 0.0 109.957 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -102.95 125.37 49.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 108.385 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 mt -108.27 141.47 40.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.179 -0.951 . . . . 0.0 110.543 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.908 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 51.6 t -124.94 135.08 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.524 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -127.86 126.46 41.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -136.55 166.03 24.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 0.0 109.434 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 m -104.24 148.54 26.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.583 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.719 ' O ' HG22 ' A' ' 84' ' ' VAL . 7.8 p -105.96 13.98 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.146 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.468 HG12 HD12 ' A' ' 119' ' ' LEU . 29.9 m -105.54 -6.81 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -127.81 102.96 21.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 109.85 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' A' ' 137' ' ' ILE . 50.1 Cg_exo -50.68 -41.82 52.56 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.036 1.824 . . . . 0.0 111.916 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -56.55 -37.4 70.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.163 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 m -69.6 -26.21 64.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.244 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.47 -50.9 41.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.55 -35.0 75.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.586 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 41.6 t-20 -56.52 -34.39 66.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 89' ' ' SER . 67.1 t -62.22 -36.84 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.088 -1.008 . . . . 0.0 109.972 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.93 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -80.27 -27.46 38.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 111.34 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -112.23 -44.76 3.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.054 -1.029 . . . . 0.0 112.479 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -85.76 1.95 47.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.903 -1.123 . . . . 0.0 113.072 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.648 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -109.16 -40.63 0.12 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.471 -1.393 . . . . 0.0 110.666 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.648 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 62.3 Cg_endo -92.36 -56.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.275 2.65 . . . . 0.0 113.253 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.6 -35.28 75.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.892 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.69 -28.85 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.71 -1.244 . . . . 0.0 110.121 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 m -59.24 -42.18 90.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 0.0 109.675 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.08 -32.55 69.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 0.0 109.691 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -63.21 -41.87 99.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 173.08 170.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 109.248 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' CYS . 51.9 Cg_exo -49.01 -164.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.503 2.136 . . . . 0.0 112.348 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.404 ' NZ ' HD13 ' A' ' 149' ' ' LEU . 64.0 mttm -80.98 138.28 36.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 168.77 16.06 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -40.37 98.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.574 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.908 ' CZ ' HG21 ' A' ' 80' ' ' VAL . 63.8 t80 -109.38 128.89 55.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.563 -0.711 . . . . 0.0 109.957 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 153' ' ' LYS . 15.3 tp -120.16 124.07 44.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 112' ' ' LEU . 39.0 tp -103.67 120.37 40.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.186 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.429 HG13 HG23 ' A' ' 155' ' ' VAL . 38.8 t -108.95 134.42 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.92 113.0 3.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 116' ' ' GLN . 13.9 m -103.11 148.79 25.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -1.13 . . . . 0.0 110.284 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' A' ' 115' ' ' THR . 92.1 mt-30 62.83 38.5 11.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 122.052 -0.405 . . . . 0.0 111.491 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 116' ' ' GLN . 21.0 pt -57.99 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 121' ' ' ASP . 88.6 m-20 52.3 18.51 0.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.364 -1.46 . . . . 0.0 109.146 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.3 tp 30.81 52.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.817 -0.552 . . . . 0.0 111.509 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 121' ' ' ASP . 97.8 mtt180 54.24 22.39 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.501 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 118' ' ' ASP . 60.9 t0 33.22 61.38 0.42 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.718 -0.614 . . . . 0.0 110.257 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 120' ' ' ARG . 81.0 m-20 -132.34 85.56 48.51 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.34 -28.33 26.6 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.5 2.133 . . . . 0.0 112.118 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -81.76 -4.34 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.066 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 98.8 m -92.83 -47.93 6.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.201 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -76.97 -48.49 25.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 110.253 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -60.8 -39.95 90.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 111.098 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -83.01 -6.61 59.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.544 -1.347 . . . . 0.0 110.39 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 129' ' ' LEU . 91.2 mt -115.45 -49.98 2.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 135' ' ' LYS . . . -55.08 -46.55 75.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 109.02 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -48.5 -24.72 1.38 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -76.27 -55.3 5.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 134' ' ' GLN . 36.1 ttpt -173.99 76.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 0.0 110.169 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 133' ' ' LYS . 3.7 mp0 33.27 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.65 -0.657 . . . . 0.0 110.673 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.2 tptm -90.35 -38.82 0.41 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 110.973 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 71.8 Cg_endo -89.09 127.5 1.78 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.845 2.363 . . . . 0.0 113.308 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 4.2 mp -96.9 135.55 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 109.357 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.9 155.68 72.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.468 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.33 -32.71 96.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.373 2.049 . . . . 0.0 111.622 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.11 -36.94 73.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.221 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 m -67.79 -29.78 69.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.283 -0.885 . . . . 0.0 108.692 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.03 62.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 0.0 110.213 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.97 -35.65 75.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.951 -1.093 . . . . 0.0 110.708 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 94.8 mttt -63.85 -36.84 85.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.855 -1.153 . . . . 0.0 109.318 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.5 tp -53.24 -43.2 67.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.753 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -70.32 -45.39 66.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.01 1.09 21.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.878 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 87.9 m-20 -66.76 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.237 . . . . 0.0 109.742 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.404 HD13 ' NZ ' ' A' ' 107' ' ' LYS . 77.3 mt -121.52 -81.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.783 . . . . 0.0 109.722 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -162.76 54.16 0.2 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.753 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -68.23 137.4 54.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.855 -1.153 . . . . 0.0 109.106 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.595 HG12 ' HG3' ' A' ' 153' ' ' LYS . 81.4 t -66.78 -54.24 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.481 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.595 ' HG3' HG12 ' A' ' 152' ' ' VAL . 58.4 mttm -156.52 159.84 38.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -128.91 146.14 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.57 HG11 ' OE1' ' A' ' 171' ' ' GLU . 34.8 m -140.16 152.1 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 110.436 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 129.99 54.81 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -134.13 143.78 48.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.968 -1.083 . . . . 0.0 110.817 -178.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 161' ' ' THR . 9.5 t -115.18 110.25 19.2 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.379 0.609 . . . . 0.0 109.391 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.3 mt -55.03 -27.97 48.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.259 -0.9 . . . . 0.0 108.707 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.3 p -125.99 171.04 11.11 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -74.02 11.65 0.86 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.674 -0.641 . . . . 0.0 109.708 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -89.34 1.18 56.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.472 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -93.83 -51.15 2.17 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.38 -39.47 71.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -1.152 . . . . 0.0 110.259 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.16 -33.02 70.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.198 -0.939 . . . . 0.0 111.329 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.42 -50.32 46.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.811 -1.181 . . . . 0.0 109.354 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.22 1.63 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.496 -0.753 . . . . 0.0 110.449 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.6 -50.83 16.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.855 -1.153 . . . . 0.0 109.768 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.55 -43.88 83.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 110.014 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.57 ' OE1' HG11 ' A' ' 155' ' ' VAL . 97.1 mt-10 -66.31 -33.08 74.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 109.88 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.42 80.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.977 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 71.7 mt -73.12 -42.33 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.994 . . . . 0.0 109.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.1 tp -59.32 -46.31 88.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.69 78.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.98 66.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.459 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.61 -39.83 89.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.193 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.818 . . . . 99.989999999999995 109.514 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 . . . . . 0 N--CA 1.492 1.642 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -138.71 161.68 36.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.888 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.2 120.23 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -93.12 130.74 38.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 t -135.0 129.65 34.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.1 t -117.89 142.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.857 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.13 133.69 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 ' CH2' ' A' ' 97' ' ' TRP . 46.7 t -140.35 134.0 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.129 -0.982 . . . . 0.0 109.491 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.55 99.83 0.15 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.36 -40.49 90.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.061 -1.258 . . . . 0.0 109.04 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -84.59 120.05 5.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 172.08 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.52 -41.72 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.11 0.79 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -61.13 -40.08 92.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -1.127 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -65.13 -41.81 94.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -30.32 65.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.12 -41.75 97.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.113 -0.992 . . . . 0.0 108.608 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.13 -39.73 82.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.225 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.5 mm -63.66 -48.17 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -58.83 -36.29 74.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 110.346 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -80.15 -50.87 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.5 m -60.39 -41.24 93.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.736 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 30.2 p -112.16 -111.42 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 109.186 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.555 ' N ' ' OG1' ' A' ' 25' ' ' THR . 37.1 p-10 -173.69 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -102.25 106.88 17.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -67.73 -42.77 36.52 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.264 -0.898 . . . . 0.0 108.876 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 31.4 Cg_exo -59.77 -26.66 82.88 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.655 2.237 . . . . 0.0 112.078 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.8 m 42.56 41.86 2.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 0.0 109.683 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 96.3 mt-10 -37.56 -35.7 0.14 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.432 -0.792 . . . . 0.0 110.456 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -117.31 122.76 44.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 33' ' ' VAL . 34.4 m -128.29 75.61 78.85 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . 0.727 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 92.7 Cg_endo -84.28 -102.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.043 2.496 . . . . 0.0 112.329 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 34' ' ' PRO . . . 158.21 41.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.2 -41.66 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.935 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.25 130.41 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 39' ' ' ASN . 50.9 t0 -93.52 -144.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.572 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 63.5 t-20 -42.71 124.94 3.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.454 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 58.0 t80 -132.08 150.3 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.454 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -103.12 141.92 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.78 133.81 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.0 m -106.19 134.53 49.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.46 135.74 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.708 . . . . 0.0 109.353 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.8 mtm -105.67 141.26 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 109.324 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 48' ' ' GLY . 81.0 mt -122.99 141.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.365 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.1 -24.97 0.61 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -80.82 -92.37 0.48 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.451 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.6 mm-40 -126.45 154.32 75.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.405 -1.056 . . . . 0.0 109.717 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.71 138.26 37.56 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.729 2.286 . . . . 0.0 112.599 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.606 ' CD2' HD12 ' A' ' 46' ' ' ILE . 97.3 m-85 -131.76 154.19 49.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.9 p -118.0 148.19 42.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.828 . . . . 0.0 109.463 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.82 122.44 37.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 0.0 109.58 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.34 126.53 8.85 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.503 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 66.5 mt -105.1 137.22 43.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -1.175 . . . . 0.0 109.367 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.487 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.7 m-85 -122.25 149.82 43.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 109.022 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 56' ' ' PHE . 84.0 m-20 -136.82 161.53 35.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 162.73 21.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.171 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.372 179.915 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 . . . . . 0 N--CA 1.493 1.679 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 43.3 m -117.57 128.41 54.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 0.0 109.654 179.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -66.17 -33.92 76.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.957 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.09 132.67 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.354 -0.841 . . . . 0.0 109.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -111.63 126.26 54.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.024 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.2 140.35 44.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.922 . . . . 0.0 109.949 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.4 136.03 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 0.0 109.165 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.2 t -129.83 121.72 27.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 115' ' ' THR . 44.1 p90 -145.97 163.23 35.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 109.303 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -89.58 137.57 32.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -93.66 -12.64 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 119' ' ' LEU . 72.4 t -90.43 -13.82 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.035 -1.04 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 m -100.6 128.59 29.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.684 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.624 ' CG ' ' NE2' ' A' ' 134' ' ' GLN . 45.7 Cg_endo -73.55 -46.36 0.35 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.988 1.792 . . . . 0.0 112.298 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -55.31 -41.78 72.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.848 -1.158 . . . . 0.0 108.933 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 93' ' ' VAL . 84.2 p -68.29 -23.09 64.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.018 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.639 ' CE1' HG21 ' A' ' 137' ' ' ILE . 57.0 t80 -72.08 -50.82 25.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 0.0 109.319 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -67.91 -37.0 81.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.47 -34.38 57.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.684 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 89' ' ' SER . 74.4 t -61.41 -38.25 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 110.457 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -93.79 -32.79 13.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.91 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -68.49 -36.58 79.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.883 -1.135 . . . . 0.0 112.416 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -113.62 -52.0 2.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.886 -1.134 . . . . 0.0 112.619 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.444 ' CH2' HG11 ' A' ' 9' ' ' VAL . 72.7 m95 -67.54 -30.71 70.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.963 . . . . 0.0 113.026 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 101' ' ' ILE . 1.9 t -72.57 -51.06 7.43 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.141 -1.599 . . . . 0.0 111.439 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.68 -47.75 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.953 1.769 . . . . 0.0 113.23 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -58.08 -40.07 80.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 111.016 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 98' ' ' VAL . 1.9 tp -64.18 -24.55 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.223 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -57.76 -39.61 77.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 110.479 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -53.56 -32.5 51.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.685 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 97.1 m-70 -84.45 7.1 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.054 . . . . 0.0 110.483 -179.132 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.7 m 55.35 69.78 1.84 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.284 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.49 128.0 26.26 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.604 2.202 . . . . 0.0 112.472 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -151.73 -39.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -62.72 156.14 66.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.502 -0.749 . . . . 0.0 109.166 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.25 135.68 71.78 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.691 2.261 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 108' ' ' THR . 98.1 m-85 -116.58 137.76 51.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.0 109.356 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 111' ' ' LEU . 38.3 tp -117.53 124.76 49.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.451 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.51 120.43 40.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 108.853 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.92 137.54 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.848 . . . . 0.0 110.357 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.0 129.25 9.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 82' ' ' PHE . 9.9 t -118.14 156.92 27.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.136 -1.214 . . . . 0.0 111.18 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 61.36 38.42 16.24 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 pt -72.3 -3.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.096 . . . . 0.0 109.764 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 86.1 m-20 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 109.378 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.597 ' HB3' HG21 ' A' ' 85' ' ' VAL . 43.7 tp -57.98 -32.81 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.26 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -59.88 -25.16 64.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.241 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 59.6 t0 -83.91 8.21 15.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.785 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -117.95 85.32 22.96 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.45 -0.781 . . . . 0.0 109.222 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.74 -23.81 16.54 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.2 p -58.52 -30.01 66.74 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.852 -1.155 . . . . 0.0 109.852 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.479 HG21 HD21 ' A' ' 119' ' ' LEU . 73.2 m -80.44 -52.81 7.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 110.009 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.46 HG23 ' H ' ' A' ' 126' ' ' ILE . 2.6 pt -56.51 -20.67 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.167 -0.958 . . . . 0.0 109.31 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.34 -50.38 70.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -56.49 -31.29 63.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.734 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.04 -36.04 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 109.074 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.01 -38.82 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.864 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -59.68 -36.29 76.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.051 . . . . 0.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.13 8.14 16.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.394 -0.816 . . . . 0.0 109.614 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.95 34.96 24.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 109.35 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.624 ' NE2' ' CG ' ' A' ' 87' ' ' PRO . 56.9 tt0 -127.4 121.12 30.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.386 -0.821 . . . . 0.0 108.811 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -92.79 156.49 40.76 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.41 -0.806 . . . . 0.0 110.058 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.17 160.35 42.44 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.118 2.545 . . . . 0.0 112.057 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' A' ' 90' ' ' PHE . 26.8 mm -97.46 126.04 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.36 155.69 79.03 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.39 -34.48 98.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.433 2.089 . . . . 0.0 111.619 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.44 -37.22 77.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 108.871 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -67.4 -32.82 73.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -0.814 . . . . 0.0 109.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.96 -39.71 61.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.72 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.41 -32.31 70.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.107 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 69.4 tttt -61.86 -38.82 89.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.956 -1.09 . . . . 0.0 109.651 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 90' ' ' PHE . 60.1 mt -63.41 -34.64 78.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 110.136 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.01 88.72 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.993 -1.067 . . . . 0.0 108.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -86.06 8.44 20.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 90.3 m-20 -84.22 -24.6 29.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 108.847 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.8 mt -121.07 -104.0 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.628 -0.67 . . . . 0.0 109.275 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -145.71 43.72 1.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.06 141.76 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.715 HG12 ' HG3' ' A' ' 153' ' ' LYS . 59.8 t -75.23 -65.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.715 ' HG3' HG12 ' A' ' 152' ' ' VAL . 67.6 mttt -145.67 160.37 41.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -131.28 150.5 52.12 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.55 154.09 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.037 -1.039 . . . . 0.0 110.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -109.66 133.94 52.54 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.53 140.21 48.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 111.025 -178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . 39.9 t -106.89 105.58 15.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.44 -0.787 . . . . 0.0 109.036 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.82 70.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.601 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.7 tp -50.91 -31.01 16.26 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 163' ' ' LYS . 18.7 p -123.84 162.45 23.23 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.09 12.32 0.12 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.553 -0.717 . . . . 0.0 109.344 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 161' ' ' THR . 67.7 mttm -88.11 2.28 52.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.684 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.72 -51.52 2.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.48 -40.64 73.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -1.226 . . . . 0.0 109.936 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.23 -29.94 70.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.407 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -71.72 -50.95 25.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.1 m -80.35 -4.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -0.763 . . . . 0.0 110.566 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.81 -50.17 21.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.181 . . . . 0.0 110.052 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.92 -42.39 99.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.246 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.36 -34.68 78.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.023 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.9 74.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 110.568 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.6 -41.48 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.899 -1.126 . . . . 0.0 110.392 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.77 -41.72 82.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.987 . . . . 0.0 110.223 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.15 77.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.961 -1.087 . . . . 0.0 110.128 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.22 89.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 110.094 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.5 mt -65.23 -37.63 87.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.997 -1.064 . . . . 0.0 109.387 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.461 -179.85 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.277 0.561 . . . . 0.0 109.487 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 157.48 46.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.8 mt -118.8 120.8 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -81.62 128.35 33.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.307 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 t -132.89 115.57 15.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -109.72 132.22 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.58 HG11 HD21 ' A' ' 20' ' ' LEU . 7.9 p -128.05 142.97 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.404 -0.81 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.99 145.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 108.983 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 171.94 22.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 12' ' ' GLY . 59.1 t0 -74.04 134.03 42.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -1.116 . . . . 0.0 109.128 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . -27.77 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.499 2.855 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . -41.4 -37.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.023 -1.281 . . . . 0.0 110.567 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 11' ' ' ASP . 58.1 t -69.3 123.97 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.671 -1.268 . . . . 0.0 109.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 73.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.1 pttp -61.26 -33.62 73.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.528 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.4 p -70.38 -42.0 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.1 m -60.39 -25.99 66.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 0.0 110.009 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 19' ' ' LEU . 44.4 tp -66.72 -39.77 88.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.387 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.58 HD21 HG11 ' A' ' 8' ' ' VAL . 70.1 mt -64.94 -42.23 94.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.269 -0.894 . . . . 0.0 109.538 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mm -70.14 -49.02 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.713 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.2 m -57.26 -36.66 71.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 109.5 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.74 -44.49 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.1 m -65.79 -47.6 74.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 110.108 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.8 p -84.48 -19.5 33.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.711 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.82 36.76 22.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -141.23 82.54 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.664 ' CE2' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -55.28 -44.25 99.53 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -56.48 -15.83 16.65 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.28 1.987 . . . . 0.0 111.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' TYR . 95.6 p -59.86 -34.18 72.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 108.995 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.3 mt-10 37.68 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.648 -0.657 . . . . 0.0 110.321 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.2 m-85 -83.76 -95.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.019 -1.051 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 33' ' ' VAL . 6.4 p 36.52 57.76 3.41 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.445 -0.784 . . . . 0.0 110.964 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.77 -18.46 32.23 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.815 2.344 . . . . 0.0 112.08 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.47 -172.68 2.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.28 140.66 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.846 . . . . 0.0 109.199 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.16 -90.06 0.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.7 p30 -138.15 -173.39 3.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.904 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -67.33 149.23 50.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.831 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -118.13 146.71 43.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.732 . . . . 0.0 109.204 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 137.25 45.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.148 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.4 138.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.861 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -93.3 133.94 36.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.284 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.1 t -120.36 135.06 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.731 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -93.57 130.59 39.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.316 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 68.5 mt -132.8 126.82 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.151 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.54 17.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.15 13.87 58.26 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 11.3 mt-10 -119.61 85.86 33.55 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.414 -1.051 . . . . 0.0 109.282 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -53.7 125.66 19.34 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.681 2.254 . . . . 0.0 113.195 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 91.3 m-85 -121.61 143.22 49.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.688 . . . . 0.0 109.232 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.5 m -76.03 131.25 39.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.32 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -128.1 129.6 46.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.79 143.45 14.64 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.17 132.24 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.407 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -118.09 131.28 56.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.809 . . . . 0.0 109.774 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.8 p30 -136.19 172.38 13.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.773 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.2 m -71.5 138.25 48.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.59 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.596 179.954 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.613 -0.514 . . . . 0.0 109.613 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 5.1 p -126.03 153.95 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 75' ' ' THR . 90.5 m-20 -138.21 -41.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.718 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.02 132.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 110.0 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -108.43 126.95 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 109.142 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 tp -118.53 126.37 51.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 109.546 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.86 138.68 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 133.84 48.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.515 ' CG ' HG21 ' A' ' 93' ' ' VAL . 31.6 p90 -138.45 158.47 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 109.379 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -77.24 138.74 39.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 109.377 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.49 -18.07 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.143 -0.973 . . . . 0.0 110.364 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 85' ' ' VAL . 61.1 t -85.8 -8.19 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.09 -1.006 . . . . 0.0 110.374 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -103.09 107.07 54.02 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.976 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.18 -49.08 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.032 1.822 . . . . 0.0 112.005 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 m -58.71 -39.56 81.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 108.95 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.756 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.9 t -62.86 -21.74 66.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.472 -0.768 . . . . 0.0 109.029 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -74.43 -50.05 19.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -66.07 -39.2 89.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -57.01 -32.91 66.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.214 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 89' ' ' SER . 71.8 t -60.91 -37.39 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -94.31 -11.06 30.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.012 -1.055 . . . . 0.0 110.229 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -73.74 -33.61 64.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.646 -1.283 . . . . 0.0 111.493 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.47 -41.9 3.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.136 -0.977 . . . . 0.0 112.25 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -82.12 0.84 38.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.094 -1.004 . . . . 0.0 112.836 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.592 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -108.22 -42.75 0.12 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.49 -1.381 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.592 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 42.9 Cg_endo -93.71 -59.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.211 2.608 . . . . 0.0 112.468 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.619 ' CG1' ' CE1' ' A' ' 110' ' ' PHE . 8.0 tp -54.08 -26.59 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.594 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 46.5 m -58.85 -37.93 77.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.759 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -53.29 -40.57 64.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.867 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.436 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 65.7 m170 -55.17 -36.17 65.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 109.262 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 0.7 OUTLIER 168.73 154.0 0.14 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.63 -33.0 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.523 2.148 . . . . 0.0 111.92 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -139.83 137.51 35.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.424 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -177.37 139.64 0.43 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 0.0 109.303 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.71 125.37 12.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.191 1.928 . . . . 0.0 112.202 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.619 ' CE1' ' CG1' ' A' ' 101' ' ' ILE . 86.8 m-85 -116.53 138.92 51.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 111' ' ' LEU . 6.6 mp -114.89 121.2 42.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.454 -0.778 . . . . 0.0 110.035 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -110.92 125.18 53.39 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.765 HG11 HG22 ' A' ' 168' ' ' VAL . 36.0 t -117.1 138.59 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.14 -0.975 . . . . 0.0 110.977 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.4 122.1 6.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 t -114.33 167.35 10.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -1.115 . . . . 0.0 110.618 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 58.74 39.37 24.33 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.51 -7.18 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.969 -1.082 . . . . 0.0 109.873 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.476 ' O ' ' OD2' ' A' ' 121' ' ' ASP . 53.8 p30 -83.69 -3.08 57.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.345 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.455 ' HG ' HG21 ' A' ' 125' ' ' THR . 30.2 tp -78.29 -27.27 47.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -84.94 93.3 8.52 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 2.4 p30 169.04 -49.45 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.1 141.44 94.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.546 -0.721 . . . . 0.0 109.234 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.52 -31.1 27.86 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.248 1.966 . . . . 0.0 112.223 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.7 m -54.3 -33.1 58.02 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.29 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.455 HG21 ' HG ' ' A' ' 119' ' ' LEU . 56.7 p -79.49 -51.11 9.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 111.012 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.15 -29.77 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 0.0 110.333 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.32 -50.09 35.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 109.663 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.17 -35.19 76.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.6 mt -74.42 -39.25 62.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 108.891 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.11 -35.92 37.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 109.486 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -59.69 -34.97 73.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 109.143 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -86.54 7.35 26.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.621 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttt 56.88 37.02 28.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -136.83 136.12 38.52 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.11 -0.994 . . . . 0.0 109.118 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -116.89 157.76 45.57 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -53.01 155.84 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.836 2.357 . . . . 0.0 111.909 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.3 mt -98.57 142.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.2 158.49 69.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.366 -0.833 . . . . 0.0 109.65 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.83 -23.05 75.8 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.684 2.256 . . . . 0.0 111.522 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.98 -38.59 89.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 m -63.67 -36.01 82.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.33 -39.4 59.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.32 -34.68 72.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.043 -1.035 . . . . 0.0 111.081 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.94 -36.24 80.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.706 -1.247 . . . . 0.0 109.425 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.06 -36.09 76.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 110.085 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 152' ' ' VAL . . . -81.12 -51.81 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.922 -1.111 . . . . 0.0 110.561 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -65.01 -1.86 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.286 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -110.21 -24.0 10.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 110.007 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.97 16.01 22.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 111.733 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 59.3 mttp 56.89 36.16 27.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.322 -1.486 . . . . 0.0 111.318 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 165.93 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.774 -1.204 . . . . 0.0 109.62 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.713 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 71.8 t 59.35 132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.262 1.029 . . . . 0.0 109.561 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -129.46 149.33 51.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.17 143.65 49.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.03 -1.044 . . . . 0.0 109.85 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 t -138.36 147.01 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -97.33 120.89 38.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -131.04 141.1 50.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.962 . . . . 0.0 110.932 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 161' ' ' THR . 29.5 t -111.62 102.8 11.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -70.18 -28.69 65.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.785 -0.572 . . . . 0.0 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 160' ' ' LEU . 6.3 mp -61.56 -25.92 67.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 163' ' ' LYS . 21.2 m -123.86 160.52 27.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.664 ' NE2' ' CE2' ' A' ' 28' ' ' PHE . 89.5 mm-40 -65.41 11.47 0.06 Allowed 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 161' ' ' THR . 97.7 mttt -94.01 5.13 52.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.051 . . . . 0.0 110.053 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.447 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -101.58 -51.14 1.14 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.274 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 165' ' ' LEU . 8.1 mp -63.35 -42.02 98.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.219 -1.165 . . . . 0.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -58.81 -30.37 67.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -85.67 -50.07 7.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.765 HG22 HG11 ' A' ' 113' ' ' VAL . 71.5 t -62.24 -34.8 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.768 . . . . 0.0 110.303 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.858 ' CE2' HD11 ' A' ' 173' ' ' ILE . 68.3 t80 -68.71 -49.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 0.0 110.285 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.54 -43.82 93.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 0.0 110.612 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.03 -45.13 71.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 110.262 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.62 -35.96 61.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.408 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.858 HD11 ' CE2' ' A' ' 169' ' ' PHE . 95.0 mt -68.9 -36.7 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.831 -1.168 . . . . 0.0 110.482 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.8 tp -53.55 -51.33 63.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.972 -1.08 . . . . 0.0 110.259 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.5 71.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.079 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.39 66.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 109.758 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 177' ' ' LEU . 3.6 mm? -63.02 -35.54 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.984 -1.073 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.561 -179.906 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.2 mtt . . . . . 0 N--CA 1.489 1.522 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 93.9 mt-30 -63.02 -33.11 74.73 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.245 -0.909 . . . . 0.0 109.493 179.735 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -135.6 160.22 39.17 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.418 -0.801 . . . . 0.0 109.843 -179.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.608 HD13 ' HA ' ' A' ' 176' ' ' ALA . 72.8 mt -121.34 119.46 59.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 46.6 mttp -95.76 129.46 42.98 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.178 -0.952 . . . . 0.0 110.059 -179.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' SG ' HD11 ' A' ' 79' ' ' LEU . 46.1 t -138.32 136.75 36.72 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.434 -0.791 . . . . 0.0 109.143 179.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 55.1 t -112.08 141.11 28.59 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.707 0 O-C-N 121.281 -0.887 . . . . 0.0 109.645 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 46.7 t -114.65 131.19 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 N-CA-C 108.744 -0.836 . . . . 0.0 108.744 179.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 11.7 p -156.85 143.98 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.436 0 O-C-N 121.148 -0.97 . . . . 0.0 109.486 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -141.67 168.17 25.65 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 109.278 -1.529 . . . . 0.0 109.278 179.646 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.551 ' O ' ' N ' ' A' ' 13' ' ' ALA . 24.0 t70 -83.12 108.17 16.2 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.074 -1.251 . . . . 0.0 108.983 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.463 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 53.94 -87.1 0.01 OUTLIER Glycine 0 N--CA 1.49 2.239 0 N-CA-C 109.069 -1.612 . . . . 0.0 109.069 -179.479 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.551 ' N ' ' O ' ' A' ' 11' ' ' ASP . . . 53.47 102.78 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.178 -1.19 . . . . 0.0 109.364 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.402 HG22 ' H ' ' A' ' 14' ' ' VAL . 3.6 m -66.63 -35.66 75.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.424 -0.798 . . . . 0.0 109.988 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -90.57 21.55 32.04 Favored Glycine 0 N--CA 1.491 2.306 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 -179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.424 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 58.9 tttt -62.11 -40.6 96.44 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.018 -1.283 . . . . 0.0 109.814 179.885 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 38.8 m -68.37 -45.65 72.19 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.225 -0.922 . . . . 0.0 109.925 -179.814 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.562 ' SG ' ' OG ' ' A' ' 30' ' ' SER . 34.4 m -61.01 -29.65 69.83 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.24 -0.913 . . . . 0.0 109.851 -179.576 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.1 tp -67.06 -42.15 85.22 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.284 -0.885 . . . . 0.0 109.476 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 42.3 tp -73.44 -46.09 50.52 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.307 -0.871 . . . . 0.0 110.283 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.9 mm -64.53 -40.32 88.66 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.121 -0.987 . . . . 0.0 110.28 -179.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 96.1 p -57.92 -31.98 67.32 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 120.938 -1.101 . . . . 0.0 109.839 -179.269 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 72.7 t80 -72.69 -38.02 67.69 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.223 -0.923 . . . . 0.0 109.58 179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 66.3 p -65.96 -30.96 71.62 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.459 -0.775 . . . . 0.0 111.292 -178.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.613 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -166.44 -1.27 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.553 -1.342 . . . . 0.0 111.427 -179.392 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.613 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.2 t30 92.21 118.9 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.879 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 -179.054 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.401 ' HZ2' ' HA ' ' A' ' 30' ' ' SER . 10.4 tttm -179.6 58.34 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.895 -0.503 . . . . 0.0 109.995 179.127 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.612 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.29 -42.58 86.12 Favored Pre-proline 0 N--CA 1.491 1.585 0 O-C-N 120.787 -1.196 . . . . 0.0 109.836 179.803 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.2 Cg_exo -58.11 -33.08 97.01 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 122.354 2.036 . . . . 0.0 112.364 -179.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.562 ' OG ' ' SG ' ' A' ' 18' ' ' CYS . 61.4 p 35.65 37.55 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.659 -0.65 . . . . 0.0 109.738 179.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.46 ' C ' ' O ' ' A' ' 30' ' ' SER . 78.5 mm-40 -38.22 -37.21 0.26 Allowed 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.53 -0.731 . . . . 0.0 110.531 -178.457 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 76.6 t80 -128.8 124.18 34.77 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.034 -1.041 . . . . 0.0 109.204 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.9 m -93.69 147.78 34.21 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.252 -0.905 . . . . 0.0 109.643 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -71.54 153.21 60.33 Favored 'Trans proline' 0 N--CA 1.493 1.495 0 C-N-CA 122.569 2.179 . . . . 0.0 112.153 179.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.5 -104.79 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.1 -1.0 . . . . 0.0 109.051 179.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 18.4 m -61.38 142.07 16.66 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.18 -0.95 . . . . 0.0 108.858 179.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.5 m-85 -100.09 125.43 46.18 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.155 -0.965 . . . . 0.0 109.864 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -108.84 164.39 12.44 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.483 -0.761 . . . . 0.0 109.308 179.795 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 85.5 m-20 -92.35 153.11 19.4 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.276 -0.89 . . . . 0.0 109.009 179.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.2 m-85 -127.78 139.15 52.84 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.342 -0.849 . . . . 0.0 109.601 179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -109.52 132.2 54.35 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.311 -0.868 . . . . 0.0 109.053 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 17.7 m -133.28 153.75 37.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.35 -0.844 . . . . 0.0 109.605 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 4.0 p -122.31 150.15 42.76 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.439 -0.788 . . . . 0.0 109.064 179.581 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.4 t -120.26 139.77 46.48 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.53 -0.731 . . . . 0.0 110.01 -179.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 65.0 mtt -84.57 131.81 34.58 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.58 ' O ' ' N ' ' A' ' 48' ' ' GLY . 74.6 mt -135.11 125.41 44.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.079 -1.013 . . . . 0.0 109.521 179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.444 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 41.97 18.93 0.04 OUTLIER Glycine 0 N--CA 1.49 2.296 0 N-CA-C 110.088 -1.205 . . . . 0.0 110.088 179.517 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.58 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 92.36 15.41 53.45 Favored Glycine 0 N--CA 1.492 2.425 0 O-C-N 121.102 -1.234 . . . . 0.0 110.215 179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.0 mm-40 -122.81 82.7 49.34 Favored Pre-proline 0 N--CA 1.495 1.804 0 O-C-N 121.318 -1.107 . . . . 0.0 109.255 179.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_exo -59.17 126.19 20.24 Favored 'Trans proline' 0 N--CA 1.495 1.579 0 C-N-CA 122.906 2.404 . . . . 0.0 113.23 -179.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.581 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 95.9 m-85 -119.17 138.04 53.21 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.836 -0.801 . . . . 0.0 108.836 179.031 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 30.2 p -80.22 143.49 33.71 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.084 -1.01 . . . . 0.0 109.431 -179.876 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 38.0 tp -124.82 124.48 42.19 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.402 -0.811 . . . . 0.0 109.591 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -102.11 124.31 8.16 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.312 -1.515 . . . . 0.0 109.312 179.776 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 56.8 mt -106.13 127.03 52.91 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.225 -1.161 . . . . 0.0 109.194 179.722 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -114.44 133.96 55.35 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.369 -0.832 . . . . 0.0 109.375 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 60.1 t0 -138.79 140.52 38.62 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.235 -0.916 . . . . 0.0 109.359 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.407 ' HA ' HH12 ' A' ' 66' ' ' ARG . 51.1 m -70.85 137.64 49.58 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.223 -0.923 . . . . 0.0 109.455 179.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -126.58 57.7 1.42 Allowed 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.402 -0.811 . . . . 0.0 109.489 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.41 ' O ' ' C ' ' A' ' 61' ' ' GLN . . . 77.24 -111.61 3.31 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 109.828 -1.309 . . . . 0.0 109.828 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.585 ' O ' ' N ' ' A' ' 63' ' ' ASP . 90.7 mt-30 44.29 -104.66 0.08 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.191 -1.182 . . . . 0.0 109.688 -179.761 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.43 ' C ' ' N ' ' A' ' 64' ' ' TYR . 82.6 tt0 61.49 -67.1 0.06 Allowed 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.59 -0.694 . . . . 0.0 109.611 -179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 61' ' ' GLN . 92.7 m-20 -50.48 -14.06 0.16 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.18 -0.95 . . . . 0.0 109.596 179.991 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.43 ' N ' ' C ' ' A' ' 62' ' ' GLU . 49.3 m-85 -84.4 10.4 10.81 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.283 -0.886 . . . . 0.0 109.522 179.897 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 59.0 t0 49.67 48.44 21.52 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.241 -0.912 . . . . 0.0 109.663 179.71 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.445 ' NH2' ' OE1' ' A' ' 61' ' ' GLN . 41.6 ttm180 -54.58 -34.37 61.81 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.193 -0.942 . . . . 0.0 109.382 179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 HD12 ' HA ' ' A' ' 67' ' ' LEU . 31.7 tp 56.79 75.34 0.36 Allowed 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.477 -0.765 . . . . 0.0 109.445 -179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.531 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 4.3 ttt180 -54.43 -47.13 98.57 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.39 -0.819 . . . . 0.0 110.442 -179.819 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.531 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 51.8 Cg_exo -52.05 -29.72 37.45 Favored 'Trans proline' 0 N--CA 1.494 1.543 0 C-N-CA 122.563 2.175 . . . . 0.0 112.92 -179.31 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' C ' ' H ' ' A' ' 72' ' ' TYR . 97.6 mt 40.6 31.85 0.13 Allowed 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.242 -0.911 . . . . 0.0 109.709 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.462 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 6.0 t 52.11 4.99 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.21 -0.931 . . . . 0.0 109.851 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' H ' ' C ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -176.71 82.18 0.26 Allowed Pre-proline 0 N--CA 1.491 1.588 0 O-C-N 121.152 -0.967 . . . . 0.0 109.371 179.94 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -56.55 135.35 69.85 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 122.754 2.303 . . . . 0.0 112.22 -179.698 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 89.3 mt-30 -96.51 3.75 52.5 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.264 -0.897 . . . . 0.0 109.222 179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 83.4 m -79.5 131.86 36.16 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.458 -0.776 . . . . 0.0 110.156 -179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -102.87 -10.55 18.97 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.413 -0.804 . . . . 0.0 108.953 179.236 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.498 HG21 ' HB1' ' A' ' 175' ' ' ALA . 47.4 t -135.42 130.5 50.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.443 -0.785 . . . . 0.0 109.248 179.372 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 91.7 m-85 -111.48 129.04 56.17 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.236 -0.915 . . . . 0.0 109.776 179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.463 HD11 ' SG ' ' A' ' 6' ' ' CYS . 62.1 mt -113.16 145.19 41.39 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.516 -0.74 . . . . 0.0 109.791 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.74 HG22 ' O ' ' A' ' 111' ' ' LEU . 28.3 m -129.76 147.32 33.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.442 -0.786 . . . . 0.0 109.052 179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 22.7 t -138.74 130.52 27.78 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.169 -0.957 . . . . 0.0 109.651 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 33.6 p90 -143.56 165.76 26.7 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.153 -0.967 . . . . 0.0 109.453 179.761 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 58.8 m -105.84 145.13 31.6 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.319 -0.863 . . . . 0.0 109.113 179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.8 p -108.76 8.74 9.17 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.34 -0.85 . . . . 0.0 109.679 -179.721 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -88.99 -23.46 6.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 O-C-N 121.133 -0.979 . . . . 0.0 109.807 179.656 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -108.6 146.37 33.55 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.343 -0.848 . . . . 0.0 109.911 -179.331 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 76.5 Cg_endo -77.58 -50.62 0.09 OUTLIER 'Trans proline' 0 N--CA 1.493 1.486 0 C-N-CA 122.677 2.251 . . . . 0.0 112.259 179.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.1 t -55.05 -35.68 64.76 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.484 -0.76 . . . . 0.0 109.79 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 87.1 p -66.71 -24.26 66.22 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.054 -1.029 . . . . 0.0 109.058 179.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 51.3 t80 -71.41 -50.91 27.26 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.394 -0.817 . . . . 0.0 109.461 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -66.85 -36.28 81.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.263 -0.898 . . . . 0.0 109.638 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 85.4 m-20 -51.53 -34.06 34.72 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.132 -0.98 . . . . 0.0 109.783 -179.518 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.8 t -63.9 -36.4 76.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 121.105 -0.997 . . . . 0.0 110.188 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 36.1 tttt -91.61 -41.55 10.7 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.752 -1.217 . . . . 0.0 110.592 -179.347 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -64.53 -37.52 87.82 Favored 'General case' 0 C--N 1.298 -1.656 0 O-C-N 121.086 -1.009 . . . . 0.0 112.037 -178.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 35.6 mttm -113.17 -51.38 2.82 Favored 'General case' 0 N--CA 1.501 2.091 0 O-C-N 120.901 -1.124 . . . . 0.0 112.638 -178.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -68.2 -39.95 82.3 Favored 'General case' 0 N--CA 1.497 1.888 0 O-C-N 120.97 -1.081 . . . . 0.0 113.249 -176.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.785 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.1 t -58.27 -52.11 76.93 Favored Pre-proline 0 N--CA 1.496 1.869 0 O-C-N 120.027 -1.67 . . . . 0.0 110.75 -178.542 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.16 -40.6 1.62 Allowed 'Trans proline' 0 N--CA 1.494 1.509 0 C-N-CA 121.677 1.585 . . . . 0.0 112.223 179.231 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -58.47 -31.05 67.45 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.405 -0.809 . . . . 0.0 110.499 -179.284 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.785 HG22 ' O ' ' A' ' 98' ' ' VAL . 5.5 tp -59.26 -24.07 26.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 O-C-N 120.883 -1.136 . . . . 0.0 110.006 -179.574 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.416 HG23 ' O ' ' A' ' 99' ' ' PRO . 62.5 p -58.42 -38.59 77.75 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.045 -1.034 . . . . 0.0 109.436 -179.69 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 90.3 m-70 -58.94 -29.99 67.53 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.213 -0.93 . . . . 0.0 109.4 179.544 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 78.9 m80 -82.94 -7.77 59.63 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.267 -0.895 . . . . 0.0 109.811 -179.687 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER 59.11 84.9 0.19 Allowed Pre-proline 0 N--CA 1.492 1.627 0 O-C-N 121.135 -0.978 . . . . 0.0 109.356 179.959 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_exo -48.56 89.67 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 122.65 2.233 . . . . 0.0 112.458 -179.605 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.4 mttm -133.52 11.32 4.09 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.413 -0.804 . . . . 0.0 109.316 179.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.561 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.3 OUTLIER -136.68 157.74 74.46 Favored Pre-proline 0 N--CA 1.491 1.584 0 O-C-N 121.354 -0.841 . . . . 0.0 109.524 -179.763 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -59.95 141.15 95.92 Favored 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 122.683 2.255 . . . . 0.0 112.268 179.836 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.561 ' CE2' ' O ' ' A' ' 108' ' ' THR . 97.3 m-85 -121.98 145.83 47.75 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.512 -0.742 . . . . 0.0 109.796 179.732 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.74 ' O ' HG22 ' A' ' 80' ' ' VAL . 5.2 mp -121.8 131.72 54.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.607 -0.683 . . . . 0.0 109.469 179.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.804 HD22 ' HB2' ' A' ' 146' ' ' ALA . 26.2 tp -103.79 118.88 37.74 Favored 'General case' 0 C--N 1.303 -1.437 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.545 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 59.7 t -112.44 137.61 44.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.319 -0.863 . . . . 0.0 110.728 -178.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -106.14 128.5 9.36 Favored Glycine 0 N--CA 1.49 2.272 0 N-CA-C 107.886 -2.085 . . . . 0.0 107.886 178.46 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.53 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 32.7 p -125.51 161.75 26.44 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.258 -1.143 . . . . 0.0 110.852 -178.801 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.53 ' CB ' ' O ' ' A' ' 115' ' ' THR . 4.3 tt0 83.71 19.1 0.2 Allowed 'General case' 0 N--CA 1.492 1.652 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.282 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.636 ' O ' ' N ' ' A' ' 119' ' ' LEU . 8.2 tt -61.3 -165.02 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 178.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.622 ' N ' HG23 ' A' ' 117' ' ' ILE . 86.1 m-20 60.65 -60.48 0.08 Allowed 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.146 -0.971 . . . . 0.0 110.006 -179.635 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.636 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.2 mp -60.02 -35.05 74.25 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.787 -1.196 . . . . 0.0 108.995 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.512 ' C ' ' O ' ' A' ' 119' ' ' LEU . 83.3 mtm180 31.65 45.99 0.05 OUTLIER 'General case' 0 N--CA 1.495 1.788 0 CA-C-O 121.198 0.523 . . . . 0.0 110.332 179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.465 ' OD2' HD12 ' A' ' 129' ' ' LEU . 7.3 t0 70.26 75.56 0.21 Allowed 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.306 -0.871 . . . . 0.0 109.166 -179.649 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 121' ' ' ASP . 0.2 OUTLIER -42.83 160.49 0.2 Allowed Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.209 -0.932 . . . . 0.0 109.383 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.448 ' O ' HG22 ' A' ' 126' ' ' ILE . 6.7 Cg_endo -52.18 -55.22 4.06 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.699 2.266 . . . . 0.0 111.915 -179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.0 p -54.76 -28.65 50.16 Favored 'General case' 0 C--N 1.3 -1.578 0 O-C-N 120.819 -1.175 . . . . 0.0 109.586 -179.645 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.431 ' CG2' ' OD1' ' A' ' 121' ' ' ASP . 28.5 m -78.21 -50.74 11.34 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.994 -1.066 . . . . 0.0 110.578 -179.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.448 HG22 ' O ' ' A' ' 123' ' ' PRO . 13.1 tt -55.46 -27.6 21.15 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.033 -1.042 . . . . 0.0 109.631 -178.544 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -65.99 -45.62 80.97 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 178.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -60.69 -36.84 79.77 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.582 -0.699 . . . . 0.0 109.384 179.426 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.465 HD12 ' OD2' ' A' ' 121' ' ' ASP . 71.3 mt -75.15 -37.76 61.21 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.353 -0.842 . . . . 0.0 109.061 179.24 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.66 -39.05 61.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.497 -0.752 . . . . 0.0 109.504 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 36.2 tttt -60.4 -40.98 92.9 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.168 -0.957 . . . . 0.0 109.366 179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 19.3 m120 -91.7 3.11 55.83 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.312 -0.868 . . . . 0.0 109.917 -179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 52.1 mttp 54.49 40.62 31.95 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.266 -0.896 . . . . 0.0 109.986 179.412 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -92.07 -52.73 4.57 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.15 -0.969 . . . . 0.0 109.743 179.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.7 mttt 65.46 139.45 0.05 OUTLIER Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.325 -0.859 . . . . 0.0 109.128 -179.623 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -66.9 154.41 74.68 Favored 'Trans proline' 0 N--CA 1.497 1.722 0 C-N-CA 122.536 2.157 . . . . 0.0 112.757 -179.393 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 26.6 mm -93.56 140.31 16.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.425 -0.797 . . . . 0.0 109.343 -179.852 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -80.86 155.43 73.03 Favored Pre-proline 0 N--CA 1.489 1.524 0 O-C-N 121.266 -0.896 . . . . 0.0 109.535 -179.565 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.6 Cg_endo -59.62 -31.92 95.13 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 C-N-CA 122.458 2.105 . . . . 0.0 111.793 179.717 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -61.47 -37.76 84.8 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.287 -0.883 . . . . 0.0 109.336 179.739 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 32.3 m -66.09 -33.59 76.13 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.277 -0.89 . . . . 0.0 108.987 179.49 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.59 -36.97 57.21 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.451 -0.781 . . . . 0.0 110.071 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -58.7 -35.01 71.96 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.059 -1.026 . . . . 0.0 110.622 -179.108 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 76.0 mttt -64.42 -36.25 83.54 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.931 -1.106 . . . . 0.0 109.79 179.851 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.4 HD12 ' HA ' ' A' ' 145' ' ' LEU . 46.2 tp -63.25 -39.2 93.93 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.345 -0.847 . . . . 0.0 110.112 -179.628 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.804 ' HB2' HD22 ' A' ' 112' ' ' LEU . . . -67.74 -45.47 74.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.079 -1.013 . . . . 0.0 109.556 -179.925 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.664 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -75.79 9.61 2.25 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.266 -0.896 . . . . 0.0 109.514 -179.646 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 59.3 t0 -71.59 -36.4 70.84 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.128 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 51.0 mt -112.43 -87.92 0.54 Allowed 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.594 -0.691 . . . . 0.0 109.81 -179.653 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 24.3 mttm -152.59 52.67 0.77 Allowed 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.24 -0.912 . . . . 0.0 109.694 179.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.451 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -64.45 131.36 46.93 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.069 -1.019 . . . . 0.0 109.312 -179.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.5 t -69.23 -51.74 40.23 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.164 -0.96 . . . . 0.0 109.927 -179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 84.3 tttt -160.1 155.61 25.45 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.111 -0.993 . . . . 0.0 110.262 -179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.0 p90 -121.02 144.42 48.54 Favored 'General case' 0 N--CA 1.493 1.681 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 179.388 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 34.0 m -142.81 154.22 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.095 -1.003 . . . . 0.0 110.285 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.465 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.8 mt-10 -120.04 142.73 48.57 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 108.412 -0.959 . . . . 0.0 108.412 179.016 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.545 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.07 149.84 42.17 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.921 -1.112 . . . . 0.0 110.697 -179.085 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 161' ' ' THR . 12.8 t -112.01 107.59 16.62 Favored 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 109.005 -0.739 . . . . 0.0 109.005 179.359 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -72.7 -31.36 64.96 Favored 'General case' 0 N--CA 1.491 1.605 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 45.5 tp -53.31 -32.07 47.09 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.499 ' O ' ' O ' ' A' ' 158' ' ' SER . 14.3 p -126.09 165.26 19.18 Favored 'General case' 0 C--N 1.303 -1.415 0 N-CA-C 108.381 -0.97 . . . . 0.0 108.381 179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.9 mm-40 -69.85 13.14 0.16 Allowed 'General case' 0 C--N 1.288 -2.096 0 O-C-N 121.642 -0.661 . . . . 0.0 109.396 -179.898 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.487 ' H ' ' C ' ' A' ' 161' ' ' THR . 58.5 tttm -85.48 -4.76 59.26 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.114 -0.991 . . . . 0.0 109.626 -179.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.43 -50.43 2.97 Favored Glycine 0 N--CA 1.488 2.134 0 C-N-CA 119.615 -1.279 . . . . 0.0 110.255 -179.744 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.966 HD22 ' H ' ' A' ' 165' ' ' LEU . 1.8 mm? -64.46 -39.37 93.68 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.089 -1.242 . . . . 0.0 109.972 -179.404 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -58.51 -32.07 68.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.09 -1.006 . . . . 0.0 110.361 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.465 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 53.1 t30 -73.8 -49.64 24.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.086 -1.009 . . . . 0.0 109.786 179.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 11.4 m -80.72 -8.34 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.414 -0.803 . . . . 0.0 111.041 -178.863 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 71.0 t80 -72.43 -50.33 27.04 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.698 -1.251 . . . . 0.0 109.817 179.875 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 89.3 m-20 -62.89 -42.42 99.77 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.283 -0.886 . . . . 0.0 110.086 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.5 mm-40 -66.29 -36.31 82.64 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.188 -0.945 . . . . 0.0 109.731 -179.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.03 -35.54 71.43 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.29 -0.881 . . . . 0.0 109.67 -179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.7 mt -63.51 -40.29 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.146 -0.971 . . . . 0.0 109.618 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 45.2 tp -52.07 -45.88 64.92 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.326 -0.859 . . . . 0.0 109.689 -179.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.498 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -62.66 -33.64 75.46 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.128 -0.982 . . . . 0.0 109.421 -179.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.608 ' HA ' HD13 ' A' ' 4' ' ' ILE . . . -52.01 -43.58 63.74 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.236 -0.915 . . . . 0.0 109.667 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 67.1 mt -62.54 -35.73 80.36 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.102 -0.998 . . . . 0.0 109.337 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 77.9 mm-40 . . . . . 0 N--CA 1.491 1.581 0 O-C-N 121.336 -0.853 . . . . 99.989999999999995 109.461 -179.918 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 69.1 mtm . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.474 -0.565 . . . . 0.0 109.474 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 70.7 tp60 -96.58 138.94 33.41 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.286 -0.884 . . . . 0.0 109.175 179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 6.0 t -132.93 162.47 31.53 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.338 -0.851 . . . . 0.0 109.532 -179.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.446 HD12 ' HA ' ' A' ' 176' ' ' ALA . 31.1 mm -115.49 119.9 63.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.457 -0.777 . . . . 0.0 109.204 179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 62.8 mttp -96.93 130.59 44.21 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.182 -0.948 . . . . 0.0 109.488 -179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.659 ' SG ' HD12 ' A' ' 79' ' ' LEU . 0.0 OUTLIER -149.47 137.95 20.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.273 -0.892 . . . . 0.0 109.708 179.837 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 58.5 t -112.97 138.43 42.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.435 -0.791 . . . . 0.0 109.407 179.913 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.2 p -120.92 142.04 38.76 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.496 -0.753 . . . . 0.0 109.481 -179.592 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.523 HG23 HG21 ' A' ' 58' ' ' THR . 12.7 p -139.96 143.39 30.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.522 0 O-C-N 121.272 -0.893 . . . . 0.0 109.155 179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -140.65 165.36 26.15 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -85.1 117.82 24.29 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.292 -1.122 . . . . 0.0 109.296 179.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 71.21 -105.44 1.64 Allowed Glycine 0 N--CA 1.489 2.216 0 N-CA-C 109.431 -1.468 . . . . 0.0 109.431 -179.861 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -177.32 -67.08 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.232 -1.158 . . . . 0.0 109.512 179.847 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.616 HG12 ' N ' ' A' ' 15' ' ' GLY . 28.4 t 54.43 -119.56 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.238 -0.914 . . . . 0.0 109.586 179.815 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.616 ' N ' HG12 ' A' ' 14' ' ' VAL . . . -95.42 25.88 22.36 Favored Glycine 0 N--CA 1.49 2.298 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 79.0 tttt -56.92 -34.39 67.9 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.206 -1.173 . . . . 0.0 109.274 179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 47.4 p -66.58 -37.61 85.3 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.305 -0.872 . . . . 0.0 108.965 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.65 ' SG ' HG11 ' A' ' 33' ' ' VAL . 10.5 m -67.22 -30.82 70.85 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.432 -0.792 . . . . 0.0 109.869 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 12.6 tp -69.91 -44.78 68.98 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.195 -0.941 . . . . 0.0 110.287 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 90.0 mt -75.3 -44.33 46.15 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.055 -1.028 . . . . 0.0 110.801 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.45 HD12 ' HA ' ' A' ' 21' ' ' ILE . 9.9 tp -64.7 -32.49 58.18 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.024 -1.048 . . . . 0.0 110.066 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 94.6 p -66.7 -28.94 68.85 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.089 -1.007 . . . . 0.0 109.739 -179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.462 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 80.5 t80 -76.58 -43.43 38.84 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.208 -0.932 . . . . 0.0 110.393 -179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.2 p -75.35 -45.09 41.49 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.149 -0.969 . . . . 0.0 111.287 -178.643 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 65.7 p -85.12 -23.09 28.6 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.843 -1.161 . . . . 0.0 110.243 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' OD1' ' O ' ' A' ' 23' ' ' TYR . 57.1 m-20 57.58 35.36 25.66 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.388 -0.82 . . . . 0.0 109.358 -179.656 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -138.22 81.51 1.86 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.122 -0.986 . . . . 0.0 110.174 -179.924 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -58.58 -41.79 90.96 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 121.249 -0.907 . . . . 0.0 109.111 179.332 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 24.0 Cg_exo -61.99 -10.61 18.23 Favored 'Trans proline' 0 N--CA 1.493 1.494 0 C-N-CA 122.493 2.128 . . . . 0.0 112.036 179.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.543 ' C ' ' H ' ' A' ' 32' ' ' TYR . 14.6 t -47.12 -32.74 4.47 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.173 -0.954 . . . . 0.0 109.554 -179.563 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 37.3 tp10 64.65 -31.46 0.13 Allowed 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.379 -0.825 . . . . 0.0 110.283 179.671 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.644 ' C ' HG23 ' A' ' 33' ' ' VAL . 87.0 m-85 -58.36 -82.29 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.832 -1.168 . . . . 0.0 108.659 179.598 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.65 HG11 ' SG ' ' A' ' 18' ' ' CYS . 2.0 t 73.74 60.05 0.32 Allowed Pre-proline 0 N--CA 1.494 1.737 0 O-C-N 121.513 -0.742 . . . . 0.0 110.415 179.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -60.47 130.66 34.58 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.024 1.816 . . . . 0.0 111.079 178.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -91.34 56.08 2.99 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.06 -1.025 . . . . 0.0 110.143 -179.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.571 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 42.1 t -119.48 134.65 62.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.324 -0.86 . . . . 0.0 109.679 179.867 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.571 ' CG ' ' O ' ' A' ' 36' ' ' VAL . 91.1 m-85 -160.56 -102.63 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.258 -0.901 . . . . 0.0 109.132 179.701 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.581 ' O ' ' CB ' ' A' ' 39' ' ' ASN . 88.7 m-20 54.02 56.62 6.84 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.235 -0.916 . . . . 0.0 110.089 179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.581 ' CB ' ' O ' ' A' ' 38' ' ' ASP . 17.1 t-20 89.86 73.27 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 CA-C-O 121.318 0.58 . . . . 0.0 109.709 -179.923 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HE2' HG22 ' A' ' 42' ' ' VAL . 57.2 t80 -111.9 145.35 39.67 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.475 -0.765 . . . . 0.0 109.155 179.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -122.1 145.29 48.31 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.283 -0.886 . . . . 0.0 109.438 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.435 HG22 ' HE2' ' A' ' 40' ' ' TYR . 44.0 t -126.02 129.63 72.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.38 -0.825 . . . . 0.0 109.558 179.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 59.9 m -92.8 124.26 36.67 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.064 -1.022 . . . . 0.0 108.733 179.355 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.2 m -130.22 159.34 42.33 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.378 -0.826 . . . . 0.0 110.794 -179.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 68.0 mtm -113.15 136.95 52.16 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 109.116 -0.698 . . . . 0.0 109.116 179.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 60.6 mt -131.76 127.08 58.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.19 -0.944 . . . . 0.0 108.987 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 68.15 15.68 67.86 Favored Glycine 0 N--CA 1.491 2.357 0 N-CA-C 109.732 -1.347 . . . . 0.0 109.732 179.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 86.62 16.17 62.36 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.799 -1.321 . . . . 0.0 109.799 179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -124.26 154.06 68.71 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 121.338 -1.096 . . . . 0.0 109.175 179.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -70.52 135.33 28.38 Favored 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 122.749 2.3 . . . . 0.0 113.258 -179.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.1 m-85 -145.32 154.9 42.83 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.513 -0.742 . . . . 0.0 109.129 178.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.9 m -125.54 139.23 53.78 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.384 -0.823 . . . . 0.0 109.869 -179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 66.1 mt -119.37 125.25 48.55 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.554 -0.716 . . . . 0.0 109.094 179.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.49 ' C ' HD22 ' A' ' 55' ' ' LEU . . . -111.07 118.28 4.83 Favored Glycine 0 N--CA 1.492 2.415 0 N-CA-C 109.645 -1.382 . . . . 0.0 109.645 -179.878 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.924 HD22 ' N ' ' A' ' 55' ' ' LEU . 1.6 mm? -102.77 129.39 49.41 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.221 -1.164 . . . . 0.0 108.999 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 97.7 m-85 -109.88 126.08 53.47 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.432 -0.792 . . . . 0.0 109.771 -179.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.449 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -103.36 164.93 11.34 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.469 -0.769 . . . . 0.0 109.382 179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.523 HG21 HG23 ' A' ' 9' ' ' VAL . 40.3 p -79.67 161.87 25.58 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.192 -0.943 . . . . 0.0 109.329 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.5 ' O ' ' OE1' ' A' ' 62' ' ' GLU . . . -166.99 -21.54 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.167 -0.958 . . . . 0.0 109.52 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.493 ' O ' ' OD1' ' A' ' 65' ' ' ASP . . . -85.03 -1.31 88.78 Favored Glycine 0 N--CA 1.49 2.245 0 N-CA-C 109.727 -1.349 . . . . 0.0 109.727 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.456 ' HG2' HH22 ' A' ' 68' ' ' ARG . 89.0 mt-30 -59.8 -27.65 66.77 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.159 -1.201 . . . . 0.0 110.146 -179.74 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.546 ' C ' ' H ' ' A' ' 64' ' ' TYR . 51.8 mp0 -76.18 -161.88 0.2 Allowed 'General case' 0 C--N 1.3 -1.55 0 O-C-N 121.206 -0.934 . . . . 0.0 109.589 -179.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 52.6 p30 -62.98 11.99 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.245 -0.909 . . . . 0.0 110.545 -178.857 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.583 ' O ' ' N ' ' A' ' 66' ' ' ARG . 80.6 m-85 -102.83 18.47 21.42 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.155 -0.966 . . . . 0.0 109.124 179.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.493 ' OD1' ' O ' ' A' ' 60' ' ' GLY . 93.7 m-20 -43.86 -14.97 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.511 -0.743 . . . . 0.0 109.861 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.66 ' CG ' HH11 ' A' ' 66' ' ' ARG . 0.0 OUTLIER -44.84 -30.17 0.93 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.977 -1.077 . . . . 0.0 109.338 -179.628 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 45.4 tp -59.71 -34.54 73.04 Favored 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.146 -0.971 . . . . 0.0 109.879 -179.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.481 ' CB ' ' CD ' ' A' ' 69' ' ' PRO . 10.7 mpt_? -46.61 -66.13 0.57 Allowed Pre-proline 0 N--CA 1.494 1.73 0 O-C-N 121.128 -0.983 . . . . 0.0 110.817 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.481 ' CD ' ' CB ' ' A' ' 68' ' ' ARG . 11.0 Cg_endo -57.12 -32.39 93.18 Favored 'Trans proline' 0 N--CA 1.492 1.435 0 C-N-CA 122.142 1.894 . . . . 0.0 112.154 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.466 ' O ' ' C ' ' A' ' 71' ' ' SER . 41.4 tp -61.26 -36.42 79.96 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.259 -0.901 . . . . 0.0 109.458 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.466 ' C ' ' O ' ' A' ' 70' ' ' LEU . 5.5 p 35.55 75.56 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.644 -0.66 . . . . 0.0 110.24 179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.691 ' H ' ' CD ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER -110.71 -43.34 0.1 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.389 -0.819 . . . . 0.0 110.229 -179.87 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.691 ' CD ' ' H ' ' A' ' 72' ' ' TYR . 34.7 Cg_exo -59.26 137.76 80.65 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.848 2.366 . . . . 0.0 112.679 -179.235 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -131.27 135.6 47.47 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.456 -0.777 . . . . 0.0 109.426 179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 5.9 t -140.5 153.08 46.07 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.139 -0.975 . . . . 0.0 109.699 179.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.6 m-20 -104.96 -5.64 20.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.316 -0.865 . . . . 0.0 109.217 179.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.4 t -136.0 133.75 50.66 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.427 -0.795 . . . . 0.0 109.718 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 49.0 t80 -109.12 121.64 45.59 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.221 -0.924 . . . . 0.0 108.619 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.659 HD12 ' SG ' ' A' ' 6' ' ' CYS . 53.6 mt -116.35 140.05 49.75 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.306 -0.871 . . . . 0.0 110.427 -179.274 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 35.9 m -131.81 152.5 37.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.431 -0.793 . . . . 0.0 109.146 179.139 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -143.64 134.23 24.95 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.226 -0.921 . . . . 0.0 109.683 -179.971 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.6 p90 -138.99 164.01 30.87 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.278 -0.889 . . . . 0.0 109.43 179.751 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 84.1 p -98.13 151.4 20.44 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.187 -0.946 . . . . 0.0 109.32 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.629 ' O ' HG22 ' A' ' 84' ' ' VAL . 12.9 p -102.27 6.71 9.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.264 -0.898 . . . . 0.0 110.279 -179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 19.6 m -100.52 -1.08 10.01 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.712 0 O-C-N 121.001 -1.062 . . . . 0.0 110.129 -179.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 69.5 m -118.86 95.82 49.55 Favored Pre-proline 0 N--CA 1.495 1.776 0 O-C-N 121.323 -0.86 . . . . 0.0 109.745 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -49.76 -52.88 8.01 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.285 1.99 . . . . 0.0 112.6 -179.771 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 22.8 t -53.56 -40.2 65.39 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.099 -1.001 . . . . 0.0 109.508 -179.427 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.542 ' O ' HG23 ' A' ' 93' ' ' VAL . 54.9 p -60.34 -14.15 16.91 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.214 -0.929 . . . . 0.0 108.851 179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 16.5 t80 -74.13 -50.66 18.45 Favored 'General case' 0 N--CA 1.49 1.527 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 179.38 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -65.72 -39.08 90.83 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.423 -0.798 . . . . 0.0 109.3 179.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 89.0 m-20 -54.15 -32.14 54.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.312 -0.868 . . . . 0.0 109.625 -179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 89' ' ' SER . 73.8 t -59.26 -37.58 69.73 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.375 -0.828 . . . . 0.0 110.274 -179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 18.2 mttp -86.59 -27.76 23.69 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 120.742 -1.224 . . . . 0.0 110.386 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -72.72 -36.45 67.78 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.116 -0.99 . . . . 0.0 112.273 -178.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 59.3 mttm -111.89 -50.62 2.9 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 120.884 -1.135 . . . . 0.0 112.509 -178.101 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.487 ' CD1' ' N ' ' A' ' 97' ' ' TRP . 33.8 m0 -68.13 -34.32 76.14 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 120.967 -1.083 . . . . 0.0 112.583 -177.078 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.43 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -68.22 -51.72 24.74 Favored Pre-proline 0 N--CA 1.495 1.806 0 O-C-N 119.964 -1.71 . . . . 0.0 111.113 -178.532 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 72.9 Cg_endo -76.69 -44.67 0.21 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 C-N-CA 121.947 1.764 . . . . 0.0 112.881 179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 85.1 tt0 -59.24 -41.94 89.92 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.291 -0.881 . . . . 0.0 111.045 -178.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.586 ' O ' ' N ' ' A' ' 105' ' ' CYS . 94.2 mt -68.34 -43.35 84.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 O-C-N 120.809 -1.182 . . . . 0.0 110.174 -179.497 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 45.8 m -60.28 -42.97 96.55 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.097 -1.002 . . . . 0.0 109.847 -179.506 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.2 m170 -60.5 -44.85 95.56 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.266 -0.896 . . . . 0.0 109.937 -179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 48.3 m80 -92.82 -10.69 35.9 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.323 -0.861 . . . . 0.0 110.432 -178.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.586 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -149.65 86.96 5.27 Favored Pre-proline 0 N--CA 1.493 1.719 0 O-C-N 120.941 -1.099 . . . . 0.0 109.878 -179.726 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 32.6 Cg_exo -53.79 -48.84 19.59 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.415 2.076 . . . . 0.0 112.072 179.86 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.434 ' O ' HG23 ' A' ' 108' ' ' THR . 29.0 mttt -147.69 110.34 4.7 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.186 -0.946 . . . . 0.0 109.506 179.644 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.459 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 3.5 p -154.11 150.16 22.0 Favored Pre-proline 0 N--CA 1.491 1.611 0 O-C-N 121.213 -0.929 . . . . 0.0 109.326 179.632 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.5 Cg_exo -47.72 118.25 2.91 Favored 'Trans proline' 0 C--N 1.314 -1.264 0 C-N-CA 122.03 1.82 . . . . 0.0 111.625 179.414 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.459 ' CE2' ' O ' ' A' ' 108' ' ' THR . 64.0 m-85 -112.9 128.9 56.59 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.409 -0.807 . . . . 0.0 110.141 -179.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.741 HD21 ' OE1' ' A' ' 171' ' ' GLU . 32.5 tp -115.78 120.28 38.78 Favored 'General case' 0 N--CA 1.488 1.45 0 N-CA-C 108.675 -0.861 . . . . 0.0 108.675 179.304 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 44.9 tp -103.58 117.56 34.7 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.236 -0.915 . . . . 0.0 108.85 179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.536 ' CG1' ' SG ' ' A' ' 157' ' ' CYS . 48.0 t -112.09 135.9 49.96 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 O-C-N 121.419 -0.801 . . . . 0.0 110.587 -178.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.7 125.31 8.53 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.31 -1.916 . . . . 0.0 108.31 178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.554 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.3 t -129.97 166.63 19.68 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.227 -1.161 . . . . 0.0 110.638 -178.768 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.554 ' CB ' ' O ' ' A' ' 115' ' ' THR . 22.9 tp60 85.66 15.42 0.15 Allowed 'General case' 0 N--CA 1.492 1.64 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.762 179.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.699 ' O ' ' N ' ' A' ' 119' ' ' LEU . 25.4 pt -63.15 -158.96 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.496 0 O-C-N 120.869 -1.144 . . . . 0.0 108.648 179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.497 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 80.4 m-20 56.97 -57.03 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.637 -0.664 . . . . 0.0 110.273 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.699 ' N ' ' O ' ' A' ' 117' ' ' ILE . 29.4 tp -50.74 -30.52 14.17 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 120.845 -1.159 . . . . 0.0 108.109 179.492 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.466 HH12 ' HD2' ' A' ' 139' ' ' PRO . 40.5 ttp180 -57.89 -15.56 9.03 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.616 -0.678 . . . . 0.0 109.59 179.381 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 118' ' ' ASP . 47.2 p30 -101.19 1.85 39.45 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.001 -1.062 . . . . 0.0 109.956 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 8.2 m-20 -78.55 150.57 76.47 Favored Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.279 -0.888 . . . . 0.0 109.632 -179.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 40.2 Cg_endo -70.9 -53.46 0.2 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.454 2.103 . . . . 0.0 111.98 179.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 20.2 m -59.17 -32.64 70.09 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.318 -0.864 . . . . 0.0 110.637 -179.333 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 39.1 m -69.71 -51.39 34.73 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.886 -1.134 . . . . 0.0 109.908 -179.636 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 38.3 pt -65.16 -35.1 74.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.654 0 O-C-N 121.23 -0.918 . . . . 0.0 109.456 -179.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.3 mt-10 -73.27 -44.57 59.06 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.201 -0.937 . . . . 0.0 109.362 179.163 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.5 tttp -59.87 -41.32 91.27 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.354 -0.841 . . . . 0.0 109.714 -179.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.411 ' HA ' HD23 ' A' ' 129' ' ' LEU . 88.1 mt -74.16 -34.07 63.69 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.215 -0.928 . . . . 0.0 108.713 178.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.57 -47.73 69.8 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.453 -0.779 . . . . 0.0 109.056 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 49.2 mttm -62.6 -35.83 80.79 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.204 -0.935 . . . . 0.0 110.119 179.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 17.0 t-20 -52.61 -57.09 11.13 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.857 -1.152 . . . . 0.0 109.562 -179.215 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.456 ' HG3' ' N ' ' A' ' 134' ' ' GLN . 14.3 pttp -171.23 -50.68 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.058 -1.026 . . . . 0.0 110.563 179.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.456 ' N ' ' HG3' ' A' ' 133' ' ' LYS . 52.6 mt-30 -143.86 -119.79 0.09 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 109.852 -179.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.88 163.22 52.51 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.204 -0.935 . . . . 0.0 110.175 -179.22 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 11.5 Cg_endo -58.33 174.26 0.78 Allowed 'Trans proline' 0 N--CA 1.495 1.614 0 C-N-CA 123.175 2.583 . . . . 0.0 112.099 179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 72.3 mt -96.32 140.04 18.07 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.257 -0.902 . . . . 0.0 109.933 -179.416 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.37 158.29 69.29 Favored Pre-proline 0 N--CA 1.488 1.455 0 O-C-N 121.35 -0.843 . . . . 0.0 109.381 -179.86 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.466 ' HD2' HH12 ' A' ' 120' ' ' ARG . 16.4 Cg_endo -60.99 -31.55 91.48 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 C-N-CA 122.58 2.187 . . . . 0.0 111.936 179.901 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -59.18 -38.12 79.05 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.329 -0.857 . . . . 0.0 109.186 179.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 39.4 m -69.37 -33.05 72.48 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 121.217 -0.927 . . . . 0.0 109.221 179.458 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.31 -39.6 59.39 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.447 -0.783 . . . . 0.0 109.921 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -59.51 -31.85 69.76 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.213 -0.929 . . . . 0.0 110.264 -179.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.2 tttt -60.93 -37.53 82.64 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.082 -1.012 . . . . 0.0 109.781 -179.817 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.703 ' N ' HD12 ' A' ' 145' ' ' LEU . 7.7 mp -65.39 -31.06 71.96 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.156 -0.965 . . . . 0.0 110.402 -179.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.97 -47.13 69.43 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 120.908 -1.12 . . . . 0.0 110.242 -179.32 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 76.4 mtm180 -82.09 9.49 8.43 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.107 -0.996 . . . . 0.0 110.399 -178.793 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 81.4 m-20 -113.45 -36.09 5.06 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.053 -1.029 . . . . 0.0 109.246 178.43 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 62.3 mt -92.02 17.09 9.87 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.538 -0.726 . . . . 0.0 110.572 -178.789 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 30.6 mmtp 65.48 30.23 10.87 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.216 -0.928 . . . . 0.0 109.865 -179.759 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.31 143.08 56.6 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.204 -0.935 . . . . 0.0 108.944 179.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.454 HG23 ' H ' ' A' ' 110' ' ' PHE . 73.0 t -66.0 -58.11 7.99 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.466 0 O-C-N 121.013 -1.054 . . . . 0.0 110.089 -179.42 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 73.5 tttt -152.49 150.47 29.64 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.028 -1.045 . . . . 0.0 110.709 -179.304 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 83.4 t80 -116.8 138.7 51.31 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.48 -0.763 . . . . 0.0 109.432 179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.421 HG11 ' OE2' ' A' ' 171' ' ' GLU . 6.2 m -141.43 153.78 19.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.18 -0.95 . . . . 0.0 109.9 179.766 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.424 ' OE2' ' CB ' ' A' ' 139' ' ' PRO . 93.2 mt-10 -110.11 132.62 54.0 Favored 'General case' 0 N--CA 1.492 1.672 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.536 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -136.64 146.28 45.81 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.115 -0.991 . . . . 0.0 110.633 -178.942 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.492 ' O ' ' O ' ' A' ' 161' ' ' THR . 18.0 t -115.78 108.93 16.96 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 108.954 -0.758 . . . . 0.0 108.954 179.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.29 -30.19 63.23 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.343 0.592 . . . . 0.0 109.45 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.711 HD12 ' N ' ' A' ' 160' ' ' LEU . 6.7 mp -59.61 -27.86 66.68 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 179.622 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.8 p -125.11 165.94 17.32 Favored 'General case' 0 C--N 1.305 -1.338 0 N-CA-C 108.46 -0.941 . . . . 0.0 108.46 179.388 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 81.4 mm-40 -71.11 12.64 0.28 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.798 -0.563 . . . . 0.0 109.597 -179.517 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.457 ' H ' ' C ' ' A' ' 161' ' ' THR . 34.9 mtmt -89.68 3.4 52.81 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.117 -0.989 . . . . 0.0 109.923 -179.238 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -96.97 -49.15 1.96 Allowed Glycine 0 N--CA 1.487 2.089 0 N-CA-C 109.881 -1.288 . . . . 0.0 109.881 -179.79 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.745 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.5 mp -61.86 -38.48 88.43 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.265 -1.138 . . . . 0.0 110.125 -179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 32.5 mttm -58.53 -32.59 69.01 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.142 -0.974 . . . . 0.0 110.303 -179.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.6 m-20 -86.64 -44.61 11.73 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.046 -1.034 . . . . 0.0 109.381 179.53 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 78.8 t -72.88 -26.9 23.94 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.509 -0.744 . . . . 0.0 110.498 -179.836 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.403 ' CE2' HG13 ' A' ' 173' ' ' ILE . 71.9 t80 -67.47 -46.81 71.9 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.039 -1.038 . . . . 0.0 110.489 -179.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.7 m-20 -54.52 -43.8 72.22 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.896 -1.127 . . . . 0.0 109.672 -179.161 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.741 ' OE1' HD21 ' A' ' 111' ' ' LEU . 96.7 mt-10 -70.61 -38.06 73.91 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.256 -0.903 . . . . 0.0 109.532 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.01 -43.69 91.57 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.187 -0.945 . . . . 0.0 110.256 -179.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.403 HG13 ' CE2' ' A' ' 169' ' ' PHE . 29.9 mm -69.67 -42.81 80.48 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 120.932 -1.105 . . . . 0.0 109.671 179.861 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 39.6 tp -56.16 -45.64 79.61 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.181 -0.949 . . . . 0.0 109.514 -179.572 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.38 -37.06 84.41 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.114 -0.991 . . . . 0.0 109.699 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.446 ' HA ' HD12 ' A' ' 4' ' ' ILE . . . -56.66 -42.66 79.34 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.111 -0.993 . . . . 0.0 109.42 -179.561 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.4 mt -64.27 -38.48 91.18 Favored 'General case' 0 N--CA 1.488 1.436 0 O-C-N 121.234 -0.916 . . . . 0.0 109.031 179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 . . . . . 0 N--CA 1.49 1.551 0 O-C-N 121.418 -0.801 . . . . 99.989999999999995 109.516 179.887 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.8 mmm . . . . . 0 N--CA 1.491 1.585 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 95.9 mt-30 -63.17 -30.87 71.93 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.257 -0.902 . . . . 0.0 109.034 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.0 m -104.37 145.27 30.5 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.6 -0.687 . . . . 0.0 109.679 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 72.8 mt -115.07 119.94 63.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.58 0 O-C-N 121.528 -0.732 . . . . 0.0 109.026 179.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.7 mttt -88.35 130.78 35.05 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.149 -0.969 . . . . 0.0 110.01 -179.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -142.49 128.18 19.23 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 121.391 -0.818 . . . . 0.0 109.12 179.624 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 46.6 t -110.41 138.27 39.06 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.374 -0.829 . . . . 0.0 109.559 -179.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.447 HG13 HD23 ' A' ' 79' ' ' LEU . 32.2 t -116.1 132.47 65.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.429 -0.795 . . . . 0.0 108.886 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.627 HG23 ' OG1' ' A' ' 58' ' ' THR . 14.6 p -152.09 145.87 15.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.077 -1.014 . . . . 0.0 109.514 179.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.28 157.41 22.88 Favored Glycine 0 N--CA 1.492 2.388 0 N-CA-C 109.202 -1.559 . . . . 0.0 109.202 179.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.454 ' O ' ' C ' ' A' ' 12' ' ' GLY . 60.3 t0 -86.01 105.76 16.69 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.187 -1.184 . . . . 0.0 109.61 -179.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.454 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.12 69.73 0.38 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.86 -1.296 . . . . 0.0 109.86 179.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.71 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -87.98 133.58 33.91 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.101 -1.235 . . . . 0.0 109.289 -179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 61.5 t -62.37 -46.45 96.4 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -0.977 . . . . 0.0 109.333 -179.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.55 49.89 0.81 Allowed Glycine 0 N--CA 1.492 2.411 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.71 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 73.6 tttt -61.28 -38.24 86.04 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.962 -1.316 . . . . 0.0 109.78 179.99 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 52.6 p -70.64 -37.02 73.72 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.227 -0.921 . . . . 0.0 109.633 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 87.7 m -63.69 -28.5 69.94 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.222 -0.924 . . . . 0.0 109.702 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 36.4 tp -68.81 -37.3 79.13 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.184 -0.947 . . . . 0.0 110.128 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 83.6 mt -64.37 -40.6 96.14 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.165 -0.959 . . . . 0.0 111.15 -178.702 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 48.3 pt -70.7 -32.14 48.3 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 120.74 -1.225 . . . . 0.0 110.07 -179.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 21.3 m -57.01 -38.68 73.45 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 120.986 -1.071 . . . . 0.0 109.983 -179.388 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -78.74 -48.48 14.81 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.145 -0.972 . . . . 0.0 110.122 -179.879 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 59.1 p -64.59 -34.33 78.02 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.203 -0.935 . . . . 0.0 109.881 -179.256 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.466 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 63.7 p -112.26 -109.61 0.35 Allowed 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.369 -0.832 . . . . 0.0 109.072 179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.466 ' CB ' ' O ' ' A' ' 25' ' ' THR . 1.3 p30 164.64 39.15 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.847 -0.798 . . . . 0.0 108.847 179.952 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 26.1 mttm -126.45 122.35 35.0 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.259 -0.901 . . . . 0.0 110.404 -179.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.672 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -96.52 -39.69 0.27 Allowed Pre-proline 0 C--N 1.304 -1.389 0 N-CA-C 108.396 -0.964 . . . . 0.0 108.396 178.583 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.672 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 12.9 Cg_exo -66.89 -10.54 28.75 Favored 'Trans proline' 0 C--N 1.313 -1.305 0 C-N-CA 122.616 2.211 . . . . 0.0 111.13 178.735 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.636 ' O ' ' N ' ' A' ' 32' ' ' TYR . 38.7 m -47.9 -36.72 12.75 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 119.595 -0.842 . . . . 0.0 109.209 179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.441 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.6 mt-10 40.38 17.7 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.54 -0.725 . . . . 0.0 109.972 179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.636 ' N ' ' O ' ' A' ' 30' ' ' SER . 70.1 t80 -141.22 118.77 11.58 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.946 -1.096 . . . . 0.0 108.419 179.684 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -99.59 153.03 37.98 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.288 -0.882 . . . . 0.0 110.206 -178.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 38.5 Cg_endo -69.81 156.11 64.04 Favored 'Trans proline' 0 N--CA 1.492 1.42 0 C-N-CA 122.846 2.364 . . . . 0.0 112.013 179.693 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -85.59 67.92 10.24 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.178 -0.951 . . . . 0.0 109.282 179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.2 m -140.55 136.25 35.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.655 0 O-C-N 121.308 -0.87 . . . . 0.0 109.711 179.672 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 83.5 m-85 -117.26 -1.93 11.72 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.395 -0.815 . . . . 0.0 109.645 179.406 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.452 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.1 p30 -77.56 166.24 23.3 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.093 -1.005 . . . . 0.0 110.113 -179.575 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.482 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 37.5 p-10 -92.91 150.78 20.34 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.434 -0.792 . . . . 0.0 109.619 179.88 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.545 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 74.0 t80 -134.53 147.98 50.41 Favored 'General case' 0 N--CA 1.495 1.792 0 O-C-N 121.382 -0.824 . . . . 0.0 109.459 179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.545 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -102.61 138.25 39.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.184 -0.947 . . . . 0.0 109.842 -179.815 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 48.0 t -107.83 138.2 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.562 -0.712 . . . . 0.0 109.545 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 38.3 m -106.03 134.49 49.08 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.358 -0.838 . . . . 0.0 109.088 179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 41.0 t -117.89 135.15 59.23 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 121.403 -0.811 . . . . 0.0 109.958 -179.577 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 88.8 mtp -109.39 133.69 52.75 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.214 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.745 HG22 ' H ' ' A' ' 48' ' ' GLY . 68.9 mt -129.11 135.77 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.307 -0.87 . . . . 0.0 108.87 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -56.68 -15.11 11.08 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 109.287 -1.525 . . . . 0.0 109.287 179.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.745 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -95.16 -8.73 58.69 Favored Glycine 0 N--CA 1.492 2.367 0 O-C-N 121.322 -1.105 . . . . 0.0 110.593 -179.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.531 ' CB ' ' O ' ' A' ' 48' ' ' GLY . 2.0 mm-40 155.43 131.23 0.0 OUTLIER Pre-proline 0 N--CA 1.503 2.224 0 O-C-N 121.507 -0.996 . . . . 0.0 109.367 179.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -72.87 137.01 26.2 Favored 'Trans proline' 0 N--CA 1.493 1.468 0 C-N-CA 122.003 1.802 . . . . 0.0 111.857 179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.488 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 97.8 m-85 -134.57 155.49 50.34 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.136 -0.978 . . . . 0.0 109.84 -179.995 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 35.1 m -119.0 141.1 48.97 Favored 'General case' 0 N--CA 1.493 1.697 0 N-CA-C 108.847 -0.797 . . . . 0.0 108.847 179.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 82.6 mt -125.91 126.34 44.24 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.277 -0.889 . . . . 0.0 109.891 179.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -97.65 128.51 9.58 Favored Glycine 0 N--CA 1.489 2.224 0 N-CA-C 108.645 -1.782 . . . . 0.0 108.645 179.126 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 48.2 mt -107.32 122.49 46.69 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.148 -1.207 . . . . 0.0 109.2 -179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -111.49 135.13 52.5 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.41 -0.806 . . . . 0.0 109.197 -179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.426 ' OD1' ' N ' ' A' ' 58' ' ' THR . 57.4 t0 -94.0 151.68 19.36 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.188 -0.945 . . . . 0.0 109.07 179.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.627 ' OG1' HG23 ' A' ' 9' ' ' VAL . 65.5 m -59.1 130.39 46.77 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.033 -1.042 . . . . 0.0 108.978 -179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -152.08 150.33 29.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.322 -0.861 . . . . 0.0 109.338 -179.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 95.96 -6.7 66.98 Favored Glycine 0 N--CA 1.491 2.319 0 N-CA-C 109.436 -1.466 . . . . 0.0 109.436 179.926 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -58.39 -22.67 54.68 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.301 -1.117 . . . . 0.0 109.362 179.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.585 ' C ' ' H ' ' A' ' 64' ' ' TYR . 96.3 mt-10 -76.89 -171.1 1.83 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.476 -0.765 . . . . 0.0 109.496 -179.904 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.433 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 53.4 p30 -63.31 24.51 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.29 -0.881 . . . . 0.0 110.714 -178.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.585 ' H ' ' C ' ' A' ' 62' ' ' GLU . 83.5 m-85 -118.82 17.99 13.38 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.046 -1.034 . . . . 0.0 109.214 179.056 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.445 ' C ' ' OD1' ' A' ' 65' ' ' ASP . 51.2 p30 -70.54 6.63 1.34 Allowed 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.302 -0.874 . . . . 0.0 110.204 -179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.1 mtt180 -56.56 -33.49 66.2 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.104 -0.998 . . . . 0.0 109.194 179.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.469 ' O ' ' O ' ' A' ' 68' ' ' ARG . 64.3 mt -61.57 -35.75 78.68 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.484 -0.76 . . . . 0.0 109.958 -179.618 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.548 ' O ' ' N ' ' A' ' 70' ' ' LEU . 1.6 mtt180 55.84 165.73 0.06 OUTLIER Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 121.021 -1.049 . . . . 0.0 109.144 -179.842 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_exo -48.28 -1.96 0.03 OUTLIER 'Trans proline' 0 N--CA 1.494 1.51 0 C-N-CA 122.371 2.047 . . . . 0.0 112.558 179.697 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' N ' ' O ' ' A' ' 68' ' ' ARG . 82.4 mt -56.39 -30.6 62.94 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.193 -0.942 . . . . 0.0 110.293 -179.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 20.7 m -61.68 -38.28 87.22 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.918 -1.114 . . . . 0.0 109.942 -179.83 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 60.6 m-85 -130.61 84.1 60.01 Favored Pre-proline 0 N--CA 1.493 1.682 0 O-C-N 121.412 -0.805 . . . . 0.0 109.686 -179.64 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.526 ' O ' ' O ' ' A' ' 74' ' ' GLN . 47.5 Cg_endo -76.95 176.12 10.53 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 C-N-CA 122.53 2.153 . . . . 0.0 112.557 -179.656 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.526 ' O ' ' O ' ' A' ' 73' ' ' PRO . 63.5 tp60 35.73 101.29 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.79 -0.569 . . . . 0.0 110.842 179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 40.1 m -105.5 130.96 53.46 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.134 -0.979 . . . . 0.0 108.99 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 58.8 t0 -63.39 -37.91 89.12 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.27 -0.894 . . . . 0.0 110.406 -179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 12.0 p -151.84 144.1 16.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.674 0 O-C-N 121.123 -0.986 . . . . 0.0 110.449 -179.9 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -104.39 126.68 51.7 Favored 'General case' 0 N--CA 1.489 1.487 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.447 HD23 HG13 ' A' ' 8' ' ' VAL . 42.6 tp -112.3 128.76 56.37 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.198 -0.939 . . . . 0.0 110.121 -179.434 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.665 HG21 ' CE2' ' A' ' 110' ' ' PHE . 40.5 t -123.18 135.78 62.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.543 -0.723 . . . . 0.0 109.12 179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -129.41 130.95 46.62 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.37 -0.831 . . . . 0.0 109.828 -179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 43.2 p90 -140.47 161.11 38.51 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.325 -0.859 . . . . 0.0 109.173 179.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 39.9 t -80.08 132.82 36.03 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.101 -1.0 . . . . 0.0 109.295 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 70.4 t -67.77 -28.25 40.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.392 -0.818 . . . . 0.0 110.869 -179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.573 HG21 HD23 ' A' ' 119' ' ' LEU . 33.4 m -92.6 7.15 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 121.041 -1.037 . . . . 0.0 111.095 -178.539 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.6 t -98.52 124.57 46.04 Favored Pre-proline 0 N--CA 1.492 1.64 0 O-C-N 120.792 -1.193 . . . . 0.0 110.003 -179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.439 ' O ' ' OE1' ' A' ' 91' ' ' GLU . 70.2 Cg_endo -77.56 -58.97 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.452 0 C-N-CA 122.264 1.976 . . . . 0.0 112.61 179.984 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 81.4 p -55.48 -32.92 63.23 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.205 -0.935 . . . . 0.0 109.762 -179.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 41.3 m -65.08 -24.52 67.47 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.114 -0.991 . . . . 0.0 109.165 179.309 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.41 ' CZ ' HG22 ' A' ' 141' ' ' THR . 56.3 t80 -68.57 -50.84 48.67 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.461 -0.774 . . . . 0.0 109.347 179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.439 ' OE1' ' O ' ' A' ' 87' ' ' PRO . 52.5 mp0 -69.13 -35.72 76.69 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.322 -0.861 . . . . 0.0 109.723 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 88.1 m-20 -54.45 -33.36 59.43 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.207 -0.933 . . . . 0.0 109.691 -179.547 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 72.9 t -62.66 -37.98 80.39 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.208 -0.933 . . . . 0.0 110.268 -179.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.684 ' HD2' HD21 ' A' ' 145' ' ' LEU . 30.0 tttt -93.43 -36.25 12.58 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.844 -1.16 . . . . 0.0 110.839 -179.45 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -67.71 -37.04 81.71 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.027 -1.045 . . . . 0.0 112.285 -177.952 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -113.68 -51.65 2.79 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.986 -1.071 . . . . 0.0 112.611 -178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 93.3 m95 -67.27 -31.77 72.32 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.198 -0.939 . . . . 0.0 113.217 -176.47 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.462 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.0 t -71.25 -51.49 10.08 Favored Pre-proline 0 N--CA 1.497 1.891 0 O-C-N 120.152 -1.592 . . . . 0.0 111.623 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.462 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 56.7 Cg_endo -71.87 -45.74 0.68 Allowed 'Trans proline' 0 N--CA 1.495 1.567 0 C-N-CA 121.827 1.685 . . . . 0.0 113.567 -179.453 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.8 mt-10 -62.22 -38.85 90.76 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.014 -1.054 . . . . 0.0 111.07 -178.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.408 HG22 ' O ' ' A' ' 98' ' ' VAL . 3.4 tp -68.58 -26.88 34.33 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.757 -1.214 . . . . 0.0 110.078 -179.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 44.7 m -61.46 -40.02 92.97 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.101 -0.999 . . . . 0.0 109.858 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 78.1 m80 -54.87 -34.44 62.98 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.284 -0.885 . . . . 0.0 109.903 -179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.573 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 56.8 t-80 -62.34 -43.66 98.3 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.136 -0.977 . . . . 0.0 109.591 179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.573 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.0 OUTLIER 160.64 158.52 0.04 OUTLIER Pre-proline 0 N--CA 1.495 1.822 0 O-C-N 121.47 -0.769 . . . . 0.0 109.629 179.845 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.503 ' O ' ' N ' ' A' ' 108' ' ' THR . 13.5 Cg_endo -60.1 -160.54 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.563 0 C-N-CA 122.759 2.306 . . . . 0.0 111.676 179.366 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 106' ' ' PRO . 20.8 mttp 42.51 -96.67 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.007 -1.058 . . . . 0.0 109.631 179.973 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.503 ' N ' ' O ' ' A' ' 106' ' ' PRO . 1.7 p 47.49 81.8 0.25 Allowed Pre-proline 0 N--CA 1.489 1.505 0 O-C-N 121.212 -0.93 . . . . 0.0 109.388 179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_exo -49.53 126.44 16.09 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 C-N-CA 122.328 2.019 . . . . 0.0 111.573 -179.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 80' ' ' VAL . 0.4 OUTLIER -113.28 125.21 54.04 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.394 -0.816 . . . . 0.0 110.017 -179.426 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.403 HD12 ' O ' ' A' ' 153' ' ' LYS . 40.5 tp -116.58 121.22 41.09 Favored 'General case' 0 N--CA 1.491 1.625 0 N-CA-C 108.933 -0.765 . . . . 0.0 108.933 179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 57.6 mt -104.58 121.83 44.34 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.274 -0.891 . . . . 0.0 109.529 -179.927 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 43.0 t -110.75 134.52 52.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.3 -0.875 . . . . 0.0 109.897 -179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -99.5 124.89 8.38 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 108.984 -1.646 . . . . 0.0 108.984 179.463 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 18.8 p -110.73 159.78 17.31 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.251 -1.146 . . . . 0.0 110.219 -179.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 57.67 40.8 26.26 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.681 -0.637 . . . . 0.0 110.663 179.543 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.5 pt -69.48 -5.36 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 120.856 -1.153 . . . . 0.0 109.933 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.8 m-20 -84.93 -22.66 29.16 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.02 -1.05 . . . . 0.0 109.096 179.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.573 HD23 HG21 ' A' ' 85' ' ' VAL . 31.4 tp -61.58 -32.73 72.84 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.56 -0.713 . . . . 0.0 109.497 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.407 HH22 ' HB ' ' A' ' 138' ' ' THR . 67.7 ttt180 -58.64 -25.22 62.51 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.323 -0.86 . . . . 0.0 109.652 179.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.0 m-20 -94.07 -5.2 47.92 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.325 -0.86 . . . . 0.0 110.116 -179.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.12 141.32 83.72 Favored Pre-proline 0 N--CA 1.489 1.478 0 O-C-N 121.003 -1.061 . . . . 0.0 109.049 179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_endo -67.62 -46.73 2.45 Favored 'Trans proline' 0 C--N 1.311 -1.406 0 C-N-CA 122.173 1.915 . . . . 0.0 111.894 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.8 p -61.22 -27.64 68.58 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.262 -0.899 . . . . 0.0 109.889 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 36.3 m -69.25 -49.02 60.03 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.204 -1.035 . . . . 0.0 108.204 178.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 80.2 mt -60.02 -40.19 82.46 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.519 0 CA-C-O 121.455 0.645 . . . . 0.0 109.3 179.69 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -74.54 -40.62 61.61 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.582 -0.699 . . . . 0.0 109.771 179.81 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 57.4 tttp -62.04 -44.7 96.13 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.327 -0.858 . . . . 0.0 110.568 -179.307 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.517 ' CD2' ' N ' ' A' ' 129' ' ' LEU . 3.5 mm? -78.7 -38.78 38.34 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.106 -0.996 . . . . 0.0 109.61 179.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.7 -50.52 71.9 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.346 -0.847 . . . . 0.0 109.686 -179.285 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 16.9 tttm -62.55 -44.41 96.4 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 120.97 -1.081 . . . . 0.0 110.081 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -70.44 -48.95 53.55 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.065 -1.022 . . . . 0.0 109.772 -179.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.4 mttp -148.38 -89.32 0.08 Allowed 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.248 -0.907 . . . . 0.0 109.637 -179.574 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.47 ' HG3' ' H ' ' A' ' 135' ' ' LYS . 9.0 pt20 -134.19 -119.32 0.18 Allowed 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.583 -0.698 . . . . 0.0 109.594 -179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.47 ' H ' ' HG3' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -133.09 167.03 24.98 Favored Pre-proline 0 N--CA 1.49 1.565 0 O-C-N 121.19 -0.943 . . . . 0.0 109.447 179.789 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -43.41 165.1 0.04 OUTLIER 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.998 2.465 . . . . 0.0 112.223 179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 74.9 mt -92.61 145.68 7.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.298 -0.876 . . . . 0.0 109.069 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.407 ' HB ' HH22 ' A' ' 120' ' ' ARG . 0.2 OUTLIER -85.69 155.99 58.81 Favored Pre-proline 0 N--CA 1.488 1.468 0 O-C-N 120.994 -1.066 . . . . 0.0 109.394 -179.852 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_endo -60.41 -24.03 76.57 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.614 2.209 . . . . 0.0 111.87 179.776 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -64.13 -41.7 97.11 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.347 -0.846 . . . . 0.0 109.615 179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.41 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 46.8 m -62.45 -36.78 83.52 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.16 -0.962 . . . . 0.0 109.331 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.47 -36.9 57.63 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.42 -0.8 . . . . 0.0 109.752 179.817 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 86.2 tt0 -62.64 -34.67 77.53 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.091 -1.006 . . . . 0.0 110.682 -179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.444 ' O ' ' CG ' ' A' ' 148' ' ' ASP . 21.0 mttm -67.3 -39.25 85.92 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.756 -1.215 . . . . 0.0 109.437 179.722 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.684 HD21 ' HD2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -62.7 -39.5 94.2 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.291 -0.881 . . . . 0.0 109.24 -179.664 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.574 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -75.36 -48.86 21.09 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.089 -1.007 . . . . 0.0 110.141 -179.753 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 55.6 ttt180 -68.97 4.97 1.27 Allowed 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.244 -0.91 . . . . 0.0 110.379 -178.768 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.444 ' CG ' ' O ' ' A' ' 144' ' ' LYS . 88.2 m-20 -108.82 -20.99 12.87 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 120.958 -1.089 . . . . 0.0 109.357 179.204 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.402 ' CD1' HG21 ' A' ' 98' ' ' VAL . 38.2 mt -110.97 34.31 4.1 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.511 -0.743 . . . . 0.0 110.037 -179.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 85.1 mttt 58.73 29.18 18.31 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.363 -0.836 . . . . 0.0 110.639 179.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.574 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -67.51 146.23 54.15 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 120.907 -1.121 . . . . 0.0 109.037 179.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 98.5 t -66.98 -61.98 1.45 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 121.034 -1.042 . . . . 0.0 110.402 -179.356 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.427 ' HG2' ' N ' ' A' ' 154' ' ' TYR . 16.4 tttp -175.37 163.3 3.01 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.236 -0.915 . . . . 0.0 109.552 -179.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.427 ' N ' ' HG2' ' A' ' 153' ' ' LYS . 28.7 p90 -120.04 154.75 34.15 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.372 -0.83 . . . . 0.0 108.922 179.479 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.623 HG21 ' OE1' ' A' ' 171' ' ' GLU . 28.0 t -132.24 140.09 48.61 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.129 -0.982 . . . . 0.0 110.057 -179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.466 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 95.9 mt-10 -100.13 126.7 46.41 Favored 'General case' 0 N--CA 1.491 1.624 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 178.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.95 140.73 47.96 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.167 -0.958 . . . . 0.0 111.071 -178.377 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.5 ' O ' ' O ' ' A' ' 161' ' ' THR . 34.6 t -104.26 102.19 11.9 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.333 -0.854 . . . . 0.0 108.892 179.293 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -70.79 -34.92 72.27 Favored 'General case' 0 N--CA 1.492 1.637 0 CA-C-O 121.209 0.528 . . . . 0.0 109.59 179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 60.6 mt -53.56 -27.02 23.9 Favored 'General case' 0 N--CA 1.488 1.458 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.5 ' O ' ' O ' ' A' ' 158' ' ' SER . 17.5 p -123.61 161.17 25.54 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 108.031 -1.1 . . . . 0.0 108.031 179.07 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 82.8 mm-40 -69.97 12.35 0.22 Allowed 'General case' 0 C--N 1.286 -2.165 0 O-C-N 121.696 -0.627 . . . . 0.0 109.33 -179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.474 ' H ' ' C ' ' A' ' 161' ' ' THR . 63.3 mttp -90.45 0.52 57.27 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.161 -0.962 . . . . 0.0 109.866 -179.301 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -91.67 -51.37 2.51 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.577 -1.297 . . . . 0.0 110.016 -179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.0 mt -64.17 -40.48 96.2 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.133 -1.216 . . . . 0.0 109.83 -179.736 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -59.45 -27.85 66.45 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.252 -0.905 . . . . 0.0 110.522 -179.556 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.466 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 35.6 t-20 -76.94 -50.73 12.56 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.065 -1.022 . . . . 0.0 109.926 -179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 15.0 m -82.02 -12.13 12.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.285 -0.884 . . . . 0.0 110.865 -179.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -73.63 -50.23 22.11 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.734 -1.228 . . . . 0.0 110.575 -179.779 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 -59.72 -41.95 92.01 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.141 -0.975 . . . . 0.0 110.057 -179.258 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.623 ' OE1' HG21 ' A' ' 155' ' ' VAL . 83.9 tt0 -65.01 -33.15 75.37 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.179 -0.95 . . . . 0.0 109.979 -179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.64 -32.68 71.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.301 -0.874 . . . . 0.0 110.087 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 78.6 mt -64.53 -39.82 86.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.036 -1.04 . . . . 0.0 109.787 179.994 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 38.3 tp -53.49 -42.14 67.0 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.193 -0.942 . . . . 0.0 109.907 -179.2 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -61.5 -33.92 74.61 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.184 -0.947 . . . . 0.0 110.333 -179.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.55 -42.45 70.97 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.144 -0.973 . . . . 0.0 109.941 -178.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.3 mt -61.96 -34.23 75.74 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 120.963 -1.085 . . . . 0.0 109.399 -179.979 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 . . . . . 0 N--CA 1.491 1.587 0 O-C-N 121.443 -0.786 . . . . 99.989999999999995 109.255 -179.564 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.0 mtm . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.528 -0.545 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 50.5 tt0 -60.86 -36.0 78.03 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.158 -0.964 . . . . 0.0 109.316 179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -136.71 160.07 39.94 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.399 -0.813 . . . . 0.0 109.772 -179.833 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 33.4 mm -115.66 121.0 66.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.55 -0.719 . . . . 0.0 109.126 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 19.5 mttt -91.66 127.86 37.27 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.25 -0.906 . . . . 0.0 109.937 -179.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.438 ' SG ' HD11 ' A' ' 53' ' ' LEU . 0.0 OUTLIER -138.74 128.33 24.7 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.45 -0.781 . . . . 0.0 109.123 179.693 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.446 HG21 HG21 ' A' ' 75' ' ' THR . 47.2 t -113.14 137.36 46.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.332 -0.855 . . . . 0.0 109.888 -179.54 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 43.2 t -117.36 134.92 59.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.915 -0.772 . . . . 0.0 108.915 179.561 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.5 p -152.09 146.59 15.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 O-C-N 121.105 -0.997 . . . . 0.0 109.277 179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.15 159.64 23.85 Favored Glycine 0 N--CA 1.493 2.44 0 N-CA-C 109.388 -1.485 . . . . 0.0 109.388 179.776 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' O ' ' C ' ' A' ' 12' ' ' GLY . 24.6 t70 -84.31 110.28 18.46 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.137 -1.213 . . . . 0.0 109.434 -179.791 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.449 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.57 63.38 1.91 Allowed Glycine 0 N--CA 1.489 2.172 0 N-CA-C 109.412 -1.475 . . . . 0.0 109.412 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.535 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -85.09 121.36 27.75 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.215 -1.167 . . . . 0.0 109.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 33.3 m -75.87 -30.08 20.72 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.37 -0.831 . . . . 0.0 109.967 -179.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.09 35.14 5.02 Favored Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.916 -1.274 . . . . 0.0 109.916 -179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.535 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 87.8 tttt -59.95 -38.59 82.9 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.098 -1.237 . . . . 0.0 110.266 179.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.7 p -63.41 -40.51 97.4 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.096 -1.002 . . . . 0.0 110.002 -179.402 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -63.35 -26.69 68.87 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.098 -1.002 . . . . 0.0 110.058 -179.674 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 45.0 tp -63.14 -41.2 99.26 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.182 -0.949 . . . . 0.0 109.825 -179.778 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.428 ' O ' HG23 ' A' ' 24' ' ' THR . 83.1 mt -66.44 -40.56 89.52 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.123 -0.985 . . . . 0.0 110.198 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 37.2 mm -62.16 -42.3 94.63 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.809 -179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.6 t -57.51 -35.82 70.76 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 110.185 -179.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.2 t80 -80.05 -50.27 10.6 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.869 -1.144 . . . . 0.0 109.801 -179.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 20' ' ' LEU . 71.6 p -59.58 -36.94 77.22 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.142 -0.974 . . . . 0.0 110.014 -179.119 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.462 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 56.5 p -120.15 -113.55 0.33 Allowed 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.289 -0.882 . . . . 0.0 109.387 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.462 ' CG ' ' O ' ' A' ' 25' ' ' THR . 11.1 m120 -167.56 12.56 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -98.09 118.82 35.57 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.286 -0.884 . . . . 0.0 110.344 -179.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.687 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -86.4 -38.52 0.54 Allowed Pre-proline 0 N--CA 1.487 1.377 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 178.751 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.687 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 17.7 Cg_exo -63.26 -27.11 71.97 Favored 'Trans proline' 0 C--N 1.312 -1.346 0 C-N-CA 122.371 2.047 . . . . 0.0 111.064 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.499 ' C ' ' O ' ' A' ' 29' ' ' PRO . 21.7 m 34.17 47.73 0.22 Allowed 'General case' 0 N--CA 1.496 1.848 0 CA-C-O 121.221 0.534 . . . . 0.0 110.298 179.568 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.423 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 -41.07 -32.05 0.23 Allowed 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.41 -0.806 . . . . 0.0 110.111 -179.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -121.7 126.0 47.93 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.257 -0.902 . . . . 0.0 109.488 179.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.1 m -99.44 109.27 54.38 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.404 -0.81 . . . . 0.0 110.032 -179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 47.8 Cg_exo -52.47 160.64 3.42 Favored 'Trans proline' 0 N--CA 1.494 1.555 0 C-N-CA 122.241 1.961 . . . . 0.0 112.049 179.302 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -98.19 67.44 1.87 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.341 -0.849 . . . . 0.0 109.341 179.719 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.414 HG22 ' H ' ' A' ' 38' ' ' ASP . 12.3 p -140.94 138.29 34.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.31 -0.869 . . . . 0.0 109.914 179.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 97.8 m-85 -118.03 0.64 11.88 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.475 -0.766 . . . . 0.0 109.326 179.401 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.414 ' H ' HG22 ' A' ' 36' ' ' VAL . 88.3 m-20 -69.2 139.46 54.55 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.289 -0.882 . . . . 0.0 110.432 -179.165 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 80.9 m-20 -62.39 160.82 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.564 -0.71 . . . . 0.0 109.356 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 93.7 m-85 -111.09 136.58 49.93 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 121.372 -0.83 . . . . 0.0 110.33 -179.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 125.75 51.68 Favored 'General case' 0 N--CA 1.492 1.653 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 178.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 46.5 t -128.19 138.64 54.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.366 -0.834 . . . . 0.0 109.693 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 30.4 p -87.94 147.08 25.22 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.075 -1.016 . . . . 0.0 109.066 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 27.5 m -130.55 156.95 42.9 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 121.488 -0.757 . . . . 0.0 110.507 -179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 67.2 mtm -130.17 137.15 49.96 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.711 -0.618 . . . . 0.0 109.549 179.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 26.6 pt -129.82 152.78 37.87 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.665 0 O-C-N 121.334 -0.854 . . . . 0.0 109.096 179.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.434 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.99 18.2 0.05 OUTLIER Glycine 0 N--CA 1.491 2.328 0 N-CA-C 109.369 -1.493 . . . . 0.0 109.369 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 84.83 15.06 68.54 Favored Glycine 0 N--CA 1.491 2.326 0 N-CA-C 110.116 -1.194 . . . . 0.0 110.116 179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.47 ' N ' ' O ' ' A' ' 46' ' ' ILE . 59.0 mt-10 -106.0 146.56 33.15 Favored Pre-proline 0 N--CA 1.493 1.708 0 O-C-N 121.102 -1.234 . . . . 0.0 109.44 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 58.3 Cg_endo -73.74 131.27 15.67 Favored 'Trans proline' 0 N--CA 1.495 1.565 0 C-N-CA 122.539 2.159 . . . . 0.0 112.829 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 20.1 m-85 -143.12 160.13 40.98 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.286 -0.884 . . . . 0.0 109.532 179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 m -117.23 138.79 51.48 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.436 -0.79 . . . . 0.0 109.093 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.438 HD11 ' SG ' ' A' ' 6' ' ' CYS . 41.8 tp -120.13 122.08 40.24 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.339 -0.851 . . . . 0.0 109.579 179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -105.79 124.57 7.91 Favored Glycine 0 N--CA 1.488 2.129 0 N-CA-C 108.996 -1.642 . . . . 0.0 108.996 179.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.3 tp -102.45 122.33 44.11 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.168 -1.195 . . . . 0.0 108.997 179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 46.5 t80 -108.23 129.31 55.2 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.46 -0.775 . . . . 0.0 109.104 -179.784 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.407 ' OD1' ' N ' ' A' ' 58' ' ' THR . 60.0 t0 -116.92 148.05 41.69 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.579 -0.701 . . . . 0.0 109.177 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.407 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.2 p -68.65 159.16 32.61 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.18 -0.95 . . . . 0.0 109.042 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.433 ' O ' ' C ' ' A' ' 60' ' ' GLY . . . -143.07 161.53 37.93 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.237 -0.915 . . . . 0.0 109.187 -179.833 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.49 ' O ' ' O ' ' A' ' 61' ' ' GLN . . . -41.26 -66.28 0.96 Allowed Glycine 0 N--CA 1.492 2.416 0 N-CA-C 109.787 -1.325 . . . . 0.0 109.787 -179.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.49 ' O ' ' O ' ' A' ' 60' ' ' GLY . 46.2 tt0 59.75 131.45 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.337 -1.096 . . . . 0.0 109.266 -179.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -174.56 -87.63 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.421 -0.799 . . . . 0.0 109.819 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.438 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 53.2 p30 -81.05 13.4 2.77 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.272 -0.892 . . . . 0.0 110.77 -178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 73.2 m-85 -74.09 4.15 5.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.835 -1.166 . . . . 0.0 109.071 179.219 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' C ' ' A' ' 66' ' ' ARG . 83.0 m-20 58.33 47.45 13.94 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.728 -0.607 . . . . 0.0 110.34 179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.572 ' CG ' HH11 ' A' ' 66' ' ' ARG . 0.2 OUTLIER 35.1 85.52 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 CA-C-O 121.327 0.584 . . . . 0.0 110.093 179.157 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.568 HD23 HD12 ' A' ' 70' ' ' LEU . 31.1 tp -72.02 123.47 22.87 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.299 -0.876 . . . . 0.0 109.159 -179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.419 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 2.2 mtm180 -74.92 -56.83 1.98 Allowed Pre-proline 0 N--CA 1.492 1.649 0 O-C-N 121.217 -0.927 . . . . 0.0 110.666 -179.406 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.419 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 76.9 Cg_exo -40.14 -27.94 0.26 Allowed 'Trans proline' 0 C--N 1.312 -1.368 0 C-N-CA 122.183 1.922 . . . . 0.0 112.352 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.568 HD12 HD23 ' A' ' 67' ' ' LEU . 61.4 mt -116.4 62.03 0.72 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.316 -0.865 . . . . 0.0 109.313 179.561 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 54.8 m -136.89 144.06 43.31 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.248 -0.908 . . . . 0.0 109.405 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 83.2 m-85 -138.63 76.27 36.01 Favored Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.208 -0.933 . . . . 0.0 109.513 179.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 39.7 Cg_exo -55.85 -34.05 90.29 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 C-N-CA 122.547 2.165 . . . . 0.0 112.165 -179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.9 tt0 -113.84 131.47 56.24 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.508 -0.745 . . . . 0.0 109.465 179.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.446 HG21 HG21 ' A' ' 7' ' ' VAL . 30.7 p -119.26 145.0 46.47 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.4 -0.813 . . . . 0.0 109.477 179.765 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 -68.85 -33.87 74.53 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.392 -0.817 . . . . 0.0 109.934 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 48.2 t -137.65 133.71 45.66 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.65 0 O-C-N 121.278 -0.889 . . . . 0.0 110.278 -179.863 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 47.1 t80 -110.7 121.42 45.27 Favored 'General case' 0 N--CA 1.491 1.584 0 N-CA-C 108.109 -1.071 . . . . 0.0 108.109 178.599 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 53.6 mt -112.81 139.18 48.65 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.236 -0.915 . . . . 0.0 110.351 -179.17 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 40.3 t -122.44 135.18 63.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 179.492 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.497 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 38.8 t -127.77 128.27 45.04 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.403 -0.811 . . . . 0.0 109.549 -179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.1 p90 -140.61 162.91 34.26 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.227 -0.921 . . . . 0.0 109.73 -179.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.556 ' OG ' HG22 ' A' ' 85' ' ' VAL . 37.9 t -92.05 142.85 27.08 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.285 -0.884 . . . . 0.0 109.209 179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.569 ' O ' HG22 ' A' ' 84' ' ' VAL . 2.4 p -100.24 -4.55 9.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 O-C-N 121.209 -0.932 . . . . 0.0 110.109 -179.468 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.571 HG11 HD23 ' A' ' 119' ' ' LEU . 30.6 m -89.79 -16.47 8.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.999 -1.063 . . . . 0.0 109.783 179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 4.5 m -98.51 134.97 21.32 Favored Pre-proline 0 N--CA 1.492 1.633 0 O-C-N 121.238 -0.913 . . . . 0.0 109.71 -179.558 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 65.6 Cg_endo -75.65 -55.68 0.07 OUTLIER 'Trans proline' 0 N--CA 1.493 1.444 0 C-N-CA 122.228 1.952 . . . . 0.0 112.198 179.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 21.3 m -55.13 -34.4 63.71 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.401 -0.812 . . . . 0.0 109.709 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 30.1 m -63.44 -25.16 68.14 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.097 -1.002 . . . . 0.0 109.248 179.448 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.423 ' CE1' HG21 ' A' ' 137' ' ' ILE . 64.9 t80 -70.36 -50.18 41.58 Favored 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.368 -0.832 . . . . 0.0 109.414 179.463 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -67.31 -37.13 82.87 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.39 -0.819 . . . . 0.0 109.89 -179.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.3 m-20 -52.55 -34.36 49.82 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.139 -0.976 . . . . 0.0 109.815 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 71.3 t -63.98 -34.97 71.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.229 -0.92 . . . . 0.0 109.986 -179.744 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 42.4 tttm -91.14 -37.75 13.17 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 120.863 -1.148 . . . . 0.0 110.192 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.4 tt0 -68.0 -35.99 79.24 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.257 -0.902 . . . . 0.0 112.094 -178.392 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 19.0 tttt -113.15 -52.55 2.77 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.976 -1.078 . . . . 0.0 112.528 -178.305 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 52.6 m95 -68.25 -37.02 80.34 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.156 -0.965 . . . . 0.0 113.428 -176.821 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.692 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.0 t -63.28 -51.43 68.85 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.003 -1.685 . . . . 0.0 111.395 -178.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.496 ' O ' HG22 ' A' ' 102' ' ' THR . 59.8 Cg_endo -73.96 -43.4 0.59 Allowed 'Trans proline' 0 N--CA 1.495 1.601 0 C-N-CA 121.828 1.685 . . . . 0.0 113.095 -179.743 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -64.82 -30.24 71.23 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.251 -0.906 . . . . 0.0 111.23 -178.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.692 HG22 ' O ' ' A' ' 98' ' ' VAL . 3.7 tp -61.71 -25.1 36.03 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 120.687 -1.258 . . . . 0.0 109.874 -179.484 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.496 HG22 ' O ' ' A' ' 99' ' ' PRO . 4.8 t -55.59 -36.61 67.09 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.131 -0.981 . . . . 0.0 109.285 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.44 ' N ' ' CG2' ' A' ' 102' ' ' THR . 52.1 m170 -51.62 -32.93 30.98 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.428 -0.795 . . . . 0.0 109.636 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 105' ' ' CYS . 76.7 m80 -93.25 -5.99 48.61 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.239 -0.913 . . . . 0.0 109.58 179.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.49 ' O ' ' O ' ' A' ' 104' ' ' HIS . 0.1 OUTLIER 53.23 168.54 0.04 OUTLIER Pre-proline 0 N--CA 1.491 1.608 0 O-C-N 121.337 -0.852 . . . . 0.0 109.541 179.909 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -79.19 26.11 0.55 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.837 2.358 . . . . 0.0 113.355 -179.48 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 77.1 mttt -56.57 -34.52 67.22 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.947 -1.096 . . . . 0.0 109.829 -179.886 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -115.92 159.61 38.52 Favored Pre-proline 0 N--CA 1.493 1.717 0 O-C-N 121.418 -0.801 . . . . 0.0 109.589 -179.943 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -63.46 147.52 93.23 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.864 2.376 . . . . 0.0 111.959 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.9 t80 -110.63 126.05 54.07 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.338 -0.851 . . . . 0.0 109.158 179.499 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 88.7 mt -116.98 128.16 54.91 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.536 -0.728 . . . . 0.0 109.854 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 28.1 tp -106.34 116.4 31.87 Favored 'General case' 0 N--CA 1.49 1.53 0 N-CA-C 108.323 -0.992 . . . . 0.0 108.323 179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 45.1 t -112.77 136.15 49.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.689 0 O-C-N 121.318 -0.864 . . . . 0.0 110.908 -178.489 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -94.96 119.03 6.01 Favored Glycine 0 N--CA 1.488 2.152 0 N-CA-C 107.853 -2.099 . . . . 0.0 107.853 178.397 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.537 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 52.0 m -118.58 148.11 43.02 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.424 -1.045 . . . . 0.0 110.465 -178.811 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.537 ' CB ' ' O ' ' A' ' 115' ' ' THR . 33.2 tt0 84.48 19.59 0.15 Allowed 'General case' 0 N--CA 1.492 1.658 0 O-C-N 122.067 -0.396 . . . . 0.0 110.47 179.292 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.646 ' O ' ' N ' ' A' ' 119' ' ' LEU . 35.1 pt -62.62 -158.79 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.54 0 N-CA-C 107.381 -1.341 . . . . 0.0 107.381 178.335 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 5.9 t70 63.0 -61.73 0.13 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.808 -1.183 . . . . 0.0 109.226 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.646 ' N ' ' O ' ' A' ' 117' ' ' ILE . 25.1 tp -53.08 -33.9 54.16 Favored 'General case' 0 N--CA 1.486 1.372 0 N-CA-C 108.059 -1.089 . . . . 0.0 108.059 179.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.409 HH12 ' HG3' ' A' ' 139' ' ' PRO . 33.0 ptt180 -54.36 -15.42 1.63 Allowed 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 178.814 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.477 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 92.9 m-20 -108.04 57.69 0.62 Allowed 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 178.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.609 ' OD2' HD12 ' A' ' 119' ' ' LEU . 7.9 m-20 -137.85 107.79 8.3 Favored Pre-proline 0 N--CA 1.488 1.465 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -179.81 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -46.66 -39.83 23.58 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 C-N-CA 121.879 1.719 . . . . 0.0 111.955 -179.571 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 22.4 m -58.73 -41.34 86.21 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.153 -0.967 . . . . 0.0 109.768 -179.802 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 60.0 m -70.67 -48.94 52.22 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 120.993 -1.067 . . . . 0.0 108.126 178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.5 mt -54.76 -36.03 35.29 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 CA-C-O 121.388 0.613 . . . . 0.0 109.479 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -65.93 -47.11 75.8 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.304 -0.872 . . . . 0.0 109.433 179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 46.0 mttt -59.0 -38.8 80.03 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.347 -0.846 . . . . 0.0 109.709 -179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 73.0 mt -75.16 -33.88 61.54 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.205 -0.934 . . . . 0.0 108.98 179.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.94 -41.81 64.85 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.553 -0.717 . . . . 0.0 109.87 -179.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 45.2 mttp -60.16 -37.23 79.53 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.043 -1.036 . . . . 0.0 109.477 179.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 -90.71 4.67 50.86 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.347 -0.846 . . . . 0.0 109.786 -179.9 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 67.7 mttm 51.65 39.3 24.84 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.182 -0.949 . . . . 0.0 109.752 179.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 99.5 mm-40 -98.99 -52.17 3.63 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.142 -0.974 . . . . 0.0 110.027 -179.888 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 2.1 mttp 68.89 146.11 0.11 Allowed Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.406 -0.809 . . . . 0.0 109.144 -179.542 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -67.3 152.24 79.54 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 122.593 2.195 . . . . 0.0 112.765 -179.642 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.423 HG21 ' CE1' ' A' ' 90' ' ' PHE . 27.0 mm -93.5 141.28 15.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 O-C-N 121.331 -0.856 . . . . 0.0 109.046 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -83.53 155.21 65.88 Favored Pre-proline 0 N--CA 1.489 1.507 0 O-C-N 121.093 -1.005 . . . . 0.0 109.591 -179.458 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.409 ' HG3' HH12 ' A' ' 120' ' ' ARG . 18.5 Cg_endo -61.65 -28.08 82.11 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 122.571 2.181 . . . . 0.0 111.791 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -63.92 -38.27 90.47 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.276 -0.89 . . . . 0.0 109.325 179.771 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 45.4 m -65.06 -35.59 81.64 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.251 -0.906 . . . . 0.0 109.175 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -76.33 -34.07 58.99 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.366 -0.834 . . . . 0.0 109.817 179.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -61.2 -34.73 75.56 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.205 -0.934 . . . . 0.0 110.485 -179.225 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.483 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 18.5 mttp -64.45 -35.69 81.73 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.962 -1.086 . . . . 0.0 109.553 179.831 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.2 tp -59.53 -40.29 86.71 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.284 -0.885 . . . . 0.0 109.679 -179.721 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.769 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -67.15 -43.54 82.07 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 121.098 -1.002 . . . . 0.0 109.661 -179.897 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.509 ' HG2' HH11 ' A' ' 147' ' ' ARG . 43.8 mtt-85 -78.7 7.78 6.4 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.244 -0.91 . . . . 0.0 110.498 -179.153 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.483 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 85.1 m-20 -83.31 -27.78 29.53 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.846 -1.159 . . . . 0.0 108.753 178.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 78.3 mt -117.38 -101.41 0.43 Allowed 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.624 -0.672 . . . . 0.0 109.308 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.0 mttp -144.9 44.9 1.36 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.213 -0.929 . . . . 0.0 109.871 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.769 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -61.95 137.4 58.25 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.075 -1.015 . . . . 0.0 109.168 179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 91.3 t -77.82 -58.85 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.105 -0.997 . . . . 0.0 110.354 -179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.6 tptt -156.66 146.54 20.97 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.169 -0.957 . . . . 0.0 109.72 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -122.22 153.73 38.45 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.394 -0.816 . . . . 0.0 109.11 179.732 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 27.1 m -144.54 157.58 14.79 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.171 -0.956 . . . . 0.0 109.904 179.799 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.5 mt-10 -104.35 128.1 52.11 Favored 'General case' 0 N--CA 1.491 1.61 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' HG13 ' A' ' 168' ' ' VAL . 15.2 m -122.02 131.45 54.0 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.333 -0.854 . . . . 0.0 110.713 -178.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.583 ' HB2' HD11 ' A' ' 117' ' ' ILE . 23.9 t -109.99 110.88 21.96 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.357 -0.839 . . . . 0.0 109.207 179.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -66.49 -28.97 68.99 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.871 -0.518 . . . . 0.0 110.08 -179.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.457 HD12 ' CE2' ' A' ' 28' ' ' PHE . 49.8 tp -51.37 -34.39 34.02 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.061 -1.024 . . . . 0.0 108.471 179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.654 ' C ' ' H ' ' A' ' 163' ' ' LYS . 55.6 m -127.95 152.0 48.42 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 179.115 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -58.57 13.53 0.01 OUTLIER 'General case' 0 C--N 1.286 -2.172 0 O-C-N 121.039 -1.038 . . . . 0.0 110.103 179.869 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.654 ' H ' ' C ' ' A' ' 161' ' ' THR . 56.9 tttm -74.59 5.92 4.33 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 120.922 -1.111 . . . . 0.0 109.278 -179.362 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -98.81 -50.86 1.45 Allowed Glycine 0 N--CA 1.488 2.147 0 C-N-CA 119.652 -1.261 . . . . 0.0 110.205 -179.761 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.753 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.5 mp -68.25 -38.47 81.84 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.198 -1.178 . . . . 0.0 109.939 -179.727 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 25.4 mttm -61.73 -29.25 69.99 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.288 -0.883 . . . . 0.0 110.336 -179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.539 ' ND2' ' O ' ' A' ' 163' ' ' LYS . 86.8 m-20 -77.96 -49.71 13.58 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.141 -0.974 . . . . 0.0 110.186 -179.773 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.573 HG13 ' SG ' ' A' ' 157' ' ' CYS . 11.3 m -74.39 -11.19 14.34 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.264 -0.898 . . . . 0.0 110.452 -179.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 68.6 t80 -73.64 -46.46 46.56 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.949 -1.094 . . . . 0.0 110.219 -179.95 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.6 m-20 -58.59 -43.29 89.45 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.206 -0.934 . . . . 0.0 110.299 -179.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -67.06 -33.39 75.41 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.05 -1.031 . . . . 0.0 109.663 -179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.56 -31.06 70.19 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.338 -0.851 . . . . 0.0 110.152 -179.441 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 34.0 mm -64.18 -42.64 96.14 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.658 0 O-C-N 120.93 -1.106 . . . . 0.0 109.916 -179.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 76.3 mt -54.24 -44.86 72.1 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.287 -0.883 . . . . 0.0 109.822 -179.224 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.71 -36.6 84.81 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.055 -1.028 . . . . 0.0 109.715 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.63 -47.44 76.59 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.261 -0.9 . . . . 0.0 109.654 -179.378 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -64.13 -39.22 93.56 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.075 -1.016 . . . . 0.0 109.398 179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.559 0 O-C-N 121.311 -0.868 . . . . 99.989999999999995 109.406 -179.956 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 88.2 mtp . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.7 mt-30 60.08 101.17 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.68 -0.637 . . . . 0.0 109.604 -179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.2 p -124.71 159.0 31.87 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.565 -0.71 . . . . 0.0 109.335 179.773 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 75.2 mt -119.16 119.16 59.95 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.429 -0.794 . . . . 0.0 109.556 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -94.3 132.69 38.62 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.219 -0.926 . . . . 0.0 109.695 -179.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.496 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -135.87 126.6 27.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.365 -0.835 . . . . 0.0 109.465 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.2 t -114.84 136.39 51.68 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.702 0 O-C-N 121.427 -0.796 . . . . 0.0 109.709 -179.723 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.7 t -121.4 138.12 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.457 -0.777 . . . . 0.0 109.049 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 13.5 p -144.54 144.68 22.03 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.162 -0.962 . . . . 0.0 109.295 179.542 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -137.47 155.63 23.1 Favored Glycine 0 N--CA 1.492 2.399 0 N-CA-C 109.629 -1.388 . . . . 0.0 109.629 179.906 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.453 ' O ' ' C ' ' A' ' 12' ' ' GLY . 26.1 t70 -89.55 105.88 18.09 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.22 -1.165 . . . . 0.0 109.43 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.453 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 39.73 68.78 0.5 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 109.733 -1.347 . . . . 0.0 109.733 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.708 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -82.3 131.06 35.23 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.244 -1.151 . . . . 0.0 109.401 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 88.7 t -62.23 -45.73 98.08 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.194 -0.941 . . . . 0.0 109.309 -179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.29 48.94 0.88 Allowed Glycine 0 N--CA 1.491 2.349 0 N-CA-C 109.506 -1.438 . . . . 0.0 109.506 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.708 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 68.1 tttt -59.69 -40.18 87.02 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.083 -1.245 . . . . 0.0 109.726 -179.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.641 HG21 HG21 ' A' ' 33' ' ' VAL . 41.8 m -64.5 -40.56 95.88 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.253 -0.904 . . . . 0.0 109.529 179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 74.4 m -56.84 -29.77 63.15 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.278 -0.889 . . . . 0.0 110.036 -179.616 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.3 tp -60.34 -42.76 96.36 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.014 -1.054 . . . . 0.0 109.22 179.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.7 mp -73.44 -40.1 64.46 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.296 -0.878 . . . . 0.0 109.545 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 39.7 mm -58.89 -48.92 84.85 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.066 -1.021 . . . . 0.0 109.289 179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 20.1 m -56.37 -32.65 64.96 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.292 -0.88 . . . . 0.0 109.859 -179.514 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 61.8 t80 -81.1 -50.63 9.39 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 121.028 -1.045 . . . . 0.0 109.671 -179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 45.2 m -55.93 -44.3 78.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.143 -0.973 . . . . 0.0 109.703 -179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.487 ' O ' ' OD1' ' A' ' 26' ' ' ASN . 82.1 p -118.39 -110.89 0.35 Allowed 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 179.712 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.487 ' OD1' ' O ' ' A' ' 25' ' ' THR . 81.5 m-20 -146.06 12.56 1.25 Allowed 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.075 -1.016 . . . . 0.0 109.882 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.441 ' O ' ' C ' ' A' ' 28' ' ' PHE . 22.7 tttm 77.91 -79.73 0.03 OUTLIER 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.568 -0.707 . . . . 0.0 109.757 -179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.441 ' C ' ' O ' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -37.16 -55.54 1.71 Allowed Pre-proline 0 C--N 1.3 -1.587 0 O-C-N 121.409 -0.807 . . . . 0.0 111.482 -179.168 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.427 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 89.0 Cg_exo -35.43 -53.47 0.78 Allowed 'Trans proline' 0 C--N 1.314 -1.245 0 C-N-CA 121.975 1.783 . . . . 0.0 112.415 -179.571 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 32.7 t -108.72 142.82 38.69 Favored 'General case' 0 N--CA 1.485 1.31 0 O-C-N 121.311 -0.868 . . . . 0.0 108.807 179.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -108.22 -19.93 13.31 Favored 'General case' 0 C--N 1.301 -1.526 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 179.216 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -133.59 161.34 34.9 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.6 -0.688 . . . . 0.0 110.183 -179.264 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.729 HG13 ' O ' ' A' ' 33' ' ' VAL . 7.7 p -123.93 79.83 57.34 Favored Pre-proline 0 N--CA 1.491 1.577 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 88.6 Cg_exo -43.2 -64.05 0.28 Allowed 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.699 2.266 . . . . 0.0 112.442 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -135.94 166.04 24.26 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.152 -0.968 . . . . 0.0 109.213 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 12.1 p -135.57 141.04 43.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.199 -0.938 . . . . 0.0 109.073 179.526 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -88.72 -84.93 0.2 Allowed 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.152 -0.968 . . . . 0.0 109.491 -179.944 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 52.3 p30 -148.83 -170.86 3.73 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.253 -0.904 . . . . 0.0 109.806 -179.798 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.483 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 40.5 p-10 -52.56 151.35 4.3 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.422 -0.799 . . . . 0.0 109.257 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -117.98 146.44 44.01 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.378 -0.826 . . . . 0.0 109.741 -179.654 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -113.39 142.86 45.37 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.331 -0.856 . . . . 0.0 108.961 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 21.2 t -129.68 134.92 62.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.282 -0.886 . . . . 0.0 109.856 -179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.8 m -90.49 131.81 36.03 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.236 -0.915 . . . . 0.0 108.914 179.315 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 46.8 t -123.17 137.59 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 O-C-N 121.413 -0.805 . . . . 0.0 110.044 -179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 95.7 mmm -91.2 137.46 32.35 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.357 -0.84 . . . . 0.0 108.814 179.369 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.435 ' O ' ' N ' ' A' ' 48' ' ' GLY . 78.4 mt -131.41 132.04 62.85 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 121.312 -0.868 . . . . 0.0 109.193 179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . 46.8 19.33 0.5 Allowed Glycine 0 N--CA 1.49 2.29 0 N-CA-C 109.765 -1.334 . . . . 0.0 109.765 179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.34 15.53 62.07 Favored Glycine 0 N--CA 1.491 2.303 0 N-CA-C 109.91 -1.276 . . . . 0.0 109.91 179.758 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.404 ' HB3' ' CE2' ' A' ' 51' ' ' TYR . 4.1 mt-10 -114.83 125.44 29.04 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.397 -1.06 . . . . 0.0 108.869 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -74.14 117.07 4.86 Favored 'Trans proline' 0 N--CA 1.493 1.451 0 C-N-CA 122.038 1.825 . . . . 0.0 113.208 -179.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE2' ' HB3' ' A' ' 49' ' ' GLU . 48.5 m-85 -127.19 139.41 52.96 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.855 -0.795 . . . . 0.0 108.855 178.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 50.8 p -86.9 149.81 24.54 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.016 -1.052 . . . . 0.0 109.783 -179.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 35.9 tp -131.79 133.84 45.17 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.425 -0.797 . . . . 0.0 109.24 179.5 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -122.2 131.11 8.26 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 -179.936 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 72.1 mt -104.84 132.99 50.4 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.322 -1.105 . . . . 0.0 109.048 179.439 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 96.0 m-85 -112.17 133.37 54.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.338 -0.851 . . . . 0.0 109.987 -179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.4 ' OD1' ' N ' ' A' ' 58' ' ' THR . 59.0 t0 -132.21 147.44 52.42 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.624 -0.672 . . . . 0.0 109.461 -179.81 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.4 ' N ' ' OD1' ' A' ' 57' ' ' ASP . 28.0 p -73.05 160.36 32.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.225 -0.922 . . . . 0.0 109.549 -179.854 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -130.73 155.69 46.21 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.369 -0.832 . . . . 0.0 109.648 -179.805 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -86.54 9.12 72.14 Favored Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.724 -1.35 . . . . 0.0 109.724 -179.838 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 88.7 mt-30 -84.46 48.85 1.57 Allowed 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.171 -1.193 . . . . 0.0 109.367 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.19 -33.29 74.26 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.358 -0.839 . . . . 0.0 110.07 -179.728 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 93.8 m-20 -53.41 -30.47 40.29 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.042 -1.036 . . . . 0.0 110.615 -178.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.3 m-85 -92.44 0.38 57.43 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.854 -1.154 . . . . 0.0 109.532 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.1 m-20 45.34 45.17 9.83 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.419 -0.8 . . . . 0.0 109.612 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 54.3 mtp180 -56.53 -32.54 65.2 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.109 -0.994 . . . . 0.0 109.75 -179.885 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 35.2 tp -95.25 124.02 39.07 Favored 'General case' 0 C--N 1.301 -1.523 0 O-C-N 121.3 -0.875 . . . . 0.0 109.585 -179.864 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.611 ' C ' ' H ' ' A' ' 70' ' ' LEU . 5.4 mtt180 -150.86 160.89 31.52 Favored Pre-proline 0 C--N 1.301 -1.54 0 N-CA-C 108.02 -1.104 . . . . 0.0 108.02 179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 7.1 Cg_endo -52.25 10.99 0.02 OUTLIER 'Trans proline' 0 C--N 1.304 -1.779 0 C-N-CA 122.518 2.145 . . . . 0.0 112.534 179.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.611 ' H ' ' C ' ' A' ' 68' ' ' ARG . 83.1 mt -59.34 -38.22 79.83 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 120.949 -1.095 . . . . 0.0 109.915 -179.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 24.7 t -130.13 151.22 50.9 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.283 -0.886 . . . . 0.0 109.963 -179.384 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 38.4 t80 -121.67 84.93 43.56 Favored Pre-proline 0 N--CA 1.491 1.614 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.759 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -48.91 148.15 9.45 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.708 2.272 . . . . 0.0 112.623 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.578 ' O ' ' CB ' ' A' ' 75' ' ' THR . 95.2 mm-40 -79.93 -63.52 1.39 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.46 -0.775 . . . . 0.0 109.473 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.578 ' CB ' ' O ' ' A' ' 74' ' ' GLN . 0.2 OUTLIER 85.62 50.81 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.756 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 -179.572 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -56.88 -33.67 67.11 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.356 -0.84 . . . . 0.0 109.394 179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 39.1 t -131.2 128.8 62.29 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.668 0 O-C-N 121.425 -0.797 . . . . 0.0 109.441 179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -105.61 124.12 49.03 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.201 -0.937 . . . . 0.0 108.767 179.516 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.496 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 55.9 mt -107.82 137.46 45.8 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.31 -0.869 . . . . 0.0 109.961 -179.48 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.536 ' CG1' ' CZ3' ' A' ' 97' ' ' TRP . 20.1 t -124.99 136.78 59.74 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.596 ' HG ' ' HG1' ' A' ' 115' ' ' THR . 45.0 t -130.04 127.34 39.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.344 -0.848 . . . . 0.0 109.843 -179.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 20.4 p90 -136.42 165.37 25.98 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.192 -0.942 . . . . 0.0 108.853 179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 50.5 m -101.83 142.63 32.85 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.118 -0.989 . . . . 0.0 109.223 179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.592 ' O ' HG22 ' A' ' 84' ' ' VAL . 4.1 p -102.84 -1.35 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.347 -0.846 . . . . 0.0 110.055 -179.327 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.6 HG11 HG21 ' A' ' 125' ' ' THR . 78.2 t -85.32 -21.67 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.092 -1.005 . . . . 0.0 109.882 179.763 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 1.6 m -111.96 108.67 55.37 Favored Pre-proline 0 N--CA 1.494 1.738 0 O-C-N 121.464 -0.772 . . . . 0.0 109.771 -179.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 46.9 Cg_exo -51.77 -38.27 66.73 Favored 'Trans proline' 0 N--CA 1.494 1.523 0 C-N-CA 122.022 1.815 . . . . 0.0 112.335 179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 87.6 p -57.62 -35.22 70.17 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.138 -0.976 . . . . 0.0 109.154 -179.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 83.7 p -67.92 -21.85 65.1 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.113 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 18.9 t80 -72.02 -50.45 28.43 Favored 'General case' 0 N--CA 1.488 1.453 0 N-CA-C 108.569 -0.9 . . . . 0.0 108.569 179.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 96.7 mt-10 -66.65 -35.77 80.96 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.366 -0.834 . . . . 0.0 109.259 179.365 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.4 m-20 -50.95 -33.83 26.16 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.284 -0.885 . . . . 0.0 109.297 -179.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.525 HG22 ' CZ3' ' A' ' 97' ' ' TRP . 81.3 t -62.39 -35.31 68.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.353 -0.842 . . . . 0.0 109.453 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 49.0 tttp -89.43 -37.56 14.73 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 120.821 -1.175 . . . . 0.0 110.247 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -67.07 -37.22 83.61 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 120.974 -1.079 . . . . 0.0 112.384 -178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 37.7 tttt -112.91 -52.05 2.8 Favored 'General case' 0 N--CA 1.5 2.069 0 O-C-N 120.762 -1.212 . . . . 0.0 112.699 -178.124 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.616 ' O ' HD13 ' A' ' 101' ' ' ILE . 30.8 m0 -66.86 -39.43 87.55 Favored 'General case' 0 N--CA 1.498 1.948 0 O-C-N 120.994 -1.066 . . . . 0.0 112.593 -176.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.474 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.1 t -61.47 -52.21 71.71 Favored Pre-proline 0 N--CA 1.497 1.892 0 O-C-N 120.143 -1.598 . . . . 0.0 111.05 -178.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.474 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 38.3 Cg_endo -68.98 -43.22 3.48 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 121.568 1.512 . . . . 0.0 112.416 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -52.82 -39.81 62.78 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.284 -0.885 . . . . 0.0 110.5 -178.738 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.616 HD13 ' O ' ' A' ' 97' ' ' TRP . 1.3 mp -66.63 -33.32 62.69 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 120.778 -1.201 . . . . 0.0 109.927 -179.708 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 57.2 m -53.77 -39.02 65.03 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.104 -0.998 . . . . 0.0 109.318 -179.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 85.0 t60 -58.93 -40.7 85.43 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.295 -0.878 . . . . 0.0 109.739 179.884 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 66.5 m80 -99.4 1.12 43.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.137 -0.977 . . . . 0.0 109.715 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.44 ' N ' ' O ' ' A' ' 101' ' ' ILE . 0.1 OUTLIER 59.42 166.32 0.08 OUTLIER Pre-proline 0 N--CA 1.491 1.603 0 O-C-N 121.107 -0.996 . . . . 0.0 109.331 179.892 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -74.7 39.92 0.6 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 C-N-CA 122.723 2.282 . . . . 0.0 112.304 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 40.7 mttp -60.17 -35.37 75.19 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.178 -0.951 . . . . 0.0 110.745 -179.457 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.07 157.74 49.92 Favored Pre-proline 0 N--CA 1.497 1.904 0 O-C-N 121.157 -0.964 . . . . 0.0 110.471 -179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -71.73 144.64 44.5 Favored 'Trans proline' 0 N--CA 1.495 1.596 0 C-N-CA 123.034 2.489 . . . . 0.0 112.696 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 88.8 m-85 -116.75 138.82 51.21 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.575 -0.703 . . . . 0.0 109.497 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.419 HD12 ' O ' ' A' ' 153' ' ' LYS . 45.8 tp -116.71 123.62 47.65 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.586 -0.696 . . . . 0.0 109.788 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 64.3 mt -101.56 116.93 33.85 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 108.407 -0.96 . . . . 0.0 108.407 178.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 48.2 t -111.03 135.64 49.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.304 -0.873 . . . . 0.0 110.672 -178.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.3 114.88 4.2 Favored Glycine 0 N--CA 1.489 2.195 0 N-CA-C 108.41 -1.876 . . . . 0.0 108.41 178.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.642 HG22 ' HG3' ' A' ' 116' ' ' GLN . 20.8 m -102.74 149.22 24.69 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.242 -1.152 . . . . 0.0 110.503 -178.692 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.642 ' HG3' HG22 ' A' ' 115' ' ' THR . 91.5 mt-30 60.68 41.18 15.48 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.931 -0.48 . . . . 0.0 110.637 179.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 20.2 pt -73.65 -6.21 7.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 120.875 -1.141 . . . . 0.0 110.191 179.86 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.487 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 84.5 m-20 -85.71 -24.03 27.13 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.049 -1.032 . . . . 0.0 109.217 179.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.614 HD13 ' HB3' ' A' ' 116' ' ' GLN . 10.2 mp -65.01 -24.98 67.66 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.417 -0.802 . . . . 0.0 109.092 179.37 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.46 ' HE ' HG11 ' A' ' 84' ' ' VAL . 97.0 mtt180 -44.99 -19.03 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.514 -0.741 . . . . 0.0 109.231 179.729 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.516 ' N ' ' O ' ' A' ' 119' ' ' LEU . 60.6 t0 -122.33 48.63 1.71 Allowed 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.52 -0.737 . . . . 0.0 109.032 179.504 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.414 ' OD1' ' C ' ' A' ' 122' ' ' ASP . 56.4 t0 -117.72 90.55 36.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.516 -0.74 . . . . 0.0 109.21 -179.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.9 Cg_exo -48.6 -40.92 37.92 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 122.197 1.931 . . . . 0.0 112.398 -179.615 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 16.5 t -57.87 -43.21 85.87 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.197 -0.939 . . . . 0.0 109.842 -179.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.6 HG21 HG11 ' A' ' 85' ' ' VAL . 45.4 m -70.58 -49.56 46.56 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.045 -1.034 . . . . 0.0 108.232 178.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 96.7 mt -50.0 -36.41 12.02 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.77 -0.581 . . . . 0.0 109.469 179.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -65.15 -43.83 90.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.187 -0.946 . . . . 0.0 108.896 179.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.5 mttm -61.78 -42.54 99.13 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.403 -0.811 . . . . 0.0 109.696 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.553 ' N ' HD22 ' A' ' 129' ' ' LEU . 3.8 mm? -75.39 -33.91 61.05 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.283 -0.885 . . . . 0.0 109.348 179.308 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.88 -39.89 40.98 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.389 -0.819 . . . . 0.0 109.469 -179.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 78.5 tttt -59.83 -35.36 74.57 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.105 -0.997 . . . . 0.0 109.495 179.778 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.38 6.81 21.76 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.2 -0.938 . . . . 0.0 109.719 -179.685 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 1.8 ttmp? 61.55 44.77 8.84 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.311 -0.868 . . . . 0.0 109.645 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 95.1 mt-30 -140.94 139.61 34.32 Favored 'General case' 0 C--N 1.305 -1.356 0 O-C-N 121.229 -0.919 . . . . 0.0 108.882 179.346 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -118.88 161.83 34.22 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 121.636 -0.665 . . . . 0.0 109.534 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -60.03 145.65 97.89 Favored 'Trans proline' 0 C--N 1.304 -1.786 0 C-N-CA 122.867 2.378 . . . . 0.0 112.328 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.555 ' CG2' ' OG1' ' A' ' 141' ' ' THR . 97.1 mt -90.99 144.56 8.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.435 -0.791 . . . . 0.0 109.835 -179.667 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -87.34 155.02 54.52 Favored Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 121.359 -0.838 . . . . 0.0 109.371 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 10.8 Cg_endo -57.54 -32.79 95.23 Favored 'Trans proline' 0 C--N 1.306 -1.673 0 C-N-CA 122.406 2.071 . . . . 0.0 111.601 179.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 97.2 mt-10 -53.35 -36.61 61.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.239 -0.913 . . . . 0.0 109.971 -179.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.555 ' OG1' ' CG2' ' A' ' 137' ' ' ILE . 65.4 p -78.57 -23.76 45.89 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 120.82 -1.175 . . . . 0.0 108.832 179.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.01 -43.88 51.22 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.448 -0.783 . . . . 0.0 109.759 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.3 tt0 -63.68 -35.62 81.16 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.162 -0.962 . . . . 0.0 110.984 -179.08 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 69.0 mttm -65.86 -38.42 88.76 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 120.769 -1.207 . . . . 0.0 109.431 179.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 149' ' ' LEU . 34.2 tp -59.7 -38.53 81.87 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.352 -0.842 . . . . 0.0 109.302 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -66.76 -43.17 84.79 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.171 -0.956 . . . . 0.0 109.494 -179.998 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.648 HH11 ' CG ' ' A' ' 147' ' ' ARG . 0.0 OUTLIER -81.26 6.54 13.82 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.232 -0.918 . . . . 0.0 109.62 -179.735 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 89.7 m-20 -111.46 -34.86 5.98 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.315 -0.866 . . . . 0.0 109.106 179.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.486 HD11 HD11 ' A' ' 145' ' ' LEU . 66.7 mt -92.68 16.9 11.18 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.417 -0.802 . . . . 0.0 110.63 -179.091 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 28.2 mttt 61.2 31.23 19.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.188 -0.945 . . . . 0.0 110.264 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -67.93 145.18 54.81 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.135 -0.978 . . . . 0.0 109.05 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.641 HG12 ' HG3' ' A' ' 153' ' ' LYS . 87.0 t -66.56 -60.64 2.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.077 -1.014 . . . . 0.0 109.952 -179.562 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.641 ' HG3' HG12 ' A' ' 152' ' ' VAL . 68.9 mttm -152.86 157.67 41.06 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.13 -0.981 . . . . 0.0 109.774 179.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.3 p90 -132.15 148.61 52.48 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.224 179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.623 HG21 ' OE1' ' A' ' 171' ' ' GLU . 46.6 t -134.11 140.95 45.1 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.169 -0.957 . . . . 0.0 110.231 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.4 mt-10 -94.86 121.84 36.88 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.422 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -130.69 140.63 50.37 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.159 -0.963 . . . . 0.0 110.761 -178.411 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.538 ' O ' ' O ' ' A' ' 161' ' ' THR . 8.7 t -115.61 115.13 25.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.409 -0.807 . . . . 0.0 109.416 179.618 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -73.9 -35.67 64.69 Favored 'General case' 0 N--CA 1.494 1.774 0 CA-C-O 121.247 0.546 . . . . 0.0 109.86 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 40.8 tp -52.45 -31.0 32.6 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.538 ' O ' ' O ' ' A' ' 158' ' ' SER . 7.4 m -118.03 152.11 36.17 Favored 'General case' 0 C--N 1.302 -1.461 0 N-CA-C 107.672 -1.232 . . . . 0.0 107.672 179.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 38.9 tt0 -66.29 12.61 0.06 Allowed 'General case' 0 C--N 1.285 -2.232 0 O-C-N 121.326 -0.859 . . . . 0.0 109.498 -179.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.531 ' H ' ' C ' ' A' ' 161' ' ' THR . 62.9 mttp -89.18 4.74 47.57 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.857 -1.152 . . . . 0.0 109.903 -179.573 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.422 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -89.08 -51.0 3.1 Favored Glycine 0 N--CA 1.487 2.099 0 C-N-CA 119.489 -1.339 . . . . 0.0 109.952 -179.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 79.6 mt -70.56 -38.62 74.16 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.203 -1.175 . . . . 0.0 110.301 -179.638 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 42.9 mttt -60.24 -29.14 68.57 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.237 -0.914 . . . . 0.0 110.459 -179.433 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.477 ' ND2' ' CG1' ' A' ' 155' ' ' VAL . 38.6 t-20 -75.59 -49.46 18.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.156 -0.965 . . . . 0.0 109.58 179.792 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.544 ' O ' HG12 ' A' ' 168' ' ' VAL . 73.0 t -79.1 -8.08 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 O-C-N 121.407 -0.808 . . . . 0.0 110.726 -179.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.573 ' CE2' HD11 ' A' ' 173' ' ' ILE . 76.1 t80 -74.95 -50.38 16.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 120.771 -1.205 . . . . 0.0 110.331 -179.861 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -60.69 -45.62 93.48 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.157 -0.964 . . . . 0.0 110.272 -179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.623 ' OE1' HG21 ' A' ' 155' ' ' VAL . 85.0 tt0 -67.23 -32.93 74.31 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.139 -0.975 . . . . 0.0 109.798 -179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -61.12 -36.61 80.18 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.13 -0.981 . . . . 0.0 110.002 -179.543 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.573 HD11 ' CE2' ' A' ' 169' ' ' PHE . 75.9 mt -72.89 -42.25 60.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.093 -1.004 . . . . 0.0 109.855 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 34.0 tp -57.5 -44.84 85.29 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.294 -0.879 . . . . 0.0 109.902 -179.341 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -66.09 -33.4 75.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.141 -0.974 . . . . 0.0 109.894 -179.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.44 -34.7 71.11 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.264 -0.898 . . . . 0.0 109.696 -179.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 70.5 mt -59.9 -39.78 86.56 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.139 -0.976 . . . . 0.0 109.071 179.741 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 78.4 mm-40 . . . . . 0 N--CA 1.491 1.615 0 O-C-N 121.489 -0.757 . . . . 99.989999999999995 109.521 179.971 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.9 mtt . . . . . 0 N--CA 1.491 1.576 0 N-CA-C 109.514 -0.551 . . . . 0.0 109.514 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 80.8 mt-30 -63.05 -34.44 77.58 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.214 -0.929 . . . . 0.0 109.33 179.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 45.6 m -124.92 147.42 48.85 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.583 -0.698 . . . . 0.0 109.781 -179.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 71.9 mt -115.25 119.6 62.26 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 179.447 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 59.7 mttp -88.92 128.38 35.68 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.233 -0.917 . . . . 0.0 110.123 -179.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 42.6 t -133.59 124.03 26.15 Favored 'General case' 0 N--CA 1.489 1.486 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 179.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.1 t -114.06 138.26 44.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.639 0 O-C-N 121.389 -0.819 . . . . 0.0 109.935 -179.499 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.571 HG22 HD23 ' A' ' 79' ' ' LEU . 46.2 t -111.32 136.07 48.54 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 N-CA-C 108.717 -0.846 . . . . 0.0 108.717 179.403 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.615 HG11 ' CH2' ' A' ' 97' ' ' TRP . 54.2 t -133.27 136.44 54.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 121.268 -0.895 . . . . 0.0 109.554 -179.93 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -139.1 142.36 12.81 Favored Glycine 0 N--CA 1.489 2.221 0 N-CA-C 109.438 -1.465 . . . . 0.0 109.438 179.701 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.451 ' O ' ' C ' ' A' ' 12' ' ' GLY . 50.7 t0 -84.99 105.06 15.48 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.094 -1.239 . . . . 0.0 109.551 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.451 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . 42.0 66.16 1.09 Allowed Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.271 -1.531 . . . . 0.0 109.271 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.699 ' HB3' ' HB2' ' A' ' 16' ' ' LYS . . . -81.53 130.25 34.98 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.301 -1.117 . . . . 0.0 109.342 -179.875 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 65.6 t -62.48 -45.74 98.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.183 -0.948 . . . . 0.0 109.221 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.22 51.91 0.67 Allowed Glycine 0 N--CA 1.491 2.365 0 N-CA-C 109.237 -1.545 . . . . 0.0 109.237 179.609 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 13' ' ' ALA . 86.3 tttt -61.8 -39.83 93.12 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.093 -1.239 . . . . 0.0 110.057 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.6 p -76.14 -35.55 59.18 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.255 -0.903 . . . . 0.0 109.967 -179.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 68.7 m -64.1 -31.18 72.28 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.167 -0.958 . . . . 0.0 110.445 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.6 tp -67.78 -42.32 81.83 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.102 -0.999 . . . . 0.0 109.711 -179.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 69.4 mt -70.45 -40.88 73.46 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.177 -0.952 . . . . 0.0 109.93 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 91.4 mt -65.9 -36.71 78.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 O-C-N 121.146 -0.971 . . . . 0.0 110.0 -179.915 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 93.6 p -60.44 -30.5 69.69 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.156 -0.965 . . . . 0.0 109.351 -179.625 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.7 t80 -82.65 -50.27 8.93 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.247 -0.908 . . . . 0.0 109.977 179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 62.2 p -66.85 -40.57 87.96 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.163 -0.961 . . . . 0.0 110.469 -179.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.545 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 54.8 m -105.08 -86.71 0.46 Allowed 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.155 -0.965 . . . . 0.0 109.645 -179.625 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.545 ' CB ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER 159.92 -10.23 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.457 -0.777 . . . . 0.0 110.032 179.768 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.4 mttt -83.92 103.92 13.57 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 120.739 -1.226 . . . . 0.0 109.783 -179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.638 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER -65.33 -41.4 51.15 Favored Pre-proline 0 C--N 1.304 -1.378 0 O-C-N 121.431 -0.793 . . . . 0.0 109.173 179.24 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 27.7 Cg_exo -59.48 -33.36 97.21 Favored 'Trans proline' 0 C--N 1.311 -1.444 0 C-N-CA 122.337 2.025 . . . . 0.0 112.068 -179.915 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.669 ' O ' ' N ' ' A' ' 32' ' ' TYR . 0.4 OUTLIER 74.99 42.25 0.27 Allowed 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.104 -0.997 . . . . 0.0 108.595 -179.797 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' O ' ' CB ' ' A' ' 32' ' ' TYR . 96.1 mt-10 -44.84 81.68 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.622 0 CA-C-O 121.125 0.488 . . . . 0.0 110.597 -179.034 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.669 ' N ' ' O ' ' A' ' 30' ' ' SER . 11.7 t80 90.05 71.38 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.084 0 CA-C-O 121.228 0.537 . . . . 0.0 110.403 179.196 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.494 HG12 ' OG ' ' A' ' 30' ' ' SER . 31.7 m -44.55 148.81 0.84 Allowed Pre-proline 0 N--CA 1.493 1.699 0 O-C-N 121.079 -1.013 . . . . 0.0 109.604 179.984 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -72.28 144.3 41.16 Favored 'Trans proline' 0 N--CA 1.496 1.628 0 C-N-CA 122.833 2.355 . . . . 0.0 112.415 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -83.03 1.02 42.12 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.372 -0.83 . . . . 0.0 110.171 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 34.5 m -109.54 142.29 22.47 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.846 0 O-C-N 121.119 -0.988 . . . . 0.0 109.969 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 95.5 m-85 -109.92 16.36 22.0 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.531 -0.731 . . . . 0.0 109.886 -179.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.477 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 59.2 t0 -63.82 129.1 38.72 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.078 -1.014 . . . . 0.0 109.679 -179.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 76.0 m-20 -70.33 151.05 45.68 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.428 -0.795 . . . . 0.0 109.588 -179.824 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.477 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 98.7 m-85 -127.97 152.56 47.76 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.395 -0.816 . . . . 0.0 109.866 179.94 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -104.59 145.48 30.26 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.324 -0.86 . . . . 0.0 109.261 179.742 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 22.7 m -128.45 147.09 33.0 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.447 -0.783 . . . . 0.0 109.842 -179.801 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.578 HG23 HG22 ' A' ' 52' ' ' THR . 58.3 m -120.53 142.53 49.24 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.583 -0.698 . . . . 0.0 109.408 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 m -124.53 158.66 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.509 -0.744 . . . . 0.0 109.818 -179.556 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.7 mtp -112.49 140.65 47.06 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.655 -0.653 . . . . 0.0 109.732 -179.848 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.543 HD12 ' CD1' ' A' ' 51' ' ' TYR . 60.4 mt -122.1 143.78 33.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -46.4 -29.19 3.7 Favored Glycine 0 N--CA 1.491 2.328 0 N-CA-C 108.726 -1.75 . . . . 0.0 108.726 179.997 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.509 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -81.13 -92.16 0.51 Allowed Glycine 0 N--CA 1.488 2.133 0 N-CA-C 109.152 -1.579 . . . . 0.0 109.152 179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -126.74 156.68 73.23 Favored Pre-proline 0 N--CA 1.493 1.724 0 O-C-N 121.403 -1.057 . . . . 0.0 109.846 -179.764 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 59.9 Cg_endo -74.7 138.07 23.32 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 C-N-CA 122.735 2.29 . . . . 0.0 112.24 179.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.543 ' CD1' HD12 ' A' ' 46' ' ' ILE . 89.9 m-85 -131.38 152.17 50.87 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.369 -0.832 . . . . 0.0 109.084 179.416 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.578 HG22 HG23 ' A' ' 43' ' ' THR . 17.8 p -117.8 157.92 25.72 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.407 -0.808 . . . . 0.0 109.673 -179.745 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -161.17 160.3 29.98 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.289 -0.882 . . . . 0.0 109.28 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -142.19 158.28 26.78 Favored Glycine 0 N--CA 1.49 2.279 0 N-CA-C 109.468 -1.453 . . . . 0.0 109.468 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 57.3 mt -106.0 129.11 54.19 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.32 -1.106 . . . . 0.0 109.058 179.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 54.9 t80 -115.99 135.08 54.3 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.46 -0.775 . . . . 0.0 109.558 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.441 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.4 p30 -139.55 167.56 21.81 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.338 -0.851 . . . . 0.0 109.387 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.25 154.11 25.55 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.068 -1.02 . . . . 0.0 109.523 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.768 ' H ' HH12 ' A' ' 66' ' ' ARG . . . -114.49 24.64 11.7 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 109.033 -0.729 . . . . 0.0 109.033 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 90.35 125.72 3.07 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 108.85 -1.7 . . . . 0.0 108.85 -179.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.474 HE22 ' CB ' ' A' ' 66' ' ' ARG . 49.4 tp60 -109.28 112.38 24.5 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.342 -1.093 . . . . 0.0 109.45 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 96.1 mt-10 -143.16 -115.8 0.1 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.115 -0.991 . . . . 0.0 109.443 -179.93 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -87.34 12.17 12.63 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.289 -0.882 . . . . 0.0 110.119 -179.511 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -77.98 -7.22 56.54 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 120.908 -1.12 . . . . 0.0 109.314 179.459 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' OD2' ' NH2' ' A' ' 68' ' ' ARG . 85.8 m-20 45.39 46.64 10.58 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.334 -0.853 . . . . 0.0 109.751 179.365 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.768 HH12 ' H ' ' A' ' 59' ' ' ALA . 58.0 mtp180 -57.31 -23.38 48.26 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.135 -0.978 . . . . 0.0 109.853 -179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 56.2 mt -83.66 7.67 16.77 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.328 -0.857 . . . . 0.0 109.87 -179.484 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.651 ' CG ' HH11 ' A' ' 68' ' ' ARG . 0.0 OUTLIER -46.51 -51.59 35.07 Favored Pre-proline 0 N--CA 1.491 1.619 0 O-C-N 121.124 -0.985 . . . . 0.0 110.797 -179.698 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.443 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 56.6 Cg_endo -74.14 -101.65 0.01 OUTLIER 'Trans proline' 0 N--CA 1.491 1.342 0 C-N-CA 121.822 1.681 . . . . 0.0 112.348 -179.384 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 84.7 mt -131.73 -110.75 0.24 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.058 -1.026 . . . . 0.0 109.611 -179.707 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 72.1 p -160.65 162.61 32.74 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.442 -0.786 . . . . 0.0 109.604 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -130.32 72.94 81.71 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.43 -0.794 . . . . 0.0 109.184 179.551 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -81.22 65.1 8.85 Favored 'Trans proline' 0 C--N 1.305 -1.751 0 C-N-CA 123.038 2.492 . . . . 0.0 112.737 -179.674 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -128.85 124.92 36.55 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.303 -0.873 . . . . 0.0 109.097 179.44 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.44 ' OG1' ' CZ ' ' A' ' 78' ' ' PHE . 1.7 p -152.12 98.44 2.43 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.155 -0.966 . . . . 0.0 109.705 -179.709 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -61.4 -34.03 74.67 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.234 -0.917 . . . . 0.0 109.546 179.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -151.78 143.54 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.316 -0.865 . . . . 0.0 110.316 179.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.489 ' CZ ' ' SG ' ' A' ' 105' ' ' CYS . 74.2 m-85 -104.71 127.3 52.43 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.314 -0.866 . . . . 0.0 109.402 179.114 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.571 HD23 HG22 ' A' ' 8' ' ' VAL . 30.7 tp -111.93 125.53 54.15 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.405 -0.81 . . . . 0.0 108.973 179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 42.2 t -128.27 137.94 56.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.68 0 O-C-N 121.234 -0.916 . . . . 0.0 109.484 -179.839 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -131.71 141.95 49.68 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.295 -0.878 . . . . 0.0 109.541 179.9 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 36.7 p90 -141.3 159.01 43.12 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.208 -0.933 . . . . 0.0 109.575 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 81.0 p -89.18 150.83 22.5 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.156 -0.965 . . . . 0.0 109.378 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.678 ' O ' HG22 ' A' ' 84' ' ' VAL . 6.7 p -98.48 4.43 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.072 -1.017 . . . . 0.0 110.218 -179.64 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 4.0 m -105.97 -2.66 9.89 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.149 -0.97 . . . . 0.0 110.367 -179.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 19.6 m -115.06 92.92 33.0 Favored Pre-proline 0 N--CA 1.495 1.78 0 O-C-N 121.204 -0.935 . . . . 0.0 109.661 -179.383 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_exo -51.03 -50.81 12.73 Favored 'Trans proline' 0 N--CA 1.494 1.508 0 C-N-CA 122.41 2.073 . . . . 0.0 112.695 -179.832 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 86.5 p -54.29 -38.68 66.15 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.052 -1.03 . . . . 0.0 109.371 -179.343 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.642 ' O ' HG23 ' A' ' 93' ' ' VAL . 60.7 p -63.65 -16.01 59.82 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.401 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 27.5 t80 -76.29 -50.78 13.45 Favored 'General case' 0 N--CA 1.49 1.558 0 N-CA-C 108.991 -0.744 . . . . 0.0 108.991 179.629 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -68.48 -39.46 81.35 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.239 -0.913 . . . . 0.0 109.592 179.87 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 82.4 m-20 -53.74 -31.56 48.86 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.244 -0.91 . . . . 0.0 109.092 -179.833 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.642 HG23 ' O ' ' A' ' 89' ' ' SER . 75.8 t -60.38 -35.59 63.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.401 0 O-C-N 121.371 -0.831 . . . . 0.0 109.697 179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 7.8 mtpm? -95.66 -30.06 13.97 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.033 -1.042 . . . . 0.0 110.605 -179.666 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 -69.56 -35.06 75.06 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.71 -1.244 . . . . 0.0 111.903 -178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 86.7 mttt -113.73 -49.69 2.87 Favored 'General case' 0 N--CA 1.499 2.012 0 O-C-N 121.045 -1.034 . . . . 0.0 112.36 -178.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.615 ' CH2' HG11 ' A' ' 9' ' ' VAL . 79.3 m95 -76.31 3.24 11.32 Favored 'General case' 0 N--CA 1.494 1.771 0 N-CA-C 113.719 1.007 . . . . 0.0 113.719 -176.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.553 HG21 HD11 ' A' ' 149' ' ' LEU . 0.9 OUTLIER -107.04 -45.98 0.12 Allowed Pre-proline 0 N--CA 1.503 2.188 0 O-C-N 120.387 -1.446 . . . . 0.0 110.851 179.42 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.491 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 91.5 Cg_endo -86.12 -53.27 0.03 OUTLIER 'Trans proline' 0 C--N 1.312 -1.384 0 C-N-CA 122.545 2.163 . . . . 0.0 112.767 -179.62 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -64.57 -34.37 78.09 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.308 -0.87 . . . . 0.0 109.928 -179.704 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 14.9 tt -58.2 -27.9 33.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.199 -0.938 . . . . 0.0 109.853 -179.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 63.1 p -66.46 -35.02 79.23 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.206 -0.933 . . . . 0.0 109.764 -179.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.8 m80 -56.84 -41.47 77.95 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.118 -0.989 . . . . 0.0 109.689 -179.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 96.6 m-70 -101.28 -8.8 21.81 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.2 -0.938 . . . . 0.0 109.788 -179.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m -147.79 77.54 10.23 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.012 . . . . 0.0 109.626 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -54.74 -44.46 49.41 Favored 'Trans proline' 0 C--N 1.306 -1.703 0 C-N-CA 122.564 2.176 . . . . 0.0 112.062 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 51.3 mttt -150.8 104.1 3.14 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.269 -0.894 . . . . 0.0 109.459 179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.501 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.7 OUTLIER -150.38 155.79 36.8 Favored Pre-proline 0 N--CA 1.491 1.607 0 O-C-N 121.227 -0.92 . . . . 0.0 109.437 179.922 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 29.4 Cg_endo -66.95 127.78 17.54 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.42 2.08 . . . . 0.0 111.857 179.775 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.501 ' CE2' ' O ' ' A' ' 108' ' ' THR . 76.7 m-85 -116.61 137.64 52.03 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.404 -0.81 . . . . 0.0 109.769 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.626 HD12 ' O ' ' A' ' 153' ' ' LYS . 8.2 tp -122.82 119.2 29.85 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.544 -0.723 . . . . 0.0 109.449 179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.793 HD12 ' N ' ' A' ' 112' ' ' LEU . 5.6 mp -107.56 127.08 53.31 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.192 -0.942 . . . . 0.0 108.818 179.279 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 29.6 t -112.04 133.08 58.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.287 -0.883 . . . . 0.0 110.03 -179.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.67 119.82 5.39 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 108.339 -1.904 . . . . 0.0 108.339 178.86 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.9 p -118.25 169.45 9.7 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.385 -1.068 . . . . 0.0 110.937 -178.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.5 ' O ' ' O ' ' A' ' 117' ' ' ILE . 82.3 mt-30 66.08 40.76 3.84 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.279 179.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.5 ' O ' ' O ' ' A' ' 116' ' ' GLN . 15.2 tt -48.97 178.08 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.559 0 O-C-N 120.918 -1.114 . . . . 0.0 108.576 178.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.628 ' O ' ' N ' ' A' ' 121' ' ' ASP . 87.7 m-20 54.26 26.17 6.55 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.819 -1.176 . . . . 0.0 109.91 -179.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.52 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.9 mt 26.88 54.69 0.05 Allowed 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.983 -0.448 . . . . 0.0 111.343 179.067 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.543 ' O ' ' CB ' ' A' ' 121' ' ' ASP . 21.2 mmm180 49.61 26.85 1.91 Allowed 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.834 -1.166 . . . . 0.0 110.189 179.475 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.628 ' N ' ' O ' ' A' ' 118' ' ' ASP . 9.7 t0 79.84 -14.74 0.82 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.919 . . . . 0.0 109.455 -179.858 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.449 ' N ' ' HD3' ' A' ' 123' ' ' PRO . 0.8 OUTLIER 53.97 62.34 9.04 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.314 -0.866 . . . . 0.0 109.756 -179.707 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HD3' ' N ' ' A' ' 122' ' ' ASP . 68.4 Cg_endo -92.68 -100.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.464 0 C-N-CA 123.02 2.48 . . . . 0.0 111.504 179.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 53.3 p -81.17 -2.4 48.4 Favored 'General case' 0 C--N 1.303 -1.432 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 178.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 53.6 m -72.41 -46.36 55.49 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.362 -0.836 . . . . 0.0 108.956 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.419 HD13 HG21 ' A' ' 126' ' ' ILE . 6.9 pt -62.63 -34.92 67.87 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.475 0 O-C-N 121.29 -0.881 . . . . 0.0 109.308 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -69.63 -50.03 48.19 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.23 -0.919 . . . . 0.0 109.584 179.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 83.0 mttt -61.34 -36.67 80.83 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.299 -0.875 . . . . 0.0 110.138 -179.739 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -74.93 -37.77 61.94 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.113 -0.992 . . . . 0.0 108.789 179.194 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.83 -38.49 61.44 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.617 -0.677 . . . . 0.0 109.475 -179.496 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 20.1 tttm -60.23 -36.73 78.39 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.137 -0.977 . . . . 0.0 109.346 179.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 23.3 m120 -85.32 5.7 29.48 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.361 -0.837 . . . . 0.0 109.546 -179.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 54.5 mttt 54.92 44.06 28.92 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.333 -0.855 . . . . 0.0 109.829 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 43.8 tp60 -135.56 91.78 2.76 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.104 -0.997 . . . . 0.0 109.416 179.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -65.85 153.22 91.75 Favored Pre-proline 0 N--CA 1.492 1.639 0 O-C-N 121.327 -0.858 . . . . 0.0 109.819 -179.501 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -62.31 161.77 25.96 Favored 'Trans proline' 0 N--CA 1.496 1.625 0 C-N-CA 122.853 2.369 . . . . 0.0 112.205 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 27.1 mm -92.11 134.09 31.44 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 O-C-N 121.273 -0.892 . . . . 0.0 109.802 -179.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.535 HG23 ' H ' ' A' ' 140' ' ' GLU . 0.4 OUTLIER -98.2 157.87 33.72 Favored Pre-proline 0 N--CA 1.49 1.537 0 O-C-N 121.466 -0.771 . . . . 0.0 109.067 -179.639 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.512 ' HA ' ' HB3' ' A' ' 142' ' ' ALA . 2.1 Cg_endo -47.93 -36.28 26.85 Favored 'Trans proline' 0 C--N 1.31 -1.498 0 C-N-CA 122.906 2.404 . . . . 0.0 113.065 -179.356 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.535 ' H ' HG23 ' A' ' 138' ' ' THR . 84.6 tt0 -46.9 -40.76 14.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.927 -1.108 . . . . 0.0 110.119 -178.276 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 72.1 p -89.25 -18.38 27.15 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.779 -1.201 . . . . 0.0 109.39 179.453 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.512 ' HB3' ' HA ' ' A' ' 139' ' ' PRO . . . -76.3 -49.88 15.8 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.323 -0.861 . . . . 0.0 110.706 -179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -63.35 -34.97 78.87 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.884 -1.135 . . . . 0.0 110.662 -178.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.471 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 87.7 mttt -61.82 -32.92 73.27 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.989 -1.07 . . . . 0.0 109.292 179.796 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 33.2 tp -56.31 -38.96 72.0 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.305 -0.872 . . . . 0.0 109.406 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -72.6 -48.07 42.67 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.18 -0.95 . . . . 0.0 109.786 -179.967 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.2 mtt180 -80.65 -0.63 38.97 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.382 -0.824 . . . . 0.0 109.849 -179.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.471 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 61.5 t0 -111.9 -43.29 3.62 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.368 -0.833 . . . . 0.0 108.814 179.147 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.553 HD11 HG21 ' A' ' 98' ' ' VAL . 9.6 tp -78.71 10.89 2.89 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.636 -0.665 . . . . 0.0 109.675 -179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 32.4 mttt 59.02 30.12 19.86 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.177 -0.952 . . . . 0.0 110.137 -179.867 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -68.4 146.9 52.79 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.184 -0.948 . . . . 0.0 108.758 179.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 74.3 t -59.81 -58.12 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.981 -1.075 . . . . 0.0 109.498 -179.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.626 ' O ' HD12 ' A' ' 111' ' ' LEU . 50.1 tttp -158.51 155.8 29.09 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.228 -0.92 . . . . 0.0 109.868 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 26.3 p90 -134.68 153.46 51.98 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.337 -0.852 . . . . 0.0 109.435 179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.531 HG21 ' OE1' ' A' ' 171' ' ' GLU . 39.3 t -133.04 138.44 51.62 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.341 -0.849 . . . . 0.0 110.062 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.531 ' O ' ' ND2' ' A' ' 167' ' ' ASN . 84.6 tt0 -102.6 132.22 48.83 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 108.157 -1.053 . . . . 0.0 108.157 178.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.428 ' HB3' HD22 ' A' ' 167' ' ' ASN . 8.4 p -167.09 176.74 6.66 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 120.904 -1.123 . . . . 0.0 110.376 -178.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.481 ' HB2' HG22 ' A' ' 117' ' ' ILE . 28.7 t -135.17 127.19 29.69 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.014 -1.054 . . . . 0.0 110.719 -179.189 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -80.09 -26.92 39.36 Favored 'General case' 0 N--CA 1.49 1.555 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 178.836 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 66.1 mt -54.66 -26.33 32.53 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.562 ' C ' ' H ' ' A' ' 163' ' ' LYS . 27.4 m -121.3 160.87 23.05 Favored 'General case' 0 C--N 1.301 -1.515 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 178.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 46.3 tp60 -64.62 11.17 0.05 Allowed 'General case' 0 C--N 1.287 -2.142 0 O-C-N 121.412 -0.805 . . . . 0.0 109.247 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.562 ' H ' ' C ' ' A' ' 161' ' ' THR . 18.5 mttm -89.84 3.0 54.28 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 120.977 -1.077 . . . . 0.0 109.564 -179.735 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.528 ' O ' HG22 ' A' ' 168' ' ' VAL . . . -91.93 -50.23 2.71 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 110.005 -1.238 . . . . 0.0 110.005 -179.628 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.752 ' N ' HD12 ' A' ' 165' ' ' LEU . 6.6 mp -67.02 -44.96 78.95 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.443 -1.034 . . . . 0.0 110.646 -179.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -58.41 -32.56 68.77 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.098 -1.001 . . . . 0.0 110.922 -178.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.531 ' ND2' ' O ' ' A' ' 156' ' ' GLU . 25.6 t-20 -79.84 -50.88 9.87 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.939 -1.101 . . . . 0.0 110.063 -179.45 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.528 HG22 ' O ' ' A' ' 164' ' ' GLY . 15.6 m -75.79 -18.13 15.56 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.251 -0.906 . . . . 0.0 110.911 -178.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 85.6 t80 -75.56 -47.37 27.05 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.82 -1.175 . . . . 0.0 110.452 -179.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -57.97 -43.71 86.64 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.159 -0.963 . . . . 0.0 110.233 -178.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.531 ' OE1' HG21 ' A' ' 155' ' ' VAL . 80.9 tt0 -67.45 -33.99 76.26 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.093 -1.005 . . . . 0.0 109.927 -179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -60.11 -31.53 70.14 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.261 -0.9 . . . . 0.0 110.323 -179.117 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 29.3 mm -67.67 -40.75 84.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.073 -1.017 . . . . 0.0 110.112 -179.78 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.539 ' N ' HD22 ' A' ' 174' ' ' LEU . 3.4 mm? -56.88 -45.59 82.44 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.013 -1.054 . . . . 0.0 110.083 -179.116 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.04 -34.97 77.22 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 120.998 -1.064 . . . . 0.0 110.052 -179.423 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -55.18 -41.98 72.6 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.036 -1.04 . . . . 0.0 109.471 -179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 76.0 mt -64.17 -36.72 84.97 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.07 -1.019 . . . . 0.0 109.511 179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.5 tt0 . . . . . 0 N--CA 1.489 1.507 0 O-C-N 121.261 -0.899 . . . . 99.989999999999995 109.529 -179.736 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 86.2 mtp . . . . . 0 N--CA 1.49 1.565 0 N-CA-C 109.338 -0.615 . . . . 0.0 109.338 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 46.4 tt0 -130.4 116.78 18.74 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.408 -0.808 . . . . 0.0 109.552 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 36.2 m -127.29 135.74 50.98 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.328 -0.857 . . . . 0.0 109.37 179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.438 HD13 ' HA ' ' A' ' 176' ' ' ALA . 68.3 mt -113.07 114.98 48.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 O-C-N 121.366 -0.834 . . . . 0.0 109.112 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 32.2 tttt -91.3 132.43 36.16 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.18 -0.95 . . . . 0.0 110.654 -179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.472 ' SG ' ' CD1' ' A' ' 79' ' ' LEU . 28.7 t -132.6 121.39 23.14 Favored 'General case' 0 N--CA 1.489 1.49 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 179.022 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 30.0 t -108.66 134.02 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.295 -0.878 . . . . 0.0 109.815 -179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.468 HG22 ' HB2' ' A' ' 79' ' ' LEU . 26.1 t -114.61 133.01 62.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.465 0 N-CA-C 108.738 -0.838 . . . . 0.0 108.738 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG21 ' CH2' ' A' ' 97' ' ' TRP . 9.1 p -143.04 142.19 26.11 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 O-C-N 121.079 -1.013 . . . . 0.0 109.582 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.01 -173.32 37.32 Favored Glycine 0 N--CA 1.492 2.403 0 N-CA-C 109.616 -1.394 . . . . 0.0 109.616 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.477 ' O ' ' C ' ' A' ' 12' ' ' GLY . 23.3 t70 -69.76 137.65 52.11 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.257 -1.143 . . . . 0.0 109.106 179.859 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.502 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . -37.16 -47.67 1.43 Allowed Glycine 0 N--CA 1.494 2.502 0 N-CA-C 110.004 -1.239 . . . . 0.0 110.004 -179.194 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.626 ' C ' HG23 ' A' ' 14' ' ' VAL . . . -42.53 167.21 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.145 -1.209 . . . . 0.0 109.658 -179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.626 HG23 ' C ' ' A' ' 13' ' ' ALA . 2.1 t 73.42 110.12 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 N-CA-C 109.111 -0.699 . . . . 0.0 109.111 -179.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -55.27 79.69 0.01 OUTLIER Glycine 0 N--CA 1.49 2.25 0 N-CA-C 110.143 -1.183 . . . . 0.0 110.143 -179.45 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.585 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.5 mttp -58.05 -31.18 66.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.212 -1.169 . . . . 0.0 108.989 179.48 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 25.5 m -67.52 -44.42 78.45 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.399 -0.813 . . . . 0.0 109.016 179.221 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 88.6 m -62.14 -27.7 69.13 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.521 -0.737 . . . . 0.0 109.637 -179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 30.0 tp -65.16 -40.27 94.08 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.172 -0.955 . . . . 0.0 108.506 179.102 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.911 ' O ' HG23 ' A' ' 24' ' ' THR . 59.8 mt -71.37 -44.06 65.7 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.582 -0.699 . . . . 0.0 109.588 179.861 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 32.1 mm -67.91 -48.02 76.83 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.128 -0.982 . . . . 0.0 109.832 -179.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.401 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 29.6 t -60.03 -35.12 74.42 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.173 -0.955 . . . . 0.0 109.812 -179.628 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 79.9 t80 -70.96 -33.17 70.2 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.291 -0.88 . . . . 0.0 109.274 179.379 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.911 HG23 ' O ' ' A' ' 20' ' ' LEU . 60.9 p -72.07 -45.77 59.45 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.555 -0.716 . . . . 0.0 110.879 -179.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.593 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 46.6 p -144.01 -2.53 0.91 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.792 -1.193 . . . . 0.0 111.581 -179.154 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.593 ' CB ' ' O ' ' A' ' 25' ' ' THR . 37.3 t30 90.35 118.78 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 -179.122 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.46 ' O ' ' OG ' ' A' ' 30' ' ' SER . 2.8 tttm 178.63 48.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.864 0 C-N-CA 120.509 -0.477 . . . . 0.0 109.99 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.653 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.3 OUTLIER -61.36 -42.75 86.7 Favored Pre-proline 0 N--CA 1.49 1.538 0 O-C-N 120.513 -1.367 . . . . 0.0 109.525 179.561 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.653 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 22.9 Cg_exo -62.19 1.99 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.908 2.406 . . . . 0.0 112.575 -179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.578 ' O ' ' N ' ' A' ' 32' ' ' TYR . 29.2 m -48.89 -42.12 35.74 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.986 -1.071 . . . . 0.0 109.762 -179.345 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.463 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.9 mt-10 39.38 23.93 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.389 -0.82 . . . . 0.0 109.62 -179.896 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.578 ' N ' ' O ' ' A' ' 30' ' ' SER . 30.3 m-85 -93.76 -102.64 0.14 Allowed 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.349 -0.844 . . . . 0.0 109.786 -179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.793 ' O ' HG12 ' A' ' 33' ' ' VAL . 46.5 t 54.44 63.18 7.6 Favored Pre-proline 0 N--CA 1.493 1.694 0 O-C-N 120.951 -1.093 . . . . 0.0 109.984 -179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.717 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 32.9 Cg_endo -68.67 -26.31 33.3 Favored 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 122.267 1.978 . . . . 0.0 111.235 179.126 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.717 ' HB2' ' O ' ' A' ' 34' ' ' PRO . . . 154.51 83.29 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.717 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 14.4 p -132.69 142.02 43.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.656 0 O-C-N 121.23 -0.919 . . . . 0.0 109.806 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -144.16 59.76 1.35 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.352 -0.842 . . . . 0.0 109.182 179.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -121.15 158.65 27.5 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.483 -0.761 . . . . 0.0 109.296 179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.491 ' OD1' ' O ' ' A' ' 55' ' ' LEU . 64.6 t30 -93.97 139.25 31.15 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.307 -0.87 . . . . 0.0 109.216 179.793 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -114.75 154.14 29.05 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.392 -0.817 . . . . 0.0 109.54 -179.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -114.55 143.62 44.68 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.368 -0.832 . . . . 0.0 109.061 179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 41.2 t -124.57 130.71 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 O-C-N 121.323 -0.861 . . . . 0.0 109.537 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 39.8 m -100.74 128.52 46.76 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.169 -0.957 . . . . 0.0 109.45 -179.983 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 40.7 t -120.01 134.14 64.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 121.486 -0.759 . . . . 0.0 110.198 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.4 ttp -118.25 128.71 54.95 Favored 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 48' ' ' GLY . 27.2 pt -131.8 152.39 36.87 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.225 -0.922 . . . . 0.0 110.162 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.414 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 42.44 16.77 0.03 OUTLIER Glycine 0 N--CA 1.491 2.31 0 N-CA-C 110.195 -1.162 . . . . 0.0 110.195 179.47 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 87.55 15.68 61.46 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 109.778 -1.329 . . . . 0.0 109.778 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.589 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.8 mt-10 -113.32 93.73 27.89 Favored Pre-proline 0 N--CA 1.493 1.693 0 O-C-N 121.438 -1.036 . . . . 0.0 109.523 -179.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.9 Cg_exo -50.91 145.6 23.87 Favored 'Trans proline' 0 N--CA 1.493 1.491 0 C-N-CA 122.479 2.12 . . . . 0.0 112.893 -179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.589 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 60.8 m-85 -150.72 160.79 43.61 Favored 'General case' 0 N--CA 1.491 1.581 0 N-CA-C 109.18 -0.674 . . . . 0.0 109.18 179.162 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 49.3 m -117.7 129.31 55.64 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.301 -0.874 . . . . 0.0 109.24 179.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 53' ' ' LEU . 34.3 tp -117.81 122.7 44.09 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.492 -0.755 . . . . 0.0 109.161 179.715 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -112.79 121.28 5.52 Favored Glycine 0 N--CA 1.491 2.334 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 -179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.491 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 56.7 mt -101.62 128.05 48.07 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.295 -1.121 . . . . 0.0 108.417 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 45.7 t80 -111.64 125.27 53.77 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.339 -0.851 . . . . 0.0 109.83 -179.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 54.4 p30 -102.91 169.54 8.52 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 121.367 -0.833 . . . . 0.0 109.017 179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 44.9 m -57.81 129.51 42.22 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.942 -1.099 . . . . 0.0 109.09 -179.905 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -110.32 -66.1 1.1 Allowed 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.469 -0.769 . . . . 0.0 109.277 -179.819 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 78.01 29.69 53.42 Favored Glycine 0 N--CA 1.49 2.262 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 179.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 91.6 mt-30 -90.09 51.01 1.95 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.156 -1.202 . . . . 0.0 109.139 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' O ' ' OD1' ' A' ' 65' ' ' ASP . 97.0 mt-10 -59.39 -33.47 71.24 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.303 -0.873 . . . . 0.0 109.922 -179.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 94.2 m-20 -45.74 -34.88 3.89 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.021 -1.049 . . . . 0.0 110.517 -179.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -101.22 -6.27 24.45 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 120.846 -1.159 . . . . 0.0 109.556 179.801 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' OD1' ' O ' ' A' ' 62' ' ' GLU . 92.3 m-20 49.07 40.78 18.09 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.351 -0.843 . . . . 0.0 109.898 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 44.3 ttm180 -62.93 -33.77 76.05 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.938 -1.101 . . . . 0.0 110.064 179.848 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 58.4 mt -90.03 7.77 35.96 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.38 -0.825 . . . . 0.0 111.047 -178.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.498 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -48.55 -47.99 68.99 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 120.639 -1.288 . . . . 0.0 110.003 -179.682 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.498 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 73.4 Cg_endo -89.28 -88.83 0.0 OUTLIER 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 122.584 2.19 . . . . 0.0 112.598 -179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.492 HD22 ' O ' ' A' ' 72' ' ' TYR . 0.7 OUTLIER 168.7 96.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.42 -0.8 . . . . 0.0 109.01 -179.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.8 t -62.96 -34.13 76.84 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.178 -0.951 . . . . 0.0 109.423 179.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' O ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -109.91 163.22 17.63 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.448 -0.783 . . . . 0.0 109.336 -179.77 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -66.16 -71.73 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.638 0 C-N-CA 122.597 2.198 . . . . 0.0 112.464 -179.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 93.6 mt-30 -145.14 163.99 32.65 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.081 -1.012 . . . . 0.0 109.038 179.837 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 27.3 p -77.0 160.11 29.4 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.093 -1.004 . . . . 0.0 109.141 179.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 53.1 t0 -121.65 -46.65 2.24 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.27 -0.894 . . . . 0.0 110.22 -179.645 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 8.2 p -151.25 142.5 16.28 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 O-C-N 121.124 -0.985 . . . . 0.0 109.903 179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -109.04 128.56 55.08 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.343 -0.848 . . . . 0.0 109.029 179.277 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.472 ' CD1' ' SG ' ' A' ' 6' ' ' CYS . 50.0 mt -108.96 141.72 40.66 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.279 -0.888 . . . . 0.0 109.925 -179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 44.5 t -124.15 136.51 60.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.453 -0.779 . . . . 0.0 109.284 179.66 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 39.0 t -129.1 126.16 38.75 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.368 -0.833 . . . . 0.0 109.499 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 45.7 p90 -139.74 168.92 18.71 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.271 -0.893 . . . . 0.0 109.607 -179.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.484 ' OG ' ' OE1' ' A' ' 116' ' ' GLN . 24.1 t -97.04 137.22 36.45 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.261 -0.899 . . . . 0.0 109.219 179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.418 ' O ' HG22 ' A' ' 84' ' ' VAL . 10.8 p -85.37 -10.68 11.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.262 -0.899 . . . . 0.0 111.222 -179.085 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.638 HG22 ' OE1' ' A' ' 116' ' ' GLN . 26.6 m -99.78 -0.93 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 120.73 -1.231 . . . . 0.0 110.215 -179.389 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 89' ' ' SER . 12.2 t -101.52 122.4 48.01 Favored Pre-proline 0 N--CA 1.492 1.663 0 O-C-N 121.105 -0.997 . . . . 0.0 109.44 -179.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 73.0 Cg_endo -78.17 -61.9 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.476 0 C-N-CA 122.211 1.94 . . . . 0.0 113.096 -179.68 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 t -52.43 -41.07 62.92 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.927 -1.108 . . . . 0.0 110.117 -178.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.476 ' OG ' ' OG ' ' A' ' 86' ' ' SER . 60.5 p -69.09 -18.68 64.02 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.141 -0.974 . . . . 0.0 109.505 -179.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.462 ' CD1' HD13 ' A' ' 137' ' ' ILE . 61.7 t80 -70.36 -50.5 38.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.281 -0.887 . . . . 0.0 109.457 179.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -74.4 -34.57 63.33 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.291 -0.88 . . . . 0.0 110.13 -179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 46.5 t30 -53.56 -39.01 64.41 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.143 -0.973 . . . . 0.0 109.967 -179.165 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 54.1 t -68.5 -33.47 60.22 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.516 0 O-C-N 121.261 -0.899 . . . . 0.0 110.144 -179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 37.9 ttpt -71.66 -25.69 62.22 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.206 -0.934 . . . . 0.0 111.35 -179.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 22.7 pt-20 -99.12 -9.45 23.8 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.705 -1.247 . . . . 0.0 111.472 -178.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 83.8 tttt -112.04 -51.44 2.85 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.039 -1.038 . . . . 0.0 111.337 -179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.54 ' CH2' HG21 ' A' ' 9' ' ' VAL . 61.6 m95 -92.4 -7.12 48.58 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.185 -0.947 . . . . 0.0 112.432 -177.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.633 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -94.33 -39.98 0.3 Allowed Pre-proline 0 N--CA 1.496 1.84 0 O-C-N 120.318 -1.489 . . . . 0.0 110.44 -179.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.633 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 87.8 Cg_endo -91.94 -49.04 0.02 OUTLIER 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 123.186 2.591 . . . . 0.0 113.517 -179.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 46.9 tp10 -51.6 -39.77 58.6 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.242 -0.911 . . . . 0.0 110.452 -178.502 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.468 HD12 ' HA ' ' A' ' 101' ' ' ILE . 9.2 tp -81.68 -19.85 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.009 -1.057 . . . . 0.0 110.042 -179.794 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.49 ' OG1' ' O ' ' A' ' 98' ' ' VAL . 57.6 m -54.7 -38.33 66.9 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.25 -0.906 . . . . 0.0 110.18 -179.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 79.2 m80 -56.4 -43.77 79.64 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.165 -0.959 . . . . 0.0 110.741 -179.014 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 70.6 m80 -103.4 11.76 36.13 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 120.957 -1.09 . . . . 0.0 111.068 -178.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.481 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 28.0 p -63.57 114.86 14.6 Favored Pre-proline 0 N--CA 1.495 1.81 0 O-C-N 120.854 -1.154 . . . . 0.0 109.468 -179.875 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -83.16 -90.92 0.0 OUTLIER 'Trans proline' 0 N--CA 1.491 1.374 0 C-N-CA 122.238 1.959 . . . . 0.0 112.632 179.862 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.48 ' C ' HG22 ' A' ' 108' ' ' THR . 27.1 mttt -87.81 -80.33 0.27 Allowed 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.303 -0.873 . . . . 0.0 109.308 -179.972 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.495 ' O ' ' OG1' ' A' ' 108' ' ' THR . 0.0 OUTLIER 173.42 58.67 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.605 0 O-C-N 121.349 -0.845 . . . . 0.0 110.226 179.363 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.461 ' HD3' ' N ' ' A' ' 108' ' ' THR . 48.1 Cg_endo -94.06 53.01 0.33 Allowed 'Trans proline' 0 C--N 1.312 -1.375 0 C-N-CA 122.955 2.437 . . . . 0.0 111.899 179.386 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 56.5 m-85 -108.66 128.26 54.69 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.218 -0.926 . . . . 0.0 110.876 -178.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.504 HD12 ' O ' ' A' ' 153' ' ' LYS . 11.1 tp -124.89 116.5 22.32 Favored 'General case' 0 N--CA 1.489 1.481 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 52.8 mt -99.16 125.55 44.74 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.98 -1.075 . . . . 0.0 108.99 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 37.5 t -108.89 134.49 50.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.5 0 O-C-N 121.34 -0.85 . . . . 0.0 110.201 -179.198 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -105.5 127.02 8.83 Favored Glycine 0 N--CA 1.489 2.231 0 N-CA-C 108.531 -1.828 . . . . 0.0 108.531 179.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.544 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 3.3 t -132.05 168.01 18.7 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.274 -1.133 . . . . 0.0 110.214 -178.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.638 ' OE1' HG22 ' A' ' 85' ' ' VAL . 21.9 tt0 84.99 20.68 0.11 Allowed 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 109.765 -0.457 . . . . 0.0 109.765 179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.693 ' O ' ' N ' ' A' ' 119' ' ' LEU . 39.0 pt -59.44 -155.44 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 O-C-N 120.94 -1.1 . . . . 0.0 108.401 179.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 57.99 -58.83 0.03 OUTLIER 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.512 -0.743 . . . . 0.0 110.255 179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.693 ' N ' ' O ' ' A' ' 117' ' ' ILE . 27.9 tp -51.78 -31.79 28.38 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.04 -1.037 . . . . 0.0 108.598 179.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 81.4 mtm180 -49.44 -17.63 0.31 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.477 -0.765 . . . . 0.0 109.482 179.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 58.3 t0 -118.87 62.55 0.78 Allowed 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.429 -0.794 . . . . 0.0 109.006 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 33.3 t0 -131.65 94.29 26.09 Favored Pre-proline 0 N--CA 1.488 1.455 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_exo -47.28 -44.72 23.77 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 122.278 1.985 . . . . 0.0 112.618 -178.985 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.7 p -55.59 -36.05 66.47 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.081 -1.012 . . . . 0.0 110.052 -179.146 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.57 HG21 HD11 ' A' ' 119' ' ' LEU . 69.1 p -78.0 -42.7 31.82 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 120.864 -1.147 . . . . 0.0 108.246 178.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 94.0 mt -54.4 -39.0 42.63 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.486 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 179.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -68.28 -40.06 81.95 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.873 . . . . 0.0 108.695 179.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 22.6 tttt -59.79 -43.17 94.55 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.509 -0.744 . . . . 0.0 109.152 179.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 57.1 mt -76.51 -29.7 56.9 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.326 -0.858 . . . . 0.0 109.264 179.263 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -49.7 -41.41 43.28 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.549 -0.719 . . . . 0.0 109.605 -179.164 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 63.1 tttm -59.21 -36.65 75.76 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.203 -0.935 . . . . 0.0 109.422 179.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 43.8 t30 -84.91 6.47 24.76 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.267 -0.896 . . . . 0.0 109.858 -179.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 89.9 mttt 58.09 43.3 21.04 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.38 -0.825 . . . . 0.0 109.908 179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 98.8 mt-30 -139.89 138.81 35.97 Favored 'General case' 0 C--N 1.304 -1.38 0 O-C-N 121.177 -0.952 . . . . 0.0 109.08 179.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -119.37 154.24 53.98 Favored Pre-proline 0 C--N 1.297 -1.683 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 179.524 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_exo -46.25 147.39 3.9 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.238 1.959 . . . . 0.0 111.819 179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.462 HD13 ' CD1' ' A' ' 90' ' ' PHE . 86.5 mt -75.58 148.98 7.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.241 -0.912 . . . . 0.0 109.443 -179.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -86.96 154.9 55.53 Favored Pre-proline 0 N--CA 1.487 1.408 0 O-C-N 121.264 -0.898 . . . . 0.0 109.193 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -59.8 -36.2 91.87 Favored 'Trans proline' 0 C--N 1.306 -1.705 0 C-N-CA 122.432 2.088 . . . . 0.0 111.777 179.965 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.4 mt-10 -60.98 -36.68 80.08 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.203 -0.936 . . . . 0.0 109.631 -179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.411 HG22 ' CZ ' ' A' ' 90' ' ' PHE . 61.6 m -68.66 -36.75 78.96 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.153 -0.967 . . . . 0.0 108.84 179.229 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.71 -42.31 64.32 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.567 -0.708 . . . . 0.0 110.008 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 98.8 mt-10 -63.38 -32.07 73.4 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.092 -1.005 . . . . 0.0 110.268 -179.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 11.1 tptm -61.12 -36.52 79.93 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.81 -1.182 . . . . 0.0 109.23 179.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 37.1 tp -54.74 -39.88 68.72 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.313 -0.867 . . . . 0.0 109.633 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -68.67 -46.04 70.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.121 -0.987 . . . . 0.0 109.577 179.935 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 58.3 mtp180 -83.71 5.02 26.21 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.246 -0.908 . . . . 0.0 110.143 -179.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -61.43 -36.13 79.48 Favored 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.965 -1.084 . . . . 0.0 109.425 179.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 85.4 mt -126.16 -73.79 0.62 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.518 -0.739 . . . . 0.0 109.46 -179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 46.1 pttt -169.89 55.13 0.04 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.336 -0.852 . . . . 0.0 109.876 -179.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.419 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -71.04 143.52 50.7 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 120.991 -1.068 . . . . 0.0 109.244 179.425 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.645 HG12 ' HG3' ' A' ' 153' ' ' LYS . 99.3 t -67.33 -56.58 12.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.242 -0.911 . . . . 0.0 110.104 -179.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.645 ' HG3' HG12 ' A' ' 152' ' ' VAL . 66.0 mttm -159.3 164.99 34.39 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.173 -0.954 . . . . 0.0 109.912 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 20.2 p90 -131.06 146.93 52.55 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.375 -0.828 . . . . 0.0 108.908 179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 9.7 t -132.26 140.16 48.42 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.234 -0.916 . . . . 0.0 110.147 -179.803 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.8 mt-10 -104.47 129.96 52.43 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 178.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -140.55 150.16 43.32 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.93 -1.106 . . . . 0.0 111.297 -178.165 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.4 ' HB2' HD11 ' A' ' 117' ' ' ILE . 21.5 t -114.56 106.46 14.28 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 179.228 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.442 ' HB1' ' CE1' ' A' ' 28' ' ' PHE . . . -73.8 -34.5 64.65 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.767 -0.583 . . . . 0.0 109.621 -179.962 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 79.2 mt -55.32 -24.19 27.62 Favored 'General case' 0 N--CA 1.488 1.44 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 179.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 15.2 p -123.24 168.74 12.06 Favored 'General case' 0 C--N 1.305 -1.367 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.141 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 89.9 mm-40 -78.17 11.81 2.16 Favored 'General case' 0 C--N 1.288 -2.103 0 O-C-N 121.686 -0.634 . . . . 0.0 109.614 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.484 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 49.3 mttt -90.64 -5.76 55.43 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.035 -1.04 . . . . 0.0 109.85 -179.485 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -87.49 -50.46 3.58 Favored Glycine 0 N--CA 1.487 2.045 0 C-N-CA 119.362 -1.399 . . . . 0.0 110.449 -179.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.686 ' N ' HD12 ' A' ' 165' ' ' LEU . 7.8 mp -65.73 -41.01 92.73 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.14 -1.211 . . . . 0.0 110.275 -179.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 21.2 mttt -59.12 -31.3 68.8 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.156 -0.965 . . . . 0.0 110.796 -179.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.484 ' OD1' ' O ' ' A' ' 163' ' ' LYS . 21.1 m120 -78.33 -50.7 11.31 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 120.926 -1.108 . . . . 0.0 110.102 -179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.557 ' O ' ' HB2' ' A' ' 172' ' ' ALA . 91.8 t -77.27 -12.3 13.95 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.387 -0.82 . . . . 0.0 110.952 -179.277 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.408 ' CE2' HD11 ' A' ' 173' ' ' ILE . 72.5 t80 -80.46 -50.53 9.95 Favored 'General case' 0 N--CA 1.493 1.719 0 O-C-N 120.679 -1.263 . . . . 0.0 110.593 -179.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -61.03 -45.88 92.99 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.078 -1.014 . . . . 0.0 110.526 -178.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -71.5 -33.0 68.86 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.179 -0.951 . . . . 0.0 110.165 -179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.557 ' HB2' ' O ' ' A' ' 168' ' ' VAL . . . -59.59 -33.44 71.46 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.17 -0.956 . . . . 0.0 110.112 -179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.408 HD11 ' CE2' ' A' ' 169' ' ' PHE . 88.5 mt -65.86 -36.28 77.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 121.102 -0.999 . . . . 0.0 110.504 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.575 ' N ' HD22 ' A' ' 174' ' ' LEU . 4.0 mm? -58.22 -44.01 87.98 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 120.92 -1.113 . . . . 0.0 109.597 -179.444 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.6 -33.89 76.61 Favored 'General case' 0 N--CA 1.489 1.486 0 O-C-N 121.032 -1.043 . . . . 0.0 109.156 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.438 ' HA ' HD13 ' A' ' 4' ' ' ILE . . . -57.6 -38.75 75.42 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.222 -0.924 . . . . 0.0 109.512 -179.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 52.7 mt -59.91 -39.73 86.43 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.202 -0.936 . . . . 0.0 108.792 179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.544 0 O-C-N 121.397 -0.814 . . . . 99.989999999999995 109.329 -179.972 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 96.0 mmm . . . . . 0 N--CA 1.492 1.632 0 N-CA-C 109.48 -0.563 . . . . 0.0 109.48 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 97.6 mt-30 -60.87 -31.75 71.21 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.267 -0.896 . . . . 0.0 109.509 179.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 26.5 p -123.3 160.59 26.35 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.598 -0.689 . . . . 0.0 109.779 -179.797 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.498 HG21 ' HA ' ' A' ' 176' ' ' ALA . 33.2 mm -116.64 119.0 60.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.696 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 17.1 mttp -87.03 121.97 30.22 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.037 -1.04 . . . . 0.0 109.786 -179.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 36.2 t -138.13 128.37 25.98 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.343 -0.848 . . . . 0.0 109.441 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 39.5 t -114.93 143.05 25.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.372 -0.83 . . . . 0.0 109.546 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 47.7 t -104.82 133.01 50.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.208 -0.932 . . . . 0.0 109.059 179.586 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.591 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 26.5 t -131.45 136.07 58.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.303 -0.873 . . . . 0.0 109.477 -179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.23 147.65 17.63 Favored Glycine 0 N--CA 1.491 2.343 0 N-CA-C 109.433 -1.467 . . . . 0.0 109.433 179.652 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.561 ' O ' ' N ' ' A' ' 13' ' ' ALA . 25.2 t70 -85.6 111.49 20.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.059 -1.26 . . . . 0.0 109.485 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.577 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 54.42 -85.42 0.01 OUTLIER Glycine 0 N--CA 1.49 2.252 0 N-CA-C 109.355 -1.498 . . . . 0.0 109.355 -179.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.23 123.94 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.285 -1.127 . . . . 0.0 109.567 179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.3 t -61.71 -43.06 96.58 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.223 -0.923 . . . . 0.0 109.526 -179.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -110.59 57.69 0.42 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 109.554 -1.418 . . . . 0.0 109.554 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 24.0 tttp -63.36 -40.72 98.05 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.159 -1.201 . . . . 0.0 109.728 179.729 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.6 p -82.82 -32.64 27.49 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.303 -0.873 . . . . 0.0 110.327 -179.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -65.72 -31.22 72.09 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.101 -1.0 . . . . 0.0 110.617 -179.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 42.9 tp -68.23 -42.41 79.78 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.97 -1.081 . . . . 0.0 109.534 -179.996 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 78.7 mt -65.9 -40.92 91.95 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.347 -0.845 . . . . 0.0 109.961 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 75.9 mt -71.41 -35.24 56.34 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.196 -0.94 . . . . 0.0 110.369 -179.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 89.3 p -50.75 -36.61 37.46 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.042 -1.036 . . . . 0.0 110.459 -178.088 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 70.7 t80 -76.62 -37.64 56.03 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 120.968 -1.083 . . . . 0.0 109.677 179.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 68.8 p -63.64 -37.69 88.31 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.337 -0.852 . . . . 0.0 111.692 -178.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.609 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.7 OUTLIER -162.08 -5.85 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.792 0 O-C-N 120.371 -1.456 . . . . 0.0 111.885 -179.051 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' CB ' ' O ' ' A' ' 25' ' ' THR . 12.7 t30 95.17 115.49 0.02 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 -179.003 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.9 tptt -179.78 58.73 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 179.09 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.617 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -61.85 -42.52 83.14 Favored Pre-proline 0 N--CA 1.49 1.56 0 O-C-N 120.778 -1.202 . . . . 0.0 109.82 179.939 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.617 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.3 Cg_exo -57.75 -31.72 92.9 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.48 2.12 . . . . 0.0 112.201 -179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.48 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.5 p 37.68 37.89 0.14 Allowed 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.568 -0.707 . . . . 0.0 109.768 179.832 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.48 ' C ' ' O ' ' A' ' 30' ' ' SER . 97.1 mt-10 -36.15 -37.43 0.11 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.559 -0.713 . . . . 0.0 110.246 -178.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.433 ' CD2' ' O ' ' A' ' 33' ' ' VAL . 68.6 t80 -125.79 122.05 35.07 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.207 -0.933 . . . . 0.0 108.699 179.268 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.433 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 17.1 m -63.6 148.64 93.78 Favored Pre-proline 0 N--CA 1.491 1.606 0 O-C-N 121.125 -0.984 . . . . 0.0 109.159 -179.666 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 10.0 Cg_endo -56.65 141.34 91.4 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.223 1.949 . . . . 0.0 112.149 -179.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -64.13 -30.95 71.98 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.362 -0.836 . . . . 0.0 109.939 -179.767 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 35.4 m -128.75 155.85 40.9 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.754 0 O-C-N 121.383 -0.823 . . . . 0.0 110.067 -179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 92.3 m-85 -106.32 25.91 10.48 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.52 -0.737 . . . . 0.0 109.098 179.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.419 ' O ' ' CE2' ' A' ' 40' ' ' TYR . 89.1 m-20 -60.77 143.67 54.02 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.324 -0.86 . . . . 0.0 110.378 -179.276 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.588 ' ND2' ' O ' ' A' ' 55' ' ' LEU . 46.3 t-20 -74.12 152.42 39.88 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.554 -0.716 . . . . 0.0 109.563 179.811 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' CE2' ' O ' ' A' ' 38' ' ' ASP . 95.9 m-85 -127.87 146.53 50.59 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.462 -0.774 . . . . 0.0 109.457 179.674 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.43 134.94 49.74 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.283 -0.885 . . . . 0.0 109.687 -179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 18.1 m -132.03 152.13 36.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 121.374 -0.829 . . . . 0.0 109.43 179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 13.1 p -118.31 143.83 46.3 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.378 -0.826 . . . . 0.0 109.609 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 42.9 t -119.45 138.67 49.36 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 121.567 -0.708 . . . . 0.0 109.815 -179.512 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 62.6 mtt -79.11 126.87 31.29 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.288 -0.882 . . . . 0.0 109.171 179.686 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.534 ' O ' ' N ' ' A' ' 48' ' ' GLY . 70.5 mt -131.56 126.2 57.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.265 -0.897 . . . . 0.0 109.196 179.521 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.93 18.98 0.1 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 110.035 -1.226 . . . . 0.0 110.035 179.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.534 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 88.81 12.95 63.36 Favored Glycine 0 N--CA 1.493 2.446 0 N-CA-C 109.684 -1.366 . . . . 0.0 109.684 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.6 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 4.1 mm-40 -123.24 81.87 52.14 Favored Pre-proline 0 N--CA 1.492 1.625 0 O-C-N 121.466 -1.02 . . . . 0.0 109.118 179.922 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -55.3 124.05 15.33 Favored 'Trans proline' 0 C--N 1.306 -1.691 0 C-N-CA 122.677 2.252 . . . . 0.0 112.91 -179.392 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.6 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 96.7 m-85 -115.49 142.68 46.38 Favored 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 179.649 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 60.4 m -75.56 135.09 40.58 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.207 -0.933 . . . . 0.0 109.922 -179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 52.5 tp -123.09 125.06 44.47 Favored 'General case' 0 N--CA 1.491 1.611 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 179.389 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -115.79 132.38 10.21 Favored Glycine 0 N--CA 1.492 2.429 0 N-CA-C 109.581 -1.408 . . . . 0.0 109.581 -179.863 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.588 ' O ' ' ND2' ' A' ' 39' ' ' ASN . 73.1 mt -104.57 135.2 46.42 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.321 -1.105 . . . . 0.0 109.022 179.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -120.11 155.68 32.55 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.255 -0.903 . . . . 0.0 109.752 -179.785 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.451 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.1 p30 -150.24 178.04 9.37 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.447 -0.783 . . . . 0.0 109.386 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.478 ' O ' ' HB2' ' A' ' 59' ' ' ALA . 47.5 m -66.25 138.66 57.81 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.155 -0.966 . . . . 0.0 109.198 179.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.478 ' HB2' ' O ' ' A' ' 58' ' ' THR . . . 176.49 145.02 0.08 Allowed 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.151 -0.968 . . . . 0.0 109.672 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.561 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -87.77 -179.6 47.59 Favored Glycine 0 N--CA 1.491 2.344 0 N-CA-C 109.589 -1.405 . . . . 0.0 109.589 -179.978 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.449 ' O ' ' N ' ' A' ' 63' ' ' ASP . 5.9 tt0 44.6 16.37 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.266 -1.138 . . . . 0.0 109.263 179.961 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 64' ' ' TYR . 84.7 tt0 -44.78 99.4 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.105 -0.997 . . . . 0.0 109.382 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.62 ' O ' ' N ' ' A' ' 65' ' ' ASP . 96.7 m-20 -25.1 88.21 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.98 0 CA-C-O 120.819 0.342 . . . . 0.0 110.169 -179.708 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 62' ' ' GLU . 2.6 m-85 -8.91 72.86 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.286 0 CA-C-O 121.283 0.563 . . . . 0.0 111.872 -179.26 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.62 ' N ' ' O ' ' A' ' 63' ' ' ASP . 94.6 m-20 -94.79 -6.1 43.71 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.315 -0.866 . . . . 0.0 109.443 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 97.6 mtt180 -117.75 74.87 0.96 Allowed 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.481 -0.762 . . . . 0.0 109.655 -179.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 53.8 mt -61.28 -38.18 85.84 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.216 -0.927 . . . . 0.0 109.444 -179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.723 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 2.4 ttp180 -112.46 -43.21 0.08 OUTLIER Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.347 -0.845 . . . . 0.0 109.946 -179.916 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.723 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 24.0 Cg_exo -61.26 -2.4 2.39 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.967 2.444 . . . . 0.0 112.379 -179.683 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 33.9 tp -51.43 -38.53 54.1 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.261 -0.899 . . . . 0.0 109.5 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 32.2 t -109.25 137.28 47.38 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.323 -0.861 . . . . 0.0 109.057 179.628 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 56.3 m-85 52.19 58.75 15.18 Favored Pre-proline 0 N--CA 1.49 1.548 0 O-C-N 121.283 -0.886 . . . . 0.0 108.912 -179.564 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 11.9 Cg_endo -59.11 141.3 97.97 Favored 'Trans proline' 0 C--N 1.309 -1.538 0 C-N-CA 122.662 2.241 . . . . 0.0 112.799 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 96.1 mt-30 -131.04 137.96 49.4 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.609 -0.682 . . . . 0.0 109.258 179.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 46.8 p -124.14 151.31 44.12 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.346 -0.846 . . . . 0.0 109.722 179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 86.0 m-20 -65.6 -35.62 81.34 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.357 -0.839 . . . . 0.0 109.826 179.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.45 HG21 ' HB1' ' A' ' 175' ' ' ALA . 35.9 t -138.54 133.33 42.39 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.236 -0.915 . . . . 0.0 110.104 -179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -102.99 128.59 49.76 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.152 -0.967 . . . . 0.0 108.981 179.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 39.4 tp -113.43 132.04 55.79 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.395 -0.815 . . . . 0.0 109.855 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 41.3 t -117.14 135.4 57.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.591 0 O-C-N 121.569 -0.707 . . . . 0.0 109.225 179.651 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 53.8 t -130.52 126.15 36.11 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.367 -0.833 . . . . 0.0 110.021 -179.72 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 46.4 p90 -143.47 168.41 19.91 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.394 -0.816 . . . . 0.0 108.86 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 42.2 m -108.01 145.93 33.25 Favored 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.24 -0.913 . . . . 0.0 109.472 -179.827 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.641 ' O ' HG22 ' A' ' 84' ' ' VAL . 14.9 p -103.79 13.9 6.98 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.396 -0.815 . . . . 0.0 109.039 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 89.2 t -79.78 -21.54 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.323 -0.861 . . . . 0.0 109.84 179.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -137.43 150.28 68.1 Favored Pre-proline 0 N--CA 1.495 1.792 0 O-C-N 121.257 -0.902 . . . . 0.0 110.061 -179.55 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.95 -33.21 3.84 Favored 'Trans proline' 0 N--CA 1.494 1.534 0 C-N-CA 122.65 2.233 . . . . 0.0 112.737 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 19.7 t -55.67 -44.63 77.45 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.091 -1.005 . . . . 0.0 109.493 -179.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.735 ' O ' HG23 ' A' ' 93' ' ' VAL . 40.9 m -66.36 -24.68 66.54 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.333 -0.855 . . . . 0.0 109.155 179.191 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -73.5 -51.26 17.7 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.458 -0.776 . . . . 0.0 109.524 179.911 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 83.7 tt0 -71.51 -39.95 70.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.316 -0.865 . . . . 0.0 110.091 -179.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.46 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 42.0 t30 -54.32 -35.28 62.51 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.134 -0.979 . . . . 0.0 109.296 -179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.735 HG23 ' O ' ' A' ' 89' ' ' SER . 65.7 t -59.06 -34.54 53.48 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.431 0 O-C-N 121.326 -0.859 . . . . 0.0 109.735 -179.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 16.9 tttp -86.82 -22.84 25.6 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.265 -0.897 . . . . 0.0 110.406 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -75.44 -30.68 60.08 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.905 -1.122 . . . . 0.0 111.89 -178.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.487 ' NZ ' ' OD1' ' A' ' 11' ' ' ASP . 7.6 ttpm? -112.53 -47.38 3.08 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.014 -1.054 . . . . 0.0 112.223 -178.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.591 ' CZ2' ' CG1' ' A' ' 9' ' ' VAL . 77.1 m95 -80.8 1.36 30.84 Favored 'General case' 0 N--CA 1.496 1.842 0 O-C-N 121.093 -1.004 . . . . 0.0 113.35 -176.53 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.607 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -107.76 -41.74 0.13 Allowed Pre-proline 0 N--CA 1.503 2.192 0 O-C-N 120.402 -1.436 . . . . 0.0 110.779 179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.607 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 24.3 Cg_endo -88.71 -53.85 0.02 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 C-N-CA 122.984 2.456 . . . . 0.0 112.691 -179.114 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 78.5 mm-40 -57.03 -37.11 71.27 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.263 -0.898 . . . . 0.0 110.405 -178.806 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 tp -66.12 -29.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 120.847 -1.158 . . . . 0.0 110.027 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 39.9 m -60.03 -45.31 93.22 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.142 -0.974 . . . . 0.0 109.931 -179.44 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 95.5 m-70 -61.16 -35.07 76.13 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.273 -0.892 . . . . 0.0 109.868 179.99 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.737 ' HD1' ' HB2' ' A' ' 105' ' ' CYS . 30.7 t-80 -64.32 -40.91 96.86 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.179 -0.95 . . . . 0.0 109.79 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.737 ' HB2' ' HD1' ' A' ' 104' ' ' HIS . 0.1 OUTLIER 171.88 165.74 0.24 Allowed Pre-proline 0 N--CA 1.494 1.745 0 O-C-N 121.211 -0.931 . . . . 0.0 109.939 -179.978 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.4 ' O ' ' O ' ' A' ' 105' ' ' CYS . 75.8 Cg_exo -43.25 171.78 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.49 0 C-N-CA 122.761 2.307 . . . . 0.0 112.228 179.392 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.3 mttt -68.44 140.86 55.78 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.204 -0.935 . . . . 0.0 110.02 -179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.61 ' O ' ' CD2' ' A' ' 110' ' ' PHE . 0.2 OUTLIER -124.94 160.28 54.97 Favored Pre-proline 0 N--CA 1.492 1.659 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 179.774 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -52.81 122.6 11.29 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 122.178 1.919 . . . . 0.0 111.748 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.61 ' CD2' ' O ' ' A' ' 108' ' ' THR . 76.3 m-85 -122.86 149.59 43.99 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.444 -0.785 . . . . 0.0 110.109 -179.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.437 ' C ' HD22 ' A' ' 112' ' ' LEU . 85.1 mt -112.98 120.01 39.91 Favored 'General case' 0 N--CA 1.489 1.513 0 N-CA-C 108.715 -0.846 . . . . 0.0 108.715 178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.529 ' N ' ' CD2' ' A' ' 112' ' ' LEU . 3.5 mm? -97.06 111.57 23.74 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.067 -1.021 . . . . 0.0 108.762 179.647 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.609 HG13 HG23 ' A' ' 155' ' ' VAL . 47.9 t -108.3 135.4 47.18 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.445 0 O-C-N 121.231 -0.918 . . . . 0.0 110.426 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -100.76 122.84 7.74 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.286 -1.926 . . . . 0.0 108.286 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.504 ' O ' ' CB ' ' A' ' 116' ' ' GLN . 5.7 p -122.14 160.9 24.15 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.385 -1.068 . . . . 0.0 110.477 -178.917 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.6 HE21 HD11 ' A' ' 160' ' ' LEU . 27.8 tp60 79.99 18.29 0.68 Allowed 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.992 -0.443 . . . . 0.0 110.233 179.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.654 ' O ' ' N ' ' A' ' 119' ' ' LEU . 29.0 pt -60.58 -160.07 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 120.723 -1.236 . . . . 0.0 108.149 178.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . . . . . . . . . 17.9 t70 61.06 -62.0 0.08 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.169 -0.957 . . . . 0.0 109.607 -179.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.654 ' N ' ' O ' ' A' ' 117' ' ' ILE . 48.7 tp -55.1 -34.75 63.94 Favored 'General case' 0 N--CA 1.486 1.349 0 O-C-N 121.089 -1.007 . . . . 0.0 108.612 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 16.3 ptm180 -61.8 -19.75 62.87 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.46 -0.775 . . . . 0.0 109.013 179.174 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -90.14 -19.59 24.1 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.513 -0.742 . . . . 0.0 109.692 179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -73.38 141.9 80.88 Favored Pre-proline 0 N--CA 1.489 1.503 0 O-C-N 121.19 -0.944 . . . . 0.0 109.51 -179.626 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.42 -29.94 19.96 Favored 'Trans proline' 0 N--CA 1.493 1.47 0 C-N-CA 122.427 2.085 . . . . 0.0 112.679 179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 21.3 m -58.26 -41.78 85.01 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.188 -0.945 . . . . 0.0 110.417 -178.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 49.3 m -72.11 -47.63 49.86 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 120.982 -1.074 . . . . 0.0 108.188 179.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 90.3 mt -55.09 -36.28 38.43 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.834 -0.541 . . . . 0.0 109.641 179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 84.0 tt0 -64.84 -46.95 79.77 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.275 -0.89 . . . . 0.0 109.198 179.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 79.4 mttt -59.06 -38.12 78.64 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.35 -0.844 . . . . 0.0 109.725 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.489 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 83.5 mt -79.14 -35.9 41.36 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.183 -0.948 . . . . 0.0 109.642 179.566 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -53.45 -41.97 66.67 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.342 -0.849 . . . . 0.0 109.801 -179.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 38.3 mttm -60.9 -36.17 78.56 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.046 -1.034 . . . . 0.0 109.108 179.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 78.9 m-20 -89.1 5.61 43.75 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 121.359 -0.838 . . . . 0.0 109.494 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 46.7 mttp 52.97 32.81 13.38 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.274 -0.891 . . . . 0.0 109.503 179.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.406 ' O ' ' O ' ' A' ' 135' ' ' LYS . 93.5 mt-30 -96.12 -53.06 3.78 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.274 -0.891 . . . . 0.0 109.606 179.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.489 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 10.9 mttm 62.36 144.86 0.07 OUTLIER Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.456 -0.778 . . . . 0.0 109.092 -179.479 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -63.05 150.69 87.91 Favored 'Trans proline' 0 N--CA 1.494 1.54 0 C-N-CA 122.538 2.159 . . . . 0.0 112.58 -179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 91.9 mt -89.07 146.95 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.259 -0.9 . . . . 0.0 109.418 179.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -86.28 157.73 55.93 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.06 -1.025 . . . . 0.0 109.375 -179.882 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -61.93 -28.8 81.36 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.528 2.152 . . . . 0.0 111.89 179.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -61.7 -38.11 86.63 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.282 -0.886 . . . . 0.0 109.343 179.838 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 31.1 m -66.76 -36.16 81.79 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.147 -0.971 . . . . 0.0 109.019 179.5 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.35 -39.98 62.43 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.459 -0.776 . . . . 0.0 109.796 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -60.18 -34.35 73.48 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.222 -0.924 . . . . 0.0 110.521 -179.37 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 37.4 ttmt -64.13 -37.63 88.13 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.013 -1.054 . . . . 0.0 109.922 179.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 40.8 tp -58.19 -40.23 81.02 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.298 -0.876 . . . . 0.0 109.861 -179.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.83 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -87.85 -52.01 5.53 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.077 -1.014 . . . . 0.0 109.844 -179.689 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.464 ' HG2' HH11 ' A' ' 147' ' ' ARG . 29.6 ttt-85 -51.34 -7.91 0.05 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.263 -0.898 . . . . 0.0 110.212 -179.363 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.467 ' N ' ' O ' ' A' ' 146' ' ' ALA . 84.4 m-20 -111.57 -15.82 13.4 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 120.971 -1.081 . . . . 0.0 109.835 179.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 98.2 mt -106.37 29.59 6.71 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.274 -0.891 . . . . 0.0 111.06 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 23.0 mttt 58.5 30.56 19.9 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.9 -1.125 . . . . 0.0 110.88 179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.83 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -71.51 144.95 49.45 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.01 -1.056 . . . . 0.0 108.83 179.201 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 75.3 t -63.45 -52.25 60.35 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.691 0 O-C-N 121.0 -1.063 . . . . 0.0 109.771 -179.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HZ2' ' CG ' ' A' ' 171' ' ' GLU . 47.1 pttt -175.92 -179.22 1.13 Allowed 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.352 -0.843 . . . . 0.0 109.804 179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -137.78 153.99 49.63 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.369 -0.832 . . . . 0.0 109.537 179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.609 HG23 HG13 ' A' ' 113' ' ' VAL . 33.6 m -137.34 148.38 26.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 O-C-N 121.241 -0.912 . . . . 0.0 109.61 179.608 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 94.1 mt-10 -110.22 134.6 52.07 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.254 -0.904 . . . . 0.0 108.861 179.51 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.573 ' SG ' ' CG1' ' A' ' 113' ' ' VAL . 0.1 OUTLIER -141.01 149.75 42.14 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.004 -1.06 . . . . 0.0 110.875 -178.933 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . . . . . . . . . 14.2 t -113.04 109.47 18.88 Favored 'General case' 0 N--CA 1.49 1.575 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.08 -36.45 61.76 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.712 -0.618 . . . . 0.0 109.564 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.6 HD11 HE21 ' A' ' 116' ' ' GLN . 61.0 mt -53.88 -26.95 27.31 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.3 -0.875 . . . . 0.0 108.645 179.886 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 13.0 p -124.05 170.24 10.86 Favored 'General case' 0 C--N 1.304 -1.373 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 91.4 mm-40 -76.32 12.0 1.36 Allowed 'General case' 0 C--N 1.289 -2.038 0 O-C-N 121.689 -0.632 . . . . 0.0 109.396 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 167' ' ' ASN . 89.1 mttt -89.5 0.01 57.18 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.102 -0.999 . . . . 0.0 109.714 -179.113 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -90.85 -51.13 2.71 Favored Glycine 0 N--CA 1.487 2.041 0 C-N-CA 119.359 -1.4 . . . . 0.0 110.298 -179.362 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.697 ' N ' HD12 ' A' ' 165' ' ' LEU . 7.5 mp -68.74 -41.25 79.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.124 -1.221 . . . . 0.0 110.246 -179.502 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 85.6 mttt -59.55 -35.61 74.55 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.127 -0.983 . . . . 0.0 110.477 -179.364 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.499 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 19.4 m120 -76.89 -49.39 15.77 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.015 -1.053 . . . . 0.0 109.532 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.535 ' O ' HG12 ' A' ' 168' ' ' VAL . 74.8 t -68.4 -9.34 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.776 . . . . 0.0 110.536 -179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.813 ' CE2' HD11 ' A' ' 173' ' ' ILE . 72.1 t80 -74.35 -46.21 42.16 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.805 -1.184 . . . . 0.0 110.58 -179.698 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 85.2 m-20 -61.58 -49.31 77.14 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.993 -1.067 . . . . 0.0 111.367 -178.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.499 ' OE1' ' O ' ' A' ' 167' ' ' ASN . 60.3 mp0 -70.72 -35.67 72.83 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 120.846 -1.159 . . . . 0.0 110.373 -179.386 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -58.71 -39.34 80.52 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.157 -0.965 . . . . 0.0 110.121 -179.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.813 HD11 ' CE2' ' A' ' 169' ' ' PHE . 97.8 mt -63.47 -38.68 82.84 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.029 -1.045 . . . . 0.0 109.915 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 30.0 tp -56.37 -43.64 79.39 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.138 -0.976 . . . . 0.0 109.767 -179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.45 ' HB1' HG21 ' A' ' 77' ' ' VAL . . . -63.51 -36.22 83.04 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.084 -1.01 . . . . 0.0 109.913 -179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.498 ' HA ' HG21 ' A' ' 4' ' ' ILE . . . -52.76 -37.75 59.92 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.213 -0.93 . . . . 0.0 109.585 -179.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 75.0 mt -62.13 -36.55 82.13 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.141 -0.974 . . . . 0.0 108.997 179.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 . . . . . 0 N--CA 1.49 1.541 0 O-C-N 121.453 -0.779 . . . . 99.989999999999995 109.446 -179.989 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 51.7 ttm . . . . . 0 N--CA 1.49 1.568 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 91.3 mt-30 -122.24 117.47 26.24 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.362 -0.836 . . . . 0.0 109.559 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -143.08 154.91 44.43 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.108 -0.995 . . . . 0.0 109.767 179.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.54 HD13 ' HB1' ' A' ' 176' ' ' ALA . 61.3 mt -122.45 122.17 65.52 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.497 -0.752 . . . . 0.0 109.127 179.516 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -87.0 131.91 33.94 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.213 -0.929 . . . . 0.0 109.74 -179.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -148.23 126.51 12.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.292 -0.88 . . . . 0.0 109.159 179.696 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.5 t -106.35 137.54 36.23 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.666 0 O-C-N 121.235 -0.916 . . . . 0.0 110.155 -179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.425 HG22 HD22 ' A' ' 79' ' ' LEU . 59.9 t -116.8 130.55 71.49 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 O-C-N 121.546 -0.721 . . . . 0.0 109.16 179.582 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 34.6 m -138.51 156.81 30.0 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.52 0 O-C-N 121.199 -0.938 . . . . 0.0 109.202 179.435 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -152.45 167.6 31.42 Favored Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.849 -1.301 . . . . 0.0 109.849 179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.577 ' CG ' HD22 ' A' ' 92' ' ' ASN . 61.1 t0 -86.0 121.82 29.16 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.365 -1.079 . . . . 0.0 109.451 179.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.695 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 71.05 -107.7 2.25 Favored Glycine 0 N--CA 1.49 2.24 0 N-CA-C 109.362 -1.495 . . . . 0.0 109.362 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.695 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 164.76 42.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.33 -1.1 . . . . 0.0 109.377 179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.953 HG13 ' H ' ' A' ' 15' ' ' GLY . 1.7 p -72.17 -85.05 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.061 -1.025 . . . . 0.0 109.63 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.953 ' H ' HG13 ' A' ' 14' ' ' VAL . . . -99.2 16.12 59.57 Favored Glycine 0 N--CA 1.491 2.301 0 N-CA-C 109.399 -1.481 . . . . 0.0 109.399 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 65.2 tttm -59.76 -38.19 81.09 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.297 -1.12 . . . . 0.0 110.087 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.5 p -74.29 -35.5 63.73 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.17 -0.957 . . . . 0.0 109.994 -179.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.647 ' SG ' ' NZ ' ' A' ' 27' ' ' LYS . 89.4 m -59.82 -30.76 69.15 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.095 -1.003 . . . . 0.0 110.824 -179.177 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 34.0 tp -67.7 -42.44 81.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.902 -1.124 . . . . 0.0 110.268 -179.325 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 89.9 mt -73.09 -43.77 61.34 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.106 -0.996 . . . . 0.0 111.059 -179.06 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 22' ' ' SER . 9.9 tp -65.85 -38.81 83.04 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 120.937 -1.102 . . . . 0.0 110.184 -178.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.449 ' N ' ' CG2' ' A' ' 21' ' ' ILE . 25.7 m -54.69 -34.62 62.6 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.027 -1.046 . . . . 0.0 110.307 -179.184 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.689 ' CD1' ' CZ ' ' A' ' 169' ' ' PHE . 82.3 t80 -70.13 -38.05 75.46 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.022 -1.049 . . . . 0.0 109.525 179.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.566 ' C ' HG22 ' A' ' 25' ' ' THR . 28.5 m -52.61 -37.2 57.86 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.418 -0.801 . . . . 0.0 109.932 -179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.606 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 179.75 9.46 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.53 0 O-C-N 120.878 -1.139 . . . . 0.0 110.584 -179.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.658 ' ND2' ' NE2' ' A' ' 162' ' ' GLN . 25.2 t-20 96.1 122.88 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.753 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -179.218 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.647 ' NZ ' ' SG ' ' A' ' 18' ' ' CYS . 53.7 tttt -64.53 -41.0 96.63 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 121.205 0.526 . . . . 0.0 111.023 -179.379 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.411 ' C ' ' O ' ' A' ' 27' ' ' LYS . 1.5 m-85 -42.94 -61.41 1.75 Allowed Pre-proline 0 N--CA 1.494 1.76 0 O-C-N 121.149 -0.97 . . . . 0.0 110.728 -178.392 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.409 ' CD ' ' CB ' ' A' ' 28' ' ' PHE . 54.4 Cg_endo -70.53 23.87 0.2 Allowed 'Trans proline' 0 N--CA 1.495 1.611 0 C-N-CA 122.463 2.109 . . . . 0.0 112.632 179.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.605 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 68.8 m -137.76 -62.0 0.61 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.116 -0.99 . . . . 0.0 109.546 179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 48.23 11.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.028 -1.045 . . . . 0.0 109.964 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.605 ' CD2' ' O ' ' A' ' 30' ' ' SER . 78.4 m-85 -91.59 -101.9 0.11 Allowed 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.945 -1.097 . . . . 0.0 109.709 -179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.796 HG22 ' O ' ' A' ' 33' ' ' VAL . 3.5 p 34.15 60.04 2.03 Favored Pre-proline 0 N--CA 1.495 1.79 0 O-C-N 121.653 -0.655 . . . . 0.0 110.982 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.411 ' HD3' ' N ' ' A' ' 33' ' ' VAL . 69.7 Cg_endo -84.23 -73.15 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 C-N-CA 122.392 2.061 . . . . 0.0 111.863 179.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.453 ' O ' ' CE2' ' A' ' 37' ' ' PHE . . . -65.35 156.46 32.07 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.31 -0.869 . . . . 0.0 109.648 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 6.6 p -74.02 140.59 17.41 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 O-C-N 121.305 -0.872 . . . . 0.0 109.344 179.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.453 ' CE2' ' O ' ' A' ' 35' ' ' ALA . 98.2 m-85 -118.13 159.2 23.68 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.531 -0.731 . . . . 0.0 109.646 -179.706 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.429 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.0 p30 -72.91 -167.21 0.36 Allowed 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.352 -0.842 . . . . 0.0 109.97 -179.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 73.6 m-20 -57.35 157.08 6.87 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.409 -0.807 . . . . 0.0 109.449 -179.761 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 73.5 m-85 -110.33 130.89 55.46 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.386 -0.821 . . . . 0.0 109.638 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -106.06 121.61 44.49 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.276 -0.89 . . . . 0.0 109.36 179.673 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.491 HG11 ' HE2' ' A' ' 23' ' ' TYR . 48.4 t -127.57 134.9 64.61 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.575 0 O-C-N 121.493 -0.754 . . . . 0.0 109.369 179.778 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 45.0 m -98.55 138.79 35.24 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.273 -0.892 . . . . 0.0 109.316 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 43.3 t -119.26 134.57 62.45 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 121.453 -0.78 . . . . 0.0 109.514 180.0 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 87.0 mtp -107.29 141.78 38.1 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.395 -0.816 . . . . 0.0 109.568 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.656 HG22 ' H ' ' A' ' 48' ' ' GLY . 73.7 mt -124.68 139.86 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 N-CA-C 108.882 -0.785 . . . . 0.0 108.882 179.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.415 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.51 -24.02 0.59 Allowed Glycine 0 N--CA 1.489 2.192 0 N-CA-C 108.605 -1.798 . . . . 0.0 108.605 179.793 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.656 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -82.89 -93.59 0.59 Allowed Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.462 -1.455 . . . . 0.0 109.462 179.611 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.533 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 13.6 mm-40 -123.11 152.44 63.46 Favored Pre-proline 0 N--CA 1.495 1.809 0 O-C-N 121.424 -1.045 . . . . 0.0 109.973 -179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 51.4 Cg_endo -72.29 141.4 35.5 Favored 'Trans proline' 0 N--CA 1.494 1.553 0 C-N-CA 122.647 2.231 . . . . 0.0 112.224 179.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.533 ' CE2' ' O ' ' A' ' 49' ' ' GLU . 98.9 m-85 -137.81 159.43 42.0 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.229 -0.919 . . . . 0.0 109.739 179.822 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 41.2 m -112.01 142.86 43.91 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.377 -0.827 . . . . 0.0 109.116 179.668 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -120.86 123.17 41.91 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.422 -0.799 . . . . 0.0 109.691 179.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -116.03 129.71 8.65 Favored Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.222 -1.551 . . . . 0.0 109.222 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.1 mt -107.74 136.59 47.22 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.306 -1.114 . . . . 0.0 109.393 179.783 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.1 m-85 -118.86 146.26 45.03 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.429 -0.794 . . . . 0.0 109.765 -179.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.455 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 52.6 p30 -156.79 164.81 37.68 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.422 -0.798 . . . . 0.0 109.595 179.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 80.4 p -67.49 137.08 55.53 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.153 -0.967 . . . . 0.0 109.261 179.803 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -99.93 134.35 42.98 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 0.0 109.851 -179.546 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -60.09 -29.99 69.45 Favored Glycine 0 N--CA 1.489 2.229 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 179.854 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -76.2 48.73 0.53 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.218 -1.166 . . . . 0.0 109.529 -179.778 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -56.84 -29.79 63.17 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.241 -0.912 . . . . 0.0 109.597 -179.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -62.37 -23.44 66.8 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.353 -0.842 . . . . 0.0 111.04 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . . . . . . . . . 97.0 m-85 -110.4 9.12 23.47 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 120.916 -1.115 . . . . 0.0 110.966 -179.031 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' O ' ' C ' ' A' ' 66' ' ' ARG . 85.3 m-20 -51.87 -42.4 62.62 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 120.91 -1.119 . . . . 0.0 109.471 -179.726 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' C ' ' O ' ' A' ' 65' ' ' ASP . 25.7 ttt-85 25.98 58.63 0.06 Allowed 'General case' 0 N--CA 1.5 2.058 0 CA-C-O 121.17 0.51 . . . . 0.0 110.748 179.66 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 91.7 mt -93.44 134.41 35.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.058 -1.026 . . . . 0.0 109.838 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.736 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 4.5 ttt180 -126.76 -45.64 0.03 OUTLIER Pre-proline 0 N--CA 1.491 1.58 0 O-C-N 121.56 -0.713 . . . . 0.0 109.738 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.736 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 11.4 Cg_exo -69.02 -16.0 40.32 Favored 'Trans proline' 0 N--CA 1.492 1.436 0 C-N-CA 122.478 2.119 . . . . 0.0 111.811 179.855 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 56.6 mt -106.46 70.28 0.82 Allowed 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 179.724 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 86.0 p -71.71 -28.15 63.5 Favored 'General case' 0 C--N 1.3 -1.552 0 O-C-N 121.495 -0.753 . . . . 0.0 109.153 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.573 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 7.6 t80 -147.41 86.75 6.26 Favored Pre-proline 0 N--CA 1.49 1.57 0 O-C-N 121.401 -0.812 . . . . 0.0 109.776 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -51.56 146.63 25.63 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 122.526 2.151 . . . . 0.0 112.001 179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 92.9 mt-30 -108.08 151.72 25.49 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.202 -0.936 . . . . 0.0 109.762 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.511 HG21 ' CE2' ' A' ' 78' ' ' PHE . 58.7 m -141.62 126.82 18.54 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.382 -0.824 . . . . 0.0 109.826 179.603 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 90.1 m-20 -102.74 -25.26 13.6 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.212 -0.93 . . . . 0.0 109.014 179.277 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 47.1 t -137.49 131.72 44.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.444 -0.785 . . . . 0.0 109.414 179.457 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.644 ' CD2' HD11 ' A' ' 101' ' ' ILE . 95.5 m-85 -105.71 127.75 53.27 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.198 -0.939 . . . . 0.0 109.237 179.825 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.425 HD22 HG22 ' A' ' 8' ' ' VAL . 7.2 tt -118.24 129.89 55.74 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.428 -0.795 . . . . 0.0 110.246 -179.64 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.495 HG22 ' O ' ' A' ' 111' ' ' LEU . 25.3 m -129.47 148.88 33.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -140.85 140.92 34.69 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.216 -0.927 . . . . 0.0 109.87 -179.719 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.418 ' CE1' HD11 ' A' ' 112' ' ' LEU . 15.8 p90 -154.98 157.33 37.5 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.305 -0.872 . . . . 0.0 109.315 179.318 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 63.5 p -83.37 157.03 22.69 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.189 -0.944 . . . . 0.0 109.441 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.7 ' O ' HG22 ' A' ' 84' ' ' VAL . 7.1 p -100.56 6.57 9.64 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.168 -0.958 . . . . 0.0 110.177 -179.713 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.774 HG11 HD23 ' A' ' 119' ' ' LEU . 14.9 m -104.13 0.44 10.24 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 121.202 -0.936 . . . . 0.0 110.333 -179.507 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -114.51 95.85 41.43 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.209 -0.932 . . . . 0.0 109.843 -179.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -51.56 -48.87 19.22 Favored 'Trans proline' 0 N--CA 1.491 1.377 0 C-N-CA 122.298 1.999 . . . . 0.0 112.284 179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.6 m -53.49 -40.47 65.37 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.027 -1.046 . . . . 0.0 109.141 -179.649 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 81.6 p -67.36 -19.75 65.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.343 -0.848 . . . . 0.0 109.084 179.538 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.4 t80 -68.66 -50.92 47.39 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.317 -0.865 . . . . 0.0 108.742 179.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -68.92 -34.63 75.69 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.474 -0.766 . . . . 0.0 109.395 179.483 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.577 HD22 ' CG ' ' A' ' 11' ' ' ASP . 48.3 t30 -54.25 -34.41 60.68 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.285 -0.885 . . . . 0.0 109.746 -179.704 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 84.5 t -62.55 -37.71 79.57 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 121.161 -0.962 . . . . 0.0 110.153 -179.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -91.94 -44.41 8.91 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.089 -1.007 . . . . 0.0 110.738 -179.387 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 97.4 mt-10 -62.2 -36.71 82.76 Favored 'General case' 0 C--N 1.297 -1.707 0 O-C-N 121.137 -0.977 . . . . 0.0 112.199 -177.915 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 76.6 tttt -114.53 -52.31 2.72 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 120.952 -1.093 . . . . 0.0 112.901 -178.639 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 77.3 m95 -68.6 -38.48 80.66 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.075 -1.016 . . . . 0.0 113.487 -176.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.51 ' O ' HG22 ' A' ' 101' ' ' ILE . 2.1 t -57.48 -52.01 77.46 Favored Pre-proline 0 N--CA 1.497 1.883 0 O-C-N 120.134 -1.604 . . . . 0.0 111.084 -178.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -70.94 -37.79 5.97 Favored 'Trans proline' 0 N--CA 1.494 1.531 0 C-N-CA 121.717 1.611 . . . . 0.0 112.787 179.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -58.97 -40.79 85.86 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.185 -0.947 . . . . 0.0 110.977 -178.693 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.644 HD11 ' CD2' ' A' ' 78' ' ' PHE . 9.1 tp -65.01 -28.69 45.37 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 120.755 -1.215 . . . . 0.0 109.538 -179.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 43.5 m -61.64 -40.84 96.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.247 -0.908 . . . . 0.0 109.939 -179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 75.0 m80 -54.52 -40.65 68.81 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.147 -0.971 . . . . 0.0 109.68 -179.611 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.521 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 64.8 m170 -57.39 -40.33 77.97 Favored 'General case' 0 N--CA 1.488 1.455 0 O-C-N 121.111 -0.993 . . . . 0.0 109.22 179.666 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.521 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 1.1 m 177.83 150.75 0.4 Allowed Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.309 -0.87 . . . . 0.0 109.399 179.678 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -63.15 -27.85 73.23 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.639 2.226 . . . . 0.0 112.319 -179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 26.6 mttp -127.64 137.84 52.65 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.485 -0.76 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.464 ' OG1' ' CE1' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -175.61 147.71 0.96 Allowed Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.315 -0.866 . . . . 0.0 109.073 179.734 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -68.84 122.01 8.91 Favored 'Trans proline' 0 C--N 1.309 -1.519 0 C-N-CA 122.217 1.945 . . . . 0.0 111.758 179.741 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 66.8 t80 -108.7 123.8 49.56 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.272 -0.893 . . . . 0.0 109.655 -179.781 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.495 ' O ' HG22 ' A' ' 80' ' ' VAL . 29.6 tp -117.47 125.18 50.46 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.396 -0.815 . . . . 0.0 109.314 179.773 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.418 HD11 ' CE1' ' A' ' 82' ' ' PHE . 49.5 tp -109.81 119.1 38.31 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.306 -0.871 . . . . 0.0 109.4 179.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 38.8 t -110.45 135.58 49.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.532 0 O-C-N 121.267 -0.896 . . . . 0.0 109.905 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -102.82 125.78 8.62 Favored Glycine 0 N--CA 1.491 2.314 0 N-CA-C 108.663 -1.775 . . . . 0.0 108.663 179.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 21.0 p -124.07 163.87 20.57 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.341 -1.093 . . . . 0.0 110.575 -179.201 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 35.9 tp60 68.74 33.95 3.56 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.802 -0.561 . . . . 0.0 110.047 179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 19.1 pt -74.29 -2.86 3.99 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 121.125 -0.985 . . . . 0.0 110.723 -179.603 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.5 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 80.0 m-20 -84.26 -26.55 28.53 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.861 -1.15 . . . . 0.0 109.603 179.344 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.774 HD23 HG11 ' A' ' 85' ' ' VAL . 28.2 tp -60.86 -30.93 70.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.443 -0.786 . . . . 0.0 109.265 179.932 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 45.5 ttp180 -57.74 -25.38 60.34 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.3 -0.875 . . . . 0.0 109.644 179.614 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 60.9 t0 -99.99 26.81 6.02 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.244 -0.91 . . . . 0.0 109.908 -179.726 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 54.7 m-20 -111.64 95.73 29.1 Favored Pre-proline 0 N--CA 1.493 1.707 0 O-C-N 121.465 -0.772 . . . . 0.0 109.451 -179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 50.4 Cg_exo -49.88 -44.14 38.09 Favored 'Trans proline' 0 N--CA 1.492 1.406 0 C-N-CA 122.174 1.916 . . . . 0.0 112.142 -179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 23.1 t -57.94 -37.03 73.37 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 121.187 -0.946 . . . . 0.0 109.483 -179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.665 HG21 HD21 ' A' ' 119' ' ' LEU . 30.1 m -73.85 -47.65 36.81 Favored 'General case' 0 N--CA 1.49 1.54 0 N-CA-C 107.753 -1.203 . . . . 0.0 107.753 178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 91.1 mt -54.34 -34.78 28.77 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.389 0 N-CA-C 108.594 -0.891 . . . . 0.0 108.594 179.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 49.2 tp10 -62.5 -46.56 87.86 Favored 'General case' 0 N--CA 1.489 1.488 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 179.029 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 37.1 mttm -59.5 -36.84 76.82 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.454 -0.779 . . . . 0.0 108.976 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.443 ' HB3' ' H ' ' A' ' 135' ' ' LYS . 77.8 mt -73.42 -37.53 65.87 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -55.4 -43.32 75.11 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.676 -0.64 . . . . 0.0 109.764 -179.307 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -59.18 -37.52 77.58 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 120.986 -1.071 . . . . 0.0 109.168 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 21.0 m120 -90.89 4.96 50.45 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.486 -0.759 . . . . 0.0 109.472 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 43.1 mttp 52.36 35.46 17.32 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.358 -0.838 . . . . 0.0 109.496 179.674 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.436 ' O ' ' O ' ' A' ' 135' ' ' LYS . 97.8 mt-30 -92.84 -53.84 4.0 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.389 -0.82 . . . . 0.0 109.681 179.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.443 ' H ' ' HB3' ' A' ' 129' ' ' LEU . 7.1 mttt 62.09 144.37 0.07 OUTLIER Pre-proline 0 N--CA 1.49 1.562 0 O-C-N 121.333 -0.854 . . . . 0.0 109.056 -179.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 29.5 Cg_endo -65.28 147.25 87.63 Favored 'Trans proline' 0 N--CA 1.495 1.559 0 C-N-CA 122.58 2.186 . . . . 0.0 112.487 -179.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 16.2 mm -78.22 149.81 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 O-C-N 121.368 -0.832 . . . . 0.0 108.79 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.03 154.32 60.57 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 120.992 -1.067 . . . . 0.0 109.037 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -60.65 -33.52 93.29 Favored 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 122.318 2.012 . . . . 0.0 111.819 179.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.3 tt0 -62.05 -36.03 80.38 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.352 -0.843 . . . . 0.0 109.649 179.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 28.3 m -68.22 -36.99 80.37 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.172 -0.955 . . . . 0.0 109.245 179.784 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.5 -44.3 44.62 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.402 -0.811 . . . . 0.0 110.099 -179.945 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.587 ' OE2' ' CE2' ' A' ' 154' ' ' TYR . 99.1 mt-10 -63.67 -32.32 73.77 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.069 -1.02 . . . . 0.0 110.35 -179.423 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.528 ' NZ ' ' OD2' ' A' ' 148' ' ' ASP . 13.2 tttm -65.95 -38.17 87.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.923 -1.111 . . . . 0.0 110.157 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 13.0 tp -58.99 -39.32 81.46 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.299 -0.875 . . . . 0.0 110.172 -179.117 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.689 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -78.75 -49.74 12.54 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.008 -1.057 . . . . 0.0 110.018 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 39.0 ttp180 -60.3 -2.57 0.48 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.33 -0.856 . . . . 0.0 110.306 -179.073 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.528 ' OD2' ' NZ ' ' A' ' 144' ' ' LYS . 86.2 m-20 -111.29 -21.58 11.8 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.035 -1.041 . . . . 0.0 109.91 179.439 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 83.5 mt -103.57 26.74 8.12 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.212 -0.93 . . . . 0.0 110.494 -179.433 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 44.6 mttt 59.79 31.03 20.58 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.224 -0.922 . . . . 0.0 110.613 179.697 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.689 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -66.11 144.75 56.49 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.099 -1.0 . . . . 0.0 108.866 179.364 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . . . . . . . . . 53.6 t -62.94 -59.62 4.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 120.973 -1.079 . . . . 0.0 109.858 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 41.0 tptt -165.31 157.26 15.09 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.133 -0.979 . . . . 0.0 109.755 -179.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.587 ' CE2' ' OE2' ' A' ' 143' ' ' GLU . 21.1 p90 -117.4 144.31 45.1 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.419 -0.801 . . . . 0.0 109.008 179.67 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 32.8 t -131.09 138.51 53.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.249 -0.907 . . . . 0.0 109.8 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -102.13 129.01 48.37 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 108.1 -1.074 . . . . 0.0 108.1 178.772 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.455 ' HB2' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -138.24 146.52 42.67 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.101 -0.999 . . . . 0.0 111.312 -178.07 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.5 ' OG ' ' OD2' ' A' ' 118' ' ' ASP . 23.6 t -115.69 110.4 19.1 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.461 -0.775 . . . . 0.0 109.044 179.321 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -75.03 -31.51 61.36 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.761 -0.587 . . . . 0.0 109.785 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 12.6 tp -53.75 -32.14 51.15 Favored 'General case' 0 C--N 1.303 -1.44 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 179.592 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.492 ' O ' ' O ' ' A' ' 158' ' ' SER . 22.2 p -125.1 166.45 16.39 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.495 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.658 ' NE2' ' ND2' ' A' ' 26' ' ' ASN . 95.2 mm-40 -70.1 12.31 0.23 Allowed 'General case' 0 C--N 1.288 -2.088 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.479 ' H ' ' C ' ' A' ' 161' ' ' THR . 48.6 mtmt -89.41 9.4 26.4 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.195 -0.94 . . . . 0.0 109.262 -179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 158' ' ' SER . . . -105.37 -50.64 0.91 Allowed Glycine 0 N--CA 1.489 2.2 0 C-N-CA 120.001 -1.095 . . . . 0.0 110.436 -179.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 23' ' ' TYR . 43.8 mt -63.02 -36.7 84.44 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 121.102 -1.234 . . . . 0.0 110.097 -179.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 84.1 mttt -58.62 -29.75 66.74 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.341 -0.849 . . . . 0.0 110.999 -179.303 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 88.8 m-20 -94.74 -41.93 9.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.958 -1.088 . . . . 0.0 110.39 -179.437 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.455 HG23 ' HB2' ' A' ' 157' ' ' CYS . 80.4 t -60.52 -38.52 78.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.349 -0.844 . . . . 0.0 111.174 -178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.689 ' CZ ' ' CD1' ' A' ' 23' ' ' TYR . 50.9 m-85 -89.94 -13.56 36.0 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 120.772 -1.205 . . . . 0.0 111.296 -178.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 57.1 t0 -61.6 -50.34 72.99 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.715 -1.241 . . . . 0.0 109.686 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 84.8 tt0 -80.79 -21.98 40.46 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.378 -0.826 . . . . 0.0 110.003 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.21 -34.58 77.95 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.18 -0.95 . . . . 0.0 110.421 -179.222 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 74.7 mt -71.65 -43.65 70.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.938 -1.101 . . . . 0.0 109.912 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 73.1 mt -58.34 -44.27 88.64 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.286 -0.884 . . . . 0.0 109.605 -179.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -65.78 -35.39 80.57 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.108 -0.995 . . . . 0.0 109.698 -179.896 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.54 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -60.56 -43.17 97.55 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.244 -0.91 . . . . 0.0 109.828 -179.425 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 44.6 tp -61.58 -40.38 94.55 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.165 -0.96 . . . . 0.0 109.115 179.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.347 -0.846 . . . . 99.989999999999995 109.477 -179.942 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 64.1 mtt . . . . . 0 N--CA 1.489 1.508 0 N-CA-C 109.401 -0.592 . . . . 0.0 109.401 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 50.25 25.37 1.79 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.251 -0.906 . . . . 0.0 108.766 -179.862 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 42.2 m -123.88 145.28 49.22 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.413 -0.804 . . . . 0.0 109.156 179.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.403 ' HB ' HD12 ' A' ' 53' ' ' LEU . 30.7 mm -109.86 115.18 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.375 -0.828 . . . . 0.0 109.17 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -82.87 122.57 28.41 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.151 -0.968 . . . . 0.0 109.5 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.538 ' HB2' HD11 ' A' ' 53' ' ' LEU . 47.3 t -132.57 119.23 20.22 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.408 -0.808 . . . . 0.0 109.311 179.833 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 43.4 t -109.93 138.79 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.614 0 O-C-N 121.345 -0.847 . . . . 0.0 109.433 -179.823 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.4 t -115.04 131.45 67.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 N-CA-C 108.874 -0.788 . . . . 0.0 108.874 179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -166.57 139.05 0.83 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.421 0 O-C-N 121.101 -0.999 . . . . 0.0 109.384 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -154.13 165.0 31.62 Favored Glycine 0 N--CA 1.491 2.311 0 N-CA-C 109.475 -1.45 . . . . 0.0 109.475 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.586 ' OD2' ' ND2' ' A' ' 92' ' ' ASN . 23.2 t70 -80.68 86.46 5.91 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.176 -1.191 . . . . 0.0 109.353 179.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 165.5 86.86 0.06 OUTLIER Glycine 0 N--CA 1.49 2.269 0 N-CA-C 109.636 -1.386 . . . . 0.0 109.636 -179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -75.68 -5.41 45.44 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.338 -1.095 . . . . 0.0 109.395 179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 54.7 t -58.21 -58.06 8.09 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.528 0 O-C-N 121.271 -0.893 . . . . 0.0 110.151 -179.149 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -111.66 16.12 26.4 Favored Glycine 0 N--CA 1.493 2.479 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -179.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.54 ' NZ ' ' OD1' ' A' ' 57' ' ' ASP . 46.9 tttm -63.33 -41.14 98.88 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 120.828 -1.395 . . . . 0.0 110.063 -179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 63.8 p -68.71 -43.24 76.42 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.206 -0.934 . . . . 0.0 110.183 -179.399 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 6.4 m -61.88 -28.56 69.59 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.185 -0.947 . . . . 0.0 110.766 -179.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.441 HD22 ' SG ' ' A' ' 81' ' ' CYS . 46.7 tp -66.39 -43.48 85.75 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 120.878 -1.139 . . . . 0.0 109.785 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 71.1 mt -68.09 -40.6 82.61 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.271 -0.893 . . . . 0.0 109.652 -179.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 73.6 mt -67.67 -44.31 86.12 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.675 0 O-C-N 121.299 -0.875 . . . . 0.0 109.852 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 24.0 m -49.97 -35.04 22.86 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.216 -0.927 . . . . 0.0 110.171 -178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 66.9 t80 -89.55 -48.51 7.26 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 120.839 -1.163 . . . . 0.0 110.04 -179.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.431 HG22 HG23 ' A' ' 25' ' ' THR . 37.0 m -57.35 -42.05 81.23 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.28 -0.888 . . . . 0.0 111.764 -178.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.542 ' O ' ' CB ' ' A' ' 26' ' ' ASN . 65.6 p -140.66 -12.34 1.0 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 120.634 -1.291 . . . . 0.0 111.683 -178.779 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.542 ' CB ' ' O ' ' A' ' 25' ' ' THR . 3.4 m-20 86.4 115.48 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 -178.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' CB ' ' O ' ' A' ' 26' ' ' ASN . 16.4 mttt 164.48 76.49 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.06 0 N-CA-C 109.001 -0.74 . . . . 0.0 109.001 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.613 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -62.19 -42.4 80.91 Favored Pre-proline 0 N--CA 1.489 1.48 0 O-C-N 120.732 -1.23 . . . . 0.0 110.108 -179.914 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.613 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 37.4 Cg_exo -55.58 -38.6 93.98 Favored 'Trans proline' 0 N--CA 1.494 1.511 0 C-N-CA 122.372 2.048 . . . . 0.0 112.335 -179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.627 ' O ' ' N ' ' A' ' 32' ' ' TYR . 1.8 p 64.55 -50.29 0.31 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.245 -0.909 . . . . 0.0 109.869 179.541 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.6 ' N ' ' O ' ' A' ' 29' ' ' PRO . 96.4 mt-10 57.02 -72.48 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.572 -0.705 . . . . 0.0 109.673 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.627 ' N ' ' O ' ' A' ' 30' ' ' SER . 81.9 t80 -107.07 124.62 49.92 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.225 -0.922 . . . . 0.0 109.525 179.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.483 ' O ' ' CD2' ' A' ' 32' ' ' TYR . 1.8 m -64.5 152.95 88.14 Favored Pre-proline 0 N--CA 1.49 1.54 0 O-C-N 121.319 -0.863 . . . . 0.0 109.329 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 9.2 Cg_endo -55.55 136.18 72.77 Favored 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 122.544 2.163 . . . . 0.0 112.337 -179.881 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -63.91 -30.63 71.7 Favored 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.496 -0.753 . . . . 0.0 110.098 -179.739 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 21.8 m -133.7 155.74 40.47 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.679 0 O-C-N 121.208 -0.932 . . . . 0.0 109.566 -179.927 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -107.68 94.15 4.93 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.323 -0.861 . . . . 0.0 109.216 179.59 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . . . . . . . . . 89.9 m-20 -123.24 147.81 46.53 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.387 -0.821 . . . . 0.0 110.07 -179.624 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 88.3 m-20 -70.63 149.09 47.39 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.433 -0.792 . . . . 0.0 109.316 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -121.28 146.37 46.9 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.437 -0.789 . . . . 0.0 109.634 -179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -115.51 146.45 41.69 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.359 -0.838 . . . . 0.0 109.455 179.63 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 14.6 p -135.93 141.92 40.45 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.258 -0.901 . . . . 0.0 109.45 179.777 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 55.5 m -97.75 134.55 40.77 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.199 -0.938 . . . . 0.0 109.869 -179.603 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.41 ' O ' ' O ' ' A' ' 51' ' ' TYR . 33.9 t -120.75 136.63 57.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.646 0 O-C-N 121.553 -0.717 . . . . 0.0 109.393 179.937 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 24.0 ttt -105.03 140.05 38.8 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.328 -0.858 . . . . 0.0 109.946 -179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.684 HG22 ' H ' ' A' ' 48' ' ' GLY . 67.0 mt -119.77 143.17 32.15 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 O-C-N 121.419 -0.8 . . . . 0.0 109.055 179.52 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . . . . . . . . . . . -48.64 -30.96 9.14 Favored Glycine 0 N--CA 1.49 2.246 0 N-CA-C 108.281 -1.928 . . . . 0.0 108.281 179.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.684 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -72.46 -96.19 0.08 OUTLIER Glycine 0 N--CA 1.486 2.005 0 N-CA-C 108.556 -1.818 . . . . 0.0 108.556 178.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.591 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -123.03 156.59 62.43 Favored Pre-proline 0 N--CA 1.493 1.69 0 O-C-N 121.566 -0.961 . . . . 0.0 109.376 179.896 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -68.03 138.4 43.84 Favored 'Trans proline' 0 C--N 1.307 -1.606 0 C-N-CA 122.651 2.234 . . . . 0.0 112.224 179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CD2' HD12 ' A' ' 46' ' ' ILE . 98.8 m-85 -141.86 162.9 34.33 Favored 'General case' 0 N--CA 1.489 1.479 0 O-C-N 121.169 -0.957 . . . . 0.0 109.088 179.535 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 p -118.87 155.74 30.72 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.41 -0.806 . . . . 0.0 109.413 -179.937 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.538 HD11 ' HB2' ' A' ' 6' ' ' CYS . 35.8 tp -118.73 118.27 31.16 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.498 -0.751 . . . . 0.0 109.357 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.73 124.67 7.73 Favored Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.366 -1.494 . . . . 0.0 109.366 179.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.637 HD13 ' N ' ' A' ' 56' ' ' PHE . 0.3 OUTLIER -107.86 121.69 45.26 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.309 -1.113 . . . . 0.0 108.481 179.692 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.637 ' N ' HD13 ' A' ' 55' ' ' LEU . 99.1 m-85 -121.29 149.38 42.99 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.281 -0.887 . . . . 0.0 109.691 -179.824 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.54 ' OD1' ' NZ ' ' A' ' 16' ' ' LYS . 21.7 t70 -153.51 157.91 40.51 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.294 -0.879 . . . . 0.0 109.124 179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 30.1 p -75.74 152.26 37.46 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.092 -1.005 . . . . 0.0 109.362 -179.844 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -76.8 -160.63 0.16 Allowed 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.288 -0.883 . . . . 0.0 109.36 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.482 ' O ' ' OE2' ' A' ' 62' ' ' GLU . . . -54.06 -52.53 42.79 Favored Glycine 0 N--CA 1.491 2.342 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 -179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 93.2 mt-30 -61.99 133.94 55.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.157 -1.202 . . . . 0.0 109.753 -179.515 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.499 ' O ' ' C ' ' A' ' 63' ' ' ASP . 53.2 mp0 -116.74 -43.23 2.91 Favored 'General case' 0 N--CA 1.492 1.636 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.598 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.599 ' C ' ' H ' ' A' ' 65' ' ' ASP . 90.3 m-20 -28.17 -67.77 0.07 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 122.086 -0.384 . . . . 0.0 111.685 -178.699 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.497 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 12.1 p90 -56.49 15.45 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.809 -1.182 . . . . 0.0 111.649 -178.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.599 ' H ' ' C ' ' A' ' 63' ' ' ASP . 54.2 p30 -89.36 2.25 54.66 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 120.654 -1.279 . . . . 0.0 109.558 179.687 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.1 ttt180 -60.3 -36.94 79.02 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.204 -0.935 . . . . 0.0 109.448 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 64.0 mt 46.43 72.15 0.25 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.385 -0.822 . . . . 0.0 109.496 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.491 ' O ' ' N ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -61.07 169.48 2.05 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.306 -0.871 . . . . 0.0 108.803 179.581 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 63.3 Cg_exo -46.1 -10.96 0.05 OUTLIER 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.345 2.03 . . . . 0.0 112.134 179.932 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ARG . 30.2 tp -57.67 -45.91 84.95 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.113 -0.992 . . . . 0.0 108.793 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 99.6 p -125.08 142.38 51.53 Favored 'General case' 0 N--CA 1.489 1.493 0 N-CA-C 108.975 -0.75 . . . . 0.0 108.975 179.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 80.2 t80 -138.0 79.87 31.42 Favored Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.391 -0.818 . . . . 0.0 109.82 -179.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -52.74 138.85 59.53 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 C-N-CA 122.306 2.004 . . . . 0.0 111.535 179.46 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 63.6 tt0 -100.36 122.17 42.7 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.203 -0.936 . . . . 0.0 109.593 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 41.5 m -114.37 131.6 56.5 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.524 -0.735 . . . . 0.0 109.403 -179.839 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 88.1 m-20 -61.25 -39.04 88.85 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.351 -0.843 . . . . 0.0 109.632 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 22.1 t -140.05 131.51 32.05 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.19 -0.944 . . . . 0.0 109.957 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 54.8 t80 -102.95 125.37 49.67 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.1 -1.0 . . . . 0.0 108.385 178.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 47.2 mt -108.27 141.47 40.0 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.179 -0.951 . . . . 0.0 110.543 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.908 HG21 ' CZ ' ' A' ' 110' ' ' PHE . 51.6 t -124.94 135.08 65.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.365 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.524 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 0.1 OUTLIER -127.86 126.46 41.64 Favored 'General case' 0 N--CA 1.493 1.697 0 O-C-N 121.324 -0.86 . . . . 0.0 109.678 -179.835 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 38.8 p90 -136.55 166.03 24.47 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.249 -0.907 . . . . 0.0 109.434 179.914 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 48.6 m -104.24 148.54 26.21 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.232 -0.918 . . . . 0.0 109.583 -179.83 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.719 ' O ' HG22 ' A' ' 84' ' ' VAL . 7.8 p -105.96 13.98 7.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 O-C-N 121.335 -0.853 . . . . 0.0 110.146 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.468 HG12 HD12 ' A' ' 119' ' ' LEU . 29.9 m -105.54 -6.81 9.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.127 -0.983 . . . . 0.0 110.111 -179.918 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 57.4 m -127.81 102.96 21.83 Favored Pre-proline 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 0.0 109.85 -179.52 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.402 ' HA ' HD11 ' A' ' 137' ' ' ILE . 50.1 Cg_exo -50.68 -41.82 52.56 Favored 'Trans proline' 0 N--CA 1.492 1.4 0 C-N-CA 122.036 1.824 . . . . 0.0 111.916 179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 24.3 t -56.55 -37.4 70.47 Favored 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.248 -0.908 . . . . 0.0 109.163 179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.463 ' O ' HG23 ' A' ' 93' ' ' VAL . 20.1 m -69.6 -26.21 64.34 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.297 -0.877 . . . . 0.0 109.244 179.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 57.9 t80 -69.47 -50.9 41.04 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.314 -0.866 . . . . 0.0 109.095 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -69.55 -35.0 75.01 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 121.226 -0.921 . . . . 0.0 109.603 179.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.586 ' ND2' ' OD2' ' A' ' 11' ' ' ASP . 41.6 t-20 -56.52 -34.39 66.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.378 -0.826 . . . . 0.0 109.95 -179.643 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 89' ' ' SER . 67.1 t -62.22 -36.84 76.59 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.088 -1.008 . . . . 0.0 109.972 -179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 83.4 tttt -82.93 -20.08 36.01 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 121.319 -0.863 . . . . 0.0 109.86 179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.3 tp10 -80.27 -27.46 38.59 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.136 -0.978 . . . . 0.0 111.34 -179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 28.8 mttt -112.23 -44.76 3.36 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.054 -1.029 . . . . 0.0 112.479 -178.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 75.4 m95 -85.76 1.95 47.55 Favored 'General case' 0 N--CA 1.496 1.828 0 O-C-N 120.903 -1.123 . . . . 0.0 113.072 -176.738 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.648 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -109.16 -40.63 0.12 Allowed Pre-proline 0 N--CA 1.5 2.047 0 O-C-N 120.471 -1.393 . . . . 0.0 110.666 -179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.648 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 62.3 Cg_endo -92.36 -56.15 0.02 OUTLIER 'Trans proline' 0 C--N 1.305 -1.732 0 C-N-CA 123.275 2.65 . . . . 0.0 113.253 -179.139 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 77.8 mm-40 -60.6 -35.28 75.74 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.266 -0.896 . . . . 0.0 110.892 -178.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 16.5 tt -67.69 -28.85 43.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 120.71 -1.244 . . . . 0.0 110.121 -179.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.0 m -59.24 -42.18 90.46 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.153 -0.967 . . . . 0.0 109.675 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 92.9 m-70 -59.08 -32.55 69.9 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.243 -0.911 . . . . 0.0 109.691 179.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m170 -63.21 -41.87 99.21 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.223 -0.923 . . . . 0.0 109.524 179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.5 ' O ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 173.08 170.34 0.24 Allowed Pre-proline 0 N--CA 1.491 1.613 0 O-C-N 121.392 -0.817 . . . . 0.0 109.248 -179.626 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.5 ' O ' ' O ' ' A' ' 105' ' ' CYS . 51.9 Cg_exo -49.01 -164.24 0.0 OUTLIER 'Trans proline' 0 N--CA 1.492 1.44 0 C-N-CA 122.503 2.136 . . . . 0.0 112.348 179.563 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.404 ' NZ ' HD13 ' A' ' 149' ' ' LEU . 64.0 mttm -80.98 138.28 36.07 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.218 -0.926 . . . . 0.0 109.623 -179.801 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -132.14 168.77 16.06 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.265 -0.897 . . . . 0.0 109.343 -179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -40.37 98.9 0.03 OUTLIER 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.57 2.18 . . . . 0.0 111.574 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.908 ' CZ ' HG21 ' A' ' 80' ' ' VAL . 63.8 t80 -109.38 128.89 55.46 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.563 -0.711 . . . . 0.0 109.957 -179.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.565 HD12 ' O ' ' A' ' 153' ' ' LYS . 15.3 tp -120.16 124.07 44.85 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.505 -0.747 . . . . 0.0 109.01 179.442 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.404 HD12 ' HA ' ' A' ' 112' ' ' LEU . 39.0 tp -103.67 120.37 40.78 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.231 -0.918 . . . . 0.0 109.186 179.814 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.429 HG13 HG23 ' A' ' 155' ' ' VAL . 38.8 t -108.95 134.42 50.99 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.594 0 O-C-N 121.238 -0.914 . . . . 0.0 110.064 -179.335 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -87.92 113.0 3.95 Favored Glycine 0 N--CA 1.491 2.302 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.553 HG22 ' HG3' ' A' ' 116' ' ' GLN . 13.9 m -103.11 148.79 25.3 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.28 -1.13 . . . . 0.0 110.284 -179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.553 ' HG3' HG22 ' A' ' 115' ' ' THR . 92.1 mt-30 62.83 38.5 11.5 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 122.052 -0.405 . . . . 0.0 111.491 179.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.494 ' O ' ' O ' ' A' ' 116' ' ' GLN . 21.0 pt -57.99 -165.96 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.402 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.585 ' O ' ' N ' ' A' ' 121' ' ' ASP . 88.6 m-20 52.3 18.51 0.92 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 120.364 -1.46 . . . . 0.0 109.146 -179.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.491 ' C ' ' O ' ' A' ' 118' ' ' ASP . 8.3 tp 30.81 52.04 0.13 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.817 -0.552 . . . . 0.0 111.509 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' O ' ' C ' ' A' ' 121' ' ' ASP . 97.8 mtt180 54.24 22.39 3.62 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.825 -1.172 . . . . 0.0 110.501 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.585 ' N ' ' O ' ' A' ' 118' ' ' ASP . 60.9 t0 33.22 61.38 0.42 Allowed 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.718 -0.614 . . . . 0.0 110.257 179.131 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.484 ' OD1' ' O ' ' A' ' 120' ' ' ARG . 81.0 m-20 -132.34 85.56 48.51 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.262 -0.899 . . . . 0.0 109.457 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_exo -51.34 -28.33 26.6 Favored 'Trans proline' 0 C--N 1.308 -1.602 0 C-N-CA 122.5 2.133 . . . . 0.0 112.118 -179.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -81.76 -4.34 56.09 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.288 -0.883 . . . . 0.0 109.066 179.592 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 98.8 m -92.83 -47.93 6.8 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.436 -0.79 . . . . 0.0 109.201 179.15 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.416 HG22 ' H ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -76.97 -48.49 25.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 O-C-N 121.267 -0.896 . . . . 0.0 110.253 -179.65 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 78.3 mm-40 -60.8 -39.95 90.84 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.441 -0.787 . . . . 0.0 111.098 -178.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 44.8 mmtm -83.01 -6.61 59.56 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.544 -1.347 . . . . 0.0 110.39 -178.801 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.406 HD23 ' HA ' ' A' ' 129' ' ' LEU . 91.2 mt -115.45 -49.98 2.74 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.279 -0.888 . . . . 0.0 110.368 -179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.422 ' HA ' ' H ' ' A' ' 135' ' ' LYS . . . -55.08 -46.55 75.47 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.821 -1.174 . . . . 0.0 109.02 179.789 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 57.1 mttt -48.5 -24.72 1.38 Allowed 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 41.2 t-20 -76.27 -55.3 5.69 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 177.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.483 ' O ' ' C ' ' A' ' 134' ' ' GLN . 36.1 ttpt -173.99 76.0 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.602 -0.686 . . . . 0.0 110.169 179.494 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.483 ' C ' ' O ' ' A' ' 133' ' ' LYS . 3.7 mp0 33.27 89.15 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.65 -0.657 . . . . 0.0 110.673 179.156 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.638 ' N ' ' CD ' ' A' ' 136' ' ' PRO . 3.2 tptm -90.35 -38.82 0.41 Allowed Pre-proline 0 N--CA 1.489 1.5 0 O-C-N 121.083 -1.011 . . . . 0.0 110.973 -179.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.638 ' CD ' ' N ' ' A' ' 135' ' ' LYS . 71.8 Cg_endo -89.09 127.5 1.78 Allowed 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 122.845 2.363 . . . . 0.0 113.308 -178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.508 ' O ' ' CG2' ' A' ' 84' ' ' VAL . 4.2 mp -96.9 135.55 30.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.584 0 O-C-N 121.498 -0.751 . . . . 0.0 109.357 -179.984 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -80.9 155.68 72.8 Favored Pre-proline 0 N--CA 1.489 1.495 0 O-C-N 121.206 -0.934 . . . . 0.0 109.468 -179.64 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.3 Cg_endo -58.33 -32.71 96.68 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.373 2.049 . . . . 0.0 111.622 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -58.11 -36.94 73.65 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.232 -0.918 . . . . 0.0 109.221 179.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 50.3 m -67.79 -29.78 69.05 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.283 -0.885 . . . . 0.0 108.692 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.72 -35.03 62.67 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.489 -0.757 . . . . 0.0 110.213 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -59.97 -35.65 75.44 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 120.951 -1.093 . . . . 0.0 110.708 -178.781 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.497 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 94.8 mttt -63.85 -36.84 85.23 Favored 'General case' 0 N--CA 1.488 1.466 0 O-C-N 120.855 -1.153 . . . . 0.0 109.318 179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 41.5 tp -53.24 -43.2 67.14 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.249 -0.907 . . . . 0.0 109.396 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.753 ' HB1' ' CB ' ' A' ' 151' ' ' ALA . . . -70.32 -45.39 66.31 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.399 -0.813 . . . . 0.0 109.796 -179.909 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 97.4 mtt180 -78.01 1.09 21.98 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.25 -0.906 . . . . 0.0 110.878 -178.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.497 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 87.9 m-20 -66.76 -31.98 72.98 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.72 -1.237 . . . . 0.0 109.742 179.268 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.404 HD13 ' NZ ' ' A' ' 107' ' ' LYS . 77.3 mt -121.52 -81.9 0.64 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.446 -0.783 . . . . 0.0 109.722 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -162.76 54.16 0.2 Allowed 'General case' 0 C--N 1.305 -1.346 0 O-C-N 121.333 -0.854 . . . . 0.0 109.29 -179.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.753 ' CB ' ' HB1' ' A' ' 146' ' ' ALA . . . -68.23 137.4 54.75 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.855 -1.153 . . . . 0.0 109.106 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.595 HG12 ' HG3' ' A' ' 153' ' ' LYS . 81.4 t -66.78 -54.24 27.08 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.503 0 O-C-N 121.214 -0.929 . . . . 0.0 109.481 -179.902 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.595 ' HG3' HG12 ' A' ' 152' ' ' VAL . 58.4 mttm -156.52 159.84 38.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.189 -0.944 . . . . 0.0 109.976 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 29.5 p90 -128.91 146.14 51.03 Favored 'General case' 0 N--CA 1.492 1.642 0 N-CA-C 108.747 -0.835 . . . . 0.0 108.747 179.201 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.57 HG11 ' OE1' ' A' ' 171' ' ' GLU . 34.8 m -140.16 152.1 21.73 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.632 0 O-C-N 121.131 -0.981 . . . . 0.0 110.436 -179.707 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -107.26 129.99 54.81 Favored 'General case' 0 N--CA 1.491 1.575 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.472 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -134.13 143.78 48.16 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.968 -1.083 . . . . 0.0 110.817 -178.603 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.425 ' O ' ' O ' ' A' ' 161' ' ' THR . 9.5 t -115.18 110.25 19.2 Favored 'General case' 0 N--CA 1.491 1.592 0 N-CA-C 108.909 -0.774 . . . . 0.0 108.909 179.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -74.38 -33.54 63.09 Favored 'General case' 0 N--CA 1.491 1.577 0 CA-C-O 121.379 0.609 . . . . 0.0 109.391 179.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 71.3 mt -55.03 -27.97 48.64 Favored 'General case' 0 N--CA 1.487 1.404 0 O-C-N 121.259 -0.9 . . . . 0.0 108.707 179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.425 ' O ' ' O ' ' A' ' 158' ' ' SER . 18.3 p -125.99 171.04 11.11 Favored 'General case' 0 C--N 1.304 -1.389 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 179.406 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 95.6 mm-40 -74.02 11.65 0.86 Allowed 'General case' 0 C--N 1.291 -1.975 0 O-C-N 121.674 -0.641 . . . . 0.0 109.708 -179.785 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 49.8 mttt -89.34 1.18 56.14 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.139 -0.976 . . . . 0.0 109.459 -179.581 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.472 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -93.83 -51.15 2.17 Favored Glycine 0 N--CA 1.488 2.126 0 N-CA-C 109.881 -1.287 . . . . 0.0 109.881 -179.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 73.0 mt -71.38 -39.47 71.2 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.242 -1.152 . . . . 0.0 110.259 -179.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 26.3 mttt -59.16 -33.02 70.42 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.198 -0.939 . . . . 0.0 111.329 -178.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 85.6 m-20 -69.42 -50.32 46.87 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.811 -1.181 . . . . 0.0 109.354 -179.964 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 28.4 m -83.22 1.63 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 O-C-N 121.496 -0.753 . . . . 0.0 110.449 -179.363 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 75.6 t80 -74.6 -50.83 16.37 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.855 -1.153 . . . . 0.0 109.768 179.678 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 86.7 m-20 -66.55 -43.88 83.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.322 -0.861 . . . . 0.0 110.014 -179.554 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.57 ' OE1' HG11 ' A' ' 155' ' ' VAL . 97.1 mt-10 -66.31 -33.08 74.94 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.166 -0.959 . . . . 0.0 109.88 -179.693 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -59.27 -38.42 80.08 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.289 -0.882 . . . . 0.0 109.977 -179.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 71.7 mt -73.12 -42.33 58.79 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.109 -0.994 . . . . 0.0 109.954 -179.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 49.1 tp -59.32 -46.31 88.95 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.207 -0.933 . . . . 0.0 110.21 -179.123 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.85 -34.69 78.49 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.972 -1.08 . . . . 0.0 109.948 -179.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -56.29 -33.98 66.04 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.125 -0.984 . . . . 0.0 109.459 -179.516 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 73.0 mt -60.61 -39.83 89.61 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.208 -0.932 . . . . 0.0 109.193 179.731 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 . . . . . 0 N--CA 1.492 1.627 0 O-C-N 121.392 -0.818 . . . . 99.989999999999995 109.514 -179.902 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 63.3 mtt . . . . . 0 N--CA 1.49 1.575 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 88.8 mm-40 59.1 98.46 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.382 -0.824 . . . . 0.0 109.011 -179.511 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.8 t -138.71 161.68 36.59 Favored 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.341 -0.85 . . . . 0.0 109.888 -179.603 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 64.0 mt -120.2 120.23 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.755 -0.831 . . . . 0.0 108.755 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 68.7 mttt -93.12 130.74 38.65 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.194 -0.941 . . . . 0.0 109.974 -179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 35.5 t -135.0 129.65 34.47 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.342 -0.848 . . . . 0.0 109.209 179.663 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 44.1 t -117.89 142.3 32.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.396 -0.815 . . . . 0.0 109.857 -179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 44.6 t -108.13 133.69 52.26 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 179.546 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.444 HG11 ' CH2' ' A' ' 97' ' ' TRP . 46.7 t -140.35 134.0 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.514 0 O-C-N 121.129 -0.982 . . . . 0.0 109.491 -179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -170.55 99.83 0.15 Allowed Glycine 0 N--CA 1.49 2.26 0 N-CA-C 109.637 -1.385 . . . . 0.0 109.637 179.696 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -60.36 -40.49 90.97 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.061 -1.258 . . . . 0.0 109.04 179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.564 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . -84.59 120.05 5.16 Favored Glycine 0 N--CA 1.487 2.085 0 N-CA-C 109.345 -1.502 . . . . 0.0 109.345 179.791 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.564 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 172.08 88.04 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.362 -1.081 . . . . 0.0 109.392 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.6 t -59.52 -41.72 85.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.478 0 O-C-N 121.259 -0.9 . . . . 0.0 109.371 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -102.56 53.11 0.79 Allowed Glycine 0 N--CA 1.49 2.266 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 179.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 35.4 pttt -61.13 -40.08 92.46 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.284 -1.127 . . . . 0.0 109.568 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.5 m -65.13 -41.81 94.46 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 121.135 -0.978 . . . . 0.0 108.979 179.385 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -57.93 -30.32 65.84 Favored 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.373 -0.829 . . . . 0.0 109.633 -179.745 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . . . . . . . . . 40.4 tp -61.12 -41.75 97.28 Favored 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.113 -0.992 . . . . 0.0 108.608 179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 81.2 mt -68.13 -39.73 82.66 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 121.414 -0.804 . . . . 0.0 109.225 179.378 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 34.5 mm -63.66 -48.17 87.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.547 0 O-C-N 121.231 -0.918 . . . . 0.0 109.588 -179.955 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 22.2 m -58.83 -36.29 74.28 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.254 -0.903 . . . . 0.0 110.346 -179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 49.9 t80 -80.15 -50.87 9.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.009 -1.057 . . . . 0.0 109.764 -179.73 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 56.5 m -60.39 -41.24 93.43 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.195 -0.941 . . . . 0.0 109.736 -179.725 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.555 ' OG1' ' N ' ' A' ' 26' ' ' ASN . 30.2 p -112.16 -111.42 0.34 Allowed 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.354 -0.841 . . . . 0.0 109.186 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.555 ' N ' ' OG1' ' A' ' 25' ' ' THR . 37.1 p-10 -173.69 21.79 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.37 -0.831 . . . . 0.0 109.218 179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 18.3 mttt -102.25 106.88 17.77 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.314 -0.866 . . . . 0.0 110.08 -179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.661 ' CD1' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -67.73 -42.77 36.52 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.264 -0.898 . . . . 0.0 108.876 178.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.647 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 31.4 Cg_exo -59.77 -26.66 82.88 Favored 'Trans proline' 0 C--N 1.31 -1.458 0 C-N-CA 122.655 2.237 . . . . 0.0 112.078 -179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.458 ' O ' ' C ' ' A' ' 31' ' ' GLU . 11.8 m 42.56 41.86 2.53 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.128 -0.982 . . . . 0.0 109.683 179.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 96.3 mt-10 -37.56 -35.7 0.14 Allowed 'General case' 0 N--CA 1.495 1.783 0 O-C-N 121.432 -0.792 . . . . 0.0 110.456 -178.997 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -117.31 122.76 44.81 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.252 -0.905 . . . . 0.0 109.502 179.723 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.673 HG23 ' O ' ' A' ' 33' ' ' VAL . 34.4 m -128.29 75.61 78.85 Favored Pre-proline 0 N--CA 1.493 1.679 0 O-C-N 121.387 -0.821 . . . . 0.0 109.756 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.727 ' O ' ' HB2' ' A' ' 35' ' ' ALA . 92.7 Cg_endo -84.28 -102.42 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.727 0 C-N-CA 123.043 2.496 . . . . 0.0 112.329 179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . 0.727 ' HB2' ' O ' ' A' ' 34' ' ' PRO . . . 158.21 41.9 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.8 -0.815 . . . . 0.0 108.8 -179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 69.3 t -69.2 -41.66 81.34 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.536 0 O-C-N 121.196 -0.94 . . . . 0.0 109.935 -179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -109.25 130.41 55.49 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.228 -0.92 . . . . 0.0 110.006 -179.553 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.572 ' CG ' ' H ' ' A' ' 39' ' ' ASN . 50.9 t0 -93.52 -144.56 0.23 Allowed 'General case' 0 N--CA 1.489 1.519 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 179.518 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.572 ' H ' ' CG ' ' A' ' 38' ' ' ASP . 63.5 t-20 -42.71 124.94 3.21 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.975 -1.078 . . . . 0.0 109.718 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.454 ' CE2' ' O ' ' A' ' 41' ' ' ALA . 58.0 t80 -132.08 150.3 52.19 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.579 -0.701 . . . . 0.0 109.517 -179.517 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.454 ' O ' ' CE2' ' A' ' 40' ' ' TYR . . . -103.12 141.92 35.02 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.257 -0.902 . . . . 0.0 109.513 -179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 47.1 t -118.78 133.81 64.42 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.624 0 O-C-N 121.501 -0.75 . . . . 0.0 109.355 179.845 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 31.0 m -106.19 134.53 49.17 Favored 'General case' 0 N--CA 1.489 1.509 0 O-C-N 121.386 -0.821 . . . . 0.0 109.694 -179.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 48.6 t -118.46 135.74 57.88 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.568 -0.708 . . . . 0.0 109.353 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 63.8 mtm -105.67 141.26 37.42 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.482 -0.761 . . . . 0.0 109.324 179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.609 HG22 ' H ' ' A' ' 48' ' ' GLY . 81.0 mt -122.99 141.73 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.627 0 O-C-N 121.426 -0.796 . . . . 0.0 109.365 179.727 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.445 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . -44.1 -24.97 0.61 Allowed Glycine 0 N--CA 1.49 2.265 0 N-CA-C 108.809 -1.716 . . . . 0.0 108.809 179.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.609 ' H ' HG22 ' A' ' 46' ' ' ILE . . . -80.82 -92.37 0.48 Allowed Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.53 -1.428 . . . . 0.0 109.53 179.641 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.451 ' O ' ' CE2' ' A' ' 51' ' ' TYR . 4.6 mm-40 -126.45 154.32 75.06 Favored Pre-proline 0 N--CA 1.494 1.747 0 O-C-N 121.405 -1.056 . . . . 0.0 109.717 -179.45 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -69.71 138.26 37.56 Favored 'Trans proline' 0 N--CA 1.494 1.542 0 C-N-CA 122.729 2.286 . . . . 0.0 112.599 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.606 ' CD2' HD12 ' A' ' 46' ' ' ILE . 97.3 m-85 -131.76 154.19 49.31 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.479 -0.763 . . . . 0.0 109.161 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 16.9 p -118.0 148.19 42.47 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.376 -0.828 . . . . 0.0 109.463 179.838 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 41.1 tp -124.82 122.44 37.43 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.542 -0.723 . . . . 0.0 109.58 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -103.34 126.53 8.85 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.102 -1.599 . . . . 0.0 109.102 179.544 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.503 ' O ' ' OD1' ' A' ' 39' ' ' ASN . 66.5 mt -105.1 137.22 43.2 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.203 -1.175 . . . . 0.0 109.367 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.487 ' O ' ' OD1' ' A' ' 57' ' ' ASP . 98.7 m-85 -122.25 149.82 43.16 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.322 -0.861 . . . . 0.0 109.022 179.46 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.487 ' OD1' ' O ' ' A' ' 56' ' ' PHE . 84.0 m-20 -136.82 161.53 35.73 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.174 -0.954 . . . . 0.0 109.367 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 26.7 p -82.94 162.73 21.42 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.279 -0.888 . . . . 0.0 109.171 179.675 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -149.72 151.3 33.43 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.167 -0.958 . . . . 0.0 109.372 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -107.51 45.34 1.32 Allowed Glycine 0 N--CA 1.489 2.228 0 N-CA-C 109.437 -1.465 . . . . 0.0 109.437 179.89 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' O ' ' N ' ' A' ' 63' ' ' ASP . 63.3 tt0 -99.27 120.81 40.16 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.304 -1.115 . . . . 0.0 109.816 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' A' ' 64' ' ' TYR . 84.3 tt0 61.1 -65.38 0.06 Allowed 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.677 -0.639 . . . . 0.0 110.222 179.902 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.588 ' N ' ' O ' ' A' ' 61' ' ' GLN . 52.9 p30 -63.12 13.82 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.167 -0.958 . . . . 0.0 110.457 -179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' O ' ' CD2' ' A' ' 64' ' ' TYR . 75.9 t80 -97.27 9.2 42.88 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.085 -1.009 . . . . 0.0 109.129 179.245 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 82.9 m-20 -60.19 -43.44 95.89 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.323 -0.861 . . . . 0.0 109.948 -179.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 40.0 ttp180 -175.42 3.14 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.208 -0.933 . . . . 0.0 109.49 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.476 ' HB3' HD21 ' A' ' 70' ' ' LEU . 55.5 mt -88.4 136.48 32.96 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.898 -1.126 . . . . 0.0 110.059 -179.709 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.787 ' H ' ' CD ' ' A' ' 69' ' ' PRO . 6.4 ttt180 -135.74 -42.96 0.02 OUTLIER Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.395 -0.815 . . . . 0.0 110.436 179.92 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.787 ' CD ' ' H ' ' A' ' 68' ' ' ARG . 14.0 Cg_exo -67.69 24.12 0.12 Allowed 'Trans proline' 0 N--CA 1.494 1.501 0 C-N-CA 122.636 2.224 . . . . 0.0 112.182 -179.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.499 ' O ' ' O ' ' A' ' 71' ' ' SER . 70.7 mt -57.03 -31.97 65.7 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.322 -0.861 . . . . 0.0 109.571 -179.786 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.499 ' O ' ' O ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER 38.74 -162.9 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.392 -0.817 . . . . 0.0 110.265 179.531 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.515 ' CD1' ' OG1' ' A' ' 75' ' ' THR . 39.7 p90 -118.36 149.64 46.32 Favored Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.442 -0.786 . . . . 0.0 109.013 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -63.95 -37.23 44.97 Favored 'Trans proline' 0 N--CA 1.493 1.467 0 C-N-CA 122.32 2.013 . . . . 0.0 112.276 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 64.1 tt0 -174.82 115.72 0.17 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.251 -0.906 . . . . 0.0 109.677 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.515 ' OG1' ' CD1' ' A' ' 72' ' ' TYR . 43.3 m -117.57 128.41 54.93 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 121.312 -0.868 . . . . 0.0 109.654 179.91 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 87.5 m-20 -66.17 -33.92 76.86 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.417 -0.802 . . . . 0.0 109.957 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 41.8 t -136.09 132.67 50.15 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.354 -0.841 . . . . 0.0 109.845 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 48.9 t80 -111.63 126.26 54.82 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.327 -0.858 . . . . 0.0 109.024 179.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 62.2 mt -110.2 140.35 44.42 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.226 -0.922 . . . . 0.0 109.949 -179.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 38.3 t -121.4 136.03 59.65 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.697 0 O-C-N 121.423 -0.798 . . . . 0.0 109.165 179.747 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 42.2 t -129.83 121.72 27.32 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.31 -0.869 . . . . 0.0 109.853 -179.822 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.472 ' O ' HG22 ' A' ' 115' ' ' THR . 44.1 p90 -145.97 163.23 35.82 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.382 -0.824 . . . . 0.0 109.303 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 34.6 t -89.58 137.57 32.21 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.152 -0.967 . . . . 0.0 109.395 -179.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.7 p -93.66 -12.64 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.189 -0.945 . . . . 0.0 110.31 -179.538 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.597 HG21 ' HB3' ' A' ' 119' ' ' LEU . 72.4 t -90.43 -13.82 9.1 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.035 -1.04 . . . . 0.0 110.015 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 47.7 m -100.6 128.59 29.7 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.213 -0.93 . . . . 0.0 109.684 -179.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.624 ' CG ' ' NE2' ' A' ' 134' ' ' GLN . 45.7 Cg_endo -73.55 -46.36 0.35 Allowed 'Trans proline' 0 N--CA 1.49 1.296 0 C-N-CA 121.988 1.792 . . . . 0.0 112.298 179.867 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 20.4 m -55.31 -41.78 72.81 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.848 -1.158 . . . . 0.0 108.933 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.409 ' O ' HG23 ' A' ' 93' ' ' VAL . 84.2 p -68.29 -23.09 64.71 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.369 -0.832 . . . . 0.0 109.018 179.336 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.639 ' CE1' HG21 ' A' ' 137' ' ' ILE . 57.0 t80 -72.08 -50.82 25.12 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.447 -0.783 . . . . 0.0 109.319 179.614 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -67.91 -37.0 81.15 Favored 'General case' 0 N--CA 1.49 1.555 0 O-C-N 121.256 -0.902 . . . . 0.0 109.563 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 56.7 t30 -53.47 -34.38 57.77 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.231 -0.918 . . . . 0.0 109.684 -179.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 89' ' ' SER . 74.4 t -61.41 -38.25 79.58 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.222 -0.924 . . . . 0.0 110.457 -179.625 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -93.79 -32.79 13.84 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.945 -1.097 . . . . 0.0 110.91 -179.082 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 78.8 mm-40 -68.49 -36.58 79.12 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.883 -1.135 . . . . 0.0 112.416 -178.145 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 58.0 tttt -113.62 -52.0 2.77 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 120.886 -1.134 . . . . 0.0 112.619 -178.376 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.444 ' CH2' HG11 ' A' ' 9' ' ' VAL . 72.7 m95 -67.54 -30.71 70.43 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.16 -0.963 . . . . 0.0 113.026 -176.561 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.538 ' O ' HG22 ' A' ' 101' ' ' ILE . 1.9 t -72.57 -51.06 7.43 Favored Pre-proline 0 N--CA 1.498 1.939 0 O-C-N 120.141 -1.599 . . . . 0.0 111.439 -179.02 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.447 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 58.3 Cg_endo -73.68 -47.75 0.27 Allowed 'Trans proline' 0 N--CA 1.496 1.676 0 C-N-CA 121.953 1.769 . . . . 0.0 113.23 -179.671 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 48.1 tp10 -58.08 -40.07 80.16 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.192 -0.943 . . . . 0.0 111.016 -178.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.538 HG22 ' O ' ' A' ' 98' ' ' VAL . 1.9 tp -64.18 -24.55 35.98 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.725 0 O-C-N 121.01 -1.056 . . . . 0.0 110.223 -179.163 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 47.2 m -57.76 -39.61 77.81 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.115 -0.991 . . . . 0.0 110.479 -179.402 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 88.6 m-70 -53.56 -32.5 51.08 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.185 -0.947 . . . . 0.0 110.685 -179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.45 ' CE1' ' CB ' ' A' ' 71' ' ' SER . 97.1 m-70 -84.45 7.1 20.89 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.013 -1.054 . . . . 0.0 110.483 -179.132 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 1.7 m 55.35 69.78 1.84 Allowed Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.049 -1.032 . . . . 0.0 109.284 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 50.7 Cg_exo -52.49 128.0 26.26 Favored 'Trans proline' 0 C--N 1.302 -1.906 0 C-N-CA 122.604 2.202 . . . . 0.0 112.472 -179.524 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 94.7 mttt -151.73 -39.62 0.12 Allowed 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.69 -0.856 . . . . 0.0 108.69 179.556 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.541 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -62.72 156.14 66.43 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 121.502 -0.749 . . . . 0.0 109.166 179.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 11.2 Cg_endo -57.25 135.68 71.78 Favored 'Trans proline' 0 C--N 1.308 -1.599 0 C-N-CA 122.691 2.261 . . . . 0.0 112.459 -179.741 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.541 ' CE2' ' O ' ' A' ' 108' ' ' THR . 98.1 m-85 -116.58 137.76 51.93 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.568 -0.707 . . . . 0.0 109.356 179.673 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.411 HD12 ' HA ' ' A' ' 111' ' ' LEU . 38.3 tp -117.53 124.76 49.5 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.491 -0.756 . . . . 0.0 109.451 179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 63.9 mt -101.51 120.43 40.3 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.149 -0.969 . . . . 0.0 108.853 179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . . . . . . . . . 41.6 t -111.92 137.54 44.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.344 -0.848 . . . . 0.0 110.357 -178.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -103.0 129.25 9.82 Favored Glycine 0 N--CA 1.491 2.36 0 N-CA-C 108.214 -1.954 . . . . 0.0 108.214 178.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.472 HG22 ' O ' ' A' ' 82' ' ' PHE . 9.9 t -118.14 156.92 27.87 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.136 -1.214 . . . . 0.0 111.18 -178.074 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 91.9 mt-30 61.36 38.42 16.24 Favored 'General case' 0 N--CA 1.495 1.8 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.73 179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 16.7 pt -72.3 -3.72 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 120.947 -1.096 . . . . 0.0 109.764 179.579 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.491 ' OD2' ' OG ' ' A' ' 158' ' ' SER . 86.1 m-20 -85.82 -22.06 27.8 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.077 -1.014 . . . . 0.0 109.378 179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.597 ' HB3' HG21 ' A' ' 85' ' ' VAL . 43.7 tp -57.98 -32.81 68.24 Favored 'General case' 0 N--CA 1.49 1.542 0 O-C-N 121.293 -0.879 . . . . 0.0 109.26 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 42.8 ttp180 -59.88 -25.16 64.85 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.27 -0.894 . . . . 0.0 109.241 179.114 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 59.6 t0 -83.91 8.21 15.75 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.445 -0.785 . . . . 0.0 109.61 -179.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 16.1 t0 -117.95 85.32 22.96 Favored Pre-proline 0 N--CA 1.492 1.653 0 O-C-N 121.45 -0.781 . . . . 0.0 109.222 -179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_exo -51.74 -23.81 16.54 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.696 2.264 . . . . 0.0 112.35 -179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 88.2 p -58.52 -30.01 66.74 Favored 'General case' 0 C--N 1.301 -1.532 0 O-C-N 120.852 -1.155 . . . . 0.0 109.852 -179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.479 HG21 HD21 ' A' ' 119' ' ' LEU . 73.2 m -80.44 -52.81 7.22 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.019 -1.051 . . . . 0.0 110.009 179.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.46 HG23 ' H ' ' A' ' 126' ' ' ILE . 2.6 pt -56.51 -20.67 11.29 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.684 0 O-C-N 121.167 -0.958 . . . . 0.0 109.31 -178.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -63.34 -50.38 70.23 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.263 -0.898 . . . . 0.0 108.701 179.325 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 51.5 tttp -56.49 -31.29 63.91 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.345 -0.847 . . . . 0.0 109.734 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 70.2 mt -75.04 -36.04 61.87 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.177 -0.952 . . . . 0.0 109.074 179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.01 -38.82 53.66 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.563 -0.711 . . . . 0.0 109.864 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 33.4 tttm -59.68 -36.29 76.17 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.018 -1.051 . . . . 0.0 109.276 179.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 79.0 m-20 -84.13 8.14 16.53 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.394 -0.816 . . . . 0.0 109.614 -179.786 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 32.4 mmtp 55.95 34.96 24.63 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.327 -0.858 . . . . 0.0 109.35 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.624 ' NE2' ' CG ' ' A' ' 87' ' ' PRO . 56.9 tt0 -127.4 121.12 30.05 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.386 -0.821 . . . . 0.0 108.811 -179.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -92.79 156.49 40.76 Favored Pre-proline 0 C--N 1.3 -1.58 0 O-C-N 121.41 -0.806 . . . . 0.0 110.058 -179.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -65.17 160.35 42.44 Favored 'Trans proline' 0 N--CA 1.496 1.62 0 C-N-CA 123.118 2.545 . . . . 0.0 112.057 179.558 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.639 HG21 ' CE1' ' A' ' 90' ' ' PHE . 26.8 mm -97.46 126.04 50.42 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.125 -0.984 . . . . 0.0 109.389 -179.771 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -78.36 155.69 79.03 Favored Pre-proline 0 N--CA 1.489 1.492 0 O-C-N 121.352 -0.843 . . . . 0.0 109.422 -179.595 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 11.0 Cg_endo -57.39 -34.48 98.0 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.433 2.089 . . . . 0.0 111.619 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.9 tt0 -59.44 -37.22 77.55 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 121.309 -0.869 . . . . 0.0 108.871 179.475 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 34.0 m -67.4 -32.82 73.98 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.398 -0.814 . . . . 0.0 109.006 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -74.96 -39.71 61.16 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.418 -0.801 . . . . 0.0 109.72 179.56 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 84.7 tt0 -59.41 -32.31 70.06 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.204 -0.935 . . . . 0.0 110.107 -179.5 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.474 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 69.4 tttt -61.86 -38.82 89.67 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 120.956 -1.09 . . . . 0.0 109.651 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.531 HD11 ' CE2' ' A' ' 90' ' ' PHE . 60.1 mt -63.41 -34.64 78.18 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.362 -0.836 . . . . 0.0 110.136 -179.756 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -64.62 -45.01 88.72 Favored 'General case' 0 C--N 1.303 -1.452 0 O-C-N 120.993 -1.067 . . . . 0.0 108.741 179.872 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 96.5 mtt180 -86.06 8.44 20.74 Favored 'General case' 0 C--N 1.304 -1.402 0 O-C-N 121.35 -0.844 . . . . 0.0 110.121 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.474 ' OD1' ' O ' ' A' ' 144' ' ' LYS . 90.3 m-20 -84.22 -24.6 29.97 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.794 -1.191 . . . . 0.0 108.847 178.513 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 74.8 mt -121.07 -104.0 0.4 Allowed 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.628 -0.67 . . . . 0.0 109.275 179.669 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 95.5 mttt -145.71 43.72 1.27 Allowed 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.137 -0.977 . . . . 0.0 109.802 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -69.06 141.76 54.69 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.16 -0.962 . . . . 0.0 109.342 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.715 HG12 ' HG3' ' A' ' 153' ' ' LYS . 59.8 t -75.23 -65.66 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.266 -0.896 . . . . 0.0 110.113 -179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.715 ' HG3' HG12 ' A' ' 152' ' ' VAL . 67.6 mttt -145.67 160.37 41.79 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.132 -0.98 . . . . 0.0 110.418 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 31.3 p90 -131.28 150.5 52.12 Favored 'General case' 0 N--CA 1.492 1.665 0 N-CA-C 108.842 -0.799 . . . . 0.0 108.842 179.193 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 35.3 m -142.55 154.09 17.93 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 121.037 -1.039 . . . . 0.0 110.138 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -109.66 133.94 52.54 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 178.918 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -132.53 140.21 48.22 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.184 -0.947 . . . . 0.0 111.025 -178.458 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.494 ' O ' ' O ' ' A' ' 161' ' ' THR . 39.9 t -106.89 105.58 15.69 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.44 -0.787 . . . . 0.0 109.036 179.333 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . . . . . . . . . . . -71.59 -34.82 70.23 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.739 -0.601 . . . . 0.0 109.558 179.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 41.7 tp -50.91 -31.01 16.26 Favored 'General case' 0 N--CA 1.488 1.435 0 N-CA-C 108.561 -0.903 . . . . 0.0 108.561 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.509 ' C ' ' H ' ' A' ' 163' ' ' LYS . 18.7 p -123.84 162.45 23.23 Favored 'General case' 0 C--N 1.304 -1.4 0 N-CA-C 108.196 -1.038 . . . . 0.0 108.196 179.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . . . . . . . . . 92.4 mt-30 -68.09 12.32 0.12 Allowed 'General case' 0 C--N 1.288 -2.091 0 O-C-N 121.553 -0.717 . . . . 0.0 109.344 -179.803 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.509 ' H ' ' C ' ' A' ' 161' ' ' THR . 67.7 mttm -88.11 2.28 52.37 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.144 -0.972 . . . . 0.0 109.684 -179.548 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.72 -51.52 2.12 Favored Glycine 0 N--CA 1.488 2.106 0 N-CA-C 109.897 -1.281 . . . . 0.0 109.897 -179.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . . . . . . . . . 80.8 mt -70.48 -40.64 73.49 Favored 'General case' 0 N--CA 1.49 1.537 0 O-C-N 121.115 -1.226 . . . . 0.0 109.936 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.5 mttm -61.23 -29.94 70.14 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.382 -0.824 . . . . 0.0 110.407 -179.503 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 19.6 t-20 -71.72 -50.95 25.56 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.134 -0.979 . . . . 0.0 109.523 179.799 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . . . . . . . . . 23.1 m -80.35 -4.37 7.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.653 0 O-C-N 121.48 -0.763 . . . . 0.0 110.566 -179.184 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -73.81 -50.17 21.72 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 120.81 -1.181 . . . . 0.0 110.052 179.817 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 88.7 m-20 -62.92 -42.39 99.78 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.168 -0.958 . . . . 0.0 110.246 -179.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 77.4 mm-40 -66.36 -34.68 78.51 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.12 -0.988 . . . . 0.0 110.023 -179.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.84 -32.9 74.57 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.196 -0.94 . . . . 0.0 110.568 -179.156 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . . . . . . . . . 80.0 mt -68.6 -41.48 82.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 O-C-N 120.899 -1.126 . . . . 0.0 110.392 -179.629 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 82.2 mt -57.77 -41.72 82.58 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.122 -0.987 . . . . 0.0 110.223 -179.004 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -63.69 -34.15 77.22 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 120.961 -1.087 . . . . 0.0 110.128 -179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -58.53 -45.22 89.31 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.023 -1.048 . . . . 0.0 110.094 -179.225 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 72.5 mt -65.23 -37.63 87.87 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.997 -1.064 . . . . 0.0 109.387 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 95.6 mt-10 . . . . . 0 N--CA 1.49 1.574 0 O-C-N 121.249 -0.907 . . . . 99.989999999999995 109.461 -179.85 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 91.6 mmm . . . . . 0 N--CA 1.491 1.615 0 N-CA-C 109.354 -0.61 . . . . 0.0 109.354 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . . . . . . . . . 94.0 mt-30 -120.57 152.09 38.56 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.506 -0.746 . . . . 0.0 109.487 179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.7 t -135.6 157.48 46.76 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.337 -0.852 . . . . 0.0 109.357 179.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . . . . . . . . . 60.8 mt -118.8 120.8 65.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 179.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 39.2 tptt -81.62 128.35 33.85 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.218 -0.926 . . . . 0.0 109.307 -179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.8 t -132.89 115.57 15.41 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.426 -0.796 . . . . 0.0 109.329 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 41.6 t -109.72 132.22 58.53 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.494 0 O-C-N 121.336 -0.852 . . . . 0.0 109.316 179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.58 HG11 HD21 ' A' ' 20' ' ' LEU . 7.9 p -128.05 142.97 42.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 121.404 -0.81 . . . . 0.0 109.674 -179.453 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . . . . . . . . . 14.7 p -147.99 145.43 18.67 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.422 0 O-C-N 121.29 -0.881 . . . . 0.0 108.983 179.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -134.64 171.94 22.12 Favored Glycine 0 N--CA 1.491 2.366 0 N-CA-C 109.907 -1.277 . . . . 0.0 109.907 -179.768 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.529 ' O ' ' C ' ' A' ' 12' ' ' GLY . 59.1 t0 -74.04 134.03 42.97 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.303 -1.116 . . . . 0.0 109.128 179.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' C ' ' O ' ' A' ' 11' ' ' ASP . . . -27.77 -75.81 0.02 OUTLIER Glycine 0 N--CA 1.499 2.855 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.322 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.41 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . -41.4 -37.32 1.01 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.023 -1.281 . . . . 0.0 110.567 -178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.502 ' N ' ' O ' ' A' ' 11' ' ' ASP . 58.1 t -69.3 123.97 24.09 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.458 0 O-C-N 120.671 -1.268 . . . . 0.0 109.028 179.942 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . -64.01 73.75 0.05 OUTLIER Glycine 0 N--CA 1.491 2.309 0 N-CA-C 109.593 -1.403 . . . . 0.0 109.593 -179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.491 ' N ' ' O ' ' A' ' 14' ' ' VAL . 18.1 pttp -61.26 -33.62 73.83 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.242 -1.152 . . . . 0.0 109.528 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 45.4 p -70.38 -42.0 72.32 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.235 -0.916 . . . . 0.0 109.633 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 84.1 m -60.39 -25.99 66.32 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.149 -0.969 . . . . 0.0 110.009 -179.731 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.406 HD12 ' HA ' ' A' ' 19' ' ' LEU . 44.4 tp -66.72 -39.77 88.15 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.121 -0.987 . . . . 0.0 109.387 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.58 HD21 HG11 ' A' ' 8' ' ' VAL . 70.1 mt -64.94 -42.23 94.83 Favored 'General case' 0 N--CA 1.488 1.469 0 O-C-N 121.269 -0.894 . . . . 0.0 109.538 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . . . . . . . . . 2.6 mm -70.14 -49.02 58.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 121.334 -0.854 . . . . 0.0 109.713 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 19.2 m -57.26 -36.66 71.27 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.121 -0.987 . . . . 0.0 109.5 -179.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . . . . . . . . . 87.1 t80 -77.74 -44.49 27.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.261 -0.899 . . . . 0.0 110.206 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 49.1 m -65.79 -47.6 74.61 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.201 -0.937 . . . . 0.0 110.108 -179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 59.8 p -84.48 -19.5 33.22 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.162 -0.961 . . . . 0.0 109.711 -179.834 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 53.5 t30 59.82 36.76 22.07 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.245 -0.909 . . . . 0.0 109.366 -179.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 14.3 tptt -141.23 82.54 1.83 Allowed 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.27 -0.894 . . . . 0.0 109.467 -179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.664 ' CE2' ' NE2' ' A' ' 162' ' ' GLN . 0.0 OUTLIER -55.28 -44.25 99.53 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.343 -0.848 . . . . 0.0 109.202 179.712 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.585 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 33.5 Cg_exo -56.48 -15.83 16.65 Favored 'Trans proline' 0 N--CA 1.493 1.469 0 C-N-CA 122.28 1.987 . . . . 0.0 111.748 179.676 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.549 ' O ' ' N ' ' A' ' 32' ' ' TYR . 95.6 p -59.86 -34.18 72.79 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.347 -0.846 . . . . 0.0 108.995 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 30' ' ' SER . 95.3 mt-10 37.68 26.28 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.648 -0.657 . . . . 0.0 110.321 179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.549 ' N ' ' O ' ' A' ' 30' ' ' SER . 2.2 m-85 -83.76 -95.32 0.06 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.019 -1.051 . . . . 0.0 109.279 179.815 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.726 HG22 ' O ' ' A' ' 33' ' ' VAL . 6.4 p 36.52 57.76 3.41 Favored Pre-proline 0 N--CA 1.494 1.771 0 O-C-N 121.445 -0.784 . . . . 0.0 110.964 179.706 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -70.77 -18.46 32.23 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 C-N-CA 122.815 2.344 . . . . 0.0 112.08 179.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ALA . . . . . . . . . . . . . . . -166.47 -172.68 2.26 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.343 -0.848 . . . . 0.0 109.329 -179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . . . . . . . . . 11.6 p -133.28 140.66 46.5 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.635 0 O-C-N 121.347 -0.846 . . . . 0.0 109.199 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . . . . . . . . . 98.7 m-85 -107.16 -90.06 0.44 Allowed 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.333 -0.855 . . . . 0.0 109.623 179.945 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 38' ' ' ASP . 53.7 p30 -138.15 -173.39 3.51 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.213 -0.929 . . . . 0.0 109.904 -179.686 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . . . . . . . . . 29.3 m120 -67.33 149.23 50.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.282 -0.886 . . . . 0.0 109.831 -179.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 91.0 m-85 -118.13 146.71 43.97 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.53 -0.732 . . . . 0.0 109.204 179.793 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -107.54 137.25 45.91 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.224 -0.923 . . . . 0.0 109.148 179.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 39.2 t -130.4 138.81 52.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.276 -0.89 . . . . 0.0 109.861 -179.681 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . . . . . . . . . 57.4 m -93.3 133.94 36.01 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.168 -0.958 . . . . 0.0 109.284 179.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 45.1 t -120.36 135.06 61.82 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.724 0 O-C-N 121.381 -0.824 . . . . 0.0 109.731 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . . . . . . . . . 70.9 mtm -93.57 130.59 39.41 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.24 -0.913 . . . . 0.0 109.316 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' O ' ' N ' ' A' ' 48' ' ' GLY . 68.5 mt -132.8 126.82 54.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.265 -0.897 . . . . 0.0 109.151 179.264 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.438 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 43.54 17.9 0.06 OUTLIER Glycine 0 N--CA 1.49 2.268 0 N-CA-C 109.73 -1.348 . . . . 0.0 109.73 179.777 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.563 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.15 13.87 58.26 Favored Glycine 0 N--CA 1.494 2.552 0 N-CA-C 110.057 -1.217 . . . . 0.0 110.057 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.598 ' O ' ' CD2' ' A' ' 51' ' ' TYR . 11.3 mt-10 -119.61 85.86 33.55 Favored Pre-proline 0 N--CA 1.494 1.731 0 O-C-N 121.414 -1.051 . . . . 0.0 109.282 -179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_exo -53.7 125.66 19.34 Favored 'Trans proline' 0 N--CA 1.495 1.593 0 C-N-CA 122.681 2.254 . . . . 0.0 113.195 -179.393 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 49' ' ' GLU . 91.3 m-85 -121.61 143.22 49.44 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.6 -0.688 . . . . 0.0 109.232 179.347 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 62.5 m -76.03 131.25 39.4 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.201 -0.937 . . . . 0.0 109.32 179.85 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 36.8 tp -128.1 129.6 46.86 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.346 -0.847 . . . . 0.0 109.57 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.79 143.45 14.64 Favored Glycine 0 N--CA 1.493 2.448 0 N-CA-C 109.562 -1.415 . . . . 0.0 109.562 179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 53.0 mt -107.17 132.24 53.26 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.353 -1.087 . . . . 0.0 109.407 179.829 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 98.3 m-85 -118.09 131.28 56.45 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.405 -0.809 . . . . 0.0 109.774 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.439 ' C ' ' OD1' ' A' ' 57' ' ' ASP . 53.8 p30 -136.19 172.38 13.1 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.381 -0.824 . . . . 0.0 109.773 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 52.2 m -71.5 138.25 48.79 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.362 -0.837 . . . . 0.0 109.59 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . . . . . . . . . . . -159.79 52.15 0.34 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.193 -0.942 . . . . 0.0 109.596 179.954 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 64.39 -127.63 34.93 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.641 -1.384 . . . . 0.0 109.641 179.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 90.0 mt-30 57.05 39.68 29.07 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.41 -1.053 . . . . 0.0 109.786 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . . . . . . . . . 85.5 tt0 -79.8 -41.74 25.84 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.153 -0.967 . . . . 0.0 109.405 179.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.458 ' C ' ' OD1' ' A' ' 63' ' ' ASP . 51.9 p30 -85.43 14.09 5.9 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.5 -0.75 . . . . 0.0 110.435 -178.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.419 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 0.3 OUTLIER -84.29 5.53 26.42 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 120.918 -1.114 . . . . 0.0 109.176 179.722 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.419 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.2 t0 73.59 12.32 4.61 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.528 -0.733 . . . . 0.0 109.426 -179.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 67.0 ttt180 -58.14 -32.47 68.19 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.411 -0.805 . . . . 0.0 109.293 179.651 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.436 ' O ' ' O ' ' A' ' 68' ' ' ARG . 49.4 mt -58.8 172.76 0.49 Allowed 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.464 -0.772 . . . . 0.0 109.859 -179.6 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.545 ' C ' ' H ' ' A' ' 70' ' ' LEU . 1.6 mmt180 61.06 146.94 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.567 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.116 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.458 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 15.9 Cg_endo -60.34 26.73 0.04 OUTLIER 'Trans proline' 0 C--N 1.309 -1.515 0 C-N-CA 122.404 2.069 . . . . 0.0 112.326 -179.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.545 ' H ' ' C ' ' A' ' 68' ' ' ARG . 15.2 tp -51.71 -61.5 2.21 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.069 -1.019 . . . . 0.0 109.119 -179.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 55.7 p -85.63 -3.61 58.93 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.316 -0.865 . . . . 0.0 109.635 -179.948 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.458 ' CD1' ' O ' ' A' ' 69' ' ' PRO . 7.8 m-85 58.33 58.57 6.35 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.301 -0.875 . . . . 0.0 109.769 -179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -61.9 147.26 95.58 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 122.539 2.159 . . . . 0.0 111.841 179.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 13.9 pt20 -141.5 160.65 39.7 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.228 -0.92 . . . . 0.0 109.613 -179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 76' ' ' ASP . 5.1 p -126.03 153.95 43.66 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.506 -0.746 . . . . 0.0 109.372 179.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.502 ' OD1' ' O ' ' A' ' 75' ' ' THR . 90.5 m-20 -138.21 -41.61 0.52 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.225 -0.922 . . . . 0.0 109.718 179.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . . . . . . . . . 46.6 t -135.02 132.32 53.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 121.316 -0.865 . . . . 0.0 110.0 -179.865 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . . . . . . . . . 94.9 m-85 -108.43 126.95 53.47 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.277 -0.89 . . . . 0.0 109.142 179.274 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . . . . . . . . . 38.3 tp -118.53 126.37 51.86 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.334 -0.854 . . . . 0.0 109.546 179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . . . . . . . . . 24.1 t -132.86 138.68 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.231 -0.918 . . . . 0.0 109.263 179.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -128.3 133.84 48.81 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.255 -0.903 . . . . 0.0 109.542 179.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.515 ' CG ' HG21 ' A' ' 93' ' ' VAL . 31.6 p90 -138.45 158.47 44.22 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.252 -0.905 . . . . 0.0 109.379 179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 67.3 m -77.24 138.74 39.6 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.15 -0.969 . . . . 0.0 109.377 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 12.6 p -90.49 -18.07 7.69 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.143 -0.973 . . . . 0.0 110.364 -179.77 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.551 HG12 ' O ' ' A' ' 85' ' ' VAL . 61.1 t -85.8 -8.19 11.08 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.09 -1.006 . . . . 0.0 110.374 -179.573 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 3.3 m -103.09 107.07 54.02 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 121.088 -1.008 . . . . 0.0 109.976 -179.319 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -52.18 -49.08 18.55 Favored 'Trans proline' 0 N--CA 1.492 1.41 0 C-N-CA 122.032 1.822 . . . . 0.0 112.005 179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 23.2 m -58.71 -39.56 81.16 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.244 -0.91 . . . . 0.0 108.95 179.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.756 ' O ' HG23 ' A' ' 93' ' ' VAL . 25.9 t -62.86 -21.74 66.18 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.472 -0.768 . . . . 0.0 109.029 179.447 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 49.2 t80 -74.43 -50.05 19.98 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.396 -0.815 . . . . 0.0 109.163 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 49.5 tp10 -66.07 -39.2 89.86 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.279 -0.888 . . . . 0.0 109.481 179.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 84.3 m-20 -57.01 -32.91 66.63 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.293 -0.879 . . . . 0.0 109.214 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.756 HG23 ' O ' ' A' ' 89' ' ' SER . 71.8 t -60.91 -37.39 76.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.342 -0.849 . . . . 0.0 109.787 -179.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . . . . . . . . . 33.4 mtmt -94.31 -11.06 30.85 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.012 -1.055 . . . . 0.0 110.229 -179.645 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 83.9 tt0 -73.74 -33.61 64.39 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 120.646 -1.283 . . . . 0.0 111.493 -178.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 98.5 mttt -113.47 -41.9 3.57 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.136 -0.977 . . . . 0.0 112.25 -178.783 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 7.3 m95 -82.12 0.84 38.88 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.094 -1.004 . . . . 0.0 112.836 -176.633 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.592 ' H ' ' CD ' ' A' ' 99' ' ' PRO . 1.2 t -108.22 -42.75 0.12 Allowed Pre-proline 0 N--CA 1.499 1.988 0 O-C-N 120.49 -1.381 . . . . 0.0 110.414 179.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.592 ' CD ' ' H ' ' A' ' 98' ' ' VAL . 42.9 Cg_endo -93.71 -59.21 0.01 OUTLIER 'Trans proline' 0 C--N 1.309 -1.514 0 C-N-CA 123.211 2.608 . . . . 0.0 112.468 -179.787 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 84.1 tt0 -62.3 -29.7 70.62 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.39 -0.819 . . . . 0.0 109.583 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.619 ' CG1' ' CE1' ' A' ' 110' ' ' PHE . 8.0 tp -54.08 -26.59 15.05 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 O-C-N 121.311 -0.868 . . . . 0.0 109.594 -179.542 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 46.5 m -58.85 -37.93 77.59 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.172 -0.955 . . . . 0.0 109.759 179.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 64.3 m170 -53.29 -40.57 64.84 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.253 -0.905 . . . . 0.0 109.867 -179.6 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.436 ' O ' ' SG ' ' A' ' 105' ' ' CYS . 65.7 m170 -55.17 -36.17 65.57 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.124 -0.985 . . . . 0.0 109.262 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.436 ' SG ' ' O ' ' A' ' 104' ' ' HIS . 0.7 OUTLIER 168.73 154.0 0.14 Allowed Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 121.378 -0.826 . . . . 0.0 109.214 179.921 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 13.6 Cg_endo -60.63 -33.0 93.94 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.523 2.148 . . . . 0.0 111.92 179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 24.9 pttm -139.83 137.51 35.01 Favored 'General case' 0 N--CA 1.49 1.559 0 O-C-N 121.441 -0.787 . . . . 0.0 109.424 179.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.534 ' O ' ' CE2' ' A' ' 110' ' ' PHE . 0.0 OUTLIER -177.37 139.64 0.43 Allowed Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.183 -0.948 . . . . 0.0 109.303 179.701 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 37.5 Cg_endo -69.71 125.37 12.1 Favored 'Trans proline' 0 N--CA 1.494 1.515 0 C-N-CA 122.191 1.928 . . . . 0.0 112.202 179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.619 ' CE1' ' CG1' ' A' ' 101' ' ' ILE . 86.8 m-85 -116.53 138.92 51.03 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.408 -0.808 . . . . 0.0 109.024 179.606 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.539 ' N ' HD12 ' A' ' 111' ' ' LEU . 6.6 mp -114.89 121.2 42.5 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.454 -0.778 . . . . 0.0 110.035 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . . . . . . . . . 62.7 mt -110.92 125.18 53.39 Favored 'General case' 0 N--CA 1.49 1.544 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 178.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.765 HG11 HG22 ' A' ' 168' ' ' VAL . 36.0 t -117.1 138.59 47.27 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.14 -0.975 . . . . 0.0 110.977 -178.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -93.4 122.1 6.86 Favored Glycine 0 N--CA 1.488 2.147 0 N-CA-C 108.257 -1.937 . . . . 0.0 108.257 178.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . . . . . . . . . 8.9 t -114.33 167.35 10.78 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.304 -1.115 . . . . 0.0 110.618 -178.518 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 93.3 mt-30 58.74 39.37 24.33 Favored 'General case' 0 N--CA 1.492 1.674 0 CA-C-O 120.972 0.415 . . . . 0.0 110.18 -179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . . . . . . . . . 17.7 pt -73.51 -7.18 9.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 120.969 -1.082 . . . . 0.0 109.873 179.833 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.476 ' O ' ' OD2' ' A' ' 121' ' ' ASP . 53.8 p30 -83.69 -3.08 57.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.163 -0.961 . . . . 0.0 109.345 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.455 ' HG ' HG21 ' A' ' 125' ' ' THR . 30.2 tp -78.29 -27.27 47.33 Favored 'General case' 0 C--N 1.302 -1.49 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 178.739 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . . . . . . . . . 44.4 ttp180 -84.94 93.3 8.52 Favored 'General case' 0 C--N 1.307 -1.282 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 178.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.523 ' N ' ' OD1' ' A' ' 121' ' ' ASP . 2.4 p30 169.04 -49.45 0.01 OUTLIER 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -68.1 141.44 94.13 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 121.546 -0.721 . . . . 0.0 109.234 179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.52 -31.1 27.86 Favored 'Trans proline' 0 N--CA 1.493 1.472 0 C-N-CA 122.248 1.966 . . . . 0.0 112.223 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 28.7 m -54.3 -33.1 58.02 Favored 'General case' 0 C--N 1.3 -1.569 0 O-C-N 121.061 -1.024 . . . . 0.0 110.29 -179.231 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.455 HG21 ' HG ' ' A' ' 119' ' ' LEU . 56.7 p -79.49 -51.11 9.77 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.983 -1.073 . . . . 0.0 111.012 -179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . . . . . . . . . 15.4 tt -60.15 -29.77 44.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 120.817 -1.177 . . . . 0.0 110.333 -178.663 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 98.6 mt-10 -71.32 -50.09 35.94 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.041 -1.037 . . . . 0.0 109.663 179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 68.2 mttm -61.17 -35.19 76.45 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.258 -0.901 . . . . 0.0 109.921 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . . . . . . . . . 93.6 mt -74.42 -39.25 62.74 Favored 'General case' 0 N--CA 1.492 1.646 0 O-C-N 121.083 -1.01 . . . . 0.0 108.891 179.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -51.11 -35.92 37.82 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.727 -0.608 . . . . 0.0 109.486 -179.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 58.2 mttm -59.69 -34.97 73.57 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.081 -1.012 . . . . 0.0 109.143 179.577 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -86.54 7.35 26.55 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.504 -0.748 . . . . 0.0 109.621 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 35.5 mttt 56.88 37.02 28.53 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 121.46 -0.775 . . . . 0.0 109.823 179.767 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 94.3 mt-30 -136.83 136.12 38.52 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.11 -0.994 . . . . 0.0 109.118 179.475 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 6.5 mttm -116.89 157.76 45.57 Favored Pre-proline 0 C--N 1.297 -1.703 0 N-CA-C 109.137 -0.69 . . . . 0.0 109.137 179.739 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 8.4 Cg_endo -53.01 155.84 10.69 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.836 2.357 . . . . 0.0 111.909 179.886 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 68.3 mt -98.57 142.85 14.03 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.149 -0.969 . . . . 0.0 109.637 -179.738 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -81.2 158.49 69.53 Favored Pre-proline 0 N--CA 1.49 1.531 0 O-C-N 121.366 -0.833 . . . . 0.0 109.65 -179.554 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -60.83 -23.05 75.8 Favored 'Trans proline' 0 C--N 1.304 -1.78 0 C-N-CA 122.684 2.256 . . . . 0.0 111.522 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 84.2 tt0 -61.98 -38.59 89.16 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.42 -0.8 . . . . 0.0 109.524 179.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 26.2 m -63.67 -36.01 82.41 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.18 -0.95 . . . . 0.0 109.418 179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -75.33 -39.4 59.45 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.297 -0.877 . . . . 0.0 110.007 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 85.9 tt0 -59.32 -34.68 72.63 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.043 -1.035 . . . . 0.0 111.081 -178.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 20.5 mttp -61.94 -36.24 80.82 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.706 -1.247 . . . . 0.0 109.425 -179.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 35.6 tp -60.06 -36.09 76.56 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.396 -0.815 . . . . 0.0 110.085 -179.72 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.713 ' HB1' ' O ' ' A' ' 152' ' ' VAL . . . -81.12 -51.81 8.05 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.922 -1.111 . . . . 0.0 110.561 -179.131 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 63.0 ttt180 -65.01 -1.86 2.34 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.263 -0.898 . . . . 0.0 110.286 -178.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 61.0 t0 -110.21 -24.0 10.93 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.083 -1.011 . . . . 0.0 110.007 179.722 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . . . . . . . . . 92.3 mt -97.97 16.01 22.28 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.087 -1.008 . . . . 0.0 111.733 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.723 ' O ' ' HB2' ' A' ' 151' ' ' ALA . 59.3 mttp 56.89 36.16 27.35 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.322 -1.486 . . . . 0.0 111.318 178.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.723 ' HB2' ' O ' ' A' ' 150' ' ' LYS . . . 165.93 -161.55 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.774 -1.204 . . . . 0.0 109.62 -179.839 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.713 ' O ' ' HB1' ' A' ' 146' ' ' ALA . 71.8 t 59.35 132.57 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.584 0 CA-C-O 122.262 1.029 . . . . 0.0 109.561 -179.058 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 68.4 mttm -129.46 149.33 51.29 Favored 'General case' 0 C--N 1.293 -1.887 0 N-CA-C 108.258 -1.016 . . . . 0.0 108.258 178.866 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -122.17 143.65 49.43 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.03 -1.044 . . . . 0.0 109.85 -179.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 25.7 t -138.36 147.01 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.512 0 O-C-N 121.36 -0.837 . . . . 0.0 109.431 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 96.0 mt-10 -97.33 120.89 38.53 Favored 'General case' 0 N--CA 1.492 1.626 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 178.86 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.447 ' SG ' ' CA ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -131.04 141.1 50.17 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.16 -0.962 . . . . 0.0 110.932 -178.449 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.498 ' O ' ' O ' ' A' ' 161' ' ' THR . 29.5 t -111.62 102.8 11.09 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.666 -0.864 . . . . 0.0 108.666 179.152 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.526 ' O ' ' CD2' ' A' ' 28' ' ' PHE . . . -70.18 -28.69 65.51 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.785 -0.572 . . . . 0.0 109.817 -179.717 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.623 ' H ' HD12 ' A' ' 160' ' ' LEU . 6.3 mp -61.56 -25.92 67.62 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 108.521 -0.918 . . . . 0.0 108.521 179.481 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.544 ' C ' ' H ' ' A' ' 163' ' ' LYS . 21.2 m -123.86 160.52 27.26 Favored 'General case' 0 C--N 1.304 -1.385 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.664 ' NE2' ' CE2' ' A' ' 28' ' ' PHE . 89.5 mm-40 -65.41 11.47 0.06 Allowed 'General case' 0 C--N 1.289 -2.049 0 O-C-N 121.496 -0.753 . . . . 0.0 109.628 -179.799 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.544 ' H ' ' C ' ' A' ' 161' ' ' THR . 97.7 mttt -94.01 5.13 52.69 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.019 -1.051 . . . . 0.0 110.053 -179.207 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.447 ' CA ' ' SG ' ' A' ' 157' ' ' CYS . . . -101.58 -51.14 1.14 Allowed Glycine 0 N--CA 1.492 2.387 0 C-N-CA 119.641 -1.266 . . . . 0.0 110.274 -179.647 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.673 ' N ' HD12 ' A' ' 165' ' ' LEU . 8.1 mp -63.35 -42.02 98.88 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.219 -1.165 . . . . 0.0 110.267 -179.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 24.0 mttt -58.81 -30.37 67.57 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.206 -0.934 . . . . 0.0 110.216 -179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 3.6 m120 -85.67 -50.07 7.48 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.156 -0.965 . . . . 0.0 109.373 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.765 HG22 HG11 ' A' ' 113' ' ' VAL . 71.5 t -62.24 -34.8 65.8 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.581 0 O-C-N 121.472 -0.768 . . . . 0.0 110.303 -179.59 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.858 ' CE2' HD11 ' A' ' 173' ' ' ILE . 68.3 t80 -68.71 -49.01 62.3 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.139 -0.976 . . . . 0.0 110.285 -179.593 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -59.54 -43.82 93.39 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.125 -0.985 . . . . 0.0 110.612 -179.045 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 49.0 tp10 -69.03 -45.13 71.25 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.076 -1.015 . . . . 0.0 110.262 -179.245 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -53.62 -35.96 61.48 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.103 -0.998 . . . . 0.0 110.408 -178.661 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.858 HD11 ' CE2' ' A' ' 169' ' ' PHE . 95.0 mt -68.9 -36.7 75.32 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.573 0 O-C-N 120.831 -1.168 . . . . 0.0 110.482 -179.768 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 40.8 tp -53.55 -51.33 63.25 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 120.972 -1.08 . . . . 0.0 110.259 -178.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -62.3 -30.5 71.18 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.933 -1.104 . . . . 0.0 110.079 -179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . . . . . . . . . . . -54.2 -39.39 66.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.145 -0.972 . . . . 0.0 109.758 -179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.589 ' N ' HD22 ' A' ' 177' ' ' LEU . 3.6 mm? -63.02 -35.54 80.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 120.984 -1.073 . . . . 0.0 109.75 179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 96.3 mt-10 . . . . . 0 N--CA 1.49 1.53 0 O-C-N 121.262 -0.899 . . . . 99.989999999999995 109.561 -179.906 . . . . . . . . 0 0 . 1 stop_ save_